var eee= [ { "ID": "1", "Trade_Name": "LIGNOSOL AEROSOL SPRAY 50 GM", "Generic_Name": "CETRIMIDE+LIDOCAINE", "Price": "18", "Price_Old": "18", "Company": "ARAB CENTER > ADM FOR TRADING & PROJECTS-EGYPT", "Pharmacology": "TOPICAL ANAESTHETIC", "Category": "مخ#~#^ مو#_#>ي", "Use": "–#?خ#<ي#< #.ل#.م #.ل#?ه#.#% #.ل#.سن#.ن . \r\n\r\n–مخ#~#^ ل#.ل#?ه#.#%#.#? #?ق#^ح#.#? #.ل#<م . \r\n\r\n–مخ#~#^ ق#%ل #.ل#>ملي#.#? #.لج#^#.حية . \r\n\r\n–مخ#~#^ ل#?خ#<ي#< #.لم #.لح#^وق ول#~غ#.#? #.لحش#^#.#? .", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من #.ل#?ه#.#% #.و #>#~وي #<ي #.لمن#-قة #.لم#^#.#~ #?خ#~ي#^ه#. ي#^جي #.س#?ش#.#^ة #.ل#-#%ي#% .", "GI": "IS USED TO OBTAIN A LOCAL ANAESTHESIA OF THE\r\nLINING OF THE INSIDE OF THE MOUTH (BUCCAL MUCOSA).\r\nIT CONTAINS TWO ACTIVE INGREDIENTS:\r\n\t LIDOCAINE, A LOCAL ANAESTHETIC, WHICH NUMBS THE PAINFUL\r\nAREA TEMPORARILY,\r\n\t CETRIMIDE, AN ANTISEPTIC, WHICH KILLS ANY MICRO ORGANISMS\r\nTHAT ARE PRESENT.\r\nLIGNOSOL SPRAY IS FOR CHILDREN OVER 4 YEARS OLD AND ADULTS.\r\nONLY A DENTIST CAN ADMINISTER THIS PRODUCT.", "Composition": "cetrimide 0.035g, lidocaine 5.05g", "Route": "SPRAY" }, { "ID": "2", "Trade_Name": "TRIVATRACIN AEROSOL POWDER", "Generic_Name": "BACITRACIN+NEOMYCIN+POLYMYXIN", "Price": "24", "Price_Old": "24", "Company": "EGYPTIAN CO. FOR ADV. PHARMA. (ECAP) > ACDIMA INTERNATIONAL TRADING", "Pharmacology": "ANTIBIOTIC TOPICAL", "Category": "م#_#.#~ حيوي مو#_#>ي", "Use": "–#.لقو#%#.ء \r\n\r\n–#.لج#^ي#%#.#? \r\n\r\n–#>#~وى #.لجل#~ حول #.ل#.ظ#.#<#^ \r\n\r\n–#.ل#.#=زيم#. #.لمص#.#%ة #%#.ل#%#=#?ي#^ي#. \r\n\r\n–#.لج#^وح #.لمص#.#%ة #%#.ل#%#=#?ي#^ي#. \r\n\r\n–#%#>#~ #.ز#.لة ش#>#^ #.لجسم \r\n\r\n–#%#>#~ #.ج#^#.ء#.#? #.لليز#^ #>لى #.لجل#~ \r\n\r\n–#>#~وى حول #.ل#<م \r\n\r\n–#.لج#^وح #.لس#-حية و#.ل#>ميقة \r\n\r\n–#.ل#~م#.مل و#.لخ#^#.#^يج \r\n\r\n–#%#>#_ ح#.ل#.#? ح#% #.لش#%#.#%", "Contraindications": "–هذ#. #.لمس#?ح#_#^ لل#.س#?#>م#.ل #.لخ#.#^جى #>لى #.لجل#~ #<ق#- \r\n\r\n–#?جن#% و#_#> #.و مل#.مسة #.ل#%خ#.خ لل#>ين \r\n\r\n–يمن#> #.س#?خ#~#.مه #>ن#~ وجو#~ حس#.سية من #.ى م#=ون من م#=ون#.#?ة #.ل#<#>#.لة \r\n\r\n–يمن#> #.س#?خ#~#.مة #.ثن#.ء #.لحمل و#.ل#^#_#.#>ة", "GI": "MECHANISM OF ACTION OF BACITRACIN\r\nBACITRACIN IS AN ANTIBIOTIC PRODUCED BY THE STRAIN OF BACILLUS SUBTILIS. IT ACTS BY INHIBITING BACTERIAL CELL WALL SYNTHESIS. IT IS ACTIVE AGAINST A VARIETY OF GRAM POSITIVE AND A FEW GRAM NEGATIVE ORGANISMS.\r\n\r\nMECHANISM OF ACTION OF NEOMYCIN\r\nAMINOGLYCOSIDES LIKE NEOMYCIN \\\"IRREVERSIBLY\\\" BIND TO SPECIFIC 30S-SUBUNIT PROTEINS AND 16S RRNA. SPECIFICALLY NEOMYCIN BINDS TO FOUR NUCLEOTIDES OF 16S RRNA AND A SINGLE AMINO ACID OF PROTEIN S12. THIS INTERFERES WITH DECODING SITE IN THE VICINITY OF NUCLEOTIDE 1400 IN 16S RRNA OF 30S SUBUNIT.\r\n\r\nMECHANISM OF ACTION OF POLYMYXIN B\r\nPOLYMYXIN B SULFATE HAS A BACTERICIDAL ACTION AGAINST ALMOST ALL GRAM-NEGATIVE BACILLI EXCEPT THE PROTEUS GROUP. POLYMYXIN B SULFATE INTERACTS WITH THE LIPOPOLYSACCHARIDE OF THE CYTOPLASMIC OUTER MEMBRANE OF GRAM-NEGATIVE BACTERIA, ALTERING MEMBRANE PERMEABILITY AND CAUSING CELL DEATH. IT DOES NOT NEED TO ENTER THE CELL.", "Composition": "bacitracin 10000i.u., polymyxin b sulfate 150000i.u., neomycin 500000i.u.", "Route": "SPRAY" }, { "ID": "3", "Trade_Name": "BIVATRACIN AEROSOL POWDER 150 GM", "Generic_Name": "BACITRACIN+NEOMYCIN", "Price": "36", "Price_Old": "24", "Company": "EGYPTIAN CO. FOR ADV. PHARMA. (ECAP) > ACDIMA INTERNATIONAL TRADING", "Pharmacology": "ANTIBIOTIC TOPICAL", "Category": "م#_#.#~ حيوي مو#_#>ي", "Use": "–#.لإ#=زيم#.. \r\n\r\n–#.لحص#< #.لجل#~ي ل#~ى #.ل#=#%#.#^. \r\n\r\n–#.لح#=ة #.لجل#~ية #.لمص#.ح#%ة #%#~م. \r\n\r\n–#.ل#%#=#?ي#^ي#. #.ل#_#.#^ة #.ل#?ي #?صي#% #.لجل#~. \r\n\r\n–#.لح#%و#% #%#=#.#<ة أنو#.#>ه#.. \r\n\r\n–#?قليل #.لآلم #<ي #.لمن#-قة #.لمص#.#%ة. \r\n\r\n–#.لح#%و#% #%#.لمن#-قة #.لحس#.سة. \r\n\r\n–#.لح#%و#% #.لث#.نوية. \r\n\r\n–#.لح#%و#% #.لظ#.ه#^ة #<ي #<#^وة #.ل#^أس. \r\n\r\n–#.لخ#^#.ج #.لجل#~ي.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #>لى #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي #<#?ح#.#? #.لأن#< و#.ل#<م. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة. \r\n\r\n–يج#% #.ل#.ل#?ز#.م #%#.لج#^#>ة #.لمح#~#~ة و#>#~م #.لإ#<#^#.#- #<يه#.. \r\n\r\n–#<#?#^ة #.لحمل. \r\n\r\n–حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء.", "GI": "Mechanism of Action of Bacitracin\r\nBacitracin is an antibiotic produced by the strain of Bacillus subtilis. It acts by inhibiting bacterial cell wall synthesis. It is active against a variety of gram positive and a few gram negative organisms.\r\n\r\nMechanism of Action of Neomycin\r\nAminoglycosides like neomycin \\\"irreversibly\\\" bind to specific 30S-subunit proteins and 16S rRNA. Specifically neomycin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes.", "Composition": "bacitracin 12500i.u., neomycin 165000i.u.", "Route": "SPRAY" }, { "ID": "4", "Trade_Name": "FLIXONASE AQUEOUS 50 MCG/METERED SPRAY DOSE", "Generic_Name": "FLUTICASONE PROPIONATE", "Price": "49.5", "Price_Old": "33", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTI-INFLAMMATORY.GLUCOCORTICOID", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "–#>ل#.ج #.ل#?ه#.#% #.لأن#< #.ل#?حسسي. \r\n\r\n–ي#?خلص من سيل#.ن #.لأن#< #.لمُزمن. \r\n\r\n–#>ل#.ج #.نس#~#.#~ #.لأن#< و#<ق#~#.ن #.لق#~#^ة #>لى #.لشم. \r\n\r\n–يوص#< #%#>#~ إج#^#.ء #>ملية #.للحمية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #?ن#.ول هذ#. #.ل#>ل#.ج لمن ل#~يهم حس#.سية #?ج#.ه م#=ون#.#? #.ل#%خ#.خ. \r\n\r\n–يمن#> #>ن #.لأ#-#<#.ل أقل من سن#?ين. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^أة #.لح#.مل.", "GI": "Description\t\r\nFluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone proprionate is marketed under several different brand names such as Flonase?. Fluticasone propionate is also available as a combination product of azelastine hydrochloride and fluticasone propionate called Dymista?. Dymista? is indicated in patients over 12 years old for symptomatic relief of seasonal allergic rhinitis.\r\n\r\nIndication\t\r\n is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the maintenance treatment of asthma as prophylactic therapy and for patients requiring oral corticosteroid therapy for asthma.", "Composition": "flutcasone 50mcg", "Route": "SPRAY" }, { "ID": "5", "Trade_Name": "4 WET INTIMATE GEL 100 ML", "Generic_Name": "", "Price": "40", "Price_Old": "40", "Company": "TURKUAZ MEDICAL CO. > BROTHER PHARMA", "Pharmacology": "LUBRICANT", "Category": "مزلق", "Use": "–COMING SOON ..", "Contraindications": "–COMING SOON ..", "GI": ".", "Composition": "Sodium benzoate, Carbomer, Citric acid, Allantoin, Alpha bisabolole, Fragrance, Hexamidine, Tegabetain, Chamomile, Polysorbate", "Route": "TOPICAL" }, { "ID": "6", "Trade_Name": "MULTISOL AEROSOL SPRAY", "Generic_Name": "BACITRACIN+NEOMYCIN+POLYMYXIN", "Price": "21", "Price_Old": "21", "Company": "ARAB CENTER > ADM FOR TRADING & PROJECTS-EGYPT", "Pharmacology": "ANTIBIOTIC TOPICAL", "Category": "م#_#.#~ حيوي مو#_#>ي", "Use": "–#.لقو#%#.ء \r\n\r\n–#.لج#^ي#%#.#? \r\n\r\n–#>#~وى #.لجل#~ حول #.ل#.ظ#.#<#^ \r\n\r\n–#.ل#.#=زيم#. #.لمص#.#%ة #%#.ل#%#=#?ي#^ي#. \r\n\r\n–#.لج#^وح #.لمص#.#%ة #%#.ل#%#=#?ي#^ي#. \r\n\r\n–#%#>#~ #.ز#.لة ش#>#^ #.لجسم \r\n\r\n–#%#>#~ #.ج#^#.ء#.#? #.لليز#^ #>لى #.لجل#~ \r\n\r\n–#>#~وى حول #.ل#<م \r\n\r\n–#.لج#^وح #.لس#-حية و#.ل#>ميقة \r\n\r\n–#.ل#~م#.مل و#.لخ#^#.#^يج \r\n\r\n–#%#>#_ ح#.ل#.#? ح#% #.لش#%#.#%", "Contraindications": "–هذ#. #.لمس#?ح#_#^ لل#.س#?#>م#.ل #.لخ#.#^جى #>لى #.لجل#~ #<ق#- \r\n\r\n–#?جن#% و#_#> #.و مل#.مسة #.ل#%خ#.خ لل#>ين \r\n\r\n–يمن#> #.س#?خ#~#.مه #>ن#~ وجو#~ حس#.سية من #.ى م#=ون من م#=ون#.#?ة #.ل#<#>#.لة \r\n\r\n–يمن#> #.س#?خ#~#.مة #.ثن#.ء #.لحمل و#.ل#^#_#.#>ة", "GI": "MECHANISM OF ACTION OF BACITRACIN\r\nBACITRACIN IS AN ANTIBIOTIC PRODUCED BY THE STRAIN OF BACILLUS SUBTILIS. IT ACTS BY INHIBITING BACTERIAL CELL WALL SYNTHESIS. IT IS ACTIVE AGAINST A VARIETY OF GRAM POSITIVE AND A FEW GRAM NEGATIVE ORGANISMS.\r\n\r\nMECHANISM OF ACTION OF NEOMYCIN\r\nAMINOGLYCOSIDES LIKE NEOMYCIN \\\"IRREVERSIBLY\\\" BIND TO SPECIFIC 30S-SUBUNIT PROTEINS AND 16S RRNA. SPECIFICALLY NEOMYCIN BINDS TO FOUR NUCLEOTIDES OF 16S RRNA AND A SINGLE AMINO ACID OF PROTEIN S12. THIS INTERFERES WITH DECODING SITE IN THE VICINITY OF NUCLEOTIDE 1400 IN 16S RRNA OF 30S SUBUNIT.\r\n\r\nMECHANISM OF ACTION OF POLYMYXIN B\r\nPOLYMYXIN B SULFATE HAS A BACTERICIDAL ACTION AGAINST ALMOST ALL GRAM-NEGATIVE BACILLI EXCEPT THE PROTEUS GROUP. POLYMYXIN B SULFATE INTERACTS WITH THE LIPOPOLYSACCHARIDE OF THE CYTOPLASMIC OUTER MEMBRANE OF GRAM-NEGATIVE BACTERIA, ALTERING MEMBRANE PERMEABILITY AND CAUSING CELL DEATH. IT DOES NOT NEED TO ENTER THE CELL.", "Composition": "bacitracin 40000i.u., polymyxin b sulfate 150000i.u., neomycin 500000i.u.", "Route": "SPRAY" }, { "ID": "7", "Trade_Name": "CANDISTAN 1% AEROSOL 50 GM", "Generic_Name": "CLOTRIMAZOLE", "Price": "18", "Price_Old": "12", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIFUNGALS.IMIDAZOLES", "Category": "م#_#.#~ لل#<#-#^ي#.#? م#> إيمي#~#.زول#.#?", "Use": "–#>ل#.ج #.لمو#_#>ي لم#^#_ #.لم#%ي#_#.#? ، وأنو#.#> مخ#?ل#<ة من س#>#<ة #.لق#~م و#.ل#^ي#.#_يين", "Contraindications": "–ل#. يس#?خ#~م #>لي #.لج#^وح #.لم#<#?وحة #.و #.لح#^وق - ل#. يس#?خ#~م ح#.ل #<#^#- #.لحس#.سية - يس#?خ#~م #<ي #.لحمل #>ن#~ #.ل#_#^و#^ة #<ق#- ل#=ن #?ح#? #.ش#^#.#< #-#%ي #=#.مل ويمن#> نه#.ئي#. #<ي #.لثل#.ث شهو#^ #.ل#.ولي - غي#^ م#>#^و#< #.ن #=#.ن يم#^ #%حلي#% #.ل#.م #.لم#^#_#> #.م ل#.", "GI": "How does it work?SCare clotrimazole cream 1% contains the active ingredient clotrimazole, which is an antifungal medicine used to treat infections with fungi and yeasts.SSmechanism:SClotrimazole kills fungi and yeasts by interfering with their cell membranes. It works by stopping the fungi from producing a substance called ergosterol, which is an essential component of fungal cell membranes. The disruption in production of ergosterol causes holes to appear in the fungal cell membrane.SSWhat is it used for?SSkin infections caused by yeasts (eg Candida), dermatophytes (eg Trichophyton, Tinea), moulds and other fungi, such as the following:SAthlete s foot (tinea pedis).SFungal infection of the groin, ie jock itch (tinea cruris).SRingworm (tinea corporis).SFungal nappy rash caused by infection with Candida albicans.SSweat rash caused by infection with Candida albicans.SRelieving the external symptoms (candidal vulvitis) of vaginal thrush (candidal vaginitis).", "Composition": "Each 100 gm of candistan Cream Contains:\r\nClotrimazole 1 g.", "Route": "SPRAY" }, { "ID": "8", "Trade_Name": "DERMOTRACIN AEROSOL POWDER 150 ML", "Generic_Name": "BACITRACIN+NEOMYCIN", "Price": "27.6", "Price_Old": "27.6", "Company": "MUP", "Pharmacology": "ANTIBIOTIC TOPICAL", "Category": "م#_#.#~ حيوي مو#_#>ي", "Use": "–#.لإ#=زيم#.. \r\n\r\n–#.لحص#< #.لجل#~ي ل#~ى #.ل#=#%#.#^. \r\n\r\n–#.لح#=ة #.لجل#~ية #.لمص#.ح#%ة #%#~م. \r\n\r\n–#.ل#%#=#?ي#^ي#. #.ل#_#.#^ة #.ل#?ي #?صي#% #.لجل#~. \r\n\r\n–#.لح#%و#% #%#=#.#<ة أنو#.#>ه#.. \r\n\r\n–#?قليل #.لآلم #<ي #.لمن#-قة #.لمص#.#%ة. \r\n\r\n–#.لح#%و#% #%#.لمن#-قة #.لحس#.سة. \r\n\r\n–#.لح#%و#% #.لث#.نوية. \r\n\r\n–#.لح#%و#% #.لظ#.ه#^ة #<ي #<#^وة #.ل#^أس. \r\n\r\n–#.لخ#^#.ج #.لجل#~ي.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #>لى #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي #<#?ح#.#? #.لأن#< و#.ل#<م. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة. \r\n\r\n–يج#% #.ل#.ل#?ز#.م #%#.لج#^#>ة #.لمح#~#~ة و#>#~م #.لإ#<#^#.#- #<يه#.. \r\n\r\n–#<#?#^ة #.لحمل. \r\n\r\n–حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء.", "GI": "Mechanism of Action of Bacitracin\r\nBacitracin is an antibiotic produced by the strain of Bacillus subtilis. It acts by inhibiting bacterial cell wall synthesis. It is active against a variety of gram positive and a few gram negative organisms.\r\n\r\nMechanism of Action of Neomycin\r\nAminoglycosides like neomycin \\\"irreversibly\\\" bind to specific 30S-subunit proteins and 16S rRNA. Specifically neomycin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes.", "Composition": "bacitracin 12500i.u., neomycin 165000i.u.", "Route": "SPRAY" }, { "ID": "9", "Trade_Name": "BRONCHOSTIM 12MCG/DOSE AEROSOL", "Generic_Name": "FORMOTEROL FUMARATE", "Price": "250", "Price_Old": "250", "Company": "T3A PHARMA", "Pharmacology": "BRONCHODILATOR.LONG ACTING BETA 2 AGONIST", "Category": "موس#> للش#>#% #.لهو#.ئية و مش#.#=ل #.ل#?ن#<س", "Use": "–يس#?خ#~م #.ل#~و#.ء ل#>ل#.ج #_يق #.ل#?ن#<س و#.ل#?ه#.#% #.لش#>#% #.لهو#.ئية . \r\n\r\n–يس#.#>#~ #.ل#~و#.ء #>لي #.ل#?ن#<س #%صو#^ة #-#%ي#>ية ويق#_ي #>لي #.نس#~#.#~ #.لش#>#% #.لهو#.ئية . \r\n\r\n–ي#>#.لج #.ن#?#<#.خ #.ل#^ئة . \r\n\r\n–يقي من #.ل#.ص#.#%ة #%#.ل#^#%و .", "Contraindications": "–#.لحس#.سية ل#<و#^مي#?#^ول #.و #.ي من م#=ون#.#? #.ل#~و#.ء #.لآخ#^ى. \r\n\r\n–#.لم#^#_ى #.لذين ي#>#.نون من ح#.لة #^#%و مس#?م#^ (نو#%ة ش#~ي#~ة مس#?م#^ة من #.ل#^#%و) #.و #.ي نو#%#.#? ح#.#~ة من #.ل#^#%و #.و #.ل#.نس#~#.#~#~ #.ل#^ئوي #.لمزمن. \r\n\r\n–ل#. يس#?خ#~م هذ#. #.ل#~و#.ء #=#>ل#.ج من#<#^#~ لل#^#%و.", "GI": "Mechanism of action\t\r\nThe pharmacologic effects of beta2-adrenoceptor agonist drugs, including formoterol, are at least in part attributable to stimulation of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3 , 5 -adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibits the release of pro-inflammatory mast-cell mediators such as histamine and leukotrienes. Formoterol also inhibits histamine-induced plasma albumin extravasation in anesthetized guinea pigs and inhibits allergen-induced eosinophil influx in dogs with airway hyper-responsiveness. The relevance of these in vitro and animal findings to humans is unknown.", "Composition": "COMING SOON ..", "Route": "INHALATION" }, { "ID": "10", "Trade_Name": "MOON HERB LACT 10 SACHETS", "Generic_Name": "FENUGREEK+NIGELLA SATIVA+FENNEL+ DILL+CUMIN+CARAWAY+ANISE FRUITS", "Price": "30", "Price_Old": "23", "Company": "FAMILY PHARMACIA > INFINITY PHARM", "Pharmacology": "LACTAGOGUE", "Category": "م#~#^ لل#%ن", "Use": "–يق#_ي #>لي مش#.#=ل #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–زي#.#~ة #.#<#^#.ز #.لل#%ن #>ن#~ #.ل#.م #.لم#^#_#>ة. \r\n\r\n–#.لق#_#.ء #>لي مش#.#=ل #.لم#>#~ة و#.ل#.ن#?#<#.خ#.#? و#.لمغص #>ن#~ #.ل#.#-#<#.ل. \r\n\r\n–يق#_ي #>لي مش#.#=ل #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–زي#.#~ة #.#<#^#.ز #.لل#%ن #>ن#~ #.ل#.م #.لم#^#_#>ة. \r\n\r\n–#.لق#_#.ء #>لي مش#.#=ل #.لم#>#~ة و#.ل#.ن#?#<#.خ#.#? و#.لمغص #>ن#~ #.ل#.#-#<#.ل. \r\n\r\n–#?حسين #>ملية #.ل#?مثيل #.لغذ#.ئي لل#.م. \r\n\r\n–ي#>مل #>لي خ#<#_ نس#%ة #.ل#~هون #<ي #.ل#~م. \r\n\r\n–خ#<#_ خ#-#^ #.ص#.#%ة #.ل#.م #%م#^#_ #.لس#=#^ي من #.لنو#> #.لث#.ني. \r\n\r\n–خ#<#_ خ#-#^ #.ص#.#%ة #.ل#.م #%س#^#-#.ن #.لث#~ي وس#^#-#.ن #.لم#%ي#_. \r\n\r\n–خ#<#_ خ#-#^ #.ل#.ص#.#%ة #%#.#^#?#<#.#> نس#%ة #.ل#=وليس#?#^ول #<ي #.ل#~م و#.م#^#.#_ #.لقل#%. \r\n\r\n–خ#<#_ خ#-#^ #.ل#.ص#.#%ة #%#.#^#?#<#.#> #_غ#- #.ل#~م #%#>#~ 6 شهو#^ من #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–#<و#.ئ#~ #.س#?#>م#.له لل#-#<ل #.ل#^#_ي#> : \r\n\r\n–#?قوية #.سن#.ن #.ل#.#-#<#.ل . \r\n\r\n–#.لح#<#.ظ #>لي #>ظ#.م #.ل#.#-#<#.ل . \r\n\r\n–#?قوية جه#.ز #.لمن#.#>ة #>ن#~ #.ل#.#-#<#.ل. \r\n\r\n–خ#<#_ #.ل#.ص#.#%ة #%#%#>#_ مش#.#=ل #.لم#>#~ة من مغص و#.ن#?#<#.خ#.#? و#>س#^#.له#_م. \r\n\r\n–#<و#.ئ#~ #.س#?#>م#.له لل#.م : \r\n\r\n–#?حسين #>ملية #.ل#?مثيل #.لغذ#.ئي لل#.م. \r\n\r\n–ي#>مل #>لي خ#<#_ نس#%ة #.ل#~هون #<ي #.ل#~م. \r\n\r\n–خ#<#_ خ#-#^ #.ص#.#%ة #.ل#.م #%م#^#_ #.لس#=#^ي من #.لنو#> #.لث#.ني. \r\n\r\n–خ#<#_ خ#-#^ #.ص#.#%ة #.ل#.م #%س#^#-#.ن #.لث#~ي وس#^#-#.ن #.لم#%ي#_. \r\n\r\n–خ#<#_ خ#-#^ #.ل#.ص#.#%ة #%#.#^#?#<#.#> نس#%ة #.ل#=وليس#?#^ول #<ي #.ل#~م و#.م#^#.#_ #.لقل#%. \r\n\r\n–خ#<#_ خ#-#^ #.ل#.ص#.#%ة #%#.#^#?#<#.#> #_غ#- #.ل#~م #%#>#~ 6 شهو#^ من #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–#<و#.ئ#~ #.س#?#>م#.له لل#-#<ل #.ل#^#_ي#> : \r\n\r\n–#?قوية #.سن#.ن #.ل#.#-#<#.ل . \r\n\r\n–#.لح#<#.ظ #>لي #>ظ#.م #.ل#.#-#<#.ل . \r\n\r\n–#?قوية جه#.ز #.لمن#.#>ة #>ن#~ #.ل#.#-#<#.ل. \r\n\r\n–خ#<#_ #.ل#.ص#.#%ة #%#%#>#_ مش#.#=ل #.لم#>#~ة من مغص و#.ن#?#<#.خ#.#? و#>س#^#.له#_م.", "Contraindications": "–#<#^#- #.لحس#.سية من أي من م#=ون#.#? #.لمس#?ح#_#^.", "GI": "Lactagogue", "Composition": "nigella sativa\r\nfennel\r\nanise\r\ncumin oil\r\nfenugreek\r\ncaraway\r\ndill oil", "Route": "SACHETS" }, { "ID": "11", "Trade_Name": "FEMINALOPRAM 8 CAPLETS", "Generic_Name": "PAMABROM+PARACETAMOL(ACETAMINOPHEN)", "Price": "6", "Price_Old": "6", "Company": "ORGANOPHARMA", "Pharmacology": "MENSTRUAL PAIN RELEIF", "Category": "مش#.#=ل #.ل#-مث", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#.م #.ل#~و#^ه #.لشه#^يه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.م #.لص#~#.#> و#.لص#~#.#> #.لنص#<ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.م #.ل#.سن#.ن و#.للثه. \r\n\r\n–يس#?خ#~م #<ي خ#<#_ #.لح#^#.#^ه.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.م#^#.#_ #.لقل#%. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.م#^#.#_ #.ل#=#%#~ و#.ل#=لي. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.م#^#.#_ #_غ#- #.ل#~م.", "GI": "pamabrom is typically recommended to women to alleviate symptoms associated with menstrual cycles\r\n The medication works, as all diuretics do, by pulling excessive water from throughout the body and increasing how frequently patients need to urinate. By flushing excess fluid from the system, patients gain relief from the uncomfortable bloating and swelling.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "12", "Trade_Name": "PREXAL 5 MG 30 CAPLETS", "Generic_Name": "OLANZAPINE", "Price": "168", "Price_Old": "120", "Company": "JOSWE MEDICAL-JORDAN > SPACE MEDICAL", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–م#>#.لجة ح#.لة #.ل#.ن#<ص#.م #<ي #.لشخصية. \r\n\r\n– م#>#.لجة نو#%#.#? #.لهوس #.ل#%سي#- منه#. و#.لش#~ي#~. \r\n\r\n–م#>#.لجة م#^#_ ثن#.ئي #.لق#-#%. \r\n\r\n– م#>#.لجة ح#.لة #.ل#.#=#?ئ#.#% #.لش#~ي#~ة.", "Contraindications": "–#.لحس#.سية من أي #.لمو#.#~ #.ل#<#>#.لة #.لم#=ونة لل#~و#.ء. \r\n\r\n–ل#. #?#%قى #~#^#.س#.#? وأ#%ح#.ث #>لمية و#-#%ية #?ث#%#? أن #>ل#.ج #.ول#.زين آمن #<ي شهو#^ #.لحمل، لذل#= #?جن#%ي #.س#?#>م#.له #<ي م#^حلة #.لحمل، ل#?جن#% ح#~وث #.ي أ#_#^#.#^ للأجنة. \r\n\r\n–ل#. ي#<#_ل #.س#?#>م#.ل #.ل#>ل#.ج للم#^#_#>#.#?، ح#?ى ل#. ي#=ون #.لس#%#% هذ#. #<ي #.ح#~#.ث #_#^#^ لل#^#_ي#>. \r\n\r\n–#?جن#% #.س#?#>م#.ل #.ل#>ل#.ج لل#.شخ#.ص #.ل#.قل من ثم#.ن #>ش#^ #>#.م. \r\n\r\n–#?جن#% #.لسو#.قة نحو #?ن#.ول #.ل#>ل#.ج، لأن من #.#=ث#^ #.لآث#.#^ #.لج#.ن#%ية #.لن#.#?جة #>ن #.ل#>ل#.ج، #.لإحس#.س #%#.ل#~وخة و#>#~م #.ل#.#?ز#.ن. \r\n\r\n–ينوه من #?#>#-ل #.ل#>ل#.ج #<جأة #~ون #.ل#>و#~ة إلى #.ل#-#%ي#%.", "GI": "Indication\t\r\nFor the acute and maintenance treatment of schizophrenia and related psychotic disorders, as well as acute treatment of manic or mixed episodes of bipolar 1 disorder. Intramuscular olanzapine is indicated for the rapid control of agitated patients.\r\nMechanism of action\tOlanzapine s antipsychotic activity is likely due to a combination of antagonism at D2 receptors in the mesolimbic pathway and 5HT2A receptors in the frontal cortex. Antagonism at D2 receptors relieves positive symptoms while antagonism at 5HT2A receptors relieves negative symptoms of schizophrenia.", "Composition": "olanzapine 5mg", "Route": "ORAL.SOLID" }, { "ID": "13", "Trade_Name": "ADOL COLD CAPLETS", "Generic_Name": "DEXTROMETHORPHAN+PARACETAMOL(ACETAMINOPHEN)+PSEUDOEPHEDRINE", "Price": "10", "Price_Old": "10", "Company": "JULPHAR", "Pharmacology": "COLD DRUGS", "Category": "لنزل#.#? #.ل#%#^#~", "Use": "–#.لص#~#.#> #.لمص#.ح#% لنزل#.#? #.ل#%#^#~ وإل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–إل#?ه#.#% #.لحلق. \r\n\r\n–ألم #.لجسم و #.لم#<#.صل. \r\n\r\n–#.لحمى (إ#^#?#<#.#> #~#^جة #.لح#^#.#^ة). \r\n\r\n–#.لس#>#.ل #.لج#.#<. \r\n\r\n–#=م#. يس#.#>#~ #<ي #?خ#<ي#< سيل#.ن #.لأن#< و#.ل#>#-#.س #<هو ي#>#?#%#^ #>ل#.ج مؤق#? لهذه #.لأ#>#^#.#_.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–م#^#_ى #.ل#=#%#~ حيث أنه يح#?وي #>لى #.ل#%#.#^#.سي#?#.مول. \r\n\r\n–#.لأ#-#<#.ل أقل من #>#.مين. \r\n\r\n–م#^#_ى #<#^#- #_غ#- #.ل#~م #.لش#~ي#~ وم#^#_ى #.لقل#%. \r\n\r\n–ل#.يس#?خ#~م ق#%ل #.لنوم #%س#.#>#.#? قليلة حيث أنه ق#~ يس#%#% أ#^ق. \r\n\r\n–ل#.يس#?خ#~م م#> #.لأ#~وية #.لآ#?ية: مث#%#-#.#? #.لشهية أو مح#<ز#.#?ه#. أو م#_#.#~#.#? #.لهيس#?#.مين. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة سوء #.ل#?غذية أو #?#>#.#-ي #.ل#=حول أو م#^#_ى #.ل#^#%و. \r\n\r\n–ل#. ين#.س#% م#^#_ى #.لجلو#=وم#. وق#^حة #.لم#>#~ة.", "GI": "About Dextromethorphan\r\nA synthetic morphine (((dextrorotatory methyl ether of Levorphanol))) derivative,A synthetic narcotic antitussive.\r\nMechanism of Action of Dextromethorphan\r\nDextromethorphan hydrobromide is a selective antitussive which raises threshold of cough centre and suppresses the cough reflex by direct action on the cough centre in the medulla. It does not depress mucociliary function of the airway mucosa and is also devoid of constipating and addicting actions. (((Its antitussive action is not exerted through opioid receptors)))", "Composition": "Each caplet contains:\r\nActive ingredients: Paracetamol 500mg\r\nCaffeine 65mg\r\n\r\nExcipients: Maize starch, povidone, polysorbate 80,\r\nmicrocrystalline cellulose, sodium strach glycolate, cross carmellose sodium, stearic acid, and talc.", "Route": "ORAL.SOLID" }, { "ID": "14", "Trade_Name": "ADOL SINUS 24 CAPLETS", "Generic_Name": "PARACETAMOL(ACETAMINOPHEN)+PSEUDOEPHEDRINE", "Price": "12", "Price_Old": "12", "Company": "EIMC > JULPHAR", "Pharmacology": "COLD DRUGS", "Category": "لنزل#.#? #.ل#%#^#~", "Use": "–يس#?خ#~م #.ل#~و#.ء #<ى #>ل#.ج #.ل#.م #.لجسم #.لمص#.ح#%ة لنزل#.#? #.ل#%#^#~ #=م#. يم#=ن #.ن يقوم #.ل#~و#.ء #%#>ل#.ج #.ح#?ق#.ن #.لحلق و#.ل#.ن#< ، #%#.ل#.#_#.#<ة #.لى #.نه يم#=ن م#>#.لجة #.لش#>و#^ #%#.ل#>#-#.س و#^شح #.ل#.ن#< . \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ل#~و#.ء #<ى م#>#.لجة #.ل#.#>#^#.#_ #.لمص#.ح#%ة لنزل#.#? #.ل#%#^#~ #=م#. يم#=ن #.ن ي#>#.لج إ#^#?#<#.#> #~#^ج#.#? #.لح#^#.#^ة ، #%#.ل#.#_#.#<ة #.لى #.نه يم#=ن #.ن ي#>#.لج حمى #.لقش و#.لحس#.سية #.لمخ#?ل#<ة \r\n\r\n–يس#.#>#~ #.ل#~و#.ء #<ى #>ل#.ج #.نس#~#.#~ وسيل#.ن #.ل#.ن#< #=م#. يم#=ن #.ن يقوم #.ل#~و#.ء #%#>ل#.ج #?س#=ين #.ل#.ل#.م و#?خ#<ي#< #.لص#~#.#> ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.ح#?ق#.ن #.لجيو#% #.ل#.ن#<ية .", "Contraindications": "–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى . \r\n\r\n–ل#. يج#% #.س#?#>م#.ل #.ل#~و#.ء خل#.ل م#^حلة #.لحمل وخ#.صة #<ى #.ل#.شه#^ #.ل#.ولى من #.لحمل ل#.نه ق#~ يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية ، #=م#. ل#. يم#=ن #.س#?خ#~#.م #.ل#~و#.ء #<ى م#^حلة #.ل#^#_#.#>ة #.ل#-#%ي#>ية ل#.ن #.ل#~و#.ء يم#^ #<ى حلي#% #.ل#.م مم#. يؤ#~ى #.لى خ#-و#^ة #>لى حي#.ة #.ل#-#<ل #.ل#^#_ي#> لذل#= ينصح #%#.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل #.خذ #.ل#~و#.ء خل#.ل م#^حل#?ى #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–#>#~ #.س#?خ#~#.م #.ل#~و#.ء للم#^#_ى #.لذين ي#>#.نون من #.ل#^#%و #.لش#>#%ى ، #=م#. يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #?#_خم #.ل#%#^وس#?#.#?#. .", "GI": "About Paracetamol\r\nAcetanilide derivative, Non narcotic Analgesic,Antipyretic.\r\nMechanism of Action of Paracetamol\r\nParacetamol has analgesic and antipyretic action. \r\nIt is more active on cyclo-oxygenase enzyme in brain. Peripherally it is a poor inhibitor of prostaglandin synthesis. \r\nAnalgesic action: Paracetamol raises the pain threshold and produces analgesic effect. \r\nAntipyretic action: Paracetamol lowers fever by direct action on the thermoregulatory centre in the Hypothalamus and block the effects of endogenous pyrogen. \r\nIndications for Paracetamol\r\n1. To relieve pain and fever \r\n2. Acute gout \r\n3. Migraine \r\nInteractions for Paracetamol\r\nCholestyramine: Reduces absorption of paracetamol. \r\nCharcoal: Activated, administered immediately reduces absorption of paracetamol. \r\nDomperidone and metochlopramide: Enhance absorption of paracetamol. \r\nAlcohol: Chronic excessive ingestion of alcohol potentiates hepatotoxicity of paracetamol. \r\nZidovudine: Effects zidovudine may be decrea", "Composition": "Paracetamol 325mg\r\nPseudoephedrine HCI 30mg", "Route": "ORAL.SOLID" }, { "ID": "15", "Trade_Name": "VALENS GEL 100 GM", "Generic_Name": "MASSAGE CREAM FORMULA", "Price": "36", "Price_Old": "36", "Company": "EL-HELOU PERFUMES & COSMETICS > BIO HEALTH", "Pharmacology": "MASSAGE", "Category": "مس#.ج و #?#~لي#=", "Use": "–#>ل#.ج إل#?و#.ء #.ل#^ق#%ة #.لش#~ي#~. \r\n\r\n–#>ل#.ج إص#.#%#.#? #.ل#>ظ#.م و#.ل#>#_ل#.#?. \r\n\r\n–#?س#=ين آل#.م أس#<ل #.لظه#^. \r\n\r\n–#>ل#.ج #?#>ذ#^ #.ل#?#<#.#< #.ل#^ق#%ة #.لذي ين#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي \r\n\r\n–#?س#=ين آل#.م #?مزق #.لأ#^#%#-ة. \r\n\r\n–#>ل#.ج #.نزل#.ق غ#_#.#^ي#< #.ل#<ق#^#.#?.", "Contraindications": "–#.لإص#.#%ة #%#.لحس#.سية #?ج#.ه أح#~ م#=ون#.#? #.ل#=#^يم. \r\n\r\n–ل#. يو#_#> #>لى #.لج#^وح. \r\n\r\n–ل#. يو#_#> #.ل#=#^يم #>لى #.لجل#~ #.لمح#^وق أو إذ#. #=#.ن #.لجل#~ مجلو#<ً#.. \r\n\r\n–يج#% #>#~م #.س#?خ#~#.م #.ل#=#^يم لم#~ة #?زي#~ #>ن أس#%و#> حيث يج#% #.ل#^جو#> إلى #.ل#-#%ي#% إذ#. #.س#?م#^ #.لألم أ#=ث#^ من أس#%و#>. \r\n\r\n–ل#. يس#?خ#~م #.ل#=#^يم #<ي ح#.لة #.لإص#.#%ة #%#?ق#^ح#.#? #.لجل#~. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#=#^يم من ق#%ل #.لسي#~#.#? #.لحو#.مل و#.لأمه#.#? #.لم#^#_#>#.#?، وذل#= لأنه لم #?ث#%#? ح#?ى #.لآن سل#.م#?ه #%#.لنس#%ة للنس#.ء #.لحو#.مل و #.لم#^#_#>#.#?. \r\n\r\n–م#^#.#>#.ة #?جن#% مل#.مسة #.ل#=#^يم لل#>ين أو #.لأن#<. \r\n\r\n–م#^#.#>#.ة #?جن#% #.س#?خ#~#.م #.ل#=#^يم #<ي #.لمن#.#-ق #.لحس#.سة من #.لجسم. \r\n\r\n–#>ن#~ ظهو#^ أي #>ل#.م#.#? #.ل#?حسس من #.س#?خ#~#.م #.ل#=#^يم مثل #.ل#.حم#^#.#^ أو #.ل#-#<ح #.لجل#~ي أو #.لش#>و#^ #%#.لح#=ة أو #.ل#?و#^م ل#.#%#~ من #.ل#.م#?ن#.#> #<و#^ً#. #>ن #.س#?خ#~#.م #.ل#=#^يم.", "GI": "Massage gel", "Composition": "COMING SOON ..", "Route": "TOPICAL" }, { "ID": "16", "Trade_Name": "REVIA 50MG SCORED 30 F.C.TAB.", "Generic_Name": "NALTREXONE", "Price": "300", "Price_Old": "300", "Company": "BRISTOL-MYERS SQUIBB > TCHERO INTERNATIONAL LTD.", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–يس#?خ#~م #.ل#~و#.ء للمس#.#>#~ #>ن إل#.قل#.#> #<ي ح#.له #.ل#.شخ#.ص #.لم#~منين للمو#.#~ #.ل#.#<يونيه، و#=ذل#= #<هو جزء من #.ل#%#^ن#.مج #.ل#>ل#.جي لم#~مني مو#.#~ #.لأ#<يون. \r\n\r\n–ي#?م #.س#?#>م#.ل #.ل#~و#.ء للح#~ من #.ل#^غ#%ه #<ي ش#^#% #.لمو#.#~ #.ل#=حولية ، #=م#. يم#=ن #.ن يقوم #.ل#~و#.ء ل#>ل#.ج و#.لمس#.#>#~ة #<ي #>ل#.ج #.#~م#.ن #.ل#=حولي#.#? .", "Contraindications": "–#.ل#?ه#.#% #.ل#=#%#~ #.لح#.#~ \r\n\r\n–#.لمس#=ن#.#? #.لأ#<يونية #.ل#>ل#.جية \r\n\r\n–#<#^#- #.لحس#.سية \r\n\r\n–غي#^ موصى #%ه#. #<ي #.لم#^ي#_ وجو#~ #?#.#^يخ #.#_#-#^#.#%#.#? #.لنزي#< \r\n\r\n–ل#. #?س#?خ#~م إذ#. #=#.ن ي#>#.ني من #.خ#?ل#.ل #=#%#~ي أو #=لوي", "GI": "About Naltrexone\r\nAn opioid receptor(competitive antagonists at ?- and ?- receptor) antagonist, In alcohol dependence and opioid dependence.\r\nMechanism of Action of Naltrexone\r\nNaltrexone is a competitive opioid antagonist. It reversibly and completely blocks all the opioid receptors (mu, kappa and delta). It is an orally administered long acting, pure opioid antagonist \r\nAlcoholism: Opioid receptors are thought to be responsible for some of the reinforcing effects of alcohol. \r\nIndications for Naltrexone\r\n1. Opioid antagonist \r\n2. Alcoholism\r\nInteractions for Naltrexone\r\nDisulfiram: The safety and efficacy of concomitant use of naltrexone and disulfiram has not been established. Concomitant use of two potentially hepatotoxic drugs is ordinarily not recommended. \r\nThioridazine: Lethargy and somnolence have been reported when naltrexone and thioridazine have been used. \r\nOthers: Patients taking naltrexone may not benefit from opioid containing medicines like cough and cold preparations,", "Composition": "naltrexone HCL 50mg", "Route": "ORAL.SOLID" }, { "ID": "17", "Trade_Name": "ADOL 500MG 24 CAPLETS", "Generic_Name": "PARACETAMOL(ACETAMINOPHEN)", "Price": "12", "Price_Old": "8", "Company": "JULPHAR", "Pharmacology": "ANTIPYRETIC", "Category": "مس#=ن و خ#.#<#_ للح#^#.#^ة", "Use": "–يس#?خ#~م #.ل#>ل#.ج #=مخ#<#< للألم (#.لخ#<ي#< إلى #.لم#?وس#-). \r\n\r\n–خ#.#<#_ للح#^#.#^ة. \r\n\r\n–#>ل#.ج #.ل#>#~ي#~ من #.لأم#^#.#_ مثل #.لص#~#.#>. \r\n\r\n–آل#.م #.ل#>#_ل#.#?. \r\n\r\n–#.ل#?ه#.#% #.لم#<#.صل. \r\n\r\n–آل#.م #.لظه#^ . \r\n\r\n–آل#.م #.لأسن#.ن. \r\n\r\n–نزل#.#? #.ل#%#^#~ .", "Contraindications": "–#.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لأي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لم#^#_ى #.لمص#.#%ين #%م#^#_ ش#~ي#~ #<ي #.ل#=#%#~ أو #<شل #<ي #.ل#=#%#~.", "GI": "About Paracetamol\r\nAcetanilide derivative, Non narcotic Analgesic,Antipyretic.\r\nMechanism of Action of Paracetamol\r\nParacetamol has analgesic and antipyretic action. \r\nIt is more active on cyclo-oxygenase enzyme in brain. Peripherally it is a poor inhibitor of prostaglandin synthesis. \r\nAnalgesic action: Paracetamol raises the pain threshold and produces analgesic effect. \r\nAntipyretic action: Paracetamol lowers fever by direct action on the thermoregulatory centre in the Hypothalamus and block the effects of endogenous pyrogen. \r\nIndications for Paracetamol\r\n1. To relieve pain and fever \r\n2. Acute gout \r\n3. Migraine \r\nInteractions for Paracetamol\r\nCholestyramine: Reduces absorption of paracetamol. \r\nCharcoal: Activated, administered immediately reduces absorption of paracetamol. \r\nDomperidone and metochlopramide: Enhance absorption of paracetamol. \r\nAlcohol: Chronic excessive ingestion of alcohol potentiates hepatotoxicity of paracetamol.", "Composition": "Each caplet contains:\r\nActive ingredients: Paracetamol 500mg\r\nCaffeine 65mg\r\n\r\nExcipients: Maize starch, povidone, polysorbate 80,\r\nmicrocrystalline cellulose, sodium strach glycolate, cross carmellose sodium, stearic acid, and talc.", "Route": "ORAL.SOLID" }, { "ID": "18", "Trade_Name": "GLEMAX 4MG 30 CAPLETS", "Generic_Name": "GLIMEPIRIDE", "Price": "38", "Price_Old": "25.2", "Company": "JOSWE MEDICAL-JORDAN > SPACE MEDICAL", "Pharmacology": "ANTI-DIABETIC.SECRETAGOGUES.SULFONYLUREA", "Category": "م#^#_ #.لس#=#^ي من #.لنو#> #.لث#.ني", "Use": "– ي#?م #.س#?خ#~#.مه #>ن#~ #.لح#.جة لل#?خلص من نس#%ة #.لجلو#=وز #.لز#.ئ#~ة #%#.ل#~م و#%#.ل#?#.لي #<هو ي#>#.لج م#^#_ #.لس#=#^ من #.لنو#> #.لث#.ني #.لذي ل#. يس#?جي#% للأنسولين #=م#. أنه يس#.#>#~ #<ي #.لح#<#.ظ #>لي #.لم#>#~ل #.ل#-#%ي#>ي للس#=#^ #<ي #.ل#~م . \r\n\r\n– وأي#_#.ً يس#?خ#~م #<ي #?قليل #.م#?ص#.ص #.لس#=#^ي#.#? #%#.لجسم #=م#. أنه يقلل من إن#?#.ج #.ل#=#%#~ للس#=#^ وأي#_#.ً يح#<ز #.لأنسولين #.ل#-#%ي#>ي #%#.لجسم . \r\n\r\n– #%#.لإ#_#.#<ة إلى أنه يسي#-#^ #>لى أ#>#^#.#_ #.#^#?#<#.#> نس#%ة #.لس#=#^ مثل #?ل#< #.ل#=#%#~ و#<ق#~#.ن #.ل#%ص#^ و#.ل#_#>#< #.لجنسي وأي#_#.ً #.لنو#%#.#? #.لقل#%ية و#.ل#~م#.غية و#.ل#?ه#.#%#.#? #.لأ#>ص#.#% .", "Contraindications": "– ل#. يج#% #.س#?خ#~#.م #.ل#>ق#.#^ #>ن#~ وجو#~ حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #.لم#=ونة له وق#~ #?ظه#^ #?ل#= #.لحس#.سية #>لي ش#=ل #?و#^م #<ي #.لوجه أو #.حم#^#.#^ #<ي #.لجل#~ . \r\n\r\n– #=م#. أنه ل#. يس#?خ#~م #<ي ح#.لة #.لحمل ل#?جن#% ح#~وث #?شوه#.#? للجنين #=م#. ل#. يس#?خ#~م أي#_#.ً #<ي ح#.ل#.#? #.ل#^#_#.#>ة حيث ي#<#^ز #<ي ل#%ن #.لأم وق#~ يس#%#% مخ#.#-#^ صحية #>لي حي#.ة #.ل#^#_ي#> . \r\n\r\n– #=م#. يمن#> #.س#?خ#~#.مه أي#_#.ً #<ي #>ل#.ج #.لنو#> #.لأول من م#^#_ #.لس#=#^ي و#.لذين ق#~ ي#>#.لج #%#.لأنسولين . \r\n\r\n– #%#.لإ#_#.#<ة إلي #.نه يمن#> #.س#?خ#~#.مه للأ#-#<#.ل أقل من 18 #>#.م . \r\n\r\n– يج#% إخ#%#.#^ #.ل#-#%ي#% #<ي ح#.لة #?ن#.ول أي نو#> من #.لأ#~وية حيث أن هن#.#= #%#>#_ #.لمو#.#~ #.ل#<#>#.لة #.ل#?ي #?#?#<#.#>ل م#> #%#>#_ه#. مس#%#%ة أث#.#^ ج#.ن#%ية خ#-ي#^ة . \r\n\r\n– ي#?#<#.#>ل م#> م#.#~ة سيمي#?ي#~ين #<#?زي#~ من #?#^#=يزه #<ي #.ل#~م وأي#_#.ً #.ل#~يجو#=سين و#=يني#~ين ي#>ملون #>لي زي#.#~ة #?أثي#^ه #<ي #.ل#~م لذ#. يج#% #_#%#- #.لج#^#>ة أثن#.ء #.س#?خ#~#.مهم م#>#. . \r\n\r\n– م#~#^#.#? #.ل#%ول وه#^مون #.ل#.س#?#^وجين ووس#.ئل من#> #.لحمل ي#>ملون #>لى زي#.#~ة نس#%ة #.لس#=#^ #<ي #.ل#~م مم#. ي#>مل ذل#= #>لي #.ل#?أثي#^ #.ل#>#=سي لل#>ق#.#^. \r\n\r\n– و#.س#?خ#~#.مه م#> #.لمو#.#~ #.ل#?ي #?ح#?وي #>لي #.ليو#~ يس#%#% ح#~وث #<شل #=لوي و#?ل#= #.لمو#.#~ #?س#?خ#~م #<ي #.ل#>ملي#.#? #.لج#^#.حية لذ#. يج#% إيق#.#< #.س#?خ#~#.مه ق#%ل #.ل#>ملي#.#? #%م#~ة ل#. #?قل #>ن 48 س#.#>ة .", "GI": "Indications :\r\n This medication is a sulfonylurea antidiabetic agent, prescribed for type 2 diabetes. It works by causing the pancreas to produce insulin\r\n\r\nDosage :\r\nThe recommended starting dose is 1-2 mg once daily,with food.Maximum: 2mg/day\r\n\r\nContraindications:\r\n Contraindicated in patients with diabetic ketoacidosis, with or without coma, and hypersensitivity", "Composition": "Each tablet Giemax 1.0 contains, as active ingredient, 1 mg glimepiride. \r\nEach tablet Giemax 2.0 contains, as active ingredient, 2 mg glimepiride. \r\nEach tablet Giemax 3.0 contains, as active ingredient, 3 mg glimepiride. \r\nEach tablet Giemax 4.0 contains,", "Route": "ORAL.SOLID" }, { "ID": "19", "Trade_Name": "THIOTACID COMPOUND 600 MG 20 F.C.CAPLETS", "Generic_Name": "THIOCTIC ACID(ALPHA LIPOIC ACID)+VITAMIN B1+VITAMIN B12", "Price": "67.5", "Price_Old": "45", "Company": "EVA PHARMA", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–#.ل#?ه#.#% #.لأ#>ص#.#% #.لن#.#?ج #>ن م#^#_ #.ل#%ول #.لس#=#^ي . \r\n\r\n–#.ل#?ه#.#% #.ل#>ص#% #.ل#%ص#^ي . \r\n\r\n–مش#=ل#.#? #.لخصو#%ة #>ن#~ #.ل#^ج#.ل . \r\n\r\n–#_#>#< #.ل#.ن#?ص#.#% . \r\n\r\n–م#^#_ ألزه#.يم#^ . \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل #.لن#.#?جة #>ن م#^#_ #.ل#^وم#.#?وي#~ . \r\n\r\n–أم#^#.#_ #.ل#=#%#~ #.لن#.#?جة #>ن #?ن#.ول #.ل#=حولي#.#? . \r\n\r\n–أم#^#.#_ #.لأ#>ص#.#% #.لم#?#>لقة #%#.لقل#% . \r\n\r\n–#.لمش#=ل#.#? #.لم#^#?#%#-ة #%#<ي#^وس نقص #.لمن#.#>ة . \r\n\r\n–أم#^#.#_ #.ل#>يون #.ل#?ي يس#%#%ه#. م#^#_ #.لس#=#^ي .", "Contraindications": "–#.لحس#.سية #.لش#~ي#~ة من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–م#^#_ى #.لس#=#^ي حيث يس#%#% هذ#. #.ل#~و#.ء #.نخ#<#.#_ نس#%ة #.لس#=#^ #<ي #.ل#~م، لذ#. يج#% #.لقي#.م #%#.ل#<حص #.لمس#?م#^ . \r\n\r\n–م#^#_ي قصو#^ #.ل#=#%#~ . \r\n\r\n–#.لم#^#_ى #.لمص#.#%ون #%#.#_#-#^#.#%#.#? #.لغ#~ة #.ل#~#^قية . \r\n\r\n–إذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من نقص نس#%ة #.لثي#.مين . \r\n\r\n–ل#. يس#?خ#~م #.ل#~و#.ء م#> #.لمش#^و#%#.#? #.ل#=حولية . \r\n\r\n–ل#. يس#?خ#~م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل ل#.ن حم#_ #.لثيو#=#?ي#= يم#=ن أن يس#%#% أ#_#^#.#^ #=#%ي#^ة للجنين . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.ل#^#_#.#>ة لأنه يم#=ن #.ن يؤث#^ #>لى نمو #.ل#-#<ل و#=مية حلي#% #.ل#^#_#.#>ة ل#~ي #.لأم .", "GI": "Alpha-Lipoic Acid is a naturally occurring micronutrient, synthesized in small amounts by plants and animals (including humans), with antioxidant and potential chemopreventive activities. Alpha-lipoic acid acts as a free radical scavenger and assists in repairing oxidative damage and regenerates endogenous antioxidants, including vitamins C and E and glutathione. This agent also promotes glutathione synthesis. In addition, alpha-lipoic acid exerts metal chelating capacities and functions as a cofactor in various mitochondrial enzyme complexes involved in the decarboxylation of alpha-keto acids.", "Composition": "Each capsule contains:Thioctic acid (alpha lipoic acid) 300 mg\r\nBenfotiamine 40 mg\r\nCyanocobalamin\r\n250 mcg\r\n\r\nThiotacid compound 600 mg:\r\nThioctic acid (alpha lipoic acid) 600mg Benfotiamine (Vit. Bt) 80 mg\r\nCyanocobalamin (Vit. BI2) 500 mcg", "Route": "ORAL.SOLID" }, { "ID": "20", "Trade_Name": "RANITAK 25MG/ML 5 AMP. FOR I.M./I.V (CANCELLED)", "Generic_Name": "RANITIDINE", "Price": "9", "Price_Old": "9", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م ل#>ل#.ج ق#^حة #.لم#>#~ة و#.لأثني #>ش#^. \r\n\r\n– ي#>#.لج ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#%#.#? #.لغي#^ #.ل#.س#?ي#^وي#~ية. \r\n\r\n–يس#?خ#~م للوق#.ية من ق#^حة #.ل#.ثني #>ش#^. \r\n\r\n– يأخذ ق#%ل إج#^#.ء #.ل#>ملي#.#? لمن#> #?ص#.#>#~ حم#_ #.لم#>#~ة. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #.#^#?ج#.#> #.لم#^يء. \r\n\r\n– ي#>#.لج م#?ل#.زمة زولينج#^ #.ليسون. \r\n\r\n–ي#>#.لج #.ل#.ل#?ه#.#% #.لم#^يئي ويخ#<#< من أ#>#^#.#_ه. \r\n\r\n–ي#>#.لج ق#^حة #.لم#>#~ة #.لن#.#?ج #>ن #.لإص#.#%ة #%#.ل#>#~وى هيلي#=و#%#.#=#?#^ #%يلو#^ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #>س#^ #.له#_م #.لمزمن. \r\n\r\n–يخ#<#< من #.لآل#.م #.لق#<ص #.لص#~#^ي ومن#-قة #<م #.لم#>#~ة. \r\n\r\n– #.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #.لإجه#.#~. \r\n\r\n–يس#.#>#~ #<ي #.لوق#.ية من ح#~وث نزي#< م#?#=#^#^ ن#?يجة #.لإص#.#%ة #%ق#^حة #.لم#>#~ة. \r\n\r\n–#>ل#.ج م#?ل#.زمة من#~لسون.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية لأح#~ي #.لم#=ون#.#? #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة #.لإص#.#%ة #%م#^#_ #.ل#%و#^#<ي#^ي#..", "GI": "About Ranitidine\r\nA histamine H2-receptor antagonist, Furan derivative, Anti-secretory G.I agent,Anti ulcer.\r\nMechanism of Action of Ranitidine\r\nRanitidine is a H2 (Histamine) receptor antagonist. Histamine is the most potent stimulus of acid secretion and acts as the common mediator. H2 receptor is a G-protein coupled receptor. It induces adenylate cyclase which converts ATP to cyclic AMP. This cyclic AMP acts on proton pump and exchange extracellular potassium ion for intracellular hydrogen ion across the parietal cell membrane. Ranitidine reversibly competes with Histamine for binding to H2 receptors on the parietal cells and predominantly inhibits basal acid secretion. \r\nAnaesthetic adjuncts: It is used in patients undergoing prolonged operations, caesarian section,obese patients those are at increased risk of gastric regurgitation and aspiration pneumonia. It raises pH of gastric juice and also reduces its volume and thus chances of regurgitation.", "Composition": "Each film coated tablet of Ranitak 150 mg contains: Ranitidine 150 mg.\r\n\r\nEach film coated tablet of Ranitak 300 mg contains: Ranitidine 300 mg.\r\n(as Ranitidine Hydrochloride)", "Route": "INJECTION" }, { "ID": "21", "Trade_Name": "HERCEPTIN 600MG/5ML VIAL SOL. FOR S.C.", "Generic_Name": "TRASTUZUMAB", "Price": "24391", "Price_Old": "24391", "Company": "F.HOFFMAN LA ROCHE", "Pharmacology": "ANTINEOPLASTIC", "Category": "م#_#.#~#.#? للأو#^#.م", "Use": "–يس#?خ#~م #<ي #>ل#.ج: س#^#-#.ن #.لث#~ي #=#>#.مل مس#.#>#~.\r\n\r\n–س#^#-#.ن #.لث#~ي .\r\n\r\n–س#^#-#.ن #.لم#>#~ة #.لمن#?ش#^.\r\n\r\n–س#^#-#.ن #.لموصل #.لم#>#~ي #.لم#^يئي #.لغ#~يّ.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "22", "Trade_Name": "BLEDEX 100MG/ML I.V. 5 AMP. 5 ML", "Generic_Name": "TRANEXAMIC ACID", "Price": "23.5", "Price_Old": "23.5", "Company": "SIGMA TEC", "Pharmacology": "BLEEDDING.FIBRINOLYTICS INHIBITORS", "Category": "م#_#.#~ للنزي#< و غز#.#^ة #.ل#-مث", "Use": "–يس#?خ#~م #%#>#~ #.ج#^#.ء #.ل#>ملي#.#? لوق#< #.لنزي#< . \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? غز#.#^ة #.ل#-مث . \r\n\r\n–يس#?خ#~م لوق#< #.لنزي#< #%#>#~ #>ملي#.#? خل#> #.ل#.سن#.ن . \r\n\r\n–يس#?خ#~م لوق#< نزي#< #.ل#.ن#< . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لنزي#< #>ن#~ #.ل#.جه#.#_ . \r\n\r\n–وق#< #.لنزي#< #%#>#~ #>ملي#.#? #.لمث#.نة و#.ل#%#^وس#?#.#?#. . \r\n\r\n–وق#< #.لنزي#< #%#>#~ #>ملي#.#? #.س#?ئص#.ل س#^#-#.ن #.ل#^حم . \r\n\r\n–#>ل#.ج #.لوذمة #.لو#>#.ئية . \r\n\r\n–#>ل#.ج #.لنزي#< #.ل#~لخلي #<ي #.ل#>ين .", "Contraindications": "–يمن#> #<ي ح#.لة من ي#>#.ني #?خث#^ #.ل#~م . \r\n\r\n–يمن#> #<ي ح#.لة #>#~م #.ن#?ظ#.م #.ل#-مث . \r\n\r\n–يمن#> #<ي ح#.لة #.خ#?ل#.#- #.ل#%ول #%#.ل#~م . \r\n\r\n–يمن#> #<ي ح#.لة #?جل#- #.ل#.و#>ية #.ل#~موية .", "GI": "About Tranexamic Acid\r\nLysine Analog, Hemostatic, competitive plasminogen activationinhibitor, Antifibrinolytic,Antihemophilic.\r\nMechanism of Action of Tranexamic Acid\r\nTranexamic acid exerts antifibrinolytic effect by forming a reversible complex with plasminogen through the lysine binding site of fibrin and thus displaces the plasminogen from the fibrin surface - preventing the binding of plasmin to fibrinogen or fibrin monomers. It inhibits the activation of plasminogen (i.e. formation of plasmin). It also acts as a weak non competitive inhibitor of plasmin and blocks it`s action on fibrin.\r\nIndications for Tranexamic Acid\r\n1.Surgical procedures \r\n2.Menorrhagia \r\n3. Metrorrhagia \r\n4.Post partum haemorrhage \r\n5.Haemorrhage after abortion \r\n6.Haemorrhage due to contraceptive device insertion \r\n7.Tooth extractions and haemorrhage in other dental procedures \r\n8.Epistaxis \r\n9.Haemoptysis \r\n10.Gastrointestinal bleeding \r\n11.Prostatectomy \r\n12.Tonsillectomy \r\n13.Fibrinolysis", "Composition": "TRANEXAMIC ACID 100 MG / ML", "Route": "INJECTION" }, { "ID": "23", "Trade_Name": "RANI 50MG/2ML 5 AMP. FOR I.V/IM INJECTION (CANCELLED)", "Generic_Name": "RANITIDINE", "Price": "13.5", "Price_Old": "9", "Company": "PHARCO", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م ل#>ل#.ج ق#^حة #.لم#>#~ة و#.لأثني #>ش#^. \r\n\r\n– ي#>#.لج ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#%#.#? #.لغي#^ #.ل#.س#?ي#^وي#~ية. \r\n\r\n–يس#?خ#~م للوق#.ية من ق#^حة #.ل#.ثني #>ش#^. \r\n\r\n– يأخذ ق#%ل إج#^#.ء #.ل#>ملي#.#? لمن#> #?ص#.#>#~ حم#_ #.لم#>#~ة. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #.#^#?ج#.#> #.لم#^يء. \r\n\r\n– ي#>#.لج م#?ل#.زمة زولينج#^ #.ليسون. \r\n\r\n–ي#>#.لج #.ل#.ل#?ه#.#% #.لم#^يئي ويخ#<#< من أ#>#^#.#_ه. \r\n\r\n–ي#>#.لج ق#^حة #.لم#>#~ة #.لن#.#?ج #>ن #.لإص#.#%ة #%#.ل#>#~وى هيلي#=و#%#.#=#?#^ #%يلو#^ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #>س#^ #.له#_م #.لمزمن. \r\n\r\n–يخ#<#< من #.لآل#.م #.لق#<ص #.لص#~#^ي ومن#-قة #<م #.لم#>#~ة. \r\n\r\n– #.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #.لإجه#.#~. \r\n\r\n–يس#.#>#~ #<ي #.لوق#.ية من ح#~وث نزي#< م#?#=#^#^ ن#?يجة #.لإص#.#%ة #%ق#^حة #.لم#>#~ة. \r\n\r\n–#>ل#.ج م#?ل#.زمة من#~لسون.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية لأح#~ي #.لم#=ون#.#? #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة #.لإص#.#%ة #%م#^#_ #.ل#%و#^#<ي#^ي#..", "GI": "About Ranitidine\r\nA histamine H2-receptor antagonist, Furan derivative, Anti-secretory G.I agent,Anti ulcer.\r\nMechanism of Action of Ranitidine\r\nRanitidine is a H2 (Histamine) receptor antagonist. Histamine is the most potent stimulus of acid secretion and acts as the common mediator. H2 receptor is a G-protein coupled receptor. It induces adenylate cyclase which converts ATP to cyclic AMP. This cyclic AMP acts on proton pump and exchange extracellular potassium ion for intracellular hydrogen ion across the parietal cell membrane. Ranitidine reversibly competes with Histamine for binding to H2 receptors on the parietal cells and predominantly inhibits basal acid secretion. \r\nAnaesthetic adjuncts: It is used in patients undergoing prolonged operations, caesarian section,obese patients those are at increased risk of gastric regurgitation and aspiration pneumonia. It raises pH of gastric juice and also reduces its volume and thus chances of regurgitation.", "Composition": "Each sachet contains:\r\nRanitidine (as hydrochloride) 150 mg", "Route": "INJECTION" }, { "ID": "24", "Trade_Name": "CONTACID CONTACT LENS SOLUTION 250 ML", "Generic_Name": "BORIC ACID+DISODIUM EDETATE+SODIUM BORATE+SODIUM CHLORIDE", "Price": "28.8", "Price_Old": "28.8", "Company": "CID", "Pharmacology": "CONTACT LENSES SOLUTION", "Category": "محلول #.ل#>#~س#.#? #.لل#.صقة", "Use": "–ينظ#< #.ل#>#~س#.#? من #.لأ#?#^#%ة و#.لشو#.ئ#% #.ل#>#.لقة #%ه#.. \r\n\r\n–ي#-ه#^ #.ل#>#~س#.#? من #.لمي#=#^و#%#.#?. \r\n\r\n–يزيل #.ل#%#^و#?ين #.لم#?#=ون #>لى #.لس#-ح #.ل#>#~س#.#?. \r\n\r\n–ي#^#-#% #.ل#>#~س#.#? ل#?#=ون م#^يحة أثن#.ء أ#^#?#~#.ئه#.. \r\n\r\n–يقوم #%ح#<ظ #.ل#>#~س#.#? #~#.خل (ح#.#<ظة #.ل#>#~س#.#?) ل#<#?#^ة #-ويلة.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "COMING SOON ..", "Composition": "boric acid, sod. Borate, sod. Chloride", "Route": "EYE" }, { "ID": "25", "Trade_Name": "APHTHTAB 2MG 20 BUCCAL BIOADHESIVE TAB.", "Generic_Name": "AMLEXANOX", "Price": "46", "Price_Old": "46", "Company": "EVA PHARMA", "Pharmacology": "MOUTH ULCER.ANTIALLERGIC.ANTI-INFLAMMATORY", "Category": "#.لج#^وح و #.لح#^وق", "Use": "–آ#<ة #.لق#^وح \r\n\r\n–ق#^حة #.لم#>#~ة #.لم#^#?#%#-ة #%م#^#_ #%هج#? \r\n\r\n–#^#%و \r\n\r\n–#.ل#?ه#.#% #.لأن#< #.ل#?حسسي \r\n\r\n–#.ل#?ه#.#% #.لمل#?حمة", "Contraindications": "–#.ل#=#%#~ أو مش#.#=ل #<ي #.ل#=لى \r\n\r\n–#?جن#% #.ل#.#?ص#.ل #.لم#%#.ش#^ م#> #.ل#>ين \r\n\r\n–غسل #.لي#~ين #%#>#~ #.ل#.س#?خ#~#.م \r\n\r\n–#<#^#- #.لحس#.سية", "GI": "Description :\t\r\nAmlexanox is an antiallergic drug, clinically effective for atopic diseases, especially allergic asthma and rhinitis. Amlexanox as a topical paste is a well tolerated treatment of recurrent aphthous ulcers. Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population.\r\n\r\nIndication :\r\nUsed as a paste in the mouth to treat aphthous ulcers\r\n\r\nMechanism of action :\r\namlexanox has anti-inflammatory and antiallergic properties. It inhibits chemical mediatory release of the slow-reacting substance of anaphylaxis (SRS-A) and may have antagonistic effects on interleukin-3. When cells are under stress, they release an inactive form of human fibroblast growth factor 1 (FGF-1), a potent mitogen (entity that causes mitosis). Amlexanox binds to FGF1, increasing its conformational stability, sterically blocking Cu(2+) induced oxidation which normally leads to activation of FGF-1.", "Composition": "Amlexanox 2mg\r\n\r\nInactive ingredients:\r\nMicrocrystalline cellulose, Carbomer, Polycarbophil, Povidone, Anhydrous Colloidal silica, Mg Trislicate.", "Route": "ORAL.SOLID" }, { "ID": "26", "Trade_Name": "EXAMIDE 10MG/ML AMP. FOR I.V INJ.", "Generic_Name": "TORSEMIDE", "Price": "11.25", "Price_Old": "10.5", "Company": "SUNNY PHARMACEUTICALS > MULTI-APEX", "Pharmacology": "DIURETIC.LOOP", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ي#>#.لج أ#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–ي#>#.لج #>#~م أن#?ظ#.م #_#^#%#.#? #.لقل#%. \r\n\r\n–#.لوق#.ية من #.لص#~#.#> #.لنص#<ى. \r\n\r\n–#.لوق#.ية من #.لذ#%حة #.لص#~#^ية. \r\n\r\n–#?قليل خ#-#^ #.لأص#.#%ة #%#.لذ#%حة #.لص#~#^ية. \r\n\r\n–يقلل من #.لحمل #>لى #>#_لة #.لقل#%. \r\n\r\n–وأي#_#. ي#>#.لج أم#^#.#_ #.لش#^#.يين #.ل#?#.جية. \r\n\r\n–ي#>#.لج أ#>#?ل#.ل #>#_لة #.لقل#%. \r\n\r\n–وأي#_#. #<شل #.لقل#% #.لأح#?ق#.نى. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لأم#^#.#_ #.لخ#.صة #%#.ل#=لي. \r\n\r\n–يس#?خ#~م #.ل#~و#.ء من #_من م#~#^#.#? #.ل#%ول وهذ#. ي#=ون #<ي ح#.ل#.#? #.ل#<شل #.ل#=#%#~ي لم #?#?م #~#^#.س#?ه #%صو#^ة م#^#_ية.", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–يمن#> لمن ي#>#.نون من أنق#-#.#> #.ل#%ول. \r\n\r\n–ومن ي#>#.نون من خلل #<ى وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–ومن ي#>#.نون من أ#^#?#<#.#> #<ى #_غ#- #.ل#~م. \r\n\r\n–يمن#> لمن ل#~يهم ق#^حة #<ى #.لم#>#~ة. \r\n\r\n–ومن ي#>#.نون من قصو#^ #.لقل#%. \r\n\r\n–#=م#. ل#. يم#=ن #?ن#.وله أي#_#. #<ى #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "About Torsemide\r\nPyridine-sulfonylurea class Loop Diuretic, Antihypertensive,in CHF, Diuretic.\r\nMechanism of Action of Torsemide\r\nTorsemide is a high ceiling loop diuretic which exerts it`s diuretic action by acting at site-2(thick ascending loop of Henle). It binds to Na+K+2Cl- symporter and inhibits Na+K+2Cl- co transport in luminal membrane of thick ascending loop of Henle. It inhibits sodium and chloride re absorption and promotes excretion of sodium, water, chloride, potassium, calcium, and magnesium. Torsemide does not significantly alter glomerular filtration rate, renal plasma flow, or acid base balance. \r\nTorsemide increase local prostaglandin synthesis and increases systemic venous capacitance and decreases left ventricular filling pressure. This causes relief in left ventricular failure and pulmonary edema. It causes renal and peripheral vasodilatation and decrease in peripheral resistance.", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "27", "Trade_Name": "EMEDROTEC 3MG 20 BUCCAL BIOADHESIVE TAB.", "Generic_Name": "PROCHLORPERAZINE", "Price": "16", "Price_Old": "16", "Company": "EVA PHARMA", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#?خ#~م #<ي ح#.ل#.#? #.لميل للقيء و#.لقيء و#.ل#~وخة و#.لص#~#.#> #.لنص#<ي .", "Contraindications": "–#<#^#- #.لحس#.سية من أي من #.لم#=ون#.#?.", "GI": "About Prochlorperazine\r\nFirst-Generation Antipsychotic, Phenothiazine derivative, Antiemetic, Antipsychotic,anxiolytic.\r\nMechanism of Action of Prochlorperazine\r\nAntipsychotic action: Prochlorperazine binds to the dopamine receptor (D1, D2, D3 &D4).It exerts its antipsychotic activity by blocking the dopamine projections in the limbic system and in mesocortical area. Peripherally and centrally it acts as a competitive Dopamine antagonist. Prochlorperazine also produces alpha adrenergic blocking activity and anticholinergic activity. It also produces weak H1 antihistaminic activity and anti serotonin activity. \r\nAntiemetic action: Antiemetic activity is by blocking dopamine receptor (D2 receptor) in the Chemoreceptor trigger zone (CTZ) \r\nMigraine: Prochlorperazine has been used in migraine to control severe nausea and vomiting unresponsive to Antiemetics and to relieve the pain of severe migraine attacks unresponsive to parenteral Dihydroergotamine or Sumatriptan.", "Composition": "Each buccal bioadhesive tablet contains:Active Substance:\r\nProchlorperazine maleate 3 mg", "Route": "ORAL.SOLID" }, { "ID": "28", "Trade_Name": "RANITIDINE 50MG/5ML 5 AMP. (CANCELLED)", "Generic_Name": "RANITIDINE", "Price": "15", "Price_Old": "10", "Company": "PHAROPHARMA", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م ل#>ل#.ج ق#^حة #.لم#>#~ة و#.لأثني #>ش#^. \r\n\r\n– ي#>#.لج ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#%#.#? #.لغي#^ #.ل#.س#?ي#^وي#~ية. \r\n\r\n–يس#?خ#~م للوق#.ية من ق#^حة #.ل#.ثني #>ش#^. \r\n\r\n– يأخذ ق#%ل إج#^#.ء #.ل#>ملي#.#? لمن#> #?ص#.#>#~ حم#_ #.لم#>#~ة. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #.#^#?ج#.#> #.لم#^يء. \r\n\r\n– ي#>#.لج م#?ل#.زمة زولينج#^ #.ليسون. \r\n\r\n–ي#>#.لج #.ل#.ل#?ه#.#% #.لم#^يئي ويخ#<#< من أ#>#^#.#_ه. \r\n\r\n–ي#>#.لج ق#^حة #.لم#>#~ة #.لن#.#?ج #>ن #.لإص#.#%ة #%#.ل#>#~وى هيلي#=و#%#.#=#?#^ #%يلو#^ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #>س#^ #.له#_م #.لمزمن. \r\n\r\n–يخ#<#< من #.لآل#.م #.لق#<ص #.لص#~#^ي ومن#-قة #<م #.لم#>#~ة. \r\n\r\n– #.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #.لإجه#.#~. \r\n\r\n–يس#.#>#~ #<ي #.لوق#.ية من ح#~وث نزي#< م#?#=#^#^ ن#?يجة #.لإص#.#%ة #%ق#^حة #.لم#>#~ة. \r\n\r\n–#>ل#.ج م#?ل#.زمة من#~لسون.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية لأح#~ي #.لم#=ون#.#? #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة #.لإص#.#%ة #%م#^#_ #.ل#%و#^#<ي#^ي#..", "GI": "About Ranitidine\r\nA histamine H2-receptor antagonist, Furan derivative, Anti-secretory G.I agent,Anti ulcer.\r\nMechanism of Action of Ranitidine\r\nRanitidine is a H2 (Histamine) receptor antagonist. Histamine is the most potent stimulus of acid secretion and acts as the common mediator. H2 receptor is a G-protein coupled receptor. It induces adenylate cyclase which converts ATP to cyclic AMP. This cyclic AMP acts on proton pump and exchange extracellular potassium ion for intracellular hydrogen ion across the parietal cell membrane. Ranitidine reversibly competes with Histamine for binding to H2 receptors on the parietal cells and predominantly inhibits basal acid secretion. \r\nAnaesthetic adjuncts: It is used in patients undergoing prolonged operations, caesarian section,obese patients those are at increased risk of gastric regurgitation and aspiration pneumonia. It raises pH of gastric juice and also reduces its volume and thus chances of regurgitation.", "Composition": "Each 2 ml ampoule contains:\r\nRanitidlne as HCI 50 mg", "Route": "INJECTION" }, { "ID": "29", "Trade_Name": "ADOL EXTRA 24 CAPLETS.", "Generic_Name": "CAFFEINE+PARACETAMOL(ACETAMINOPHEN)", "Price": "16.5", "Price_Old": "11", "Company": "JULPHAR", "Pharmacology": "ANTIPYRETIC", "Category": "مس#=ن وم#_#.#~ لل#.ل#?ه#.#%", "Use": "–#.لص#~#.#> و#.ل#.لم #<ى #.ل#>#_ل#.#? \r\n\r\n–#.ل#.م #.لظه#^ و #.ل#.م #.ل#.سن#.ن \r\n\r\n–مس#=ن لل#.لم سو#.ء #=#.ن ح#.#~ #.و مزمن \r\n\r\n–#.وج#.#> #.ل#?ه#.#% #.لم#<#.صل \r\n\r\n–#.لم #.ل#.سن#.ن \r\n\r\n–#.لم #.ل#^وم#.#?يزم \r\n\r\n–#.وج#.#> #.س#<ل #.لظه#^ \r\n\r\n–#.ل#.ل#.م #%#>#~ #>ملي#.#? #.ل#?لقيح #%ش#=ل #>#.م \r\n\r\n–#.وج#.#> #.لحلق و #.لجسم #%س#%#% نزل#.#? #.ل#%#^#~ و#.ل#.ن#<لونز#. \r\n\r\n–يق#_ى #>لى #.لص#~#.#> #.لنص#<ى \r\n\r\n–#.ل#?ه#.#% #.للوز#?ين و#.لحنج#^ة \r\n\r\n–#.لم #.ل#.ذنين \r\n\r\n–#.لم #.ل#^وم#.#?يزم \r\n\r\n–#.ل#?ه#.#% #.لجيو#% #.ل#.ن#<ية \r\n\r\n–#.ل#.م #.ل#>#_ل#.#? و#.ل#.ل#.م #.ل#>ص#%ية \r\n\r\n–#.ل#.ل#.م #.لمص#.ح#%ة ل#~و#^ة #.ل#-مث \r\n\r\n–#.ل#.ل#.م #<ى م#^#_ى #.لق#^حة", "Contraindications": "–#<#^#- حس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى . \r\n\r\n–م#^#_ ش#~ي#~ #<ى #.ل#=#%#~. \r\n\r\n–قصو#^ #<ى وظ#.ئ#< #.ل#=لي.", "GI": "mechanism:\r\nIt is thought paracetamol reduces fever by affecting an area of the brain that regulates our body temperature (the hypothalamic heat-regulating center).\r\nParacetamol is about as effective as aspirin or ibuprofen at relieving mild to moderate pain and fever, but unlike aspirin and ibuprofen it has no anti-inflammatory effect.\r\nCaffeine is a mild stimulant that helps reduce fatigue. Caffeine is also thought to enhance the painkilling effect of paracetamol.\r\n\r\nWhat is it used for?\r\nMild to moderate pain, such as headache, migraine, toothache, sore throat, muscular and rheumatic pain, nerve pain (neuralgia), backache (lumbago) and period pain.\r\nRelieving aches, pains, sore throat and fever associated with colds and flu.", "Composition": "Each caplet contains:\r\nActive ingredients: Paracetamol 500mg\r\nCaffeine 65mg\r\n\r\nExcipients: Maize starch, povidone, polysorbate 80,\r\nmicrocrystalline cellulose, sodium strach glycolate, cross carmellose sodium, stearic acid, and talc.", "Route": "ORAL.SOLID" }, { "ID": "30", "Trade_Name": "IPRAVENT-S AEROSOL FOR INHALATION 200 DOSES", "Generic_Name": "IPRATROPIUM BROMIDE+SALBUTAMOL", "Price": "33.25", "Price_Old": "22.2", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIMUSCARINIC.ASTHMA.COMBINED WITH BETA AGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–#.لسي#-#^ة #>لي مش#.#=ل #_يق #.ل#?ن#<س . \r\n\r\n–#.ل#?ه#.#% #.لقص#%#.#? #.لهو#.ئية . \r\n\r\n–#.ل#.نس#~#.#~ #.ل#^ئوي #.لمزمن .", "Contraindications": "–#<ي ح#.لة وجو#~ حس#.سية م#<#^#-ة #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.لحمل ل#?جن#% ح#~وث #?شوه#.#? للجنين . \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.ل#^#_#.#>ة من#>#. لنزول #.ل#~و#.ء #<ي حلي#% #.لث#~ي .", "GI": "About Ipratropium Bromide\r\nAnticholinergic, Muscarinic antagonist,Tropane derivative, Bronchodilator( Anti asthma)\r\nMechanism of Action of Ipratropium Bromide\r\nIpratropium bromide selectively acts on bronchial muscle without altering volume or consistency of respiratory secretions. It inhibits vagally mediated reflexes by antagonizing the actions of acetylcholine. It prevents the acetylcholine mediated increase in intracellular cyclic GMP concentration that results from interaction of acetylcholine with muscarinic receptor on bronchial smooth muscle. It does not depress the muco-ciliary clearance by bronchial epithelium. It blocks the cholinergic constrictor tone and acts primarily in the larger airways.", "Composition": "COMING SOON ..", "Route": "SPRAY" }, { "ID": "31", "Trade_Name": "BETAFOS 1 AMP. 2ML", "Generic_Name": "BETAMETHASONE DIPROPIONATE+BETAMETHASONE SODIUM PHOSPHATE", "Price": "16", "Price_Old": "12", "Company": "AMOUN", "Pharmacology": "GLUCOCORTICOID", "Category": "أم#^#.#_ #.لمن#.#>ة #.لذ#.#?ية و #.لحس#.سية و #.ل#.ل#?ه#.#%#.#? و #.ل#^#%و و ز#^#.#>ة #.لأ#>#_#.ء", "Use": "–#.لحس#.سية #.لش#~ي#~ة. \r\n\r\n–#.ل#^#%و #.لش#~ي#~. \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#^وم#.#?يزم \r\n\r\n–#.لإل#?ه#.#% #.لم#<صلي #.لنق#^سي \r\n\r\n–#.ل#?ه#.#% #.لم#<صلي #.لص#~#<ي \r\n\r\n–#.للم#%#.جو \r\n\r\n–#.لقصو#^ #.لغ#~ة #.ل#=ظ#^ية \r\n\r\n–#.ل#?ه#.#%#.#? #.لغ#~ة #.ل#~#^قية \r\n\r\n–#.ل#?ه#.#% #.لقولون #.ل#?ق#^حي \r\n\r\n–إل#?ه#.#% #.لأم#>#.ء \r\n\r\n–مس#=ن #<ي ح#.ل#.#? س#^#-#.ن #.ل#~م و#=ذل#= #.لأو#^#.م #.للي#<ية. \r\n\r\n–#.لحس#.سية وإل#?ه#.#%#.#? #.ل#>ين #.لش#~ي#~ة.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.لحقن للأ#-#<#.ل و#.ل#^#_#> حيث إنه يح#?وى #>لى م#.#~ة #=حول #%نزيلي و#.لذي يس#%#% #.لو#<#.ة لهم. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم حس#.سية م#<#^#-ة #.#?ج#.ه م#.#~ة #.ل#%ي#?#.ميث#.زون. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل ح#?ى ل#. يس#%#% #?شوه #.لأجنة. \r\n\r\n–ينصح #%#>#~م أخذ #.لحقن للم#^أة #.لم#^#_#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه.", "GI": "About Betamethasone dipropionate\r\nA synthetic glucocorticoid, anti-inflammatory.\r\n\r\nIndications for Betamethasone dipropionate\r\n1.Eczema \r\n2.Psoriasis \r\n3.Contact dermatitis \r\n4.Anal and vulval Pruritis \r\n5.Inflammation of the skin \r\n\r\nContra-indications of Betamethasone dipropionate\r\n1.Hypersensitivity to Betamethasone \r\n2.Untreated bacterial virus or fungal infections \r\n3.Acne vulgaris \r\n4.Peri-oral dermatitis \r\n5.Tuberculosis of the skin \r\n6.Varicose ulcers \r\n7.Skin lesions caused by infections with herpes simplex vaccinia or varicella viruses. fungi (e.g. Candida Tinea) or bacteria (e.g. impetigo) \r\n8.Discoid lupus Erythematosus", "Composition": "betamethasone 7mg", "Route": "INJECTION" }, { "ID": "32", "Trade_Name": "ATROPINE SULPHATE 1MG/ML 25 AMP.", "Generic_Name": "ATROPINE SULPHATE", "Price": "81", "Price_Old": "26", "Company": "MISR", "Pharmacology": "ANTIMUSCARINIC", "Category": "للقل#% و مش#.#=ل #.لجه#.ز #.له#_مى", "Use": "–#?س#^ي#> ن#%#_ #.لقل#% #<ي ح#.ل#.#? #.نخ#<#.#_ و#?ي#^ة #.لن#%#_ أث#^ خلل جزئي #%#.ل#?وصيل #.ل#=ه#^#%#.ئي #<ي #.لقل#%، وخل#.ل #>ملي#.#? #.لإن#>#.ش و#.لإحي#.ء.\r\n\r\n–إ#_#.#<ة ل#>ل#.ج #.ل#?سمم #%غ#.ز #.لأ#>ص#.#%.\r\n\r\n–#<ي #%#>#_ #.ل#~ول، ي#?م إ#>#-#.ء #.لأ#?#^و#%ين م#~موج#. أو مصحو#%#. #%#>ق#.#^ #.ل#~ي#<سو#=نيل#.#? (Difnoksilat)، وهو #>ق#.#^ م#_#.#~ للإسه#.ل، وذل#= من أجل #?قليل #?قلص#.#? #.ل#%#-ن و#.لمغص #.لم#^#.#<ق#.ن ل#.ل#?ه#.#% #.لأم#>#.ء.\r\n\r\n–#=م#. ي#?م إ#>#-#.ء #.لأ#?#^و#%ين #=جزء من #>ملية #.ل#.س#?#>#~#.#~ و#.ل#?ح#_ي#^ لل#>ملي#.#? #.لج#^#.حية #.ل#?ي ي#?م إج#^#.ؤه#. #?ح#? #.ل#?خ#~ي#^ #.ل#=#.مل.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.م#%ول#.#? #.ل#.#?#^و#%ين #<ي ح#.ل#.#? #<#^#- #.لحس#.سية منه#.. \r\n\r\n–#=ذل#= #<ي ح#.ل#.#? #.ل#.ص#.#%ة #%#.لجلو#=وم#. #.و #.لمي#.ه #.لز#^ق#.ء #>لى #.ل#>ين من #.لنو#> #_يق #.لز#.وية. \r\n\r\n–#=ذل#= #<ي ح#.ل#.#? م#^#_ #?#_خم #.ل#%#^وس#?#.#?#. وم#^#_ #.لوهن #.ل#>#_لي #.لو#%يلي. \r\n\r\n–#<ي ح#.ل#.#? م#^#_ى شلل #.ل#.م#>#.ء و#.ل#?ه#.#%#.#? #.لقولون #.ل#?ق#^حي . \r\n\r\n–يج#% #.ن #?س#?خ#~م #%حذ#^ #<ي ح#.ل#.#? #.ل#.#-#<#.ل و#=#%#.#^ #.لسن \r\n\r\n–و#=ذل#= #.لح#.ل #<ي #.لح#.ل#.#? #.لم#^#_ية #.ل#?ي #?#>#.ني من #.ل#.سه#.ل #.و #.ح#?#%#.س #.ل#%ول \r\n\r\n–#=م#. يس#?خ#~م #%حذ#^ #<ي ح#.ل#.#? #.#^#?#<#.#> #~#^ج#.#? ح#^#.#^ة #.ل#-قس \r\n\r\n–ل#.نه يمن#> #.ل#?#>#^ق و#%#.ل#?#.لي ق#~ يؤ#~ي #.لى #.#^#?#<#.#> #~#^جة ح#^#.#^ة #.لجسم #.ل#~#.خلية \r\n\r\n–وم#^#_ى #.ل#_غ#- #.لم#^#?#<#> #=م#. يس#?خ#~م #%حذ#^ #<ي ح#.ل#.#? #.لم#^#_ى #.لذين ي#>#.نون من #.ل#?سمم #.ل#^ئوي .", "GI": "Description :\r\nAn alkaloid, originally from Atropa belladonna, but found in other plants, mainly solanaceae.\r\n\r\nIndication :\r\nFor the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as organophosphorous or carbamate insecticides and may prescribed for dilatation of pupil. It is used to relieve pain caused by swelling and inflammation of the eye. \t\r\n\r\nMechanism of action\t : \r\nAtropine binds to and inhibit muscarinic acetylcholine receptors, producing a wide range of anticholinergic effects.\r\n\r\nAbsorption : \r\nAtropine is rapidly and well absorbed after intramuscular administration. Atropine disappears rapidly from the blood and is distributed throughout the various body tissues and fluids\r\n\r\nHalf life : \r\n3.0 ? 0.9 hours in adults. The half-life of atropine is slightly shorter (approximately 20 minutes) in females than males.", "Composition": "atropine 1mg", "Route": "INJECTION" }, { "ID": "33", "Trade_Name": "SEREVENT 25MCG ROTADISKS", "Generic_Name": "SALMETEROL", "Price": "60", "Price_Old": "60", "Company": "GLAXO SMITHKLINE", "Pharmacology": "BRONCHODILATOR", "Category": "موس#> للش#>#% #.لهو#.ئية", "Use": "–#>ل#.ج #.ل#^#%و #.لمزمن. \r\n\r\n–موس#> للش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #_يق #.ل#?ن#<س. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#^ئوية.", "Contraindications": "–#.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ي #.لص#^#> و#.لقل#%. \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ي #.لس#=#^. \r\n\r\n–يمن#> #<ي ح#.لة #.لنو#%#.#? #.ل#^#%و #.لح#.#~ة.", "GI": "About Salmeterol\r\nA long-acting beta2-adrenergic agonist, Phenethylamine derivative, Bronchodilator(Antiasthma).\r\nMechanism of Action of Salmeterol\r\nSalmeterol is a long acting BETA2 receptor agonist. It directly relaxes the airway smooth muscles and produces bronchodilation. Stimulation of BETA2 receptors activates Gs adenylyl-cyclase -cyclic AMP path way and produces reduction in smooth muscle tone. BETA2 receptor agonists also increases the conductance of large Ca2+ sensitive K+ channels in airway smooth muscles and leads to membrane hyperpolarisation and relaxation of smooth muscles. Its BETA2 receptor selectivity is about 50 times greater than Salbutamol. \r\n?2 receptor agonists also suppress the release of Leukotrienes and histamine from the mast cells in the lung tissue and enhance mucociliary function and decrease micro vascular permeability and also inhibits Phospholipase A2 which produces inhibition of prostaglandins production.", "Composition": "salmeterol 50mcg or 25mcg", "Route": "INHALATION" }, { "ID": "34", "Trade_Name": "MIACALCIC 100 I.U/ML 5 AMP. FOR I.M./I.V./S.C INJ.", "Generic_Name": "CALCITONIN", "Price": "133.5", "Price_Old": "133.5", "Company": "NOVARTIS", "Pharmacology": "OSTEOPOROSIS.ANTIRESORPTIVES", "Category": "هش#.شة #.ل#>ظ#.م م#> م#_#.#~ لل#>#^ق", "Use": "–يس#?خ#~م #<ي #>ل#.ج م#^#_ #%#.جي#?. \r\n\r\n–ي#>#.لج هش#.شة #.ل#>ظ#.م. \r\n\r\n–ي#>#.لج زي#.#~ة نس#%ة #.ل#=#.لسيوم #<ي #.لجسم و#.ل#?ي #?س#%#% س#^#-#.ن #.ل#>ظ#.م. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #<ق#~#.ن #.ل#>ظ#.م و#?#=س#^ه#..", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ للم#^أة #.لح#.مل حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.ل للجنين ويس#%#% #?شوه #.لأجنة. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ للم#^أة #.لم#^#_#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من نقص #<ي مس#?وي #.ل#=#.لسيوم. \r\n\r\n–يحذ#^ #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? #>ن#~ #?ن#.ول #.ل#>ق#.#^ حيث يس#%#% #.ل#~وخة و#<ق#~#.ن #.ل#?#^#=يز.", "GI": "PRESCRIBED FOR:\r\n Injectable calcitonin is used to treat osteoporosis and Paget s disease. Injectable calcitonin also is used to treat seriously elevated blood calcium levels. The nasal spray is used only for osteoporosis in women who are at least 5 years postmenopausal.\r\n\r\nDOSING:\r\n Injectable calcitonin is injected under the skin or into the muscle. The nasal spray is administered into the nostril. To achieve optimal results, patients with osteoporosis should simultaneously receive adequate amounts of calcium and vitamin D.", "Composition": "salmon calcitonin 100i.u. or 200i.u or 50i.u", "Route": "INJECTION" }, { "ID": "35", "Trade_Name": "DIPROCORTIN 1 AMP. 2ML", "Generic_Name": "BETAMETHASONE DIPROPIONATE+BETAMETHASONE SODIUM PHOSPHATE", "Price": "20", "Price_Old": "13.2", "Company": "SIGMA TEC", "Pharmacology": "GLUCOCORTICOID", "Category": "أم#^#.#_ #.لمن#.#>ة #.لذ#.#?ية و #.لحس#.سية و #.ل#.ل#?ه#.#%#.#? و #.ل#^#%و و ز#^#.#>ة #.لأ#>#_#.ء", "Use": "–#.لحس#.سية #.لش#~ي#~ة. \r\n\r\n–#.ل#^#%و #.لش#~ي#~. \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#^وم#.#?يزم \r\n\r\n–#.لإل#?ه#.#% #.لم#<صلي #.لنق#^سي \r\n\r\n–#.ل#?ه#.#% #.لم#<صلي #.لص#~#<ي \r\n\r\n–#.للم#%#.جو \r\n\r\n–#.لقصو#^ #.لغ#~ة #.ل#=ظ#^ية \r\n\r\n–#.ل#?ه#.#%#.#? #.لغ#~ة #.ل#~#^قية \r\n\r\n–#.ل#?ه#.#% #.لقولون #.ل#?ق#^حي \r\n\r\n–إل#?ه#.#% #.لأم#>#.ء \r\n\r\n–مس#=ن #<ي ح#.ل#.#? س#^#-#.ن #.ل#~م و#=ذل#= #.لأو#^#.م #.للي#<ية. \r\n\r\n–#.لحس#.سية وإل#?ه#.#%#.#? #.ل#>ين #.لش#~ي#~ة.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.لحقن للأ#-#<#.ل و#.ل#^#_#> حيث إنه يح#?وى #>لى م#.#~ة #=حول #%نزيلي و#.لذي يس#%#% #.لو#<#.ة لهم. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم حس#.سية م#<#^#-ة #.#?ج#.ه م#.#~ة #.ل#%ي#?#.ميث#.زون. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل ح#?ى ل#. يس#%#% #?شوه #.لأجنة. \r\n\r\n–ينصح #%#>#~م أخذ #.لحقن للم#^أة #.لم#^#_#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه.", "GI": "About Betamethasone dipropionate\r\nA synthetic glucocorticoid, anti-inflammatory.\r\n\r\nIndications for Betamethasone dipropionate\r\n1.Eczema \r\n2.Psoriasis \r\n3.Contact dermatitis \r\n4.Anal and vulval Pruritis \r\n5.Inflammation of the skin \r\n\r\nContra-indications of Betamethasone dipropionate\r\n1.Hypersensitivity to Betamethasone \r\n2.Untreated bacterial virus or fungal infections \r\n3.Acne vulgaris \r\n4.Peri-oral dermatitis \r\n5.Tuberculosis of the skin \r\n6.Varicose ulcers \r\n7.Skin lesions caused by infections with herpes simplex vaccinia or varicella viruses. fungi (e.g. Candida Tinea) or bacteria (e.g. impetigo) \r\n8.Discoid lupus Erythematosus", "Composition": "betamethasone dipropionate,betamethasone Na Phosphate", "Route": "INJECTION" }, { "ID": "36", "Trade_Name": "A.ONE SOAP 100 GM", "Generic_Name": "", "Price": "9.5", "Price_Old": "9.5", "Company": "A ONE PHARM", "Pharmacology": "ANTIFUNGAL", "Category": "م#_#.#~ لل#<#-#^ي#.#?", "Use": "–COMING SOON ..", "Contraindications": "–COMING SOON ..", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "SOAP" }, { "ID": "37", "Trade_Name": "KINOPRID 5MG/ML 5 AMP.", "Generic_Name": "BIPERIDENE", "Price": "46", "Price_Old": "46", "Company": "DELTA PHARMA", "Pharmacology": "ANTIPARKINSON AGENTS. MUSCARINIC ANTAGONIST", "Category": "للشلل #.ل#^#>#.ش", "Use": "–يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.لشلل #.ل#^#>#.ش #%جمي#> أش#=#.له سو#.ء أ#=#.ن #%س#%#% #.ل#?ه#.#% #<ي #.ل#~م#.غ أو #%س#%#% #?صل#% #<ي #.لش#^#.يين أو #=#.ن مجهول #.لس#%#%. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#.ل#.#? #.#_#-#^#.#% #.لنظ#.م خ#.#^ج #.له#^مي #.لذي يصي#% #.لم#^ي#_ #%س#%#% #?ن#.وله لأ#~وية #?سمى #.ل#<ينوثي#.زين.", "Contraindications": "–يمن#> #?ن#.وله للم#^#_ى #.لذين ي#>#.نون من حس#.سية من #.ل#>ق#.#^ أو لأي من م#=ون#.#?ه. \r\n\r\n–يحظ#^ #?ن#.وله #>لى من ي#>#.ني من م#^#_ #.لمي#.ه #.لز#^ق#.ء “#.لجلو#=وم#.”. \r\n\r\n–يحظ#^ وص#<ه لم#^#_ى #.نس#~#.#~ #.لأم#>#.ء. \r\n\r\n–م#^#_ى #.لوهن #.ل#>#_لي #.لو#%يل. \r\n\r\n–لمن ي#>#.ني من مش#.#=ل #<ي #.لقل#% وخ#.صة #?ل#= #.ل#?ي #?ن#?ج #>ن نزي#< #~#.خلي. \r\n\r\n–لمن ي#>#.ني من ص#>و#%ة #<ي #.ل#?#%ول. \r\n\r\n–ح#.ل#.#? #?#_خم #.لقولون أو م#. ي#>#^#< #%إسم ميج#. #=ولون. \r\n\r\n–م#^#_ى #.ل#_يق #.لمي#=#.ني#=ي #%#.لجه#.ز #.له#_مي.", "GI": "Description\t\r\nA muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.\r\n\r\nIndication:\r\nFor use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.\r\n\r\nMechanism of action\tParkinsonism is thought to result from an imbalance between the excitatory (cholinergic) and inhibitory (dopaminergic) systems in the corpus striatum. The mechanism of action of centrally active anticholinergic drugs such as biperiden is considered to relate to competitive antagonism of acetylcholine at cholinergic receptors in the corpus striatum, which then restores the balance.", "Composition": "biperiden 5mg", "Route": "INJECTION" }, { "ID": "38", "Trade_Name": "NAUSILEX 50MG/2ML I.V/I.M 3 AMP.", "Generic_Name": "ALIZAPRIDE", "Price": "21", "Price_Old": "21", "Company": "MINA PHARM", "Pharmacology": "DOPAMINE ANTAGONIST", "Category": "م#_#.#~ للقيء", "Use": "–م#_#.#~ للقئ -ومنظم لح#^#=ة #.ل#.م#>#.ء", "Contraindications": "–ل#. #?س#?#>مل #.ل#>ق#.#^ إن #=#.ن#? ل#~ي#= حس#.سية م#<#^#-ة لأي من م#=ون#.#? #.ل#>ق#.#^ #.ل#<#>#.لة. \r\n\r\n–ق#%ل أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ وأي #>ق#.قي#^ أخ#^ى يج#% أن #?#%لغ #-#%ي#%#= #>ن #.لق#.ئمة #.ل#?ي #?#?ن#.وله#. من #.لأ#~وية و#.لمن#?ج#.#? #.لأخ#^ى، #>لى س#%يل #.لمث#.ل: (م#=مل#.#? #>ش#%ية أو #<ي#?#.مين#.#? وغي#^ه). \r\n\r\n–أخ#%#^ #-#%ي#%#= إن #=#.ن ل#~ي#= حس#.سية، وأخ#%#^ه أي#_#.ً إن #>ن #.لأم#^#.#_ #.ل#?ي #=#.ن#? موجو#~ة من ق#%ل. \r\n\r\n–أخ#%#^ #-#%ي#%#= #>ن ظ#^و#<#= #.لصحية #.لح#.لية #>لى س#%يل #.لمث#.ل: (هن#.#= ج#^#.حة ق#.#~مة، #>لى وش#= #.لحمل وغي#^ه). \r\n\r\n–#^#%م#. #?ج#>ل#= #%#>#_ #.لمش#.#=ل #.لصحية م#>#^#_#.ً أ#=ث#^ لح#~وث أ#>#^#.#_ ج#.ن#%ية، #?ن#.ول #.ل#>ق#.#^ حس#% إ#^ش#.#~#.#? و#?وجيه#.#? #.ل#-#%ي#% أو #.#?#%#> #.ل#?وجيه#.#? و#.ل#?#>ليم#.#? #.لموجو#~ة #~#.خل #.ل#>ق#.#^. \r\n\r\n–#?ن#.ول #.لج#^#>ة ي#?م #%ن#.ء #>لى ح#.ل#?#=، #>لي#= #%إخ#%#.#^ #-#%ي#%#= إن #=#.ن#? ح#.ل#?#= #?سوء.", "GI": "Description :\r\nAlizapride is a dopamine antagonist with prokinetic and antiemetic effects\r\n\r\nIndication :\r\n used in the treatment of nausea and vomiting, including postoperative nausea and vomiting.\r\n\r\nMechanism of action :\r\nThe anti-emetic action of Alizapride is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone (CTZ) in the central nervous system (CNS)?this action prevents nausea and vomiting triggered by most stimuli. Structurally similar to metoclopramide and, therefore, shares similar other atributres related to emesis and prokinetics.\r\n\r\nHalf life :\r\n3 hours", "Composition": "Nausilex tablets:\r\nEach tablet contains:\r\nAlizapride hydrochloride 55.8 mg equal to 50 mg of alizapride.\r\nNausilex ampoule:\r\n\r\nEach ampoule contains:\r\nAlizapride hydrochloride 55.8 mg equal to 50 mg of alizapride.\r\nExcipients: Sodium Chloride, Water for injectio", "Route": "INJECTION" }, { "ID": "39", "Trade_Name": "ALFACLINDAMYCIN 300MG/2ML 5 AMP. I.V./I.M. INJ.", "Generic_Name": "CLINDAMYCIN", "Price": "99.5", "Price_Old": "71", "Company": "ALEXANDRIA > ROTABIOGEN FOR PHARMACEUTICAL INVEST.", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "clindamycin 300mg or 600mg", "Route": "INJECTION" }, { "ID": "40", "Trade_Name": "CALCIDOL 1 MCG 30 CAPS.", "Generic_Name": "ALFACALCIDOL", "Price": "51", "Price_Old": "51", "Company": "KAHIRA > MULTIPHARMA", "Pharmacology": "VITAMIN D", "Category": "#<ي#?#.مين #~", "Use": "–يس#?خ#~م #=#?#>وي#_ #>ن #<ي#?#.مين #~ #<ي #.لم#^#_ى #.لذين ي#>#.نون من نقص #<ي#?#.مين #~ لي#?سنى لجسمهم #.لقي#.م #%#>ملي#.#? #.لأي#_ #.ل#?ي #?خص #.ل#>ظ#.م #%ش#=ل صحيح. \r\n\r\n–#%#.ل#?#.لي يس#?خ#~م #.ل#>ل#.ج للم#^#_ى #.لذين ل#~يهم #.#_#-#^#.#%#.#? #<ي أي#_ #.ل#=#.لسيوم #<ي جسمهم ، مثل ح#.ل#.#?: \r\n\r\n–خلل #.ل#>ظ#.م #.لم#^#?#%#- #%أم#^#.#_ #.ل#=لى. \r\n\r\n–#<#^#- نش#.#- #.لغ#~ة ج#.#^ة #.ل#~#^قية. \r\n\r\n–نقص نش#.#- #.لغ#~ة #.لج#.#^ #~#^قية. \r\n\r\n–نقص #.ل#=#.لسيوم #>ن#~ ح#~يثي #.لول#.#~ة. \r\n\r\n–لين #.ل#>ظ#.م و #.ل#=س#.ح #.لم#^#?#%#- #%سوء #.ل#?غذية أو #%#.ل#.م#?ص#.ص.", "Contraindications": "–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ قلة #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#?جن#% #.س#?خ#~#.مه للم#^#_ى #.لذين ل#~يهم حصو#.#? #<ي #.ل#=لي. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء لمن يأخذ #~و#.ء #.ل#~يجو#=سين وغي#^ #<#>#.ل #<ي #.س#?خ#~#.مه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #.لحمل أو #.ل#^#_#.#>ة وق#%ل #.س#?خ#~#.مه يلزم #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "Description :\t\r\nAlfacalcidol is an active metabolite of Vitamin D, \r\n\r\nIndication\t:\r\nprescribed for hypocalcaemia, hypoparathyroidism, hypophosphataemia, renal osteodystrophy, and osteomalacia.\r\n\r\ndosage :\r\nAdult- PO- The recommended starting dose is 1mcg/day. Maintenance: 0.25-1 mcg/day. \r\nAdult- IV- The recommended initial dose is 1 mcg per dialysis two to three times a week. \r\n\r\nMechanism of action\tThe first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains.", "Composition": "alpha calcidol 1mcg", "Route": "ORAL.SOLID" }, { "ID": "41", "Trade_Name": "URINEX 24 CAPS.", "Generic_Name": "ALPHA PINENE+ANETHOL+BETA PINENE+BORNEOL+CAMPHENE+CINEOL+FENCHONEL", "Price": "9", "Price_Old": "5.9", "Company": "PHARCO", "Pharmacology": "URINARY.ANALGESIC.ANTISEPTIC", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#.ل#?خلص من حصو#.#? #.ل#=لي و #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #>#~وي #.لمس#.ل#= #.ل#%ولية و #.لجه#.ز #.ل#%ولي. \r\n\r\n–#?قليل نس#%ة #.ل#.مل#.ح #.ل#>#.لية #<ي #.لجسم. \r\n\r\n–#>ل#.ج #?قلص#.#? و آل#.م #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.لمغص #.ل#=لوي. \r\n\r\n–م#-ه#^ للمس#.ل#= #.ل#%ولية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.ل#.س#?#>م#.ل #<ي ح#.لة #.م#^#.#_ #.ل#=#%#~ و #.ل#=لي. \r\n\r\n–يمن#> #.ل#.س#?خ#~#.م #<ي ح#.لة #.ل#?ه#.#% و#?مزق #.ل#.و#?#.#^. \r\n\r\n–يمن#> #?ن#.ول #.ل#.#~وية #.لم#_#.#~ة للمي#=#^و#%#.#?.", "GI": "Indications And Usage:\r\nUrolithiasis, nephrolithiasis and mild urinary tract infections. It promotes the disintegration of stones, and by its spasmolytic action promotes the spontaneous passage of stones in the renal and urinary tracts. It gives symptomatic relief of mild to moderate renal and urinary colic associated with the presence of stones in the renal and urinary tracts. It is also indicated for the relief of frequency and urgency associated with mild urinary tract infections.", "Composition": "Each Capsule contains: \r\nPinene (a +B) 31 mg \r\nCamphene 15 mg \r\nBorneol 10 mg \r\nFenchone 4 mg \r\nAnethole 4 mg \r\nCineole 3 mg", "Route": "ORAL.SOLID" }, { "ID": "42", "Trade_Name": "THIOGLU 60 CAPS.", "Generic_Name": "THIOCTIC ACID(ALPHA LIPOIC ACID)+BIOTIN", "Price": "60", "Price_Old": "60", "Company": "MEPACO", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–خس#.#^ة #.لوزن. \r\n\r\n–#.#>#?ل#.ل #.لأ#>ص#.#% #.لس#=#^ي. \r\n\r\n–ح#^ق م#?ل#.زمة #.ل#<م. \r\n\r\n–أم#^#.#_ #.ل#>يون. \r\n\r\n–نقص #.ل#%يو#?ين. \r\n\r\n–#?س#.ق#- #.لش#>#^. \r\n\r\n–#.لأظ#.#<#^ #.ل#_#>ي#<ة.", "Contraindications": "–#.#_#-#^#.#% #.لغ#~ة #.ل#~#^قية \r\n\r\n–مش#.#=ل #.ل#=لى أو #.ل#=#%#~ \r\n\r\n–#.نخ#<#.#_ س#=#^ #.ل#~م \r\n\r\n–ل#. #?أخذ هذ#. #.ل#~و#.ء #=#>ل#.ج وحي#~ لم#^#_ #.لس#=#^ي وم#_#.#>#<#.#?ه \r\n\r\n–#.ل#?#<#.#>ل#.#? #.ل#~و#.ئية : \r\n\r\n–Armour Thyroid \r\n\r\n–Carbamazepine \r\n\r\n–Clozapine \r\n\r\n–Fluvoxamine \r\n\r\n–Haloperidol \r\n\r\n–Imipramine \r\n\r\n–Levothyroxine \r\n\r\n–Liotrix \r\n\r\n–Mexiletine \r\n\r\n–Olanzapine", "GI": "About Alpha-Lipoic acid\r\nNaturally occurring dithiol compound , antioxidant, Agent for neuropathies.\r\nMechanism of Action of Alpha-Lipoic acid\r\nAlpha-lipoic acid and its reduced metabolite, Dihydrolipoic acid (DHLA), form a redox couple and may scavenge a wide range of reactive oxygen species. Alpha-lipoic acid has been found to decrease urinary isoprostanes, O-LDL and plasma protein carbonyls, markers of oxidative stress. Further, alpha-lipoic acid and its redox couple DHLA have been found to have antioxidant activity in aqueous, as well as in lipophilic regions, and in extra cellular and intracellular environments. Alpha-lipoic acid participates in the recycling of other important biologic antioxidants, such as vitamins E and C, Ubiquinone and glutathione. \r\nBoth alpha-lipoic acid and DHLA can scavenge hydroxyl radicals, the nitric oxide radical, peroxynitrite, hydrogen peroxide and hypochlorite. Alpha-lipoic acid may scavenge singlet oxygen, and DHLA may scavenge super oxide and per", "Composition": "thioctic acid 300mg", "Route": "ORAL.SOLID" }, { "ID": "43", "Trade_Name": "ONE ALPHA 1 MCG 30 CAPS.", "Generic_Name": "ALFACALCIDOL", "Price": "90", "Price_Old": "72", "Company": "MINA PHARM > LEO PHARMACEUTICAL PRODUCTS", "Pharmacology": "VITAMIN D", "Category": "#<ي#?#.مين #~", "Use": "–يس#?خ#~م #=#?#>وي#_ #>ن #<ي#?#.مين #~ #<ي #.لم#^#_ى #.لذين ي#>#.نون من نقص #<ي#?#.مين #~ لي#?سنى لجسمهم #.لقي#.م #%#>ملي#.#? #.لأي#_ #.ل#?ي #?خص #.ل#>ظ#.م #%ش#=ل صحيح. \r\n\r\n–#%#.ل#?#.لي يس#?خ#~م #.ل#>ل#.ج للم#^#_ى #.لذين ل#~يهم #.#_#-#^#.#%#.#? #<ي أي#_ #.ل#=#.لسيوم #<ي جسمهم ، مثل ح#.ل#.#?: \r\n\r\n–خلل #.ل#>ظ#.م #.لم#^#?#%#- #%أم#^#.#_ #.ل#=لى. \r\n\r\n–#<#^#- نش#.#- #.لغ#~ة ج#.#^ة #.ل#~#^قية. \r\n\r\n–نقص نش#.#- #.لغ#~ة #.لج#.#^ #~#^قية. \r\n\r\n–نقص #.ل#=#.لسيوم #>ن#~ ح#~يثي #.لول#.#~ة. \r\n\r\n–لين #.ل#>ظ#.م و #.ل#=س#.ح #.لم#^#?#%#- #%سوء #.ل#?غذية أو #%#.ل#.م#?ص#.ص.", "Contraindications": "–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ قلة #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#?جن#% #.س#?خ#~#.مه للم#^#_ى #.لذين ل#~يهم حصو#.#? #<ي #.ل#=لي. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء لمن يأخذ #~و#.ء #.ل#~يجو#=سين وغي#^ #<#>#.ل #<ي #.س#?خ#~#.مه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #.لحمل أو #.ل#^#_#.#>ة وق#%ل #.س#?خ#~#.مه يلزم #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "Description :\t\r\nAlfacalcidol is an active metabolite of Vitamin D, \r\n\r\nIndication\t:\r\nprescribed for hypocalcaemia, hypoparathyroidism, hypophosphataemia, renal osteodystrophy, and osteomalacia.\r\n\r\ndosage :\r\nAdult- PO- The recommended starting dose is 1mcg/day. Maintenance: 0.25-1 mcg/day. \r\nAdult- IV- The recommended initial dose is 1 mcg per dialysis two to three times a week. \r\n\r\nMechanism of action\tThe first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains.", "Composition": "Alfacalcidol 0.25 microgram or 1 microgram", "Route": "ORAL.SOLID" }, { "ID": "44", "Trade_Name": "AMANTINE 100MG 24CAPS.", "Generic_Name": "AMANTADINE", "Price": "6", "Price_Old": "6", "Company": "MEMPHIS", "Pharmacology": "ANTIVIRAL.UNCOATING INHIBITOR", "Category": "للشلل #.ل#^#>#.ش", "Use": "–\"ل#>ل#.ج #.لشلل #.ل#^#>#.ش و#.ل#.#_#-#^#.#%#.#? #<ى #.ل#.#>ص#.#% ويس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سى و#>ل#.ج #.ل#.ن#<لونز#. ومق#.ومة #.ل#>#~وى #.ل#%#=#?ي#^ية", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم #<#^#- حس#.سية #.#?ج#.ه م#=ون#.#? #.ل#>ق#.#^. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%ق#^حة #<ي #.لم#>#~ة. \r\n\r\n– لمن ي#>#.نون من نو#%#.#? ص#^#> أو #?شنج#.#? #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n– ل#. ينصح #%#.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة ح#^ص#. #>لى صحة #.ل#^#_ي#>. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل ح#.#~ة #<ي #.ل#=لي #?جن#% #?ن#.ول #.ل#>ق#.#^.", "GI": "(Indications) :\r\n This medication is a synthetic anti-viral and antiparkinson agent, prescribed for Parkinson s disease and also for treating certain types of flu. It also is used to prevent and treat respiratory infections caused by influenza A virus\r\n\r\n (Dosage) :\r\n- Influenza A -100 mg/day for 5 days. \r\n- Herpes zoster- 100 mg twice daily for 14 days, may continue for another 14 day if pain persists.\r\nParkinson s disease-100 mg/day, up to 100 mg twice daily after 1 wk. Max: 400 mg/day", "Composition": "amantadine 100mg", "Route": "ORAL.SOLID" }, { "ID": "45", "Trade_Name": "ROWACHOL 45 CAPSULES", "Generic_Name": "ALPHA PINENE+BETA PINENE+BORNEOL+CAMPHENE+CINEOL+MENTHOL+MENTHONE", "Price": "27", "Price_Old": "18", "Company": "ROWA-WAGNER K.G.W GERMANY > AMOUN", "Pharmacology": "CHOLERETIC", "Category": "#.ل#?ه#.#% #.لم#^#.#^ة و مش#.#=ل #.ل#=#%#~", "Use": "–#.ل#?خلص من حصو#.#? #.لقن#.ة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية و#.لم#^#.#^ة. \r\n\r\n–#>ل#.ج سوء #.له#_م #.لن#.#?ج #>ن #.ل#-#>#.م. \r\n\r\n–يس#?خ#~م #=مس#=ن لل#?خلص من #.لمغص #.لم#^#.#^ي. \r\n\r\n–#>ل#.ج #>س#^ ه#_م #.ل#~هون. \r\n\r\n–#>ل#.ج #.#_#-#^#.#%#.#? إنزيم#.#? #.ل#=#%#~ #.لح#.#~ة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.نس#~#.#~ #<ي #.لم#^#.#^ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل وقصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ مزمنة يحذ#^ #>ليهم #.س#?خ#~#.م #.ل#~و#.ء. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%أل#?ه#.#%#.#? #.لم#^#.#^ة #.لص#~ي#~ية يج#% #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #<ي #.ل#~و#.ء.", "GI": "Rowachol? contains essential oils that help to dissolve or break up cholesterol-based gallstones. It also reduces the cholesterol content of bile, an important digestive juice that is formed in the liver. This may enable existing gallstones to dissolve and help prevent new gallstones from forming. Rowachol? also increases bile production and relaxes the bile ducts. This helps reduce painful spasms of the bile ducts. It also makes it easier for any gallstones present to be passed out (expelled) with the bile.\r\nRowachol? Capsules are intended for use in the breaking up (dissolving or disintegrating) or passage (expulsion) of gallstones. Use in combination with a medicine called chenodeoxycholic acid.", "Composition": "Each Capsule contains;\r\nMenthol 32 mg \r\nMenthone 6 mg\r\nAlpha Pinene 13.6 mg \r\nBeta Pinene 3.4 mg \r\nBorneol 5 mg \r\nCamphene 5 mg\r\nCineol 2 mg \r\nOlive Oil q.s. add to 100 mg", "Route": "ORAL.SOLID" }, { "ID": "46", "Trade_Name": "ALFUZOSINE 10 MG PROLONGED RELEASE CAP.", "Generic_Name": "ALFUZOSIN", "Price": "15", "Price_Old": "15", "Company": "BORG", "Pharmacology": "ANTIHYPERTENSIVE.SELECTIVE ALPHA 1 RECEPTOR BLOCKERS", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#~و#.ء ين#?مي إلى #>#.ئلة ح#.ص#^#.#? #.ل#<#. #.ل#.ن#?ق#.ئية (Selective Alpha Blockers)، #.ل#?ي #?س#?خ#~م ل#>ل#.ج #.ل#?#_خم #.لحمي#~ #<ي #.ل#%#^وس#?#.#?#. (Benign Prostatic Hypertrophy). #?س#.هم مس#?ق#%ل#.#? أل#<#. (Alphareceptors) #<ي #?قلص #.ل#>#_ل#.#? #.لملس#.ء، وهي من#?ش#^ة #%ش#=ل #=#%ي#^ #<ي غ#~ة #.ل#%#^وس#?#.#?#. و#>نق #.لمث#.نة #.ل#%ولية. ي#?يح حص#^ #.لمس#?ق#%ل#.#? #%و#.س#-ة #.لأل#<وزوسين (Alfuzosin)، #.#^#?خ#.ء #>#_ل#.#? #>نق #.لمث#.نة #.ل#%ولية و#.ل#%#^وس#?#.#?#.، #.لأم#^ #.لذي يحسن من #?#~#<ق #.ل#%ول ويخ#<#< من أ#>#^#.#_ #.لم#^#_.", "Contraindications": "–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.لقل#% ، #.لش#^ي#.ن #.ل#?#.جى ، #.ل#_غ#- #.لم#^#?#<#> . \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ى #.ل#=لى : يج#% ظ#%#- #.لج#^#>ة #%و#.س#-ة #.ل#-#%ي#% #.لم#?خصص . \r\n\r\n–ل#. يس#?خ#~م م#> م#^#_ى #.ل#=#%#~ . \r\n\r\n–ق#~ يس#%#% #<ق#~#.ن #.لو#>ى ( SYNOCOPE ) و إنخ#<#.#_ #<ى #_غ#- #.ل#~م م#> أول ج#^#>ة #<ق#- . \r\n\r\n–#.ل#?#~#.خل#.#? #.ل#~و#.ئية : \r\n\r\n–ل#. يس#?خ#~م م#> #.لأ#~وية #.لمنش#-ة جنسي#. #.ل#?ى #?ح#?وى #>لى أى من #.لمو#.#~ #.ل#?#.لية : \r\n\r\n–SILDENAFIL , VERDENAFIL , TADALAFIL : #=ل منهم#. يزي#~ #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–يس#?خ#~م #%حذ#^ م#> أ#~وية #>ل#.ج #.ل#_غ#- #.لم#^#?#<#> . \r\n\r\n–ل#. يس#?خ#~م م#> #.لأ#~وية #.ل#?ى #?ح#?وى #>لى أى من #.لمو#.#~ #.ل#?#.لية : \r\n\r\n–KETOCONAZOLE , ITRACONAZOLE , RITONAVIR : هذه #.لأ#~وية #?#>مل #>لى زي#.#~ة #?#^#=يز م#.#~ة ALFUZOSIN #%#.ل#~م مم#. يزي#~ من آث#.#^ه#. #.لج#.ن#%ية .", "GI": "Description\t\r\nAlfuzosin (INN, provided as the hydrochloride salt) is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia\r\n\r\nIndication :\r\nFor the reduction of urinary obstruction and relief of associated manifestations (eg. sensation of incomplete bladder emptying or straining, urgency, interrupted or weak stream) in patients with symptomatic beningn prostatic hyperplasia.\r\n\r\ndosage:\r\nThe recommended dose is 2.5 mg 3 times/day. Max: 10 mg/day.\r\n\r\nMechanism of action:\r\nAlfuzosin is a non-subtype specific alpha(1)-adrenergic blocking agent that exhibits selectivity for alpha(1)-adrenergic receptors in the lower urinary tract. Inhibition of these adrenoreceptors leads to the relaxation of smooth muscle in the bladder neck and prostate, resulting in the improvement in urine flow and a reduction in symptoms in benign prostate hyperplasia. Alfuzosin also inhibits the vasoconstrictor effect of circulating and locally released catecholamines (epinephrine and norepinephrine)", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "47", "Trade_Name": "ADAMINE 100MG 20 CAPS.", "Generic_Name": "AMANTADINE", "Price": "7", "Price_Old": "7", "Company": "RAMEDA", "Pharmacology": "ANTIVIRAL.UNCOATING INHIBITOR", "Category": "للشلل #.ل#^#>#.ش", "Use": "–\"ل#>ل#.ج #.لشلل #.ل#^#>#.ش و#.ل#.#_#-#^#.#%#.#? #<ى #.ل#.#>ص#.#% ويس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سى و#>ل#.ج #.ل#.ن#<لونز#. ومق#.ومة #.ل#>#~وى #.ل#%#=#?ي#^ية", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم #<#^#- حس#.سية #.#?ج#.ه م#=ون#.#? #.ل#>ق#.#^. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%ق#^حة #<ي #.لم#>#~ة. \r\n\r\n– لمن ي#>#.نون من نو#%#.#? ص#^#> أو #?شنج#.#? #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n– ل#. ينصح #%#.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة ح#^ص#. #>لى صحة #.ل#^#_ي#>. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل ح#.#~ة #<ي #.ل#=لي #?جن#% #?ن#.ول #.ل#>ق#.#^.", "GI": "(Indications) :\r\n This medication is a synthetic anti-viral and antiparkinson agent, prescribed for Parkinson s disease and also for treating certain types of flu. It also is used to prevent and treat respiratory infections caused by influenza A virus\r\n\r\n (Dosage) :\r\n- Influenza A -100 mg/day for 5 days. \r\n- Herpes zoster- 100 mg twice daily for 14 days, may continue for another 14 day if pain persists.\r\nParkinson s disease-100 mg/day, up to 100 mg twice daily after 1 wk. Max: 400 mg/day", "Composition": "Each capsule contains:\r\nAmantadine Hydrochloride 100 mg", "Route": "ORAL.SOLID" }, { "ID": "48", "Trade_Name": "AMILO 10MG 20 TAB.", "Generic_Name": "AMLODIPINE", "Price": "22", "Price_Old": "22", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "ANTIHYPERTENSIVE.SELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–يس#?خ#~م ل#>ل#.ج #.لذ#%حة #.لو#>#.ئية #.ل#?شنجية. \r\n\r\n–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#.لوق#.ية من #.لذ#%ح#.#? #.لص#~#^ية. \r\n\r\n–يخ#<#< من آل#.م #.لص#~#^. \r\n\r\n–#>ل#.ج نو#%#.#? #.لص#~#^ية وأم#^#.#_ #.لقل#%. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #_يق #.لش#^#.يين #.ل#?#.جية.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.لحس#.سية للأملو#~ي#%ين \r\n\r\n–#.لحذ#^ #<ي ح#.لة م#^#_ى #.نخ#<#.#_ #_غ#- #.ل#~م لأنه يخ#<#_ #_غ#- #.ل#~م \r\n\r\n–خ#.صة #<ي م#^#_ى #_يق #.لصم#.م #.ل#.و#^#-ي. \r\n\r\n–#<شل #.لقل#% #.ل#.ح#?ق#.ني. \r\n\r\n–#.ل#_يق #.لأو#^#-ي #.لش#~ي#~ \r\n\r\n–#.لذ#%حة #.لص#~#^ية غي#^ #.لمس#?ق#^ة \r\n\r\n–نقص إم#~#.#~ #.ل#~م للخل#.ي#.", "GI": "About Amlodipine\r\nCalcium Channel Blocker, Anti hypertensive,anti angina.\r\n\r\nMechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\n\r\nIndications for Amlodipine\r\n1.Hypertension \r\n2.Prinzmetal`s angina \r\n3.Stable angina", "Composition": "Amilo 5 mg Tablet contains:\r\nActive Ingredient: Amlodipine besylate 6.9 mg (Equivalent to 5 mg amlodipine). \r\n\r\nAmilo 10 mg Tablet contains:\r\nActive Ingredient: Amlodipine besylate 13.8 mg (Equivalent to 10 mg amlodipine).", "Route": "ORAL.SOLID" }, { "ID": "49", "Trade_Name": "VIRAFLU 100MG 10 CAPS.", "Generic_Name": "AMANTADINE", "Price": "4", "Price_Old": "4", "Company": "SIGMA", "Pharmacology": "ANTIVIRAL.UNCOATING INHIBITOR", "Category": "للشلل #.ل#^#>#.ش", "Use": "–\"ل#>ل#.ج #.لشلل #.ل#^#>#.ش و#.ل#.#_#-#^#.#%#.#? #<ى #.ل#.#>ص#.#% ويس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سى و#>ل#.ج #.ل#.ن#<لونز#. ومق#.ومة #.ل#>#~وى #.ل#%#=#?ي#^ية", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم #<#^#- حس#.سية #.#?ج#.ه م#=ون#.#? #.ل#>ق#.#^. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%ق#^حة #<ي #.لم#>#~ة. \r\n\r\n– لمن ي#>#.نون من نو#%#.#? ص#^#> أو #?شنج#.#? #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n– ل#. ينصح #%#.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة ح#^ص#. #>لى صحة #.ل#^#_ي#>. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل ح#.#~ة #<ي #.ل#=لي #?جن#% #?ن#.ول #.ل#>ق#.#^.", "GI": "(Indications) :\r\n This medication is a synthetic anti-viral and antiparkinson agent, prescribed for Parkinson s disease and also for treating certain types of flu. It also is used to prevent and treat respiratory infections caused by influenza A virus\r\n\r\n (Dosage) :\r\n- Influenza A -100 mg/day for 5 days. \r\n- Herpes zoster- 100 mg twice daily for 14 days, may continue for another 14 day if pain persists.\r\nParkinson s disease-100 mg/day, up to 100 mg twice daily after 1 wk. Max: 400 mg/day", "Composition": "amantadine 100mg", "Route": "ORAL.SOLID" }, { "ID": "50", "Trade_Name": "VALYSERNEX 1000MG 20 F.C. CAPLETS", "Generic_Name": "VALACYCLOVIR", "Price": "170", "Price_Old": "170", "Company": "EVA PHARMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#?", "Use": "–م#_#.#~ لل#<ي#^وس#.#?. \r\n\r\n–#?#?حول إلى #.لأسي#=لو#<ي#^ #%و#.س#-ة #>ملي#.#? #.لأي#_ #<ي #.ل#=#%#~ و#.لأم#>#.ء .#=م#. #?#%#-ئ من نمو و#.ن#?ش#.#^ #<ي#^وس #.له#^#%س #%حيث يس#?#-ي#> #.لجسم مح#.#^#%ة #.ل#>#~وى. \r\n\r\n–ل#. ي#>#.لج ، ل#=نه يقلل من أ#>#^#.#_ #.ل#>#~وى. \r\n\r\n–#.لأم#^#.#_ #.ل#?ي يس#%#%ه#. #<ي#^وس #.له#^#%س #?شمل ه#^#%س #.لأ#>#_#.ء #.ل#?ن#.سلية، و#.لق#^وح #.ل#%#.#^#~ة، وج#~#^ي #.لم#.ء. \r\n\r\n–يس#?خ#~م #.ل#>ل#.ج #<ي : \r\n\r\n–#.ل#>#~وى #<ي#^وسية #.لن#.#?جة #>ن #<ي#^وس #.لهِ#^ْ#%ِسٌ #.لنُ#-#.قِيّ , \r\n\r\n–حلأ #?َن#.سلي , \r\n\r\n–#.له#^#%س #.لن#-#.قي , \r\n\r\n–ج#~#^ي #.لم#.ء .", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج.", "GI": "Indication\tFor the treatment or suppression of cold sores (herpes labialis), herpes zoster (shingles), genital herpes in immunocompetent individuals, and recurrent genital herpes in HIV-infected individuals.\r\nMechanism of action\tValaciclovir is phosphorylated by viral thymidine kinase to acyclovir triphosphate (the active metabolite) which then inhibits herpes viral DNA replication by competitive inhibition of viral DNA polymerase, and by incorporation into and termination of the growing viral DNA chain. When used as a substrate for viral DNA polymerase, acyclovir triphosphate competitively inhibits dATP leading to the formation of faulty DNA. This is where acyclovir triphosphate is incorporated into the DNA strand replacing many of the adenosine bases. This results in the prevention of DNA synthesis, as phosphodiester bridges can longer to be built, destabilizing the strand.", "Composition": "Film coated caplets:VALYSERNEX 500mg: Valaciclovir 500 mg\r\nVALYSERNEX 1000mg: Valaciclovir 1000 mg", "Route": "ORAL.SOLID" }, { "ID": "51", "Trade_Name": "PSORIN 10 MG 10 CAPS.", "Generic_Name": "ACITRETIN", "Price": "25", "Price_Old": "25", "Company": "INTERNATIONAL DRUG AGENCY (IDI)", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "Description:\t\r\nAn oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. \r\n\r\nIndication :\r\nFor the treatment of severe psoriasis in adults.\r\n\r\nMechanism of action\t:\r\nThe mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.\r\n\r\nHalf life : \r\n49 hours (range 33 to 96 hours)\r\n\r\nDosage :\r\nThe recommended dose is 25 to 50 mg per day, given as a single dose with the main meal.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "52", "Trade_Name": "NEOTIGASON 10MG 30 CAPS.(N/A)", "Generic_Name": "ACITRETIN", "Price": "151.25", "Price_Old": "108", "Company": "ACTAVIS > MULTIPHARMA", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "53", "Trade_Name": "OST-MAP 60MG 20 CAPS.", "Generic_Name": "ACEMETACIN", "Price": "16", "Price_Old": "16", "Company": "MULTI-APEX", "Pharmacology": "NSAID.ANALGESIC", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل. \r\n\r\n–#>ل#.ج آل#.م أس#<ل #.لظه#^. \r\n\r\n–#?خ#<ي#< من #.لآل#.م #>ق#% #>مل #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#.ذ#. #=ن#? #?#>#.ني من مش#.#=ل #<ي #.لم#>#~ة. \r\n\r\n–حس#.سية من م#=ون#.#? هذ#. #.ل#>ق#.#^. \r\n\r\n– #.لحس#.سية #<ي #.لجل#~. \r\n\r\n–أم#^#.#_ #.ل#^#%و. \r\n\r\n–#.لحمل و#.ل#^#_#.#>ة.", "GI": "Description :\r\na non-steroidal anti-inflammatory drug (NSAID).\r\n\r\nIndication :\r\nReducing pain and inflammation in conditions such as rheumatoid arthritis and osteoarthritis.\r\nLower back pain.\r\nReducing pain and inflammation following surgery.\r\n\r\nmechanism of action :\r\nAcemetacin works by blocking the action of a substance in the body called cyclo-oxygenase (COX). Cyclo-oxygenase is involved in the production of various chemicals in the body, some of which are known as prostaglandins.\r\nProstaglandins are produced by the body in response to injury and certain diseases and conditions, and cause pain, swelling and inflammation. Acemetacin blocks the production of these prostaglandins and is therefore effective at reducing inflammation and pain", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "54", "Trade_Name": "NEOTIGASON 25MG 30 CAPS.(N/A)", "Generic_Name": "ACITRETIN", "Price": "336", "Price_Old": "240", "Company": "ACTAVIS > MULTIPHARMA", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "55", "Trade_Name": "UNITRIN 10MG 30 CAPS", "Generic_Name": "ACITRETIN", "Price": "84", "Price_Old": "84", "Company": "UNIPHARMA CO.", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "Description:\t\r\nAn oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. \r\n\r\nIndication :\r\nFor the treatment of severe psoriasis in adults.\r\n\r\nMechanism of action\t:\r\nThe mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.\r\n\r\nHalf life : \r\n49 hours (range 33 to 96 hours)\r\n\r\nDosage :\r\nThe recommended dose is 25 to 50 mg per day, given as a single dose with the main meal.", "Composition": "acitretin 10mg or 25mg", "Route": "ORAL.SOLID" }, { "ID": "56", "Trade_Name": "ACITRETIN 10MG 30 CAPS.", "Generic_Name": "ACITRETIN", "Price": "87", "Price_Old": "87", "Company": "KAHIRA > SABAA", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "Description:\t\r\nAn oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. \r\n\r\nIndication :\r\nFor the treatment of severe psoriasis in adults.\r\n\r\nMechanism of action\t:\r\nThe mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.\r\n\r\nHalf life : \r\n49 hours (range 33 to 96 hours)\r\n\r\nDosage :\r\nThe recommended dose is 25 to 50 mg per day, given as a single dose with the main meal.", "Composition": "ACITRETIN 10 mg CAPSULE\r\nEach capsule contains acitretin 10 mg.\r\nACITRETIN 25 mg CAPSULE Each capsule contains acitretin 25 mg.", "Route": "ORAL.SOLID" }, { "ID": "57", "Trade_Name": "ACITRETIN 25MG 30 CAPS.", "Generic_Name": "ACITRETIN", "Price": "135", "Price_Old": "135", "Company": "KAHIRA > SABAA", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "Description:\t\r\nAn oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. \r\n\r\nIndication :\r\nFor the treatment of severe psoriasis in adults.\r\n\r\nMechanism of action\t:\r\nThe mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.\r\n\r\nHalf life : \r\n49 hours (range 33 to 96 hours)\r\n\r\nDosage :\r\nThe recommended dose is 25 to 50 mg per day, given as a single dose with the main meal.", "Composition": "ACITRETIN 10 mg CAPSULE\r\nEach capsule contains acitretin 10 mg.\r\nACITRETIN 25 mg CAPSULE Each capsule contains acitretin 25 mg.", "Route": "ORAL.SOLID" }, { "ID": "58", "Trade_Name": "CEFACET PLUS 10 CAPS.", "Generic_Name": "ACETYLSALICYLIC ACID+CAFFEINE+PARACETAMOL(ACETAMINOPHEN)", "Price": "5", "Price_Old": "5", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "NSAID.ANALGESIC", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–مس#=ن #>#.م للآل#.م . \r\n\r\n–#>ل#.ج أل#.م #.لأسن#.ن و إل#?ه#.#%#.#% #.للثة . \r\n\r\n–خ#.#<#_ للح#^#.#^ة . \r\n\r\n–#>ل#.ج آل#.م #.ل#~و#^ة #.لشه#^ية . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> و #.لص#~#.#> #.لنص#<ى . \r\n\r\n–#>ل#.ج آل#.م خشونة #.لم#<#.صل . \r\n\r\n–#>ل#.ج آل#.م #.ل#^ق#%ة و #.لظه#^ و #.ل#=سو#^ و #.ل#=#~م#.#? و #.ل#?و#^م#.#? . \r\n\r\n–#>ل#.ج آل#.م حصو#.#? #.ل#=لى و #.لم#^#.#^ة .", "Contraindications": "–#<#^#- #.لحس#.سية للم#=ون#.#? وخ#.صة #.لأس#%#^ين، وم#_#.#~#.#? #.ل#.ل#?ه#.#% #.لل#. س#?ي#^و#~ية #%#.ل#>موم.\r\n\r\n–م#^#_ى ق#^حة #.لم#>#~ة أو #.لإثنى #>ش#^.\r\n\r\n–م#^#_ى #.ل#<شل #.ل#=لوي، و#.ل#=#%#~ي، و#.لقل#%ي.\r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل خ#.صةً #<ي #.لثلث #.ل#.خي#^.\r\n\r\n–يمن#> إ#>#-#.ء هذ#. #.ل#~و#.ء للأ#-#<#.ل #~ون سن #.لس#.#~سة.\r\n\r\n–يمن#> إ#>#-#.ء هذ#. #.ل#~و#.ء للأ#-#<#.ل #.و #.لم#^#.هقين #.لمص#.#%ين #%م#^#_ ج#~#^ي #.لم#.ء أو غي#^ه من #.ل#.ل#?ه#.#%#.#? #.ل#<ي#^وسية.\r\n\r\n–يمن#> #.#>#-#.ء #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من م#^#_ #.لنزي#< #.لنش#- #=#.لهيمو#<يلي#.، أول#~يهم ق#.#%لية للنزي#<.", "GI": "Description:\r\nIt contain three active ingredients, aspirin, paracetamol and caffeine.\r\n\r\nAspirin: belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the body called cyclo-oxygenase.\r\n\r\nParacetamol : is another medicine used in the treatment of mild to moderate pain\r\n\r\nCaffeine is a mild stimulant that helps reduce fatigue. Caffeine is also thought to enhance the pain-relieving effects of aspirin and paracetamol.\r\n\r\nIndication :\r\nMild to moderate pain, such as headache, migraine, toothache, sore throat, muscular and rheumatic pain, sprains and strains, nerve pain (neuralgia), sciatica, backache (lumbago) and period pain.\r\nRelieving aches, pains, headaches, sore throat and fever associated with colds and flu.\r\n\r\ndosage\r\nAdults aged 16 years and over should take two tablets up to four times a day as needed. Leave at least four hours between doses.\r\nDo not take more than 8 tablets in 24 hours.", "Composition": "Acetyl salicylic acid 250mg &Caffeine 65mg&acetaminophen 250mg", "Route": "ORAL.SOLID" }, { "ID": "59", "Trade_Name": "PSORIN 25MG 10 CAPS.", "Generic_Name": "ACITRETIN", "Price": "40", "Price_Old": "40", "Company": "INTERNATIONAL DRUG AGENCY (IDI)", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "Description:\t\r\nAn oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. \r\n\r\nIndication :\r\nFor the treatment of severe psoriasis in adults.\r\n\r\nMechanism of action\t:\r\nThe mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.\r\n\r\nHalf life : \r\n49 hours (range 33 to 96 hours)\r\n\r\nDosage :\r\nThe recommended dose is 25 to 50 mg per day, given as a single dose with the main meal.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "60", "Trade_Name": "HYDROFERRIN 100MG/2ML 3 AMP.", "Generic_Name": "IRON", "Price": "24.5", "Price_Old": "16.2", "Company": "BORG", "Pharmacology": "ANEMIA.IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~ ل#<ق#^ #.ل#~م #.ل#.نيمي#.", "Use": "–يس#?خ#~م ل#>ل#.ج #.لأنيمي#. #%#.لجسم. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ق#.#^ #<ي ح#.لة #>ل#.ج نقص #.لح#~ي#~ #.ل#?ي #?س#?لزم #>ل#.ج س#^ي#>. \r\n\r\n–إذ#. ح#~ث خلل #<ي #.م#?ص#.ص #.لح#~ي#~ من #.لقن#.ة #.له#_مية يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^. \r\n\r\n–إذ#. #=#.ن#? #.لج#^#>#.#? #.ل#?ي #?س#?خ#~مه#. ي#?م #?ن#.وله#. #>ن #-#^يق #.ل#<م ل#. يوج#~ #?أثي#^ قوي له#. ول#=ن يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ من خل#.ل #.س#?ش#.#^ه #.ل#-#%ي#%.", "Contraindications": "–إذ#. #=ن#? #?#>#.ني من #.لحس#.سية #.لم#<#^#-ة ل#. يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#>ق#.#^ ل#. يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^. \r\n\r\n–يج#% أن يخزن #.ل#>ق#.#^ #<ي #~#^جة ح#^#.#^ة أقل من 25 #~#^جة مئوية. \r\n\r\n–يج#% أن يح#<ظ هذ#. #.ل#>ق#.#^ #%#>ي#~#. #>ن م#?ن#.ول #.لأ#-#<#.ل. \r\n\r\n–يج#% أن #?قوم #%#.س#?خ#~#.م #.لمحلول #.لم#?ج#.نس #<ق#- لل#%#>#~ #>ن أي آث#.#^ ج#.ن#%ية. \r\n\r\n–ل#. يج#% أن #?قوم #%#?جمي#~ #.ل#>ق#.#^ ح#?ى ل#. ي#<س#~ . \r\n\r\n–ل#. يج#% أن #?قوم #%مزج هذ#. #.ل#>ق#.#^ م#> أي #>ق#.#^ آخ#^ #<ي ن#<س #.لحقنة لمن#> ح#~وث أي أ#_#^#.#^ ج#.ن#%ية أو أي أم#^#.#_ يص#>#% #>ل#.جه#. #>لى #.لم#~ى #.لقصي#^. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من ح#.لة زي#.#~ة #.لح#~ي#~ #<ي #.لجسم ل#. يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^. \r\n\r\n–ل#. يس#?خ#~م هذ#. #.ل#>ق#.#^ #<ي ح#.لة أنو#.#> #.لأنيمي#. #.لأخ#^ى #.ل#?ي ي#=ون س#%#%ه#. شيئ غي#^ #.لح#~ي#~.", "GI": "Description\t\r\nA metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.SSIndication\tSUsed in preventing and treating iron-deficiency anemia.SSMechanism of action\tSIron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "61", "Trade_Name": "BECORENZ 1 AMP. FOR I.M./I.V INJ.", "Generic_Name": "NICOTINAMIDE+PANTHENOL+VITAMIN B1+VITAMIN B2+VITAMIN B6", "Price": "4", "Price_Old": "4", "Company": "GRAND PHARMA > DELTA GRAND PHARMA", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–حول #<ي#?#.مين ق#.#%ل للذو#%#.ن nicotinamidewater (#% #.لم#^#=#% #<ي#?#.مين B3) ، amide من حم#_ #.لني#=و#?يني#=. آلية #>مل ني#=و#?ين#.مي#~يني#=و#?ين#.مي#~ #?م#.#^س #>مله#. #%#.ل#?أثي#^ #>لى #^#~و#~ #.لأي#_. ي#?م #?حويله إلى أنزيم#.#? cozymes ncotinamide #.لأ#~ينين #.لنو#=ليو#?ي#~ (nad) و ncotinamide #.ل#<وس#<#.#? #.لأ#~ينين #.ل#<وس#<#.#? ثن#.ئي #.لنو#=ليو#?ي#~ (nadp) #.لمش#.#^#=ة #<ي #?#<#.#>ل#.#? #?قليل #.لأ#=س#~ة. هذه #.لنيو#=ليو#?ي#~#.#? #.ل#%ي#^ي#~ين #%مث#.#%ة مس#?ق#%ل#.#? #.لهي#~#^وجين #<ي سلسلة نقل #.لإل#=#?#^ون #<ي #.ل#?ن#<س #.لأنسجة ، #?حلل #.ل#~هون ، و#?خليق #.ل#~هون. حم#_ #.لني#=و#?يني#= #<ي #.لج#^#>#.#? #.ل#>#.لية له #?أثي#^#.#? موس#>ة للأو#>ية ويحسن أي#_#. مس#?وى #.ل#~هون - يخ#<#_ #.ل#=وليس#?#^ول #<ي #.ل#~م ، وي#^#<#> مس#?وى HDl ، ويخ#<#< vldl ، ومس#?وي#.#? ldl.indications ل nicotinamide1.pellagra 2.niacin deficiency 3.hartnup disease", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.", "GI": "About Nicotinamide\r\nWater Soluble Vitamin(B complex- vitamin B3), Amide of nicotinic acid.\r\nMechanism of Action of Nicotinamide\r\nNicotinamide exerts its action by influencing metabolic reactions. It is converted in to coenzymes Ncotinamide adenine dinucleotide (NAD) and its phosphate Ncotinamide adenine dinucleotide phosphate (NADP) involved in oxidation reduction reactions. These pyridine nucleotides act as hydrogen acceptors in the electron transport chain in tissue respiration, glycolysis, and fat synthesis. Nicotinic acid in high doses has vasodilator effects and also improves lipid profile- reduces serum cholesterol, raises HDL level, lowers VLDL, and LDL levels.\r\nIndications for Nicotinamide\r\n1.Pellagra \r\n2.Niacin deficiency \r\n3.Hartnup disease", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "62", "Trade_Name": "METOCLOPRAMIDE 10MG/2ML 5 AMP. FOR IV/IM INJ.", "Generic_Name": "METOCLOPRAMIDE", "Price": "8", "Price_Old": "8", "Company": "SEDICO", "Pharmacology": "DOPAMINE ANTAGONIST", "Category": "م#_#.#~ للقيء", "Use": "–#>ل#.ج ح#.لة #.لغثي#.ن و#.ل#?َقَيؤ #.لمص#.ح#% لل#>ل#.ج #.ل#=يمي#.ئي أو #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#.#^#?ج#.#> #.لم#^يء. \r\n\r\n–خزل #.لم#>#~ة #.لم#^#.#<ق لم#^#_ #.لس#=#^ي. \r\n\r\n–#.#<#^#.غ #.لم#>#~ة من مح#?وي#.#?ه#. لل#?ح#_ي#^ ل#>ملي#.#? ج#^#.حية. \r\n\r\n–#.ل#<حص #.لإش#>#.#>ي للجه#.ز #.له#_مي #.ل#>لوي.", "Contraindications": "–#<#^#- #.لحس#.سية لل#>ل#.ج أو لأي م#=ون آخ#^ من م#=ون#.#?ه. \r\n\r\n–#.نس#~#.#~ أو #.نثق#.#% أو نزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–وجو#~ #?#.#^يخ م#^#_ي لحصول نو#%#.#? ص#^#>. \r\n\r\n–من #.لمم#=ن أن يس#%#% خلل #.لح#^#=ة #.لم#?أخ#^، #<إذ#. و#.جه#?#= أي #.خ#?ل#.ل#.#? #%#.لح#^#=ة، #^#>#.ش أو #?قلص#.#? #?#~ل #>لى #.لإص#.#%ة #%خلل #.لح#^#=ة يج#% #.ل#?وق#< #<و#^#.ً #>ن #?ن#.ول #.ل#~و#.ء.", "GI": "About Metoclopramide\r\nIt is a dopamine antagonist - antiemetic gastroprokinetic agent.\r\nMechanism of Action of Metoclopramide\r\nMetoclopramide acts through both serotonergic and dopaminergic receptors. Metoclopramide binds to Serotonin (5 HT3 &5HT4) and Dopamine (D2) receptor. \r\nAntiemetic action: Metoclopramide inhibits Dopamine receptor in the chemoreceptor trigger zone and produces antiemetic action. \r\nIntestinal motility modifying action: The binding of Metoclopramide on 5HT4 receptor will activate interneuron and enhance the release of acetylcholine innervating the smooth muscles. This produces gastric emptying and enhances lower esophageal sphincter tone. \r\nMigraine: Metoclopramide is used in migraine to relieve nausea and vomiting \r\nAnaesthetic adjuncts: It is used preoperatively in order to reduce the post operative vomiting.", "Composition": "metoclopramide 10mg", "Route": "INJECTION" }, { "ID": "63", "Trade_Name": "SACROFER 100MG/5ML 5 AMP FOR I.V. INJ.", "Generic_Name": "IRON", "Price": "146", "Price_Old": "106", "Company": "AMOUN", "Pharmacology": "ANEMIA.IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~ ل#<ق#^ #.ل#~م #.ل#.نيمي#.", "Use": "–يس#?خ#~م ل#>ل#.ج #.لأنيمي#. #%#.لجسم. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ق#.#^ #<ي ح#.لة #>ل#.ج نقص #.لح#~ي#~ #.ل#?ي #?س#?لزم #>ل#.ج س#^ي#>. \r\n\r\n–إذ#. ح#~ث خلل #<ي #.م#?ص#.ص #.لح#~ي#~ من #.لقن#.ة #.له#_مية يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^. \r\n\r\n–إذ#. #=#.ن#? #.لج#^#>#.#? #.ل#?ي #?س#?خ#~مه#. ي#?م #?ن#.وله#. #>ن #-#^يق #.ل#<م ل#. يوج#~ #?أثي#^ قوي له#. ول#=ن يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ من خل#.ل #.س#?ش#.#^ه #.ل#-#%ي#%.", "Contraindications": "–إذ#. #=ن#? #?#>#.ني من #.لحس#.سية #.لم#<#^#-ة ل#. يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#>ق#.#^ ل#. يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^. \r\n\r\n–يج#% أن يخزن #.ل#>ق#.#^ #<ي #~#^جة ح#^#.#^ة أقل من 25 #~#^جة مئوية. \r\n\r\n–يج#% أن يح#<ظ هذ#. #.ل#>ق#.#^ #%#>ي#~#. #>ن م#?ن#.ول #.لأ#-#<#.ل. \r\n\r\n–يج#% أن #?قوم #%#.س#?خ#~#.م #.لمحلول #.لم#?ج#.نس #<ق#- لل#%#>#~ #>ن أي آث#.#^ ج#.ن#%ية. \r\n\r\n–ل#. يج#% أن #?قوم #%#?جمي#~ #.ل#>ق#.#^ ح#?ى ل#. ي#<س#~ . \r\n\r\n–ل#. يج#% أن #?قوم #%مزج هذ#. #.ل#>ق#.#^ م#> أي #>ق#.#^ آخ#^ #<ي ن#<س #.لحقنة لمن#> ح#~وث أي أ#_#^#.#^ ج#.ن#%ية أو أي أم#^#.#_ يص#>#% #>ل#.جه#. #>لى #.لم#~ى #.لقصي#^. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من ح#.لة زي#.#~ة #.لح#~ي#~ #<ي #.لجسم ل#. يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^. \r\n\r\n–ل#. يس#?خ#~م هذ#. #.ل#>ق#.#^ #<ي ح#.لة أنو#.#> #.لأنيمي#. #.لأخ#^ى #.ل#?ي ي#=ون س#%#%ه#. شيئ غي#^ #.لح#~ي#~.", "GI": "Description\t\r\nA metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.SSIndication\tSUsed in preventing and treating iron-deficiency anemia.SSMechanism of action\tSIron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.", "Composition": "iron 100mg", "Route": "INJECTION" }, { "ID": "64", "Trade_Name": "MEMORAL 1GM/5ML 5 AMP", "Generic_Name": "PIRACETAM", "Price": "24", "Price_Old": "16", "Company": "SIGMA", "Pharmacology": "CEREBRAL CIRCULATORY INHANCER", "Category": "محسن #.ل#~و#^ة #.ل#~موية #.ل#~م#.غية", "Use": "–#?نشي#- #.ل#~و#^ة #.ل#~موية و#?وصيل #.ل#.#=سجين للمخ. \r\n\r\n–#.لح#~ من #.#_#-#^#.#%#.#? #.ل#~و#.#^ و #.ل#~وخة و#-نين #.ل#.ذن. \r\n\r\n–#>ل#.ج #.ل#?قلص#.#? #.ل#.#^#?ج#.#<ية #.ل#>#_لية #<ي #.لقش#^ة #.لمخية. \r\n\r\n–#>ل#.ج م#^#_ #.لزه#.يم#^ و #.لنسي#.ن و#.لخ#^#< #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?نشي#- #.لذ#.#=#^ة و#.ل#?#^#=يز و#.لح#~ من #_#>#< #.ل#?#^#=يز #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?حسين و#?نشي#- #.لق#~#^#.#? #.ل#>قلية #>ن#~ #.ل#.#-#<#.ل و#=#%#.#^ #.لسن و#%#>#~ #.لس#=#?#.#? #.ل#~م#.غية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.ل#=لي و #.ل#=#%#~. \r\n\r\n–يج#% #.خ#%#.#^ #.ل#-#%ي#% ق#%ل #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لح#.ل#.#? #.ل#.#?ية: \r\n\r\n–#.ذ#. #=ن#? ح#.مل أو #?خ#-#-ين للحمل ، #.ثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من نزي#< #%#.لمخ ، نزي#< غي#^ #-#%ي#>ي. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من م#?ل#.زمة هن#?نغ#?ون. \r\n\r\n–من ي#>#.ني #.#_#-#^#.#%#.#? #<ي #?خث#^ #.ل#~م.", "GI": "The way piracetam works is not fully understood. It may work by altering the availability of the brain s supply of neurochemicals (neurotransmitters, enzymes and hormones) or by improving the brain s oxygen supply.\r\n\r\nWhat is it used for?\r\nUncontrollable twitching or jerking of the muscles, particularly in the arms and legs, caused by a problem in the brain or nervous system (myoclonus of cortical origin). This medicine is used in combination with other treatments for this condition.", "Composition": "Each hard gelatin capsule contains:\r\nActive ingredient:\r\nPiracetam 400 mg\r\n\r\nInactive ingredients:\r\nMagnesium stearate, croscarmellose sodium and colloidal silicon dioxide.\r\nComposition of capsule shell: gelatin, titanium dioxide, sunset yellow, brilliant blue,", "Route": "INJECTION" }, { "ID": "65", "Trade_Name": "NORICEPT 200 MG/ML I.M. AMP.", "Generic_Name": "NORETHISTERONE", "Price": "14.4", "Price_Old": "14.4", "Company": "CID", "Pharmacology": "SYNTHETIC PROGESTERONE", "Category": "مش#.#=ل #.ل#-مث", "Use": "–يس#?#>مل #.ل#~و#.ء #<ي #.ل#?خلص من نزي#< غي#^ نزي#< #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يس#?خ#~م #=#>ل#.ج لم#?ل#.زمة م#. ق#%ل #.لحي#_. \r\n\r\n–يس#.هم #<ي #?أجيل #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يس#?#>مل أي#_#. #<ي #>ل#.ج ل#.ل#?ه#.#%#.#? #%#-#.نة #.ل#^حم وم#>#.لجة #.ل#_مو#^ #.ل#^حمي. \r\n\r\n–ي#>#.لج #.#_#-#^#.#%#.#? #.لث#~ي و#.لس#^#-#.ن #.ل#?#~#^يجي للث#~ي. \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من نو#>ين من #.ل#-مث: #.ل#.#%#?#~#.ئي و#.لث#.نوي.", "Contraindications": "–يحذ#^ #?ن#.ول #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لأح#~ م#^#=#%#.#? أو م#=ون#.#? #.ل#>ق#.#^. \r\n\r\n–ل#. يج#% #.خذ #.ل#~و#.ء للم#^#_ي #.لذين ي#>#.نون من #.خ#?ل#.ل #<ي وظ#.ئ#< #.ل#=#%#~ أو أو#^#.م #.ل#=#%#~. \r\n\r\n–يج#% أخ#%#.#^ #-#%ي#%#= ق#%ل #?ن#.وله، إذ#. #=ن#?ي م#~خنة أو ل#~ى #>#.ئل#?#= م#~خنين أو ل#~ي#=ي #?#.#^يخ م#^#_ي أو ل#~ى أح#~ أ#<#^#.#~ #>#.ئل#?#= مثل #.لجل#-#.#?. \r\n\r\n–ل#. يؤخذ #.ل#~و#.ء #<ي م#^حلة #.لحمل و#.ل#^#_#.#>ة لأنه يس#%#% خ#-#^ #>لى حي#.ة #.لجنين و#.ل#-#<ل #.ل#^#_ي#> لأنه يم#^ #<ي ل#%ن #.لأم. \r\n\r\n–(يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء خصوص#. #<ي #<#?#^ة #.لحمل و#.ل#^#_#.#>ة). \r\n\r\n–يج#% إيق#.#< #.ل#~و#.ء #<ي #.لح#.ل#.#? #.ل#?#.لية #<و#^#.ً: \r\n\r\n–#>ن#~ ح#~وث ص#~#.#> م#?#=#^#^ أو ص#~#.#> ح#.#~ غي#^ م#>#?#.#~. \r\n\r\n–#>ن#~ #.لش#>و#^ #%#.#_#-#^#.#%#.#? #<ي #.لجه#.ز #.لسم#>ي و#.ل#%ص#^ي. \r\n\r\n–#>ن#~ ظهو#^ #.لآم غي مح#?ملة و#?و#^م #<ي #.لس#.قين. \r\n\r\n–#.لأحس#.س #%وخز #<ي #.ل#?ن#<س أو #_يق أو ألم #<ي #.لص#~#^ غي#^ م#>#?#.#~. \r\n\r\n–#>ن#~ ح#~وث س#>#.ل م#<#.جئ #%#~ون س#%#% و#.#_ح. \r\n\r\n–يج#% إيق#.#< #.ل#~و#.ء #<و#^#. #>ن#~ ح#~وث #.لحمل أو هن#.#= ش#= #<ي ح#~وث حمل مثل #?أخ#^ #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–إذ#. ح#~ث #.#^#?#<#.#> #<ي #_غ#- #.ل#~م م#<#.جئ #%#>#~ #?ن#.وله. \r\n\r\n–ظهو#^ #>#^#_ من أ#>#^#.#_ #.لحس#.سية مثل #.له#^ش #<ي جمي#> أجز#.ء #.لجسم. \r\n\r\n–ح#~وث خلل و#.#_ح #<ي #.لأنش#-ة #.لح#^#=ية. \r\n\r\n–ي#?س#%#% #?ن#.ول #.ل#>ق#.#^ للسي#~#.#? #.لمص#.#%#.#? #%س#^#-#.ن #.لث#~ي #<ي #.#^#?#<#.#> نس#%ة #.ل#=#.لسيوم ولذل#= يج#% إيق#.#< #?ن#.وله.", "GI": "About Norethisterone\r\nNorethisterone and its acetate and enanthate esters are synthetic progestogens given by mouth given in the treatment of abnormal uterine bleeding and endometriosis.\r\nIndications for Norethisterone\r\nPrimary & secondary amenorrhoea of long duration, metropathia haemorrhagica, menorrhagia, dysmenorrhoea, polymenorrhoea, premenstrual syndrome. Female subfertility, endometriosis. Timing of menstruation. As contraceptive drug.", "Composition": "norethisterone 200mg", "Route": "INJECTION" }, { "ID": "66", "Trade_Name": "PROFENID 100MG/2ML 3 AMP.", "Generic_Name": "KETOPROFEN", "Price": "8.25", "Price_Old": "5.45", "Company": "SANOFI", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "Active ingredient:\r\nEach 100 gm gel contains, Ketoprofen 2.500 gm\r\nInactive ingredient:\r\nCarbomer 940, Trolamine, Lavender Oil & Alcohol.", "Route": "INJECTION" }, { "ID": "67", "Trade_Name": "ETAPHYLLINE 500 MG/ 5ML 6 AMP.", "Generic_Name": "PIPERAZINE THEOPHYLLINE ETHANOATE", "Price": "33.75", "Price_Old": "22.5", "Company": "MEMPHIS", "Pharmacology": "BRONCHODILATOR", "Category": "موس#> للش#>#% #.لهو#.ئية", "Use": "–موس#> للش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#^ئوية. \r\n\r\n–#.لسي#-#^ة #>لي ح#.ل#.#? #.ل#^#%و. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية.", "Contraindications": "–#.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ل#. يس#?خ#~م م#> من ي#>#.ني من #.ل#?ق#^ح#.#? #.لم#>#~ية. \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ي #>#~م #.ن#?ظ#.م ن#%#_#.#? #.لقل#%.", "GI": "COMING SOON ..", "Composition": "Composition :\r\nEach 1 ml contains :\r\nAcefylline Piperazine 0.1 g", "Route": "INJECTION" }, { "ID": "68", "Trade_Name": "KETOGESIC 100MG/2ML 3 AMP.", "Generic_Name": "KETOPROFEN", "Price": "7.5", "Price_Old": "5", "Company": "PHAROPHARMA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "Ketoprofen 200 mg", "Route": "INJECTION" }, { "ID": "69", "Trade_Name": "WATER FOR INJECTION I.M/I.V AMPOULE", "Generic_Name": "WATER FOR INJECTION", "Price": "0.5", "Price_Old": "0.5", "Company": "EIPICO", "Pharmacology": "WATER FOR INJECTION", "Category": "م#.ء مق#-#^", "Use": "–هو م#.ء ذو جو#~ة #>#.لية ج#~#. ل#. يح#?وي أي مُلوِّث#.#? ذ#.#? أهمية #?ُذ#=#^، وهو م#.ءٌ #%ش#=لٍ مُ#>قَّم يُس#?خ#~م #<ي #?ح#_ي#^ #.لمح#.ليل #.ل#?ي س#?ُحقًن \r\n\r\n–#%ش#=لٍ #>#.م ي#?م إ#_#.#<ة مو#.#~ أخ#^ى لج#>ل محلول #.لحقن أ#=ث#^ أو أقل م#>#.#~لةً لل#?#^#=يز ق#%ل أن ي#?م #.س#?#>م#.له. من #.لمم#=ن أن ي#?م حقن هذ#. #.لمحلول #<ي #.لو#^ي#~، أو #<ي #.ل#>#_ل، أو #?ح#? #.لجل#~. أم#. #.لش#=ل غي#^ #.لم#>قم #<من #.لمم#=ن أن ي#?م #.س#?#>م#.له #<ي #.ل#?صني#> #>لى أن ي#?م #.ل#?#>قيم ل#.حق#. #_من #>ملية #.لإن#?#.ج. \r\n\r\n–وهو م#.ء #?#?م #?نقي#?ه #%#>مليّة #.ل#?ق#-ي#^ (#.لوسيلة #.ل#?ي #?#>#?م#~ #>لى #>مليّة #.ل#?#%خ#^ و#?جمي#> #.لس#.ئل #.لن#.#?ج #%#.ل#?#=ثي#< #=وسيلة ل#?نقية #.لس#.ئل) #.و #%#>مليّة #.ل#?ن#.#_ح #.ل#>#=سي و#.ل#?ي يُقص#~ #%ه#. #.ل#?ي #?#?م #%ه#. #?نقية #.لمُذي#% #=#.لم#.ء من #.لم#.#~ة #.لمُذ#.#%ة #>ن #-#^يق #~#<#> #.لم#.ء #%قوّة #>#%#^ غش#.ء ش#%ه مُن#<ذ و#%#.ل#?#.لي #?#>#%#^ #.لم#.#~ة #.لمُذي#%ة #~ون #.لم#.#~ة #.لذ#.ئ#%ة. #>#.#~ةً م#. ي#?م #?خزين هذ#. #.لم#.ء و#?وزي#>ه #?ح#? #~#^جة ح#^#.#^ة #?صل #.لى 80 #~#^جة مئويّة ل#_م#.ن م#?#-ل#%#.#? #.لجو#~ة #.لمي#=#^و#%يّة.", "Contraindications": "–إذ#. #?مّ حقنه #<ي #.لو#^ي#~ #~ون ج#>له أ#=ث#^ أو أقل م#>#.#~لةً لل#?#^#=يز، #<ق#~ يحصل #?#=سّ#^ ل#=#^ي#.#? #.ل#~م #.لحم#^#.ء. مم#. ق#~ يؤ#~ي إلى مش#=لة #.لقصو#^ #.ل#=لوي . \r\n\r\n–#=م#. أن حقنه #%#=مي#.#? مُ#<#^ِ#-ة يؤ#~ي إلى #<#^#- حجم #.ل#~م. #>موم#. ي#?م #?ح#_ي#^ م#.ء #.لحقن #%#.ل#?ق#-ي#^ أو #%#.لأسموزية #.لم#>#.#=سة. يج#% أن يح#?وي #>لى أقل من مغ و#.ح#~ من #.ل#>ن#.ص#^ #>#~#. #.لم#.ء ل#=ل 100 مل. #=م#. وي#?و#.#<#^ منه أش#=#.ل #?ح#?وي مو#.#~ #?#>مل #>لى إيق#.#< #.لنمو #.ل#%#=#?ي#^ي.", "GI": "pu?ri?fied wa?ter\r\nwater obtained by distillation or deionization.", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "70", "Trade_Name": "UNITRIN 25MG 30 CAPS.", "Generic_Name": "ACITRETIN", "Price": "135", "Price_Old": "135", "Company": "UNIPHARMA CO.", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–ل#>ل#.ج #.لنو#.قص #.لش#~ي#~ة ل#?ق#^ن #.لجل#~ (Keratinization)، #.ل#?ي ل#. #?س#?جي#% لل#>ل#.ج#.#? #.لأخ#^ى: مثل #.لصَّ#~َ#<ية (Psoriasis) أو غي#^ه#. من #.لأم#^#.#_ #.لجل#~ية #.لن#.#~#^ة #.لم#^#?#%#-ة #%#.لإن#?#.ج غي#^ #.ل#-#%ي#>ي من #.ل#=ي#^#.#?ين", "Contraindications": "–#<#^#- #.لحس#.سية #.#?ج#.ة #.ل#.سي#?#^ي#?ين #.و #.ى من م#=ون#.#?ة . \r\n\r\n–#.ل#^#_#.#>ه #.ل#-#%ي#>ية . \r\n\r\n–#.لحمل #.و #.ل#?خ#-ي#- للحمل . \r\n\r\n–#.لمص#.#%ين #%#.#^#?#<#.#> مس#?وى #.ل#=#.لسيوم #<ى #.ل#~م . \r\n\r\n–#.لمص#.#%ين #%#.م#^#.#_ #.ل#=#%#~ و#.ل#=لى .", "GI": "Description:\t\r\nAn oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate. \r\n\r\nIndication :\r\nFor the treatment of severe psoriasis in adults.\r\n\r\nMechanism of action\t:\r\nThe mechanism of action of acitretin is unknown, however it is believed to work by targeting specific receptors (retinoid receptors such as RXR and RAR) in the skin which help normalize the growth cycle of skin cells.\r\n\r\nHalf life : \r\n49 hours (range 33 to 96 hours)\r\n\r\nDosage :\r\nThe recommended dose is 25 to 50 mg per day, given as a single dose with the main meal.", "Composition": "acitretin 10mg or 25mg", "Route": "ORAL.SOLID" }, { "ID": "71", "Trade_Name": "REGENERATE 30MG 20 CAPS.", "Generic_Name": "ADENOSINE TRIPHOSPHATE DISODIUM", "Price": "10", "Price_Old": "10", "Company": "PHAROPHARMA", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–#.لنقل #.لغش#.ئي . \r\n\r\n–#?#^#=ي#% #.لم#^#=#%#.#? #.لخلوية . \r\n\r\n–أ#>م#.ل آلية . \r\n\r\n–#?جهيز #.ل#-#.قة #.لل#.زمة لنقل #.لصو#~يوم خل#.ل غش#.ء #.لخلية. \r\n\r\n–و#?نشي#- #.ل#^ي#%وسوم#.#? ل#?#=وين #.ل#%#^و#?ين . \r\n\r\n–و#?جهيز #.ل#-#.قة #.ل#_#^و#^ية لل#?قلص #.ل#>#_لي . \r\n\r\n–#_#^#%#.#? #.لقل#% #.لغي#^ من#?ظمة #.ل#?ي #?س#%#%ه#. #?قلص#.#? غي#^ #-#%ي#>ية #<ي #.لجزء #.ل#>لوي من #.لقل#% (#>#~م #.ن#?ظ#.م #_#^#%#.#? #.لقل#% #<وق #.ل#%#-يني) #%م#. #<ي ذل#= #%م#. #<ي ذل#= م#. ي#^#?#%#- منه#. #%م#?ل#.زمة ول#< #%#.#^#=نسون #.ل#.#%ي#_", "Contraindications": "–م#?َل#.َزمةُ #.ل#>ُقْ#~َةِ #.لجَي#%ِيَّةِ #.لم#^ِيْ#_َة و #.ل#~#^جة #.لث#.نية أو #.لث#.لثة من #.حص#.#^ #.ل#>ق#~ة #.لأذينية #.ل#%#-ينية ( م#. #>#~#. #.لم#^#_ى #.لذين يس#?خ#~مون جه#.ز #?نظيم #_#^#%#.#? #.لقل#% #.ل#.ص#-ن#.#>ي) \r\n\r\n–#.ل#^#%و أو أي أم#^#.#_ #?#_يق #.لقص#%#.#? #.لهو#.ئية . \r\n\r\n–#.ل#^#<#^#<ة #.لأذينية #^ج#<#.ن أُذيْني \r\n\r\n– #<#^#- #.لحس#.سية ل#.ي من م#=ون#.#? #.ل#~و#.ء", "GI": "Description:\r\n Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.\r\n\r\nIndication :\r\nUsed as an initial treatment for the termination of paroxysmal supraventricular tachycardia (PVST), including that associated with accessory bypass tracts, and is a drug of choice for terminating stable, narrow-complex supraventricular tachycardias (SVT).\r\n\r\nMechanism of action\tAdenosine slows conduction time through the AV node and can interrupt the reentry pathways through the AV node, resulting in the restoration of normal sinus rhythm in patients with paroxysmal supraventricular tachycardia (PSVT), including PSVT associated with Wolff-Parkinson-White Syndrome. This effect may be mediated through the drug s activation of cell-surface A1 and A2 adenosine receptors. Adenosine also inhibits the slow inward calcium current and activation of adenylate cyclase in smooth muscle cells", "Composition": "adenosine triphosphate 30mg", "Route": "ORAL.SOLID" }, { "ID": "72", "Trade_Name": "NOVIRUS 200 MG 8 CAPS.", "Generic_Name": "ACYCLOVIR", "Price": "13.2", "Price_Old": "13.2", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لله#^#%س", "Use": "–#.لقو#%#.ء #.لمن#-قية #.لخ#-ي#^ة #%#.ل#.م#?#~#.#~ أو #%#?#~#^ج #.لآ#<#.#? ، \r\n\r\n–ج#~#^ي #.لم#.ء #<ي #.لنس#.ء #.لحو#.مل #.للو#.#?ي يح#~ث #.ل#-#<ح #.لجل#~ي #<ي غ#_ون 8 إلى 10 أي#.م ق#%ل #.لول#.#~ة ، \r\n\r\n–ج#~#^ي #.لم#.ء ح#~يثي #.لول#.#~ة ، \r\n\r\n–#.لولي#~ ق#%ل أي ثو#^#.ن ، #>ن#~م#. #%#~أ#? #.لأم #<ي #.لإص#.#%ة #%ج#~#^ي #.لم#.ء #<ي #.لأي#.م #.لخمسة #.لس#.#%قة و يومين #%#>#~ #.لول#.#~ة ، \r\n\r\n–أش#=#.ل ش#~ي#~ة من #.لج#~#^ي ل#~ى #.لأ#-#<#.ل #~ون سن 1 سنة ، \r\n\r\n–ج#~#^ي #.لم#.ء #.لم#>ق#~ ، خ#.صة ج#~#^ي #.لم#.ء ، \r\n\r\n–#.ل#?ه#.#%#.#? #<ي#^وس #.له#^#%س #.ل#%سي#- \r\n\r\n–#.ل#>#~وى #.لأولية #.ل#?ن#.سلية #.ل#>ق#%ولية #.لش#~ي#~ة ، \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#<م و#.للثة #.له#^#%سي #.لح#.#~ ، #>ن#~م#. يج#>ل #.ل#.نز#>#.ج #.لوظي#<ي #.ل#-#^يق #.ل#<موي مس#?حيل#.ً ، \r\n\r\n–#>ل#.ج م#?ل#.زمة #=#.#%وسي جوليوس#%#^غ ، \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. و#.ل#~م#.غ.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي. \r\n\r\n– لمن ي#>#.نون من #_#>#< #<ي #.لجه#.ز #.لمن#.#>ي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> #.ل#?#-#>يم#.#? و#.ل#?حصين#.#?. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية. \r\n\r\n– ل#. يس#?خ#~م #.ل#>ق#.#^ لحم#.ية #.ن#?ش#.#^ #.له#^#%س #.ل#?ن#.سلي. يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة", "GI": "(Indications) : \r\nThis medication is an antiviral agent, prescribed for herpes simplex, genital herpes, herpes zoster and chickenpox. It slows down the growth and spread of the herpes virus. Acyclovir is also sometimes used to treat eczema herpeticum, herpes infections of the skin, eyes, nose, and mouth in patients with human immunodeficiency virus (HIV) . \r\n\r\n (Dosage) : \r\nAcute Treatment of Herpes Zoster: 800 mg every 4 hours orally, 5 times daily for 7 to 10 days. \r\nGenital Herpes: Treatment of Initial Genital Herpes: 200 mg every 4 hours, 5 times daily for 10 days. \r\nChronic Suppressive Therapy for Recurrent Disease: 400 mg 2 times daily for up to 12 months, followed by re-evaluation. \r\nTreatment of Chickenpox: Children (2 years of age and older): 20 mg/kg per dose orally 4 times daily (80 mg/kg/day) for 5 days. \r\nAdults and Children over 40 kg: 800 mg 4 times daily for 5 days.", "Composition": "acyclovir sod. 5%", "Route": "ORAL.SOLID" }, { "ID": "73", "Trade_Name": "SEMPREX 8MG 24 CAPS.", "Generic_Name": "ACRIVASTINE", "Price": "18.8", "Price_Old": "18.8", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTIHISTAMINE.SECOND-GENERATION", "Category": "م#_#.#~ للحس#.سية", "Use": "–#~و#.ء م#_#.#~ للهيس#?#.مين غي#^ مس#=ن: #?خ#<ي#< أ#>#^#.#_ #.لحس#.سية #.لأن#<ية (حس#.سية #.لأن#<) مثل حمى #.لقش. #?خ#<ي#< أ#>#^#.#_ #.ل#-#<ح #.لجل#~ي #.لمصحو#% #%#.لح#=ة", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء . #.لأ#-#<#.ل #~ون #>م#^ 12 سنة.", "GI": "Description:\r\na non-sedating antihistamine\r\n\r\nIndication :\r\nRelieving the symptoms of nasal allergies (allergic rhinitis) such as hay fever.\r\nRelieving the symptoms of an itchy skin rash with no known cause (chronic idiopathic urticaria).\r\n\r\nMechanism of action\t:\r\nAcrivastine works by blocking histamine H1 receptors. It doesn t prevent the actual release of histamine from mast cells, but prevents it binding to its receptors. This in turn prevents the release of other allergy chemicals and increased blood supply to the area, and provides relief from the typical symptoms of nasal allergies such as hayfever.\r\nAcrivastine can also be used to relieve the symptoms of various itchy rashes and hives. Blocking the actions of histamine relieves the itching and reduces the rash\r\n\r\ndosage:\r\nAdults and adolescents aged 12 years and over should take one capsule up to three times a day when needed to relieve symptoms.", "Composition": "acrivastine 8mg", "Route": "ORAL.SOLID" }, { "ID": "74", "Trade_Name": "A1 CREAM 100 GM", "Generic_Name": "CASTOR OIL+ZINC OXIDE+ARACHIS OIL+BEES WAX", "Price": "40", "Price_Old": "15", "Company": "EGPI > EGD", "Pharmacology": "MOISTURIZING CREAM", "Category": "#=#^يم #?#^#-ي#%", "Use": "–مل#-#< وم#_#.#~ لحمو #.لنيل \r\n\r\n–#>ل#.ج ح#^وق #.لشمس \r\n\r\n–#.ل#>ن#.ية #%#%ش#^ة #.ل#^#_#> \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لح#<#.#_#.#? \r\n\r\n–مل#-#< لل#%ش#^ة \r\n\r\n–م#^#-#% للجل#~ #.لج#.#< \r\n\r\n–م#_#.#~ للح#=ة و#.لحس#.سية و#.له#^ش \r\n\r\n–مل#-#< للجل#~ و#?ن#>يم #%ش#^ة #.لجل#~ \r\n\r\n–#?ن#>يم #.لجل#~ \r\n\r\n–#.لوق#.ية من #.ش#>ة #.لشمس \r\n\r\n–. Soothing and emollient for the skin", "Contraindications": "–#.لحس#.سية #.لم#<#^#-ة لأح#~ م#=ون#.#? #.ل#~و#.ء .", "GI": "Soothing cream for napkin area", "Composition": "bee wax,cetearth", "Route": "TOPICAL" }, { "ID": "75", "Trade_Name": "CALCIDOL 0.25 MCG 30 CAPS.", "Generic_Name": "ALFACALCIDOL", "Price": "25.5", "Price_Old": "25.5", "Company": "KAHIRA > MULTIPHARMA", "Pharmacology": "VITAMIN D", "Category": "#<ي#?#.مين #~", "Use": "–يس#?خ#~م #=#?#>وي#_ #>ن #<ي#?#.مين #~ #<ي #.لم#^#_ى #.لذين ي#>#.نون من نقص #<ي#?#.مين #~ لي#?سنى لجسمهم #.لقي#.م #%#>ملي#.#? #.لأي#_ #.ل#?ي #?خص #.ل#>ظ#.م #%ش#=ل صحيح. \r\n\r\n–#%#.ل#?#.لي يس#?خ#~م #.ل#>ل#.ج للم#^#_ى #.لذين ل#~يهم #.#_#-#^#.#%#.#? #<ي أي#_ #.ل#=#.لسيوم #<ي جسمهم ، مثل ح#.ل#.#?: \r\n\r\n–خلل #.ل#>ظ#.م #.لم#^#?#%#- #%أم#^#.#_ #.ل#=لى. \r\n\r\n–#<#^#- نش#.#- #.لغ#~ة ج#.#^ة #.ل#~#^قية. \r\n\r\n–نقص نش#.#- #.لغ#~ة #.لج#.#^ #~#^قية. \r\n\r\n–نقص #.ل#=#.لسيوم #>ن#~ ح#~يثي #.لول#.#~ة. \r\n\r\n–لين #.ل#>ظ#.م و #.ل#=س#.ح #.لم#^#?#%#- #%سوء #.ل#?غذية أو #%#.ل#.م#?ص#.ص.", "Contraindications": "–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ قلة #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#?جن#% #.س#?خ#~#.مه للم#^#_ى #.لذين ل#~يهم حصو#.#? #<ي #.ل#=لي. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء لمن يأخذ #~و#.ء #.ل#~يجو#=سين وغي#^ #<#>#.ل #<ي #.س#?خ#~#.مه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #.لحمل أو #.ل#^#_#.#>ة وق#%ل #.س#?خ#~#.مه يلزم #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "Description :\t\r\nAlfacalcidol is an active metabolite of Vitamin D, \r\n\r\nIndication\t:\r\nprescribed for hypocalcaemia, hypoparathyroidism, hypophosphataemia, renal osteodystrophy, and osteomalacia.\r\n\r\ndosage :\r\nAdult- PO- The recommended starting dose is 1mcg/day. Maintenance: 0.25-1 mcg/day. \r\nAdult- IV- The recommended initial dose is 1 mcg per dialysis two to three times a week. \r\n\r\nMechanism of action\tThe first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains.", "Composition": "alpha calcidol 0.25mcg", "Route": "ORAL.SOLID" }, { "ID": "76", "Trade_Name": "SEMPRA-GUIDE 10 CAPS.", "Generic_Name": "ACRIVASTINE+PSEUDOEPHEDRINE", "Price": "7", "Price_Old": "7", "Company": "WESTERN PHARMACEUTICALS INDUSTRIES", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY.COMBINED WITH VASOCONSTRICTOR AGENT", "Category": "م#_#.#~ للحس#.سية", "Use": "–مح#~#~ ل#>ل#.ج #.ل#%#^#~, #.ل#?ه#.#% #.لأن#< #.ل#?حسسي #.لموسمي, #.ل#>#-س, سيل#.ن #.لأن#<, #.لح#=ة, #.ل#~م#>, إح#?ق#.ن #%#.لأن#<, #.لحس#.سية, #.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة, #.ح#?ق#.ن #.لجيو#% #.لأن#<ية و#.ل#_غ#-و #.لح#.ل#.#? #.ل#.خ#^ى", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء أو أح#~ #.لأ#~وية #.لم#_#.#~ة للهيس#?#.مين #.ل#?#.#%#>ة لمجمو#>ة #.لأل#=يلأمين.\r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م #.لش#~ي#~.\r\n\r\n–أم#^#.#_ #.لقل#% #.ل#?#.جية #.لش#~ي#~ة.\r\n\r\n–أخذه م#?ز#.من#.ً م#> أو خل#.ل 14 يوم من #?لقي #.ل#>ل#.ج #.لذي يح#?وي #>لى مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين.", "GI": "Description:\r\nThis medication contains a non-sedating antihistamine (acrivastine), and a nasal decongestant(pseudoephedrine)\r\n\r\nIndication :\r\nprescribed to temporarily relieve seasonal allergic rhinitis such as sneezing, rhinorrhea, pruritus, lacrimation, nasal congestion. It is also used for itchy or watery eyes, hives, skin rash, itching, and other symptoms of allergies and the common cold.\r\n\r\nMechanism of action\t:\r\nAcrivastine works by blocking histamine H1 receptors. It doesn t prevent the actual release of histamine from mast cells, but prevents it binding to its receptors. \r\nPseudoephedrine works by acting on alpha receptors that are found in the walls of blood vessels in the linings of the nasal passages and sinuses. It causes these blood vessels to contract and narrow, thereby decreasing blood flow into the linings of the nose and sinuses. This reduces the feeling of congestion and also reduces the production of mucus\r\n\r\ndosage :\r\none capsule (8mg/60mg), every 4 to 6 /day", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "77", "Trade_Name": "ONE ALPHA 0.25MCG 30 CAPS.", "Generic_Name": "ALFACALCIDOL", "Price": "48", "Price_Old": "43.25", "Company": "LEO PHARMACEUTICAL PRODUCTS > MINA PHARM", "Pharmacology": "VITAMIN D", "Category": "#<ي#?#.مين #~", "Use": "–يس#?خ#~م #=#?#>وي#_ #>ن #<ي#?#.مين #~ #<ي #.لم#^#_ى #.لذين ي#>#.نون من نقص #<ي#?#.مين #~ لي#?سنى لجسمهم #.لقي#.م #%#>ملي#.#? #.لأي#_ #.ل#?ي #?خص #.ل#>ظ#.م #%ش#=ل صحيح. \r\n\r\n–#%#.ل#?#.لي يس#?خ#~م #.ل#>ل#.ج للم#^#_ى #.لذين ل#~يهم #.#_#-#^#.#%#.#? #<ي أي#_ #.ل#=#.لسيوم #<ي جسمهم ، مثل ح#.ل#.#?: \r\n\r\n–خلل #.ل#>ظ#.م #.لم#^#?#%#- #%أم#^#.#_ #.ل#=لى. \r\n\r\n–#<#^#- نش#.#- #.لغ#~ة ج#.#^ة #.ل#~#^قية. \r\n\r\n–نقص نش#.#- #.لغ#~ة #.لج#.#^ #~#^قية. \r\n\r\n–نقص #.ل#=#.لسيوم #>ن#~ ح#~يثي #.لول#.#~ة. \r\n\r\n–لين #.ل#>ظ#.م و #.ل#=س#.ح #.لم#^#?#%#- #%سوء #.ل#?غذية أو #%#.ل#.م#?ص#.ص.", "Contraindications": "–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ قلة #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#?جن#% #.س#?خ#~#.مه للم#^#_ى #.لذين ل#~يهم حصو#.#? #<ي #.ل#=لي. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء لمن يأخذ #~و#.ء #.ل#~يجو#=سين وغي#^ #<#>#.ل #<ي #.س#?خ#~#.مه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #.لحمل أو #.ل#^#_#.#>ة وق#%ل #.س#?خ#~#.مه يلزم #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "Description :\t\r\nAlfacalcidol is an active metabolite of Vitamin D, \r\n\r\nIndication\t:\r\nprescribed for hypocalcaemia, hypoparathyroidism, hypophosphataemia, renal osteodystrophy, and osteomalacia.\r\n\r\ndosage :\r\nAdult- PO- The recommended starting dose is 1mcg/day. Maintenance: 0.25-1 mcg/day. \r\nAdult- IV- The recommended initial dose is 1 mcg per dialysis two to three times a week. \r\n\r\nMechanism of action\tThe first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains.", "Composition": "Alfacalcidol 0.25 microgram or 1 microgram", "Route": "ORAL.SOLID" }, { "ID": "78", "Trade_Name": "GLYCERIN ADULT 6 SUPP.", "Generic_Name": "GLYCERIN", "Price": "4.8", "Price_Old": "4.8", "Company": "EL NILE.", "Pharmacology": "LAXATIVE", "Category": "م#_#.#~ لل#.مس#.#=", "Use": "– ي#>#.لج #.ل#.مس#.#= #%ش#=ل س#^ي#> و#<#>#.ل . \r\n\r\n– ي#>#.لج #.ل#%و#.سي#^ ويخ#<#< من ح#~#?ه#. . \r\n\r\n– يس#?خ#~م #%#>#~ #.ج#^#.ء #>ملي#.#? #.لش#^ج و#.لمس#?قيم . \r\n\r\n– يسمح #%#.س#?خ#~#.مه لل#=#%#.#^ و#.لصغ#.#^ . \r\n\r\n– ي#>#.لج #.لش#^خ #.لش#^جي . \r\n\r\n– ي#>مل #>لي #?#<#^يغ #.لأم#>#.ء و#.ل#?خلص من #.ل#<#_ل#.#? #.لموجو#~ة #<يه#..", "Contraindications": "– يج#% #?جن#% #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث ل#. #?وج#~ #~#^#.س#.#? مؤ#=#~ة و#=#.#<ية حول سل#.مة #.س#?خ#~#.م #.ل#>ل#.ج #>لى #.لجنين #=م#. #.نه من غي#^ #.لم#>#^و#< إن #=#.ن #.ل#>ل#.ج ي#<#^ز #<ي #.لحلي#% ويؤث#^ #>لي #.ل#-#<ل #.ل#^#_ي#> أم ل#. ولذل#= من #.ل#.#<#_ل #>#~م #.س#?خ#~#.مه أو #.س#?#>م#.له #%حذ#^ #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج #.و #.لصي#~لي #>لي #.لأقل . \r\n\r\n– #>#~م #.س#?#>م#.له لل#.شخ#.ص #.لذين ي#>#.نون من حس#.سية #?ج#.ه #.ح#~ م#=ون#.#? #.ل#~و#.ء ل#?جن#% آث#.#^ه #.لج#.ن#%ية . \r\n\r\n– #?جن#% #.خذ ج#^#>#.#? ز#.ئ#~ة من #.ل#~و#.ء و#.ل#.ل#?ز#.م #%#.لج#^#>ة #.لمح#~#~ة من ق#%ل #.ل#-#%ي#% #.لم#>#.لج #%#.ل#.#_#.#<ة #.لي #.ل#.ل#?ز#.م #%#.ل#<#?#^ة #.ل#>ل#.جية #.ل#?ي يح#~#~ه#. #.ل#-#%ي#% . \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#>ق#.#^ لل#.#-#<#.ل #.قل من #>م#^ سن#?ين . \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة #.ل#.ص#.#%ة #%#.نس#~#.#~ #<ي #.لأم#>#.ء أو ح#~وث #.نحس#.#^ #<ي #.ل#%#^#.ز #%ش#=ل ش#~ي#~. \r\n\r\n– يج#% #.ل#?وق#< #>ن #.س#?خ#~#.م #.ل#>ق#.#^ #<ي ح#.لة ح#~وث ج#<#.#< ش#~ي#~ ل#?جن#% ح#~وث م#_#.#>#<#.#? خ#-ي#^ة #>لي صحة #.لم#^ي#_ .", "GI": "Mechanism of Action of Glycerine\r\nGlycerine is a sweet clear viscous liquid with dehydrating property. It produces a warm sensation and irritates mucous membranes. When used as a suppository and applied to anal canal it induces evacuation. Glycerine soothes the irritated skin so it is used as a component of cough mixtures. When a 50% solution of Glycerine in water is applied to dry and chapped skin it acts as an emollient. When used a 10% solution I.V. it reduces intraocular or intracranial pressure. When used as a diuretic it significantly increases the osmolality of plasma and tubular fluid. It is pharmacologically inert and freely filtered at glomerulus and undergoes limited reabsorption by renal tubule and acts as osmotic diuretic.", "Composition": "Each Suppository contains 0.7359 gm or 1.47 gm of Glycerin", "Route": "RECTAL" }, { "ID": "79", "Trade_Name": "ONE ALPHA 0.5MCG 30 CAPS.", "Generic_Name": "ALFACALCIDOL", "Price": "67.5", "Price_Old": "54", "Company": "LEO PHARMACEUTICAL PRODUCTS > PHARMA OVER SEAS", "Pharmacology": "VITAMIN D", "Category": "#<ي#?#.مين #~", "Use": "–يس#?خ#~م #=#?#>وي#_ #>ن #<ي#?#.مين #~ #<ي #.لم#^#_ى #.لذين ي#>#.نون من نقص #<ي#?#.مين #~ لي#?سنى لجسمهم #.لقي#.م #%#>ملي#.#? #.لأي#_ #.ل#?ي #?خص #.ل#>ظ#.م #%ش#=ل صحيح. \r\n\r\n–#%#.ل#?#.لي يس#?خ#~م #.ل#>ل#.ج للم#^#_ى #.لذين ل#~يهم #.#_#-#^#.#%#.#? #<ي أي#_ #.ل#=#.لسيوم #<ي جسمهم ، مثل ح#.ل#.#?: \r\n\r\n–خلل #.ل#>ظ#.م #.لم#^#?#%#- #%أم#^#.#_ #.ل#=لى. \r\n\r\n–#<#^#- نش#.#- #.لغ#~ة ج#.#^ة #.ل#~#^قية. \r\n\r\n–نقص نش#.#- #.لغ#~ة #.لج#.#^ #~#^قية. \r\n\r\n–نقص #.ل#=#.لسيوم #>ن#~ ح#~يثي #.لول#.#~ة. \r\n\r\n–لين #.ل#>ظ#.م و #.ل#=س#.ح #.لم#^#?#%#- #%سوء #.ل#?غذية أو #%#.ل#.م#?ص#.ص.", "Contraindications": "–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ قلة #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#?جن#% #.س#?خ#~#.مه للم#^#_ى #.لذين ل#~يهم حصو#.#? #<ي #.ل#=لي. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء لمن يأخذ #~و#.ء #.ل#~يجو#=سين وغي#^ #<#>#.ل #<ي #.س#?خ#~#.مه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #.لحمل أو #.ل#^#_#.#>ة وق#%ل #.س#?خ#~#.مه يلزم #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "Description :\t\r\nAlfacalcidol is an active metabolite of Vitamin D, \r\n\r\nIndication\t:\r\nprescribed for hypocalcaemia, hypoparathyroidism, hypophosphataemia, renal osteodystrophy, and osteomalacia.\r\n\r\ndosage :\r\nAdult- PO- The recommended starting dose is 1mcg/day. Maintenance: 0.25-1 mcg/day. \r\nAdult- IV- The recommended initial dose is 1 mcg per dialysis two to three times a week. \r\n\r\nMechanism of action\tThe first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains.", "Composition": "Alfacalcidol 0.25 microgram or 1 microgram", "Route": "ORAL.SOLID" }, { "ID": "80", "Trade_Name": "NUCLEO CMP FORTE LYOPHILIZED AMPOULES", "Generic_Name": "CYTIDINE+URIDINE", "Price": "10.25", "Price_Old": "8.25", "Company": "SIGMA TEC > FERRER INTERNATIONAL SA -SPAIN", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–#.ل#.#>#?ل#.ل#.#? #.ل#>ظمية #.لم#<صلية، مثل #>#^ق #.لنس#.، و#.ل#?ه#.#% #.لجذ#^. \r\n\r\n–#.ل#.#>#?ل#.ل#.#? #.لأي#_ية، مثل #.لس#=#^ي، و#.ل#?ه#.#% #.لأ#>ص#.#% #.لم#?#>#~#~ #.ل#=حولي. \r\n\r\n–#.ل#.#>#?ل#.ل#.#? #.ل#.ل#?ه#.#%ية #.لمنشأ، مثل #.لإص#.#%ة #%#>#~وى #<ي#^وس #.له#^#%س #.لن#-#.قي. \r\n\r\n–#.ل#.#>#?ل#.ل#.#? #.ل#>ص#%ية #.لأخ#^ى، مثل #.#>#?ل#.ل #>ص#% #.لوجه، أو #.ل#>ص#% ثل#.ثي #.ل#?و#.ئم، أو غي#^ه#..", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "Abstract\r\nThe pyrimidines cytidine (as CTP) and uridine (which is converted to UTP and then CTP) contribute to brain phosphatidylcholine and phosphatidylethanolamine synthesis via the Kennedy pathway. Their uptake into brain from the circulation is initiated by nucleoside transporters located at the blood-brain barrier (BBB), and the rate at which uptake occurs is a major factor determining phosphatide synthesis. Two such transporters have been described: a low-affinity equilibrative system and a high-affinity concentrative system. It is unlikely that the low-affinity transporter contributes to brain uridine or cytidine uptake except when plasma concentrations of these compounds are increased several-fold experimentally.", "Composition": "cytidine 5mguridine 1.33mg", "Route": "INJECTION" }, { "ID": "81", "Trade_Name": "EM-EX 3MG/3ML 1 AMP", "Generic_Name": "GRANISETRON", "Price": "84", "Price_Old": "84", "Company": "AMOUN", "Pharmacology": "5-HT3 ANTAGONIST.ANTI-EMETIC", "Category": "#>ل#.ج م#?ل#.زمة #.لقولون #.ل#>ص#%ي و م#_#.#~#.#? للحمو#_ة و #.لوق#.ية و#.ل#>ل#.ج من #.لغثي#.ن و#.لقيء", "Use": "– #.لغثي#.ن #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية \r\n\r\n– ش#>و#^ من #.لم#^#_ و#.لقيء #%س#%#% #.ل#>ل#.ج #.ل#=يمي#.ئي للس#^#-#.ن و#.ل#>ل#.ج #.لإش#>#.#>ي \r\n\r\n– #.لقيء #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية", "Contraindications": "–#<#^#- #.لحس#.سية لل#~و#.ء و#%#.لإ#_#.#<ة إلى ذل#=، ل#. ين#%غي أن #?#?ن#.ول #.ل#~و#.ء إذ#. #=#.ن ل#~ي#= #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n– Dolasetron أو أون#~#.نسي#?#^ون \r\n\r\n– #.لمخ#~#^#.#? ه#^مون #.لسي#^و#?ونين \r\n\r\n– #>#~م #.ن#?ظ#.م #_#^#%#.#? #.لقل#% أو #.لقل#% و#.#_#-#^#.#%#.#? \r\n\r\n– #<#^#- #.لحس#.سية \r\n\r\n– مش#.#=ل و#^#.ثية من #.ل#?#>ص#% #.لجل#.#=#?وز \r\n\r\n– نقص #.لل#.#=#?#.ز أو #.لجلو#=وز \r\n\r\n– ل#. يج#% #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية ش#~ي#~ة من م#.#~ة ج#^#.نيسي#?#^ون #.و #.لمو#.#~ #.لم#=ونة لل#>ق#.#^ . \r\n\r\n– يج#% #?وخي #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة .", "GI": "About Granisetron\r\nSelective 5HT3 receptor antagonist, Tropane derivative, Antiemetic, antinauseant.\r\n\r\nMechanism of Action of Granisetron\r\nGranisetron is a selective 5HT3 receptor antagonist. 5HT3 receptors are present in vagal nerve terminals and chemoreceptor trigger zone of area postrema of the brain. \r\nCytotoxic chemotherapy is associated with release of Serotonin from Enterochromaffin cells in the small intestine. Serotonin triggers vomiting through 5HT3 vagal receptor that activates the vomiting reflex. Since Granisetron is a 5HT3 receptor antagonist, it is indicated for the prevention of nausea and vomiting associated in chemotherapy. \r\n\r\nIndications for Granisetron\r\n1.Nausea and vomiting associated with cytotoxic chemotherapy or radiotherapy.", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "82", "Trade_Name": "GENTAMICIN-SIGMA 20MG/2ML 6 AMP. FOR IM/IV", "Generic_Name": "GENTAMICIN", "Price": "10.5", "Price_Old": "10.5", "Company": "SIGMA TEC", "Pharmacology": "ANTIBIOTICS.AMINOGLYCOSIDES", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "– #>ل#.ج #.ل#>#~وي #.ل#%#=#?ي#^ية #.ل#?ي #?صي#% #.لجسم مثل #.لز#.ئقة #.لم#?قل#%ة #.ل#.#>#?ي#.#~ية و#.لم#=و#^#.#? #.ل#>نقو#~ية موج#%ة #.لج#^#.م. \r\n\r\n– #>ل#.ج #>#~وي و#.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.ل#^ئوية و#.لش#>#% #.لهو#.ئية. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.لم#^#.#^ة. \r\n\r\n– #>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #>ل#.ج ح#.ل#.#? #.ل#?سمم #%#.ل#~م. \r\n\r\n– #>ل#.ج #>#~وي #.ل#?ه#.#% #.لشغ#.#<. \r\n\r\n– #>ل#.ج #~#.ء #.ل#%#^وسيل#.#?. \r\n\r\n– #>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n– #>ل#.ج م#^#_ #.ل#?ول#.#^يمية. \r\n\r\n– #>ل#.ج #>#~وي و#.ل#?ه#.#%#.#? #.لأم#>#.ء و#.لم#>#~ة. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لخ#.#^جية. \r\n\r\n– #>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n– #>ل#.ج م#^#_ #.ل#-#.#>ون.", "Contraindications": "–1. يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#>ق#.#^. \r\n\r\n–2. لمن ي#>#.نون من وهن #%#.ل#>#_ل#.#?. \r\n\r\n–3. #<ي ح#.لة #.ل#?#>#% #.لس#^ي#> و#>#~م #.لسي#-#^ة #.ل#-و#>ية #>لى #.ل#>#_ل#.#?. \r\n\r\n–4. يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث ي#>#^#_ #.لجنين للخ#-#^.", "GI": "About Gentamicin\r\nAminoglycoside antibiotic.\r\n\r\nMechanism of Action of Gentamicin\r\nGentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. The process involves 1. Penetration of bacterial cell membrane & binding directly to the bacterial ribosome, 2. Misleading of m-RNA codon by bacterial ribosome, 3. Formation of peptide chains with wrong amino acid sequence which gets incorporated into bacterial cell membrane and alters its permeability, 4. Bacterial cell lysis. Some bacterial strains resistant to other amino glycosides are sensitive to Gentamicin.\r\n\r\nIndications for Gentamicin\r\n1. Infections caused by staphylococci, pseudomonas, proteous, klebsiella, enterobacter & serratia. \r\n2. Meningitis. \r\n3. Endocarditis \r\n4. Urinary Tract Infections. \r\n5. Otitis & Ocular infections. \r\n6. Infections of burns & Skin ulcers", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "83", "Trade_Name": "LOWPARIN 60MG/0.6ML SOLN. FOR S.C INJECTION (N/A)", "Generic_Name": "ENOXAPARIN SODIUM", "Price": "16", "Price_Old": "16", "Company": "EL NILE. > EPCI", "Pharmacology": "ANTICOAGULANT.LOW MWT HEPARIN", "Category": "م#_#.#~ لل#?جل#-", "Use": "–يس#?خ#~م #.ل#~و#.ء ل#>ل#.ج ومن#> خل#-#.#? #.ل#~م #<ي #.لس#.قين و#.ل#^ئ#?ين وجل#-#.#? #.ل#~م #<ي #.لش#^ي#.ن #.ل#?#.جي . \r\n\r\n–يقي من #.ل#.ص#.#%ة #%جل#-#.#? #.ل#~م #%#>#~ #.لخ#_و#> ل#>ملي#.#? ج#^#.حية . \r\n\r\n–ي#>#.لج #.م#^#.#_ #.لقل#% مثل #.لذ#%حة #.لص#~#^ية و#.لنو#%#.#? #.لقل#%ية . \r\n\r\n–م#<ي#~ لل#.شخ#.ص #.لمص#.#%ون #%#.م#^#.#_ #.ل#=لي #.لش#~ي#~ة .", "Contraindications": "–يمن#> لل#.شخ#.ص #.لمص#.#%ون #%نقص #<ي #.لص#<#.ئح #.ل#~موية . \r\n\r\n–يمن#> #.س#?#>م#.ل هذ#. #.ل#~و#.ء لل#.شخ#.ص #.لمص#.#%ون #%نزي#< ح#.#~ . \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.لة #=#.ن #.لم#^ي#_ مص#.#% #%#?حسس #_#~ م#.#~ة #.لهي#%#.#^ين ومن#?ج#.#? #.لخن#.زي#^ أو #.ل#=حول #.ل#%نزيلي .", "GI": "About Enoxaparin Sodium\r\nA low molecular weight heparin, Anticoagulant.\r\n\r\nMechanism of Action of Enoxaparin Sodium\r\nEnoxaparin sodium is a low molecular weight heparin that accelerates formation of antithrombin III- thrombin complex and deactivates thrombin and also prevents conversion of fibrinogen to fibrin.\r\n\r\nIndications for Enoxaparin Sodium\r\n1.To prevent deep vein thrombosis\r\n\r\nContra-indications of Enoxaparin Sodium\r\n1.Hypersensitivity to Enoxaparin \r\n2.Uncontrolled active bleeding \r\n3.Allergy to pork products", "Composition": "enoxaparin sod . 40mg", "Route": "INJECTION" }, { "ID": "84", "Trade_Name": "CIDOLUT DEPOT 250MG 1 AMP.", "Generic_Name": "HYDROXYPROGESTERONE CAPROATE", "Price": "11.25", "Price_Old": "7.5", "Company": "CID", "Pharmacology": "GYNECOLOGY.HORMONE", "Category": "#.لول#.#~ة #.لم#%#=#^ة و #.لإجه#.#_ #.لم#%#=#^", "Use": "– يح#?وي #.ل#~و#.ء #>لي م#.#~ه #.لهي#~#^و#=سي #%#^وجيس#?ي#^ون وهو #.ح#~ أش#=#.ل ه#^مون #.ل#%#^وجيس#?ي#^ون #.لذي ي#?م إن#?#.جه #-#%ي#>ي#. #<ي جس#~ #.لأنثى. \r\n\r\n– هو ه#^مون #.لأنوثة #.لهي#~#^و#=سي #%#^وجيس#?ي#^ون ه#^مون صن#.#>ي ي#>#-ي #>ن #-#^يق #.لحقن #.ل#>#_لي #.ل#%#-يء ليمن#> #.لح#.مل من خ#-#^ #.لول#.#~ة #.لم#%#=#^ة ول#=ن #.ذ#. #~خل#? #.لم#^أة #<ي ح#.له #.لول#.#~ة #.لم#%#=#^ة #%#.ل#<#>ل ل#. يم#=ن لل#~و#.ء #<#>ل أي #?أثي#^ ولم ي#?وصل #.ل#>لم#.ء إلي #-#^يقه #>مل #.ل#~و#.ء إلي #.لأن", "Contraindications": "– #<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?. و#.ل#%#^وجيس#?ي#^ون. \r\n\r\n– مش#.#=ل #<ي #?خث#^ #.ل#~م. \r\n\r\n– س#^#-#.ن #.لث#~ي أو #.لأ#>#_#.ء #.ل#?ن#.سلية #.لم#>#?م#~ #>لى #.له#^مون#.#? أو #?#.#^يخ #.لإص#.#%ة #%ه. \r\n\r\n– #.لنز#< #.لمه#%لي غي#^ #.لمشخص ول#. #>ل#.قة له #%#.لحمل. \r\n\r\n– #.لي#^ق#.ن #.ل#^#=و#~ي من #.لحمل. \r\n\r\n– أم#^#.#_ #<ي #.ل#=#%#~ أو أو#^#.م #.ل#=#%#~. \r\n\r\n– #.#^#?#<#.#> #_غ#- #.ل#~م غي#^ #.لمن#_#%#-.", "GI": "About Hydroxyprogesterone\r\nA C-21 steroid hormone,Progestagen, Progestational agent, Diagnostic aid( estrogen production).\r\nMechanism of Action of Hydroxyprogesterone\r\nIt is a progestin derivative exerts it`s action through nuclear progesterone receptors situated in female genital tract, breast, CNS, and pituitary. When the drug binds to progesterone receptors it undergoes dimerization and attaches to progesterone response element of target genes and regulates transcription through coactivators- which ultimately leads to modification of protein synthesis. It contributes to proper development and maintenance of female sexual functions. It prepare uterus for nidation and maintenance of pregnancy. It prevents endometrial shedding, decreases uterine motility, and also inhibits immunological rejection of the foetus by decreasing T-cell function and cell mediated immunity.", "Composition": "17- alpha, hydroxy-progesterone -17- caproate", "Route": "INJECTION" }, { "ID": "85", "Trade_Name": "EM-EX 1MG/ML 3 AMPS.", "Generic_Name": "GRANISETRON", "Price": "90", "Price_Old": "90", "Company": "AMOUN", "Pharmacology": "5-HT3 ANTAGONIST.ANTI-EMETIC", "Category": "#>ل#.ج م#?ل#.زمة #.لقولون #.ل#>ص#%ي و م#_#.#~#.#? للحمو#_ة و #.لوق#.ية و#.ل#>ل#.ج من #.لغثي#.ن و#.لقيء", "Use": "– #.لغثي#.ن #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية \r\n\r\n– ش#>و#^ من #.لم#^#_ و#.لقيء #%س#%#% #.ل#>ل#.ج #.ل#=يمي#.ئي للس#^#-#.ن و#.ل#>ل#.ج #.لإش#>#.#>ي \r\n\r\n– #.لقيء #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية", "Contraindications": "–#<#^#- #.لحس#.سية لل#~و#.ء و#%#.لإ#_#.#<ة إلى ذل#=، ل#. ين#%غي أن #?#?ن#.ول #.ل#~و#.ء إذ#. #=#.ن ل#~ي#= #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n– Dolasetron أو أون#~#.نسي#?#^ون \r\n\r\n– #.لمخ#~#^#.#? ه#^مون #.لسي#^و#?ونين \r\n\r\n– #>#~م #.ن#?ظ#.م #_#^#%#.#? #.لقل#% أو #.لقل#% و#.#_#-#^#.#%#.#? \r\n\r\n– #<#^#- #.لحس#.سية \r\n\r\n– مش#.#=ل و#^#.ثية من #.ل#?#>ص#% #.لجل#.#=#?وز \r\n\r\n– نقص #.لل#.#=#?#.ز أو #.لجلو#=وز \r\n\r\n– ل#. يج#% #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية ش#~ي#~ة من م#.#~ة ج#^#.نيسي#?#^ون #.و #.لمو#.#~ #.لم#=ونة لل#>ق#.#^ . \r\n\r\n– يج#% #?وخي #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة .", "GI": "About Granisetron\r\nSelective 5HT3 receptor antagonist, Tropane derivative, Antiemetic, antinauseant.\r\n\r\nMechanism of Action of Granisetron\r\nGranisetron is a selective 5HT3 receptor antagonist. 5HT3 receptors are present in vagal nerve terminals and chemoreceptor trigger zone of area postrema of the brain. \r\nCytotoxic chemotherapy is associated with release of Serotonin from Enterochromaffin cells in the small intestine. Serotonin triggers vomiting through 5HT3 vagal receptor that activates the vomiting reflex. Since Granisetron is a 5HT3 receptor antagonist, it is indicated for the prevention of nausea and vomiting associated in chemotherapy. \r\n\r\nIndications for Granisetron\r\n1.Nausea and vomiting associated with cytotoxic chemotherapy or radiotherapy.", "Composition": "COMING SOON ..", "Route": "INJECTION" }, { "ID": "86", "Trade_Name": "FLUORESCEIN 500 MG I.V. AMP.", "Generic_Name": "FLUORESCEIN SODIUM", "Price": "4.2", "Price_Old": "4.2", "Company": "CID", "Pharmacology": "RADIOGRAPHIC PROCEDURES.CONTRAST AGENT", "Category": "إج#^#.ء#.#? #.ل#?صوي#^ #.لش#>#.#>ي", "Use": "–يس#?خ#~م مو#_#>ي#.: ل#?لوين #.لس#-ح #.لخ#.#^جي لل#>ين لأغ#^#.#_ #.ل#>ملي#.#? ، و #.ل#=ش#< #>ن إص#.#%ة #.لق#^نية . ي#>#-ى #%#.لحقن لأغ#^#.#_ #?صوي#^ #.لأو#>ية #.ل#~موية #<ي #.ل#>ين لل#=ش#< #>ن #?#~#<ق #.ل#~م #<ي #.ل#>ين .", "Contraindications": "–#<#^#- #.لحس#.سية لهذ#. #.ل#~و#.ء أو لأي من م#=ون#.#?ه .", "GI": "About Fluorescein Sodium\r\nFluorone dye,Fluorescent dye, dibasic acid xanthine dye, Diagnostic agent(angiography or angioscopy of fundus and of iris vasculature of eye)", "Composition": "fluorescein 500mg", "Route": "INJECTION" }, { "ID": "87", "Trade_Name": "CIDOLUT DEPOT 125MG 1 AMP.", "Generic_Name": "HYDROXYPROGESTERONE CAPROATE", "Price": "6.75", "Price_Old": "4.5", "Company": "CID", "Pharmacology": "GYNECOLOGY.HORMONE", "Category": "#.لول#.#~ة #.لم#%#=#^ة و #.لإجه#.#_ #.لم#%#=#^", "Use": "– يح#?وي #.ل#~و#.ء #>لي م#.#~ه #.لهي#~#^و#=سي #%#^وجيس#?ي#^ون وهو #.ح#~ أش#=#.ل ه#^مون #.ل#%#^وجيس#?ي#^ون #.لذي ي#?م إن#?#.جه #-#%ي#>ي#. #<ي جس#~ #.لأنثى. \r\n\r\n– هو ه#^مون #.لأنوثة #.لهي#~#^و#=سي #%#^وجيس#?ي#^ون ه#^مون صن#.#>ي ي#>#-ي #>ن #-#^يق #.لحقن #.ل#>#_لي #.ل#%#-يء ليمن#> #.لح#.مل من خ#-#^ #.لول#.#~ة #.لم#%#=#^ة ول#=ن #.ذ#. #~خل#? #.لم#^أة #<ي ح#.له #.لول#.#~ة #.لم#%#=#^ة #%#.ل#<#>ل ل#. يم#=ن لل#~و#.ء #<#>ل أي #?أثي#^ ولم ي#?وصل #.ل#>لم#.ء إلي #-#^يقه #>مل #.ل#~و#.ء إلي #.لأن", "Contraindications": "– #<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?. و#.ل#%#^وجيس#?ي#^ون. \r\n\r\n– مش#.#=ل #<ي #?خث#^ #.ل#~م. \r\n\r\n– س#^#-#.ن #.لث#~ي أو #.لأ#>#_#.ء #.ل#?ن#.سلية #.لم#>#?م#~ #>لى #.له#^مون#.#? أو #?#.#^يخ #.لإص#.#%ة #%ه. \r\n\r\n– #.لنز#< #.لمه#%لي غي#^ #.لمشخص ول#. #>ل#.قة له #%#.لحمل. \r\n\r\n– #.لي#^ق#.ن #.ل#^#=و#~ي من #.لحمل. \r\n\r\n– أم#^#.#_ #<ي #.ل#=#%#~ أو أو#^#.م #.ل#=#%#~. \r\n\r\n– #.#^#?#<#.#> #_غ#- #.ل#~م غي#^ #.لمن#_#%#-.", "GI": "About Hydroxyprogesterone\r\nA C-21 steroid hormone,Progestagen, Progestational agent, Diagnostic aid( estrogen production).\r\nMechanism of Action of Hydroxyprogesterone\r\nIt is a progestin derivative exerts it`s action through nuclear progesterone receptors situated in female genital tract, breast, CNS, and pituitary. When the drug binds to progesterone receptors it undergoes dimerization and attaches to progesterone response element of target genes and regulates transcription through coactivators- which ultimately leads to modification of protein synthesis. It contributes to proper development and maintenance of female sexual functions. It prepare uterus for nidation and maintenance of pregnancy. It prevents endometrial shedding, decreases uterine motility, and also inhibits immunological rejection of the foetus by decreasing T-cell function and cell mediated immunity.", "Composition": "17- alpha, hydroxy-progesterone -17- caproate", "Route": "INJECTION" }, { "ID": "88", "Trade_Name": "MESOCEPT 50/5MG I.M. AMP.", "Generic_Name": "ESTRADIOL+NORETHISTERONE", "Price": "13", "Price_Old": "10.5", "Company": "CID", "Pharmacology": "GYNECOLOGY.HORMONE", "Category": "مو#.ن#> #.لحمل", "Use": "–من#> #.لحمل. \r\n\r\n–من#> ح#~وث #>ملية #.ل#?خصي#%.", "Contraindications": "–ل#. #?#>#-ي #%#>#~ #.ليوم #.لخ#.مس من #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–#?من#> لمن #?#>#.ني #>#~م #.ن#?ظ#.م #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #.لحمل #.و #.ل#?خ#-ي#- للحمل. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #.ل#^#_#.#>ة #.ل#-#%ي#>ية.", "GI": "Indication\tFor the treatment of urogenital symptoms associated with post-menopausal atrophy of the vagina (such as dryness, burning, pruritus and dyspareunia) and/or the lower urinary tract (urinary urgency and dysuria).\r\nPharmacodynamics\tEstradiol, the principal intracellular human estrogen, is substantially more active than its metabolites, estrone and estriol, at the cellular level.\r\nMechanism of action\tEstradiol enters target cells freely (e.g., female organs, breasts, hypothalamus, pituitary) and interacts with a target cell receptor. When the estrogen receptor has bound its ligand it can enter the nucleus of the target cell, and regulate gene transcription which leads to formation of messenger RNA. The mRNA interacts with ribosomes to produce specific proteins that express the effect of estradiol upon the target cell. Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stim", "Composition": "1 ml Mesocept contains 50 mg norethisterone enanthate and 5 mg estradiol valerate in oily solution.", "Route": "INJECTION" }, { "ID": "89", "Trade_Name": "FAST FREE I.M. 3 AMP.", "Generic_Name": "HYOSCINE+KETOPROFEN", "Price": "11.25", "Price_Old": "11.25", "Company": "DELTA PHARMA", "Pharmacology": "GIT.ANTI-SPASMODIC", "Category": "م#_#.#~ لل#?قلص#.#?", "Use": "–#.لنزلة #.لم#>وية و#.لق#_#.ء #>لى #.لمغص و#.ل#?قلص#.#? #.لم#>وية. \r\n\r\n–خ#<#_ #~#^ج#.#? #.لح#^#.#^ة #.ل#>#.لية و#?س#=ين #.لآل#.م #.لح#.#~ة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.ل#~و#.#^. \r\n\r\n–يس#.#>#~ #<ي #?شخيص ح#.ل#.#? #.ل#.نس#~#.#~ #.لم#>وي. \r\n\r\n–#=#>ل#.ج مس#.#>#~ #<ي #%#>#_ #.لح#.ل#.#? #.ل#?شخيصية مثل ح#.ل#.#? #.لمنظ#.#^ #.لم#>وي و#.لأش#>ة #.ل#?ل#<زيونية #>لى #.ل#%#-ن و#.لحو#_. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لأم#>#.ء و#.ل#.ثنى #>ش#^. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.ل#.ل#?ه#.#% #.لم#^#.#^ي #.لح#.#~. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لمغص #.ل#=لوي.", "Contraindications": "–#%#.ل#-#%#> يج#% أن يم#?ن#> #>ن #?ن#.ول #.ل#~و#.ء من #=#.ن ل#~يهم حس#.سيه م#<#^#-ة #.#?ج#.ه #.ح#~ى م#=ون#.#?ه. \r\n\r\n–لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ مثل م#^#_ى #.ل#<شل #.ل#=#%#~ي #.و #.ل#.ل#?ه#.#% #.ل#=#%#~ي #.لو#%#.ئي. \r\n\r\n–#=م#. #.نه يج#% #.ل#.م#?ن#.#> #>ن #.س#?#>م#.ل #.ل#~و#.ء لم#^#_ى #.ل#=لى #.لذين ي#>#.نون من قصو#^ #<ي وظ#.ئ#<ه#.. \r\n\r\n–ل#. يج#% #.ن ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة و#.ل#^#_#> و#.لأ#-#<#.ل #.لأقل من 13 #>#.م.", "GI": "About Hyoscine Butyl Bromide\r\nAnti-cholinergic, a tropane alkaloid, Antispasmodic in GI and GU spasm.\r\nMechanism of Action of Hyoscine Butyl Bromide\r\n\r\nHyoscine butyl bromide is an anticholinergic drug. It exerts its action by inhibiting muscarinic (cholinergic) receptors on smooth muscles and prevents the effect of Acetylcholine. Inhibition of Acetylcholine produces relaxation of smooth muscles of gastrointestinal tract and genitourinary tract and reduces the painful spasm and cramp. \r\nIt does not produce CNS effect. \r\nAntivertigo: Hyoscine suppresses the end organ receptors or inhibit central cholinergic pathway in vestibular nuclei. \r\nGeneral anaesthesia: Once muscle paralysis is no longer desired, acetyl cholinesterase inhibitors are combined with a muscarinic receptor antagonist such as Glycopyrrolate or Hyoscine or Atropine to offset the muscarinic activation resulting from esterase inhibition", "Composition": "Hyoscine N butyl bromide 20 mg\r\nKeto profen 100 mg", "Route": "INJECTION" }, { "ID": "90", "Trade_Name": "BRONCHOPRO RETARD 75MG 10 CAPS.", "Generic_Name": "AMBROXOL", "Price": "14", "Price_Old": "9.25", "Company": "OCTOBER PHARMA", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–#?ح#^ي#= #.لمخ#.#- وإذ#.#%#?ه \r\n\r\n–مه#~ئ للس#>#.ل \r\n\r\n–منظم لح#^#=ة #.ل#?ن#<س. \r\n\r\n–#-#.#^#~ لل#%لغم #<ي وق#? ق#^ي#% م#> #.ل#.ل#?ز#.م #%مو#.#>ي#~ #.لج#^#>#.#? #.لم#-لو#%ة و#.لمسموح #%ه#.. \r\n\r\n–يس#.#>#~ #>لي #>ل#.ج #.#_#-#^#.#% #.ل#^ئة. \r\n\r\n–يخ#<#< #.#_#-#^#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.لن#.#?جة #>ن ش#~ة #.لس#>#.ل و#.ل#=حة. \r\n\r\n–ي#>#.لج آل#.م #.لش#>#% #.لهو#.ئية ن#?يجة #.لمخ#.#- #.لذي يؤث#^ #?أثي#^ م#%#.ش#^ #>لي صحة #.ل#^ئ#?ين #%#.لسل#%. \r\n\r\n–يس#.#>#~ #>لي #.ل#?ن#<س حيث يح#^#= #.ل#%لغم #.لذي يس#~ م#~خل #.لأ#=سجين.", "Contraindications": "–#.لحس#.سية من #.لم#.#~ة #.ل#<#>#.لة. \r\n\r\n–يج#% أخذ #.ل#.ح#?ي#.#-#.#? #>ن#~ #?ن#.وله أثن#.ء #.لحمل وخ#.صة #<ي #.لشهو#^ #.لثل#.ث #.لأولي #.لمسئولة #>ن #?#=وين ونمو #.لجنين لذي ل#. يؤخذ إل#. #?ح#? إش#^#.#< #.ل#-#%ي#% #.لم#?#.#%#> لصحة #.لحمل. \r\n\r\n–يج#% أل#. #?#?ن#.وله #.لم#^أة #.لح#.مل لأنه ين#<ذ خل#.ل #.لل#%ن مم#. يؤث#^ #>لي #.ل#-#<ل. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#~و#.ء أثن#.ء #.لحمل وخ#.صة #<ي #.لشهو#^ #.لأولي. \r\n\r\n–ي#^#.#>ي #>#~م #?ن#.وله أثن#.ء #.ل#^#_#.#>ة #.ل#-#%ي#>ية.", "GI": "(Indications):\r\nThis medication is a mucolytic agent, prescribed for various respiratory diseases such as emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, tracheobronchitis (respiratory tract inflammation), bronchiectasis, bronchitis with bronchospasm asthma. \r\n(dosage) : The recommended dose is 30-120 mg/day in 2-3 divided doses.\r\n(Warnings and Precautions) : Caution needed for pregnant and breastfeeding women.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "91", "Trade_Name": "TRISOLVIN 10 SOFT GELATIN CAPS.", "Generic_Name": "AMBROXOL+GUAIFENESIN+THEOPHYLLINE", "Price": "5.2", "Price_Old": "5.2", "Company": "GLAXO SMITHKLINE", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يس#?خ#~م ل#>ل#.ج أم#^#.#_ #.لقص#%ية #.ل#^ئوية و#.لم#^#?#%#-ة #%إ#<#^#.ز #.لمخ#.#- #.لغي#^ #-#%ي#>ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #_يق #.ل#?ن#<س و#_يق #.لص#~#^. \r\n\r\n–ي#>#.لج #.لس#>#.ل وص#<ي#^ #>ن#~ #.ل#?ن#<س. \r\n\r\n–ي#>#.لج #.نق#-#.#> #.ل#?ن#<س #>ن#~ #.لمو#.لي#~. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ح#?ق#.ن #.لص#~#^. \r\n\r\n–مذي#% لل#%لغم. \r\n\r\n–يخ#<#< من أ#>#^#.#_ #.ل#%#^#~.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #.ل#>ق#.#^ #<ي ح#.لة #.لحس#.سية من ل#.م#%#^و#=سول أو #%#^ومهي#=سين. \r\n\r\n–لمن ي#>#.نون من ص#>و#%ة #<ي #.ل#?ن#<س. \r\n\r\n–#<ي ح#.لة #?ن#.ول أ#=ث#^ من أ#~وية ل#>ل#.ج #.ل#%#^#~ و#.لس#>#.ل.", "GI": "(Indications) : \r\nThis medication is a mucolytic agent, prescribed for various respiratory diseases such as emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, tracheobronchitis (respiratory tract inflammation), bronchiectasis, bronchitis with bronchospasm asthma. \r\nTheophylline and guaifenesin combination is used to treat or prevent the symptoms of asthma or to treat chronic bronchitis and emphysema. This medicine relieves cough, wheezing, shortness of breath, and troubled breathing. It works by opening up the bronchial tubes (air passages) of the lungs and increasing the flow of air through them.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "92", "Trade_Name": "TRI-BROXOL 10 CAPS.", "Generic_Name": "AMBROXOL+GUAIFENESIN+THEOPHYLLINE", "Price": "6", "Price_Old": "6", "Company": "SIGMA > FUTURE PHARMACEUTICAL INDUSTRIES (FPI)", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يس#?خ#~م ل#>ل#.ج أم#^#.#_ #.لقص#%ية #.ل#^ئوية و#.لم#^#?#%#-ة #%إ#<#^#.ز #.لمخ#.#- #.لغي#^ #-#%ي#>ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #_يق #.ل#?ن#<س و#_يق #.لص#~#^. \r\n\r\n–ي#>#.لج #.لس#>#.ل وص#<ي#^ #>ن#~ #.ل#?ن#<س. \r\n\r\n–ي#>#.لج #.نق#-#.#> #.ل#?ن#<س #>ن#~ #.لمو#.لي#~. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ح#?ق#.ن #.لص#~#^. \r\n\r\n–مذي#% لل#%لغم. \r\n\r\n–يخ#<#< من أ#>#^#.#_ #.ل#%#^#~.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #.ل#>ق#.#^ #<ي ح#.لة #.لحس#.سية من ل#.م#%#^و#=سول أو #%#^ومهي#=سين. \r\n\r\n–لمن ي#>#.نون من ص#>و#%ة #<ي #.ل#?ن#<س. \r\n\r\n–#<ي ح#.لة #?ن#.ول أ#=ث#^ من أ#~وية ل#>ل#.ج #.ل#%#^#~ و#.لس#>#.ل.", "GI": "(Indications) : \r\nThis medication is a mucolytic agent, prescribed for various respiratory diseases such as emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, tracheobronchitis (respiratory tract inflammation), bronchiectasis, bronchitis with bronchospasm asthma. \r\nTheophylline and guaifenesin combination is used to treat or prevent the symptoms of asthma or to treat chronic bronchitis and emphysema. This medicine relieves cough, wheezing, shortness of breath, and troubled breathing. It works by opening up the bronchial tubes (air passages) of the lungs and increasing the flow of air through them.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "93", "Trade_Name": "MUCOSIN SR 75MG 10 CAPS.", "Generic_Name": "AMBROXOL", "Price": "8.5", "Price_Old": "8.5", "Company": "RAMEDA", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–#?ح#^ي#= #.لمخ#.#- وإذ#.#%#?ه \r\n\r\n–مه#~ئ للس#>#.ل \r\n\r\n–منظم لح#^#=ة #.ل#?ن#<س. \r\n\r\n–#-#.#^#~ لل#%لغم #<ي وق#? ق#^ي#% م#> #.ل#.ل#?ز#.م #%مو#.#>ي#~ #.لج#^#>#.#? #.لم#-لو#%ة و#.لمسموح #%ه#.. \r\n\r\n–يس#.#>#~ #>لي #>ل#.ج #.#_#-#^#.#% #.ل#^ئة. \r\n\r\n–يخ#<#< #.#_#-#^#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.لن#.#?جة #>ن ش#~ة #.لس#>#.ل و#.ل#=حة. \r\n\r\n–ي#>#.لج آل#.م #.لش#>#% #.لهو#.ئية ن#?يجة #.لمخ#.#- #.لذي يؤث#^ #?أثي#^ م#%#.ش#^ #>لي صحة #.ل#^ئ#?ين #%#.لسل#%. \r\n\r\n–يس#.#>#~ #>لي #.ل#?ن#<س حيث يح#^#= #.ل#%لغم #.لذي يس#~ م#~خل #.لأ#=سجين.", "Contraindications": "–#.لحس#.سية من #.لم#.#~ة #.ل#<#>#.لة. \r\n\r\n–يج#% أخذ #.ل#.ح#?ي#.#-#.#? #>ن#~ #?ن#.وله أثن#.ء #.لحمل وخ#.صة #<ي #.لشهو#^ #.لثل#.ث #.لأولي #.لمسئولة #>ن #?#=وين ونمو #.لجنين لذي ل#. يؤخذ إل#. #?ح#? إش#^#.#< #.ل#-#%ي#% #.لم#?#.#%#> لصحة #.لحمل. \r\n\r\n–يج#% أل#. #?#?ن#.وله #.لم#^أة #.لح#.مل لأنه ين#<ذ خل#.ل #.لل#%ن مم#. يؤث#^ #>لي #.ل#-#<ل. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#~و#.ء أثن#.ء #.لحمل وخ#.صة #<ي #.لشهو#^ #.لأولي. \r\n\r\n–ي#^#.#>ي #>#~م #?ن#.وله أثن#.ء #.ل#^#_#.#>ة #.ل#-#%ي#>ية.", "GI": "(Indications):\r\nThis medication is a mucolytic agent, prescribed for various respiratory diseases such as emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, tracheobronchitis (respiratory tract inflammation), bronchiectasis, bronchitis with bronchospasm asthma. \r\n(dosage) : The recommended dose is 30-120 mg/day in 2-3 divided doses.\r\n(Warnings and Precautions) : Caution needed for pregnant and breastfeeding women.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "94", "Trade_Name": "AMLOBENZAMIR 10/20MG 10 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "16", "Price_Old": "16", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > MIRA INTERNATIONAL", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "95", "Trade_Name": "ATENORETIC 30 CAPS.", "Generic_Name": "AMILORIDE+ATENOLOL+HYDROCHLOROTHIAZIDE", "Price": "40.5", "Price_Old": "27", "Company": "SIGMA > QUEEN PHARMA INTERNATIONAL", "Pharmacology": "DIURETICS.POTASSIUM SPARING AND THIAZIDE COMBINED WITH BETA BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م #%جمي#> ح#.ل#.#?ه. \r\n\r\n–ي#>#.لج #.ح#?ش#.ء #>#_لة #.لقل#%. \r\n\r\n–قصو#^ #.لقل#% #.ل#.ح#?ق#.ني #.لن#.#?ج #>ن نقص #%و#?#.سيوم #.ل#~م. \r\n\r\n–ي#>#.لج #.#^#?#<#.#> #_غ#- #.ل#~م #.لن#.#?ج #>ن نقص #%و#?#.سيوم #.ل#~م.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لم#^#_ي #.ل#=#%#~. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ #%ش#=ل م#?ز#.من م#> أ#~وية م#~#^ة لل#%ول. \r\n\r\n–لمن ي#>#.نون من قصو#^ #<ي #.ل#=لي ح#.#~ #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ل#. يس#?خ#~م لم#^#_ي #.لذئ#%ة #.لحم#.مية. \r\n\r\n–يج#% #.ل#?قليل من ش#^#% #.ل#=حول و#.ل#?#~خين. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ #<ي ح#.لة وجو#~ #^#~ #<#>ل #?حسسي من #.ل#>ق#.#^. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.نق#-#.#> #.ل#%ول أو قلة إن#?#.ج #.ل#%ول. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #<#^#- #%و#?#.سيوم #.ل#~م. \r\n\r\n–لمن ي#>#.نون من ص#~مة #.لقل#%ية. \r\n\r\n–يحذ#^ #.س#?خ#~م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ولم#^#_ي #.لس#=#^ و#.ل#<شل #.ل#=لوي و#?سمم #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #.#>#?ل#.ل #.ل#=لية #.لس#=#^ي.", "GI": "About Atenolol\r\nCardioselective Beta(Beta1 )-adrenergic blocking agent, Antihypertensive,anti anginal.\r\nMechanism of Action of Atenolol\r\nAtenolol is a cardio selective beta-1 adrenergic antagonist. It has negative chronotropic and negative inotropic effects on heart. It decreases oxygen consumption- cardiac work and aortic pressure. It decreases nor adrenaline and renin releases. It decreases central sympathetic out flow In sympathetic over activity, it prolongs systole by retarding conduction. It increases oxygen supply and exercise tolerance in angina patients. The drug decreases BP in hypertensive individuals- both systolic and diastolic BP is reduced. \r\nAntimigraine action: Atenolol is useful in migraine due to its beta blockade action. Through beta blockade action it inhibits vasodilation and relieves migraine.", "Composition": "Each capsule contains:\r\nAtenolol 50 mg \r\nHydrochlorothiazide 25 mg\r\nAmiloride Hydrochloride 2.5 mg", "Route": "ORAL.SOLID" }, { "ID": "96", "Trade_Name": "FARCOSOLVIN 24 CAPS.", "Generic_Name": "AMBROXOL+GUAIFENESIN+THEOPHYLLINE", "Price": "11.25", "Price_Old": "7.5", "Company": "PHARCO", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يس#?خ#~م ل#>ل#.ج أم#^#.#_ #.لقص#%ية #.ل#^ئوية و#.لم#^#?#%#-ة #%إ#<#^#.ز #.لمخ#.#- #.لغي#^ #-#%ي#>ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #_يق #.ل#?ن#<س و#_يق #.لص#~#^. \r\n\r\n–ي#>#.لج #.لس#>#.ل وص#<ي#^ #>ن#~ #.ل#?ن#<س. \r\n\r\n–ي#>#.لج #.نق#-#.#> #.ل#?ن#<س #>ن#~ #.لمو#.لي#~. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ح#?ق#.ن #.لص#~#^. \r\n\r\n–مذي#% لل#%لغم. \r\n\r\n–يخ#<#< من أ#>#^#.#_ #.ل#%#^#~.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #.ل#>ق#.#^ #<ي ح#.لة #.لحس#.سية من ل#.م#%#^و#=سول أو #%#^ومهي#=سين. \r\n\r\n–لمن ي#>#.نون من ص#>و#%ة #<ي #.ل#?ن#<س. \r\n\r\n–#<ي ح#.لة #?ن#.ول أ#=ث#^ من أ#~وية ل#>ل#.ج #.ل#%#^#~ و#.لس#>#.ل.", "GI": "(Indications) : \r\nThis medication is a mucolytic agent, prescribed for various respiratory diseases such as emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, tracheobronchitis (respiratory tract inflammation), bronchiectasis, bronchitis with bronchospasm asthma. \r\nTheophylline and guaifenesin combination is used to treat or prevent the symptoms of asthma or to treat chronic bronchitis and emphysema. This medicine relieves cough, wheezing, shortness of breath, and troubled breathing. It works by opening up the bronchial tubes (air passages) of the lungs and increasing the flow of air through them.", "Composition": "Each 100 ml contains:\r\nAmbroxol HCI 0.30 gm\r\nGuaifenesin 0.60 gm\r\nTheophylline anhydrous 1.00 gm", "Route": "ORAL.SOLID" }, { "ID": "97", "Trade_Name": "AMLO-ACE 5/10 MG 10 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "19.2", "Price_Old": "19.2", "Company": "DELTA PHARMA > ADVOCURE", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "98", "Trade_Name": "AMBRODOXY 10 CAPS.", "Generic_Name": "AMBROXOL+DOXYCYCLINE", "Price": "12", "Price_Old": "12", "Company": "ADWIA", "Pharmacology": "ANTIBIOTIC WITH MUCOLYTIC", "Category": "م#_#.#~ حيوي م#> مذي#% لل#%لغم", "Use": "–#.لأم#^#.#_ #.لقص#%ية #.ل#^ئوية #.لح#.#~ة و#.لمزمنة #.لم#^#?#%#-ة إ#<#^#.ز #.لمخ#.#- غي#^ #-#%ي#>ي \r\n\r\n–#.لح#.#~ #.ل#?ه#.#% #<ي #.لحلق \r\n\r\n–م#^#_ ل#.يم \r\n\r\n–#.ل#?ه#.#% #.ل#%#^وس#?#.#? #.لمزمن \r\n\r\n–إل#?ه#.#% #.لجي#% \r\n\r\n–م#^#_ #.ل#?ه#.#% #.لحو#_ \r\n\r\n–ح#% #.لش#%#.#% \r\n\r\n–#.لو#^#~ية", "Contraindications": "–#.ل#^#_#.#>ة \r\n\r\n–#?#.#^يخ من #.لحس#.سية ل#.م#%#^و#=سول أو #%#^ومهي#=سين \r\n\r\n–#<#^#- #.لحس#.سية", "GI": "Mechanism of Action of Doxycycline\r\nDoxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein and by passive diffusion & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals).Doxycycline interfering the attachment of aminoacyl-tRNA to the mRNA-ribosome complex and peptide chain fails to grow. It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. \r\nMechanism of Action of Ambroxol\r\nAmbroxol hydrochloride acts as an expectoration improver and mucolytic agent. It decreases mucus viscosity by altering its structure. It depolymerises mucopolysaccharides directly as well as by liberating lysosomal enzymes and by breaking network of fibres in tenacious sputum . It induces thin copious bronchial secretion and possesses antioxidant propertie", "Composition": "Each capsule contains: \r\nDoxycycline 100 mg. \r\nAmbroxol HCl 75 mg.", "Route": "ORAL.SOLID" }, { "ID": "99", "Trade_Name": "AMLOBENZAMIR 2.5/10MG 10 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "10", "Price_Old": "10", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > MIRA INTERNATIONAL", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "100", "Trade_Name": "ROACCUTANE 20MG 30 CAPS.", "Generic_Name": "ISOTRETINOIN", "Price": "240", "Price_Old": "240", "Company": "F.HOFFMAN LA ROCHE", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#>ق#~ي، و#.لش#~ي#~ #.ل#~#^جة أو #.لمس#?#>صى، و#.لذي ل#. يس#?جي#% لل#>ل#.ج #.ل#?قلي#~ي. \r\n\r\n–يس#?خ#~م أحي#.ن#.ً #%ه#~#< #.لوق#.ية من #.لإص#.#%ة من #%#>#_ أنو#.#> #.لس#^#-#.ن #.لذي ق#~ يصي#% #.لجل#~ . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#%سي#- و#.لم#?#=يس.", "Contraindications": "–ق#%ل #.س#?خ#~#.م #.ل#>ق#.#^ يج#% إج#^#.ء #.ل#=ش#< #.ل#-#%ي لل#?#>#^#< #>لى #.لح#.لة وأس#%#.#% ظهو#^ ح#% #.لش#%#.#% و#>لى هذ#. #.لأس#.س ي#?م #?ح#~ي#~ #.ل#>ق#.#^ #.لمن#.س#%. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #.ل#=#^يم#.#? و#.ل#>ق#.#^#.#? #.لأخ#^ى و#>#~م #<#.#>لي#?ه#. ي#?م #.للجوء إلى هذ#. #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول ج#^#>ة م#%#.لغه أو ز#.ئ#~ة #>ن #.لج#^#>ة #.لمح#~#~ة م جهة #.ل#-#%ي#% ح#?ى ل#. #?أ#?ي #%ن#?#.ئج #>#=سية #>لى #.لجسم. \r\n\r\n–#<ي ح#.لة نسي#.ن #.لج#^#>ة ي#?م أخذه#. إل#. #<ي ح#.لة ق#^#% مي#>#.#~ #.لج#^#>ة #.ل#?#.لية ويحذ#^ #?ن#.ول ج#^#>ة م#_#.#>#<ة. \r\n\r\n–يج#% #>مل #.ل#?ح#.ليل #.ل#~و#^ية و#.لم#?#.#%#>ة م#> #.ل#-#%ي#% لل#?#>#^#< #>لى وظ#.ئ#< #.ل#=#%#~ و#>#~م #?أث#^ه #%#.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.ل#?#>#^#_ لأش#>ة #.لشمس أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يج#% #?ن#.ول #.لم#.ء #%#=مي#.#? #=#.#<ية. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لليز#^ إل#. #%#>#~ م#^و#^ #>#.م #%#>#~ #.ل#>ل#.ج و#.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه#. #?ؤث#^ #>لى صحة #.لجنين. \r\n\r\n–#<ي ح#.لة وجو#~ #^غ#%ة #<ي #.لحمل يج#% #.ل#?وق#< #>ن #.ل#>ل#.ج #%م#~ة ل#. #?قل #>ن ثل#.ث أشه#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لمقش#^#.#? #.ل#%ش#^ة خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة وجو#~ أي م#^#_ أو مش#.#=ل ن#<سية يج#% إخ#%#.#^ #.ل#-#%ي#% وخ#.صة لمن ي#>#.نون من #_#>#< #<ي #.ل#>ظ#.م وأم#^#.#_ #.لقل#% و#.لس#=#^ و#.ل#=#%#~. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> أي أ#~وية أو مس#?ح#_#^#.#? #-#%ية مثل #.ل#?#?#^#.سي#=لين. \r\n\r\n–ينصح #%إ#?#%#.#> نظ#.م غذ#.ئي ي#>#?م#~ #>لى #.لخ#_#^#.و#.#? و#.ل#<#.#=هة أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "About Isotretinoin\r\nVitamin A isomer, Retinoic Acid Derivative, Anti-acne.\r\n\r\nMechanism of Action of Isotretinoin\r\nIsotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. Isotretinoin decreases sebocyte number and reduces sebum synthesis and therefore used in the treatment of acne.It reduces sebaceous gland size and inhibits sebaceous gland differentiation. \r\nIsotretinoin reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones formation. It alters DNA transcription\r\n\r\nInteractions for Isotretinoin\r\nAlcohol: Etretinate formed in presence of alcohol. \r\nAntibacterials: Possible increased risk of benign intracranial hypertension with tetracyclines. \r\nWarfarin: Possible reduction in anticoagulant effect. \r\nAntiepileptics: Plasma concentration of carbamazepine may be reduced. \r\nCytotoxic drugs: Plasma concentration of methotrexate may be increased.", "Composition": "isotretinoin 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "101", "Trade_Name": "ITRACON 100MG 14 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "63", "Price_Old": "63", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "Each Itracon capsule contains itraconazole 100 mg.", "Route": "ORAL.SOLID" }, { "ID": "102", "Trade_Name": "FUNGITRANAZOLE 100 MG 10 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "32", "Price_Old": "32", "Company": "DEBEIKY", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "itraconazole 100", "Route": "ORAL.SOLID" }, { "ID": "103", "Trade_Name": "NETLOOK 40MG 20 SOFT GELATIN CAPSULE", "Generic_Name": "ISOTRETINOIN", "Price": "200.25", "Price_Old": "154", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > ANDALOUS PHARMA", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#>ق#~ي، و#.لش#~ي#~ #.ل#~#^جة أو #.لمس#?#>صى، و#.لذي ل#. يس#?جي#% لل#>ل#.ج #.ل#?قلي#~ي. \r\n\r\n–يس#?خ#~م أحي#.ن#.ً #%ه#~#< #.لوق#.ية من #.لإص#.#%ة من #%#>#_ أنو#.#> #.لس#^#-#.ن #.لذي ق#~ يصي#% #.لجل#~ . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#%سي#- و#.لم#?#=يس.", "Contraindications": "–ق#%ل #.س#?خ#~#.م #.ل#>ق#.#^ يج#% إج#^#.ء #.ل#=ش#< #.ل#-#%ي لل#?#>#^#< #>لى #.لح#.لة وأس#%#.#% ظهو#^ ح#% #.لش#%#.#% و#>لى هذ#. #.لأس#.س ي#?م #?ح#~ي#~ #.ل#>ق#.#^ #.لمن#.س#%. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #.ل#=#^يم#.#? و#.ل#>ق#.#^#.#? #.لأخ#^ى و#>#~م #<#.#>لي#?ه#. ي#?م #.للجوء إلى هذ#. #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول ج#^#>ة م#%#.لغه أو ز#.ئ#~ة #>ن #.لج#^#>ة #.لمح#~#~ة م جهة #.ل#-#%ي#% ح#?ى ل#. #?أ#?ي #%ن#?#.ئج #>#=سية #>لى #.لجسم. \r\n\r\n–#<ي ح#.لة نسي#.ن #.لج#^#>ة ي#?م أخذه#. إل#. #<ي ح#.لة ق#^#% مي#>#.#~ #.لج#^#>ة #.ل#?#.لية ويحذ#^ #?ن#.ول ج#^#>ة م#_#.#>#<ة. \r\n\r\n–يج#% #>مل #.ل#?ح#.ليل #.ل#~و#^ية و#.لم#?#.#%#>ة م#> #.ل#-#%ي#% لل#?#>#^#< #>لى وظ#.ئ#< #.ل#=#%#~ و#>#~م #?أث#^ه #%#.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.ل#?#>#^#_ لأش#>ة #.لشمس أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يج#% #?ن#.ول #.لم#.ء #%#=مي#.#? #=#.#<ية. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لليز#^ إل#. #%#>#~ م#^و#^ #>#.م #%#>#~ #.ل#>ل#.ج و#.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه#. #?ؤث#^ #>لى صحة #.لجنين. \r\n\r\n–#<ي ح#.لة وجو#~ #^غ#%ة #<ي #.لحمل يج#% #.ل#?وق#< #>ن #.ل#>ل#.ج #%م#~ة ل#. #?قل #>ن ثل#.ث أشه#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لمقش#^#.#? #.ل#%ش#^ة خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة وجو#~ أي م#^#_ أو مش#.#=ل ن#<سية يج#% إخ#%#.#^ #.ل#-#%ي#% وخ#.صة لمن ي#>#.نون من #_#>#< #<ي #.ل#>ظ#.م وأم#^#.#_ #.لقل#% و#.لس#=#^ و#.ل#=#%#~. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> أي أ#~وية أو مس#?ح#_#^#.#? #-#%ية مثل #.ل#?#?#^#.سي#=لين. \r\n\r\n–ينصح #%إ#?#%#.#> نظ#.م غذ#.ئي ي#>#?م#~ #>لى #.لخ#_#^#.و#.#? و#.ل#<#.#=هة أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "About Isotretinoin\r\nVitamin A isomer, Retinoic Acid Derivative, Anti-acne.\r\n\r\nMechanism of Action of Isotretinoin\r\nIsotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. Isotretinoin decreases sebocyte number and reduces sebum synthesis and therefore used in the treatment of acne.It reduces sebaceous gland size and inhibits sebaceous gland differentiation. \r\nIsotretinoin reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones formation. It alters DNA transcription\r\n\r\nInteractions for Isotretinoin\r\nAlcohol: Etretinate formed in presence of alcohol. \r\nAntibacterials: Possible increased risk of benign intracranial hypertension with tetracyclines. \r\nWarfarin: Possible reduction in anticoagulant effect. \r\nAntiepileptics: Plasma concentration of carbamazepine may be reduced. \r\nCytotoxic drugs: Plasma concentration of methotrexate may be increased.", "Composition": "isotretinoin 10mg or 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "104", "Trade_Name": "ITRAFUNGEX 100MG 15 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "60", "Price_Old": "60", "Company": "FUTURE PHARMACEUTICAL INDUSTRIES (FPI) > UTOPIA PHARMACEUTICALS COMPANY", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "Each hard gelatin capsule contains:\r\nActive ingredients:\r\nItraconazole 100 mg.", "Route": "ORAL.SOLID" }, { "ID": "105", "Trade_Name": "ITRACON 100MG 4 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "21.6", "Price_Old": "21.6", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "Each Itracon capsule contains itraconazole 100 mg.", "Route": "ORAL.SOLID" }, { "ID": "106", "Trade_Name": "FUNGITRANAZOLE 100 MG 4 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "15.6", "Price_Old": "15.6", "Company": "DEBEIKY", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "itraconazole 100", "Route": "ORAL.SOLID" }, { "ID": "107", "Trade_Name": "ITRAFUNGEX 100 MG 4 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "18", "Price_Old": "18", "Company": "FUTURE PHARMACEUTICAL INDUSTRIES (FPI) > UTOPIA PHARMACEUTICALS COMPANY", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "Each hard gelatin capsule contains:\r\nActive ingredients:\r\nItraconazole 100 mg.", "Route": "ORAL.SOLID" }, { "ID": "108", "Trade_Name": "AROZOLE 100MG 4CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "19.2", "Price_Old": "19.2", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "itraconazole 100mg", "Route": "ORAL.SOLID" }, { "ID": "109", "Trade_Name": "ITRAFUNGIZOLE 100 MG 12 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "42", "Price_Old": "42", "Company": "AL ROWAD PHARMACEUTICAL INDUSTRIAL CO.", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "itraconazole 100", "Route": "ORAL.SOLID" }, { "ID": "110", "Trade_Name": "USPAVERINE 200 MR CAP.", "Generic_Name": "MEBEVERINE", "Price": "8", "Price_Old": "8", "Company": "EPCI", "Pharmacology": "ANTIMUSCARINIC.IRRITABLE BOWEL SYNDROME", "Category": "مش#.#=ل #.لجه#.ز #.له#_مي", "Use": "–#>ل#.ج أ#>#^#.#_ إ#_#-#^#.#% #.لقولون #.ل#>ص#%ى \r\n\r\n–يخ#<#< من #.لمغص \r\n\r\n–#>ل#.ج #?قلص#.#? #.لقولون و#?قلص#.#? #.لم#>#~ه \r\n\r\n–#>ل#.ج إل#?ه#.#% #.لقولون #.ل#>ص#%ي \r\n\r\n–#>ل#.ج إن#?#<#.خ #.لقولون #.ل#>ص#%ي وغ#.ز#.#? #.ل#%#-ن \r\n\r\n–#%#>#_ ح#.ل#.#? #.لإن#?#<#.خ #.لمص#.ح#%ة لل#>ملي#.#? #.لج#^#.حية", "Contraindications": "–ل#. يس#?خ#~م #.ل#~و#.ء #<ى ح#.لة #.لحس#.سية #?ج#.ه أى من #.ل#>ن#.ص#^ #.لم#=ونة لل#~و#.ء \r\n\r\n–ل#. يس#?خ#~م للم#^#_ى #.لذين ي#>#.نون من م#^#_ #?#_خم #.ل#%#^وس#?#.#?#.", "GI": "About Mebeverine\r\nReserpine derivative, antimuscarinic, a musculotropic antispasmodic, Motility stimulant.\r\nMechanism of Action of Mebeverine\r\nMebeverine has a direct relaxant effect on smooth muscle. This will inhibits gastrointestinal propulsive motility and gastric acid secretion.\r\n\r\nIndications for Mebeverine\r\n1.Irritable bowel syndrome\r\n\r\nTypical Dosage for Mebeverine\r\nAdult: 405 mg / day in 3- divided doses to be taken 20 minutes before meals. Dose can be gradually reduced after 1 week if sufficient response is obtained. \r\nChildren above 10 years: 405 mg / day in 3- divided doses to be taken 20 minutes before meals. Dose can be gradually reduced after 1 week if sufficient response is obtained. \r\nChildren below 10 years: contraindicated.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "111", "Trade_Name": "PONOFORTE 500MG 20 CAPS.", "Generic_Name": "MEFENAMIC ACID", "Price": "13", "Price_Old": "13", "Company": "UNIPHARMA CO.", "Pharmacology": "NSAID.FENAMATES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–مس#=ن لآل#.م #.لجسم. \r\n\r\n–م#_#.#~ لل#.ل#?ه#.#%. \r\n\r\n–خ#.#<#_ للح#^#.#^ة. \r\n\r\n–مس#=ن لآل#.م #.لأسن#.ن. \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#>. \r\n\r\n–#>ل#.ج إص#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل و#.ل#^وم#.#?يزم #.لل#.م#<صلي. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لنص#<ي. \r\n\r\n–ي#>#.لج آل#.م #.ل#~و#^ة #.لشه#^ية و#.#_#-#^#.#%ه#.. \r\n\r\n–مس#=ن لآل#.م #.لن#.#?جة #>ن #.لج#^وح و#.لإص#.#%#.#? و#.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–مس#=ن لح#.لة #?هيج #?أ#=ل #.لغ#_#.#^ي#<. \r\n\r\n–#>ل#.ج ح#.ل#.#? #_#^#%ة #.لشمس.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لأ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية أو لمن ي#>#.نون من حس#.سية #_#~ #.لأس#%#^ين و#.ليو#~. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #<ي #.لقن#.ة #.له#_مية. \r\n\r\n–لمن ي#>#.نون من #?ق#^ح#.#? #<ي #.لم#>#~ة #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لم#^#_ي #.ل#=لي. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–#<ي ح#.لة ظهو#^ إسه#.ل م#?#=#^#^ من #?ن#.ول #.ل#>ق#.#^ يج#% #.ل#?وق#< #>ن #?ن#.وله #%ش#=ل مؤق#?. \r\n\r\n–لم#^#_ي #.لقل#% و#.لأو#>ية #.ل#~موية #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.م #.ل#>ق#.#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية.", "GI": "About Mefenamic Acid\r\nNSAID, Analgesic,antiinflammatory.\r\n\r\nMechanism of Action of Mefenamic Acid\r\nMefenamic acid has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other analgesics. Mefenamic acid inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions.\r\n\r\nIndications for Mefenamic Acid\r\n1.Muscular aches \r\n2.Primary Dysmenorrhoea \r\n3.Headaches \r\n4.Acute gout \r\n5.Dental pain \r\n6.Patent ductus arteriosus \r\n\r\nTypical Dosage for Mefenamic Acid\r\nAdult: initial dose: 500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren above 14 years: \r\n500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren below 14 years: not recommended.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "112", "Trade_Name": "MEFENAM 500MG 20 CAPS.", "Generic_Name": "MEFENAMIC ACID", "Price": "14", "Price_Old": "14", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "NSAID.FENAMATES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–مس#=ن لآل#.م #.لجسم. \r\n\r\n–م#_#.#~ لل#.ل#?ه#.#%. \r\n\r\n–خ#.#<#_ للح#^#.#^ة. \r\n\r\n–مس#=ن لآل#.م #.لأسن#.ن. \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#>. \r\n\r\n–#>ل#.ج إص#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل و#.ل#^وم#.#?يزم #.لل#.م#<صلي. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لنص#<ي. \r\n\r\n–ي#>#.لج آل#.م #.ل#~و#^ة #.لشه#^ية و#.#_#-#^#.#%ه#.. \r\n\r\n–مس#=ن لآل#.م #.لن#.#?جة #>ن #.لج#^وح و#.لإص#.#%#.#? و#.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–مس#=ن لح#.لة #?هيج #?أ#=ل #.لغ#_#.#^ي#<. \r\n\r\n–#>ل#.ج ح#.ل#.#? #_#^#%ة #.لشمس.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لأ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية أو لمن ي#>#.نون من حس#.سية #_#~ #.لأس#%#^ين و#.ليو#~. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #<ي #.لقن#.ة #.له#_مية. \r\n\r\n–لمن ي#>#.نون من #?ق#^ح#.#? #<ي #.لم#>#~ة #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لم#^#_ي #.ل#=لي. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–#<ي ح#.لة ظهو#^ إسه#.ل م#?#=#^#^ من #?ن#.ول #.ل#>ق#.#^ يج#% #.ل#?وق#< #>ن #?ن#.وله #%ش#=ل مؤق#?. \r\n\r\n–لم#^#_ي #.لقل#% و#.لأو#>ية #.ل#~موية #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.م #.ل#>ق#.#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية.", "GI": "About Mefenamic Acid\r\nNSAID, Analgesic,antiinflammatory.\r\n\r\nMechanism of Action of Mefenamic Acid\r\nMefenamic acid has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other analgesics. Mefenamic acid inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions.\r\n\r\nIndications for Mefenamic Acid\r\n1.Muscular aches \r\n2.Primary Dysmenorrhoea \r\n3.Headaches \r\n4.Acute gout \r\n5.Dental pain \r\n6.Patent ductus arteriosus \r\n\r\nTypical Dosage for Mefenamic Acid\r\nAdult: initial dose: 500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren above 14 years: \r\n500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren below 14 years: not recommended.", "Composition": "mefenamic acid 500mg", "Route": "ORAL.SOLID" }, { "ID": "113", "Trade_Name": "ADWINERVE 500 MCG 20 CAPS.", "Generic_Name": "MECOBALAMIN", "Price": "8", "Price_Old": "8", "Company": "ADWIA", "Pharmacology": "VITAMIN B", "Category": "#<ي#?#.مين #%", "Use": "–#>ل#.ج ومن#> #.نخ#<#.#_ مس#?وى #<ي#?#.مين#.#? مجمو#>ة \"#%12\" ل#~ى #.لأشخ#.ص #.لذ#~ين ي#>#.نون من سوء #.ل#?غذية، و#>#~م #.لحصول #>لى ح#.ج#.#?هم #.ليومية من #.ل#-#>#.م، أو ن#?يجة #.لأم#^#.#_ و#.لأ#~وية، أو #<ق#~#.ن #.لشهية. \r\n\r\n–حل مش#.#=ل #.لنمو #.لن#.#?جة #>ن نقص #.ل#<ي#?#.مين#.#?. \r\n\r\n–#.لأو#^#.م #.لخ#%يثة لل#%ن#=#^ي#.س أو #.لأم#>#.ء. \r\n\r\n–#>وز حم#_ #.ل#<ولي#=. \r\n\r\n–قلة إ#<#^#.ز #.ل#>#.مل #.ل#~#.خلي. \r\n\r\n–مش#.#=ل و#_#>#< #.لأ#>ص#.#% وخ#.صة #.ل#-#^#<ية. \r\n\r\n–#<ق#^ #.ل#~م #.لو#%يل. \r\n\r\n–نمو ز#.ئ#~ ل#%#=#?ي#^ي#. #.لأم#>#.ء #.ل#~قيقة. \r\n\r\n–#.س#?ئص#.ل #.لم#>#~ة #.ل#=لي أو #.لجزئي. \r\n\r\n–#.ل#.#>ْ#?ِل#.لُ #.لمِ#>َوِيُّ #.لغلو#?يني.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.. \r\n\r\n–#~#.ء لي#%#^.", "GI": "About Mecobalamin\r\nWater soluble, Form of Vitamin B12\r\n\r\nMechanism of Action of Mecobalamin\r\nMecobalamin is the neurologically active form of vitamin B12 and occurs as a water-soluble vitamin in the body. It is a cofactor in the enzyme methionine synthase, which functions to transfer methyl groups for the regeneration of methionine from homocysteine. In anaemia, it increases erythrocyte production by promoting nucleic acid synthesis in the bone marrow and by promoting maturation and division of erythrocytes.\r\n\r\nIndications for Mecobalamin\r\n1.Peripheral neuropathies \r\n2.Megaloblastic anaemia \r\n\r\nInteractions for Mecobalamin\r\n1.Decreased GI tract absorption with neomycin, aminosalicylic acid, H2-blockers and colchicines \r\n2.Reduced serum concentrations with oral contraceptives \r\n3.Reduced effects in anaemia with parenteral chloramphenicol", "Composition": "Each capsule contains: \r\nMecobalamin 500 mcg.", "Route": "ORAL.SOLID" }, { "ID": "114", "Trade_Name": "SALAZINE 500MG 30 CAPS.", "Generic_Name": "MESALAZINE(MESALAMINE)(5-ASA)(5-AMINOSALICYLIC ACID)", "Price": "63", "Price_Old": "63", "Company": "PHAROPHARMA", "Pharmacology": "ULCERATIVE COLITIS", "Category": "#.ل#?ه#.#% #.لقولون #.ل#?ق#^حي", "Use": "–م#_#.#~ حيوى #_#~ #.ل#%#=#?ي#^ي#. #.ل#?ى #?صي#% #.لجه#.ز #.له#_مى و خصوص#. #.لقولون .\r\n\r\n–#>ل#.ج إل#?ه#.#% #.لقولون #.ل#?ق#^حى .", "Contraindications": "–ل#. يس#?خ#~م للأ#-#<#.ل أقل من 5 سنو#.#? .\r\n\r\n–ل#. يس#?خ#~م م#> #.لأ#-#<#.ل #.لمص#.#%ون #%#.لج#~ي#^ى #.لم#.ئى أو #.لمص#.#%ون #%أ#>#^#.#_ #.ل#%#^#~ .\r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=#%#~ و #.ل#=لى .\r\n\r\n–ي#<#_ل #?جن#% #.ل#?#>#^#_ للشمس ل#<#?#^ة #-ويلة أثن#.ء #<#?#^ة #.ل#>ل#.ج ، ل#?جن#% #.لإص#.#%ة #%#.لحس#.سية #>ن#~ #%#>#_ #.لم#^#_ى خصوص#. م#> م#^#_ى #.لإ#=زيم#. أو #.لإل#?ه#.#%#.#? #.لجل#~ية .", "GI": "About MesalazineS5-Aminosalicylic Acid Derivative, Anti-inflammatory bowel agent.SSMechanism of Action of MesalazineSMesalazine exerts its anti-inflammatory action by inhibiting lipoxygenase enzyme. This will leads to decreased production of pro-inflammatory leukotrienes (LTB4) and 5-hydroxy eicosa tetra enoic acids (HETE) in the intestinal wall. It inhibits the production of inflammatory mediators like interleukin-1, tumor necrosis factor-alpha etc. SSIndications for MesalazineS1.Ulcerative colitis S2.Crohn`s disease S3.Proctitis and Proctosigmoiditis (use only suppositories)", "Composition": "mesalazine 1g or 500mg", "Route": "ORAL.SOLID" }, { "ID": "115", "Trade_Name": "PONSTAN FORTE 500MG 20 F.C. TABS.", "Generic_Name": "MEFENAMIC ACID", "Price": "14", "Price_Old": "14", "Company": "PFIZER", "Pharmacology": "NSAID.FENAMATES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–مس#=ن لآل#.م #.لجسم. \r\n\r\n–م#_#.#~ لل#.ل#?ه#.#%. \r\n\r\n–خ#.#<#_ للح#^#.#^ة. \r\n\r\n–مس#=ن لآل#.م #.لأسن#.ن. \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#>. \r\n\r\n–#>ل#.ج إص#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل و#.ل#^وم#.#?يزم #.لل#.م#<صلي. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لنص#<ي. \r\n\r\n–ي#>#.لج آل#.م #.ل#~و#^ة #.لشه#^ية و#.#_#-#^#.#%ه#.. \r\n\r\n–مس#=ن لآل#.م #.لن#.#?جة #>ن #.لج#^وح و#.لإص#.#%#.#? و#.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–مس#=ن لح#.لة #?هيج #?أ#=ل #.لغ#_#.#^ي#<. \r\n\r\n–#>ل#.ج ح#.ل#.#? #_#^#%ة #.لشمس.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لأ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية أو لمن ي#>#.نون من حس#.سية #_#~ #.لأس#%#^ين و#.ليو#~. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #<ي #.لقن#.ة #.له#_مية. \r\n\r\n–لمن ي#>#.نون من #?ق#^ح#.#? #<ي #.لم#>#~ة #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لم#^#_ي #.ل#=لي. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–#<ي ح#.لة ظهو#^ إسه#.ل م#?#=#^#^ من #?ن#.ول #.ل#>ق#.#^ يج#% #.ل#?وق#< #>ن #?ن#.وله #%ش#=ل مؤق#?. \r\n\r\n–لم#^#_ي #.لقل#% و#.لأو#>ية #.ل#~موية #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.م #.ل#>ق#.#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية.", "GI": "About Mefenamic Acid\r\nNSAID, Analgesic,antiinflammatory.\r\n\r\nMechanism of Action of Mefenamic Acid\r\nMefenamic acid has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other analgesics. Mefenamic acid inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions.\r\n\r\nIndications for Mefenamic Acid\r\n1.Muscular aches \r\n2.Primary Dysmenorrhoea \r\n3.Headaches \r\n4.Acute gout \r\n5.Dental pain \r\n6.Patent ductus arteriosus \r\n\r\nTypical Dosage for Mefenamic Acid\r\nAdult: initial dose: 500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren above 14 years: \r\n500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren below 14 years: not recommended.", "Composition": "1 Film coated tablet contains 500 mg mefenamic acid.", "Route": "ORAL.SOLID" }, { "ID": "116", "Trade_Name": "PONO 250MG 20 CAPS.", "Generic_Name": "MEFENAMIC ACID", "Price": "6", "Price_Old": "6", "Company": "UNIPHARMA CO.", "Pharmacology": "NSAID.FENAMATES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–مس#=ن لآل#.م #.لجسم. \r\n\r\n–م#_#.#~ لل#.ل#?ه#.#%. \r\n\r\n–خ#.#<#_ للح#^#.#^ة. \r\n\r\n–مس#=ن لآل#.م #.لأسن#.ن. \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#>. \r\n\r\n–#>ل#.ج إص#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل و#.ل#^وم#.#?يزم #.لل#.م#<صلي. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لنص#<ي. \r\n\r\n–ي#>#.لج آل#.م #.ل#~و#^ة #.لشه#^ية و#.#_#-#^#.#%ه#.. \r\n\r\n–مس#=ن لآل#.م #.لن#.#?جة #>ن #.لج#^وح و#.لإص#.#%#.#? و#.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–مس#=ن لح#.لة #?هيج #?أ#=ل #.لغ#_#.#^ي#<. \r\n\r\n–#>ل#.ج ح#.ل#.#? #_#^#%ة #.لشمس.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لأ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية أو لمن ي#>#.نون من حس#.سية #_#~ #.لأس#%#^ين و#.ليو#~. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #<ي #.لقن#.ة #.له#_مية. \r\n\r\n–لمن ي#>#.نون من #?ق#^ح#.#? #<ي #.لم#>#~ة #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لم#^#_ي #.ل#=لي. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–#<ي ح#.لة ظهو#^ إسه#.ل م#?#=#^#^ من #?ن#.ول #.ل#>ق#.#^ يج#% #.ل#?وق#< #>ن #?ن#.وله #%ش#=ل مؤق#?. \r\n\r\n–لم#^#_ي #.لقل#% و#.لأو#>ية #.ل#~موية #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.م #.ل#>ق#.#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية.", "GI": "About Mefenamic Acid\r\nNSAID, Analgesic,antiinflammatory.\r\n\r\nMechanism of Action of Mefenamic Acid\r\nMefenamic acid has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other analgesics. Mefenamic acid inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions.\r\n\r\nIndications for Mefenamic Acid\r\n1.Muscular aches \r\n2.Primary Dysmenorrhoea \r\n3.Headaches \r\n4.Acute gout \r\n5.Dental pain \r\n6.Patent ductus arteriosus \r\n\r\nTypical Dosage for Mefenamic Acid\r\nAdult: initial dose: 500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren above 14 years: \r\n500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren below 14 years: not recommended.", "Composition": "Pono Capsule\r\nEach capsule contains: 250 mg of Mefenamic acid \r\n\r\nPono Forte Capsule\r\nEach capsule contains: 500 mg of Mefenamic acid", "Route": "ORAL.SOLID" }, { "ID": "117", "Trade_Name": "ANTI-COX II 7.5MG 20 CAPS.", "Generic_Name": "MELOXICAM", "Price": "24", "Price_Old": "16", "Company": "ADWIA", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–ي#>#.لج #.ل#?ه#.#%#.#? #<ق#^#.#? #.ل#>مو#~. \r\n\r\n–يس#.#>#~ #<ي #?س#=ين #.لآل#.م #.لن#.#?جة من #.ل#.ل#?ه#.#%#.#?. \r\n\r\n–ي#>#.لج #.لآل#.م #.لن#.#?جة من #.لنق#^س. \r\n\r\n–ي#>مل #>لى #>ل#.ج أم#^#.#_ #.ل#^وم#.#?وي#~ و#.ل#.ل#?ه#.#%#.#? #.ل#^وم#.#?يزمية.", "Contraindications": "–#?جن#% #.س#?خ#~#.مه من ق#%ل #.لح#.مل أو #.لم#^#_#>ة. \r\n\r\n–#.ل#?وق#< #>ن#~ #.س#?خ#~#.م أ#~وية #?خث#^ #.ل#~م. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه لم#^#_ى #.لقل#% ومن ي#?ن#.ولون أ#~وية للأو#>ية #.ل#~موية. \r\n\r\n–من ل#~يه ق#^حة #%#.لم#>#~ة. \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.ل#?ه#.#%#.#? #.لقولون. \r\n\r\n–من ل#~يه مش#.#=ل #%#.ل#=لى وأم#^#.#_ #.ل#=#%#~. \r\n\r\n–#?جن#% #.س#?خ#~#.مه للأ#-#<#.ل #~ون #.لخمسة #>ش#^ #>#.م. \r\n\r\n–من ي#>#.ني من #<#^#- #.لحس#.سية وخ#.صة من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.ل#?وق#< #.ل#<و#^ي لمن ي#>#.ني من #.لنزي#< #.لح#.#~. \r\n\r\n–من #.لمم#=ن أن #?صي#% #.ل#>ين #%زغللة و#>#~م #.ل#^ؤية #%ش#=ل و#.#_ح.", "GI": "About Meloxicam\r\nNSAID, Thiazole derivative, Oxicam class, Analgesic,anti-inflammatory.\r\n\r\nMechanism of Action of Meloxicam\r\nThis drug reduces the prostaglandin synthesis peripherally by inhibiting COX1 & COX2 isoenzymes. This results its antinflammatory action. It is a preferential COX2 inhibitor. It also inhibits TXA2 production.\r\n\r\nIndications for Meloxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute gout", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "118", "Trade_Name": "MEFENTAN 250MG 10CAPS.", "Generic_Name": "MEFENAMIC ACID", "Price": "3.25", "Price_Old": "3.25", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "NSAID.FENAMATES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–مس#=ن لآل#.م #.لجسم. \r\n\r\n–م#_#.#~ لل#.ل#?ه#.#%. \r\n\r\n–خ#.#<#_ للح#^#.#^ة. \r\n\r\n–مس#=ن لآل#.م #.لأسن#.ن. \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#>. \r\n\r\n–#>ل#.ج إص#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل و#.ل#^وم#.#?يزم #.لل#.م#<صلي. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لنص#<ي. \r\n\r\n–ي#>#.لج آل#.م #.ل#~و#^ة #.لشه#^ية و#.#_#-#^#.#%ه#.. \r\n\r\n–مس#=ن لآل#.م #.لن#.#?جة #>ن #.لج#^وح و#.لإص#.#%#.#? و#.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–مس#=ن لح#.لة #?هيج #?أ#=ل #.لغ#_#.#^ي#<. \r\n\r\n–#>ل#.ج ح#.ل#.#? #_#^#%ة #.لشمس.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لأ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية أو لمن ي#>#.نون من حس#.سية #_#~ #.لأس#%#^ين و#.ليو#~. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #<ي #.لقن#.ة #.له#_مية. \r\n\r\n–لمن ي#>#.نون من #?ق#^ح#.#? #<ي #.لم#>#~ة #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لم#^#_ي #.ل#=لي. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–#<ي ح#.لة ظهو#^ إسه#.ل م#?#=#^#^ من #?ن#.ول #.ل#>ق#.#^ يج#% #.ل#?وق#< #>ن #?ن#.وله #%ش#=ل مؤق#?. \r\n\r\n–لم#^#_ي #.لقل#% و#.لأو#>ية #.ل#~موية #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.م #.ل#>ق#.#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية.", "GI": "About Mefenamic Acid\r\nNSAID, Analgesic,antiinflammatory.\r\n\r\nMechanism of Action of Mefenamic Acid\r\nMefenamic acid has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other analgesics. Mefenamic acid inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions.\r\n\r\nIndications for Mefenamic Acid\r\n1.Muscular aches \r\n2.Primary Dysmenorrhoea \r\n3.Headaches \r\n4.Acute gout \r\n5.Dental pain \r\n6.Patent ductus arteriosus \r\n\r\nTypical Dosage for Mefenamic Acid\r\nAdult: initial dose: 500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren above 14 years: \r\n500 mg followed by 250 mg every 6 hours. Treatment is continued maximum up to 1 week. \r\nChildren below 14 years: not recommended.", "Composition": "mefenamic acid 250mg", "Route": "ORAL.SOLID" }, { "ID": "119", "Trade_Name": "ULTRA-MEDANINE 10MG 20CAPS.", "Generic_Name": "METHOXSALEN=AMMOIDIN=XANTHOTOXIN", "Price": "15", "Price_Old": "15", "Company": "MEMPHIS", "Pharmacology": "PSORIASIS", "Category": "م#_#.#~ للص#~#<ية", "Use": "–يوص#< م#> #.ل#.ش#>ه #<وق #.ل#%ن#<سجيه #<ي #>ل#.ج #.ل#.#>#^#.#_ #.لش#~ي#~ة و#.لمس#%#%ه لل#>جز #<ى م#^#_ #.لص#~#.#< و#=ذل#= #>ل#.ج م#^#_ #.ل#%هق ( #.ل#%#^ص ) و#.لأ#>#^#.#_ #.لجل#~يه #<ى م#^#_ ليم#<وم#. خل#.ي#. \r\n\r\n– #? #<ى #.لأشخ#.ص #.لذين لم يس#?جي#%و#. لل#.نو#.#> #.لأخ#^ى من #.ل#>ل#.ج.", "Contraindications": "–#.ل#.شخ#.ص #.لذين #>ن#~هم حس#.سيه لمينو#=س#.لين آو م#^#=#%#.#? سو#^#.لين.\r\n\r\n–#.لم#^#_ي #.لذين #>ن#~هم #?#.#^يخ حس#.سيه لح#.ل#.#? م#^#_يه مثل ذ#.#% حم#.مي و #.لمهق.\r\n\r\n–#.لم#^#_ى #.لذين ي#?#>#^#_ون للميل#.نوم#.، س#^#-#.ن #.لخل#.ي#. #.لح#^ش#<يه أوأ#%ن#.#=ي#..", "GI": "About Methoxsalen\r\nTopical Psoralen ,Photosensitizing agent, Antipsoriatic.\r\nMechanism of Action of Methoxsalen\r\nMethoxsalen is 8-methoxy-psoralen. Methoxsalen selectively inhibits the synthesis of deoxyribonucleic acid (DNA). At high concentrations it suppresses cellular RNA and protein. \r\nIt binds preferentially to the guanine and cytosine moieties of DNA, leading to cross-linking of DNA and inhibits DNA synthesis and DNA function. Methoxsalen, upon photoactivation, conjugates and forms covalent bonds with DNA which leads to the formation of both monofunctional (addition to a single strand of DNA) and bifunctional adducts (cross linking of Psoralen to both strands of DNA). Reactions with proteins have also been described. \r\nPUVA promotes melanogenesis in normal skin. It increases pigmentation from transfer of melanosomes to keratinocytes.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "120", "Trade_Name": "ZOLLIPAK 30MG 10 CAPS", "Generic_Name": "LANSOPRAZOLE", "Price": "33.6", "Price_Old": "33.6", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "lansoprazole 15mg or 30mg", "Route": "ORAL.SOLID" }, { "ID": "121", "Trade_Name": "DECONGESS L 14CAPS.", "Generic_Name": "LORATADINE+PSEUDOEPHEDRINE", "Price": "11", "Price_Old": "11", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY.COMBINED WITH VASOCONSTRICTOR AGENT", "Category": "م#_#.#~ للحس#.سية", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#.ح#?ق#.ن. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج نزل#.#? #.ل#%#^#~ و#.ل#.ن#<لونز#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.ل#.ن#<يه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#>#-س ومش#=ل#.#? #.ل#.ن#<. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#=ه #.ل#>ين. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج و#?قليل #.لحس#.سيه.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.ل#.ص#.#%ه #%#_غ#- #.ل#~م #.لش#~ي#~. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #<#^#- نش#.#- #.لغ#~ه #.ل#~#^قيه. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من خلل #<ي #.ل#.و#>يه #.ل#~مويه. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء لل#.#-#<#.ل #.قل من 12 #>#.م. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء #%#.#<#^#.#-. \r\n\r\n–#<ي ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ه ل#.نه غي#^ #.من #<ي هذه #.ل#<#?#^ه ويج#% #.س#?ش#.#^ه #.ل#-#%ي#%.", "GI": "About Loratadine\r\nSecond Generation H1 Antagonist, Antihistamine.\r\nMechanism of Action of Loratadine\r\nLoratadine blocks one type of receptor for histamine (the H1 receptor) and thus prevents activation (activation releasing other chemicals which produce the symptoms associated with allergy) of cells by histamine. Drug also has mast cell stabilizing property.\r\nInteractions for Loratadine\r\nMacrolide antibiotics, ketoconazole, cimetidine, ranitidine and theophylline: Caution should be exerted while co-administration of these drugs which are known to inhibit hepatic metabolism.\r\nAbout Pseudoephedrine\r\nAlpha/Beta Adrenergic Agonist, a phenethylamine derivative, A nasal decongestant.\r\nMechanism of Action of Pseudoephedrine\r\nIt is a nasal decongestant with alpha-2 agonistic action. It produces local vasoconstriction, reduces blood flow, and causes shrinkage of mucosa which provides relief of nasal congestion. It reduces oedema of the nasal mucosa, thus improving ventilation, drainage and nasa", "Composition": "loratadine 5mg, pseudoephedrine 120mg", "Route": "ORAL.SOLID" }, { "ID": "122", "Trade_Name": "LOPODIUM 2MG 10CAPS", "Generic_Name": "LOPERAMIDE", "Price": "3.2", "Price_Old": "3.2", "Company": "MEMPHIS", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–يس#?خ#~م ل#>ل#.ج #.لإسه#.ل #.لح#.#~ و#.لمزمن.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج، \r\n\r\n–#<ي ح#.لة وجو#~ ألم #<ي #.ل#%#-ن (غي#^ م#?#^#.#<ق م#> #.سه#.ل)، \r\n\r\n–#<ي #.لأ#-#<#.ل #~ون سن #.لث#.نية. \r\n\r\n–#=م#. ينصح #%#?جن#% #.س#?خ#~#.م #.ل#>ل#.ج #=خي#.#^ أول \r\n\r\n–#<ي #>ل#.ج إل#?ه#.#% #.لقولون #.لم#?ق#^ح #.لح#.#~ّ أو #.لزح#.#^ #.لح#.#~ \r\n\r\n–#.ل#.ل#?ه#.#% #.لم#>#~ي #.لقولوني أو #.ل#?ه#.#% #.لقولولن #.لغش#.ئي #.ل#=#.ذ#%.", "GI": "About Loperamide\r\nA synthetic piperidine derivative, Opioid, Antidiarrhoeal, Analgesic.\r\nMechanism of Action of Loperamide\r\nLoperamide is a mu receptor agonist. It inhibits the release of Acetylcholine on myenteric plexus in the gastrointestinal tract. This results in slowing intestinal motility and reduces peristalsis and increase intestinal transit time. This will results in increased absorption of water from fecal matter. Loperamide also has a direct action on intestinal smooth muscle. It does not have any effect on central nervous system.\r\nIndications for Loperamide\r\n1.Diarrhoea\r\nTypical Dosage for Loperamide\r\nAdult (Oral): Initial dose: 4 mg followed by 2 mg after each loose motion. Maintenance dose: 6 - 8 mg daily \r\nMaximum dose: 16 mg / day \r\nChildren: \r\n2 - 5 years: 3 mg / day in 3 divided doses \r\n6 - 8 years: 4 mg / day in 2 divided doses \r\n8 - 12 years: 6 mg / day in 3 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "123", "Trade_Name": "L-CARNITINE 350 MG 20 CAPS.", "Generic_Name": "L-CARNITINE", "Price": "39.75", "Price_Old": "26.4", "Company": "MEPACO", "Pharmacology": "ANTIOXIDANT", "Category": "#<ي#?#.مين#.#?", "Use": "–يس#?خ#~م ل#>ل#.ج #.#_#-#^#.#% و#^#.ثي م#>ين و#.لذي يس#%#% #.نخ#<#.#_ م#.#~ة #.ل#=#.#^ني#?ين #<ي #.لجسم. \r\n\r\n–يس#?خ#~م لم#^#_ي غسيل #.ل#=لي. \r\n\r\n–لمن ي#>#.نون م#?ل#.زمة م#>ينة #%نظ#.م غذ#.ئي ن#%#.#?ي ص#.#^م. \r\n\r\n–يس#?خ#~م للأ#-#<#.ل #.لخ#~ج. \r\n\r\n–يس#?خ#~م لمن ي#>#.نون من نقص ح#.#~ #<ي #.لوزن. \r\n\r\n–لمن ي#?#%#>ون نظ#.م حمية غذ#.ئية. \r\n\r\n–يم#=ن أن يس#?خ#~م #<ي #%#>#_ ح#.ل#.#? م#?#>لقة #%#.لقل#% مثل آل#.م #<ي #.لص#~#^ ن#.#?جة #>ن مش#.#=ل #<ي #.لقل#%. \r\n\r\n–يس#?خ#~م #<ي ح#.لة #_#>#< #>#_لة #.لقل#%. \r\n\r\n–لمني ي#>#.نون من م#_#.#>#<#.#? م#^#_ #.ل#~#<#?ي#^ي#.. \r\n\r\n–يس#?خ#~م #<ي #.#^#?#<#.#> #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–لمن ي#>#.نون من آل#.م #<ي #.لس#.قين ن#.جمة #>ن مش#.#=ل #<ي #.ل#~و#^ة #.ل#~موية. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.#_#-#^#.#%#.#? #.ل#>#_لية #.لم#^#?#%#-ة #%أ#~وية #.ل#?ي #?#>#.لج #.لإي#~ز. \r\n\r\n–يس#?خ#~م #<ي ح#.لة #.نخ#<#.#_ #>#~#~ #.لحيو#.ن#.#? #.لمنوية #>ن#~ #.لذ#=و#^. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج م#^#_ ل#.يم. \r\n\r\n–ي#~خل #<ي #>ل#.ج م#^#_ #.لس#=#^. \r\n\r\n–ي#~خل #<ي #>ل#.ج م#?ل#.زمة #.ل#?#>#% #.لمزمن. \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #^ي#? وهو #.#_#-#^#.#% #<ي نمو و#?#-و#^ #.ل#~م#.غ. \r\n\r\n–ي#~خل #<ي #>ل#.ج #<#^#- نش#.#- #.لغ#~ة #.ل#~#^قية. \r\n\r\n–لمن ي#>#.نون من #<#^#- ح#^#=ة ونقص #<ي #.ل#.ن#?#%#.ه. \r\n\r\n–يس#.#>#~ #<ي #?حسين #.لأ#~و#.ء #.ل#^ي#.#_ي ويزي#~ من #.لق#~#^ة #>لى #?حمل #.لأحم#.ل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ق#^حة #.لس#.قين.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث ل#. #?وج#~ م#>لوم#.#? #=#.#<ية حول أمن #.ل#>ق#.#^ #>لى #.لجنين و#.لم#^أة #.لح#.ل. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من قصو#^ #<ي #.لغ#~ة #.ل#~#^قية. \r\n\r\n–لمن ي#>#.نون من نو#%#.#? #.لص#^#> #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^ حيث إنه يزي#~ من نو#%#.#? #.لص#^#>. \r\n\r\n–ي#>#?#%#^ #.ل#>ق#.#^ أمن #>لى #.لأ#-#<#.ل و#.لم#^أة #.لم#^#_#>ة ول#=ن يج#% #.ل#.ل#?ز#.م #%#.لج#^#>ة #.لمح#~#~ة. \r\n\r\n–يمن#> إس#?خ#~#.م أسينو#=وم#.#^ول م#> هذ#. #.ل#~و#.ء لأنه ي#?#<#.#>ل #%صو#^ة #=#%ي#^ة. \r\n\r\n–ل#. يس#?خ#~م أي ه#^مون من ه#^مون#.#? #.لغ#~ة #.ل#~#^قية م#> هذ#. #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#=وم#.#~ين م#> هذ#. #.ل#>ق#.#^. \r\n\r\n–ل#. يس#?خ#~م #.لو#.#^#<#.#^ين #%#.ل#?ز#.من م#> هذ#. #.ل#~و#.ء لأنه يزي#~ من #<#^صة ح#~وث نزي#<.", "GI": "About L-carnitine\r\nDietary supplement, Amino acid derivative, Antioxidant.\r\n\r\nMechanism of Action of L-carnitine\r\nCarnitine is an essential co-factor of fatty acid metabolism in the heart, liver, and skeletal muscle. It is normally synthesised in the liver, brain, and kidneys in sufficient quantities to meet human requirements. It is an antioxidant. It protects neurons from damage caused by super oxide radicals.\r\n\r\nIndications for L-carnitine\r\n1.As antioxidant \r\n2.Carnitine deficiency", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "124", "Trade_Name": "LOUJAIN 60MG 20 CAPS.", "Generic_Name": "LOXOPROFEN", "Price": "20", "Price_Old": "20", "Company": "HOCHSTER PHARMACEUTICAL INDUSTRIES", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–ي#>#.لج #.ل#~و#.ء #.ل#.ل#?ه#.#%#.#? #.لغي#^ سي#?#^وي#~ية. \r\n\r\n– يس#?خ#~م #=مس#=ن قوي لجمي#> آل#.م #.لظه#^. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل. \r\n\r\n–يخ#<#< من آل#.م #.ل#=#?#< و#.لي#~. \r\n\r\n–ي#>#.لج #.لإل#?ه#.#% #>ق#% #.ل#>ملي#.#? #.لج#^#.حية #<ي #.لأسن#.ن، و#<ي ح#.لة خل#> #.لأسن#.ن أي#_ً#.. \r\n\r\n–ي#>مل #=مس#=ن قوي لجمي#> #.لآل#.م #<ي #.لجسم. \r\n\r\n–ي#>#.لج #.لإ#^#?#<#.#> #<ي #~#^ج#.#? #.لح#^#.#^ة. \r\n\r\n–ي#>مل #>لى #>ل#.ج #.ل#?ه#.#% #.لقص#%#.#?. \r\n\r\n– ي#>#.لج جمي#> #.لإل#?ه#.#%#.#? #.لش#~ي#~ة #<ي #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء #.ذ#. #=ن#? #?#>#.ني من #<#^#- #.لحس#.سية #?ج#.ه #.ح#~ م#=ون#.#? #.ل#~و#.ء #.و #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء #.لأخ#^ي. \r\n\r\n–ل#. ينصح #%أس#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة #.لحمل #.و #.ل#^#_#.#>ة، إل#. #.ذ#. #=#.ن#? #.ل#<و#.ئ#~ #.لن#.#?جه من #.س#?خ#~#.مة #?#<وق #.لأ#_#^#.#^ #.ل#?ي يم#=ن #.ن يح#~ثه#. #.ل#~و#.ء. \r\n\r\n–ل#. يس#?خ#~م #.ل#~و#.ء #<ي ح#.لة #.لم#^#_ي #.لمص#.#%ين #%ق#^حة #<ي #.لم#>#~ة، #.و أ#_#-#^#.#%#.#? #~موية، و#=ذل#= #.لمص#.#%ون #%إ#_#-#^#.#%#.#? #%ولية خ#-ي#^ة، وم#?ل#.زمة #.لن#<#^ون. \r\n\r\n–يحذ#^ #.س#?#>م#.لة #<ي ح#.لة #.لم#^#_ #.لذي ي#>#.نون من #.ل#<شل #<ي #.لقل#%، #.و قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ #.و #?#.#^يخ م#> مش#.#=ل #.ل#=#%#~، و#=ذل#= #.ل#.#_#-#^#.#%#.#? #<ي #.ل#=لية. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#~و#.ء للم#^#_ي #.لمص#.#%ين #%#.ل#^#%و #.لقص#%ي، و#=ذل#= #.ل#.شخ#.ص #.لذين ل#~يهم #?#.#^يخ س#.#%ق م#> مش#?مل#.#? #<#^#- #.لحس#.سية.", "GI": "About Loxoprofen Sodium\r\nNSAID, Propionic acid derivative, Antiinflammatory and Antipyretic Property\r\n\r\nMechanism of Action of Loxoprofen Sodium\r\nLoxoprofen is a non-selective cyclooxygenase inhibitor. It works by reducing the synthesis of prostaglandins from arachidonic acid. It is a prodrug that is rapidly converted to its active metabolite after oral admin.\r\n\r\nIndications for Loxoprofen Sodium\r\nPain and inflammation associated with musculoskeletal and joint disorders\r\nInteractions for Loxoprofen Sodium\r\nPossible increased risk of seizures when used with ciprofloxacin and norfloxacin \r\nMay also increase serum levels of warfarin, methotrexate, lithium salts and sulphonylurea derivatives", "Composition": "loxoprofen 60mg", "Route": "ORAL.SOLID" }, { "ID": "125", "Trade_Name": "LOXAPINE 25MG 10CAPS.", "Generic_Name": "LOXAPINE", "Price": "8", "Price_Old": "8", "Company": "GLOBAL NAPI PHARMACEUTICALS > AL DELTA PHARMACEUTICALS TRADING CO.", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#>ل#.ج #.ل#.#_#-#^#.#%#.#? #.لن#<سية و#.ل#>قلية. \r\n\r\n–#>ل#.ج #.لهل#.وس #.ل#%ص#^ية و#.لسم#>ية. \r\n\r\n–#>ل#.ج #.ل#.ن#<ص#.ل #>ن #.لو#.ق#>. \r\n\r\n–#>ل#.ج #.ن#<ص#.م #.لشخصية. \r\n\r\n–مه#~ئ م#_#.#~ للذه#.ن.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.لقل#% و#.ل#=#%#~. \r\n\r\n–من ي#>#.ني من #.ل#.#=#?ئ#.#% #.لح#.#~.", "GI": "About Loxapine\r\nA dibenzazepine derivative, A typical antipsychotic.\r\nMechanism of Action of Loxapine\r\nLoxapine produce its antipsychotic activity by blocking the post synaptic receptor in the CNS.\r\nIndications for Loxapine\r\nPsychoses\r\nInteractions for Loxapine\r\nAlcohol & other CNS depressants: Additive CNS depression. \r\nTCAs & Antiparkinsonism drugs: Anticholinergic effects potentiated. \r\nClonidine & Methyldopa: Hypotensive effect of these drugs inhibited. \r\nMAOIs: Orthostatic hypotension with MAOIs.", "Composition": "loxapine 25mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "126", "Trade_Name": "LOPERASIN 2MG 6 CAPS.", "Generic_Name": "LOPERAMIDE", "Price": "2.55", "Price_Old": "2.55", "Company": "ALEXANDRIA", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–يس#?خ#~م ل#>ل#.ج #.لإسه#.ل #.لح#.#~ و#.لمزمن.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج، \r\n\r\n–#<ي ح#.لة وجو#~ ألم #<ي #.ل#%#-ن (غي#^ م#?#^#.#<ق م#> #.سه#.ل)، \r\n\r\n–#<ي #.لأ#-#<#.ل #~ون سن #.لث#.نية. \r\n\r\n–#=م#. ينصح #%#?جن#% #.س#?خ#~#.م #.ل#>ل#.ج #=خي#.#^ أول \r\n\r\n–#<ي #>ل#.ج إل#?ه#.#% #.لقولون #.لم#?ق#^ح #.لح#.#~ّ أو #.لزح#.#^ #.لح#.#~ \r\n\r\n–#.ل#.ل#?ه#.#% #.لم#>#~ي #.لقولوني أو #.ل#?ه#.#% #.لقولولن #.لغش#.ئي #.ل#=#.ذ#%.", "GI": "About Loperamide\r\nA synthetic piperidine derivative, Opioid, Antidiarrhoeal, Analgesic.\r\nMechanism of Action of Loperamide\r\nLoperamide is a mu receptor agonist. It inhibits the release of Acetylcholine on myenteric plexus in the gastrointestinal tract. This results in slowing intestinal motility and reduces peristalsis and increase intestinal transit time. This will results in increased absorption of water from fecal matter. Loperamide also has a direct action on intestinal smooth muscle. It does not have any effect on central nervous system.\r\nIndications for Loperamide\r\n1.Diarrhoea\r\nTypical Dosage for Loperamide\r\nAdult (Oral): Initial dose: 4 mg followed by 2 mg after each loose motion. Maintenance dose: 6 - 8 mg daily \r\nMaximum dose: 16 mg / day \r\nChildren: \r\n2 - 5 years: 3 mg / day in 3 divided doses \r\n6 - 8 years: 4 mg / day in 2 divided doses \r\n8 - 12 years: 6 mg / day in 3 divided doses", "Composition": "loperamide 2mg", "Route": "ORAL.SOLID" }, { "ID": "127", "Trade_Name": "LOXAPINE 50MG 10CAPS.", "Generic_Name": "LOXAPINE", "Price": "15", "Price_Old": "15", "Company": "GLOBAL NAPI PHARMACEUTICALS > AL DELTA PHARMACEUTICALS TRADING CO.", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#>ل#.ج #.ل#.#_#-#^#.#%#.#? #.لن#<سية و#.ل#>قلية. \r\n\r\n–#>ل#.ج #.لهل#.وس #.ل#%ص#^ية و#.لسم#>ية. \r\n\r\n–#>ل#.ج #.ل#.ن#<ص#.ل #>ن #.لو#.ق#>. \r\n\r\n–#>ل#.ج #.ن#<ص#.م #.لشخصية. \r\n\r\n–مه#~ئ م#_#.#~ للذه#.ن.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.لقل#% و#.ل#=#%#~. \r\n\r\n–من ي#>#.ني من #.ل#.#=#?ئ#.#% #.لح#.#~.", "GI": "About Loxapine\r\nA dibenzazepine derivative, A typical antipsychotic.\r\nMechanism of Action of Loxapine\r\nLoxapine produce its antipsychotic activity by blocking the post synaptic receptor in the CNS.\r\nIndications for Loxapine\r\nPsychoses\r\nInteractions for Loxapine\r\nAlcohol & other CNS depressants: Additive CNS depression. \r\nTCAs & Antiparkinsonism drugs: Anticholinergic effects potentiated. \r\nClonidine & Methyldopa: Hypotensive effect of these drugs inhibited. \r\nMAOIs: Orthostatic hypotension with MAOIs.", "Composition": "loxapine 25mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "128", "Trade_Name": "CARNITOL 500MG 30 CAPS.", "Generic_Name": "L-CARNITINE", "Price": "54", "Price_Old": "36", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIOXIDANT", "Category": "#<ي#?#.مين#.#?", "Use": "–يس#?خ#~م ل#>ل#.ج #.#_#-#^#.#% و#^#.ثي م#>ين و#.لذي يس#%#% #.نخ#<#.#_ م#.#~ة #.ل#=#.#^ني#?ين #<ي #.لجسم. \r\n\r\n–يس#?خ#~م لم#^#_ي غسيل #.ل#=لي. \r\n\r\n–لمن ي#>#.نون م#?ل#.زمة م#>ينة #%نظ#.م غذ#.ئي ن#%#.#?ي ص#.#^م. \r\n\r\n–يس#?خ#~م للأ#-#<#.ل #.لخ#~ج. \r\n\r\n–يس#?خ#~م لمن ي#>#.نون من نقص ح#.#~ #<ي #.لوزن. \r\n\r\n–لمن ي#?#%#>ون نظ#.م حمية غذ#.ئية. \r\n\r\n–يم#=ن أن يس#?خ#~م #<ي #%#>#_ ح#.ل#.#? م#?#>لقة #%#.لقل#% مثل آل#.م #<ي #.لص#~#^ ن#.#?جة #>ن مش#.#=ل #<ي #.لقل#%. \r\n\r\n–يس#?خ#~م #<ي ح#.لة #_#>#< #>#_لة #.لقل#%. \r\n\r\n–لمني ي#>#.نون من م#_#.#>#<#.#? م#^#_ #.ل#~#<#?ي#^ي#.. \r\n\r\n–يس#?خ#~م #<ي #.#^#?#<#.#> #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–لمن ي#>#.نون من آل#.م #<ي #.لس#.قين ن#.جمة #>ن مش#.#=ل #<ي #.ل#~و#^ة #.ل#~موية. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.#_#-#^#.#%#.#? #.ل#>#_لية #.لم#^#?#%#-ة #%أ#~وية #.ل#?ي #?#>#.لج #.لإي#~ز. \r\n\r\n–يس#?خ#~م #<ي ح#.لة #.نخ#<#.#_ #>#~#~ #.لحيو#.ن#.#? #.لمنوية #>ن#~ #.لذ#=و#^. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج م#^#_ ل#.يم. \r\n\r\n–ي#~خل #<ي #>ل#.ج م#^#_ #.لس#=#^. \r\n\r\n–ي#~خل #<ي #>ل#.ج م#?ل#.زمة #.ل#?#>#% #.لمزمن. \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #^ي#? وهو #.#_#-#^#.#% #<ي نمو و#?#-و#^ #.ل#~م#.غ. \r\n\r\n–ي#~خل #<ي #>ل#.ج #<#^#- نش#.#- #.لغ#~ة #.ل#~#^قية. \r\n\r\n–لمن ي#>#.نون من #<#^#- ح#^#=ة ونقص #<ي #.ل#.ن#?#%#.ه. \r\n\r\n–يس#.#>#~ #<ي #?حسين #.لأ#~و#.ء #.ل#^ي#.#_ي ويزي#~ من #.لق#~#^ة #>لى #?حمل #.لأحم#.ل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ق#^حة #.لس#.قين.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث ل#. #?وج#~ م#>لوم#.#? #=#.#<ية حول أمن #.ل#>ق#.#^ #>لى #.لجنين و#.لم#^أة #.لح#.ل. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من قصو#^ #<ي #.لغ#~ة #.ل#~#^قية. \r\n\r\n–لمن ي#>#.نون من نو#%#.#? #.لص#^#> #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^ حيث إنه يزي#~ من نو#%#.#? #.لص#^#>. \r\n\r\n–ي#>#?#%#^ #.ل#>ق#.#^ أمن #>لى #.لأ#-#<#.ل و#.لم#^أة #.لم#^#_#>ة ول#=ن يج#% #.ل#.ل#?ز#.م #%#.لج#^#>ة #.لمح#~#~ة. \r\n\r\n–يمن#> إس#?خ#~#.م أسينو#=وم#.#^ول م#> هذ#. #.ل#~و#.ء لأنه ي#?#<#.#>ل #%صو#^ة #=#%ي#^ة. \r\n\r\n–ل#. يس#?خ#~م أي ه#^مون من ه#^مون#.#? #.لغ#~ة #.ل#~#^قية م#> هذ#. #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#=وم#.#~ين م#> هذ#. #.ل#>ق#.#^. \r\n\r\n–ل#. يس#?خ#~م #.لو#.#^#<#.#^ين #%#.ل#?ز#.من م#> هذ#. #.ل#~و#.ء لأنه يزي#~ من #<#^صة ح#~وث نزي#<.", "GI": "About L-carnitine\r\nDietary supplement, Amino acid derivative, Antioxidant.\r\n\r\nMechanism of Action of L-carnitine\r\nCarnitine is an essential co-factor of fatty acid metabolism in the heart, liver, and skeletal muscle. It is normally synthesised in the liver, brain, and kidneys in sufficient quantities to meet human requirements. It is an antioxidant. It protects neurons from damage caused by super oxide radicals.\r\n\r\nIndications for L-carnitine\r\n1.As antioxidant \r\n2.Carnitine deficiency", "Composition": "Solution: Each 100 ml contains 30 g L-Carnitine. \r\n\r\nExcipients: Sucrose, sorbitol solution, methyl p-hydroxybenzoate, propyl p-hydroxybenzoate, L-tartaric acid and cherry flavor.\r\n\r\nCapsules: Each capsule contains 500 mg L-Carnitine tartrate equivalent to 33", "Route": "ORAL.SOLID" }, { "ID": "129", "Trade_Name": "SPASMAG 20 CAPS.", "Generic_Name": "MAGNESIUM SULPHATE+YEAST", "Price": "8.4", "Price_Old": "8.4", "Company": "GLOBAL NAPI PHARMACEUTICALS > SEROLAM-FRANCE", "Pharmacology": "SEXUAL TONIC", "Category": "منش#- جنسي", "Use": "–يس#.#>#~ #<ي #>ل#.ج أم#^#.#_ #.لش#^#.يين وهش#.شة #.ل#>ظ#.م و#%#>#_ أنو#.#> #.لس#^#-#.ن. \r\n\r\n–له أث#^ #<#>#.ل #<ي #?خ#<ي#_ مس#?وى #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–ي#>مل #>لى حم#.ية #.لش#^#.يين من #.ل#_غ#- #.لن#.#?ج #>ن #.ل#.#^#?#<#.#> #.لم#<#.جئ #<ي #_غ#- #.ل#~م. \r\n\r\n–يس#?خ#~م لمن ي#>#.نون من نقص #.لمغنيسيوم #<ي #.ل#~م. \r\n\r\n–#>#.مل مح#<ز للأنزيم#.#? وخ#.صة #.لأنزيم#.#? #.ل#?ي #?#?#>لق #%إن#?#.ج #.ل#-#.قة #<ي #.لجسم.", "Contraindications": "–لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–و#<ى ح#.له #.لحمل و#.ل#^#_#.#>ة يج#% أس#?ش#.#^ه #.ل#-#%ي#%. \r\n\r\n–من ي#>#.نى من #.لقصو#^ #.ل#=لوى و#.ل#=#%#~ى #.لح#.#~.", "GI": "About MAGNESIUM SULPHATE\r\nSaline Laxative, Osmotically acting\r\nMechanism of Action of MAGNESIUM SULPHATE\r\nOral: Magnesium sulfate increases peristaltic activity by causing osmotic retention of fluids, thus resulting in bowel evacuation. Parenteral: Magnesium sulfate decreases levels of acetylcholine in motor nerve terminals. It also acts on the myocardium by decreasing the rate of SA node impulse formation and prolonging the conduction time\r\nIndications for MAGNESIUM SULPHATE\r\n1.Seizures in pregnancy \r\n2.Hypomagnesaemia \r\n3.Heart attack \r\n4.Asthma \r\n5.Constipation \r\nInteractions for MAGNESIUM SULPHATE\r\nOral: Decreases absorption of tetracyclines and biphosphonates \r\nAdditive neuromuscular blocking effects with aminoglycosides, digitalis glycosides \r\nAdditive effects with nifedipine and CNS depressants", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "130", "Trade_Name": "ITRANOX 100MG 15 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "54", "Price_Old": "54", "Company": "ADWIA", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "Each capsule contains: Itraconazole 100mg", "Route": "ORAL.SOLID" }, { "ID": "131", "Trade_Name": "RAWAKAN 100MG 20CAPS.", "Generic_Name": "KAVA-KAVA", "Price": "9", "Price_Old": "9", "Company": "ATOS PHARMA", "Pharmacology": "PSYCHIATRIC.MOOD STABILIZERS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#~و#.ء مه#~يء للأ#>ص#.#% .\r\n\r\n–ي#>#.لج #.لقلق #.لن#<سي .\r\n\r\n–ي#>#.لج #.ل#.م#^#.#_ #.لن#<سية و#.لجسم#.نية .", "Contraindications": "–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء #<ي ح#.لة وجو#~ حس#.سية #?ج#.ه أح#~ م#=ون#.#?ه #.ل#<#>#.لة.\r\n\r\n–ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء خل#.ل #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#%.\r\n\r\n–ل#. يج#% #?ن#.ول #~و#.ء #^و#.#=#.ن من قِ#%ل #.لأشخ#.ص #.لذين ل#~يهم حس#.سية من م#.#~ة #.ل#=#.#<#. #=#.#<#..\r\n\r\n–ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء من قِ#%ل #.لأشخ#.ص #.لذين ي#>#.نون من #.لهوس.\r\n\r\n–ي#?#>#.#^#_ هذ#. #.ل#~و#.ء من #.لأ#~وية #.ل#%#.س#-ة لل#>#_ل#.#? ويمن#> #?ن#.ولهم م#>#.ً #<ي وق#? م#?ز#.من.\r\n\r\n–ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء من قِ#%ل #.لم#^#_ى #.لمص#.#%ين #%شلل #^#>#.ش.\r\n\r\n–ي#?#<#.#>ل هذ#. #.ل#~و#.ء من #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #=حول ويمن#> #?ن#.ولهم م#>#.ً #<ي وق#? م#?ز#.من.\r\n\r\n–ل#. يج#% #?ن#.ول #~و#.ء #^و#.#=#.ن من قِ#%ل #.لم#^#_ى #.لذين ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#%.", "GI": "COMING SOON ..", "Composition": "kava kava extract 100mg", "Route": "ORAL.SOLID" }, { "ID": "132", "Trade_Name": "IVERMINE 6MG 2 CAPS.", "Generic_Name": "IVERMECTIN", "Price": "2.25", "Price_Old": "2.25", "Company": "ADWIA", "Pharmacology": "ANTHELMINTIC", "Category": "م#_#.#~ لل#~ي#~#.ن", "Use": "–ح#.ل#.#? #.لج#^#% . \r\n\r\n–#>#~وى #.ل#-#<يلي#.#? #.ل#~و#~ية مثل : س#?#^ونجلوي#~س س#?ي#^#=ول#.#^س . \r\n\r\n–#~#.ء #.ل#<يل . \r\n\r\n–#~#.ء #>مى #.لنه#^ .", "Contraindications": "–يمن#> #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> للأ#-#<#.ل أقل من 5 سنو#.#? \r\n\r\n–يمن#> خل#.ل #<#?#^#.#? #.لحمل و#.ل#^#_#.#>ة", "GI": "Description\t\r\nIvermectin is a broad-spectrum anti-parasite medication. It was used against worms (except tapeworms), but, in 2012, it was approved for the topical treatment of head lice infestations in patients 6 months of age and older\r\n\r\nMechanism of action\r\nIvermectin binds selectively and with high affinity to glutamate-gated chloride ion channels in invertebrate muscle and nerve cells of the microfilaria. This binding causes an increase in the permeability of the cell membrane to chloride ions and results in hyperpolarization of the cell, leading to paralysis and death of the parasite. Ivermectin also is believed to act as an agonist of the neurotransmitter gamma-aminobutyric acid (GABA), thereby disrupting GABA-mediated central nervous system (CNS) neurosynaptic transmission. Ivermectin may also impair normal intrauterine development of O. volvulus microfilariae and may inhibit their release from the uteri of gravid female worms.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "133", "Trade_Name": "ITRAPEX 100MG 4 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "19.2", "Price_Old": "19.2", "Company": "MULTI-APEX", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "Each capsule contains: 100 mg Itraconazole", "Route": "ORAL.SOLID" }, { "ID": "134", "Trade_Name": "KETOFAN 50MG 20 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "10.5", "Price_Old": "7", "Company": "EUROPEAN EGYPTIAN PHARM. IND.", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "ketoprofen 100mg or 200mg", "Route": "ORAL.SOLID" }, { "ID": "135", "Trade_Name": "KAVA 150MG 12CAPS.", "Generic_Name": "KAVA-KAVA", "Price": "11", "Price_Old": "11", "Company": "OCTOBER PHARMA", "Pharmacology": "PSYCHIATRIC.MOOD STABILIZERS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#~و#.ء مه#~يء للأ#>ص#.#% .\r\n\r\n–ي#>#.لج #.لقلق #.لن#<سي .\r\n\r\n–ي#>#.لج #.ل#.م#^#.#_ #.لن#<سية و#.لجسم#.نية .", "Contraindications": "–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء #<ي ح#.لة وجو#~ حس#.سية #?ج#.ه أح#~ م#=ون#.#?ه #.ل#<#>#.لة.\r\n\r\n–ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء خل#.ل #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#%.\r\n\r\n–ل#. يج#% #?ن#.ول #~و#.ء #^و#.#=#.ن من قِ#%ل #.لأشخ#.ص #.لذين ل#~يهم حس#.سية من م#.#~ة #.ل#=#.#<#. #=#.#<#..\r\n\r\n–ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء من قِ#%ل #.لأشخ#.ص #.لذين ي#>#.نون من #.لهوس.\r\n\r\n–ي#?#>#.#^#_ هذ#. #.ل#~و#.ء من #.لأ#~وية #.ل#%#.س#-ة لل#>#_ل#.#? ويمن#> #?ن#.ولهم م#>#.ً #<ي وق#? م#?ز#.من.\r\n\r\n–ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء من قِ#%ل #.لم#^#_ى #.لمص#.#%ين #%شلل #^#>#.ش.\r\n\r\n–ي#?#<#.#>ل هذ#. #.ل#~و#.ء من #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #=حول ويمن#> #?ن#.ولهم م#>#.ً #<ي وق#? م#?ز#.من.\r\n\r\n–ل#. يج#% #?ن#.ول #~و#.ء #^و#.#=#.ن من قِ#%ل #.لم#^#_ى #.لذين ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#%.", "GI": "COMING SOON ..", "Composition": "kava kava extract 150mg", "Route": "ORAL.SOLID" }, { "ID": "136", "Trade_Name": "SPORANOX 100MG 14CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "108", "Price_Old": "108", "Company": "JANSSEN CILAG > SOFICOPHARM", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "itraconazole 100", "Route": "ORAL.SOLID" }, { "ID": "137", "Trade_Name": "ALCOFAN 50MG 12 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "6.75", "Price_Old": "4.5", "Company": "ALEXANDRIA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "Ketoprofen 2.5%", "Route": "ORAL.SOLID" }, { "ID": "138", "Trade_Name": "SPORANOX 100MG 4 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "42", "Price_Old": "42", "Company": "JANSSEN CILAG > SOFICOPHARM", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "itraconazole 100", "Route": "ORAL.SOLID" }, { "ID": "139", "Trade_Name": "KETOGESIC 50MG 20 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "13.5", "Price_Old": "9", "Company": "PHAROPHARMA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "Ketoprofen 200 mg", "Route": "ORAL.SOLID" }, { "ID": "140", "Trade_Name": "FURFURIL 200MG 12 CAP.", "Generic_Name": "NIFUROXAZIDE", "Price": "5.25", "Price_Old": "5.25", "Company": "ORGANOPHARMA", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "nifuroxazide 200mg", "Route": "ORAL.SOLID" }, { "ID": "141", "Trade_Name": "PARAZOXANIDE 500 MG 18 CAP.", "Generic_Name": "NITAZOXANIDE", "Price": "63", "Price_Old": "42", "Company": "MISR > PHARMACARE", "Pharmacology": "ANTHELMENTIC", "Category": "م#_#.#~ لل#~ي#~#.ن", "Use": "–يس#?خ#~م #<ي #.لسي#-#^ة #>لي ح#~ة #.ل#>#~وي #.لمخ#?ل#<ة #.ل#%#=#?ي#^ية و#.ل#-#<يلية #.ل#?ي #?صي#% #.لجه#.ز #.له#_مي ن#?يجة #?ن#.ول #.ل#-#>#.م و#.لش#^#.#% #.لملوث. \r\n\r\n–يس#?خ#~م #>لي م#~ي #=#%ي#^ #<ي #>ل#.ج و#.لق#_#.ء #>لي #-#<يلي#.#? #.لأمي#%#. و#.لجي#.#^#~ي#. وهي#. من #.ل#-#<يلي#.#? #.لم#?و#=نة #<ي ش#>و#% #.ل#>#.لم #.لث#.لث ن#?يجة #?لوث #.ل#-#>#.م و#.لخ#_#^و#.#? و#.ل#<و#.#=ة #%#.ل#%وي#_#.#? #.لخ#.صة #%ه#. وإن#?ق#.له#. من شخص للآخ#^. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لنزل#.#? #.لم#>وية وهي#. من #.لمش#.#=ل #.لم#>وية #.ل#?ي #?صي#% #.لم#^ي#_ و#?س#%#% #.ل#>#~ي#~ من #.لأ#>#^#.#_ #.لم#^#_ية #.لمخ#?ل#<ة مثل؛ #.#^#?ق#.#> #~#^جة #.لح#^#.#^ة و#.ل#?#^جي#> و#.لإسه#.ل وألم #.ل#%#-ن. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإسه#.ل #.لمي#=#^و#%ي و#.ل#-#<يلي #.لذي ين#?ج #>ن #?لوث #.لم#>#~ة و#.لقولون وخ#.صة #.لأ#-#<#.ل صغ#.#^ #.لسن #.لذين ي#_#>ون أي شئ من #>لي #.ل#.#^#_ #<ي #.ل#<م م#> #?لوثه#. ي#.ل#-#<يلي#.#? و#.ل#%#=#?ي#^ي#..", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة #=ن#? #?#>#.ني من #.لحس#.سية #.لم#<#^#-ة #?ج#.ه م#=ون#.#? #.ل#~و#.ء من#>#. لأي م#_#.#>#<#.#? م#^#_ية #>لي صح#?#= و#.ل#?ي ق#~ #?زي#~ ح#~#?ه#. وي#?ق#.قم #.لأم#^ و#?ه#~#~ #.لحي#.ة. \r\n\r\n–ل#. #?س#?خ#~ميه #<ي ح#.لة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية من#>#. ل#?أثي#^ #.ل#~و#.ء #.ل#_#.#^ #>لي صحة #^#_ي#>#= أو جنين#= #<#?وخي #=#.مل حذ#^#= #.لش#~ي#~. \r\n\r\n–يج#% #?وخي #.لحذ#^ وإخ#%#.#^ #-#%ي#%#= #.لخ#.ص م#. إذ#. #=ن#? #?#>#.ني من أي مش#.#=ل م#^#_ية م#?#>لقة #%إل#?ه#.#%#.#? #.ل#=#%#~ و#.ل#<شل #.ل#=لوي و#<ي#^وس نقص #.لمن#.#>ة #.لم#=#?س#% ومن ي#>#.نون #%ص#<ة #>#.مة من جه#.ز من#.#>ة #_#>ي#<. \r\n\r\n–ل#. #?س#?خ#~مه #<ي ح#.لة مل#.حظ#?#= أي #?غي#^ #<يزي#.ئي #<ي ش#=ل وقو#.م #.ل#~و#.ء #.و #.لأق#^#.ص #<ق#~ #?#=ون #?#>#^#_#? لل#<س#.#~ ن#.#?ج #>ن سوء #?خزينه#. أو #?ج#.وزه#. صل#.حية #.لإن#?ه#.ء #.لم#~ونة #>لي #.ل#>ل#%ة خ#.#^جي#..", "GI": "About Nitazoxanide\r\nA synthetic nitrothiazolyl-salicylamide derivative, Antihelminthics ,in schistosomiasis.\r\nMechanism of Action of Nitazoxanide\r\nIt excerts its action by blocking anaerobic energy metabolism. The drug interfering with the pyruvate-ferredoxin oxidoreductase enzyme depended electron transfer reaction which is an essential step in anaerobic glucose energy metabolism. \r\nIndications for Nitazoxanide\r\n1.Helminthiasis \r\n2.Giardiasis \r\n3.Amoebiasis \r\n4.Trichomoniasis \r\n5.Fasciolasis \r\n6.Cryptosporidiosis \r\nInteractions for Nitazoxanide\r\nCaution should be exercised while administering nitazoxanide with drugs which are highly plasma bound.", "Composition": "nitazoxanide 500mg", "Route": "ORAL.SOLID" }, { "ID": "142", "Trade_Name": "TASIGNA 200 MG 28 CAPS.", "Generic_Name": "NILOTINIB", "Price": "5700", "Price_Old": "5700", "Company": "NOVARTIS", "Pharmacology": "ANTITUMORS", "Category": "م#_#.#~#.#? للأو#^#.م", "Use": "–#>ل#.ج ح#.ل#.#? س#^#-#.ن #.ل#~م #.لنخ#.#>ي . \r\n\r\n–يس#.#>#~ #~و#.ء TASIGNA #?#.سيجن#. #<ي وق#< #.لخل#.ي#. #.لس#^#-#.نية ومن#> #?#=ونه#. .", "Contraindications": "–يمن#> #.س#?خ#~#.م #~و#.ء TASIGNA #?#.سيجن#. خل#.ل #<#?#^ة #.لحمل . \r\n\r\n–يج#% #.ل#?وق#< #>ن #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Indication\tFor the potential treatment of various leukemias, including chronic myeloid leukemia (CML).\r\nPharmacodynamics\tNilotinib is a transduction inhibitor that targets BCR-ABL, c-kit and PDGF, for the potential treatment of various leukemias, including chronic myeloid leukemia (CML).\r\nMechanism of action\tChronic myelogenous leukaemia (CML) is caused by the BCR-ABL oncogene. Nilotinib inhibits the tyrosine kinase activity of the BCR-ABL protein. Nilotinib fits into the ATP-binding site of the BCR-ABL protein with higher affinity than imatinib, over-riding resistance caused by mutations. The ability of AMN107 to inhibit TEL-platelet-derived growth factor receptor-beta (TEL-PDGFRbeta), which causes chronic myelomonocytic leukaemia, and FIP1-like-1-PDGFRalpha, which causes hypereosinophilic syndrome, suggests potential use of AMN107 for myeloproliferative diseases characterised by these kinase fusions (Stover et al, 2005- Weisberg et al, 2005). AMN107 also inhibits the c-Kit receptor k", "Composition": "nilotinib hcl 200mg", "Route": "ORAL.SOLID" }, { "ID": "143", "Trade_Name": "INTEST-RELIEF 200 MG 10 CAPS.", "Generic_Name": "NIFUROXAZIDE", "Price": "3", "Price_Old": "3", "Company": "MULTI-APEX", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "144", "Trade_Name": "MEPAFURAN 50MG 20 CAPS.", "Generic_Name": "NITROFURANTOIN", "Price": "6.5", "Price_Old": "6.5", "Company": "MEPACO", "Pharmacology": "UTI INFECTIONS", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحو#_ و#.لمث#.نة. \r\n\r\n–#=#>ل#.ج وق#.ئي من #.ل#.ل#?ه#.#%#.#? #<ي #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#.نيمي#. #.ل#<ول. \r\n\r\n–ح#.ل#.#? #.نق#-#.#> #.ل#%ول. \r\n\r\n–#.ل#.#-#<#.ل #.قل من 12 #>#.م. \r\n\r\n–#.#_#-#^#.#% #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Nitrofurantoin\r\nNitrofuran derivative antibiotic, Urinary germicide, Miscellaneous Antibiotic.\r\n\r\nMechanism of Action of Nitrofurantoin\r\nNitrofurantoin is a bacteriostatic drug. It undergoes enzymatic reduction and produces active metabolite which damages the DNA of the bacteria. Bacteria reduce Nitrofurantoin more rapidly than mammalian cells.\r\nIndications for Nitrofurantoin\r\n1. Urinary tract infection\r\nInteractions for Nitrofurantoin\r\nAntichlolinergic drugs: Bioavailability of nitrofurantoin increased due to delayed gastric emptying. \r\nProbenecid: Decreased renal clearance and increased serum levels of nitrofurantoin resulting in toxicity. \r\nMagnesium trisilicate: May delay or decrease the absorption of nitrofurantoin. \r\nFood: Increases bioavailability of nitrofurantoin. \r\nLab tests: Serum glucose decreased. Elevated serum bilirubin and alkaline phosphates. Elevated urinary creatinine levels. False-positive urinary glucose using benedicts reagent.", "Composition": "nitrofurantoin 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "145", "Trade_Name": "MACROFURAN 50 MG 30CAPS.", "Generic_Name": "NITROFURANTOIN", "Price": "15", "Price_Old": "12.75", "Company": "KAHIRA", "Pharmacology": "UTI INFECTIONS", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحو#_ و#.لمث#.نة. \r\n\r\n–#=#>ل#.ج وق#.ئي من #.ل#.ل#?ه#.#%#.#? #<ي #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#.نيمي#. #.ل#<ول. \r\n\r\n–ح#.ل#.#? #.نق#-#.#> #.ل#%ول. \r\n\r\n–#.ل#.#-#<#.ل #.قل من 12 #>#.م. \r\n\r\n–#.#_#-#^#.#% #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Nitrofurantoin\r\nNitrofuran derivative antibiotic, Urinary germicide, Miscellaneous Antibiotic.\r\n\r\nMechanism of Action of Nitrofurantoin\r\nNitrofurantoin is a bacteriostatic drug. It undergoes enzymatic reduction and produces active metabolite which damages the DNA of the bacteria. Bacteria reduce Nitrofurantoin more rapidly than mammalian cells.\r\nIndications for Nitrofurantoin\r\n1. Urinary tract infection\r\nInteractions for Nitrofurantoin\r\nAntichlolinergic drugs: Bioavailability of nitrofurantoin increased due to delayed gastric emptying. \r\nProbenecid: Decreased renal clearance and increased serum levels of nitrofurantoin resulting in toxicity. \r\nMagnesium trisilicate: May delay or decrease the absorption of nitrofurantoin. \r\nFood: Increases bioavailability of nitrofurantoin. \r\nLab tests: Serum glucose decreased. Elevated serum bilirubin and alkaline phosphates. Elevated urinary creatinine levels. False-positive urinary glucose using benedicts reagent.", "Composition": "nitrofurantoin 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "146", "Trade_Name": "NIFUROXAZIDE 200 MG 20 CAPS.", "Generic_Name": "NIFUROXAZIDE", "Price": "18", "Price_Old": "12", "Company": "EL-OBOUR", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "147", "Trade_Name": "CALSTER 250 MG 30 CHEW. TABS.", "Generic_Name": "CALCIUM", "Price": "18.75", "Price_Old": "18.75", "Company": "EVA PHARMA", "Pharmacology": "CALCIUM SUPPLEMENT", "Category": "م#=مل #.ل#=#.لسيوم", "Use": "–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? نقص #.ل#=#.لسيوم #<ي #.لجسم . \r\n\r\n–يس#.#>#~ #>لي #.ل#?ح#=م #<ي #.#^#?#<#.#> مس#?وي #.لمغنيسيوم و#.ل#%و#?#.سيوم و#.ل#<وس#<و#^ #<ي #.ل#~م . \r\n\r\n–ي#?م #?ن#.ول هذ#. #.ل#~و#.ء #%ج#.ن#% #.خذ #<ي#?#.مين #~ ل#?قليل #<ق#~#.ن #.ي م#>#~#.ن #<ي #.ل#>ظ#.م وخ#.صة لل#.شخ#.ص #.لذين ي#?ن#.ولون أ#~وية #.ل#=و#^#?ي#=وس#?ي#^وي#~ ل#<#?#^#.#? #-ويلة. \r\n\r\n–يم#=ن #.س#?#>م#.له للحو#.مل ل#?#>وي#_ نقص #.ل#=#.لسيوم #<ي #.لجسم . \r\n\r\n–يمن#> #.ل#.ص#.#%ة #%هش#.شة #.ل#>ظ#.م . \r\n\r\n–يقي من #.ل#.ص#.#%ة #%#.ل#>#~ي#~ من #.نو#.#> #.ل#.و#^#.م #.لس#^#-#.نية #.لمخ#?ل#<ة . \r\n\r\n–يقلل #.ل#~و#.ء #<ي م#>#~ل #.#<#^#.ز #.لغ#~ة #.ل#~#^قية لل#.شخ#.ص #.لمص#.#%ون #%#<شل #.ل#=لي أو #.#^#?#<#.#> #<ي مس#?وي #.لغ#~ة .", "Contraindications": "–يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #>لي م#>#~ة #<#.#^غة لل#.شخ#.ص #.لمص#.#%ون #%نقص #<ي مس#?وي حم#_ #.لم#>#~ة . \r\n\r\n–يج#% #>#~م #.ل#?#~خين خل#.ل #<#?#^ة #.ل#>ل#.ج لأنه يؤ#~ي #.لي #?قليل #.م#?ص#.ص #.لم#>#~ة لل#~و#.ء و#%#.ل#?#.لي نقص ن#?#.ئجه و#?أثي#^ه . \r\n\r\n–ي#?#~#.خل م#> #.ل#>ل#.ج #%ه#^مون#.#? #.لغ#~ة #.ل#~#^قية لذل#= ل#.#%#~ من #.ل#<صل #>لى #.لأقل أ#^#%#> س#.#>#.#? #%ين #=ل #~و#.ء و#.لأخ#^. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.س#?#>م#.ل هذ#. #.ل#~و#.ء لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي #.ل#=#%#~ أو #<#^#- نس#%ة #.ل#=#.لسيوم #<ي #.ل#~م .", "GI": "Treating or preventing calcium deficiency. It may also be used for other conditions as determined by your doctor.SSCalcium carbonate is a dietary supplement. It works by providing extra calcium to the body.SSDo NOT use calcium carbonate if:SSyou are allergic to any ingredient in calcium carbonateSyou have high blood calcium levels", "Composition": "Calcium 500mg", "Route": "ORAL.SOLID" }, { "ID": "148", "Trade_Name": "NIFUNAL 200MG 14 CAPS.", "Generic_Name": "NIFUROXAZIDE", "Price": "10.5", "Price_Old": "7.75", "Company": "AMRIYA", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "149", "Trade_Name": "TROMACURE TOPICAL GEL 40 GM", "Generic_Name": "AESCIN+DIETHYLAMINE SALICYLATE", "Price": "8.5", "Price_Old": "8.5", "Company": "EVA PHARMA", "Pharmacology": "NSAID.ANTIREHUMATIC.SALICYLATES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م ل#>ل#.ج آل#.م #.ل#^قية. \r\n\r\n–#>ل#.ج آل#.م #.ل#>مو#~ #.ل#<ق#^ي. \r\n\r\n–مس#=ن مو#_#>ي للآل#.م. \r\n\r\n–#>ل#.ج #.ل#?و#^م#.#?. \r\n\r\n–م#_#.#~ لل#.ل#?ه#.#%#.#?. \r\n\r\n–#>ل#.ج #.لإ#?و#.ء#.#?. \r\n\r\n–مس#=ن للآل#.م #.لن#.#?جة #>ن #.ل#.ص#-#~#.م. \r\n\r\n–#>ل#.ج #.ل#^#_و#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#?جل#-ية #.لس#-حية. \r\n\r\n–#>ل#.ج #.للم#%#.جو. \r\n\r\n–مس#=ن لآل#.م #>#^ق #.لنس#.. \r\n\r\n–#>ل#.ج #.ل#=#~م#.#? و#.ل#?خ#<ي#< من #.ل#?جم#>#.#? #.ل#~موية. \r\n\r\n–#>ل#.ج آل#.م #.لغ#_#^و#<.", "Contraindications": "–إ#_#-#^#.#%#.#? #%#.لج#.هز #.له#_مي. \r\n\r\n–حس#.سية مثل #-#<ح جل#~ي وح#=ة و#.حم#^#.#^ #%#.لوجه و#_يق #<ي #.ل#?ن#<س و#?و#^م #%#.لأ#-#^#.#<. \r\n\r\n–#<ي ح#.ل#.#? ن#.#~#^ة #?ح#~ث #.ل#?ه#.#%#.#? #%#.لأغشية #.لمخ#.#-ية #%#.لجه#.ز #.له#_مي.", "GI": "Indications :SS- In cases of contusions, crush injuries, sprains .bruises, haematoma and tenosynovitis.S- Painful conditions of the vertebral column (disc lesions, neck pain, lumbago, sciatica).S- In superficial thrombophlebitis ,varicose veins ,for care ofS- the veins after injections or infusions.SSContraindications :SSHypersensitivity to any of the drug components. Reparil-Gel N should not be applied to eyes, broken skin, mucous membranes or skin areas exposed to radiotherapy.", "Composition": "COMING SOON ..", "Route": "TOPICAL" }, { "ID": "150", "Trade_Name": "VISCOFREE 100 MG CAP.", "Generic_Name": "MECYSTIENE", "Price": "4", "Price_Old": "4", "Company": "ARAB CAPS > HOCHSTER PHARMACEUTICAL INDUSTRIES", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يح#?وي #>لى نش#.#- م#%#.ش#^ م#_#.#~ لل#%لغم من خل#.ل مجمو#>ة #.لسل#<هي#~#^يل #.لح#^ة ، و#.ل#?ي #?#>مل م#%#.ش#^ة #>لى #.ل#%#^و#?ين#.#? #.لمخ#.#-ية ل#<#?ح #^و#.#%#- ث#.ني #=#%#^ي#?ي#~ و#%#.ل#?#.لي #?قلل من لزوجة #.لمخ#.#- و#?سهل إز#.ل#?ه#. #>ن #-#^يق #>مل #.لمخ#.#- #.له#~#%ي ونخ#.م#?ه.\r\n\r\n–#.لميسيس#?ين يحسن ق#~#^ة #.ل#%ل#>مة لل#%ل#.#>م.\r\n\r\n–يحمي #.ل#^ئة من #.ل#.ذي #.لمخ#?ل#<.", "Contraindications": "–#<#^#- #.لحس#.سية من أي من #.لم#=ون#.#?.", "GI": "Mecystiene HCL has a mucolytic activity through its free sulfhydryl group, which acts directly on the mucoproteins to open the disulfide bonds and thus lowers the viscosity of the mucous and facilitates its removal by the muco-ciliary action and expectoration.\r\n\r\n Mecystiene improves the phagocytic capacity of alveolar macrophages. It protects lung from a variety of insults.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "151", "Trade_Name": "TIGER GEL STRAWBERRY 60 ML", "Generic_Name": "PURIFIED WATER+TRIETHANOLAMINE+HYDROXYMETHYL CELLULOSE+GLYCERIN+PROPYLENE GLYCOL+METHYL PARABEN", "Price": "35", "Price_Old": "25", "Company": "LEADER COSMETICS > MARVEL", "Pharmacology": "LUBRICANT", "Category": "مزلق", "Use": "–مزلق أثن#.ء #.لجم#.#>.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.", "GI": "Lubricant during sexual intercourse", "Composition": "aleo vera0.5%, carbamide 2%, ethanol 5%, menthol 0.3%", "Route": "TOPICAL" }, { "ID": "152", "Trade_Name": "APIFORTYL 30 CAPSULE", "Generic_Name": "MINERALS+VITAMINS", "Price": "47.25", "Price_Old": "31.5", "Company": "OCTOBER PHARMA", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #>ل#.ج جمي#> #.لح#.ل#.#? #.ل#?ي #?#>#.ني من نقص #<ي #.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج #.لح#.ل#.#? #.ل#?ي #?#>#.ني من #.لإ#^ه#.ق #.ل#>#.م، \r\n\r\n–و#=ذل#= جمي#> #.لح#.ل#.#? #.ل#?ي #?#>#.ني من #.لإ#^ه#.ق ن#?يجة #%ذل مجهو#~ ش#.ق. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ل#.ج #<ي أثن#.ء #<#?#^ة #.لنق#.هة و#=ذل#= خل#.ل م#^حلة #.ل#%لوغ، \r\n\r\n–حيث أن هذه #.لم#^حلة من أهم #.لم#^#.حل #.ل#?ي يح#?#.ج #<يه#. #.لجسم \r\n\r\n–إلى #=مية #=#%ي#^ة من #.لأمل#.ح و#.لم#>#.#~ن و#.ل#<ي#?#.مين#.#? #.له#.مة ج#~#.ً. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج #.لح#.ل#.#? #.ل#?ي #?#>#.ني من سوء ش#~ي#~ #<ي #.ل#?غذية. \r\n\r\n–#=ذل#= #?س#?خ#~م هذه #.لأق#^#.ص #<ي #>ل#.ج جمي#> #.لأم#^#.#_ #.لن#.#?جة #>ن #.لشيخوخة، وي#>مل #=مقو #>#.م للجسم.", "Contraindications": "–ي#>#~ هذ#. #.ل#~و#.ء من #.ل#>ق#.قي#^ #.لآمنة ج#~#.ً و#.ل#?ي لم يث#%#? ح#?ى #.لآن وجو#~ أي من #.لمو#.ن#> #.ل#-#%ية ج#^#.ء #.س#?خ#~#.مه#. سوى #.لح#.ل#.#? #.ل#?ي #?#>#.ني من #?سمم #<ي #.لغ#~ة #.ل#~#^قية أو وجو#~ أي #.#_#-#^#.#%#.#? #<ي #>مله#. لذل#= يج#% أن يقوم #.لم#^ي#_ #%#>مل #<حوص#.#? جي#~ة للغ#~ة #.ل#~#^قية ق#%ل أن ي#?م #?ن#.ول هذ#. #.ل#~و#.ء.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "153", "Trade_Name": "ADAMAT 250MG 30CAPS.", "Generic_Name": "METHYLDOPA", "Price": "6.59", "Price_Old": "6.59", "Company": "EL NASR", "Pharmacology": "ANTIHYPERTENSIVES.CENTERAL ALPHA 2 AGONIST", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ي#=ون #>ل#.ج س#^ي#> #<ي ح#.لة #.لإص#.#%ة #%#.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–يُس#.#>#~ #>لى أس#?#^خ#.ء #.لأو#>ية #.ل#~موية. \r\n\r\n–يُس#.#>#~ #<ي أ#^#?خ#.ء #.لأو#>ية #%#.ل#~م#.غ.", "Contraindications": "–يج#% #.ل#.م#?ن#.#> #>ن #?ن#.ول هذ#. #.ل#~و#.ء ل#=#%#.#^ #.لسن حيث أنهم أ#=ث#^ #>ُ#^#_ة للآث#.#^ #.لج#.ن#%ية. \r\n\r\n–ي#=ون خ#-#^ #>لى م#^#_ى خ#<#_ وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #?ن#.وله لم#^#_ى #.ل#=#%#~. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.ل#.#=#?ئ#.#% و#.لأم#^#.#_ #.لن#<سية.", "GI": "About Methyldopa\r\nCentrally acting Alpha-2 agonist ,a phenylalanine derivative, Antihypertensive (pregnancy-induced hypertension).\r\nMechanism of Action of Methyldopa\r\nMethyl dopa gets metabolized in the adrenergic neurons to alpha methyl nor adrenaline which acts centrally by stimulating alpha 2 adrenergic receptors in the vasomotor centre to decrease efferent sympathetic activity and total peripheral resistance. It also inhibits renin release from the kidneys and has some direct action on blood vessels. Since methyl dopa serves as an alternate substrate to L-aromatic amino acid decarboxylase it ultimately decrease the concentration of Dopamine, Nor-adrenaline, Epinephrine and Serotonin in the CNS and periphery.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "154", "Trade_Name": "ITRAPEX 100MG 15 CAPS.", "Generic_Name": "ITRACONAZOLE", "Price": "66", "Price_Old": "66", "Company": "MULTI-APEX", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#=#%سول#.#? م#_#.#~ة لل#<#-#^ي#.#? . \r\n\r\n–#>ل#.ج #.ل#%ق#> #.لملونة قش#.#^ي #>لى من#-قة #.لص#~#^ و#.لظه#^ . \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.ل#>#~ل#.#? أو م#^#_ #.لإي#~ز . \r\n\r\n–#>ل#.ج #.ل#<#-#^ي#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي للإن#.ث . \r\n\r\n–#<#-#^ي#.#? م#. #%ين #.ص#.#%#> #.لق#~م و#.لأظ#.#<#^ . \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #.ل#<#-#^ي#.#? . \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<#-#^ية #.ل#?ي #?صي#% #.ل#>ين و#.ل#%#^وس#?#.#?#. . \r\n\r\n–#>ل#.ج #>#~وى #.ل#<#-#^ي#.#? #.لن#.#?جة #>ن #.لس#^#-#.ن أو #.لن#.#?جة #>ن #.ل#>ل#.ج #.ل#=يمي#.ئي أو #.لإش#>#.#>ي .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ل#~يهم حس#.سية من مش#?ق#.#? #.لأزول . \r\n\r\n–ل#. ينصح #%وص#<ه لمن ي#>#.نون من #_#>#< #.ل#%#-ين أو #<شل #.لقل#% أو لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%#<شل #.لقل#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه ل#>ل#.ج #<#-#^ي#.#? #.لأظ#.#<#^ أثن#.ء #<#?#^ة #.لحمل .", "GI": "About Itraconazole\r\nA synthetic triazole derivative, Systemic Antifungal.\r\n\r\nMechanism of Action of Itraconazole\r\nItraconazole is a fungicidal or fungistatic depending on the drug concentrations. It inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis in fungi.\r\n\r\nIndications for Itraconazole\r\n1.Histoplasmosis \r\n2.Blastomycosis \r\n3.Aspergillosis \r\n4.Oropharyngeal candidiasis \r\n5.Oesopharyngeal candidiasis \r\n6.Vaginal candidiasis \r\n7.Sporotrichosis \r\n8.Coccidioidomycosis \r\n9.Paracoccidioidomycosis \r\n10.Tinea pedis \r\n11.Tinea corporis \r\n12.Tinea versicolor \r\n13.Tinea cruris \r\n14.Chromomycosis", "Composition": "Each capsule contains: 100 mg Itraconazole", "Route": "ORAL.SOLID" }, { "ID": "155", "Trade_Name": "SUPRAVIT 28 CAPS.", "Generic_Name": "MINERALS+VITAMINS", "Price": "18", "Price_Old": "18", "Company": "GLAXO SMITHKLINE", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–يم#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و #.لم#>#.#~ن و #.ل#>ن#.ص#^ #.له#.مة . \r\n\r\n–مقوى #>#.م للجسم . \r\n\r\n–يس#.#>#~ #>لى #?حسين و ظ#.ئ#< #.لجسم . \r\n\r\n–م#_#.#~ للأ#=س#~ه و يس#.#>#~ #>لى حم#.ية خل#.ي#. #.لجسم من #.ل#?ل#< . \r\n\r\n–يح#.#<ظ #>لى قوة #.لش#>ي#^#.#? #.ل#~موية . \r\n\r\n–#>ل#.ج ح#.ل#.#? سوء #.ل#?غ#~ية . \r\n\r\n–#.لح#<#.ظ #>لى سل#.مة #.لجل#~ و #.لأظ#.#<#^ و #.لش#>#^ . \r\n\r\n–م#=مل غذ#.ئى أثن#.ء #.ل#^يجيم . \r\n\r\n–#>ل#.ج #.ل#_#>#< #.ل#>#.م و #.لإ#^ه#.ق و #_#>#< #.ل#?#^#=يز . \r\n\r\n–يم#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و #.لم#>#.#~ن و #.ل#>ن#.ص#^ #.له#.مة #.ل#?ى #?س#.#>#~ه #<ى #.لنمو #.لصحى و #?قوية #.ل#>ظ#.م و ظهو#^ #.لأسن#.ن و #?قوية جه#.زه #.لمن#.#>ى . \r\n\r\n–يس#.#>#~ #>لى #<#?ح #.لشهية للذين ي#^#<#_ون #?ن#.ول #.ل#-#>#.م حيث يس#.#>#~ #>لى #?حسين #>ملية #.له#_م . \r\n\r\n–يس#.#>#~ #<ى إم#?ص#.ص #=#.#<ة #.ل#>ن#.ص#^ #.لغذ#.ئية من #.ل#-#>#.م و #.لإس#?#<#.#~ه منه#. . \r\n\r\n–يس#.#>#~ #>لى زي#.#~ة #.ل#?#^#=يز .", "Contraindications": "–ل#. يج#% #?ن#.ول #<ي#?#.مين “أ” #<ي #<#?#^ة #?ن#.ول هذه #.ل#=#%سول#.#? ح#?ى ل#. #?زي#~ #.لج#^#>ة وي#?س#%#% #<ي وجو#~ #.#>#^#.#_ ج#.ن#%ية. \r\n\r\n–ل#. #?#>#-ى للم#^#_ى #.لذينِ ي#>#.نون من حس#.سية ح#%و#% #.لقمح ل#>#~م ظهو#^ إي أ#>#^#.#_ ج#.ن#%ية. \r\n\r\n–يمن#> م#> #.لم#^#_ىِ #.لذين ي#>#.نون من حس#.سية #?ج#.ه أي نو#> من م#=ون#.#? #.لمس#?ح#_#^. \r\n\r\n–#<ي ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة يج#% أخذ هذهِ #.ل#=#%سول#.#? #?ح#? إش#^#.#< #.ل#-#%ي#% #.لم#>#.لج.", "GI": "COMING SOON ..", "Composition": "bee pollen 50mg, calcium 50mg, copper, folic acid 25 mcg, iron 10mg, lysine 20mg, manganese, pantothenate ca. 3mg, para aminobenzoic acid 50mg, potassium 2mg, rutin 10mg, vit a 2000i.u., vit b1 15mg, vit b12 5mcg, vit b2 3mg, vit b3 15mg, vit b6 2mg, vit", "Route": "ORAL.SOLID" }, { "ID": "156", "Trade_Name": "IXEL 50MG 28CAPS.", "Generic_Name": "MILNACIPRAN HYDROCHLORIDE", "Price": "80", "Price_Old": "80", "Company": "PIERRE - FABRE FRANCE > RAMCO", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يُس#?خ#~م #.ل#~و#.ء ل#>ل#.ج #.لألم #.لن#.#?ج #>ن #.ل#.ل#?ه#.#% #.ل#>#_لي #.للي#<ي. \r\n\r\n–#?س#=ين آل#.م #.ل#>#_ل#.#? و#.لأ#^#%#-ة و#.لأو#?#.#^ و#.لأنسجة #.لمحي#-ة #%ه#.. \r\n\r\n–يس#.#>#~ #%ش#=ل ث#.نوي #>لى #.ل#?خلص من #.لش#>و#^ #.ل#~#.ئم #%#.لحزن و#.ل#.#=#?ئ#.#%.", "Contraindications": "–إلى ج#.ن#% #.لم#.#~ة #.ل#<#>#.لة هن#.#= #%#>#_ #.لمو#.#~ #.ل#=يمي#.ئية #.لأخ#^ى #.ل#?ي #?#~خل #<ي #?#^#=ي#% أق#^#.ص #.#<ي#^و ميل#.ن Averomilan، و#%#.ل#?#.لي ق#~ يظه#^ #>لى جسم #.لم#^ي#_ #<#^#- حس#.سية #?ج#.ه و#.ح#~ أو أ#=ث#^ من هذه #.لم#=ون#.#?، وهن#. يج#% #>#~م #.س#?خ#~#.م #.ل#~و#.ء و#.ل#^جو#> إلى #.ل#-#%ي#% #<و#^#.ً للحصول #>لى #.لإج#^#.ء #.ل#-#%ي #.لمن#.س#%. \r\n\r\n–ل#. يس#?خ#~م #.ل#~و#.ء #%#.ل#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#.#=#?ئ#.#% #<ئة أ#=سي#~#.ز أح#.#~ي #.لأمين MAO لأنه#. #?ؤ#~ي إلى #?أثي#^#.#? صحية خ#-ي#^ة وممي#?ة. \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> #.لأشخ#.ص #.لذين ي#>#.نون من أم#^#.#_ #.لقل#% لأنه ي#^#<#> م#>#~ل ن#%#_#.#? #.لقل#%، ويس#?خ#~م #%ح#^ص أي#_#.ً #<ي ح#.لة #.لإص#.#%ة #%#.#^#?#<#.#> #_غ#- #.ل#~م لأن #.لم#.#~ة #.ل#<#>#.لة #<ي #.ل#~و#.ء #?#^#<#> مس#?وى #_غ#- #.ل#~م. \r\n\r\n–ل#. يُس#?خ#~م #<ي ح#.لة م#^#_ى #.ل#=#%#~ لأن أي#_ #.ل#~و#.ء ي#?م #<ي #.ل#=#%#~ و#%#.ل#?#.لي ق#~ يؤ#~ي ذل#= إلى #?#^#.#=م #.لسموم ونو#.#?ج #.لأي#_ #<ي #.لجسم، ول#. يُس#?خ#~م أي#_#.ً #<ي ح#.لة م#^#_ى قصو#^ وظ#.ئ#< #.ل#=لى لأن نو#.#?ج #.لأي#_ ي#?م #?نقية #.ل#~م منه#. #%و#.س#-ة #.ل#=لى. \r\n\r\n–ل#. يُس#?خ#~م #<ي ح#.لة #.لإص#.#%ة #%#.لمي#.ه #.لز#^ق#.ء (#.لجلو#=وم#.) أو إذ#. #=#.ن هذ#. #.لم#^#_ من#?ش#^#.ً #<ي #.ل#>#.ئلة لأن #.ل#~و#.ء يؤث#^ #%ش#=ل سل#%ي #>لى صحة #.ل#>ين وق#~ يؤ#~ي إلى #?#~هو#^ ح#.لة #.ل#>ين #.لصحية. \r\n\r\n–ل#. يُس#?خ#~م #<ي ح#.لة م#~مني #.لمو#.#~ #.ل#=حولية. \r\n\r\n–ل#. يُس#?خ#~م #<ي ح#.لة م#^#_ى #?#_خم #.ل#%#^وس#?#.#?#..", "GI": "Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI). Exactly how milnacipran works to treat fibromyalgia is not known. It may work by restoring the balance of certain natural substances in the brain (serotonin and norepinephrine).", "Composition": "milnacipran 50mg", "Route": "ORAL.SOLID" }, { "ID": "157", "Trade_Name": "CELLCEPT 250 MG 100 CAPS.", "Generic_Name": "MYCOPHENOLATE MOFETIL", "Price": "700", "Price_Old": "700", "Company": "F.HOFFMAN LA ROCHE", "Pharmacology": "IMMUNOSUPPRESSANTS", "Category": "مث#%#-#.#? #.لمن#.#>ة", "Use": "–يس#?خ#~م هذ#. #.ل#~و#.ء لمن#> #.لجسم من #^#<#_ #.لأ#>#_#.ء #%#>#~ ز#^#.#>#?ه#. مثل ز#^#.#>ة #.ل#=لى \r\n\r\n–يس#?خ#~م #.ل#~و#.ء #<ى خ#<#_ نش#.#- #%#>#_ #.لخل#.ي#. #.ل#?ى ش#=ل جزء من جه#.ز #.لمن#.#>ه \r\n\r\n–ي#>#.لج إل#?ه#.#%#.#? #.ل#=لى #.لذئ#%ية \r\n\r\n–ي#<ي#~ #.ل#>ق#.#^ #<ى #>ل#.ج #.#>#^#.#_ #.لأم#^#.#_ #.لجل#~ة وإل#?ه#.#%#.#? #.لأغشية #.لمصلية \r\n\r\n–ي#>#.لج نقص #.لص#<#.ئح #.ل#~موية مجهولة #.لس#%#% \r\n\r\n–ي#>#.لج #?ي#%س #.لجل#~ #.لمن#.#>ى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج إل#?ه#.#% #.ل#>#_ل#.#? #.لمن#.#>ى", "Contraindications": "–يمن#> #.س#?#>م#.ل هذ#. #.ل#~و#.ء #<ى ح#.ل#.#? #.لإص#.#%ة #%#.لحس#.سية #.لم#<#^#-ة لأح#~ م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يس#?خ#~م #.ل#~و#.ء #%حذ#^ م#> #=#%#.#^ #.لسن #.لأ#=ث#^ حس#.سية للأ#>#^#.#_ #.لج#.ن#%ية \r\n\r\n–ل#. يس#?خ#~م #.ل#~و#.ء من ق#%ل #.لأشخ#.ص #.لمص#.#%ين #%ص#>و#%ة #<ى #.ل#?ن#<س أو #.لمص#.#%ين #%نزي#< #<ى #.لم#>#~ة و#.لأم#>#.ء \r\n\r\n–يحذ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء من ق#%ل #.لأ#-#<#.ل \r\n\r\n–ل#. يس#?خ#~م #.ل#~و#.ء أثن#.ء #.لحمل و#.ل#^#_#.#>ه #.ل#-#%ي#>ية \r\n\r\n–هذ#. #.ل#~و#.ء ممنو#> #<ى ح#.ل#.#? #.لإص#.#%ة #%خلل #<ى وظ#.ئ#< #.ل#=#%#~ أو #.ل#=لى", "GI": "Indication\t\r\nFor the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. Mycophenolate mofetil should be used concomitantly with cyclosporine and corticosteroids.\r\n\r\nMechanism of action\t\r\nMycophenolate mofetil is hydrolyzed to form mycophenolic acid (MPA), which is the active metabolite. MPA is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, MPA has potent cytostatic effects on lymphocytes. MPA inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of MPA on lymphocytes.", "Composition": "mycophenolate sod. 250mg, 500mg", "Route": "ORAL.SOLID" }, { "ID": "158", "Trade_Name": "VITOP 30 CAPS.", "Generic_Name": "METHYLTESTOSTERONE+MINERALS+PHOSPHOLIPIDS+SAFFLOWER OIL+VITAMINS", "Price": "13.5", "Price_Old": "13.5", "Company": "MISR", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–حل مش#.#=ل #.لنمو #.لن#.#?جة #>ن نقص #.ل#<ي#?#.مين#.#?، وخ#.صة #<ي#?#.مين #%. \r\n\r\n–#?ل#%ية #.ح#?ي#.ج#.#? #.لجسم من #.ل#<ي#?#.مين#.#? #.لز#.ئ#~ة #>ن #.لم#>#~ل #.ل#-#%ي#>ي، ح#.ل #.ح#?#.ج #.لجسم إلى ذل#=. \r\n\r\n–#~#>م #.لمن#.#>ة لمق#.ومة #.ل#>#~وى. \r\n\r\n–#.لنو#%#.#? #.ل#?شنجية #.لن#.#?جة #>ن نقص #<ي#?#.مين #%. \r\n\r\n–ي#>مل #=م#_#.#~#.#? #.ل#.ل#?ه#.#% #.ل#-#%ي#>ية. \r\n\r\n–يقلل نس#%ة #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–يمن#> ح#~وث جل#-#.#? #~موية. \r\n\r\n–#.لح#<#.ظ #>لي صحة #.ل#%ش#^ة، و#>#~م ظهو#^ #.ل#?ج#.#>ي#~.", "Contraindications": "–#<#^#- #.لحس#.سية من #.ي من #.لم#=ون#.#?.", "GI": "COMING SOON ..", "Composition": "choline, copper, dicalcium phosphate, iron, magnesium, vit a, vit b1, vit b2, vit b6, vit b7, vit c, vit d, vit e, zinc", "Route": "ORAL.SOLID" }, { "ID": "159", "Trade_Name": "CEREBROMAP 200MG 30 CAPS.", "Generic_Name": "NAFTIDROFURYL", "Price": "51", "Price_Old": "51", "Company": "MULTI-APEX", "Pharmacology": "ANTI-ISCHEMIC", "Category": "نقص #?#^وية #.لقل#%", "Use": "–إذ#. #=ن#? #?#>#.ني من #.#_#-#^#.#% #<ي #.لأو#>ية #.ل#~موية #.ل#~م#.غية أو #.#_#-#^#.#% #<ي #.لأو#>ية #.ل#~موية #.ل#-#^#<ية يج#% أن #?قوم #%#.س#?خ#~#.م #.ل#>ق#.#^. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من #.ل#?شنج و#.لآل#.م #.ل#~م#.غ #>لي#= أن #?قوم #%#.س#?خ#~#.م هذ#. #.ل#>ق#.#^. \r\n\r\n–#.لش#>و#^ #%#.لألم ح#.ل#.#? #.ل#?شنج #.لأخ#^ى يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ للش#<#.ء #.ل#?#.م منه. \r\n\r\n–إذ#. #=ن#? #?#^ي#~ أن #?#>#.لج مس#?وى #.لأي#_ #.لخلوي #<ي #.لجسم #>لي#= أن #?س#?شي#^ #.ل#-#%ي#% #<ي هذ#. #.ل#>ق#.#^ #.لذي ي#?ن#.س#% م#> ح#.ل#?#=.", "Contraindications": "–يمن#> #.س#?#>م#.ل #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–ينصح #%#_#^و#^ة ش#^#% #=مي#.#? #=#%ي#^ة من #.لم#.ء #?ز#.من#.ً م#> #.س#?#>م#.ل #.ل#~و#.ء لمن#> #?#=ون حصو#.#? . \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #.لمش#^و#%#.#? #.ل#=حولية خل#.ل #<#?#^ة #.س#?#>م#.ل #.ل#~و#.ء . \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #.ل#~و#.ء لم#^#_ي #<#^#- #.لحس#.سية #?ج#.ة م#=ون#.#?ه .", "GI": "Naftidrofuryl oxalate works in two main ways. Firstly, it causes the blood vessels to widen. Secondly, it increases the ability of cells to remove waste products.\r\nIn peripheral vascular diseases, the blood vessels in the extremities are narrowed and the blood and oxygen supply to cells in the hands, feet or legs is reduced. Oxygen is required by cells in order for them to remove waste products, therefore in these conditions waste products can build up. This can cause damage to cells and lead to symptoms such as pain, cramps or ulceration.\r\nNaftidrofuryl improves these symptoms by increasing blood and oxygen supply to the affected areas and also increasing the ability of the cells to remove waste products.", "Composition": "Each Cerebromap 100 mg capsule contains: 100 mg Naftidrofuryl oxalate.\r\nEach Cerebromap 200 mg capsule contains: 200 mg Naftidrofuryl oxalate.", "Route": "ORAL.SOLID" }, { "ID": "160", "Trade_Name": "LANZOFUTAL 15 MG 10 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "22.2", "Price_Old": "22.2", "Company": "GLOBAL NAPI PHARMACEUTICALS > FUTURE PHARMACEUTICAL INDUSTRIES (FPI)", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "Lansoprazole 15mg", "Route": "ORAL.SOLID" }, { "ID": "161", "Trade_Name": "ABIONEM CREAM 60 GM", "Generic_Name": "HYALURONIC ACID+COLLAGEN+NIGELLA SATIVA+MENTHOL", "Price": "20.95", "Price_Old": "20.95", "Company": "EL-HELOU PERFUMES & COSMETICS > ALLIANCE PHARMA", "Pharmacology": "MASSAGE", "Category": "مس#.ج و #?#~لي#=", "Use": "–#=#^يم #?#~لي#= #~#.#>م للم#<#.صل #.ل#?ن#=سية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.", "GI": "Supportive massage cream for degenerative joints", "Composition": "COMING SOON ..", "Route": "TOPICAL" }, { "ID": "162", "Trade_Name": "LANTANON 30MG 10 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "45", "Price_Old": "30", "Company": "UNIPHARMA CO.", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "Each capsule contains:\r\nLansoprazole 30 mg.", "Route": "ORAL.SOLID" }, { "ID": "163", "Trade_Name": "LANZOR 15MG CAP.", "Generic_Name": "LANSOPRAZOLE", "Price": "35", "Price_Old": "35", "Company": "AVENTIS PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "lansoprazole 15mg or 30mg", "Route": "ORAL.SOLID" }, { "ID": "164", "Trade_Name": "LORAL 30MG 10 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "30", "Price_Old": "30", "Company": "PHARCO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "lansoprazole 30mg", "Route": "ORAL.SOLID" }, { "ID": "165", "Trade_Name": "LANZOR 30 MG 10 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "65", "Price_Old": "65", "Company": "SANOFI", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "lansoprazole 15mg or 30mg", "Route": "ORAL.SOLID" }, { "ID": "166", "Trade_Name": "GASTROCURE 30MG 10 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "33.6", "Price_Old": "33.6", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "Each capsule Gastrocure contains:\r\nLansoprazole enteric coated pellet 352.943 mg (equivalent to Lansoprazole 30 mg).", "Route": "ORAL.SOLID" }, { "ID": "167", "Trade_Name": "LOPRAL 30MG 5 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "27.5", "Price_Old": "18.3", "Company": "T3A PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "lansoprazole 30mg", "Route": "ORAL.SOLID" }, { "ID": "168", "Trade_Name": "ZOLLIPAK 15MG 10 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "22.2", "Price_Old": "22.2", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "lansoprazole 15mg or 30mg", "Route": "ORAL.SOLID" }, { "ID": "169", "Trade_Name": "PEPTAZOL 30MG 14CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "67.5", "Price_Old": "45", "Company": "SPIMACO > EIMC", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "lansoprazole 30mg", "Route": "ORAL.SOLID" }, { "ID": "170", "Trade_Name": "FURYXEL 200MG 10 CAPSULES", "Generic_Name": "NAFTIDROFURYL", "Price": "13", "Price_Old": "13", "Company": "HIKMA PHARMA", "Pharmacology": "ANTI-ISCHEMIC", "Category": "نقص #?#^وية #.لقل#%", "Use": "–إذ#. #=ن#? #?#>#.ني من #.#_#-#^#.#% #<ي #.لأو#>ية #.ل#~موية #.ل#~م#.غية أو #.#_#-#^#.#% #<ي #.لأو#>ية #.ل#~موية #.ل#-#^#<ية يج#% أن #?قوم #%#.س#?خ#~#.م #.ل#>ق#.#^. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من #.ل#?شنج و#.لآل#.م #.ل#~م#.غ #>لي#= أن #?قوم #%#.س#?خ#~#.م هذ#. #.ل#>ق#.#^. \r\n\r\n–#.لش#>و#^ #%#.لألم ح#.ل#.#? #.ل#?شنج #.لأخ#^ى يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ للش#<#.ء #.ل#?#.م منه. \r\n\r\n–إذ#. #=ن#? #?#^ي#~ أن #?#>#.لج مس#?وى #.لأي#_ #.لخلوي #<ي #.لجسم #>لي#= أن #?س#?شي#^ #.ل#-#%ي#% #<ي هذ#. #.ل#>ق#.#^ #.لذي ي#?ن#.س#% م#> ح#.ل#?#=.", "Contraindications": "–يمن#> #.س#?#>م#.ل #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–ينصح #%#_#^و#^ة ش#^#% #=مي#.#? #=#%ي#^ة من #.لم#.ء #?ز#.من#.ً م#> #.س#?#>م#.ل #.ل#~و#.ء لمن#> #?#=ون حصو#.#? . \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #.لمش#^و#%#.#? #.ل#=حولية خل#.ل #<#?#^ة #.س#?#>م#.ل #.ل#~و#.ء . \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #.ل#~و#.ء لم#^#_ي #<#^#- #.لحس#.سية #?ج#.ة م#=ون#.#?ه .", "GI": "Naftidrofuryl oxalate works in two main ways. Firstly, it causes the blood vessels to widen. Secondly, it increases the ability of cells to remove waste products.\r\nIn peripheral vascular diseases, the blood vessels in the extremities are narrowed and the blood and oxygen supply to cells in the hands, feet or legs is reduced. Oxygen is required by cells in order for them to remove waste products, therefore in these conditions waste products can build up. This can cause damage to cells and lead to symptoms such as pain, cramps or ulceration.\r\nNaftidrofuryl improves these symptoms by increasing blood and oxygen supply to the affected areas and also increasing the ability of the cells to remove waste products.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "171", "Trade_Name": "NIFEDIPINE 60 MG SR 10 CAPS.", "Generic_Name": "NIFEDIPINE", "Price": "10", "Price_Old": "10", "Company": "SIGMA", "Pharmacology": "ANTIHYPERTENSIVE.SELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #.لذ#%حة #.لص#~#^ية و#.لوق#.ية من #.ل#.ص#.#%ة #%ه#. . \r\n\r\n–#>ل#.ج #<#>#.ل #<ي ح#.ل#.#? هجم#.#? #.لذ#%حة #.لص#~#^ية . \r\n\r\n–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م .", "Contraindications": "–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لذين #.صي#%و#. من ق#%ل #%نو#%#.#? قل#%ية خل#.ل شه#^ ق#%ل #?ن#.ول #.ل#~و#.ء . \r\n\r\n–يج#% #>#~م #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? #.ل#.ص#.#%ة #%ذ#%حة ص#~#^ية غي#^ ث#.#%#?ة ول#=نه م#<ي#~ للذ#%ح#.#? #.لص#~#^ية #.ل#.خ#^ي . \r\n\r\n–ل#. ي#?م #.س#?#>م#.ل هذ#. #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.ون من #%و#^#<ي#^ي#..", "GI": "About Nifedipine\r\nA dihydropyridine calcium channel blocker, Antianginal, antihypertensive,tocolytic.\r\nMechanism of Action of Nifedipine\r\nNifedipine is a dihydropyridine Ca channel blocker. It exerts it`s antianginal, antihypertensive actions through blocking the influx of Ca2+ ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins, decrease after load and increase cardiac index. It do not compromise haemodynamics and cerebral and renal perfusion. It inhibits platelet aggregation and relaxes bronchial, uterine, and ureteric smooth muscles. It is an effective uterine relaxant agent. \r\nMigraine: It is used in migraine by reducing intracellular Ca+2 overload due to brain hypoxia and other causes.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "172", "Trade_Name": "NIFEDIPINE 30 MG SR 10 CAPS.", "Generic_Name": "NIFEDIPINE", "Price": "7", "Price_Old": "7", "Company": "SIGMA", "Pharmacology": "ANTIHYPERTENSIVE.SELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #.لذ#%حة #.لص#~#^ية و#.لوق#.ية من #.ل#.ص#.#%ة #%ه#. . \r\n\r\n–#>ل#.ج #<#>#.ل #<ي ح#.ل#.#? هجم#.#? #.لذ#%حة #.لص#~#^ية . \r\n\r\n–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م .", "Contraindications": "–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لذين #.صي#%و#. من ق#%ل #%نو#%#.#? قل#%ية خل#.ل شه#^ ق#%ل #?ن#.ول #.ل#~و#.ء . \r\n\r\n–يج#% #>#~م #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? #.ل#.ص#.#%ة #%ذ#%حة ص#~#^ية غي#^ ث#.#%#?ة ول#=نه م#<ي#~ للذ#%ح#.#? #.لص#~#^ية #.ل#.خ#^ي . \r\n\r\n–ل#. ي#?م #.س#?#>م#.ل هذ#. #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.ون من #%و#^#<ي#^ي#..", "GI": "About Nifedipine\r\nA dihydropyridine calcium channel blocker, Antianginal, antihypertensive,tocolytic.\r\nMechanism of Action of Nifedipine\r\nNifedipine is a dihydropyridine Ca channel blocker. It exerts it`s antianginal, antihypertensive actions through blocking the influx of Ca2+ ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins, decrease after load and increase cardiac index. It do not compromise haemodynamics and cerebral and renal perfusion. It inhibits platelet aggregation and relaxes bronchial, uterine, and ureteric smooth muscles. It is an effective uterine relaxant agent. \r\nMigraine: It is used in migraine by reducing intracellular Ca+2 overload due to brain hypoxia and other causes.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "173", "Trade_Name": "NAFTIDUR 200 MG 20 CAPS.", "Generic_Name": "NAFTIDROFURYL", "Price": "40", "Price_Old": "40", "Company": "INTERNATIONAL DRUG AGENCY (IDI) > NOVELL PHARMA", "Pharmacology": "ANTI-ISCHEMIC", "Category": "نقص #?#^وية #.لقل#%", "Use": "–إذ#. #=ن#? #?#>#.ني من #.#_#-#^#.#% #<ي #.لأو#>ية #.ل#~موية #.ل#~م#.غية أو #.#_#-#^#.#% #<ي #.لأو#>ية #.ل#~موية #.ل#-#^#<ية يج#% أن #?قوم #%#.س#?خ#~#.م #.ل#>ق#.#^. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من #.ل#?شنج و#.لآل#.م #.ل#~م#.غ #>لي#= أن #?قوم #%#.س#?خ#~#.م هذ#. #.ل#>ق#.#^. \r\n\r\n–#.لش#>و#^ #%#.لألم ح#.ل#.#? #.ل#?شنج #.لأخ#^ى يج#% أن #?س#?خ#~م هذ#. #.ل#>ق#.#^ للش#<#.ء #.ل#?#.م منه. \r\n\r\n–إذ#. #=ن#? #?#^ي#~ أن #?#>#.لج مس#?وى #.لأي#_ #.لخلوي #<ي #.لجسم #>لي#= أن #?س#?شي#^ #.ل#-#%ي#% #<ي هذ#. #.ل#>ق#.#^ #.لذي ي#?ن#.س#% م#> ح#.ل#?#=.", "Contraindications": "–يمن#> #.س#?#>م#.ل #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–ينصح #%#_#^و#^ة ش#^#% #=مي#.#? #=#%ي#^ة من #.لم#.ء #?ز#.من#.ً م#> #.س#?#>م#.ل #.ل#~و#.ء لمن#> #?#=ون حصو#.#? . \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #.لمش#^و#%#.#? #.ل#=حولية خل#.ل #<#?#^ة #.س#?#>م#.ل #.ل#~و#.ء . \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #.ل#~و#.ء لم#^#_ي #<#^#- #.لحس#.سية #?ج#.ة م#=ون#.#?ه .", "GI": "Naftidrofuryl oxalate works in two main ways. Firstly, it causes the blood vessels to widen. Secondly, it increases the ability of cells to remove waste products.\r\nIn peripheral vascular diseases, the blood vessels in the extremities are narrowed and the blood and oxygen supply to cells in the hands, feet or legs is reduced. Oxygen is required by cells in order for them to remove waste products, therefore in these conditions waste products can build up. This can cause damage to cells and lead to symptoms such as pain, cramps or ulceration.\r\nNaftidrofuryl improves these symptoms by increasing blood and oxygen supply to the affected areas and also increasing the ability of the cells to remove waste products.", "Composition": "naftidrofuryl 200mg", "Route": "ORAL.SOLID" }, { "ID": "174", "Trade_Name": "DIA-FURYL 200MG 10 CAPS.", "Generic_Name": "NIFUROXAZIDE", "Price": "4.75", "Price_Old": "4.75", "Company": "BORG", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "175", "Trade_Name": "DIA-FURYL 100MG 20 CAPS.", "Generic_Name": "NIFUROXAZIDE", "Price": "9", "Price_Old": "9", "Company": "BORG", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "176", "Trade_Name": "EPILAT 10MG 30 SOFT GELATIN CAPS.", "Generic_Name": "NIFEDIPINE", "Price": "5.7", "Price_Old": "5.7", "Company": "EIPICO", "Pharmacology": "ANTIHYPERTENSIVE.SELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #.لذ#%حة #.لص#~#^ية و#.لوق#.ية من #.ل#.ص#.#%ة #%ه#. . \r\n\r\n–#>ل#.ج #<#>#.ل #<ي ح#.ل#.#? هجم#.#? #.لذ#%حة #.لص#~#^ية . \r\n\r\n–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م .", "Contraindications": "–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لذين #.صي#%و#. من ق#%ل #%نو#%#.#? قل#%ية خل#.ل شه#^ ق#%ل #?ن#.ول #.ل#~و#.ء . \r\n\r\n–يج#% #>#~م #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? #.ل#.ص#.#%ة #%ذ#%حة ص#~#^ية غي#^ ث#.#%#?ة ول#=نه م#<ي#~ للذ#%ح#.#? #.لص#~#^ية #.ل#.خ#^ي . \r\n\r\n–ل#. ي#?م #.س#?#>م#.ل هذ#. #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.ون من #%و#^#<ي#^ي#..", "GI": "About Nifedipine\r\nA dihydropyridine calcium channel blocker, Antianginal, antihypertensive,tocolytic.\r\nMechanism of Action of Nifedipine\r\nNifedipine is a dihydropyridine Ca channel blocker. It exerts it`s antianginal, antihypertensive actions through blocking the influx of Ca2+ ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins, decrease after load and increase cardiac index. It do not compromise haemodynamics and cerebral and renal perfusion. It inhibits platelet aggregation and relaxes bronchial, uterine, and ureteric smooth muscles. It is an effective uterine relaxant agent. \r\nMigraine: It is used in migraine by reducing intracellular Ca+2 overload due to brain hypoxia and other causes.", "Composition": "nifedipine 10mg", "Route": "ORAL.SOLID" }, { "ID": "177", "Trade_Name": "ANTINAL 200MG 24 CAPS.", "Generic_Name": "NIFUROXAZIDE", "Price": "21", "Price_Old": "14", "Company": "AMOUN", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "Capsules: Each capsule contains nifuroxazide 200 mg. \r\n\r\nSuspension: Each 5 mL suspension contains nifuroxazide 220 mg.", "Route": "ORAL.SOLID" }, { "ID": "178", "Trade_Name": "ESSENTIALE FORTE 300MG 30CAPS.", "Generic_Name": "NICOTINAMIDE+PHOSPHOLIPIDS+VITAMIN B1+VITAMIN B2+VITAMIN B6+VITAMIN B12+VITAMIN E", "Price": "21.6", "Price_Old": "21.6", "Company": "AMRIYA > SANOFI AVENTIS", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#.ل#.ل#?ه#.#% #.ل#=#%#~ي ، #.لذي يحمل #>ل#.مة مخ#?ل#<ة ، ويح#~ث #<ي أش#=#.ل مخ#?ل#<ة. \r\n\r\n–#?لي#< #.ل#=#%#~. \r\n\r\n–أم#^#.#_ مخ#?ل#<ة للجه#.ز ، #?نشأ #_#~ #?#-و#^ أم#^#.#_ #.لأ#>#_#.ء #.لأخ#^ى . \r\n\r\n–#.لأم#^#.#_ #.لن#.#?جة #>ن #.ل#?سمم. \r\n\r\n–#.ل#?سمم #>ن#~ #.لنس#.ء #.للو#.#?ي يحملن #-#<ل#.ً . \r\n\r\n–#>ل#.ج #.لأم#^#.#_ #.لن#.#?جة #>ن #.ل#?#>#^#_ للإش#>#.#> .", "Contraindications": "–#.لحس#.سية #.لم#<#^#-ة من #.لم#=ون#.#? #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–#.لأشخ#.ص #.لمص#.#%ين #%خلل ه#^موني. \r\n\r\n–#.لإص#.#%ة #%س#^#-#.ن #.لم#%ي#_ أو #.ل#^حم أو #.لث#~ي وس#^#-#.ن #%#-#.نة #.ل#^حم. \r\n\r\n–#.لإص#.#%ة #%أو#^#.م لي#<ية #^حمية. \r\n\r\n–م#^#_ي #.لس#=#^ لأنه ي#>مل #>لى #?خ#<ي#_ #.لس#=#^ #%#.ل#~م.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "179", "Trade_Name": "DIAX 200MG 12 CAPS.", "Generic_Name": "NIFUROXAZIDE", "Price": "10.5", "Price_Old": "7", "Company": "HIKMA PHARMA", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–جمي#> ح#.ل#.#? #.لنزلة #.لم#>وية. \r\n\r\n–يس#?خ#~م من أجل #>ل#.ج ح#.ل#.#? #.لإسه#.ل #.لمخ#?ل#<ة. \r\n\r\n–#=م#. أنه ي#>#.لج ح#.ل#.#? #.لقولون #.لمخ#?ل#<ة. \r\n\r\n–يس#?#>مل #=م#-ه#^ م#>وي قوي و#<#>#.ل. \r\n\r\n–يس#?خ#~م أي#_#. من أجل #.لوق#.ية من #.ل#?ه#.#%#.#? #.ل#?ي ق#~ #?ح#~ث #<يم#. #%#>#~ #>ملي#.#? #.ل#%#-ن.", "Contraindications": "–ي#>#~ من #.لأ#~وية #.ل#?ي ل#. #?م#?ص من ق#%ل #.لم#>#~ة ولذل#= #<إنه ي#>#~ من #.لأ#~وية #.لآمنة ج#~#.ً، ول#. يوج#~ له مو#.ن#> #.س#?خ#~#.م #?ذ#=#^ سوى #.لحس#.سية #.لش#~ي#~ة و#.لم#<#^#-ة من م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Indications\r\n\r\nInfectious diarrhea in children and adults, chronic colitis, enterocolitis, as an adjunctive treatment in combined therapy of intestinal dysbiosis.\r\n\r\nContraindication\r\n\r\nHypersensitivity to 5-nitrofurane derivatives and/or other components of the drug.\r\n\r\nDosage and administration\r\n\r\nNifuroxazide should be taken orally, with or without meals.\r\n\r\nAdults and children over 6 years of age - 1 tablet 4 times daily (a daily dose - 800 mg).\r\n\r\nThe treatment course is 5 - 7 days.\r\nSide effects\r\n\r\nNifuroxazide is well tolerated- however, the following effects may be occasionally observed:\r\n\r\ngastrointestinal disorders: short-term abdominal pain, nausea, aggravation of diarrhea.\r\n\r\nHypersensitivity reactions (require discontinuation of the drug):\r\n\r\nrespiratory disorders: asthma-\r\n\r\nskin disorders: rash, pruritus.", "Composition": "Diax Capsule\r\nEach capsule contains:\r\nNifuroxazide 200 mg\r\n\r\nExcipients: PVP K, Talc, Magnesium sterate, Aerosil, Lactose monohydrate, Gelatin, Titanium dioxide, Ponceau, Quinoline.\r\n\r\nDiax Oral suspension:\r\nEach 5 ml contains:\r\nNifuroxazide 220 mg\r\n\r\nExcipients: s", "Route": "ORAL.SOLID" }, { "ID": "180", "Trade_Name": "KUPAN 50MG 20 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "7", "Price_Old": "7", "Company": "HIKMA PHARMA > CHEMIPHARM", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "*- Tablets:\r\nKupan 25 mg tablets, each tablet contains: Ketoprofen 25 mg.\r\n\r\n- Capsules:\r\nKupan 50 mg capsules, each capsule contains:\r\n -Ketoprofen 50 mg. \r\n\r\nKupan 200 mg S.R. capsules, each capsule contains: Ketoprofen 200 mg sustained release.\r\n\r\n- Suppositori", "Route": "ORAL.SOLID" }, { "ID": "181", "Trade_Name": "MAXDINIR 125MG/5ML 60ML SUSP", "Generic_Name": "CEFDINIR", "Price": "36", "Price_Old": "24", "Company": "CHEMIPHARM", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "cefdinir 125mg or 250mg/5ml or 300mg", "Route": "ORAL.LIQUID" }, { "ID": "182", "Trade_Name": "KETOFAN 75MG 30 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "15", "Price_Old": "15", "Company": "AMRIYA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "ketoprofen 100mg or 200mg", "Route": "ORAL.SOLID" }, { "ID": "183", "Trade_Name": "PROFENID 50MG 24 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "12", "Price_Old": "8", "Company": "SANOFI", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "ketoprofen 50mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "184", "Trade_Name": "LACTEOL FORTE 5 BILLION 12CAPS.", "Generic_Name": "LACTOBACILLUS", "Price": "36", "Price_Old": "18", "Company": "RAMEDA > AXCAN PHARMA-FRANCE", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–يس#?خ#~م #.ل#~و#.ء #=م#_#.#~ قوي للإسه#.ل #.لذي يح#~ث #%س#%#% #.لإص#.#%ة #%#>#~وي مي#=#^و#%ية ش#~ي#~ة. \r\n\r\n–ي#>مل #.ل#~و#.ء #>لى حم#.ية خل#.ي#. #.لأم#>#.ء من #.ل#?#>#^#_ لأي مي#=#^و#%#.#? م#^#_ية. \r\n\r\n–ي#?ميز #.ل#~و#.ء #%م#~ى #<#.#>لي#?ه و#?أثي#^ه #.ل#=#%ي#^ #>لى من#> نمو أي #%#=#?ي#^ي#. #_#.#^ة #<ي جسم #.لإنس#.ن. \r\n\r\n–ي#?ميز #.ل#~و#.ء #%ق#~#^#?ه #>لي #?نشي#- من#.#>ة #.لغش#.ء #.لذي ي#%#-ن #.لأم#>#.ء و#%#.ل#?#.لى يزي#~ من #<#.#>لية م#.#~ة #.ميونوجلو#%يولين أ. \r\n\r\n–ي#?خصص #.ل#~و#.ء #<ي زي#.#~ة من#.#>ة #.لأم#>#.ء ول#>ل ذل#= ي#^ج#> من خل#.ل #<#.#>لية #.ل#~و#.ء #<ي #.ل#?أثي#^ #>لى نمو #.ل#=#.ئن#.#? #.ل#-#%ي#>ية #.لمن#.#>ية #.لحم#_ية #.ل#?ي #?وج#~ #<ي #.لأم#>#.ء.", "Contraindications": "–يمن#> #?ن#.ول ووص#< #.ل#~و#.ء للأشخ#.ص #.ل#?ى ل#~يه#. حس#.سية من #.لم#.#~ة #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–ي#<#_ل أن ي#?م #?جن#% #?ن#.ول هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#>لى وجه #.ل#?ح#~ي#~ خل#.ل #.لأشه#^ #.لأولي من #.لحمل وذل#= #>ق#% أن ي#?م إس#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص ح#?ى ل#. ي#_#^ #%صحة #.لجنين.", "GI": "About Lactobacillus\r\nLactic acid bacteria, Probiotic,Antidiarrhoeal.\r\nMechanism of Action of Lactobacillus\r\nLactobacillus is a probiotic and it is called as friendly bacteria. It is used along with antibiotic in order to restore the body`s natural microbial flora with in the digestive tract. Lactobacillus helps in the breakdown of food and leads to the production of lactic acid, hydrogen peroxide and other byproducts. This will alter the intestinal pH and that make the environment hostile for pathogens.\r\nIndications for Lactobacillus\r\n1.Aphthous stomatitis \r\n2.Hypochlorhydria \r\n3.Hepatic encephalopathy \r\n4.Adjuvant to antibiotic therapy \r\n5.Diarrhoea.\r\nTypical Dosage for Lactobacillus\r\nAdult: 60 - 150 million spores 3 times daily depending on the severity of infections. \r\nVaginal bacterial infections: 1- 2 billion bacteria 2 - 3 times daily \r\nSuppositories: \r\nVaginal infections, cystitis: 1 - 2 suppositories are inserted in to vagina at night for 2 weeks. Each suppository contains 1 -", "Composition": "lactobacillus acidophilus 5billons \r\nor sachets or 10billons", "Route": "ORAL.SOLID" }, { "ID": "185", "Trade_Name": "KETOPREK 75 MG 20 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "18", "Price_Old": "12", "Company": "ALEXANDRIA > BORG", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "Each capsule contains:\r\nKetoprofen 75 mg", "Route": "ORAL.SOLID" }, { "ID": "186", "Trade_Name": "GESIKET 75 MG 20 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "18", "Price_Old": "12", "Company": "EL-OBOUR > ATM PHARMACEUTICAL INDUSTRIES", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "ketoprofen 75mg", "Route": "ORAL.SOLID" }, { "ID": "187", "Trade_Name": "FLAMOGUARD XR 150MG 10 EXTENDED RELEASE CAPS.", "Generic_Name": "KETOPROFEN", "Price": "7.5", "Price_Old": "7.5", "Company": "EVA PHARMA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "ketoprofen 150mg", "Route": "ORAL.SOLID" }, { "ID": "188", "Trade_Name": "FLAMIBRU 75MG 20 CAPS.", "Generic_Name": "KETOPROFEN", "Price": "18", "Price_Old": "12", "Company": "SPIMACO MISR", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–أم#^#.#_ #.لم#<#.صل #.ل#?ن#=سية. \r\n\r\n–مش#.#=ل #.ل#>#_ل#.#? و#.لم#<#.صل مثل #.ل#?ه#.#% #.لأو#?#.#^ و#.لإل#?و#.ء. \r\n\r\n–#.لمغص #.ل#=لوي. \r\n\r\n–#.لآل#.م #.لن#.#?جة #>ن #?هيج #.لأ#>ص#.#% مثل #>#^ق #.لنس#.. \r\n\r\n–#?س#=ين #.لآل#.م #.لمخ#?ل#<ة مثل #.لص#~#.#>، وآل#.م #.لأسن#.ن، وآل#.م #.لظه#^، وآل#.م #.ل#-مث.", "Contraindications": "–وجو#~ حس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة، ونزي#< #.لجه#.ز #.له#_مي. \r\n\r\n–أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي، و#~#.ء #=#^ون. \r\n\r\n–أم#^#.#_ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م وأم#^#.#_ #.لقل#%. \r\n\r\n–أم#^#.#_ #?جل#- #.ل#~م. \r\n\r\n–#=ي#?و#%#^و#<ين ل#. يس#?خ#~م للأ#-#<#.ل أقل من 13 سنة.", "GI": "About Ketoprofen\r\nNSAID, propionic acid derivative, Analgesic,antipyretic,antiinflammatory.\r\n\r\nMechanism of Action of Ketoprofen\r\nIt inhibits cyclo oxygenase enzymes both COX1 and COX2.These cyclooxygenase enzyme catalyses the synthesis of prostaglandins from arachidonic acid in the tissue. These inhibition produces its analgesic, antipyretic and anti inflammatory effects. It can also stabilize the lysosomal membrane. It is a Non Steroidal Anti Inflammatory Drug. It is a propionic acid derivative.\r\n\r\nIndications for Ketoprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Pain due to dysmenorrhea \r\n4. Treatment for exacerbations of musculo skeletal, periarticular and soft tissue disorders \r\n5. Migraine \r\n6. Gout-Acute attack", "Composition": "ketoprofen 75mg", "Route": "ORAL.SOLID" }, { "ID": "189", "Trade_Name": "LANSOPRAZOLE 15MG 5 CAPS.", "Generic_Name": "LANSOPRAZOLE", "Price": "14.4", "Price_Old": "14.4", "Company": "GLOBAL NAPI PHARMACEUTICALS > REXCEL", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#% ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ . \r\n\r\n–#.لوق#.ية من ق#^حة #.لم#>#~ة #.لن#.#?جة #>ن #?ن#.ول أ#~وية م#_#.#~ة لل#.ل#?ه#.#% غي#^ #.لس#?ي#^وي#~ية مثل #.لأس#%#^ين و#.ي#%و#%#^و#<ين و#=ي#?و#%#^و#<ين و#%ي#^و#=س#=#.م . \r\n\r\n–#>ل#.ج زي#.#~ة حمو#_ة #.لم#>#~ة . \r\n\r\n–#>ل#.ج #>س#^ #.له#_م . \r\n\r\n–#>ل#.ج #.#^#?#~#.#~ حم#_ #.لم#>#~ة إلى #.لم#^يء . \r\n\r\n–#.ل#?خ#<ي#< من #.لش#>و#^ #%#.لح#^ق#.ن #.لص#.#~#^ من #.لحنج#^ة و#.ل#-#>م #.لل#.ذ#> #<ي #.ل#<م . \r\n\r\n–#>ل#.ج #-ويل #.لأم#~ لم#^#_ م#?ل#.زمة #.ليسون زولينج#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.ل#.#? #.لحس#.سية لل#.نسو#%#^#.زول. \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة #?صل إلى 3 سنو#.#? ق#~ يس#%#% سوء #.م#?ص#.ص #<ي#?#.مين #%12 #<ي #.لجسم و#?قليل #?#^#=يزه ولذل#= ينصح #%#?ن#.ول م#=مل#.#? غذ#.ئية #?ح#?وى #>لى #<ي#?#.مين #%12 . \r\n\r\n–#?ن#.ول #.ل#>ق#.#^ لم#~ة #-ويلة يس#%#% نقص مس#?وى #.لم#.غنيسيوم و#.ل#=#.لسيوم #<ي #.ل#~م ولذل#= ينصح #?#>وي#_ه#. #%#?ن#.ول #.لم#=مل#.#? #.لغذ#.ئية . \r\n\r\n–يج#% #.س#?خ#~#.مه #%حذ#^ لم#^#_ي #.ل#=#%#~ و#.ل#=لى . \r\n\r\n–يم#=ن #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.لحمل وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% و#<ي #.ل#_#^و#^ة #.لقصوى . \r\n\r\n–ينصح #%#>#~م #.س#?خ#~#.مه أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "Description\t\r\nLansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products\r\n\r\nMechanism of action\t\r\nLansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus.", "Composition": "Lansoprazole 15mg", "Route": "ORAL.SOLID" }, { "ID": "190", "Trade_Name": "MACROFURAN 100 MG 30CAPS.", "Generic_Name": "NITROFURANTOIN", "Price": "21", "Price_Old": "18", "Company": "KAHIRA", "Pharmacology": "UTI INFECTIONS", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحو#_ و#.لمث#.نة. \r\n\r\n–#=#>ل#.ج وق#.ئي من #.ل#.ل#?ه#.#%#.#? #<ي #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#.نيمي#. #.ل#<ول. \r\n\r\n–ح#.ل#.#? #.نق#-#.#> #.ل#%ول. \r\n\r\n–#.ل#.#-#<#.ل #.قل من 12 #>#.م. \r\n\r\n–#.#_#-#^#.#% #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Nitrofurantoin\r\nNitrofuran derivative antibiotic, Urinary germicide, Miscellaneous Antibiotic.\r\n\r\nMechanism of Action of Nitrofurantoin\r\nNitrofurantoin is a bacteriostatic drug. It undergoes enzymatic reduction and produces active metabolite which damages the DNA of the bacteria. Bacteria reduce Nitrofurantoin more rapidly than mammalian cells.\r\nIndications for Nitrofurantoin\r\n1. Urinary tract infection\r\nInteractions for Nitrofurantoin\r\nAntichlolinergic drugs: Bioavailability of nitrofurantoin increased due to delayed gastric emptying. \r\nProbenecid: Decreased renal clearance and increased serum levels of nitrofurantoin resulting in toxicity. \r\nMagnesium trisilicate: May delay or decrease the absorption of nitrofurantoin. \r\nFood: Increases bioavailability of nitrofurantoin. \r\nLab tests: Serum glucose decreased. Elevated serum bilirubin and alkaline phosphates. Elevated urinary creatinine levels. False-positive urinary glucose using benedicts reagent.", "Composition": "nitrofurantoin 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "191", "Trade_Name": "NIZATECT 150 MG 20 CAPS.", "Generic_Name": "NIZATIDINE", "Price": "30", "Price_Old": "20", "Company": "MARCYRL CO.", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م #<ى #.م#^#.#_ #.#^#?ج#.#> #.لح#.م#_ #%#.لم#^ئ . \r\n\r\n–يس#?خ#~م #<ى ق#^حة #.لم#>#~ة وق#^حة #.لأثني #>ش#^ (#.لنش#-ة ولمن#>ه#.) . \r\n\r\n–يس#?خ#~م #<ى #.لحمو#_ة #.لم#>وية و#>س#^ #.له#_م #.لحم#_ي .", "Contraindications": "–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن ل#~ي#= حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#.#>له للنيز#.ني#~ين #.و #.ي من م#=ون#.#? #.لمس#?ح#_#^ #.و #^#.ن#?ي#~ين ، #<#.مو#?ي#~ين #.و سيمي#?#~ين . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #<ى ح#.ل#.#? #.ل#^#_#.#>ة ل#.نة ي#<#^ز #<ى ل#%ن #.ل#.م . \r\n\r\n–يس#?خ#~م #.ثن#.ء #.لحمل #.ذ#. #=#.ن#? هن#.#= ح#.جة و#.#_حة #.لي #.س#?خ#~#.مه . \r\n\r\n–ممنو#> #.س#?خ#~#.مه لم#^#_ى #.ل#=#%#~ #.و #.ل#=لى . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن #.لم#^#_ م#~خن .", "GI": "Indication\t\r\nFor the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.\r\nPharmacodynamics\t\r\nNizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.\r\n\r\nMechanism of action\t\r\nNizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.", "Composition": "Each Hard Gelatin Capsule contains:\r\nNizatidine 150mg Or Nizatidine 300mg", "Route": "ORAL.SOLID" }, { "ID": "192", "Trade_Name": "NITROMAK RETARD 5MG 30 CAPS.", "Generic_Name": "NITROGLYCERIN", "Price": "22.5", "Price_Old": "22.5", "Company": "OCTOBER PHARMA", "Pharmacology": "ANTI-ISCHEMIC", "Category": "نقص #?#^وية #.لقل#%", "Use": "–يخلص #.لشخص من مش#=لة #.لذ#%حة #.لص#~#^ية. \r\n\r\n–#.لوق#.ية من #.ل#?#>#^#_ إلى #.لذ#%حة #.لص#~#^ية. \r\n\r\n–خل#.ل #.لجل#-#.#? #.لقل#%ية ي#>#~ #.ل#~و#.ء #<#>#.ل ج#~#. #<ي #.ل#?خلص من #<شل #.لقل#% #.ل#.ح#?ق#.ني.", "Contraindications": "–#.ل#~و#.ء ممنو#> #>لى من ي#>#.ني من #.لمش#.#=ل #.لم#^#_ية #.ل#?#.لية: \r\n\r\n–أن ي#>#.ني #.لم#^ي#_ من #.ل#?حسس ل#.ح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#<ي ح#.لة ح#~وث #.#>#?ل#.ل ل#>#_لة #.لقل#%. \r\n\r\n–أن ي#=ون #.لم#^ي#_ ي#>#.ني من #.لمي#.ه #.لز#^ق#.ء #<ق#~ ي#?#>#.#^#_ #.ل#~و#.ء م#> #.لأ#~وية #.ل#?ي ي#?ن#.وله#. خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.ل#.#? #<ق#^ #.ل#~م أو #.لم#>#.ن#.ة من #.لأنيمي#. وأن ي#?#>#^#_ #.لم#^ي#_ #%ش#=ل ملحوظ ل#.نخ#<#.#_ #<ي #_غ#- #.ل#~م. \r\n\r\n–أن يس#?خ#~م #.لم#^ي#_ #<ي #.لوق#? ذ#.#?ه مح#<ز#.#? أنزيم #.لجو#.نلي#? مم#. يؤ#~ى إلى أنخ#<#.#_ #<ي #_غ#- #.ل#~م.", "GI": "Indication\tFor the prevention of angina\r\nPharmacodynamics\tNitroglycerin, an organic nitrate, is available in many forms as a vasodilator. Nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension, to produce controlled hypotension during surgical procedures, to treat hypertensive emergencies, and to treat congestive heart failure associated with myocardial infarction.\r\nMechanism of action\tSimilar to other nitrites and organic nitrates, nitroglycerin is converted to nitric oxide (NO), an active intermediate compound which activates the enzyme guanylate cyclase. This stimulates the synthesis of cyclic guanosine 3 ,5 -monophosphate (cGMP) which then activates a series of protein kinase-dependent phosphorylations in the smooth muscle cells, eventually resulting in the dephosphorylation of the myosin light chain of the smooth muscle fiber. The subsequent release of calcium ions results in the relaxation of the smooth muscle cells and vasodilation.", "Composition": "1 capsule of NITRO MAK RETARD 2.5 mg with sustained action contains: Nitroglycerin 2.5 mg.\r\n\r\n1 capsule of NITRO MAK RETARD 5 mg with sustained action contains:\r\nNitroglycerin 5 mg.", "Route": "ORAL.SOLID" }, { "ID": "193", "Trade_Name": "MEPAFURAN 100MG 20 CAPS.", "Generic_Name": "NITROFURANTOIN", "Price": "8.75", "Price_Old": "8.75", "Company": "MEPACO", "Pharmacology": "UTI INFECTIONS", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحو#_ و#.لمث#.نة. \r\n\r\n–#=#>ل#.ج وق#.ئي من #.ل#.ل#?ه#.#%#.#? #<ي #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#.نيمي#. #.ل#<ول. \r\n\r\n–ح#.ل#.#? #.نق#-#.#> #.ل#%ول. \r\n\r\n–#.ل#.#-#<#.ل #.قل من 12 #>#.م. \r\n\r\n–#.#_#-#^#.#% #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Nitrofurantoin\r\nNitrofuran derivative antibiotic, Urinary germicide, Miscellaneous Antibiotic.\r\n\r\nMechanism of Action of Nitrofurantoin\r\nNitrofurantoin is a bacteriostatic drug. It undergoes enzymatic reduction and produces active metabolite which damages the DNA of the bacteria. Bacteria reduce Nitrofurantoin more rapidly than mammalian cells.\r\nIndications for Nitrofurantoin\r\n1. Urinary tract infection\r\nInteractions for Nitrofurantoin\r\nAntichlolinergic drugs: Bioavailability of nitrofurantoin increased due to delayed gastric emptying. \r\nProbenecid: Decreased renal clearance and increased serum levels of nitrofurantoin resulting in toxicity. \r\nMagnesium trisilicate: May delay or decrease the absorption of nitrofurantoin. \r\nFood: Increases bioavailability of nitrofurantoin. \r\nLab tests: Serum glucose decreased. Elevated serum bilirubin and alkaline phosphates. Elevated urinary creatinine levels. False-positive urinary glucose using benedicts reagent.", "Composition": "nitrofurantoin 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "194", "Trade_Name": "NIZATECT 300MG 20 CAPS.", "Generic_Name": "NIZATIDINE", "Price": "43.25", "Price_Old": "28.8", "Company": "MARCYRL CO.", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م #<ى #.م#^#.#_ #.#^#?ج#.#> #.لح#.م#_ #%#.لم#^ئ . \r\n\r\n–يس#?خ#~م #<ى ق#^حة #.لم#>#~ة وق#^حة #.لأثني #>ش#^ (#.لنش#-ة ولمن#>ه#.) . \r\n\r\n–يس#?خ#~م #<ى #.لحمو#_ة #.لم#>وية و#>س#^ #.له#_م #.لحم#_ي .", "Contraindications": "–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن ل#~ي#= حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#.#>له للنيز#.ني#~ين #.و #.ي من م#=ون#.#? #.لمس#?ح#_#^ #.و #^#.ن#?ي#~ين ، #<#.مو#?ي#~ين #.و سيمي#?#~ين . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #<ى ح#.ل#.#? #.ل#^#_#.#>ة ل#.نة ي#<#^ز #<ى ل#%ن #.ل#.م . \r\n\r\n–يس#?خ#~م #.ثن#.ء #.لحمل #.ذ#. #=#.ن#? هن#.#= ح#.جة و#.#_حة #.لي #.س#?خ#~#.مه . \r\n\r\n–ممنو#> #.س#?خ#~#.مه لم#^#_ى #.ل#=#%#~ #.و #.ل#=لى . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن #.لم#^#_ م#~خن .", "GI": "Indication\t\r\nFor the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.\r\nPharmacodynamics\t\r\nNizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.\r\n\r\nMechanism of action\t\r\nNizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.", "Composition": "Each Hard Gelatin Capsule contains:\r\nNizatidine 150mg Or Nizatidine 300mg", "Route": "ORAL.SOLID" }, { "ID": "195", "Trade_Name": "NIZATINE 150 MG 20 CAPS.", "Generic_Name": "NIZATIDINE", "Price": "21", "Price_Old": "21", "Company": "HI-PHARM", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م #<ى #.م#^#.#_ #.#^#?ج#.#> #.لح#.م#_ #%#.لم#^ئ . \r\n\r\n–يس#?خ#~م #<ى ق#^حة #.لم#>#~ة وق#^حة #.لأثني #>ش#^ (#.لنش#-ة ولمن#>ه#.) . \r\n\r\n–يس#?خ#~م #<ى #.لحمو#_ة #.لم#>وية و#>س#^ #.له#_م #.لحم#_ي .", "Contraindications": "–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن ل#~ي#= حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#.#>له للنيز#.ني#~ين #.و #.ي من م#=ون#.#? #.لمس#?ح#_#^ #.و #^#.ن#?ي#~ين ، #<#.مو#?ي#~ين #.و سيمي#?#~ين . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #<ى ح#.ل#.#? #.ل#^#_#.#>ة ل#.نة ي#<#^ز #<ى ل#%ن #.ل#.م . \r\n\r\n–يس#?خ#~م #.ثن#.ء #.لحمل #.ذ#. #=#.ن#? هن#.#= ح#.جة و#.#_حة #.لي #.س#?خ#~#.مه . \r\n\r\n–ممنو#> #.س#?خ#~#.مه لم#^#_ى #.ل#=#%#~ #.و #.ل#=لى . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن #.لم#^#_ م#~خن .", "GI": "Indication\t\r\nFor the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.\r\nPharmacodynamics\t\r\nNizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.\r\n\r\nMechanism of action\t\r\nNizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.", "Composition": "Each capsule contains : (Nizatidine 150 mg&300 mg)", "Route": "ORAL.SOLID" }, { "ID": "196", "Trade_Name": "NITROTARD 2.5MG 60 CAPS.", "Generic_Name": "NITROGLYCERIN", "Price": "18", "Price_Old": "18", "Company": "MUP", "Pharmacology": "ANTI-ISCHEMIC", "Category": "نقص #?#^وية #.لقل#%", "Use": "–يخلص #.لشخص من مش#=لة #.لذ#%حة #.لص#~#^ية. \r\n\r\n–#.لوق#.ية من #.ل#?#>#^#_ إلى #.لذ#%حة #.لص#~#^ية. \r\n\r\n–خل#.ل #.لجل#-#.#? #.لقل#%ية ي#>#~ #.ل#~و#.ء #<#>#.ل ج#~#. #<ي #.ل#?خلص من #<شل #.لقل#% #.ل#.ح#?ق#.ني.", "Contraindications": "–#.ل#~و#.ء ممنو#> #>لى من ي#>#.ني من #.لمش#.#=ل #.لم#^#_ية #.ل#?#.لية: \r\n\r\n–أن ي#>#.ني #.لم#^ي#_ من #.ل#?حسس ل#.ح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#<ي ح#.لة ح#~وث #.#>#?ل#.ل ل#>#_لة #.لقل#%. \r\n\r\n–أن ي#=ون #.لم#^ي#_ ي#>#.ني من #.لمي#.ه #.لز#^ق#.ء #<ق#~ ي#?#>#.#^#_ #.ل#~و#.ء م#> #.لأ#~وية #.ل#?ي ي#?ن#.وله#. خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.ل#.#? #<ق#^ #.ل#~م أو #.لم#>#.ن#.ة من #.لأنيمي#. وأن ي#?#>#^#_ #.لم#^ي#_ #%ش#=ل ملحوظ ل#.نخ#<#.#_ #<ي #_غ#- #.ل#~م. \r\n\r\n–أن يس#?خ#~م #.لم#^ي#_ #<ي #.لوق#? ذ#.#?ه مح#<ز#.#? أنزيم #.لجو#.نلي#? مم#. يؤ#~ى إلى أنخ#<#.#_ #<ي #_غ#- #.ل#~م.", "GI": "Indication\tFor the prevention of angina\r\nPharmacodynamics\tNitroglycerin, an organic nitrate, is available in many forms as a vasodilator. Nitroglycerin is used in the treatement of angina pectoris and perioperative hypertension, to produce controlled hypotension during surgical procedures, to treat hypertensive emergencies, and to treat congestive heart failure associated with myocardial infarction.\r\nMechanism of action\tSimilar to other nitrites and organic nitrates, nitroglycerin is converted to nitric oxide (NO), an active intermediate compound which activates the enzyme guanylate cyclase. This stimulates the synthesis of cyclic guanosine 3 ,5 -monophosphate (cGMP) which then activates a series of protein kinase-dependent phosphorylations in the smooth muscle cells, eventually resulting in the dephosphorylation of the myosin light chain of the smooth muscle fiber. The subsequent release of calcium ions results in the relaxation of the smooth muscle cells and vasodilation.", "Composition": "nitroglycerin 2.5g", "Route": "ORAL.SOLID" }, { "ID": "197", "Trade_Name": "ULCFREE 150MG 20 CAPS.", "Generic_Name": "NIZATIDINE", "Price": "21", "Price_Old": "21", "Company": "EVA PHARMA", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م #<ى #.م#^#.#_ #.#^#?ج#.#> #.لح#.م#_ #%#.لم#^ئ . \r\n\r\n–يس#?خ#~م #<ى ق#^حة #.لم#>#~ة وق#^حة #.لأثني #>ش#^ (#.لنش#-ة ولمن#>ه#.) . \r\n\r\n–يس#?خ#~م #<ى #.لحمو#_ة #.لم#>وية و#>س#^ #.له#_م #.لحم#_ي .", "Contraindications": "–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن ل#~ي#= حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#.#>له للنيز#.ني#~ين #.و #.ي من م#=ون#.#? #.لمس#?ح#_#^ #.و #^#.ن#?ي#~ين ، #<#.مو#?ي#~ين #.و سيمي#?#~ين . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #<ى ح#.ل#.#? #.ل#^#_#.#>ة ل#.نة ي#<#^ز #<ى ل#%ن #.ل#.م . \r\n\r\n–يس#?خ#~م #.ثن#.ء #.لحمل #.ذ#. #=#.ن#? هن#.#= ح#.جة و#.#_حة #.لي #.س#?خ#~#.مه . \r\n\r\n–ممنو#> #.س#?خ#~#.مه لم#^#_ى #.ل#=#%#~ #.و #.ل#=لى . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن #.لم#^#_ م#~خن .", "GI": "Indication\t\r\nFor the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.\r\nPharmacodynamics\t\r\nNizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.\r\n\r\nMechanism of action\t\r\nNizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.", "Composition": "Each capsule contains:Nizatidine 150 mg", "Route": "ORAL.SOLID" }, { "ID": "198", "Trade_Name": "UVAMINE RETARD 100MG 20CAPS.", "Generic_Name": "NITROFURANTOIN", "Price": "22", "Price_Old": "11", "Company": "MUP > ACINO", "Pharmacology": "UTI INFECTIONS", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحو#_ و#.لمث#.نة. \r\n\r\n–#=#>ل#.ج وق#.ئي من #.ل#.ل#?ه#.#%#.#? #<ي #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#.نيمي#. #.ل#<ول. \r\n\r\n–ح#.ل#.#? #.نق#-#.#> #.ل#%ول. \r\n\r\n–#.ل#.#-#<#.ل #.قل من 12 #>#.م. \r\n\r\n–#.#_#-#^#.#% #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Nitrofurantoin\r\nNitrofuran derivative antibiotic, Urinary germicide, Miscellaneous Antibiotic.\r\n\r\nMechanism of Action of Nitrofurantoin\r\nNitrofurantoin is a bacteriostatic drug. It undergoes enzymatic reduction and produces active metabolite which damages the DNA of the bacteria. Bacteria reduce Nitrofurantoin more rapidly than mammalian cells.\r\nIndications for Nitrofurantoin\r\n1. Urinary tract infection\r\nInteractions for Nitrofurantoin\r\nAntichlolinergic drugs: Bioavailability of nitrofurantoin increased due to delayed gastric emptying. \r\nProbenecid: Decreased renal clearance and increased serum levels of nitrofurantoin resulting in toxicity. \r\nMagnesium trisilicate: May delay or decrease the absorption of nitrofurantoin. \r\nFood: Increases bioavailability of nitrofurantoin. \r\nLab tests: Serum glucose decreased. Elevated serum bilirubin and alkaline phosphates. Elevated urinary creatinine levels. False-positive urinary glucose using benedicts reagent.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "199", "Trade_Name": "NIZATINE 300 MG 20 CAPS.", "Generic_Name": "NIZATIDINE", "Price": "30", "Price_Old": "30", "Company": "HI-PHARM", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م #<ى #.م#^#.#_ #.#^#?ج#.#> #.لح#.م#_ #%#.لم#^ئ . \r\n\r\n–يس#?خ#~م #<ى ق#^حة #.لم#>#~ة وق#^حة #.لأثني #>ش#^ (#.لنش#-ة ولمن#>ه#.) . \r\n\r\n–يس#?خ#~م #<ى #.لحمو#_ة #.لم#>وية و#>س#^ #.له#_م #.لحم#_ي .", "Contraindications": "–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن ل#~ي#= حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#.#>له للنيز#.ني#~ين #.و #.ي من م#=ون#.#? #.لمس#?ح#_#^ #.و #^#.ن#?ي#~ين ، #<#.مو#?ي#~ين #.و سيمي#?#~ين . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #<ى ح#.ل#.#? #.ل#^#_#.#>ة ل#.نة ي#<#^ز #<ى ل#%ن #.ل#.م . \r\n\r\n–يس#?خ#~م #.ثن#.ء #.لحمل #.ذ#. #=#.ن#? هن#.#= ح#.جة و#.#_حة #.لي #.س#?خ#~#.مه . \r\n\r\n–ممنو#> #.س#?خ#~#.مه لم#^#_ى #.ل#=#%#~ #.و #.ل#=لى . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن #.لم#^#_ م#~خن .", "GI": "Indication\t\r\nFor the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.\r\nPharmacodynamics\t\r\nNizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.\r\n\r\nMechanism of action\t\r\nNizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.", "Composition": "Each capsule contains : (Nizatidine 150 mg&300 mg)", "Route": "ORAL.SOLID" }, { "ID": "200", "Trade_Name": "FERROFOL VIT-Z 30 CAP.", "Generic_Name": "FERROUS SULPHATE+FOLIC ACID+NICOTINAMIDE+VITAMIN B1+VITAMIN B2+VITAMIN B6+VITAMIN C + ZINC", "Price": "18.5", "Price_Old": "18.5", "Company": "EIPICO", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–#.لوق#.ية و#.ل#>ل#.ج من نقص #.لح#~ي#~ وحم#_ #.ل#<ولي#= و#.ل#<ي#?#.مين#.#? و#>ن#~ #.لح#.جة إلى م#=مل#.#? #.لزن#= ، خ#.صة #%#.لنس#%ة للنس#.ء #.لحو#.مل و#.لأمه#.#? #.لم#^#_#>#.#? وم#^#_ى #.لمسنين وح#.ل#.#? أخ#^ى من #.ل#<ي#?#.مين#.#? ونقص #.لم#>#.#~ن.", "Contraindications": "–#.ل#.س#?خ#~#.م #.لم#?ز#.من للح#~ي#~ م#> م#_#.#~#.#? #.لحمو#_ة ، م#=مل#.#? #.ل#=#.لسيوم ، #.لش#.ي ، #.لقهوة ، #.لحلي#% أو من#?ج#.#? #.لحلي#% ق#~ يقلل من #.م#?ص#.ص #.لح#~ي#~ و#%#.ل#?#.لي ، ل#. ين#%غي أن #?ؤخذ م#=مل#.#? #.لح#~ي#~ #<ي غ#_ون س#.#>ة و#.ح#~ة ق#%ل أو #%#>#~ س#.#>#?ين من #?ن#.ول أي من #.لمذ#=و#^ة أ#>ل#.ه. ويج#% #?جن#% #.ل#?ن#.ول #.لم#?ز#.من م#> #.ل#?#?#^#.سي#=لين ، حيث أن مخلو#- #.لح#~ي#~ م#> #.ل#?#?#^#.سي#=لين و#.م#?ص#.ص #=ل منه#. ق#~ ي#_#>#< #.ل#.خ#^.", "GI": "COMING SOON ..", "Composition": "ferrous sulfate 150mg+folic acid 0.5mg", "Route": "ORAL.SOLID" }, { "ID": "201", "Trade_Name": "NOPECIA 1 MG 30 CAPS.", "Generic_Name": "FINASTERIDE", "Price": "36", "Price_Old": "24", "Company": "ADWIA", "Pharmacology": "ANTI-ANDROGEN.ALOPECIA TTT", "Category": "#>ل#.ج #?#_خم #.ل#%#^وس#?#.#?#. و#<ق#~#.ن ش#>#^ #<#^وة #.ل#^أس", "Use": "–يس#?خ#~م ل#>ل#.ج و#_#%#- #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~ (BPH) #<ي #.لم#^#_ى #.لذين ي#>#.نون من #?#_خم #.ل#%#^وس#?#.#?#. من أجل:\r\n\r\n–يس#%#% #?#^#.ج#> #<ي #?#_خم #.ل#%#^وس#?#.#?#.، ويحسن #?#~#<ق #.ل#%ول ويحسن #.لأ#>#^#.#_ #.لمص#.ح#%ة ل#?#_خم #.ل#%#^وس#?#.#?#..\r\n\r\n–#?قليل ح#~وث #.ح#?#%#.س #.ل#%ول #.لح#.#~ و#.لح#.جة إلى #.لج#^#.حة #%م#. #<ي ذل#= #.س#?ئص#.ل #.ل#%#^وس#?#.#?#. #>#%#^ #.لإحليل (TURP) و#.س#?ئص#.ل #.ل#%#^وس#?#.#?#..\r\n\r\n–ويم#=ن #.س#?#>م#.له #<ي #>ل#.ج سقو#- #.لش#>#^ #.لذ#=و#^ي #.لنم#- ولمن ي#>#.نون من #.لق#^#.#> حيث يس#.هم #%ش#=ل #=#%ي#^ #<ي زي#.#~ة نمو #.لش#>#^ #%#.ل#^أس، ويمن#> #?س#.ق#-ه م#^ة أخ#^ى.", "Contraindications": "–#.لأشخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لل#~و#.ء أو لأي م#=ون من م#=ون#.#?ه. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#~و#.ء للسي#~#.#? #<ق#~ أظه#^#? #.ل#~#^#.س#.#? #%أن أق#^#.ص نو#%يشي#. ل#. #?#>مل ل#~ى #.لسي#~#.#? #.لل#.#?ي ي#>#.نين من #?س#.ق#- #.لش#>#^. \r\n\r\n–ل#. يج#% #?ن#.وله إذ#. #=#.ن ل#~ي#= مش#=لة #<ي #.ل#%#^وس#?#.#?#. مثل #.ل#?#_خم #.لحمي#~. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأ#-#<#.ل. \r\n\r\n–#<ي ح#.لة #.لقي#.#~ة من #.لمح#?مل أن يؤث#^ هذ#. #.ل#~و#.ء #>لي#= لذل#= من #.ل#.#<#_ل #>#~م #.لقي#.#~ة أثن#.ء #.ل#>ل#.ج.", "GI": "About Finasteride\r\n5 Alpha-Reductase Inhibitor, Synthetic anti-androgen.\r\n\r\nMechanism of Action of Finasteride\r\nThis synthetic 4-azasteroid derivative competitively inhibits steroid 5alpha reductase, which is an enzyme responsible for active androgen dehydrotestosterone (this enzyme influences the development of prostate gland, so decreasing level of this hormone relieve the symptoms associated with benign prostatic hyperplasia)from testosterone.\r\n\r\nIndications for Finasteride\r\n1. Benign prostatic hyperplasia \r\n2. 1st stage of prostate cancer \r\n3. Hirsuitism \r\n4. Acne \r\n5. Adjuvant therapy of radical prostectomy \r\n6. Androgenic baldness", "Composition": "Each capsule contains: Finasteride 1 mg.", "Route": "ORAL.SOLID" }, { "ID": "202", "Trade_Name": "RAPIDO 180MG 10 CAPS.", "Generic_Name": "FEXOFENADINE", "Price": "12", "Price_Old": "12", "Company": "SEDICO", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY", "Category": "م#_#.#~ للحس#.سية", "Use": "– يس#.#>#~ #>لى #.لق#_#.ء #>لى #.لحس#.سية وأ#>#^#.#_ه#.. \r\n\r\n– يخ#<#< من سيل#.ن #.لأن#< و#.ل#~مو#> و#.ل#>#-س #.لم#?#=#^#^ وح#=ة #.لأن#<. \r\n\r\n– ي#<ي#~ #<ي #>ل#.ج #.لح#=ة و#.ل#-#<ح #.لجل#~ي. \r\n\r\n– ي#>مل #>لى #.ل#?خلص من #.لإحم#^#.#^ و#.لح#=ة #.ل#?ي #?ح#~ث #%س#%#% ل#~غ#.#? #.لحش#^#.#? وي#>#.لج أس#%#.#% #.لمهيج#.#? #.ل#?ي #?ح#~ث #%س#%#% #.ل#?حسس #.لجل#~ي أو #.ل#?#>#^#_ لص#%غ#.#? #.لش#>#^. \r\n\r\n– يس#.#>#~ #>لى #.ل#?قليل من حس#.سية موسم #.ل#^#%ي#>. \r\n\r\n– يس#?خ#~م لل#?خ#<ي#< من أ#>#^#.#_ إل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n– يس#.#>#~ #>لى م#>#.لجة #.لحس#.سية #.لموسمية للأ#-#<#.ل و#.ل#=#%#.#^ ول#=ن #%ج#^#>#.#? من#.س#%ة ل#=ل #>م#^.", "Contraindications": "–إذ#. #=#.ن #.لشخص ي#>#.ني من أي مش#=لة #<ي #.ل#=لى #<#>ليه إس#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.وله. \r\n\r\n–ل#. يج#% إس#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #<#?#^ة #.لحمل وهو غي#^ آمن وخصوص#.ً #<ي #.لشهو#^ #.لأولى من هذه #.ل#<#?#^ة، وإذ#. #=#.ن من #.ل#_#^و#^ي #?ن#.وله #<ل#.#%#~ من إس#?ش#.#^ة وم#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص أول#.ً. \r\n\r\n–#<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية ينصح #%#>#~م إس#?خ#~#.مه. \r\n\r\n–ل#. يس#?#>مل هذ#. #.ل#~و#.ء #%#>#~ إن#?ه#.ء صل#.حي#?ه #.لم#~ونة #>لى #.ل#>#%وة. \r\n\r\n–ل#. يج#% #?خزينه #<ي #~#^جة ح#^#.#^ة أقل أو زي#.#~ة #>ن 20 إلى 25 #~#^جة مئوية. \r\n\r\n–#?جن#% #?ن#.وله م#> #.لأ#~وية #.ل#?ي #?#>#.لج #.ل#^شح و#.ل#%#^#~ مثل #<لو#^س#? و#%#.ن#.#~ول #=ول#~. \r\n\r\n–من #.ل#_#^و#^ي إ#%ق#.ء هذ#. #.ل#~و#.ء #%#>ي#~ #>ن م#?ن#.ول #.لأ#-#<#.ل. \r\n\r\n–يقوم هذ#. #.ل#~و#.ء #<ي #%#>#_ #.لأحي#.ن #%#?غيي#^ #.ل#<حوص#.#? #.لمخ#%#^ية لذل#= يم#=ن #?أجيل هذه #.ل#<حوص#.#? أو إ#>ل#.م من يقوم #%أخذ #.ل#?حليل أن#= #?#?ن#.ول هذ#. #.ل#~و#.ء.", "GI": "About Fexofenadine\r\nSecond Generation H1 Antagonist, Antihistamine.\r\n\r\nMechanism of Action of Fexofenadine\r\nFexofenadine blocks one type of peripheral receptor for histamine (the H1 receptor) and thus prevents activation of H1 receptor-containing cells by histamine (Histamine is released from histamine-storing cells (mast cells) and then attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be \\\"activated,\\\" releasing other chemicals that produce the effects that we associate with allergy, e.g., sneezing.) and the allergic symptoms produced by it.", "Composition": "fexofenadine 120mg or 180mg", "Route": "ORAL.SOLID" }, { "ID": "203", "Trade_Name": "FEXODINE 120MG 10 CAP.", "Generic_Name": "FEXOFENADINE", "Price": "8", "Price_Old": "8", "Company": "MEMPHIS", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY", "Category": "م#_#.#~ للحس#.سية", "Use": "– يس#.#>#~ #>لى #.لق#_#.ء #>لى #.لحس#.سية وأ#>#^#.#_ه#.. \r\n\r\n– يخ#<#< من سيل#.ن #.لأن#< و#.ل#~مو#> و#.ل#>#-س #.لم#?#=#^#^ وح#=ة #.لأن#<. \r\n\r\n– ي#<ي#~ #<ي #>ل#.ج #.لح#=ة و#.ل#-#<ح #.لجل#~ي. \r\n\r\n– ي#>مل #>لى #.ل#?خلص من #.لإحم#^#.#^ و#.لح#=ة #.ل#?ي #?ح#~ث #%س#%#% ل#~غ#.#? #.لحش#^#.#? وي#>#.لج أس#%#.#% #.لمهيج#.#? #.ل#?ي #?ح#~ث #%س#%#% #.ل#?حسس #.لجل#~ي أو #.ل#?#>#^#_ لص#%غ#.#? #.لش#>#^. \r\n\r\n– يس#.#>#~ #>لى #.ل#?قليل من حس#.سية موسم #.ل#^#%ي#>. \r\n\r\n– يس#?خ#~م لل#?خ#<ي#< من أ#>#^#.#_ إل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n– يس#.#>#~ #>لى م#>#.لجة #.لحس#.سية #.لموسمية للأ#-#<#.ل و#.ل#=#%#.#^ ول#=ن #%ج#^#>#.#? من#.س#%ة ل#=ل #>م#^.", "Contraindications": "–إذ#. #=#.ن #.لشخص ي#>#.ني من أي مش#=لة #<ي #.ل#=لى #<#>ليه إس#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.وله. \r\n\r\n–ل#. يج#% إس#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #<#?#^ة #.لحمل وهو غي#^ آمن وخصوص#.ً #<ي #.لشهو#^ #.لأولى من هذه #.ل#<#?#^ة، وإذ#. #=#.ن من #.ل#_#^و#^ي #?ن#.وله #<ل#.#%#~ من إس#?ش#.#^ة وم#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص أول#.ً. \r\n\r\n–#<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية ينصح #%#>#~م إس#?خ#~#.مه. \r\n\r\n–ل#. يس#?#>مل هذ#. #.ل#~و#.ء #%#>#~ إن#?ه#.ء صل#.حي#?ه #.لم#~ونة #>لى #.ل#>#%وة. \r\n\r\n–ل#. يج#% #?خزينه #<ي #~#^جة ح#^#.#^ة أقل أو زي#.#~ة #>ن 20 إلى 25 #~#^جة مئوية. \r\n\r\n–#?جن#% #?ن#.وله م#> #.لأ#~وية #.ل#?ي #?#>#.لج #.ل#^شح و#.ل#%#^#~ مثل #<لو#^س#? و#%#.ن#.#~ول #=ول#~. \r\n\r\n–من #.ل#_#^و#^ي إ#%ق#.ء هذ#. #.ل#~و#.ء #%#>ي#~ #>ن م#?ن#.ول #.لأ#-#<#.ل. \r\n\r\n–يقوم هذ#. #.ل#~و#.ء #<ي #%#>#_ #.لأحي#.ن #%#?غيي#^ #.ل#<حوص#.#? #.لمخ#%#^ية لذل#= يم#=ن #?أجيل هذه #.ل#<حوص#.#? أو إ#>ل#.م من يقوم #%أخذ #.ل#?حليل أن#= #?#?ن#.ول هذ#. #.ل#~و#.ء.", "GI": "About Fexofenadine\r\nSecond Generation H1 Antagonist, Antihistamine.\r\n\r\nMechanism of Action of Fexofenadine\r\nFexofenadine blocks one type of peripheral receptor for histamine (the H1 receptor) and thus prevents activation of H1 receptor-containing cells by histamine (Histamine is released from histamine-storing cells (mast cells) and then attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be \\\"activated,\\\" releasing other chemicals that produce the effects that we associate with allergy, e.g., sneezing.) and the allergic symptoms produced by it.", "Composition": "fexofenadine 120mg or 180mg", "Route": "ORAL.SOLID" }, { "ID": "204", "Trade_Name": "DIFLUCAN 50MG 7 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "95.25", "Price_Old": "68", "Company": "PFIZER", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg, 50mg, 2mg, 5mg", "Route": "ORAL.SOLID" }, { "ID": "205", "Trade_Name": "PROSTRIDE 5MG 30 CAPS.", "Generic_Name": "FINASTERIDE", "Price": "109.25", "Price_Old": "78", "Company": "ADWIA", "Pharmacology": "5 ALPHA-REDUCTASE INHIBITOR", "Category": "#>ل#.ج #?#_خم #.ل#%#^وس#?#.#?#. و#<ق#~#.ن ش#>#^ #<#^وة #.ل#^أس", "Use": "–يس#?خ#~م ل#>ل#.ج و#_#%#- #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~ (BPH) #<ي #.لم#^#_ى #.لذين ي#>#.نون من #?#_خم #.ل#%#^وس#?#.#?#. من أجل:\r\n\r\n–يس#%#% #?#^#.ج#> #<ي #?#_خم #.ل#%#^وس#?#.#?#.، ويحسن #?#~#<ق #.ل#%ول ويحسن #.لأ#>#^#.#_ #.لمص#.ح#%ة ل#?#_خم #.ل#%#^وس#?#.#?#..\r\n\r\n–#?قليل ح#~وث #.ح#?#%#.س #.ل#%ول #.لح#.#~ و#.لح#.جة إلى #.لج#^#.حة #%م#. #<ي ذل#= #.س#?ئص#.ل #.ل#%#^وس#?#.#?#. #>#%#^ #.لإحليل (TURP) و#.س#?ئص#.ل #.ل#%#^وس#?#.#?#..\r\n\r\n–ويم#=ن #.س#?#>م#.له #<ي #>ل#.ج سقو#- #.لش#>#^ #.لذ#=و#^ي #.لنم#- ولمن ي#>#.نون من #.لق#^#.#> حيث يس#.هم #%ش#=ل #=#%ي#^ #<ي زي#.#~ة نمو #.لش#>#^ #%#.ل#^أس، ويمن#> #?س#.ق#-ه م#^ة أخ#^ى.", "Contraindications": "–#.لأشخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لل#~و#.ء أو لأي م#=ون من م#=ون#.#?ه. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#~و#.ء للسي#~#.#? #<ق#~ أظه#^#? #.ل#~#^#.س#.#? #%أن أق#^#.ص نو#%يشي#. ل#. #?#>مل ل#~ى #.لسي#~#.#? #.لل#.#?ي ي#>#.نين من #?س#.ق#- #.لش#>#^. \r\n\r\n–ل#. يج#% #?ن#.وله إذ#. #=#.ن ل#~ي#= مش#=لة #<ي #.ل#%#^وس#?#.#?#. مثل #.ل#?#_خم #.لحمي#~. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأ#-#<#.ل. \r\n\r\n–#<ي ح#.لة #.لقي#.#~ة من #.لمح#?مل أن يؤث#^ هذ#. #.ل#~و#.ء #>لي#= لذل#= من #.ل#.#<#_ل #>#~م #.لقي#.#~ة أثن#.ء #.ل#>ل#.ج.", "GI": "About Finasteride\r\n5 Alpha-Reductase Inhibitor, Synthetic anti-androgen.\r\n\r\nMechanism of Action of Finasteride\r\nThis synthetic 4-azasteroid derivative competitively inhibits steroid 5alpha reductase, which is an enzyme responsible for active androgen dehydrotestosterone (this enzyme influences the development of prostate gland, so decreasing level of this hormone relieve the symptoms associated with benign prostatic hyperplasia)from testosterone.\r\n\r\nIndications for Finasteride\r\n1. Benign prostatic hyperplasia \r\n2. 1st stage of prostate cancer \r\n3. Hirsuitism \r\n4. Acne \r\n5. Adjuvant therapy of radical prostectomy \r\n6. Androgenic baldness", "Composition": "Finasteride 5 mg", "Route": "ORAL.SOLID" }, { "ID": "206", "Trade_Name": "FEXODINE 180MG 10 CAPS.", "Generic_Name": "FEXOFENADINE", "Price": "15.6", "Price_Old": "15.6", "Company": "MEMPHIS", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY", "Category": "م#_#.#~ للحس#.سية", "Use": "– يس#.#>#~ #>لى #.لق#_#.ء #>لى #.لحس#.سية وأ#>#^#.#_ه#.. \r\n\r\n– يخ#<#< من سيل#.ن #.لأن#< و#.ل#~مو#> و#.ل#>#-س #.لم#?#=#^#^ وح#=ة #.لأن#<. \r\n\r\n– ي#<ي#~ #<ي #>ل#.ج #.لح#=ة و#.ل#-#<ح #.لجل#~ي. \r\n\r\n– ي#>مل #>لى #.ل#?خلص من #.لإحم#^#.#^ و#.لح#=ة #.ل#?ي #?ح#~ث #%س#%#% ل#~غ#.#? #.لحش#^#.#? وي#>#.لج أس#%#.#% #.لمهيج#.#? #.ل#?ي #?ح#~ث #%س#%#% #.ل#?حسس #.لجل#~ي أو #.ل#?#>#^#_ لص#%غ#.#? #.لش#>#^. \r\n\r\n– يس#.#>#~ #>لى #.ل#?قليل من حس#.سية موسم #.ل#^#%ي#>. \r\n\r\n– يس#?خ#~م لل#?خ#<ي#< من أ#>#^#.#_ إل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n– يس#.#>#~ #>لى م#>#.لجة #.لحس#.سية #.لموسمية للأ#-#<#.ل و#.ل#=#%#.#^ ول#=ن #%ج#^#>#.#? من#.س#%ة ل#=ل #>م#^.", "Contraindications": "–إذ#. #=#.ن #.لشخص ي#>#.ني من أي مش#=لة #<ي #.ل#=لى #<#>ليه إس#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.وله. \r\n\r\n–ل#. يج#% إس#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #<#?#^ة #.لحمل وهو غي#^ آمن وخصوص#.ً #<ي #.لشهو#^ #.لأولى من هذه #.ل#<#?#^ة، وإذ#. #=#.ن من #.ل#_#^و#^ي #?ن#.وله #<ل#.#%#~ من إس#?ش#.#^ة وم#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص أول#.ً. \r\n\r\n–#<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية ينصح #%#>#~م إس#?خ#~#.مه. \r\n\r\n–ل#. يس#?#>مل هذ#. #.ل#~و#.ء #%#>#~ إن#?ه#.ء صل#.حي#?ه #.لم#~ونة #>لى #.ل#>#%وة. \r\n\r\n–ل#. يج#% #?خزينه #<ي #~#^جة ح#^#.#^ة أقل أو زي#.#~ة #>ن 20 إلى 25 #~#^جة مئوية. \r\n\r\n–#?جن#% #?ن#.وله م#> #.لأ#~وية #.ل#?ي #?#>#.لج #.ل#^شح و#.ل#%#^#~ مثل #<لو#^س#? و#%#.ن#.#~ول #=ول#~. \r\n\r\n–من #.ل#_#^و#^ي إ#%ق#.ء هذ#. #.ل#~و#.ء #%#>ي#~ #>ن م#?ن#.ول #.لأ#-#<#.ل. \r\n\r\n–يقوم هذ#. #.ل#~و#.ء #<ي #%#>#_ #.لأحي#.ن #%#?غيي#^ #.ل#<حوص#.#? #.لمخ#%#^ية لذل#= يم#=ن #?أجيل هذه #.ل#<حوص#.#? أو إ#>ل#.م من يقوم #%أخذ #.ل#?حليل أن#= #?#?ن#.ول هذ#. #.ل#~و#.ء.", "GI": "About Fexofenadine\r\nSecond Generation H1 Antagonist, Antihistamine.\r\n\r\nMechanism of Action of Fexofenadine\r\nFexofenadine blocks one type of peripheral receptor for histamine (the H1 receptor) and thus prevents activation of H1 receptor-containing cells by histamine (Histamine is released from histamine-storing cells (mast cells) and then attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be \\\"activated,\\\" releasing other chemicals that produce the effects that we associate with allergy, e.g., sneezing.) and the allergic symptoms produced by it.", "Composition": "fexofenadine 120mg or 180mg", "Route": "ORAL.SOLID" }, { "ID": "207", "Trade_Name": "AMRIFLUCAN 50 MG 7 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "24", "Price_Old": "24", "Company": "AMRIYA", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg", "Route": "ORAL.SOLID" }, { "ID": "208", "Trade_Name": "RAPIDO 120MG 10 CAPS.", "Generic_Name": "FEXOFENADINE", "Price": "10", "Price_Old": "10", "Company": "SEDICO", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY", "Category": "م#_#.#~ للحس#.سية", "Use": "– يس#.#>#~ #>لى #.لق#_#.ء #>لى #.لحس#.سية وأ#>#^#.#_ه#.. \r\n\r\n– يخ#<#< من سيل#.ن #.لأن#< و#.ل#~مو#> و#.ل#>#-س #.لم#?#=#^#^ وح#=ة #.لأن#<. \r\n\r\n– ي#<ي#~ #<ي #>ل#.ج #.لح#=ة و#.ل#-#<ح #.لجل#~ي. \r\n\r\n– ي#>مل #>لى #.ل#?خلص من #.لإحم#^#.#^ و#.لح#=ة #.ل#?ي #?ح#~ث #%س#%#% ل#~غ#.#? #.لحش#^#.#? وي#>#.لج أس#%#.#% #.لمهيج#.#? #.ل#?ي #?ح#~ث #%س#%#% #.ل#?حسس #.لجل#~ي أو #.ل#?#>#^#_ لص#%غ#.#? #.لش#>#^. \r\n\r\n– يس#.#>#~ #>لى #.ل#?قليل من حس#.سية موسم #.ل#^#%ي#>. \r\n\r\n– يس#?خ#~م لل#?خ#<ي#< من أ#>#^#.#_ إل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n– يس#.#>#~ #>لى م#>#.لجة #.لحس#.سية #.لموسمية للأ#-#<#.ل و#.ل#=#%#.#^ ول#=ن #%ج#^#>#.#? من#.س#%ة ل#=ل #>م#^.", "Contraindications": "–إذ#. #=#.ن #.لشخص ي#>#.ني من أي مش#=لة #<ي #.ل#=لى #<#>ليه إس#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.وله. \r\n\r\n–ل#. يج#% إس#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #<#?#^ة #.لحمل وهو غي#^ آمن وخصوص#.ً #<ي #.لشهو#^ #.لأولى من هذه #.ل#<#?#^ة، وإذ#. #=#.ن من #.ل#_#^و#^ي #?ن#.وله #<ل#.#%#~ من إس#?ش#.#^ة وم#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص أول#.ً. \r\n\r\n–#<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية ينصح #%#>#~م إس#?خ#~#.مه. \r\n\r\n–ل#. يس#?#>مل هذ#. #.ل#~و#.ء #%#>#~ إن#?ه#.ء صل#.حي#?ه #.لم#~ونة #>لى #.ل#>#%وة. \r\n\r\n–ل#. يج#% #?خزينه #<ي #~#^جة ح#^#.#^ة أقل أو زي#.#~ة #>ن 20 إلى 25 #~#^جة مئوية. \r\n\r\n–#?جن#% #?ن#.وله م#> #.لأ#~وية #.ل#?ي #?#>#.لج #.ل#^شح و#.ل#%#^#~ مثل #<لو#^س#? و#%#.ن#.#~ول #=ول#~. \r\n\r\n–من #.ل#_#^و#^ي إ#%ق#.ء هذ#. #.ل#~و#.ء #%#>ي#~ #>ن م#?ن#.ول #.لأ#-#<#.ل. \r\n\r\n–يقوم هذ#. #.ل#~و#.ء #<ي #%#>#_ #.لأحي#.ن #%#?غيي#^ #.ل#<حوص#.#? #.لمخ#%#^ية لذل#= يم#=ن #?أجيل هذه #.ل#<حوص#.#? أو إ#>ل#.م من يقوم #%أخذ #.ل#?حليل أن#= #?#?ن#.ول هذ#. #.ل#~و#.ء.", "GI": "About Fexofenadine\r\nSecond Generation H1 Antagonist, Antihistamine.\r\n\r\nMechanism of Action of Fexofenadine\r\nFexofenadine blocks one type of peripheral receptor for histamine (the H1 receptor) and thus prevents activation of H1 receptor-containing cells by histamine (Histamine is released from histamine-storing cells (mast cells) and then attaches to other cells that have receptors for histamine. The attachment of the histamine to the receptors causes the cell to be \\\"activated,\\\" releasing other chemicals that produce the effects that we associate with allergy, e.g., sneezing.) and the allergic symptoms produced by it.", "Composition": "fexofenadine 120mg or 180mg", "Route": "ORAL.SOLID" }, { "ID": "209", "Trade_Name": "FLOCAZOLE 50MG 7CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "40", "Price_Old": "40", "Company": "SPIMACO > EIMC", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "210", "Trade_Name": "CONVENTIN 400MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "81", "Price_Old": "81", "Company": "EVA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each Capsule of :Conventin 100mg contains : active ingredient: Gabapentin 100 mg\r\nConventin 300 mg contains : active ingredient: Gabapentin 300 mg\r\nConventin 400mg contains : active ingredient: Gabapentin 400 mg\r\nInactive ingredients :\r\nMicrocrystalline cellu", "Route": "ORAL.SOLID" }, { "ID": "211", "Trade_Name": "REMINYL16MG 7 PROLON. REL. CAPS.", "Generic_Name": "GALANTAMINE", "Price": "150", "Price_Old": "150", "Company": "JANSSEN CILAG > SOFICOPHARM", "Pharmacology": "ALZHEIMER S DISEASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لخ#^#< . \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لذه#.ن و#.لزه#.يم#^ . \r\n\r\n–يقلل من خ#-و#^ة و#.#>#^#.#_ م#^#_ #.لزه#.يم#^ .", "Contraindications": "–يمن#> خل#.ل #<#?#^ة #.لحمل لأنه خ#-#^ #>لي حي#.ة #.لجنين . \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.س#?خ#~#.م هذ#. #.ل#~و#.ء #-و#.ل م#^حلة #.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه خ#-ي#^ #>لي #.ل#.#-#<#.ل #.ل#^#_#> . \r\n\r\n–يحذ#^ #.س#?خ#~#.مه من ق#%ل #.لمسنين #.ل#. #?ح#? #.ش#^#.#< #.ل#-#%ي#% #.لمخ#?ص . \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة منه #<يج#% #.ل#.ل#?ز#.م #%#.لج#^#>ة #.ل#?ي يسمح #%ه#. #.ل#-#%ي#% #.لمخ#?ص .", "GI": "Description\t\r\nA benzazepine derived from norbelladine. It is found in galanthus and other amaryllidaceae. Galantamine is a cholinesterase inhibitor that has been used to reverse the muscular effects of gallamine triethiodide and tubocurarine, and has been studied as a treatment for Alzheimer?s disease and other central nervous system disorders.\r\n\r\nMechanism of action\t\r\nGalantamine is a phenanthrene alkaloid and a reversible, competitive acetylcholinesterase inhibitor. It is not structurally related to other acetylcholinesterase inhibitors. Galantamine s proposed mechanism of action involves the reversible inhibition of acetylcholinesterase, which prevents the hydrolysis of acetycholine, leading to an increased concentration of acetylcholine at cholinergic synapses. Galantamine also binds allosterically with nicotinic acetylcholine receptors and may possibly potentiate the action of agonists (such as acetylcholine) at these receptors.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "212", "Trade_Name": "REMINYL 8MG 7 PROLON. REL. CAPS.", "Generic_Name": "GALANTAMINE", "Price": "90", "Price_Old": "90", "Company": "JANSSEN CILAG", "Pharmacology": "ALZHEIMER S DISEASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لخ#^#< . \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لذه#.ن و#.لزه#.يم#^ . \r\n\r\n–يقلل من خ#-و#^ة و#.#>#^#.#_ م#^#_ #.لزه#.يم#^ .", "Contraindications": "–يمن#> خل#.ل #<#?#^ة #.لحمل لأنه خ#-#^ #>لي حي#.ة #.لجنين . \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.س#?خ#~#.م هذ#. #.ل#~و#.ء #-و#.ل م#^حلة #.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه خ#-ي#^ #>لي #.ل#.#-#<#.ل #.ل#^#_#> . \r\n\r\n–يحذ#^ #.س#?خ#~#.مه من ق#%ل #.لمسنين #.ل#. #?ح#? #.ش#^#.#< #.ل#-#%ي#% #.لمخ#?ص . \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة منه #<يج#% #.ل#.ل#?ز#.م #%#.لج#^#>ة #.ل#?ي يسمح #%ه#. #.ل#-#%ي#% #.لمخ#?ص .", "GI": "Description\t\r\nA benzazepine derived from norbelladine. It is found in galanthus and other amaryllidaceae. Galantamine is a cholinesterase inhibitor that has been used to reverse the muscular effects of gallamine triethiodide and tubocurarine, and has been studied as a treatment for Alzheimer?s disease and other central nervous system disorders.\r\n\r\nMechanism of action\t\r\nGalantamine is a phenanthrene alkaloid and a reversible, competitive acetylcholinesterase inhibitor. It is not structurally related to other acetylcholinesterase inhibitors. Galantamine s proposed mechanism of action involves the reversible inhibition of acetylcholinesterase, which prevents the hydrolysis of acetycholine, leading to an increased concentration of acetylcholine at cholinergic synapses. Galantamine also binds allosterically with nicotinic acetylcholine receptors and may possibly potentiate the action of agonists (such as acetylcholine) at these receptors.", "Composition": "galantamine 16mg or 4mg or 8mg", "Route": "ORAL.SOLID" }, { "ID": "213", "Trade_Name": "GAPTIN 400MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "84", "Price_Old": "84", "Company": "DELTA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each capsule contains:\r\nGabapentin 100,300 or 400 mg.\r\n\r\nEach Box contains:\r\nGabapentin 250 mg 15 ml Syrup", "Route": "ORAL.SOLID" }, { "ID": "214", "Trade_Name": "BIOSTRONG 21 SOFT GELATIN CAPS.", "Generic_Name": "GINSENG+ROYAL JELLY+WHEAT GERM OIL", "Price": "49.5", "Price_Old": "33", "Company": "OCTOBER PHARMA", "Pharmacology": "SEXUAL TONIC", "Category": "م#=مل غذ#.ئي", "Use": "–#?#>زيز و#?قوية جه#.ز #.لمن#.#>ة وخ#.صة #<ى #<#?#^#.#? #.لنق#.هه. \r\n\r\n–#>ل#.ج مش#=لة #.ل#.ن#?ص#.#% #>ن#~ #.ل#^ج#.ل. \r\n\r\n–ي#>مل #>لى زي#.#~ة #.ل#^غ#%ة #.لجنسية #>ن#~ #.لنس#.ء. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #_#>#< #.لذ#.#=#^ة و#.ل#.جه#.#~ #.لذهنى. \r\n\r\n–#.لوق#.ية من #.لقلق و#.ل#.جه#.#~ #.ل#>ص#%ى #%ش#=ل #>#.م. \r\n\r\n–ي#>مل #>لى #?نشي#- و#?ج#~ي#~ #.#>#_#.ء #.لجسم. \r\n\r\n–يس#?خ#~م #<ى ح#.ل#.#? #>#~م #.ل#.#?ز#.ن #.و #.لش#>و#^ #%#.ل#<#?و#^. \r\n\r\n–#?ج#~ي#~ #.لخل#.ي#. وحم#.ي#?ه#. #.لذى ي#>#.نى منه #=#%#.#^ #.لسن. \r\n\r\n–ح#.ل#.#? #.ل#_#>#< #.ل#>#.م.", "Contraindications": "–لمن ي#>#.نون من م#^#_ #.لس#=#^ى. \r\n\r\n–#.لم#^#_ى #.لذين ي#>#.نون من مش#.#=ل #>قلية. \r\n\r\n–يمن#> #?ن#.ول #.ل#=#.#<يين #<ى #<#?#^ة #.س#?خ#~#.م #.ل#>ل#.ج. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #<ى ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة.", "GI": "About Ginseng\r\nSteroid glycosides.\r\nMechanism of Action of Ginseng\r\nIt contains chemicals called ginsenosides that seem to affect insulin levels in the body and lower blood sugar. Other chemicals, called polysaccharides, might affect the immune system.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "215", "Trade_Name": "GINKOR FORT 20 CAPSULE", "Generic_Name": "GINKGO BILOBA+HEPTAMINOL+TROXERUTIN", "Price": "26.4", "Price_Old": "26.4", "Company": "ARAB DRUG COMPANY. > IPSEN", "Pharmacology": "BLOOD CIRCULATION INHANCER", "Category": "#?#>زيز #.ل#~و#^ة #.ل#~موية", "Use": "–#>ل#.ج قصو#^ #.ل#~و#^ة #.ل#~موية . \r\n\r\n–#?نشي#- #.ل#~و#^ة #.ل#~موية للمخ . \r\n\r\n–#>ل#.ج إ#_#-#^#.#% #.ل#?و#.زن و #.ل#~و#.#^ و #.ل#~وخة . \r\n\r\n–#?نشي#- #.لذ#.#=#^ة .", "Contraindications": "–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.لس#=#^ ، #.لص#^#> ، ح#.ل#.#? #.لنزي#< . \r\n\r\n–يج#% #.ل#?وق#< #>ن #?ن#.ول #.ل#~و#.ء ق#%ل #.لقي#.م #%#.ل#>ملي#.#? #.لج#^#.حية ، ل#?جن#% ح#~وث #.لنزي#< . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.ل#_غ#- #.لم#^#?#<#> .", "GI": "Mechanism of Action of Ginkgo Biloba\r\nThe mechanism of action of ginkgo is believed to be produced by its functions as a neuroprotective agent, an antioxidant, a free-radical scavenger, a membrane stabilizer, and an inhibitor of platelet-activating factor via the terpene ginkgolide B.Other pharmacologic effects include the following: endothelium relaxation mediated by inhibition of 3 ,5 -cyclic GMP (guanosine monophosphate) phosphodiesterase- inhibition of age-related loss of muscarinergic cholinoceptors and ?-adrenoceptors- and stimulation of choline uptake in the hippocampus.Ginkgo extract also has been shown to inhibit beta-amyloid deposition.\r\nIndications for Ginkgo Biloba\r\n1.Dementia \r\n2.Cerebrovascular and peripheral activator", "Composition": "ginkgo biloba 14mg heptaminol hcl 300mg troxeutin 300mg", "Route": "ORAL.SOLID" }, { "ID": "216", "Trade_Name": "NEUROGLOPENTIN 400MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "73.5", "Price_Old": "73.5", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each Neuroglopentin capsule contains 100 mg, 300 mg, or 400 mg of gabapentin.", "Route": "ORAL.SOLID" }, { "ID": "217", "Trade_Name": "GINSENG 85 MG 20 CAPS.", "Generic_Name": "GINSENG", "Price": "5.34", "Price_Old": "5.34", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "SEXUAL TONIC", "Category": "منش#- جنسي", "Use": "– يس#?خ#~م ل#?حسين #.لوظ#.ئ#< #<ي #.لمخ #<هو يزي#~ من #.ل#?#^#=يز #.ل#>#.م وقوة #.ل#>ملي#.#? #.لذهنية وي#?#_ح #?أثي#^ه #%قوه #>لي #=#%#.#^ #.لسن \r\n\r\n– #?حسين وظ#.ئ#< #.لقل#% ووق#.ي#?ه من #.لقصو#^ \r\n\r\n– يس#.#>#~ #%قوه #<ي #?حسين #.ل#%ش#^ة حيث ي#_ي#< له#. #.لحيوية و#.لن#_#.#^ة \r\n\r\n– يس#.#>#~ #<ي #>ل#.ج #_#>#< #.ل#.ن#?ص#.#% و#_#>#< #.لق#~#^ة #.لجنسية \r\n\r\n– يس#.#>#~ #<ي #>ل#.ج #?س#.ق#- #.لش#>#^ ويحسن من ح#.ل#?ه #.لصحية \r\n\r\n– يح#?وي #>لي م#_#.#~#.#? #.لأ#=س#~ة #.ل#?ي #?قي #.لجسم من #.لأجس#.م #.لح#^ة \r\n\r\n– يح#.#^#% #>ل#.م#.#? #?ق#~م #.ل#>م#^ #>لي #.ل#%ش#^ة \r\n\r\n– يس#.#>#~ #>لي #.ل#?مثيل #.لغذ#.ئي وح#^ق #.لس#>#^#.#? و#%#.ل#?#.لي خ#<#_ #.لوزن \r\n\r\n– ل#. يس#?خ#~م #<ي ح#.ل#.#? س#^#-#.ن #.ل#^حم أو س#^#-#.ن #.لث#~ي #.و #.و#^#.م #.ل#^حم #.للي#<يه", "Contraindications": "– ل#. يس#?خ#~م #.ل#~و#.ء #.ذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من حس#.سيه ل#.ح#~ م#=ون#.#? #.ل#~و#.ء \r\n\r\n– أث#%#?#? #.لأ#%ح#.ث #.ل#>لمية #.ن له أ#_#^#.#^ #%#.لغه #>لي #.لجنين لذل#= ل#. يس#?خ#~م #<ي #<#?#^ه #.لحمل وين#%غي #>#~ #?ن#.ول \r\n\r\n– أي م#=مل#.#? غذ#.ئية أو أي أنو#.#> من #.ل#>سل #.نه ل#. يح#?وي #>لي ن#%#.#? #.لجنسنج \r\n\r\n– ل#. يج#% #.س#?خ#~مه لم#~ه #?زي#~ #>ن س#? #.شه#^ م#?و#.صلة ل#.ن #.ل#%#.حثين ي#>#?ق#~ون أنه#. #?س#%#% #?أثي#^ مش#.#%هه لله#^مون#.#? و#.ل#?ي ل#. ين#%غي أن #?س#?خ#~م #>لي #<#?#^#.#? #-ويله \r\n\r\n– يج#% #.خذ #.لحذ#^ #.ذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من م#^#_ #.لس#=#^ي \r\n\r\n– يج#% #.حذ #.لحذ#^ #.ذ#. #=#.ن #.لم#^ي#_ ي#>#.ني م #.#_#-#^#.#%#.#? #<ي مو#.#>ي#~ #.لنوم \r\n\r\n– يج#% إل#. يس#?خ#~م أل#. #?ح#? إش#^#.#< #-#%ي ش#~ي#~ #.ذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من أم#^#.#_ #<ي #.لقل#% أو #.لأو#>ية #.ل#~موي", "GI": "About Ginseng\r\nSteroid glycosides.\r\nMechanism of Action of Ginseng\r\nIt contains chemicals called ginsenosides that seem to affect insulin levels in the body and lower blood sugar. Other chemicals, called polysaccharides, might affect the immune system.\r\nIndications for Ginseng\r\n1.Adaptogen-adapt to internal/external stressors, fight fatigue, increase stamina \r\n2.Lowering blood sugar after a meal in people with type 2 diabetes \r\n3.Preventing respiratory tract infections such as the common cold or influenza in adults \r\nInteractions for Ginseng\r\n1.Warfarin:Ginseng decreases its effectiveness. \r\n2.Medications for diabetes (Antidiabetes drugs). \r\n3.Antidepressants: Panax ginseng might stimulate the body.. Taking Panax ginseng with these medications used for depression might cause too much stimulation. This might cause side effects such as anxiousness, headache, restlessness, and insomnia.", "Composition": "ginseng 100mg or 47mg", "Route": "ORAL.SOLID" }, { "ID": "218", "Trade_Name": "LEPTICURE 400 MG 10 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "31.2", "Price_Old": "31.2", "Company": "PHAROPHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "gabapentin 300mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "219", "Trade_Name": "JOFLEX 500MG 30 CAPS.", "Generic_Name": "GLUCOSAMINE", "Price": "20.75", "Price_Old": "13.8", "Company": "GLOBAL NAPI PHARMACEUTICALS > EMA PHARM", "Pharmacology": "OSTEOARTHRITIS", "Category": "م#_#.#~ ل#.ل#?ه#.#% #.لم#<#.صل", "Use": "–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل . \r\n\r\n– #>ل#.ج خشونة و#?آ#=ل #.لم#<#.صل . \r\n\r\n– #>ل#.ج #?أ#=ل #.لغ#_#.#^ي#< #.لم#^#?#%#- #%خشونة #.لم#<#.صل . \r\n\r\n– يحسن من و#_#> #.لم#<صل . \r\n\r\n– #~و#.ء مس#=ن لآل#.م #.لم#<#.صل . \r\n\r\n– يح#.#<ظ #>لى صحة #.لغ#_#^و#< و#.لم#<#.صل . \r\n\r\n– يس#?خ#~م #=#>ل#.ج مس#.#>#~ ل#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n– #>ل#.ج آل#.م أس#<ل #.لظه#^ . \r\n\r\n– مش#.#=ل #.لم#<#.صل . \r\n\r\n– #.ل#?ه#.#%#.#? #.لم#<#.صل #<ي #.ل#^#=#%ة . \r\n\r\n– آل#.م #.لم#<#.صل #.لن#.#?جة #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n– يس#?خ#~م لل#?خ#<ي#< من آل#.م #.لخ#<ي#<ة و#.لم#>#?#~لة . \r\n\r\n– يقلل من #<#^ص #.لإص#.#%ة #%هش#.شة #.ل#>ظ#.م . \r\n\r\n– #>ل#.ج #.لإص#.#%#.#? #.ل#^ي#.#_ية .", "Contraindications": "– #-#<ح جل#~ي . \r\n\r\n– ح#=ة و#?و#^م #<ي #.لجسم . \r\n\r\n– #?و#^م #<ي #.للس#.ن و#.لش#<#?ين . \r\n\r\n– #.حم#^#.#^ #.لوجه .", "GI": "About Glucosamine\r\nAmino sugar,Monosaccharide derivative, Anti-inflammatory,Antiarthritic.\r\nMechanism of Action of Glucosamine\r\nIt stimulates cartilage cells to produce glucosaminoglycans and proteoglycans which are the building blocks of cartilage. This stops the progression of OA (osteoarthritis) and possibly reverses the process. It also has anti-inflammatory properties by its inhibition of proteolytic enzymes.\r\nIndications for Glucosamine\r\n1. Osteo arthritis. \r\n2. Rheumatoid arthritis \r\nTypical Dosage for Glucosamine\r\nOral- \r\nAdult:1200mg /day", "Composition": "Each capsule contains:\r\nGlucosamine sulfate. Pot. Salt 500 mg - (Sodium free).", "Route": "ORAL.SOLID" }, { "ID": "220", "Trade_Name": "ORACAL 500MG 30 TAB.", "Generic_Name": "CALCIUM", "Price": "21.6", "Price_Old": "21.6", "Company": "DELTA PHARMA", "Pharmacology": "CALCIUM SUPPLEMENT", "Category": "م#=مل #.ل#=#.لسيوم", "Use": "–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? نقص #.ل#=#.لسيوم #<ي #.لجسم . \r\n\r\n–يس#.#>#~ #>لي #.ل#?ح#=م #<ي #.#^#?#<#.#> مس#?وي #.لمغنيسيوم و#.ل#%و#?#.سيوم و#.ل#<وس#<و#^ #<ي #.ل#~م . \r\n\r\n–ي#?م #?ن#.ول هذ#. #.ل#~و#.ء #%ج#.ن#% #.خذ #<ي#?#.مين #~ ل#?قليل #<ق#~#.ن #.ي م#>#~#.ن #<ي #.ل#>ظ#.م وخ#.صة لل#.شخ#.ص #.لذين ي#?ن#.ولون أ#~وية #.ل#=و#^#?ي#=وس#?ي#^وي#~ ل#<#?#^#.#? #-ويلة. \r\n\r\n–يم#=ن #.س#?#>م#.له للحو#.مل ل#?#>وي#_ نقص #.ل#=#.لسيوم #<ي #.لجسم . \r\n\r\n–يمن#> #.ل#.ص#.#%ة #%هش#.شة #.ل#>ظ#.م . \r\n\r\n–يقي من #.ل#.ص#.#%ة #%#.ل#>#~ي#~ من #.نو#.#> #.ل#.و#^#.م #.لس#^#-#.نية #.لمخ#?ل#<ة . \r\n\r\n–يقلل #.ل#~و#.ء #<ي م#>#~ل #.#<#^#.ز #.لغ#~ة #.ل#~#^قية لل#.شخ#.ص #.لمص#.#%ون #%#<شل #.ل#=لي أو #.#^#?#<#.#> #<ي مس#?وي #.لغ#~ة .", "Contraindications": "–يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #>لي م#>#~ة #<#.#^غة لل#.شخ#.ص #.لمص#.#%ون #%نقص #<ي مس#?وي حم#_ #.لم#>#~ة . \r\n\r\n–يج#% #>#~م #.ل#?#~خين خل#.ل #<#?#^ة #.ل#>ل#.ج لأنه يؤ#~ي #.لي #?قليل #.م#?ص#.ص #.لم#>#~ة لل#~و#.ء و#%#.ل#?#.لي نقص ن#?#.ئجه و#?أثي#^ه . \r\n\r\n–ي#?#~#.خل م#> #.ل#>ل#.ج #%ه#^مون#.#? #.لغ#~ة #.ل#~#^قية لذل#= ل#.#%#~ من #.ل#<صل #>لى #.لأقل أ#^#%#> س#.#>#.#? #%ين #=ل #~و#.ء و#.لأخ#^. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.س#?#>م#.ل هذ#. #.ل#~و#.ء لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي #.ل#=#%#~ أو #<#^#- نس#%ة #.ل#=#.لسيوم #<ي #.ل#~م .", "GI": "Treating or preventing calcium deficiency. It may also be used for other conditions as determined by your doctor.SSCalcium carbonate is a dietary supplement. It works by providing extra calcium to the body.SSDo NOT use calcium carbonate if:SSyou are allergic to any ingredient in calcium carbonateSyou have high blood calcium levels", "Composition": "calcium carbonate 1250mg", "Route": "ORAL.SOLID" }, { "ID": "221", "Trade_Name": "GABALEPSY 300MG 20 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "46", "Price_Old": "46", "Company": "EL-OBOUR", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Gabapentin 100,300 ,600", "Route": "ORAL.SOLID" }, { "ID": "222", "Trade_Name": "CONVENTIN 300MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "60", "Price_Old": "60", "Company": "EVA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each Capsule of :Conventin 100mg contains : active ingredient: Gabapentin 100 mg\r\nConventin 300 mg contains : active ingredient: Gabapentin 300 mg\r\nConventin 400mg contains : active ingredient: Gabapentin 400 mg\r\nInactive ingredients :\r\nMicrocrystalline cellu", "Route": "ORAL.SOLID" }, { "ID": "223", "Trade_Name": "GAPTIN 100MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "45", "Price_Old": "30", "Company": "DELTA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each capsule contains:\r\nGabapentin 100,300 or 400 mg.\r\n\r\nEach Box contains:\r\nGabapentin 250 mg 15 ml Syrup", "Route": "ORAL.SOLID" }, { "ID": "224", "Trade_Name": "NEUROGLOPENTIN 300 MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "51", "Price_Old": "51", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each Neuroglopentin capsule contains 100 mg, 300 mg, or 400 mg of gabapentin.", "Route": "ORAL.SOLID" }, { "ID": "225", "Trade_Name": "GAPTIN 300MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "66", "Price_Old": "66", "Company": "DELTA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each capsule contains:\r\nGabapentin 100,300 or 400 mg.\r\n\r\nEach Box contains:\r\nGabapentin 250 mg 15 ml Syrup", "Route": "ORAL.SOLID" }, { "ID": "226", "Trade_Name": "ADAPTAN 300 MG 10 SOFT GELATIN CAP.", "Generic_Name": "GABAPENTIN", "Price": "21.6", "Price_Old": "21.6", "Company": "EUROPEAN EGYPTIAN PHARM. IND.", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "gabapentin 300mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "227", "Trade_Name": "LEPTICURE 300 MG 10 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "20.4", "Price_Old": "20.4", "Company": "PHAROPHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "gabapentin 300mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "228", "Trade_Name": "NEUROGLOPENTIN 100 MG 30 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "28.5", "Price_Old": "28.5", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each Neuroglopentin capsule contains 100 mg, 300 mg, or 400 mg of gabapentin.", "Route": "ORAL.SOLID" }, { "ID": "229", "Trade_Name": "NEURONTIN 300MG 20 CAPS.", "Generic_Name": "GABAPENTIN", "Price": "64", "Price_Old": "64", "Company": "PFIZER", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "gabapentin 300mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "230", "Trade_Name": "TRICONAL 50MG 7 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "53", "Price_Old": "35.3", "Company": "T3A PHARMA", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "231", "Trade_Name": "FLUCORAL 150MG 2 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "17.52", "Price_Old": "17.52", "Company": "SEDICO", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "232", "Trade_Name": "FLOCAZOLE 150MG 1 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "21.6", "Price_Old": "21.6", "Company": "SPIMACO > EIMC", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "233", "Trade_Name": "ALKANAZOLE 150MG 1 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "17.64", "Price_Old": "17.64", "Company": "FUTURE PHARMACEUTICAL INDUSTRIES (FPI) > INTERNATIONAL TRADING OFFICE", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "234", "Trade_Name": "TREFLUCAN 150MG 1 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "15", "Price_Old": "10", "Company": "EIPICO", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "235", "Trade_Name": "FUNGICAN 150MG 2 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "36", "Price_Old": "24", "Company": "AMOUN", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "Fungican 150 capsule contains as its active ingredient fluconazole 150mg.", "Route": "ORAL.SOLID" }, { "ID": "236", "Trade_Name": "DIFLUCAN 150MG 1 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "48.75", "Price_Old": "32.4", "Company": "PFIZER", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg, 50mg, 2mg, 5mg", "Route": "ORAL.SOLID" }, { "ID": "237", "Trade_Name": "JENFUNGA 150 MG 1 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "4.5", "Price_Old": "4.5", "Company": "EGPI > JENIKO MEDICINE PHARMACEUTICALS", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "238", "Trade_Name": "AMRIFLUCAN 150 MG 2 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "11", "Price_Old": "11", "Company": "AMRIYA", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg", "Route": "ORAL.SOLID" }, { "ID": "239", "Trade_Name": "TRICONAL 150MG 1 CAPS.", "Generic_Name": "FLUCONAZOLE", "Price": "26.5", "Price_Old": "17.64", "Company": "T3A PHARMA > VODACHEM PHARMACEUTICALS", "Pharmacology": "ANTIFUNGALS.TRIAZOLES", "Category": "م#_#.#~#.#? لل#<#-#^ي#.#? م#> #?#^ي#.زول", "Use": "–#.ل#?ه#.#% #.لسح#.ي#. #.ل#~م#.غي. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأظ#.#<#^. \r\n\r\n–#.ل#?ه#.#%#.#? #.لقل#% #.ل#<#-#^ية و#.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.ل#^ئوية و#.لجل#~ية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لمه#%لية #>ن#~ #.لنس#.ء، و#.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية #>ن#~ #.ل#^ج#.ل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#<م و#.لحلق و#.لمج#.#^ي #.له#_مية. \r\n\r\n–#.ل#?ه#.#%#.#? #.لق#~م #.لم#?نو#>ة (س#>#<ة #.لق#~م #.ل#^ي#.#_ية #=مث#.ل). \r\n\r\n–#?س#?خ#~م #=ذل#= لم#^#_ى نقص #.لمن#.#>ة #.لم#=#?س#%ة، ل#>ل#.ج #.ل#?ق#^ح#.#? و#.ل#<#-#^ي#.#? #.لمص#.ح#%ة للم#^#_، و#.ل#?خ#<ي#< من ح#~#?ه#..", "Contraindications": "–ل#. #?س#?خ#~م هذ#. #.ل#~و#.ء أ#%#~ً#. #>ن#~ وجو#~ أي من #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–#.لحس#.سية #.لش#~ي#~ة #?ج#.ه أي م#^#=#% ي#~خل #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–وجو#~ أية مش#.#=ل صحية #%#.لقل#% أو #.ل#=لى أو #.ل#=#%#~. \r\n\r\n–ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة، ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء. \r\n\r\n–#?#>#.#-ي #.ل#~و#.ء م#> أي #~و#.ء آخ#^ #~ون إ#>ل#.م #.ل#-#%ي#% #.لمش#^#< #>لى #.ل#>ل#.ج، #=ون ذل#= ق#~ يس#%#% ح#.ل#.#? #?سمم #~و#.ئي و#.خ#?ل#.#-#.#? #~و#.ئية غي#^ م#^غو#%ة. \r\n\r\n–#>ن#~ قي#.#~ة #.لسي#.#^ة، ي#<#_ل #>#~م #?ن#.ول #.ل#~و#.ء نظ#^ً#. ل#=ونه ق#~ يس#%#% #.ل#~و#.#^ أو #.لص#~#.#> ويؤث#^ #>لى #.لق#~#^ة #>لى #.ل#?ق#~ي#^ #.لصحيح.", "GI": "About Fluconazole\r\nA triazole derivative, A board range Antifungal.\r\n\r\nMechanism of Action of Fluconazole\r\nFluconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\n\r\nInteractions for Fluconazole\r\nCimetidine: Decreased efficacy of fluconazole. \r\nCyclosporine: Increase in serum cyclosporine plasma concentration. \r\nHydrochlorothiazide: Reduction in renal clearance of fluconazole. \r\nPhenytoin: Efficacy of phenytoin enhanced. \r\nRifampicin: Efficacy of fluconazole decreased, higher dosage required. \r\nSulfonylureas: Efficacy of tolbutamide, glyburide and glipizide increased. \r\nWarfarin: Potentiates the anticoagulant effect resulting in increase in prothrombin time. \r\n\r\nIndications for Fluconazole\r\n1.Oesophageal candidiasis \r\n2.Oropharyngeal candidiasis \r\n3.Vaginal candidiasis \r\n4.Systemic candidiasis \r\n5.Cryptoc", "Composition": "fluconazole 150mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "240", "Trade_Name": "INDOMETHACIN 25MG 24 CAPS.", "Generic_Name": "INDOMETHACIN", "Price": "4.75", "Price_Old": "4.75", "Company": "PHARCO", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=مس#=ن لل#.لم وخ#.#<#_ للح#^#.#^ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.لنق#^سي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.لم#<صلي #.لي#<#>ي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لح#.ل#.#? #.لم#?وس#-ة و#.لش#~ي#~ة من #.ل#^وم#.#?وي#~ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #>س#^ #.ل#-مث وآل#.م م#. #%#>#~ #.لول#.#~ة و#.لج#^#.حة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#?#.لنق#^س #.لح#.#~ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج إص#.#%#.#? #.لأغشية #.ل#^خوة و #.ل#?ه#.#%#.#? أل#.#^#%#-ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج آل#.م #.ل#>#_ل#.#? #.ل#^وم#.#?يزمية \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لج#^#.#% و #.ي#_#. #.ل#?ه#.#% #.ل#.و#?#.#^ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% و#?ي#%س #<ق#^#.#? #.ل#>مو#~ #.ل#<ق#^ى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لم #.ل#>#_ل#.#? و#.ي#_#. يس#?خ#~م لل#.ل#.م #.س#<ل #.لظه#^", "Contraindications": "–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #.ل#^#%و \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لم#?وق#> خ#_و#>هم ل#>ملية لقل#% #.لم#<#?وح \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من ق#^حة #%#.لم#>#~ة #.و نزي#< #%#.لجه#.ز #.له#_مى \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #=#%#~ى #.و #=لوى ش#~ي#~", "GI": "About Indomethacin\r\nNSAID, Indole derivative, Anti-inflammatory, potent antipyretic and analgesic.\r\n\r\nMechanism of Action of Indomethacin\r\nIndomethacin acts by inhibition of Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Indomethacin does not affect the tenderness induced by PGs but block the pain producing mechanism induced by inflammatory mediators by inhibiting the enzyme cyclo-oxygenase. \r\n\r\nInteractions for Indomethacin\r\nAnticoagulants: May prolong prothrombin time. Instruct patients to watch for signs & symptoms of bleeding. \r\nBeta-Blockers: Antihypertensive effect may be blunted. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nDigoxin: Serum digoxin levels may be increased by ibuprofen and indomethacin. \r\nHydantoins: Serum hydantoin levels increased resulting in increased pharmacological and toxic effects. \r\nLithium: Serum lithium levels may be increased.", "Composition": "Each Capsule contains: indomethacin 25 mg.\r\n\r\nEach Suppository Contains: indomethacin 100 mg.", "Route": "ORAL.SOLID" }, { "ID": "241", "Trade_Name": "ISORIFAMPIN 10 CAPS.", "Generic_Name": "ISONIAZID+RIFAMPICIN", "Price": "10", "Price_Old": "10", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTITUBERCULAR", "Category": "م#_#.#~ للسل", "Use": "–م#_#.#~ حيوي و#.س#> #.لمج#.ل . \r\n\r\n–ي#>#.لج م#^#_ #.لسل م#> #~و#.ء أيزوني#.زي#~ و#%ي#^#.زين#.مي#~ . \r\n\r\n–#>ل#.ج #.لجذ#.م . \r\n\r\n–#>ل#.ج #~#.ء #.ل#<ي#.لقة . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.ل#?ي ل#. #?س#?جي#% #%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون وي#?م #?ن#.ول #.ل#^ي#<#.مي#%سين م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين . \r\n\r\n–#>ل#.ج حمى #.لم#.ل#-ية #%ج#.ن#%ه #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول و#?#^ي ميثو#%#^يم . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية أو #.لمس#?#~مية #.لنزلية .", "Contraindications": "–لمن ل#~يهم حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لم#^#_ى #.لي#^ق#.ن #?جن#% #.س#?خ#~#.م #^يم#.#=#?#.زي#~ . \r\n\r\n–ل#. ي#?م أخذ أ#~وية #^ي#<#.مي#%سين #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~ .", "GI": "About Isoniazid\r\nHydrazine derivative, Antitubercular Agent.\r\nMechanism of Action of Isoniazid\r\nIsoniazid is a bactericidal drug. I t inhibits the mycolic acid synthesis which is essential for the cell wall formation. It also inhibits DNA, RNA and protein synthesis and cell metabolism. As the results of these bacterial death occurs.\r\nIndications for Isoniazid\r\n1.Tuberculosis (pulmonary &extra pulmonary)\r\nInteractions for Isoniazid\r\nAlcohol: Regular ingestion of alcohol is associated with higher incidence of INH-related hepatitis. \r\nAluminium Salts: Oral absorption of INH reduced leading to decreased serum levels. \r\nOral anticoagulants: Efficacy of oral anticoagulants increased. \r\nBenzodiazepines: Activity of benzodiazepines that undergo oxidative metabolism is possibly increased. \r\nCarbamazepine: Isoniazid hepatotoxicity & carbamazepine toxicity may occur from concurrent use. \r\nCycloserine: Increased cycloserine related CNS side effects, especially dizziness.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "242", "Trade_Name": "HAEMOJET 100 MG 36 SOFT GELATIN CAPS.", "Generic_Name": "IRON", "Price": "47.25", "Price_Old": "31.5", "Company": "EUROPEAN EGYPTIAN PHARM. IND.", "Pharmacology": "ANEMIA.IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~ ل#<ق#^ #.ل#~م #.ل#.نيمي#.", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لأنيمي#. #.لن#.#?جة #>ن نقص #.لح#~ي#~. \r\n\r\n–ي#>و#_ #<ق#~ #.ل#~م #<ي ح#.ل#.#? #.لنزي#< #>ن#~ #.لسي#~#.#?. \r\n\r\n–م#^#_ي #.لنزي#< #.لم#?#=#^#^. \r\n\r\n–م#=مل غذ#.ئي للح#.مل و#.لم#^#_#>ة و#.لأ#-#<#.ل #.ل#^#_#>.", "Contraindications": "–إذ#. #=#.ن #.لم#^ي#_ ي#>#.ني م#^#_ و#^#.ثي يؤ#~ي إلى #?خزين #.لح#~ي#~ #<ي #.ل#=ثي#^ من #.لأنسجة. \r\n\r\n–للأشخ#.ص #.لذين ي#>#.نون #%ش#=ل م#?#=#^#^ لنقل #.ل#~م.لم#^#_ى #.ل#?ه#.#% #.لأم#>#.ء مثل #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي أو م#^#_ #=#^ون أو وجو#~ ق#^حة ه#_مية نش#-ة. \r\n\r\n–للم#^#_ى #.لذين ي#>#.نون من #.#_#-#^#.#% يؤث#^ #>لى #?خزين #.لح#~ي#~ #<ي #.لجسم. \r\n\r\n–إذ#. #=#.ن #.لم#^ي#_ ل#~يه حس#.سية من أي م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–للأشخ#.ص #.لذين ي#>#.نون من #<ق#^ #.ل#~م #%س#%#% نقص حم#_ #.ل#<ولي#=. \r\n\r\n–أثن#.ء #<#?#^ة #.لحمل: يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #.س#?#>م#.ل #~و#.ء هيموجي#?، ول#=ن من #.لمم#=ن أن #?أخذ م#=مل#.#? #.لح#~ي#~ خل#.ل #<#?#^ة #.لحمل. \r\n\r\n–أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية: أث#%#?#? #.ل#~#^#.س#.#? #.ل#-#%ية أنه ليس ل#~و#.ء أي أث#.#^ #_#.#^ة م#>#^و#<ة #>ن#~ #.س#?#>م#.ل هيموجي#? ش#^#.#%، لذل#= يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء.", "GI": "Description\t\r\nA metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.SSIndication\tSUsed in preventing and treating iron-deficiency anemia.SSMechanism of action\tSIron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "243", "Trade_Name": "INDOMIN 25MG 30 CAPS.", "Generic_Name": "INDOMETHACIN", "Price": "1.9", "Price_Old": "1.9", "Company": "MISR", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=مس#=ن لل#.لم وخ#.#<#_ للح#^#.#^ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.لنق#^سي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.لم#<صلي #.لي#<#>ي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لح#.ل#.#? #.لم#?وس#-ة و#.لش#~ي#~ة من #.ل#^وم#.#?وي#~ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #>س#^ #.ل#-مث وآل#.م م#. #%#>#~ #.لول#.#~ة و#.لج#^#.حة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#?#.لنق#^س #.لح#.#~ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج إص#.#%#.#? #.لأغشية #.ل#^خوة و #.ل#?ه#.#%#.#? أل#.#^#%#-ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج آل#.م #.ل#>#_ل#.#? #.ل#^وم#.#?يزمية \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لج#^#.#% و #.ي#_#. #.ل#?ه#.#% #.ل#.و#?#.#^ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% و#?ي#%س #<ق#^#.#? #.ل#>مو#~ #.ل#<ق#^ى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لم #.ل#>#_ل#.#? و#.ي#_#. يس#?خ#~م لل#.ل#.م #.س#<ل #.لظه#^", "Contraindications": "–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #.ل#^#%و \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لم#?وق#> خ#_و#>هم ل#>ملية لقل#% #.لم#<#?وح \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من ق#^حة #%#.لم#>#~ة #.و نزي#< #%#.لجه#.ز #.له#_مى \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #=#%#~ى #.و #=لوى ش#~ي#~", "GI": "About Indomethacin\r\nNSAID, Indole derivative, Anti-inflammatory, potent antipyretic and analgesic.\r\n\r\nMechanism of Action of Indomethacin\r\nIndomethacin acts by inhibition of Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Indomethacin does not affect the tenderness induced by PGs but block the pain producing mechanism induced by inflammatory mediators by inhibiting the enzyme cyclo-oxygenase. \r\n\r\nInteractions for Indomethacin\r\nAnticoagulants: May prolong prothrombin time. Instruct patients to watch for signs & symptoms of bleeding. \r\nBeta-Blockers: Antihypertensive effect may be blunted. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nDigoxin: Serum digoxin levels may be increased by ibuprofen and indomethacin. \r\nHydantoins: Serum hydantoin levels increased resulting in increased pharmacological and toxic effects. \r\nLithium: Serum lithium levels may be increased.", "Composition": "indomethacin 25mg", "Route": "ORAL.SOLID" }, { "ID": "244", "Trade_Name": "RIOZID 150/300 MG 8CAPS.", "Generic_Name": "ISONIAZID+RIFAMPICIN", "Price": "10", "Price_Old": "10", "Company": "MUP", "Pharmacology": "ANTITUBERCULAR", "Category": "م#_#.#~ للسل", "Use": "–م#_#.#~ حيوي و#.س#> #.لمج#.ل . \r\n\r\n–ي#>#.لج م#^#_ #.لسل م#> #~و#.ء أيزوني#.زي#~ و#%ي#^#.زين#.مي#~ . \r\n\r\n–#>ل#.ج #.لجذ#.م . \r\n\r\n–#>ل#.ج #~#.ء #.ل#<ي#.لقة . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.ل#?ي ل#. #?س#?جي#% #%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون وي#?م #?ن#.ول #.ل#^ي#<#.مي#%سين م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين . \r\n\r\n–#>ل#.ج حمى #.لم#.ل#-ية #%ج#.ن#%ه #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول و#?#^ي ميثو#%#^يم . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية أو #.لمس#?#~مية #.لنزلية .", "Contraindications": "–لمن ل#~يهم حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لم#^#_ى #.لي#^ق#.ن #?جن#% #.س#?خ#~#.م #^يم#.#=#?#.زي#~ . \r\n\r\n–ل#. ي#?م أخذ أ#~وية #^ي#<#.مي#%سين #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~ .", "GI": "About Isoniazid\r\nHydrazine derivative, Antitubercular Agent.\r\nMechanism of Action of Isoniazid\r\nIsoniazid is a bactericidal drug. I t inhibits the mycolic acid synthesis which is essential for the cell wall formation. It also inhibits DNA, RNA and protein synthesis and cell metabolism. As the results of these bacterial death occurs.\r\nIndications for Isoniazid\r\n1.Tuberculosis (pulmonary &extra pulmonary)\r\nInteractions for Isoniazid\r\nAlcohol: Regular ingestion of alcohol is associated with higher incidence of INH-related hepatitis. \r\nAluminium Salts: Oral absorption of INH reduced leading to decreased serum levels. \r\nOral anticoagulants: Efficacy of oral anticoagulants increased. \r\nBenzodiazepines: Activity of benzodiazepines that undergo oxidative metabolism is possibly increased. \r\nCarbamazepine: Isoniazid hepatotoxicity & carbamazepine toxicity may occur from concurrent use. \r\nCycloserine: Increased cycloserine related CNS side effects, especially dizziness.", "Composition": "isoniazid 150mg,rifampicin 300mg", "Route": "ORAL.SOLID" }, { "ID": "245", "Trade_Name": "ISORIFA 150/300 MG 10 CAPS.", "Generic_Name": "ISONIAZID+RIFAMPICIN", "Price": "10.5", "Price_Old": "10.5", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "ANTITUBERCULAR", "Category": "م#_#.#~ للسل", "Use": "–م#_#.#~ حيوي و#.س#> #.لمج#.ل . \r\n\r\n–ي#>#.لج م#^#_ #.لسل م#> #~و#.ء أيزوني#.زي#~ و#%ي#^#.زين#.مي#~ . \r\n\r\n–#>ل#.ج #.لجذ#.م . \r\n\r\n–#>ل#.ج #~#.ء #.ل#<ي#.لقة . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.ل#?ي ل#. #?س#?جي#% #%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون وي#?م #?ن#.ول #.ل#^ي#<#.مي#%سين م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين . \r\n\r\n–#>ل#.ج حمى #.لم#.ل#-ية #%ج#.ن#%ه #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول و#?#^ي ميثو#%#^يم . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية أو #.لمس#?#~مية #.لنزلية .", "Contraindications": "–لمن ل#~يهم حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لم#^#_ى #.لي#^ق#.ن #?جن#% #.س#?خ#~#.م #^يم#.#=#?#.زي#~ . \r\n\r\n–ل#. ي#?م أخذ أ#~وية #^ي#<#.مي#%سين #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~ .", "GI": "About Isoniazid\r\nHydrazine derivative, Antitubercular Agent.\r\nMechanism of Action of Isoniazid\r\nIsoniazid is a bactericidal drug. I t inhibits the mycolic acid synthesis which is essential for the cell wall formation. It also inhibits DNA, RNA and protein synthesis and cell metabolism. As the results of these bacterial death occurs.\r\nIndications for Isoniazid\r\n1.Tuberculosis (pulmonary &extra pulmonary)\r\nInteractions for Isoniazid\r\nAlcohol: Regular ingestion of alcohol is associated with higher incidence of INH-related hepatitis. \r\nAluminium Salts: Oral absorption of INH reduced leading to decreased serum levels. \r\nOral anticoagulants: Efficacy of oral anticoagulants increased. \r\nBenzodiazepines: Activity of benzodiazepines that undergo oxidative metabolism is possibly increased. \r\nCarbamazepine: Isoniazid hepatotoxicity & carbamazepine toxicity may occur from concurrent use. \r\nCycloserine: Increased cycloserine related CNS side effects, especially dizziness.", "Composition": "isoniazid 150mg,rifampicin 300mg", "Route": "ORAL.SOLID" }, { "ID": "246", "Trade_Name": "BONIDON 75MG 20 DEPOCAPS.", "Generic_Name": "INDOMETHACIN", "Price": "16", "Price_Old": "16", "Company": "MUP > ACINO", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=مس#=ن لل#.لم وخ#.#<#_ للح#^#.#^ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.لنق#^سي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.لم#<صلي #.لي#<#>ي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لح#.ل#.#? #.لم#?وس#-ة و#.لش#~ي#~ة من #.ل#^وم#.#?وي#~ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #>س#^ #.ل#-مث وآل#.م م#. #%#>#~ #.لول#.#~ة و#.لج#^#.حة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#?#.لنق#^س #.لح#.#~ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج إص#.#%#.#? #.لأغشية #.ل#^خوة و #.ل#?ه#.#%#.#? أل#.#^#%#-ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج آل#.م #.ل#>#_ل#.#? #.ل#^وم#.#?يزمية \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لج#^#.#% و #.ي#_#. #.ل#?ه#.#% #.ل#.و#?#.#^ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% و#?ي#%س #<ق#^#.#? #.ل#>مو#~ #.ل#<ق#^ى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لم #.ل#>#_ل#.#? و#.ي#_#. يس#?خ#~م لل#.ل#.م #.س#<ل #.لظه#^", "Contraindications": "–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #.ل#^#%و \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لم#?وق#> خ#_و#>هم ل#>ملية لقل#% #.لم#<#?وح \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من ق#^حة #%#.لم#>#~ة #.و نزي#< #%#.لجه#.ز #.له#_مى \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #=#%#~ى #.و #=لوى ش#~ي#~", "GI": "About Indomethacin\r\nNSAID, Indole derivative, Anti-inflammatory, potent antipyretic and analgesic.\r\n\r\nMechanism of Action of Indomethacin\r\nIndomethacin acts by inhibition of Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Indomethacin does not affect the tenderness induced by PGs but block the pain producing mechanism induced by inflammatory mediators by inhibiting the enzyme cyclo-oxygenase. \r\n\r\nInteractions for Indomethacin\r\nAnticoagulants: May prolong prothrombin time. Instruct patients to watch for signs & symptoms of bleeding. \r\nBeta-Blockers: Antihypertensive effect may be blunted. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nDigoxin: Serum digoxin levels may be increased by ibuprofen and indomethacin. \r\nHydantoins: Serum hydantoin levels increased resulting in increased pharmacological and toxic effects. \r\nLithium: Serum lithium levels may be increased.", "Composition": "indomethacin 75mg", "Route": "ORAL.SOLID" }, { "ID": "247", "Trade_Name": "RIFAZID 150/300 8CAPS.", "Generic_Name": "ISONIAZID+RIFAMPICIN", "Price": "6", "Price_Old": "6", "Company": "EL NASR", "Pharmacology": "ANTITUBERCULAR", "Category": "م#_#.#~ للسل", "Use": "–م#_#.#~ حيوي و#.س#> #.لمج#.ل . \r\n\r\n–ي#>#.لج م#^#_ #.لسل م#> #~و#.ء أيزوني#.زي#~ و#%ي#^#.زين#.مي#~ . \r\n\r\n–#>ل#.ج #.لجذ#.م . \r\n\r\n–#>ل#.ج #~#.ء #.ل#<ي#.لقة . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?جة #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.ل#?ي ل#. #?س#?جي#% #%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون وي#?م #?ن#.ول #.ل#^ي#<#.مي#%سين م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين . \r\n\r\n–#>ل#.ج حمى #.لم#.ل#-ية #%ج#.ن#%ه #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول و#?#^ي ميثو#%#^يم . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية أو #.لمس#?#~مية #.لنزلية .", "Contraindications": "–لمن ل#~يهم حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لم#^#_ى #.لي#^ق#.ن #?جن#% #.س#?خ#~#.م #^يم#.#=#?#.زي#~ . \r\n\r\n–ل#. ي#?م أخذ أ#~وية #^ي#<#.مي#%سين #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~ .", "GI": "About Isoniazid\r\nHydrazine derivative, Antitubercular Agent.\r\nMechanism of Action of Isoniazid\r\nIsoniazid is a bactericidal drug. I t inhibits the mycolic acid synthesis which is essential for the cell wall formation. It also inhibits DNA, RNA and protein synthesis and cell metabolism. As the results of these bacterial death occurs.\r\nIndications for Isoniazid\r\n1.Tuberculosis (pulmonary &extra pulmonary)\r\nInteractions for Isoniazid\r\nAlcohol: Regular ingestion of alcohol is associated with higher incidence of INH-related hepatitis. \r\nAluminium Salts: Oral absorption of INH reduced leading to decreased serum levels. \r\nOral anticoagulants: Efficacy of oral anticoagulants increased. \r\nBenzodiazepines: Activity of benzodiazepines that undergo oxidative metabolism is possibly increased. \r\nCarbamazepine: Isoniazid hepatotoxicity & carbamazepine toxicity may occur from concurrent use. \r\nCycloserine: Increased cycloserine related CNS side effects, especially dizziness.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "248", "Trade_Name": "INDOMETHACIN 50MG 24 CAPS.", "Generic_Name": "INDOMETHACIN", "Price": "5.25", "Price_Old": "5.25", "Company": "PHARCO", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=مس#=ن لل#.لم وخ#.#<#_ للح#^#.#^ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.لنق#^سي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.لم#<صلي #.لي#<#>ي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لح#.ل#.#? #.لم#?وس#-ة و#.لش#~ي#~ة من #.ل#^وم#.#?وي#~ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #>س#^ #.ل#-مث وآل#.م م#. #%#>#~ #.لول#.#~ة و#.لج#^#.حة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#?#.لنق#^س #.لح#.#~ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج إص#.#%#.#? #.لأغشية #.ل#^خوة و #.ل#?ه#.#%#.#? أل#.#^#%#-ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج آل#.م #.ل#>#_ل#.#? #.ل#^وم#.#?يزمية \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لج#^#.#% و #.ي#_#. #.ل#?ه#.#% #.ل#.و#?#.#^ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% و#?ي#%س #<ق#^#.#? #.ل#>مو#~ #.ل#<ق#^ى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لم #.ل#>#_ل#.#? و#.ي#_#. يس#?خ#~م لل#.ل#.م #.س#<ل #.لظه#^", "Contraindications": "–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #.ل#^#%و \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لم#?وق#> خ#_و#>هم ل#>ملية لقل#% #.لم#<#?وح \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من ق#^حة #%#.لم#>#~ة #.و نزي#< #%#.لجه#.ز #.له#_مى \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #=#%#~ى #.و #=لوى ش#~ي#~", "GI": "About Indomethacin\r\nNSAID, Indole derivative, Anti-inflammatory, potent antipyretic and analgesic.\r\n\r\nMechanism of Action of Indomethacin\r\nIndomethacin acts by inhibition of Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Indomethacin does not affect the tenderness induced by PGs but block the pain producing mechanism induced by inflammatory mediators by inhibiting the enzyme cyclo-oxygenase. \r\n\r\nInteractions for Indomethacin\r\nAnticoagulants: May prolong prothrombin time. Instruct patients to watch for signs & symptoms of bleeding. \r\nBeta-Blockers: Antihypertensive effect may be blunted. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nDigoxin: Serum digoxin levels may be increased by ibuprofen and indomethacin. \r\nHydantoins: Serum hydantoin levels increased resulting in increased pharmacological and toxic effects. \r\nLithium: Serum lithium levels may be increased.", "Composition": "Indomethacin 25 mg or 50 mq", "Route": "ORAL.SOLID" }, { "ID": "249", "Trade_Name": "CORONIT 20MG 20 LENTOCAPS.", "Generic_Name": "ISOSORBIDE DINITRATE", "Price": "7.5", "Price_Old": "7.5", "Company": "ALEXANDRIA", "Pharmacology": "ANTI-ISCHEMIC", "Category": "نقص #?#^وية #.لقل#% و #.لذ#%حة #.لص#~#^ية", "Use": "–#>ل#.ج #.لذ#%حة #.لص#~#^ية . \r\n\r\n–#.لوق#.ية من #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–ل#. ينصح #<ي ح#.لة #.س#?خ#~#.م #.#~وية مث#%#-#.#? #.نزيم #<وس#<و#~#.يس#?#^يز #^قم 5 وهي من #.#~وية #_#>#< #.ل#.ن#?ص#.#% مثل #.ل#?#.#~#.ل#.#<يل أو #.ل#<ي#.ج#^#. أو #.ل#<#.#^#~ين#.#<يل حيث إنه يؤ#~ي إلى ه#%و#- ح#.#~ #<ي #_غ#- #.ل#~م وقصو#^ #<ي #?#^وية #.لقل#% . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> #.#~وية مح#<ز#.#? إنزيم #.لجو#.نيلي#? #.لحلقي #.لذ#.ئ#% مثل #^يوسيجو#.#? حيث إنه يس#%#% ه#%و#- #<ي #_غ#- #.ل#~م . \r\n\r\n–لم#^#_ى #<ق#^ #.ل#~م #?جن#% #.س#?خ#~#.مه. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ #_غ#- #.ل#~م #>ني#< #.ل#.#%#?#>#.#~ #>ن #?ن#.وله. \r\n\r\n–لمن ي#>#.نون من م#^#_ #.لأ#%ه#^ي وهو #_يق #.لصم#.م #.لأو#^#-ي #?جن#% #?ن#.وله. \r\n\r\n–#<ي ح#.لة #.لحس#.سية من #.لن#?#^#.#? . \r\n\r\n–#.لص#~مة ونزي#< #<ي #.لمخ . \r\n\r\n–#.ل#>ل#.ج #%#.لن#?#^#.#? ق#~ ي#<#.قم ح#.لة #.لذ#%حة #.لص#~#^ية #.لن#.#?جة #>ن #.#>#?ل#.ل #>#_لة #.لقل#% #.ل#_خ#.مي . \r\n\r\n–#<ي ح#.لة #?ن#.ول ج#^#>ة #>#.لية ي#?م #?ن#.ول سو#.ئل #^#.#<#>ة #.ل#_غ#- . \r\n\r\n–يس#?خ#~م #%حذ#^ #<ي ح#.لة #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية . \r\n\r\n–#<ي ح#.لة #>#~م و#_وح #.ل#^ؤية #>ن#~ #?ن#.وله يج#% #.ل#?وق#< #>ن #.س#?خ#~#.مه و إخ#%#.#^ #.ل#-#%ي#% . \r\n\r\n–ل#. يس#?خ#~م م#> #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "About Isosorbide Dinitrate\r\nAlkyl nitrate derivative, a direct vasodilator, Antianginal.\r\nMechanism of Action of Isosorbide Dinitrate\r\nIt is a direct smooth muscle relaxant, which have a prominent action vascular smooth muscles preferentially veins than arteries. It is enzymatically denitrated in the smooth muscle cells to release the reactive free radical nitric oxide which activates cytosolic guanylyl cyclase thus increases cyclic GMP levels which causes dephosphorylation of myosin light chain kinase(MLCK) through a cyclic GMP dependent protein kinase. Reduced availability of phosphorylated (active) MLCK interferes with activation of myosin and myosin fails to interact with actin to cause contraction and consequently relaxation occurs. Elevated levels of cyclic GMP also reduce calcium entry which also contributing to relaxation. It dilates veins more than arteries because veins have greater amount of enzyme that generate nitric oxide from nitrates.", "Composition": "isosrbide dinitrate 20 mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "250", "Trade_Name": "ARTHROSAMINE 30 CAPS.", "Generic_Name": "GLUCOSAMINE+GINKO BILOBA LEAF EXTRACT", "Price": "31.5", "Price_Old": "31.5", "Company": "AL ROWAD PHARMACEUTICAL INDUSTRIAL CO.", "Pharmacology": "ANTIRHEUMATIC.OSTEOARTHRITIS.ANABOLIC AGENTS", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #.لجلو#=وز#.مين و#.ل#?ي ي#<ق#~ه#. #.لجسم م#> #?ق#~م #.ل#>ُم#^ وهي #?#=ون ق#.#~#^ة #>لى إ#>#.#~ة #%ن#.ء #.لغ#_#.#^ي#< #%#.لجسم. \r\n\r\n–يس#.#>#~ #>لى #.لمشي #%ش#=ل #-#%ي#>ي وصحي. \r\n\r\n–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #?#=ون س#%#%#.ً #<ي #?نشي#- خل#.ي#. #.لجسم و#?قليل #.لآلم. \r\n\r\n– يمن#> #?آ#=ل #.لغ#_#.#^ي#< ويمن#> خشونة #.ل#^#=#%ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#^ق#%ة و#.ل#^#=#%ة وأي#_#.ً آل#.م #.ل#<خذ. \r\n\r\n–ي#=ون ق#.#~#^ #>لى #?س#=ين #.لآل#.م #.ل#?ي ي#?#>#^#_ له#. #.ل#>مو#~ #.ل#<ق#^ي.", "Contraindications": "–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء من ل#~يهم حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ي#=ون خ#-#^ #>لى #.لح#.مل وأي#_#.ً #.لأم #.لم#^#_#>ة. \r\n\r\n–يمن#> #?ن#.وله للأ#-#<#.ل إل#. #%وص#< من #.ل#-#%ي#% #.لم#>#.لج.", "GI": "About Glucosamine\r\nAmino sugar,Monosaccharide derivative, Anti-inflammatory,Antiarthritic.\r\nMechanism of Action of Glucosamine\r\nIt stimulates cartilage cells to produce glucosaminoglycans and proteoglycans which are the building blocks of cartilage. This stops the progression of OA (osteoarthritis) and possibly reverses the process. It also has anti-inflammatory properties by its inhibition of proteolytic enzymes.\r\nIndications for Glucosamine\r\n1. Osteo arthritis. \r\n2. Rheumatoid arthritis \r\nTypical Dosage for Glucosamine\r\nOral- \r\nAdult:1200mg /day", "Composition": "ginko biloba+glucosamine", "Route": "ORAL.SOLID" }, { "ID": "251", "Trade_Name": "GLUTOMARINE 20 CAPS.", "Generic_Name": "GLUTATHIONE+SILYMARINE+VITAMIN B12+VITAMIN C", "Price": "24", "Price_Old": "24", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.م#^#.#_ #.ل#=#%#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.م#^#.#_ #.ل#=#%#~ #.ل#?ي #?ن#?ج #>ن #?ن#.ول #.ل#=حولي#.#?. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج زي#.#~ه #.ل#~هون #>لي #.ل#=#%#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?سمم #.ل#=#%#~ي #.لذي ين#?ج #>ن #?ن#.ول #.لمخ#~#^#.#?. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#=#%#~ #.ل#~هني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج خل#.ي#. #.لس#^#-#.نيه لل#=#%#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج وحم#.يه #.ل#=#%#~ من #.لنلي#<.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء ل#=#%#.#^ #.لسن. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء لل#.#-#<#.ل #?ح#? سن 12 #>#.م. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من م#^#_ #.لس#=#^ي.", "GI": "About Glutathione\r\nTripeptide with an unusual peptide linkage between the amine group of cysteine (which is attached by normal peptide linkage to a glycine) and the carboxyl group of the glutamate side-chain.\r\nMechanism of Action of Glutathione\r\nPowerful antioxidant- co-factor in Phase I hepatic detoxification- involved in synthesis of DNA & proteins, amino acid transport, enzyme activation, immune system function.", "Composition": "glutathione 50mg, silymarin 140mg, vit b12 100mcg, vit c 110mg", "Route": "ORAL.SOLID" }, { "ID": "252", "Trade_Name": "GLUCOSAMINE 30 CAPS.", "Generic_Name": "GLUCOSAMINE+VITAMIN C", "Price": "16.8", "Price_Old": "16.8", "Company": "EVA PHARMA", "Pharmacology": "ANTIARTHRITIC", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "–أل#.م #.لخشونة #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–ألم #?ي#%يس #.لم#<#.صل. \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<صل #.لنق#^سي. \r\n\r\n–ألم #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#^وم#.#?وي#~. \r\n\r\n–آل#.م #.ل#?ه#.#%#.#? #.لم#<#.صل. \r\n\r\n–#.ل#?ه#.#%#.#? #.ل#^وم#.#?وي#~. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأنسجة و#.لأ#^#%#-ة. \r\n\r\n–#.لآلم #.لذي يش#>#^ #%ه #.لم#^ي#_ #%#>#~ إج#^#.ء #>ملية ج#^#.حية. \r\n\r\n–#.ل#?ه#.#%#.#? هش#.شة #.ل#>ظ#.م. \r\n\r\n–#.لص#~#.#> #.لنص#<ي. \r\n\r\n–ألم #.لإص#.#%#.#? #.ل#^ي#.#_ية و#.ل#.ل#?و#.ء#.#?.", "Contraindications": "–يحذ#^ من #.س#?#>م#.ل #.ل#~و#.ء #<ي #<#?#^ة #.لحمل. \r\n\r\n–يحذ#^ من #.س#?#>م#.ل #.ل#~و#.ء #<ي #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–يحظ#^ من #?ن#.ول #.ل#~و#.ء لمن ي#>#.ني من حس#.سية #.لأ#~وية.", "GI": "About Glucosamine\r\nAmino sugar,Monosaccharide derivative, Anti-inflammatory,Antiarthritic.\r\nMechanism of Action of Glucosamine\r\nIt stimulates cartilage cells to produce glucosaminoglycans and proteoglycans which are the building blocks of cartilage. This stops the progression of OA (osteoarthritis) and possibly reverses the process. It also has anti-inflammatory properties by its inhibition of proteolytic enzymes.\r\nIndications for Glucosamine\r\n1. Osteo arthritis. \r\n2. Rheumatoid arthritis \r\nTypical Dosage for Glucosamine\r\nOral- \r\nAdult:1200mg /day", "Composition": "ach capsule contains:\r\nGlucosamine sulfate\r\n500 mg\r\nAscorbic Acid\r\n300 mg", "Route": "ORAL.SOLID" }, { "ID": "253", "Trade_Name": "CARTISAMINE 30 CAPS.", "Generic_Name": "GLUCOSAMINE+GINKO BILOBA LEAF EXTRACT", "Price": "31.5", "Price_Old": "31.5", "Company": "EL-OBOUR > SPIMACO MISR", "Pharmacology": "ANTIRHEUMATIC.OSTEOARTHRITIS.ANABOLIC AGENTS", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #.لجلو#=وز#.مين و#.ل#?ي ي#<ق#~ه#. #.لجسم م#> #?ق#~م #.ل#>ُم#^ وهي #?#=ون ق#.#~#^ة #>لى إ#>#.#~ة #%ن#.ء #.لغ#_#.#^ي#< #%#.لجسم. \r\n\r\n–يس#.#>#~ #>لى #.لمشي #%ش#=ل #-#%ي#>ي وصحي. \r\n\r\n–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #?#=ون س#%#%#.ً #<ي #?نشي#- خل#.ي#. #.لجسم و#?قليل #.لآلم. \r\n\r\n– يمن#> #?آ#=ل #.لغ#_#.#^ي#< ويمن#> خشونة #.ل#^#=#%ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#^ق#%ة و#.ل#^#=#%ة وأي#_#.ً آل#.م #.ل#<خذ. \r\n\r\n–ي#=ون ق#.#~#^ #>لى #?س#=ين #.لآل#.م #.ل#?ي ي#?#>#^#_ له#. #.ل#>مو#~ #.ل#<ق#^ي.", "Contraindications": "–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء من ل#~يهم حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ي#=ون خ#-#^ #>لى #.لح#.مل وأي#_#.ً #.لأم #.لم#^#_#>ة. \r\n\r\n–يمن#> #?ن#.وله للأ#-#<#.ل إل#. #%وص#< من #.ل#-#%ي#% #.لم#>#.لج.", "GI": "About Glucosamine\r\nAmino sugar,Monosaccharide derivative, Anti-inflammatory,Antiarthritic.\r\nMechanism of Action of Glucosamine\r\nIt stimulates cartilage cells to produce glucosaminoglycans and proteoglycans which are the building blocks of cartilage. This stops the progression of OA (osteoarthritis) and possibly reverses the process. It also has anti-inflammatory properties by its inhibition of proteolytic enzymes.\r\nIndications for Glucosamine\r\n1. Osteo arthritis. \r\n2. Rheumatoid arthritis \r\nTypical Dosage for Glucosamine\r\nOral- \r\nAdult:1200mg /day", "Composition": "ginko biloba 50mg+glucosamine 500mg", "Route": "ORAL.SOLID" }, { "ID": "254", "Trade_Name": "DORMIVAL 20 CAPS.", "Generic_Name": "HUMULUS LUPULUS EXTRACT+VALERIANA EXTRACT", "Price": "6", "Price_Old": "6", "Company": "MEPACO", "Pharmacology": "INSOMNIA", "Category": "م#_#.#~ لل#.#^ق", "Use": "–يس#?خ#~م ل#>ل#.ج #.لأ#^ق . \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? #.ل#?و#?#^ و#.لقلق #.ل#>ص#%ي . \r\n\r\n–يخ#<#< من #.ل#^#%و #.ل#>ص#%ي . \r\n\r\n–يقلل من أ#>#^#.#_ #.نق#-#.#> #.ل#-مث #>ن#~ #.لنس#.ء مثل #.ل#?و#?#^ و#.له#%#.#? #.لس#.خنة . \r\n\r\n–#~و#.ء يس#.#>#~ #>لى #.ل#~خول #<ي #.لنوم #%ش#=ل سليم . \r\n\r\n–#~و#.ء مه#~ىء لل#.#>ص#.#% ويخ#<#< من #.ل#?و#?#^ #.ل#>ص#%ي #.لن#.#?ج #>ن #.لص#~#.#> #.لنص#<ي . \r\n\r\n–ي#~خل م#> #.#~وية #.ل#.#=#?ئ#.#% و#.#~وية #.لص#^#> . \r\n\r\n–يس#?خ#~م م#> #.#~وية #<#^#- #.لح#^#=ة حيث أنه له خو#.ص مه#~ئة لل#?و#?#^ . \r\n\r\n–يخ#<#< من آل#.م #.ل#-مث و#.ل#.#_#-#^#.#%#.#? #.لن#<سية #.لم#^#?#%#-ة #%سن #.ليأس . \r\n\r\n–يخ#<#< من آل#.م #.لم#<#.صل و#.ل#>ظ#.م .", "Contraindications": "–ل#. يج#% #.س#?خ#~#.م #~و#^مي#<#.ل لمن ل#~يهم #<#^#- حس#.سية #?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من قصو#^ #<ي #.ل#=لى #?جن#% #?ن#.ول #.ل#>ق#.#^ . \r\n\r\n–ل#. يس#?خ#~م #=#%سول#.#? #~و#^مي#<#.ل لمن ي#>#.نون من قصو#^ #<ي #.لقل#% . \r\n\r\n–#<ي ح#.لة #.ل#.ص#.#%ة #%خلل #<ي وظ#.ئ#< #.ل#=#%#~ #?جن#% #?ن#.ول #.ل#>ق#.#^ .", "GI": "Dormival capsule is a combination of Valeriana and Humulus extracts that are considerd a powerful sedative and hypnotic extracts which act synchronously to achieve sedation and induce sleep. Valeriana extract was found to be effective in reducing the sleep induction time,and this effect was thought to be due to its action on GABA (gamma-aminobutyric acid) as valeriana extract increases the level of GABA at the synaptic cleft through decreasing its re-uptake, valeriana extract also contains high levels of glutamine which crosses the blood brain barrier and is converted to GABA. GABA and Glutamine are considered inhibitory neurotransimitters responsible for sleep induction and sedation. Humulus Lupulus Soft Extract composed of humulone,lupulone,Volatilie oil (humulenel.resins and flavonoids which have a sedative and sleep-inducing effects.\r\n\r\nDormival capsule is powerful remedy for relieving all types of insomnia and\r\nanxiety disorder without inducing any addiction or habituation.", "Composition": "Valeriana Dry Extract 100 mg\r\nHumulus Lupulus Soft Extract 25 mg", "Route": "ORAL.SOLID" }, { "ID": "255", "Trade_Name": "KELLAGON 20MG 20 CAPS.", "Generic_Name": "HALFA BAR EXTRACT+KHELLIN", "Price": "10.5", "Price_Old": "7", "Company": "MEPACO", "Pharmacology": "UTI INFECTIONS", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–يس#.#>#~ #>لي #.ل#?خلص من #.لمغص #.ل#=لوي . \r\n\r\n–يس#.#>#~ #>لي #>ل#.ج حصو#.#? #.ل#=لى . \r\n\r\n–يس#.#>#~ #>لي #.ل#?خلص من #?قلص#.#? #.لم#>#~ة . \r\n\r\n–م#_#.#~ #<#>#.ل ل#?قلص#.#? #>#_ل#.#? #.لح#.ل#% . \r\n\r\n–يس#.#>#~ #>لي إ#~#^#.#^ #.ل#%ول . \r\n\r\n–يس#.#>#~ #>لي #-#^#~ #.لحصو#.#? من #.لجه#.ز #.ل#%ولي . \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لمغص #.ل#=لوي . \r\n\r\n–ي#>#.لج ح#.ل#.#? حصو#.#? #.لح#.ل#% . \r\n\r\n–م#-ه#^ لمج#^ي #.ل#%ول .", "Contraindications": "–يحذ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي #<#?#^ة #.لحمل حيث يُش#=ل خ#-#^#.ً #>لى #.لجنين وق#~ يح#~ث #?شوه#.#? . \r\n\r\n–يش#=ل خ#-#^#. #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث ق#~ يؤ#~ي #.لي مش#.#=ل صحية لل#^#_ي#> . \r\n\r\n–يش#=ل خ#-#^#.ً هذ#. #.ل#~و#.ء #>لى #.لأشخ#.ص #.لذين يُ#>#.نون من حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء .", "GI": "COMING SOON ..", "Composition": "Each capsule contains:\r\nAmmi visnaga dry extract 180 mg\r\nCymbopogon proximus dry extract 72 mg", "Route": "ORAL.SOLID" }, { "ID": "256", "Trade_Name": "GINCOSTAZEN 30 CAP", "Generic_Name": "GLUCOSAMINE+GINKO BILOBA LEAF EXTRACT", "Price": "39.75", "Price_Old": "26.4", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "ANTIRHEUMATIC.OSTEOARTHRITIS.ANABOLIC AGENTS", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #.لجلو#=وز#.مين و#.ل#?ي ي#<ق#~ه#. #.لجسم م#> #?ق#~م #.ل#>ُم#^ وهي #?#=ون ق#.#~#^ة #>لى إ#>#.#~ة #%ن#.ء #.لغ#_#.#^ي#< #%#.لجسم. \r\n\r\n–يس#.#>#~ #>لى #.لمشي #%ش#=ل #-#%ي#>ي وصحي. \r\n\r\n–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #?#=ون س#%#%#.ً #<ي #?نشي#- خل#.ي#. #.لجسم و#?قليل #.لآلم. \r\n\r\n– يمن#> #?آ#=ل #.لغ#_#.#^ي#< ويمن#> خشونة #.ل#^#=#%ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#^ق#%ة و#.ل#^#=#%ة وأي#_#.ً آل#.م #.ل#<خذ. \r\n\r\n–ي#=ون ق#.#~#^ #>لى #?س#=ين #.لآل#.م #.ل#?ي ي#?#>#^#_ له#. #.ل#>مو#~ #.ل#<ق#^ي.", "Contraindications": "–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء من ل#~يهم حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ي#=ون خ#-#^ #>لى #.لح#.مل وأي#_#.ً #.لأم #.لم#^#_#>ة. \r\n\r\n–يمن#> #?ن#.وله للأ#-#<#.ل إل#. #%وص#< من #.ل#-#%ي#% #.لم#>#.لج.", "GI": "About Glucosamine\r\nAmino sugar,Monosaccharide derivative, Anti-inflammatory,Antiarthritic.\r\nMechanism of Action of Glucosamine\r\nIt stimulates cartilage cells to produce glucosaminoglycans and proteoglycans which are the building blocks of cartilage. This stops the progression of OA (osteoarthritis) and possibly reverses the process. It also has anti-inflammatory properties by its inhibition of proteolytic enzymes.\r\nIndications for Glucosamine\r\n1. Osteo arthritis. \r\n2. Rheumatoid arthritis \r\nTypical Dosage for Glucosamine\r\nOral- \r\nAdult:1200mg /day", "Composition": "Ct-D-Glucosamine Sulphate 500 mg\r\nGinkgo biloba leaf extract 50 mg", "Route": "ORAL.SOLID" }, { "ID": "257", "Trade_Name": "EMACARDIN 450 MG 20 CAPS.", "Generic_Name": "CRATAGEUS (HAWTHORN) EXTRACT", "Price": "19", "Price_Old": "19", "Company": "PHAROPHARMA > EMA PHARM", "Pharmacology": "CARDIOTONIC", "Category": "مش#.#=ل #.لقل#%", "Use": "– يس#?خ#~م ل#>ل#.ج #.له#%و#- #.لوظي#<ي #.ل#%سي#- ل#>#_لة #.لقل#%. \r\n\r\n– يس#?خ#~م ل#>ل#.ج إ#^#?#<#.#> #_غ#- #.ل#~م #.لم#?#^#~#~. \r\n\r\n– يس#?خ#~م ل#>ل#.ج #_#>#< #>#_لة #.لقل#% #.لمص#.ح#% ل#?ق#~م #.لسن. \r\n\r\n– يس#?خ#~م ل#>ل#.ج قصو#^ #.لش#^#.يين #.ل#?#.جية. \r\n\r\n– يس#?خ#~م ل#?حسين وظ#.ئ#< #>#_له #.لقل#%. \r\n\r\n– يس#?خ#~م ل#?وسي#> #.لش#^#.يين #.ل#-#^#<يه. \r\n\r\n– يس#?خ#~م ل#?قليل من #.لمق#.ومه #.ل#-#^#<يه.", "Contraindications": "– يج#% #.س#?ش#.#^ه #.ل#-#%ي#% #.ول#. ق#%ل #?ن#.وله ح#?ي ل#. يح#~ث #.#_#^#.#^. \r\n\r\n– يمن#> للح#.ل#.#? #.لحمل و#.ل#^#_#.#>ه #.ل#-#%ي#>يه. \r\n\r\n– يمن#> لل#.#-#<#.ل #.قل من 12سنه.", "GI": "EMACARDIN is a cardiotonic with a very wide safety margin for long term use in cases of Congestive Heart Failure and Ischemic Heart Disease.\r\nComposition:\r\nEach capsule contains 450 mg Hawthorn (crataegus) Hydroalcoholic extract.\r\n\r\n \t\r\nPharmacological Action: Emacardin properties are attributed to Hawthorn content of flavonoids and procyanidins. Emacardin action is mediated through phosphodiesterase inhibition leading to increase in intracellular CAMP and increased calcium membrane permeability, leading to vasodilation, increased coronary blood flow, and positive inotropic effect. Emacardin improves myocardial tissue perfusion, reduces peripheral resistance and improves exercise tolerance in cardiac patients.\r\n\r\n \t\r\nIndications/ Uses:\r\nIschemic Heart Disease\r\nHeart failure NYHA class I & II\r\n\r\n \t\r\nDosage:\r\n1 -2 capsules daily or as prescribed by your physician.", "Composition": "crataegus ext. 450mg", "Route": "ORAL.SOLID" }, { "ID": "258", "Trade_Name": "DOROFEN 30 CAPS.", "Generic_Name": "GLUCOSAMINE+GINKO BILOBA LEAF EXTRACT", "Price": "56.25", "Price_Old": "37.5", "Company": "SPIMACO MISR > LIPTIS", "Pharmacology": "ANTIRHEUMATIC.OSTEOARTHRITIS.ANABOLIC AGENTS", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #.لجلو#=وز#.مين و#.ل#?ي ي#<ق#~ه#. #.لجسم م#> #?ق#~م #.ل#>ُم#^ وهي #?#=ون ق#.#~#^ة #>لى إ#>#.#~ة #%ن#.ء #.لغ#_#.#^ي#< #%#.لجسم. \r\n\r\n–يس#.#>#~ #>لى #.لمشي #%ش#=ل #-#%ي#>ي وصحي. \r\n\r\n–ي#>مل #>لى #?زوي#~ #.لجسم #%م#.#~ة #?#=ون س#%#%#.ً #<ي #?نشي#- خل#.ي#. #.لجسم و#?قليل #.لآلم. \r\n\r\n– يمن#> #?آ#=ل #.لغ#_#.#^ي#< ويمن#> خشونة #.ل#^#=#%ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#^ق#%ة و#.ل#^#=#%ة وأي#_#.ً آل#.م #.ل#<خذ. \r\n\r\n–ي#=ون ق#.#~#^ #>لى #?س#=ين #.لآل#.م #.ل#?ي ي#?#>#^#_ له#. #.ل#>مو#~ #.ل#<ق#^ي.", "Contraindications": "–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء من ل#~يهم حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ي#=ون خ#-#^ #>لى #.لح#.مل وأي#_#.ً #.لأم #.لم#^#_#>ة. \r\n\r\n–يمن#> #?ن#.وله للأ#-#<#.ل إل#. #%وص#< من #.ل#-#%ي#% #.لم#>#.لج.", "GI": "About Glucosamine\r\nAmino sugar,Monosaccharide derivative, Anti-inflammatory,Antiarthritic.\r\nMechanism of Action of Glucosamine\r\nIt stimulates cartilage cells to produce glucosaminoglycans and proteoglycans which are the building blocks of cartilage. This stops the progression of OA (osteoarthritis) and possibly reverses the process. It also has anti-inflammatory properties by its inhibition of proteolytic enzymes.\r\nIndications for Glucosamine\r\n1. Osteo arthritis. \r\n2. Rheumatoid arthritis \r\nTypical Dosage for Glucosamine\r\nOral- \r\nAdult:1200mg /day", "Composition": "ginko biloba 50mg+glucosamine 500mg", "Route": "ORAL.SOLID" }, { "ID": "259", "Trade_Name": "DISARTAN-CO 80/12.5MG 14 CAPS.", "Generic_Name": "HYDROCHLOROTHIAZIDE+VALSARTAN", "Price": "38", "Price_Old": "38", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIHYPERTENSIVE. COMBINED ANGIOTENSIN BLOCKER WITH DIURETIC", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م لل#.شخ#.ص #.ل#%#.لغين . \r\n\r\n–#.ل#?ح#=م #<ي #.ل#_غ#- لم#^#_ي #.#^#?#<#.#> #_غ#- #.ل#~م #.لمزمن . \r\n\r\n–ي#>#.لج #.ح#?#%#.س #.لسو#.ئل #<ي #.لجسم. \r\n\r\n–ي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#<شل #.لقل#%.", "Contraindications": "–من ل#~يهم حس#.سية م#<#^#-ة #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–من ي#>#.ني #?#_يق #<ي #.لش#^ي#.ن #.ل#=لوي #.لثن#.ئي . \r\n\r\n–ينصح #%#>#~م #.خذ #.ل#~و#.ء #<ي #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة ح#?ي ل#.يؤث#^ #>لي #.لجنين #.و #.ل#-#<ل #.ل#^#_ي#> ويج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#~و#.ء .", "GI": "About Hydrochlorothiazide\r\nThiazide derivatibve, Diuretic.\r\nMechanism of Action of Hydrochlorothiazide\r\nIt is thiazide diuretic which exerts its action by acting at site-3(central dilating segment of early distal tubule). It binds to Na+Cl- symporter and inhibits Na+Cl- symport at the luminal membrane. It has additional carbonic anhydrase inhibitory actions in proximal tubules. It increases natriuresis, kaliuresis and diuresis. It decreases Ca2+ excretion and increases Mg2+excretion. It also has minor carbonic anhydrase inhibitory action. It also causes direct arteriolar vasodilatation and decreases total peripheral resistance. The antihypertensive actions of the drug may be attributable to depletion of sodium and subsequent reduction in plasma volume and a decrease in peripheral resistance. Decrease in peripheral resistance is due to either the loss of sodium from the arteriolar wall or a direct action on the vascular bed. It is an effective drug in edema associated with congestive he", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "260", "Trade_Name": "FLUOZAC 40MG 10 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "20.4", "Price_Old": "20.4", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine hcl 20", "Route": "ORAL.SOLID" }, { "ID": "261", "Trade_Name": "FERRO SANOL GYN 30 CAP.", "Generic_Name": "FERROUS GLYCINE SULPHATE COMPLEX+FOLIC ACID", "Price": "39", "Price_Old": "39", "Company": "MINA PHARM > SCHWARZ", "Pharmacology": "ANEMIA.IRON SUPPLEMENT COMBINED WITH FOLIC ACID", "Category": "م#=مل غذ#.ئي ل #.ل#.نيمي#. و #<ق#^ #.ل#~م م#> حم#_ #.ل#<ولي#=", "Use": "–م#=مل غذ#.ئى ل#?#>وي#_ نقص #.لح#~ي#~ و #%#>#_ #.ل#<ي#?#.مين#.#? #%#.لجسم . \r\n\r\n–#.لوق#.ية من #.لإص#.#%ة #%#.لأنيمي#. . \r\n\r\n–م#=مل غذ#.ئى أثن#.ء #.لحمل .", "Contraindications": "–#.لحمل : أمن للإس#?خ#~#.م أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–ق#~ يس#%#% #?غي#^ #<ى لون #.ل#%#^#.ز إلى #.للون #.لأسو#~ #.ل#~#.#=ن . \r\n\r\n–يج#% #?جن#% #?ن#.ول #.لقهوة و #.لش#.ي و #.لحلي#% و #.ل#%ي#_ #<ى ن#<س #.لوق#? م#> أ#~وية #.لح#~ي#~ ل#.نه#. #?قلل من إم#?ص#.ص #.لح#~ي#~ و يج#% #.ل#<صل #%ينهم#. #%س#.#>#?ين #>لى #.لأقل . \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ى #.لجه#.ز #.له#_مى مثل م#^#_ى ق#^حة #.لم#>#~ة و #.لأم#>#.ء و إل#?ه#.#%#.#? #.لقولون : ق#~ #?س#%#% إ#_#-#^#.#%#.#? #%#.لجه#.ز #.له#_مى . \r\n\r\n–ق#~ يس#%#% ح#~وث إمس#.#= . \r\n\r\n–ل#. يس#?خ#~م لم#~ة #?زي#~ #>ن 6 أشه#^ إل#. #%#>#~ إس#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–يج#% #.ل#<صل #%ين أ#~وية #.ل#=#.لسيوم و #.لح#~ي#~ و ل#. ي#?م #?ن#.ولهم#. م#>#. : حيث ي#>مل #.ل#=#.لسيوم #>لى #?قلل إم#?ص#.ص #.لح#~ي#~ و #%#.ل#?#.لى #?قل #<#.#>لية #>نص#^ #.لح#~ي#~ . \r\n\r\n–#.لأ#~وية #.لم#_#.#~ة للحمو#_ه و ح#^قة #.لم#>#~ة #.ل#?ى #?ح#?وى #>لى هي#~#^و#=سي#~ #.لم#.غنيسيوم أو هي#~#^و#=سي#~ #.لأليومنيوم أو #=#^#%ون#.#? #.ل#=#.لسيوم : #?قلل من إم#?ص#.ص أ#~وية #.لح#~ي#~ لذل#= يج#% #.ل#<صل #%ينهم #%م#~ة ل#. #?قل #>ن س#.#>#?ين .", "GI": "About Folic Acid\r\nDietary supplement, Folate derivative( B9 ), Water Soluble Vitamin.\r\nMechanism of Action of Folic Acid\r\nFolic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively. Tetrahydrofolic acid acts as a coenzyme which mediates a number of one carbon transfer reactions by carrying a methyl group as an adduct. It involves a number of reactions such as 1).conversion of homocysteine to methionine. 2).synthesis of thymidylate which is an essential constituent of DNA from methylene-tetrahydrofolic acid. 3). Conversion of serine to glycine by tetrahydrofolic acid and forms methylene-tetrahydrofolic acid. 4).to introduce carbon units at position 2 and 8 during de novo purine synthesis requires formyl-tetrahydrofolic acid and methenyl-tetrahydrofolic acid.5).generation and utilization of \\\"formate pool\\\". 6).For mediating formino group transfer in histidine metabolism. Folic acid is required to maintain normal", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "262", "Trade_Name": "FOLICAP 2.5MG 24 CAP.", "Generic_Name": "FOLIC ACID", "Price": "8.25", "Price_Old": "5.5", "Company": "SAFE PHARMA > PHARCO", "Pharmacology": "FOLIC ACID SUPPLEMENT", "Category": "م#=مل حم#_ #.ل#<ولي#=", "Use": "–#>ل#.ج ح#.ل#.#? نقص حم#_ #.ل#<ولي#= و#%#>#_ أنو#.#> #.لأنيمي#.، مثل: #.لأنيمي#. #.لمص#.ح#%ة #%#?#_خم #=#^#.#? #.ل#~م #.لحم#^#.ء، و#.لأنيمي#. #.لمص#.ح#%ة #%زي#.#~ة #?#^#=يز #.لح#~ي#~ #<ي خل#.ي#. #.ل#~م، و#.لأنيمي#. #.لن#.#?جة #>ن #.#^#?#<#.#> م#>#~ل #?#=سي#^ #=#^ي#.#? #.ل#~م #.لحم#^#.ء. \r\n\r\n–#<ي #.لحمل للوق#.ية من #?شوه#.#? قن#.ة #.لح#%ل #.لشو#=ي #<ي #.لجنين. \r\n\r\n–م#=مل غذ#.ئي #<ي ح#.ل#.#? سوء #.ل#?غذية و#.ل#.م#?ص#.ص. \r\n\r\n–#.لغسيل #.ل#=لوي. \r\n\r\n–#<ي أم#^#.#_ #.ل#=#%#~ و#?لي#< #.لنخ#.#>. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #%#>#_ #.لأ#~وية ل#<#?#^ة #-ويلة #=م#_#.#~#.#? #.ل#?شنج#.#? و#.لإس#?ي#^وجين#.#? و#.لميثو#?#^ي#=س#.#? و#?#^يميثو#%#^يم.", "Contraindications": "–#.ل#?حسس من حم#_ #.ل#<ولي#=. \r\n\r\n–#>#~م #?شخيص #.لأنيمي#. من ق#%ل #-#%ي#% مخ#?ص. \r\n\r\n–ل#. يس#?خ#~م #%م#<#^#~ه #<ي ح#.ل#.#? نقص #<ي#?#.مين #%12.", "GI": "About Folic Acid\r\nDietary supplement, Folate derivative( B9 ), Water Soluble Vitamin.\r\n\r\nMechanism of Action of Folic Acid\r\nFolic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively. Tetrahydrofolic acid acts as a coenzyme which mediates a number of one carbon transfer reactions by carrying a methyl group as an adduct. It involves a number of reactions such as 1).conversion of homocysteine to methionine. 2).synthesis of thymidylate which is an essential constituent of DNA from methylene-tetrahydrofolic acid. 3). Conversion of serine to glycine by tetrahydrofolic acid and forms methylene-tetrahydrofolic acid. 4).to introduce carbon units at position 2 and 8 during de novo purine synthesis requires formyl-tetrahydrofolic acid and methenyl-tetrahydrofolic acid.5).generation and utilization of \\\"formate pool\\\". 6).For mediating formino group transfer in histidine metabolism.", "Composition": "Folic acid 0.5 mg or 2.5 mg", "Route": "ORAL.SOLID" }, { "ID": "263", "Trade_Name": "FROBEN SR 200 MG 10CAPS", "Generic_Name": "FLURBIPROFEN", "Price": "14.5", "Price_Old": "14.5", "Company": "KAHIRA > ABBOTT LABORATORIES", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "– يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ ل#?خ#<ي#< ش#~َّة #.لآل#.م و#.ل#.ل#?ه#.#% و#.لحمَّى. \r\n\r\n– يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ لل#?َّخ#<ي#< من آل#.م #.ل#~و#^ة #.لشه#^ية (#.ل#-َّمث). \r\n\r\n– يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ ل#>ل#.ج #.ل#?ه#.#% #.لم#<#.صِل. \r\n\r\n– يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ ل#>ل#.ج نو#%#.#? #.لنِّق#^س. \r\n\r\n– يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ ل#>ل#.ج #.لصُّ#~#.#> #.لنِّص#<ي.", "Contraindications": "–ل#~ي#= حس#.سية من أي #>نص#^ #<ي #<لو#^#%ي#%#^و#<ين. \r\n\r\n–ل#~ي#= #^#~ #<#>ل #?حسسي ش#~ي#~ (#>لى س#%يل #.لمث#.ل، #-#<ح جل#~ي ش#~ي#~، ص#>و#%ة #<ي #.ل#?ن#<س، زو#.ئ#~ #<ي #.لأن#<، أو #~وخة) من #.لأس#%#^ين أو #.لأ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% (مثل #.ي#%و#%#^و#<ين، #.لسيلي#=و#=سي#%). \r\n\r\n–#=#.ن ل#~ي#= مؤخ#^#. ج#^#.حة #.لقل#% #.ل#.ل#?#<#.#<ية. \r\n\r\n–#=ن#? #<ي 3 أشه#^ #.لأخي#^ة من #.لحمل. \r\n\r\n–#.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–#.ذ#. #=#.ن ل#~ي#= #?#.#^يخ أم#^#.#_ #.ل#=لى أو أم#^#.#_ #.ل#=#%#~. \r\n\r\n–م#^#_ #.لس#=#^ي أو أم#^#.#_ #.لم#>#~ة أو #.لأم#>#.ء. \r\n\r\n–ل#~ي#= #?#.#^يخ من #?و#^م أو #?#^#.#=م #.لسو#.ئل. \r\n\r\n–#.ل#^#%و. \r\n\r\n–زو#.ئ#~ أن#<ية. \r\n\r\n–#.ل#?ه#.#% #.ل#<م. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#.#_#-#^#.#% #<ي #.ل#~م \r\n\r\n–#.لنزي#< أو مش#.#=ل #.ل#?خث#^ \r\n\r\n–مش#.#=ل #<ي #.لقل#% (#>لى س#%يل #.لمث#.ل، #<شل #.لقل#%) \r\n\r\n–أم#^#.#_ #.لأو#>ية #.ل#~موية \r\n\r\n–ش#^#% #.ل#=حول، أو #=#.ن ل#~ي#= #?#.#^يخ من #?#>#.#-ي #.ل#=حول", "GI": "About Flurbiprofen\r\nNSAID, Oral, phenylalkanoic acid derivative, Analgesic and anti-inflammatory, Anti arthritic.\r\n\r\nMechanism of Action of Flurbiprofen\r\nIt reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes both COX1 and COX2.In higher doses it reduces the thromboxane A2 synthesis by COX1 inhibition. So platelet aggregation is inhibited by this drug. After topical application in the case of ophthalmic preparation it prevents miosis by reducing ocular prostaglandins synthesis. It is a phenylalkalonic acid derivative Non Steroidal Anti Inflammatory Drug.\r\n\r\nIndications for Flurbiprofen\r\n1. Rheumatoid arthritis \r\n2. Osteo arthritis \r\n3. Ankylosing spondylitis \r\n4. Pain in patients with dysmenorrhea. \r\n5. Acute gout \r\n6. Migraine", "Composition": "flurbiprofen 100mg or 50mg or 200mg", "Route": "ORAL.SOLID" }, { "ID": "264", "Trade_Name": "FORADIL 12 MCG 30 CAPS.+INHALER", "Generic_Name": "FORMOTEROL FUMARATE", "Price": "141", "Price_Old": "130.25", "Company": "NOVARTIS > SANDOZ", "Pharmacology": "BRONCHODILATOR.LONG ACTING BETA 2 AGONIST", "Category": "موس#> للش#>#% #.لهو#.ئية و مش#.#=ل #.ل#?ن#<س", "Use": "–يس#?خ#~م #.ل#~و#.ء ل#>ل#.ج #_يق #.ل#?ن#<س و#.ل#?ه#.#% #.لش#>#% #.لهو#.ئية . \r\n\r\n–يس#.#>#~ #.ل#~و#.ء #>لي #.ل#?ن#<س #%صو#^ة #-#%ي#>ية ويق#_ي #>لي #.نس#~#.#~ #.لش#>#% #.لهو#.ئية . \r\n\r\n–ي#>#.لج #.ن#?#<#.خ #.ل#^ئة . \r\n\r\n–يقي من #.ل#.ص#.#%ة #%#.ل#^#%و .", "Contraindications": "–#.لحس#.سية ل#<و#^مي#?#^ول #.و #.ي من م#=ون#.#? #.ل#~و#.ء #.لآخ#^ى. \r\n\r\n–#.لم#^#_ى #.لذين ي#>#.نون من ح#.لة #^#%و مس#?م#^ (نو#%ة ش#~ي#~ة مس#?م#^ة من #.ل#^#%و) #.و #.ي نو#%#.#? ح#.#~ة من #.ل#^#%و #.و #.ل#.نس#~#.#~#~ #.ل#^ئوي #.لمزمن. \r\n\r\n–ل#. يس#?خ#~م هذ#. #.ل#~و#.ء #=#>ل#.ج من#<#^#~ لل#^#%و.", "GI": "Mechanism of action\t\r\nThe pharmacologic effects of beta2-adrenoceptor agonist drugs, including formoterol, are at least in part attributable to stimulation of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3 , 5 -adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibits the release of pro-inflammatory mast-cell mediators such as histamine and leukotrienes. Formoterol also inhibits histamine-induced plasma albumin extravasation in anesthetized guinea pigs and inhibits allergen-induced eosinophil influx in dogs with airway hyper-responsiveness. The relevance of these in vitro and animal findings to humans is unknown.", "Composition": "fenoterol 12mcg", "Route": "ORAL.SOLID" }, { "ID": "265", "Trade_Name": "VITAFERROL 30 SOFT GELATIN CAPS.", "Generic_Name": "FOLIC ACID+IRON+MANGANESE+VITAMIN B12+VITAMIN C+ZINC", "Price": "27", "Price_Old": "18", "Company": "EVA PHARMA", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–م#=مل غذ#.ئى ل#?#>وي#_ نقص #.لح#~ي#~ و #.ل#=#.لسيوم و حم#_ #.ل#<ولي#= #%#.لجسم . \r\n\r\n–#.لوق#.ية من #.لإص#.#%ة #%#.لأنيمي#. . \r\n\r\n–يس#.#>#~ #>لى #>ل#.ج و #.لوق#.ية من #.لإص#.#%ة #%هش#.شة #.ل#>ظ#.م . \r\n\r\n–م#=مل غذ#.ئى أثن#.ء #.لحمل و #.ل#^#_#.#>ة ل#?#>وي#_ نقص #.ل#=#.لسيوم و #.لح#~ي#~ و حم#_ #.ل#<ولي#= ل#~ى #.لأم .", "Contraindications": "–#.لأ#~وية #.لم#_#.#~ة للحمو#_ة و ح#^قة #.لم#>#~ة #.ل#?ى #?ح#?وى #>لى هي#~#^و#=سي#~ #.لم#.غنيسيوم أو هي#~#^و#=سي#~ #.لألومنيوم أو #=#^#%ون#.#? #.ل#=#.لسيوم ق#~ #?قلل من إم#?ص#.ص أ#~وية #.لح#~ي#~ ، لذل#= يج#% #.ل#<صل #%ينهم #%م#~ة ل#. #?قل #>ن س#.#>#?ين . \r\n\r\n–زي#.#~ة #.ل#=#.لسيوم #<ى #.ل#~م. \r\n\r\n–#.لحس#.سية ل#.ى من م#=ون#.#? #.ل#~و#.ء.", "GI": "PROPERTIES:\r\nVitaferroI is a well balanced formula that allows maximal absorption and utilization of iron. It contains Ferrous fumarate which has the highest content of elemental iron compared to other iron salts. The product also contains Cyanocobalamin (B12) which helps building up of nucleic acids necessary for body cells and red cells formation. Ascorbic acid is included to facilitate the absorption of iron by maintaining more of the iron in the absorbable ferrous state, while Folic acid, Manganese and Zinc are considered necessary with iron as supplements for hemoglobin synthesis.\r\nINDICATIONS:\r\nTreatment and prophylaxis of iron deficiency anemia in cases of: blood loss of various origin (menstruation, hemorrhage, surgical operations), nutritional deficiency, adolescence and convalescence.Prophylaxis during pregnancy.", "Composition": "Each soft gelatin capsule contains:Ferrous Fumarate (equivalent to 115.5 mg of elemental iron) 350 mg\r\nCyanocobalamin\r\n7.5 mcg\r\nFolic Acid\r\n1 mg\r\nAscorbic Acid\r\n150 mg\r\nManganese(as sulphate)\r\n2.5 mg\r\nZinc (as sulphate) 7 mg", "Route": "ORAL.SOLID" }, { "ID": "266", "Trade_Name": "FOLICAP 0.5MG 24 CAPS.", "Generic_Name": "FOLIC ACID", "Price": "6", "Price_Old": "4", "Company": "PHARCO", "Pharmacology": "FOLIC ACID SUPPLEMENT", "Category": "م#=مل حم#_ #.ل#<ولي#=", "Use": "–#>ل#.ج ح#.ل#.#? نقص حم#_ #.ل#<ولي#= و#%#>#_ أنو#.#> #.لأنيمي#.، مثل: #.لأنيمي#. #.لمص#.ح#%ة #%#?#_خم #=#^#.#? #.ل#~م #.لحم#^#.ء، و#.لأنيمي#. #.لمص#.ح#%ة #%زي#.#~ة #?#^#=يز #.لح#~ي#~ #<ي خل#.ي#. #.ل#~م، و#.لأنيمي#. #.لن#.#?جة #>ن #.#^#?#<#.#> م#>#~ل #?#=سي#^ #=#^ي#.#? #.ل#~م #.لحم#^#.ء. \r\n\r\n–#<ي #.لحمل للوق#.ية من #?شوه#.#? قن#.ة #.لح#%ل #.لشو#=ي #<ي #.لجنين. \r\n\r\n–م#=مل غذ#.ئي #<ي ح#.ل#.#? سوء #.ل#?غذية و#.ل#.م#?ص#.ص. \r\n\r\n–#.لغسيل #.ل#=لوي. \r\n\r\n–#<ي أم#^#.#_ #.ل#=#%#~ و#?لي#< #.لنخ#.#>. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #%#>#_ #.لأ#~وية ل#<#?#^ة #-ويلة #=م#_#.#~#.#? #.ل#?شنج#.#? و#.لإس#?ي#^وجين#.#? و#.لميثو#?#^ي#=س#.#? و#?#^يميثو#%#^يم.", "Contraindications": "–#.ل#?حسس من حم#_ #.ل#<ولي#=. \r\n\r\n–#>#~م #?شخيص #.لأنيمي#. من ق#%ل #-#%ي#% مخ#?ص. \r\n\r\n–ل#. يس#?خ#~م #%م#<#^#~ه #<ي ح#.ل#.#? نقص #<ي#?#.مين #%12.", "GI": "About Folic Acid\r\nDietary supplement, Folate derivative( B9 ), Water Soluble Vitamin.\r\n\r\nMechanism of Action of Folic Acid\r\nFolic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively. Tetrahydrofolic acid acts as a coenzyme which mediates a number of one carbon transfer reactions by carrying a methyl group as an adduct. It involves a number of reactions such as 1).conversion of homocysteine to methionine. 2).synthesis of thymidylate which is an essential constituent of DNA from methylene-tetrahydrofolic acid. 3). Conversion of serine to glycine by tetrahydrofolic acid and forms methylene-tetrahydrofolic acid. 4).to introduce carbon units at position 2 and 8 during de novo purine synthesis requires formyl-tetrahydrofolic acid and methenyl-tetrahydrofolic acid.5).generation and utilization of \\\"formate pool\\\". 6).For mediating formino group transfer in histidine metabolism.", "Composition": "Folic acid 0.5 mg or 2.5 mg", "Route": "ORAL.SOLID" }, { "ID": "267", "Trade_Name": "CRONOGUARD 10CAPS.", "Generic_Name": "FOLIC ACID+VITAMIN B6+VITAMIN B12", "Price": "5", "Price_Old": "5", "Company": "EPCI", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–#.لأنيمي#. #.ل#?ي #?ن#?ج #>ن نقص #<ي#?#.مين #%12 #<ي #.ل#~م. \r\n\r\n–مش#.#=ل #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n–زي#.#~ة ح#.جة #.لجسم إلى حم#_ #.ل#<ولي#= و#.ل#<ي#?#.مين#.#? #.له#.مة و#.ل#?ي من #%ينه#. #%12 و#%6. \r\n\r\n–#.ل#_#>#< #.ل#>#.م #<ي #.لجسم. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ي ح#.ل#.#? #.ل#>قم ل#~ي #.لذ#=و#^. \r\n\r\n–#>ل#.ج مس#.#>#~ من ي#>#.ني من م#_#.#>#<#.#? م#^#_ #.لس#=#^. \r\n\r\n–#>ل#.ج مس#.#>#~ هش#.شة #.ل#>ظ#.م و#.ل#_#>#< #.ل#>#.م. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ي ح#.لة #.لم#^#_ي #.لن#<سيين خ#.صة #.ل#.#=#?ئ#.#%. \r\n\r\n–#>ل#.ج مس#.#>#~ لل#>مل #>لى #.لوق#.ية من س#^#-#.ن #>قم #.ل#^حم وغي#^ه#. من #.لأم#^#.#_.", "Contraindications": "–حس#.سية لأي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لأم#^#.#_ #.لو#^#.ثية #.ل#?ي #?صي#% #.ل#>ين. \r\n\r\n–من #.لمم#=ن أن ي#?#<#.#>ل #.ل#~و#.ء م#> أ#~وية أخ#^ي لذ#. ل#.#%#~ من #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أن ي#?م #.س#?خ#~#.مه#..", "GI": "About Folic Acid\r\nDietary supplement, Folate derivative( B9 ), Water Soluble Vitamin.\r\nMechanism of Action of Folic Acid\r\nFolic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively. Tetrahydrofolic acid acts as a coenzyme which mediates a number of one carbon transfer reactions by carrying a methyl group as an adduct. It involves a number of reactions such as 1).conversion of homocysteine to methionine. 2).synthesis of thymidylate which is an essential constituent of DNA from methylene-tetrahydrofolic acid. 3). Conversion of serine to glycine by tetrahydrofolic acid and forms methylene-tetrahydrofolic acid. 4).to introduce carbon units at position 2 and 8 during de novo purine synthesis requires formyl-tetrahydrofolic acid and methenyl-tetrahydrofolic acid.5).generation and utilization of \\\"formate pool\\\". 6).For mediating formino group transfer in histidine metabolism. Folic acid is required to maintain normal", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "268", "Trade_Name": "SCIENCESTAT 40 MG 7 CAPS.", "Generic_Name": "FLUVASTATIN", "Price": "16", "Price_Old": "16", "Company": "DELTA PHARMA > SCIENCE PHARMA-EGYPT", "Pharmacology": "STATINS.HMGCOA REDUCTASE", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#.لوق#.ية من خ#-#^ أم#^#.#_ #.لقل#% و#.لأو#>ية #.ل#~موية ل#~ى م#^#_ى #<#^#- #=وليس#?ي#^ول #.ل#~م م#> أم#^#.#_ #.لقل#% #.ل#?#.جية أو #.لم#>#^#_ين لخ#-#^ أم#^#.#_ #.لش#^#.يين #.ل#?#.جية : خ#<#_ م#>#~ل#.#? أم#^#.#_ #.لقل#% (#.ح#?ش#.ء #>#_لة #.لقل#% و إج#^#.ء#.#? إِ#>#.#~َةُ #.ل#?َّوَ#>ِّي للش#^#.يين #.ل#?#.جية / غي#^ #.ل#?#.جية ) و#.لو#<ي#.#? ؛ و#.لح#~ من خ#-#^ #.ل#.ص#.#%ة #%#.لس#=#?ة. #<#^ْ#-ُ شحْمِيّ#.#?ِ #.ل#~مّ : للح#~ من #.#^#?#<#.#> #.ل#=ولس#?#^ول #.ل#=لي ، #.ل#=وليس#?س#^ول منخ#<#_ #.ل#=ث#.#<ة #.ل#_#.#^ (LDL) ، صَميمُ #.ل#%#^و#?ين #.لشَّحْمِيّ #% ، #.ل#~هون #.لثل#.ثية، #.للي#%و#%#^و#?ين ذو #.ل#=ث#.#<ة #.لشحمية #.لمنخ#<#_ة ج#~#.ً ،وزي#.#~ة #.ل#%#^و#?ين #.ل#~هني #.ل#>#.لي #.ل#=ث#.#<ة #<ي #.لم#^#_ى #.لذين ي#>#.نون من #.#^#?#<#.#> #.ل#=ولس#?#^ول #.ل#.#%#?#~#.ئية .", "Contraindications": "–م#^#_ #.ل#=#%#~ #.لنش#-. #.#^#?#<#.#> غي#^ م#%#^#^ #<ي ن#?#.ئج #.خ#?#%#.#^#.#? وظ#.ئ#< #.ل#=#%#~ ( #.#^#?#<#.#> #.لإنزيم ن#.قِلَ #.لأَمين ). #.ل#^#_#.#>ة #.ل#-#%ي#>ية. #.لحمل. #<#^#- #.لحس#.سية ل#.ي من م#=ون#.#? #.ل#~و#.ء", "GI": "About Fluvastatin\r\nHMGCoA reductase inhibitor,Statins,Antilipemi agent\r\n\r\nMechanism of Action of Fluvastatin\r\nFluvastatin selectively and competitively inhibits the hepatic enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase is responsible for converting HMG-CoA to mevalonate, the rate-limiting step in cholesterol biosynthesis. Inhibition results in a decrease in hepatic cholesterol levels which stimulates the synthesis of LDL receptors and increases hepatic uptake of LDL cholesterol. The end result is decreased levels of plasma total and LDL cholesterol.\r\n\r\nIndications for Fluvastatin\r\n1.Hyperlipidaemias \r\n2.Hypercholesterolaemia \r\n3.Atherosclerosis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "269", "Trade_Name": "CONVENTIN 100MG 30 CAP.", "Generic_Name": "GABAPENTIN", "Price": "27.75", "Price_Old": "27.75", "Company": "EVA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "– #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n– #>ل#.ج آل#.م #.لأ#>ص#.#%. \r\n\r\n– #>ل#.ج م#_#.#>#<#.#? م#^#_ #.لحز#.م #.لن#.#^ي #.له#^#%س, و#.لذي يؤ#~ي إلي #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية. \r\n\r\n– #>ل#.ج م#^#_ #.ل#%ول #.لس#=#^ي. \r\n\r\n– #>ل#.ج مش#=ل#.#? #.لأ#>ص#.#% #.لن#.#?جة #>ن م#^#_ #.لس#=#^ي. \r\n\r\n– يس#?خ#~م #<ي #>ل#.ج م#^#_ #?ململ #.لس#.قين, و#.لذي ي#>#-ي ش#>و#^#. #~#.ئم#. #%#>#~م #.ل#^#.حة #<ي #.لق#~مين و#.ل#^غ#%ة #.ل#~#.ئمة #<ي #?ح#^ي#=ه#. #~ون #?وق#<. \r\n\r\n– #>ل#.ج #?نميل #.لأ#-#^#.#< مثل #.لي#~ين و#.لق#~مين. \r\n\r\n– #>ل#.ج سخونة #.لأ#-#^#.#<. \r\n\r\n– يس#?خ#~م #<ي خ#<#_ #~#^جة ح#^#.#^ة #.لجسم #%#>#~ #>ملي#.#? #.س#?ئص#.ل #.ل#^حم, أو #>ن#~ #?وق#< #.ل#-مث #>ن#~ #.لسي#~#.#?.", "Contraindications": "– ل#. ينصح للذين ي#>#.نون من أم#^#.#_ #.ل#=لي حيث له آث#^ سئ. \r\n\r\n– إذ#. #=ن#? #?#>#.ني من حس#.سية من #.لم#.#~ة #.ل#<#>#.لة #<#>لي#= #%إ#%ل#.غ #-#%ي#%#= ح#?ي يؤخذ حذ#^ه. \r\n\r\n– #>ن#~ #.س#?خ#~#.مه ل#=#%#.#^ #.لسن ل#.#%#~ من #.س#?خ#~#.م ج#^#>#.#? قليلة #<ي #%#.#~ئ #.لأم#^ ثم زي#.#~ة هذه #.لج#^#>#.#? #?#~#^يجي#.. \r\n\r\n– #>#~م #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لح#~ #.لم#-لو#% حيث أن ذل#= سو#< يؤث#^ #>لي #.لصحة وين#?ج #>نه #%#>#_ #.لآث#.#^ #.لج#.ن#%ية مثل #.ل#~وخة و#.لإسه#.ل و#<ق#~#.ن #.لو#>ي و#.لن#>#.س. \r\n\r\n– #<ي ح#.لة #.ل#<شل #.ل#=لوي و#_#^و#^ة #.س#?خ#~#.م #.ل#~و#.ء #<سو#< يص#< ل#= #.ل#-#%ي#% #.لج#^#>ة #.لمن#.س#%ة لح#.ل#?#= #.لصحية #~ون #.لمس#.س #%صحة #.ل#=لي#?ين. \r\n\r\n– ل#. يج#% أن #?وق#< #.س#?#>م#.ل #.ل#~و#.ء من #?لق#.ء ن#<س#= حيث أن ذل#= سو#< ي#>#^#_#= لآث#.#^ ج#.ن#%ية #<هذه #.لج#^#>#.#? #>ن#~ #?وق#<ه#. ل#.#%#~ من #.#?#%#.#> نظ#.م #?#~#^يجي وليس #<ج#.ئي ح#?ي ل#. يح#~ث #.#_#-#^#.#% #<ي #.لجسم يؤث#^ #>لي #.لصحة #.ل#>#.مة ويس#%#% #.لمزي#~ من #.لمش#.#=ل #%#~ل#. من #>ل#.ج مش#=لة و#.ح#~ة لأن مثل هذه #.ل#>ل#.ج#.#? له#. #~و#^ #<ي #.ل#?أثي#^ #>لي ه#^مون#.#? #.لجسم مم#. يح#~ث #%#>#_ #.لخلل #<ي ح#.لة #.ل#?وق#< #.ل#<ج#.ئي لل#~و#.ء.", "GI": "About Gabapentin\r\nA GABA analogue, Anticonvulsant, Mood stabilizer.\r\n\r\nMechanism of Action of Gabapentin\r\nGabapentin is a GABA derivative and it bounds to lipophilic molecule. The mechanism of action of Gabapentin is not exactly known. It crosses blood brain barrier and enhances release of GABA.\r\n\r\nIndications for Gabapentin\r\n1.Antiepileptic(Treatment of partial seizure) \r\n2.Treatment of neuropathic pain \r\n\r\nTypical Dosage for Gabapentin\r\nAdult: Initial dose: 300 mg / day increase the dose by 300 mg/day for next 2 days (up to 900 mg / day in 3 divided doses). Thereafter increase the dose until sufficient therapeutic response is obtained. \r\nMaintenance dose: 900-1800mg /day in 3 divided doses \r\nMaximum dose: 3.6 g /day \r\nChildren above 12 years: 10mg / kg / day in 3 divided doses, then gradually increase the dose until sufficient therapeutic response is obtained.", "Composition": "Each Capsule of :Conventin 100mg contains : active ingredient: Gabapentin 100 mg\r\nConventin 300 mg contains : active ingredient: Gabapentin 300 mg\r\nConventin 400mg contains : active ingredient: Gabapentin 400 mg\r\nInactive ingredients :\r\nMicrocrystalline cellu", "Route": "ORAL.SOLID" }, { "ID": "270", "Trade_Name": "CYTODROX 500MG 100CAPS.", "Generic_Name": "HYDROXYUREA", "Price": "121", "Price_Old": "121", "Company": "CIPLA LTD. - INDIA > STAR INTERNATIONAL COMPANY", "Pharmacology": "ANTINEOPLASTIC", "Category": "م#_#.#~#.#? للأو#^#.م", "Use": "–يس#?خ#~م #<ي #>ل#.ج: #.لمل#.نوم (و#^م ميل#.نيني) #.#%ي#_#.#_ #.ل#~م #.لنقوي #.لمزمن #.لح#^ون س#^#-#.ن #.لم#%ي#_ (#<ي ح#.لة #.لو#^م #.ل#^#.ج#> أو #.لمن#?ش#^ أو #.لذي ل#. يم#=ن #>ل#.جه #%#>ملية) #.لس#^#-#.نة ح#^ش#<ية #.لخل#.ي#. (#<ي #.ل#^أس و#.ل#>نق): #=#>#.مل مس#.#>#~ لل#>ل#.ج #.ل#.ش#>#.#>ي، #%#.س#?ثن#.ء س#^#-#.ن #.لش#<ة #<ي م#^#_ى #<ق#^ #.ل#~م #.لمنجلي: ل#?خ#<ي#_ #?و#.#?#^ نو#%#.#? #.لألم #<ي #.لم#^#_ى #.ل#%#.لغين ي#>#.نون من نو#%#.#? #.لألم #.لح#.#~ة #.لم#?#=#^#^ة", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#~و#.ء أو لأي جزء من م#=ون#.#?ه، أو #<ي ح#.لة وجو#~ ه#%و#- ش#~ي#~ #<ي وظ#.ئ#< نخ#.#> #.ل#>ظم (أي #.ل#=#^ي#.#? #.ل#%ي#_ < 2500 أو #.لص#<#.ئح #.ل#~موية < 100000، أو #<ق#^ #.ل#~م #.لش#~ي#~)", "GI": "About Hydroxyurea\r\nAntimetabolite,a ribonucleotide reductase inhibitor, Antineoplastic.\r\nMechanism of Action of Hydroxyurea\r\nDrug converted into free radical nitroxide invivo, and transported by diffusion into cells where it quenches the tyrosyl free radical at the active site of the M2 protein subunit of ribonucleotide reductase, is inactivated. This cause DNA synthesis inhibition selectively and producing cell death in S phase. Repair of DNA damaged by chemicals or irradiation is also inhibited by hydroxyurea.This produces synergistic effect with radiation or alkylating agent.Hydroxyurea also increase the level of fetal Hb, leading to a reduction in the incidence of vasooclussive crisis in sickle cell anaemia.The drug selectively reduces the level of episomal DNA and thus potentially reduces drug resistance associated with duplicated genes retained as episomes.", "Composition": "hydroxyurea 500mg", "Route": "ORAL.SOLID" }, { "ID": "271", "Trade_Name": "MUSLGIX 20 CAPS.", "Generic_Name": "IBUPROFEN+METHOCARBAMOL", "Price": "17", "Price_Old": "17", "Company": "PHAROPHARMA > EMA PHARM", "Pharmacology": "CNS.ANALGESIC.SKELETAL MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#? #%و#.س#-ة #.لجه#.ز #.ل#>ص#%ي #.لم#^#=زي", "Use": "–مس#=ن لآل#.م #.س#<ل #.لظه#^. \r\n\r\n–مس#=ن ل#.ل#?ه#.#% #.ل#.#>ص#.#%. \r\n\r\n–ح#.ل#.#? #^#_و#_ #.ل#>#_ل#.#?. \r\n\r\n–مس#=ن للآل#.م #.ل#^وم#.#?يزمية. \r\n\r\n–#?شنج#.#? و#?مزق#.#? #.ل#>#_ل#.#?. \r\n\r\n–ح#.ل#.#? #?آ#=ل #.ل#<ق#^#.#? #.ل#>نقية. \r\n\r\n–#.لص#~#.#> #.لن#.#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#=#%سول#.#?. \r\n\r\n–ل#. يس#?خ#~م #.ل#~و#.ء #.#=ث#^ من 21 يوم #.ل#. #%#.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ي ق#^حة و#.ل#?ه#.#% #.لم#>#~ة. \r\n\r\n–يمن#> #.ل#.س#?#>م#.ل #<ي ح#.ل#.#? م#^#_ي #.ل#=#%#~.", "GI": "Muslgix provides, a double approach to the management of discomfort associated with musculoskeletal disorders through muscle relaxation and analgesic effect.\r\n\r\nIndications/ Uses:\r\nMuslgix is used in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.\r\n*Muscle spasms.\r\n*Sprains & Strains.\r\n*Fibromyalgia.\r\n*Low back pain & sciatica.\r\n*Rheumatoid pain associated with muscle spasms.\r\n*Ankylosing spondylitis.\r\n*Tension headache.\r\n*Menstrual cramps.\r\n\r\n \t\r\nDosage:\r\nAdults and children over 12 year of age:\r\nOne to two capsules three to four times daily.", "Composition": "Methocarbamol 400 mg\r\nIbuprofen 200 mg", "Route": "ORAL.SOLID" }, { "ID": "272", "Trade_Name": "MARCOFEN 400 MG SR 10 CAPS.", "Generic_Name": "IBUPROFEN", "Price": "5.84", "Price_Old": "5.84", "Company": "GLAXO SMITHKLINE", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يُس#?خ#~م ل#>ل#.ج #.لآل#.م #.و #.ل#?و#^م#.#? #.لن#.#?جة #>ن #.لأل#?ه#.#%#.#?. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #>لى س#%يل #.لمث#.ل (#.ل#^وم#.#?يزم \r\n\r\n– #.ل#^م#.#?وي#~). \r\n\r\n–يُس#?خ#~م ل#>ل#.ج خشونة #.لم#<#.صل. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج ألم #.لظه#^ و#.ل#=#?#< و#.ل#>#_ل#.#? و#.لأو#?#.#^. \r\n\r\n–يُس#?خ#~م ل#?س#=ين آل#.م #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يُس#?خ#~م ل#?س#=ين آل#.م #.لأسن#.ن و#.للثة. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج #.لمغص #.ل#=لوى #.لن#.#?ج #>ن وجو#~ حصو#.#? #.ل#=لى. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج آل#.م حصو#.#? #.لم#^#.#^ة.", "Contraindications": "–لمن ل#~يهم حس#.سية من #.لأي#%و#%#^و#<ين. \r\n\r\n–يُمن#> إس#?خ#~#.مة للحو#.مل و#%#.ل#?ح#~ي#~ #<ى #.لشهو#^ #.ل#.خي#^ة من #.لحمل. \r\n\r\n–يُمن#> إس#?خ#~#.م #.ل#~و#.ء لم#^#_ى #.ل#^#%و. \r\n\r\n–يُمن#> إس#?خ#~#.مه #<ى ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة (ق#^حة #.لم#>#~ة #.و #.ل#.ثنى #>ش#^). \r\n\r\n–يُمن#> إس#?خ#~#.مة لم#^#_ى قصو#^ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–يُمن#> إس#?خ#~#.م #%#^و#<ين للأ#-#<#.ل #?ح#? سن 6 شهو#^.", "GI": "About Ibuprofen\r\nNSAID, a propionic acid derivative, Analgesic and anti-inflammatory.\r\n\r\nMechanism of Action of Ibuprofen\r\nIbuprofen has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Ibuprofen inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions. It also inhibits platelet aggregation and prolongs bleeding time.\r\n\r\nIndications for Ibuprofen\r\n1.Rheumatoid arthritis \r\n2.Ankylosing spondylitis \r\n3.Acute gout \r\n4.Joint disorders e.g. inflammatory disease in joints, crystal deposition in the joints \r\n5.Osteoarthritis \r\n6.For the relief of fever, pain and inflammation in dental, minor surgery and orthopedic \r\n7.Dysmenorrhoea \r\n8.Juvenile arthritis \r\n9.Migraine \r\n10.Patent ductus arteriosus(IV)", "Composition": "Coated Tablet Each tablet contains 400 mg Ibuprofen.\r\n\r\nCapsules SR: each capsule contains 400 mg Ibuprofen\r\n\r\nSuspension: 100 mg / 5 ml Ibuprofen\r\n\r\nSuppository: each suppository contains 100,300 or 500 mg Ibuprofen", "Route": "ORAL.SOLID" }, { "ID": "273", "Trade_Name": "MOMENTUM 300MG 24 CAPS.", "Generic_Name": "HYPERICUM", "Price": "14.4", "Price_Old": "14.4", "Company": "PHARCO", "Pharmacology": "PSYCHIATRIC.MOOD STABILIZERS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لإ#=#?ئ#.#% #.لش#~ي#~ة #%#.لإ#_#.#<ة ل#~و#^ه #<ى #>ل#.ج #.لقلق و#.ل#?#>#%. \r\n\r\n– يس#.هم #<ى #>ل#.ج إ#_#-#^#.#%#.#? #.لنوم #.لش#~ي#~ة. \r\n\r\n– ي#>#.لج #.ل#?قل#%#.#? #.لمز#.جية #.ل#>#~ي#~ة #.ل#?ى ي#>#.نى منه#. #.ل#=ثي#^ من #.لأ#<#^#.#~. \r\n\r\n– يس#.هم #<ى #.ل#?خلص من ألم #.ل#~و#^ة #.لشه#^ية. \r\n\r\n– يس#.#>#~ #<ى #.ل#?خلص من #.لوسو#.س #.لقه#^ى #.لش#~ي#~ #.لذى ي#>#.ني منه #.ل#=ثي#^ من #.لأ#<#^#.#~. \r\n\r\n– ي#>#.لج #.لإ#_#-#^#.#%#.#? #.لن#<سية #.لش#~ي#~ة.", "Contraindications": "– ي#>#?#%#^ هذ#. #.ل#~و#.ء غي#^ أمن #?م#.مً#. خل#.ل #<#?#^ة #.لحمل وذل#= لأن #.ل#~#^#.س#.#? أث#%#?#? أن هذ#. #.ل#~و#.ء يح#~ث #?شوه#.#? و#>يو#% خلقية #<ى ح#.لة #?ن#.وله خل#.ل #.لثل#.ثة أشه#^ #.لأولى من #.لحمل. \r\n\r\n– يمن#> #?ن#.ول أو وص#< هذ#. #.ل#~و#.ء للأ#-#<#.ل #.لأقل من #>م#^ 6 سنو#.#?. \r\n\r\n– يمن#> #?ن#.وله #<ى ح#.لة وجو#~ مش#.#=ل #<ى #.لخصو#%ة \r\n\r\n– إس#?خ#~#.م هذ#. #.ل#~و#.ء ل#<#?#^ة #=#%ي#^ة ق#~ يح#~ث م#_#.#>#<#.#? وأث#.#^ سل#%ية #<ى ح#.لة إج#^#.ء ج#^#.ح#.#? قل#%ية ولذل#= ي#<#_ل أن ي#?م #.ل#?وق#< #>ن #?ن#.وله ق#%ل #.لقي#.م #%#>ملية #.لج#^#.حة #%أس#%و#>ين #>لى #.لأقل. \r\n\r\n– يمن#> #?ن#.وله #<ى وق#? #.ل#^#_#.#>ة #.ل#-#%ي#>ية وذل#= لأنه ينزل م#> ل#%ن #.لأم و#%#.ل#?#.لي #<من #.لمح#?مل أن يؤ#~ى لن#?#.ئج سل#%ية وم#_#.#>#<#.#? #>لى صحة #.ل#-#<ل #.لمولو#~.", "GI": "Mechanism of action\t\r\nHyperforin is believed to be the primary active constituent responsible for the antidepressant and anxiolytic properties of the extracts of St. John s wort. It acts as a reuptake inhibitor of monoamines, including serotonin, norepinephrine, dopamine, and of GABA and glutamate, with IC50 values of 0.05-0.10 mcg/ml for all compounds, with the exception of glutamate, which is in the 0.5 mcg/ml range. It appears to exert these effects by activating the transient receptor potential ion channel TRPC6. Activation of TRPC6 induces the entry of sodium and calcium into the cell which causes inhibition of monoamine reuptake.", "Composition": "st. john wort ext. 300mg", "Route": "ORAL.SOLID" }, { "ID": "274", "Trade_Name": "INDOCID 25 MG 30 CAPSULES", "Generic_Name": "INDOMETHACIN", "Price": "8.5", "Price_Old": "5.59", "Company": "KAHIRA", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=مس#=ن لل#.لم وخ#.#<#_ للح#^#.#^ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.لنق#^سي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.لم#<صلي #.لي#<#>ي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لح#.ل#.#? #.لم#?وس#-ة و#.لش#~ي#~ة من #.ل#^وم#.#?وي#~ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #>س#^ #.ل#-مث وآل#.م م#. #%#>#~ #.لول#.#~ة و#.لج#^#.حة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#?#.لنق#^س #.لح#.#~ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج إص#.#%#.#? #.لأغشية #.ل#^خوة و #.ل#?ه#.#%#.#? أل#.#^#%#-ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج آل#.م #.ل#>#_ل#.#? #.ل#^وم#.#?يزمية \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لج#^#.#% و #.ي#_#. #.ل#?ه#.#% #.ل#.و#?#.#^ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% و#?ي#%س #<ق#^#.#? #.ل#>مو#~ #.ل#<ق#^ى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لم #.ل#>#_ل#.#? و#.ي#_#. يس#?خ#~م لل#.ل#.م #.س#<ل #.لظه#^", "Contraindications": "–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #.ل#^#%و \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لم#?وق#> خ#_و#>هم ل#>ملية لقل#% #.لم#<#?وح \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من ق#^حة #%#.لم#>#~ة #.و نزي#< #%#.لجه#.ز #.له#_مى \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #=#%#~ى #.و #=لوى ش#~ي#~", "GI": "About Indomethacin\r\nNSAID, Indole derivative, Anti-inflammatory, potent antipyretic and analgesic.\r\n\r\nMechanism of Action of Indomethacin\r\nIndomethacin acts by inhibition of Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Indomethacin does not affect the tenderness induced by PGs but block the pain producing mechanism induced by inflammatory mediators by inhibiting the enzyme cyclo-oxygenase. \r\n\r\nInteractions for Indomethacin\r\nAnticoagulants: May prolong prothrombin time. Instruct patients to watch for signs & symptoms of bleeding. \r\nBeta-Blockers: Antihypertensive effect may be blunted. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nDigoxin: Serum digoxin levels may be increased by ibuprofen and indomethacin. \r\nHydantoins: Serum hydantoin levels increased resulting in increased pharmacological and toxic effects. \r\nLithium: Serum lithium levels may be increased.", "Composition": "indomethacin 25mg or 100mg", "Route": "ORAL.SOLID" }, { "ID": "275", "Trade_Name": "POWERCAPS 20 CAPS.", "Generic_Name": "IBUPROFEN+PSEUDOEPHEDRINE", "Price": "19.5", "Price_Old": "13", "Company": "CHEMIPHARM", "Pharmacology": "COLD & FLU DRUGS", "Category": "لل#%#^#~ و #.ل#^شح", "Use": "–يس#?خ#~م للق#_#.ء #>لى #.لأن#<لونز#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج حس#.سية #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#.ل#?خلص من #.ل#.ح#?ق#.ن. \r\n\r\n–#>ل#.ج #.لجيو#% #.لأن#<ية. \r\n\r\n–مس#=ن لآل#.م #.لجسم و#.لص#~#.#>. \r\n\r\n–خ#.#<#_ للح#^#.#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجسم. \r\n\r\n–#>ل#.ج #.نس#~#.#~ #.لأن#< وآل#.م #.لحلق. \r\n\r\n–#>ل#.ج آل#.م #.ل#>#_ل#.#? و#.لوجه. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ #?ن#.وله للأ#-#<#.ل أقل من 12 #>#.م. \r\n\r\n–لمن ي#>#.نون من حس#.سية #?ج#.ه #.لم#.#~ة #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من ق#^حة #<ي #.لم#>#~ة نش#-ة. \r\n\r\n–يحذ#^ #.س#?خ#~مه ق#%ل أو #%#>#~ #>ملي#.#? #.لقل#%.", "GI": "About Ibuprofen\r\nNSAID, a propionic acid derivative, Analgesic and anti-inflammatory.\r\nMechanism of Action of Ibuprofen\r\nIbuprofen has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Ibuprofen inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions. It also inhibits platelet aggregation and prolongs bleeding time.\r\nAbout Pseudoephedrine\r\nAlpha/Beta Adrenergic Agonist, a phenethylamine derivative, A nasal decongestant.\r\nMechanism of Action of Pseudoephedrine\r\nIt is a nasal decongestant with alpha-2 agonistic action. It produces local vasoconstriction, reduces blood flow, and causes shrinkage of mucosa which provides relief of nasal congestion. It reduces oedema of the nasal mucosa, thus improving ventilation, drainage and nasal stuffiness.", "Composition": "Each capsule contains:\r\nIbuprofen 300 mg.\r\nPseudoephedrine HCI 45 mg.", "Route": "ORAL.SOLID" }, { "ID": "276", "Trade_Name": "RAPIFEN 200MG 10 SOFT GELATIN CAPS.", "Generic_Name": "IBUPROFEN", "Price": "5.5", "Price_Old": "5.5", "Company": "SAFE PHARMA > MUP", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يُس#?خ#~م ل#>ل#.ج #.لآل#.م #.و #.ل#?و#^م#.#? #.لن#.#?جة #>ن #.لأل#?ه#.#%#.#?. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #>لى س#%يل #.لمث#.ل (#.ل#^وم#.#?يزم \r\n\r\n– #.ل#^م#.#?وي#~). \r\n\r\n–يُس#?خ#~م ل#>ل#.ج خشونة #.لم#<#.صل. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج ألم #.لظه#^ و#.ل#=#?#< و#.ل#>#_ل#.#? و#.لأو#?#.#^. \r\n\r\n–يُس#?خ#~م ل#?س#=ين آل#.م #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يُس#?خ#~م ل#?س#=ين آل#.م #.لأسن#.ن و#.للثة. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج #.لمغص #.ل#=لوى #.لن#.#?ج #>ن وجو#~ حصو#.#? #.ل#=لى. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج آل#.م حصو#.#? #.لم#^#.#^ة.", "Contraindications": "–لمن ل#~يهم حس#.سية من #.لأي#%و#%#^و#<ين. \r\n\r\n–يُمن#> إس#?خ#~#.مة للحو#.مل و#%#.ل#?ح#~ي#~ #<ى #.لشهو#^ #.ل#.خي#^ة من #.لحمل. \r\n\r\n–يُمن#> إس#?خ#~#.م #.ل#~و#.ء لم#^#_ى #.ل#^#%و. \r\n\r\n–يُمن#> إس#?خ#~#.مه #<ى ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة (ق#^حة #.لم#>#~ة #.و #.ل#.ثنى #>ش#^). \r\n\r\n–يُمن#> إس#?خ#~#.مة لم#^#_ى قصو#^ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–يُمن#> إس#?خ#~#.م #%#^و#<ين للأ#-#<#.ل #?ح#? سن 6 شهو#^.", "GI": "About Ibuprofen\r\nNSAID, a propionic acid derivative, Analgesic and anti-inflammatory.\r\n\r\nMechanism of Action of Ibuprofen\r\nIbuprofen has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Ibuprofen inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions. It also inhibits platelet aggregation and prolongs bleeding time.\r\n\r\nIndications for Ibuprofen\r\n1.Rheumatoid arthritis \r\n2.Ankylosing spondylitis \r\n3.Acute gout \r\n4.Joint disorders e.g. inflammatory disease in joints, crystal deposition in the joints \r\n5.Osteoarthritis \r\n6.For the relief of fever, pain and inflammation in dental, minor surgery and orthopedic \r\n7.Dysmenorrhoea \r\n8.Juvenile arthritis \r\n9.Migraine \r\n10.Patent ductus arteriosus(IV)", "Composition": "ibuprofen 200mg", "Route": "ORAL.SOLID" }, { "ID": "277", "Trade_Name": "IMATIB 100MG 10CAPS.", "Generic_Name": "IMATINIB", "Price": "250", "Price_Old": "250", "Company": "CIPLA LTD. - INDIA > STAR INTERNATIONAL COMPANY", "Pharmacology": "ANTICANCER", "Category": "م#_#.#~ للس#^#-#.ن", "Use": "–#>ل#.ج أنو#.#> مخ#?ل#<ة من #.لس#^#-#.ن مثل س#^#-#.ن #.ل#~م ، س#^#-#.ن نخ#.#> #.ل#>ظ#.م ، س#^#-#.ن #.لجه#.ز #.له#_مى و غي#^ه#. .", "Contraindications": "–غي#^ أمن للإس#?خ#~#.م أثن#.ء #.لحمل \r\n\r\n–غي#^ أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ى #.ل#=#%#~ \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> ح#.ل#.#? #.لنزي#< \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.لقل#% \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.لغ#~ة #.ل#~#^قية", "GI": "About Imatinib\r\nAnticancer, Tyrosine- kinase inhibitor, First generation.\r\nMechanism of Action of Imatinib\r\nImatinib is an inhibitor of multiple tyrosine kinases including Kit, abl, and PDGFR( platelet-derived growth factor receptor) and inhibit phosphorelation.\r\nIndications for Imatinib\r\n1.Chronic myelogenous leukemia \r\n2.Lymphoblastic leukemia (PH+ALL) \r\n3.Gastrointestinal stromal tumors \r\n4.Systemic mastocytosis \r\n5.Hypereosinophilic syndrome \r\n6.Dermatofibrosarcoma protuberans. \r\n7.Plexiform neurofibromas \r\nInteractions for Imatinib\r\nCYP3A4 inhibitors e.g. ketoconazole, erythromycin, clarithromycin, itraconazole, grapefruit juice)---- decrease metabolism---- increase Imatinib exposure (40%) \r\n\r\nCYP3A4 inducers (dexamethasone, phenytoin, carbamazepine, rifampicin, phenobarbital or St. John?s Wort)----- increase metabolism---- decrease Imatinib exposure (74%) \r\n\r\nCYP2D6 inhibitors (e.g. doxorubicin, quinidine, vinca alkaloids, dextropropoxyphene)---- decrease metabolism---- increased", "Composition": "imatinib 100mg", "Route": "ORAL.SOLID" }, { "ID": "278", "Trade_Name": "IBUFEN 200MG 10 SOFT GELATIN CAPS.", "Generic_Name": "IBUPROFEN", "Price": "5.5", "Price_Old": "5.5", "Company": "ALEXANDRIA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يُس#?خ#~م ل#>ل#.ج #.لآل#.م #.و #.ل#?و#^م#.#? #.لن#.#?جة #>ن #.لأل#?ه#.#%#.#?. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #>لى س#%يل #.لمث#.ل (#.ل#^وم#.#?يزم \r\n\r\n– #.ل#^م#.#?وي#~). \r\n\r\n–يُس#?خ#~م ل#>ل#.ج خشونة #.لم#<#.صل. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج ألم #.لظه#^ و#.ل#=#?#< و#.ل#>#_ل#.#? و#.لأو#?#.#^. \r\n\r\n–يُس#?خ#~م ل#?س#=ين آل#.م #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يُس#?خ#~م ل#?س#=ين آل#.م #.لأسن#.ن و#.للثة. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج #.لمغص #.ل#=لوى #.لن#.#?ج #>ن وجو#~ حصو#.#? #.ل#=لى. \r\n\r\n–يُس#?خ#~م ل#>ل#.ج آل#.م حصو#.#? #.لم#^#.#^ة.", "Contraindications": "–لمن ل#~يهم حس#.سية من #.لأي#%و#%#^و#<ين. \r\n\r\n–يُمن#> إس#?خ#~#.مة للحو#.مل و#%#.ل#?ح#~ي#~ #<ى #.لشهو#^ #.ل#.خي#^ة من #.لحمل. \r\n\r\n–يُمن#> إس#?خ#~#.م #.ل#~و#.ء لم#^#_ى #.ل#^#%و. \r\n\r\n–يُمن#> إس#?خ#~#.مه #<ى ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة (ق#^حة #.لم#>#~ة #.و #.ل#.ثنى #>ش#^). \r\n\r\n–يُمن#> إس#?خ#~#.مة لم#^#_ى قصو#^ #.ل#=لى و#.ل#=#%#~. \r\n\r\n–يُمن#> إس#?خ#~#.م #%#^و#<ين للأ#-#<#.ل #?ح#? سن 6 شهو#^.", "GI": "About Ibuprofen\r\nNSAID, a propionic acid derivative, Analgesic and anti-inflammatory.\r\n\r\nMechanism of Action of Ibuprofen\r\nIbuprofen has analgesic, anti-inflammatory and antipyretic action. It acts by inhibiting Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Ibuprofen inhibits cyclo-oxygenase enzyme and antagonizes prostaglandin actions. It also inhibits platelet aggregation and prolongs bleeding time.\r\n\r\nIndications for Ibuprofen\r\n1.Rheumatoid arthritis \r\n2.Ankylosing spondylitis \r\n3.Acute gout \r\n4.Joint disorders e.g. inflammatory disease in joints, crystal deposition in the joints \r\n5.Osteoarthritis \r\n6.For the relief of fever, pain and inflammation in dental, minor surgery and orthopedic \r\n7.Dysmenorrhoea \r\n8.Juvenile arthritis \r\n9.Migraine \r\n10.Patent ductus arteriosus(IV)", "Composition": "ibuprofen 100mg or 200mg", "Route": "ORAL.SOLID" }, { "ID": "279", "Trade_Name": "INDOMETHACIN 25 MG 30 CAPS.", "Generic_Name": "INDOMETHACIN", "Price": "1.7", "Price_Old": "1.7", "Company": "MISR", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=مس#=ن لل#.لم وخ#.#<#_ للح#^#.#^ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.لنق#^سي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.لم#<صلي #.لي#<#>ي \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لح#.ل#.#? #.لم#?وس#-ة و#.لش#~ي#~ة من #.ل#^وم#.#?وي#~ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #>س#^ #.ل#-مث وآل#.م م#. #%#>#~ #.لول#.#~ة و#.لج#^#.حة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#?#.لنق#^س #.لح#.#~ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج إص#.#%#.#? #.لأغشية #.ل#^خوة و #.ل#?ه#.#%#.#? أل#.#^#%#-ة \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج آل#.م #.ل#>#_ل#.#? #.ل#^وم#.#?يزمية \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لج#^#.#% و #.ي#_#. #.ل#?ه#.#% #.ل#.و#?#.#^ \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% و#?ي#%س #<ق#^#.#? #.ل#>مو#~ #.ل#<ق#^ى \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لم #.ل#>#_ل#.#? و#.ي#_#. يس#?خ#~م لل#.ل#.م #.س#<ل #.لظه#^", "Contraindications": "–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #.ل#^#%و \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لم#?وق#> خ#_و#>هم ل#>ملية لقل#% #.لم#<#?وح \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من ق#^حة #%#.لم#>#~ة #.و نزي#< #%#.لجه#.ز #.له#_مى \r\n\r\n–يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من م#^#_ #=#%#~ى #.و #=لوى ش#~ي#~", "GI": "About Indomethacin\r\nNSAID, Indole derivative, Anti-inflammatory, potent antipyretic and analgesic.\r\n\r\nMechanism of Action of Indomethacin\r\nIndomethacin acts by inhibition of Prostaglandin (PGs) synthesis and their release at the site of injury. Prostaglandins cause tenderness and amplify the action of other algesics. Indomethacin does not affect the tenderness induced by PGs but block the pain producing mechanism induced by inflammatory mediators by inhibiting the enzyme cyclo-oxygenase. \r\n\r\nInteractions for Indomethacin\r\nAnticoagulants: May prolong prothrombin time. Instruct patients to watch for signs & symptoms of bleeding. \r\nBeta-Blockers: Antihypertensive effect may be blunted. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nDigoxin: Serum digoxin levels may be increased by ibuprofen and indomethacin. \r\nHydantoins: Serum hydantoin levels increased resulting in increased pharmacological and toxic effects. \r\nLithium: Serum lithium levels may be increased.", "Composition": "Each Capsule contains: indomethacin 25 mg.\r\n\r\nEach Suppository Contains: indomethacin 100 mg.", "Route": "ORAL.SOLID" }, { "ID": "280", "Trade_Name": "ALZAC 10MG 20 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "18", "Price_Old": "18", "Company": "FUTURE PHARMACEUTICAL INDUSTRIES (FPI)", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine 10mg", "Route": "ORAL.SOLID" }, { "ID": "281", "Trade_Name": "FLUOXETINE 20 MG H.G.CAPS.", "Generic_Name": "FLUOXETINE", "Price": "8", "Price_Old": "8", "Company": "SIGMA", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine hcl 20", "Route": "ORAL.SOLID" }, { "ID": "282", "Trade_Name": "FLUOXETINE 20 MG 10 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "18.6", "Price_Old": "18.6", "Company": "MISR", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine hcl 20", "Route": "ORAL.SOLID" }, { "ID": "283", "Trade_Name": "PHILOZAC 10MG 10 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "9", "Price_Old": "9", "Company": "AMOUN", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "Each capsule contains :\r\nFluoxetine (HCL) 10 or 20 mg.", "Route": "ORAL.SOLID" }, { "ID": "284", "Trade_Name": "PHILOZAC 20MG 10 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "11", "Price_Old": "11", "Company": "AMOUN", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "Each capsule contains :\r\nFluoxetine (HCL) 10 or 20 mg.", "Route": "ORAL.SOLID" }, { "ID": "285", "Trade_Name": "FLUTIN 20MG 14 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "11.15", "Price_Old": "11.15", "Company": "EIPICO", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "Fluoxetine hydrochloride equivalent to 20 mg Fluoxetine base.", "Route": "ORAL.SOLID" }, { "ID": "286", "Trade_Name": "FLOROSIN 20MG 10 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "11", "Price_Old": "11", "Company": "T3A PHARMA", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine hcl 20", "Route": "ORAL.SOLID" }, { "ID": "287", "Trade_Name": "OCTOZAC 20MG 10 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "21.6", "Price_Old": "21.6", "Company": "OCTOBER PHARMA", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine hcl 20", "Route": "ORAL.SOLID" }, { "ID": "288", "Trade_Name": "DEPREBAN 20MG 10 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "18.18", "Price_Old": "18.18", "Company": "AMRIYA", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine hcl 20", "Route": "ORAL.SOLID" }, { "ID": "289", "Trade_Name": "PROZAC 20MG 14 CAPS.", "Generic_Name": "FLUOXETINE", "Price": "65", "Price_Old": "65", "Company": "ELI LILLY", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–يس#.#>#~ #.ل#>ق#.#^ #>لى #.ل#?خلص من #.لوسو#.س #.لقه#^ي \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#=#?ئ#.#% و #.لإ#_#-#^#.#% و #.لهل#> \r\n\r\n–#.لإ#_#-#^#.#% #<ي #.لأ#=ل \r\n\r\n–#.لإ#_#-#^#.#% #.لن#<سي \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لح#.لة #.لمز#.جية \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من إ#_#-#^#.#%#.#? #.لنوم \r\n\r\n–يس#.#>#~ #<ي #.ل#?خلص من #.لإ#_#-#^#.#% #.لن#<سي #.لمص#.ح#% #.لإ#~م#.ن", "Contraindications": "–هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي #>ليه#. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء لم#. له من #?أثي#^ سئ #>ليهم، من هذه #.لح#.ل#.#?: \r\n\r\n–#.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لم#=ون#.#? هذ#. #.ل#~و#.ء (#<لو#=سي#?ين \r\n\r\n– #.ل#.سي#?#.ل#%#^#.م \r\n\r\n– #.لسي#?#.لو#%#^#.م) \r\n\r\n–يحظ#^ #.س#?خ#~#.م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل أو #.ل#^#_#.#>ة ق#%ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء م#> أي نو#> آخ#^ من مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين إل#. #%#>#~ م#^و#^ أس#%و#>ين #>لى #.لأقل", "GI": "About Fluoxetine\r\nSelective Serotonin Reuptake Inhibitor, Antidepressant.\r\n\r\nMechanism of Action of Fluoxetine\r\nFluoxetine preferentially inhibits the re-uptake of Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect. Fluoxetine has only less affinity towards Dopaminergic, Cholinergic and Adrenergic receptors.\r\n\r\nInteractions for Fluoxetine\r\nMAOIs: Serious life threatening reactions. At least 14 days should elapse after MAOIs withdrawal and initiation of fluoxentine. At least 5 weeks should elapse after fluoxentine withdrawal and initiation of the therapy with MAOIs. \r\nDiazepam: Half-life of diazepam prolonged. \r\nHaloperidol: Chances of severe extrapyramidal reactions. \r\nLithium: Serum lithium levels increased leading to toxicity. \r\nTCAs: Efiicacy and toxic effects of TCAs enhanced. \r\nWarfarin,", "Composition": "fluoxetine hcl 20", "Route": "ORAL.SOLID" }, { "ID": "290", "Trade_Name": "CORONIT 40MG 20 LENTOCAPS.", "Generic_Name": "ISOSORBIDE DINITRATE", "Price": "10", "Price_Old": "10", "Company": "ALEXANDRIA", "Pharmacology": "ANTI-ISCHEMIC", "Category": "نقص #?#^وية #.لقل#% و #.لذ#%حة #.لص#~#^ية", "Use": "–#>ل#.ج #.لذ#%حة #.لص#~#^ية . \r\n\r\n–#.لوق#.ية من #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–ل#. ينصح #<ي ح#.لة #.س#?خ#~#.م #.#~وية مث#%#-#.#? #.نزيم #<وس#<و#~#.يس#?#^يز #^قم 5 وهي من #.#~وية #_#>#< #.ل#.ن#?ص#.#% مثل #.ل#?#.#~#.ل#.#<يل أو #.ل#<ي#.ج#^#. أو #.ل#<#.#^#~ين#.#<يل حيث إنه يؤ#~ي إلى ه#%و#- ح#.#~ #<ي #_غ#- #.ل#~م وقصو#^ #<ي #?#^وية #.لقل#% . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> #.#~وية مح#<ز#.#? إنزيم #.لجو#.نيلي#? #.لحلقي #.لذ#.ئ#% مثل #^يوسيجو#.#? حيث إنه يس#%#% ه#%و#- #<ي #_غ#- #.ل#~م . \r\n\r\n–لم#^#_ى #<ق#^ #.ل#~م #?جن#% #.س#?خ#~#.مه. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ #_غ#- #.ل#~م #>ني#< #.ل#.#%#?#>#.#~ #>ن #?ن#.وله. \r\n\r\n–لمن ي#>#.نون من م#^#_ #.لأ#%ه#^ي وهو #_يق #.لصم#.م #.لأو#^#-ي #?جن#% #?ن#.وله. \r\n\r\n–#<ي ح#.لة #.لحس#.سية من #.لن#?#^#.#? . \r\n\r\n–#.لص#~مة ونزي#< #<ي #.لمخ . \r\n\r\n–#.ل#>ل#.ج #%#.لن#?#^#.#? ق#~ ي#<#.قم ح#.لة #.لذ#%حة #.لص#~#^ية #.لن#.#?جة #>ن #.#>#?ل#.ل #>#_لة #.لقل#% #.ل#_خ#.مي . \r\n\r\n–#<ي ح#.لة #?ن#.ول ج#^#>ة #>#.لية ي#?م #?ن#.ول سو#.ئل #^#.#<#>ة #.ل#_غ#- . \r\n\r\n–يس#?خ#~م #%حذ#^ #<ي ح#.لة #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية . \r\n\r\n–#<ي ح#.لة #>#~م و#_وح #.ل#^ؤية #>ن#~ #?ن#.وله يج#% #.ل#?وق#< #>ن #.س#?خ#~#.مه و إخ#%#.#^ #.ل#-#%ي#% . \r\n\r\n–ل#. يس#?خ#~م م#> #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية .", "GI": "About Isosorbide Dinitrate\r\nAlkyl nitrate derivative, a direct vasodilator, Antianginal.\r\nMechanism of Action of Isosorbide Dinitrate\r\nIt is a direct smooth muscle relaxant, which have a prominent action vascular smooth muscles preferentially veins than arteries. It is enzymatically denitrated in the smooth muscle cells to release the reactive free radical nitric oxide which activates cytosolic guanylyl cyclase thus increases cyclic GMP levels which causes dephosphorylation of myosin light chain kinase(MLCK) through a cyclic GMP dependent protein kinase. Reduced availability of phosphorylated (active) MLCK interferes with activation of myosin and myosin fails to interact with actin to cause contraction and consequently relaxation occurs. Elevated levels of cyclic GMP also reduce calcium entry which also contributing to relaxation. It dilates veins more than arteries because veins have greater amount of enzyme that generate nitric oxide from nitrates.", "Composition": "isosrbide dinitrate 20 mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "291", "Trade_Name": "ISOTRETINOIN 10MG 10 SOFT GELATIN CAPS.", "Generic_Name": "ISOTRETINOIN", "Price": "38", "Price_Old": "33", "Company": "RANBAXY", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#>ق#~ي، و#.لش#~ي#~ #.ل#~#^جة أو #.لمس#?#>صى، و#.لذي ل#. يس#?جي#% لل#>ل#.ج #.ل#?قلي#~ي. \r\n\r\n–يس#?خ#~م أحي#.ن#.ً #%ه#~#< #.لوق#.ية من #.لإص#.#%ة من #%#>#_ أنو#.#> #.لس#^#-#.ن #.لذي ق#~ يصي#% #.لجل#~ . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#%سي#- و#.لم#?#=يس.", "Contraindications": "–ق#%ل #.س#?خ#~#.م #.ل#>ق#.#^ يج#% إج#^#.ء #.ل#=ش#< #.ل#-#%ي لل#?#>#^#< #>لى #.لح#.لة وأس#%#.#% ظهو#^ ح#% #.لش#%#.#% و#>لى هذ#. #.لأس#.س ي#?م #?ح#~ي#~ #.ل#>ق#.#^ #.لمن#.س#%. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #.ل#=#^يم#.#? و#.ل#>ق#.#^#.#? #.لأخ#^ى و#>#~م #<#.#>لي#?ه#. ي#?م #.للجوء إلى هذ#. #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول ج#^#>ة م#%#.لغه أو ز#.ئ#~ة #>ن #.لج#^#>ة #.لمح#~#~ة م جهة #.ل#-#%ي#% ح#?ى ل#. #?أ#?ي #%ن#?#.ئج #>#=سية #>لى #.لجسم. \r\n\r\n–#<ي ح#.لة نسي#.ن #.لج#^#>ة ي#?م أخذه#. إل#. #<ي ح#.لة ق#^#% مي#>#.#~ #.لج#^#>ة #.ل#?#.لية ويحذ#^ #?ن#.ول ج#^#>ة م#_#.#>#<ة. \r\n\r\n–يج#% #>مل #.ل#?ح#.ليل #.ل#~و#^ية و#.لم#?#.#%#>ة م#> #.ل#-#%ي#% لل#?#>#^#< #>لى وظ#.ئ#< #.ل#=#%#~ و#>#~م #?أث#^ه #%#.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.ل#?#>#^#_ لأش#>ة #.لشمس أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يج#% #?ن#.ول #.لم#.ء #%#=مي#.#? #=#.#<ية. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لليز#^ إل#. #%#>#~ م#^و#^ #>#.م #%#>#~ #.ل#>ل#.ج و#.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه#. #?ؤث#^ #>لى صحة #.لجنين. \r\n\r\n–#<ي ح#.لة وجو#~ #^غ#%ة #<ي #.لحمل يج#% #.ل#?وق#< #>ن #.ل#>ل#.ج #%م#~ة ل#. #?قل #>ن ثل#.ث أشه#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لمقش#^#.#? #.ل#%ش#^ة خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة وجو#~ أي م#^#_ أو مش#.#=ل ن#<سية يج#% إخ#%#.#^ #.ل#-#%ي#% وخ#.صة لمن ي#>#.نون من #_#>#< #<ي #.ل#>ظ#.م وأم#^#.#_ #.لقل#% و#.لس#=#^ و#.ل#=#%#~. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> أي أ#~وية أو مس#?ح#_#^#.#? #-#%ية مثل #.ل#?#?#^#.سي#=لين. \r\n\r\n–ينصح #%إ#?#%#.#> نظ#.م غذ#.ئي ي#>#?م#~ #>لى #.لخ#_#^#.و#.#? و#.ل#<#.#=هة أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "About Isotretinoin\r\nVitamin A isomer, Retinoic Acid Derivative, Anti-acne.\r\n\r\nMechanism of Action of Isotretinoin\r\nIsotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. Isotretinoin decreases sebocyte number and reduces sebum synthesis and therefore used in the treatment of acne.It reduces sebaceous gland size and inhibits sebaceous gland differentiation. \r\nIsotretinoin reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones formation. It alters DNA transcription\r\n\r\nInteractions for Isotretinoin\r\nAlcohol: Etretinate formed in presence of alcohol. \r\nAntibacterials: Possible increased risk of benign intracranial hypertension with tetracyclines. \r\nWarfarin: Possible reduction in anticoagulant effect. \r\nAntiepileptics: Plasma concentration of carbamazepine may be reduced. \r\nCytotoxic drugs: Plasma concentration of methotrexate may be increased.", "Composition": "isotretinoin 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "292", "Trade_Name": "ANGIOFOX (EFFOX) 50MG LONG 20 CAPS.", "Generic_Name": "ISOSORBIDE-5-MONONITRATE", "Price": "47.5", "Price_Old": "24", "Company": "MINA PHARM > SCHWARZ", "Pharmacology": "ANTIANGINAL", "Category": "م#_#.#~ للذ#%حة #.لص#~#^ية", "Use": "–يل#>#% #.ل#~و#.ء #~و#^#. ه#.م#. #<ي #>ل#.ج #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#?م #.س#?خ#~#.مه #=#>ل#.ج وق#.ئي من خ#-#^ #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#>#.لج #_غ#- #.ل#~م #.لم#^#?#<#> وينظمه. \r\n\r\n–#?س#?خ#~م لمن#> خ#-#^ #?صل#% #.لش#^#.يين #.لح#.#~.", "Contraindications": "–يحظ#^ #.س#?خ#~#.م #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من حس#.سية #>#.لية للمو#.#~ #.لم#>ق#~ة و#.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#%#-ل#.ن هذ#. #.ل#~و#.ء م#> جمي#> مث#%#-#.#? #<س#<و#~#.يس#?#^#.ز مثل talafalafil لأنه يؤ#~ي إلى #.نخ#<#.#_ ش#~ي#~ #<ي #_غ#- #.ل#~م. \r\n\r\n–#?جن#% #?#>#.#-ي #.ل#~و#.ء #<ي م#^حلة #.لحمل، لأنه لم يث#%#? ح#?ى #.لآن سل#.مة هذ#. #.ل#~و#.ء #>لى صحة #.لم#^أة #.لح#.مل و#%#.ل#?#.لي ل#. ي#<#_ل #?ن#.وله إل#. #<ي #.لح#.ل#.#? #.لقصوى و#%موج#% نصيحة #.ل#-#%ي#%. \r\n\r\n–يحظ#^ #?ن#.ول #.ل#~و#.ء خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية، لأنه ينزل م#> حلي#% #.لث#~ي و#%#.ل#?#.لي من #.لمح#?مل أن ي#?س#%#% #<ي #_#^#^ #=#%ي#^ لل#-#<ل.", "GI": "About Isosorbide-5-Mononitrate\r\nAlkyl nitrate derivative, a direct vasodilator, Antianginal.\r\nMechanism of Action of Isosorbide-5-Mononitrate\r\nIt is a direct smooth muscle relaxant, which have a prominent action vascular smooth muscles preferentially veins than arteries. It is enzymatically denitrated in the smooth muscle cells to release the reactive free radical nitric oxide which activates cytosolic guanylyl cyclase thus increases cyclic GMP levels which causes dephosphorylation of myosin light chain kinase(MLCK) through a cyclic GMP dependent protein kinase. Reduced availability of phosphorylated (active) MLCK interferes with activation of myosin and myosin fails to interact with actin to cause contraction and consequently relaxation occurs. Elevated levels of cyclic GMP also reduce calcium entry which also contributing to relaxation. It dilates veins more than arteries because veins have greater amount of enzyme that generate nitric oxide from nitrates.", "Composition": "Each 20 mg tablet contains 20 mg isosorbide mononitrate.\r\nEach 40 mg tablet contains 40 mg isosorbide mononitrate.\r\n\r\nProlonged release capsules\r\nEach 25 mg, prolonged release capsule contains 25 mg isosorbide mononitrate.\r\nEach 50 mg, prolonged release capsul", "Route": "ORAL.SOLID" }, { "ID": "293", "Trade_Name": "CARDIOGUARD M 20MG SR 10CAPS.", "Generic_Name": "ISOSORBIDE-5-MONONITRATE", "Price": "6", "Price_Old": "6", "Company": "AMOUN", "Pharmacology": "ANTIANGINAL", "Category": "م#_#.#~ للذ#%حة #.لص#~#^ية", "Use": "–يل#>#% #.ل#~و#.ء #~و#^#. ه#.م#. #<ي #>ل#.ج #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#?م #.س#?خ#~#.مه #=#>ل#.ج وق#.ئي من خ#-#^ #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#>#.لج #_غ#- #.ل#~م #.لم#^#?#<#> وينظمه. \r\n\r\n–#?س#?خ#~م لمن#> خ#-#^ #?صل#% #.لش#^#.يين #.لح#.#~.", "Contraindications": "–يحظ#^ #.س#?خ#~#.م #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من حس#.سية #>#.لية للمو#.#~ #.لم#>ق#~ة و#.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#%#-ل#.ن هذ#. #.ل#~و#.ء م#> جمي#> مث#%#-#.#? #<س#<و#~#.يس#?#^#.ز مثل talafalafil لأنه يؤ#~ي إلى #.نخ#<#.#_ ش#~ي#~ #<ي #_غ#- #.ل#~م. \r\n\r\n–#?جن#% #?#>#.#-ي #.ل#~و#.ء #<ي م#^حلة #.لحمل، لأنه لم يث#%#? ح#?ى #.لآن سل#.مة هذ#. #.ل#~و#.ء #>لى صحة #.لم#^أة #.لح#.مل و#%#.ل#?#.لي ل#. ي#<#_ل #?ن#.وله إل#. #<ي #.لح#.ل#.#? #.لقصوى و#%موج#% نصيحة #.ل#-#%ي#%. \r\n\r\n–يحظ#^ #?ن#.ول #.ل#~و#.ء خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية، لأنه ينزل م#> حلي#% #.لث#~ي و#%#.ل#?#.لي من #.لمح#?مل أن ي#?س#%#% #<ي #_#^#^ #=#%ي#^ لل#-#<ل.", "GI": "About Isosorbide-5-Mononitrate\r\nAlkyl nitrate derivative, a direct vasodilator, Antianginal.\r\nMechanism of Action of Isosorbide-5-Mononitrate\r\nIt is a direct smooth muscle relaxant, which have a prominent action vascular smooth muscles preferentially veins than arteries. It is enzymatically denitrated in the smooth muscle cells to release the reactive free radical nitric oxide which activates cytosolic guanylyl cyclase thus increases cyclic GMP levels which causes dephosphorylation of myosin light chain kinase(MLCK) through a cyclic GMP dependent protein kinase. Reduced availability of phosphorylated (active) MLCK interferes with activation of myosin and myosin fails to interact with actin to cause contraction and consequently relaxation occurs. Elevated levels of cyclic GMP also reduce calcium entry which also contributing to relaxation. It dilates veins more than arteries because veins have greater amount of enzyme that generate nitric oxide from nitrates.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "294", "Trade_Name": "ISOTRETINOIN 20MG 10 SOFT GELATIN CAPS.", "Generic_Name": "ISOTRETINOIN", "Price": "75", "Price_Old": "50", "Company": "RANBAXY", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#>ق#~ي، و#.لش#~ي#~ #.ل#~#^جة أو #.لمس#?#>صى، و#.لذي ل#. يس#?جي#% لل#>ل#.ج #.ل#?قلي#~ي. \r\n\r\n–يس#?خ#~م أحي#.ن#.ً #%ه#~#< #.لوق#.ية من #.لإص#.#%ة من #%#>#_ أنو#.#> #.لس#^#-#.ن #.لذي ق#~ يصي#% #.لجل#~ . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#%سي#- و#.لم#?#=يس.", "Contraindications": "–ق#%ل #.س#?خ#~#.م #.ل#>ق#.#^ يج#% إج#^#.ء #.ل#=ش#< #.ل#-#%ي لل#?#>#^#< #>لى #.لح#.لة وأس#%#.#% ظهو#^ ح#% #.لش#%#.#% و#>لى هذ#. #.لأس#.س ي#?م #?ح#~ي#~ #.ل#>ق#.#^ #.لمن#.س#%. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #.ل#=#^يم#.#? و#.ل#>ق#.#^#.#? #.لأخ#^ى و#>#~م #<#.#>لي#?ه#. ي#?م #.للجوء إلى هذ#. #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول ج#^#>ة م#%#.لغه أو ز#.ئ#~ة #>ن #.لج#^#>ة #.لمح#~#~ة م جهة #.ل#-#%ي#% ح#?ى ل#. #?أ#?ي #%ن#?#.ئج #>#=سية #>لى #.لجسم. \r\n\r\n–#<ي ح#.لة نسي#.ن #.لج#^#>ة ي#?م أخذه#. إل#. #<ي ح#.لة ق#^#% مي#>#.#~ #.لج#^#>ة #.ل#?#.لية ويحذ#^ #?ن#.ول ج#^#>ة م#_#.#>#<ة. \r\n\r\n–يج#% #>مل #.ل#?ح#.ليل #.ل#~و#^ية و#.لم#?#.#%#>ة م#> #.ل#-#%ي#% لل#?#>#^#< #>لى وظ#.ئ#< #.ل#=#%#~ و#>#~م #?أث#^ه #%#.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.ل#?#>#^#_ لأش#>ة #.لشمس أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يج#% #?ن#.ول #.لم#.ء #%#=مي#.#? #=#.#<ية. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لليز#^ إل#. #%#>#~ م#^و#^ #>#.م #%#>#~ #.ل#>ل#.ج و#.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه#. #?ؤث#^ #>لى صحة #.لجنين. \r\n\r\n–#<ي ح#.لة وجو#~ #^غ#%ة #<ي #.لحمل يج#% #.ل#?وق#< #>ن #.ل#>ل#.ج #%م#~ة ل#. #?قل #>ن ثل#.ث أشه#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لمقش#^#.#? #.ل#%ش#^ة خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة وجو#~ أي م#^#_ أو مش#.#=ل ن#<سية يج#% إخ#%#.#^ #.ل#-#%ي#% وخ#.صة لمن ي#>#.نون من #_#>#< #<ي #.ل#>ظ#.م وأم#^#.#_ #.لقل#% و#.لس#=#^ و#.ل#=#%#~. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> أي أ#~وية أو مس#?ح#_#^#.#? #-#%ية مثل #.ل#?#?#^#.سي#=لين. \r\n\r\n–ينصح #%إ#?#%#.#> نظ#.م غذ#.ئي ي#>#?م#~ #>لى #.لخ#_#^#.و#.#? و#.ل#<#.#=هة أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "About Isotretinoin\r\nVitamin A isomer, Retinoic Acid Derivative, Anti-acne.\r\n\r\nMechanism of Action of Isotretinoin\r\nIsotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. Isotretinoin decreases sebocyte number and reduces sebum synthesis and therefore used in the treatment of acne.It reduces sebaceous gland size and inhibits sebaceous gland differentiation. \r\nIsotretinoin reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones formation. It alters DNA transcription\r\n\r\nInteractions for Isotretinoin\r\nAlcohol: Etretinate formed in presence of alcohol. \r\nAntibacterials: Possible increased risk of benign intracranial hypertension with tetracyclines. \r\nWarfarin: Possible reduction in anticoagulant effect. \r\nAntiepileptics: Plasma concentration of carbamazepine may be reduced. \r\nCytotoxic drugs: Plasma concentration of methotrexate may be increased.", "Composition": "isotretinoin 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "295", "Trade_Name": "NETLOOK 10MG 20 SOFT GELATIN CAPS.", "Generic_Name": "ISOTRETINOIN", "Price": "76", "Price_Old": "60", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > ANDALOUS PHARMA", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#>ق#~ي، و#.لش#~ي#~ #.ل#~#^جة أو #.لمس#?#>صى، و#.لذي ل#. يس#?جي#% لل#>ل#.ج #.ل#?قلي#~ي. \r\n\r\n–يس#?خ#~م أحي#.ن#.ً #%ه#~#< #.لوق#.ية من #.لإص#.#%ة من #%#>#_ أنو#.#> #.لس#^#-#.ن #.لذي ق#~ يصي#% #.لجل#~ . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#%سي#- و#.لم#?#=يس.", "Contraindications": "–ق#%ل #.س#?خ#~#.م #.ل#>ق#.#^ يج#% إج#^#.ء #.ل#=ش#< #.ل#-#%ي لل#?#>#^#< #>لى #.لح#.لة وأس#%#.#% ظهو#^ ح#% #.لش#%#.#% و#>لى هذ#. #.لأس#.س ي#?م #?ح#~ي#~ #.ل#>ق#.#^ #.لمن#.س#%. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #.ل#=#^يم#.#? و#.ل#>ق#.#^#.#? #.لأخ#^ى و#>#~م #<#.#>لي#?ه#. ي#?م #.للجوء إلى هذ#. #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول ج#^#>ة م#%#.لغه أو ز#.ئ#~ة #>ن #.لج#^#>ة #.لمح#~#~ة م جهة #.ل#-#%ي#% ح#?ى ل#. #?أ#?ي #%ن#?#.ئج #>#=سية #>لى #.لجسم. \r\n\r\n–#<ي ح#.لة نسي#.ن #.لج#^#>ة ي#?م أخذه#. إل#. #<ي ح#.لة ق#^#% مي#>#.#~ #.لج#^#>ة #.ل#?#.لية ويحذ#^ #?ن#.ول ج#^#>ة م#_#.#>#<ة. \r\n\r\n–يج#% #>مل #.ل#?ح#.ليل #.ل#~و#^ية و#.لم#?#.#%#>ة م#> #.ل#-#%ي#% لل#?#>#^#< #>لى وظ#.ئ#< #.ل#=#%#~ و#>#~م #?أث#^ه #%#.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.ل#?#>#^#_ لأش#>ة #.لشمس أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يج#% #?ن#.ول #.لم#.ء #%#=مي#.#? #=#.#<ية. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لليز#^ إل#. #%#>#~ م#^و#^ #>#.م #%#>#~ #.ل#>ل#.ج و#.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه#. #?ؤث#^ #>لى صحة #.لجنين. \r\n\r\n–#<ي ح#.لة وجو#~ #^غ#%ة #<ي #.لحمل يج#% #.ل#?وق#< #>ن #.ل#>ل#.ج #%م#~ة ل#. #?قل #>ن ثل#.ث أشه#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لمقش#^#.#? #.ل#%ش#^ة خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة وجو#~ أي م#^#_ أو مش#.#=ل ن#<سية يج#% إخ#%#.#^ #.ل#-#%ي#% وخ#.صة لمن ي#>#.نون من #_#>#< #<ي #.ل#>ظ#.م وأم#^#.#_ #.لقل#% و#.لس#=#^ و#.ل#=#%#~. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> أي أ#~وية أو مس#?ح#_#^#.#? #-#%ية مثل #.ل#?#?#^#.سي#=لين. \r\n\r\n–ينصح #%إ#?#%#.#> نظ#.م غذ#.ئي ي#>#?م#~ #>لى #.لخ#_#^#.و#.#? و#.ل#<#.#=هة أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "About Isotretinoin\r\nVitamin A isomer, Retinoic Acid Derivative, Anti-acne.\r\n\r\nMechanism of Action of Isotretinoin\r\nIsotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. Isotretinoin decreases sebocyte number and reduces sebum synthesis and therefore used in the treatment of acne.It reduces sebaceous gland size and inhibits sebaceous gland differentiation. \r\nIsotretinoin reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones formation. It alters DNA transcription\r\n\r\nInteractions for Isotretinoin\r\nAlcohol: Etretinate formed in presence of alcohol. \r\nAntibacterials: Possible increased risk of benign intracranial hypertension with tetracyclines. \r\nWarfarin: Possible reduction in anticoagulant effect. \r\nAntiepileptics: Plasma concentration of carbamazepine may be reduced. \r\nCytotoxic drugs: Plasma concentration of methotrexate may be increased.", "Composition": "isotretinoin 10mg or 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "296", "Trade_Name": "CARDIOGUARD M 40 MG SR 10 CAPS.", "Generic_Name": "ISOSORBIDE-5-MONONITRATE", "Price": "10", "Price_Old": "10", "Company": "AMOUN", "Pharmacology": "ANTIANGINAL", "Category": "م#_#.#~ للذ#%حة #.لص#~#^ية", "Use": "–يل#>#% #.ل#~و#.ء #~و#^#. ه#.م#. #<ي #>ل#.ج #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#?م #.س#?خ#~#.مه #=#>ل#.ج وق#.ئي من خ#-#^ #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#>#.لج #_غ#- #.ل#~م #.لم#^#?#<#> وينظمه. \r\n\r\n–#?س#?خ#~م لمن#> خ#-#^ #?صل#% #.لش#^#.يين #.لح#.#~.", "Contraindications": "–يحظ#^ #.س#?خ#~#.م #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من حس#.سية #>#.لية للمو#.#~ #.لم#>ق#~ة و#.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#%#-ل#.ن هذ#. #.ل#~و#.ء م#> جمي#> مث#%#-#.#? #<س#<و#~#.يس#?#^#.ز مثل talafalafil لأنه يؤ#~ي إلى #.نخ#<#.#_ ش#~ي#~ #<ي #_غ#- #.ل#~م. \r\n\r\n–#?جن#% #?#>#.#-ي #.ل#~و#.ء #<ي م#^حلة #.لحمل، لأنه لم يث#%#? ح#?ى #.لآن سل#.مة هذ#. #.ل#~و#.ء #>لى صحة #.لم#^أة #.لح#.مل و#%#.ل#?#.لي ل#. ي#<#_ل #?ن#.وله إل#. #<ي #.لح#.ل#.#? #.لقصوى و#%موج#% نصيحة #.ل#-#%ي#%. \r\n\r\n–يحظ#^ #?ن#.ول #.ل#~و#.ء خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية، لأنه ينزل م#> حلي#% #.لث#~ي و#%#.ل#?#.لي من #.لمح#?مل أن ي#?س#%#% #<ي #_#^#^ #=#%ي#^ لل#-#<ل.", "GI": "About Isosorbide-5-Mononitrate\r\nAlkyl nitrate derivative, a direct vasodilator, Antianginal.\r\nMechanism of Action of Isosorbide-5-Mononitrate\r\nIt is a direct smooth muscle relaxant, which have a prominent action vascular smooth muscles preferentially veins than arteries. It is enzymatically denitrated in the smooth muscle cells to release the reactive free radical nitric oxide which activates cytosolic guanylyl cyclase thus increases cyclic GMP levels which causes dephosphorylation of myosin light chain kinase(MLCK) through a cyclic GMP dependent protein kinase. Reduced availability of phosphorylated (active) MLCK interferes with activation of myosin and myosin fails to interact with actin to cause contraction and consequently relaxation occurs. Elevated levels of cyclic GMP also reduce calcium entry which also contributing to relaxation. It dilates veins more than arteries because veins have greater amount of enzyme that generate nitric oxide from nitrates.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "297", "Trade_Name": "ROACCUTANE 10MG 30 CAPS.", "Generic_Name": "ISOTRETINOIN", "Price": "114", "Price_Old": "38", "Company": "F.HOFFMAN LA ROCHE", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#>ق#~ي، و#.لش#~ي#~ #.ل#~#^جة أو #.لمس#?#>صى، و#.لذي ل#. يس#?جي#% لل#>ل#.ج #.ل#?قلي#~ي. \r\n\r\n–يس#?خ#~م أحي#.ن#.ً #%ه#~#< #.لوق#.ية من #.لإص#.#%ة من #%#>#_ أنو#.#> #.لس#^#-#.ن #.لذي ق#~ يصي#% #.لجل#~ . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#%سي#- و#.لم#?#=يس.", "Contraindications": "–ق#%ل #.س#?خ#~#.م #.ل#>ق#.#^ يج#% إج#^#.ء #.ل#=ش#< #.ل#-#%ي لل#?#>#^#< #>لى #.لح#.لة وأس#%#.#% ظهو#^ ح#% #.لش#%#.#% و#>لى هذ#. #.لأس#.س ي#?م #?ح#~ي#~ #.ل#>ق#.#^ #.لمن#.س#%. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #.ل#=#^يم#.#? و#.ل#>ق#.#^#.#? #.لأخ#^ى و#>#~م #<#.#>لي#?ه#. ي#?م #.للجوء إلى هذ#. #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول ج#^#>ة م#%#.لغه أو ز#.ئ#~ة #>ن #.لج#^#>ة #.لمح#~#~ة م جهة #.ل#-#%ي#% ح#?ى ل#. #?أ#?ي #%ن#?#.ئج #>#=سية #>لى #.لجسم. \r\n\r\n–#<ي ح#.لة نسي#.ن #.لج#^#>ة ي#?م أخذه#. إل#. #<ي ح#.لة ق#^#% مي#>#.#~ #.لج#^#>ة #.ل#?#.لية ويحذ#^ #?ن#.ول ج#^#>ة م#_#.#>#<ة. \r\n\r\n–يج#% #>مل #.ل#?ح#.ليل #.ل#~و#^ية و#.لم#?#.#%#>ة م#> #.ل#-#%ي#% لل#?#>#^#< #>لى وظ#.ئ#< #.ل#=#%#~ و#>#~م #?أث#^ه #%#.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.ل#?#>#^#_ لأش#>ة #.لشمس أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يج#% #?ن#.ول #.لم#.ء #%#=مي#.#? #=#.#<ية. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لليز#^ إل#. #%#>#~ م#^و#^ #>#.م #%#>#~ #.ل#>ل#.ج و#.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه#. #?ؤث#^ #>لى صحة #.لجنين. \r\n\r\n–#<ي ح#.لة وجو#~ #^غ#%ة #<ي #.لحمل يج#% #.ل#?وق#< #>ن #.ل#>ل#.ج #%م#~ة ل#. #?قل #>ن ثل#.ث أشه#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لمقش#^#.#? #.ل#%ش#^ة خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة وجو#~ أي م#^#_ أو مش#.#=ل ن#<سية يج#% إخ#%#.#^ #.ل#-#%ي#% وخ#.صة لمن ي#>#.نون من #_#>#< #<ي #.ل#>ظ#.م وأم#^#.#_ #.لقل#% و#.لس#=#^ و#.ل#=#%#~. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> أي أ#~وية أو مس#?ح#_#^#.#? #-#%ية مثل #.ل#?#?#^#.سي#=لين. \r\n\r\n–ينصح #%إ#?#%#.#> نظ#.م غذ#.ئي ي#>#?م#~ #>لى #.لخ#_#^#.و#.#? و#.ل#<#.#=هة أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "About Isotretinoin\r\nVitamin A isomer, Retinoic Acid Derivative, Anti-acne.\r\n\r\nMechanism of Action of Isotretinoin\r\nIsotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. Isotretinoin decreases sebocyte number and reduces sebum synthesis and therefore used in the treatment of acne.It reduces sebaceous gland size and inhibits sebaceous gland differentiation. \r\nIsotretinoin reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones formation. It alters DNA transcription\r\n\r\nInteractions for Isotretinoin\r\nAlcohol: Etretinate formed in presence of alcohol. \r\nAntibacterials: Possible increased risk of benign intracranial hypertension with tetracyclines. \r\nWarfarin: Possible reduction in anticoagulant effect. \r\nAntiepileptics: Plasma concentration of carbamazepine may be reduced. \r\nCytotoxic drugs: Plasma concentration of methotrexate may be increased.", "Composition": "isotretinoin 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "298", "Trade_Name": "ANGIOFOX (EFFOX) 25MG LONG 30 CAPS.", "Generic_Name": "ISOSORBIDE-5-MONONITRATE", "Price": "43.5", "Price_Old": "19.5", "Company": "MINA PHARM > SCHWARZ", "Pharmacology": "ANTIANGINAL", "Category": "م#_#.#~ للذ#%حة #.لص#~#^ية", "Use": "–يل#>#% #.ل#~و#.ء #~و#^#. ه#.م#. #<ي #>ل#.ج #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#?م #.س#?خ#~#.مه #=#>ل#.ج وق#.ئي من خ#-#^ #.لذ#%حة #.لص#~#^ية. \r\n\r\n–ي#>#.لج #_غ#- #.ل#~م #.لم#^#?#<#> وينظمه. \r\n\r\n–#?س#?خ#~م لمن#> خ#-#^ #?صل#% #.لش#^#.يين #.لح#.#~.", "Contraindications": "–يحظ#^ #.س#?خ#~#.م #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من حس#.سية #>#.لية للمو#.#~ #.لم#>ق#~ة و#.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#%#-ل#.ن هذ#. #.ل#~و#.ء م#> جمي#> مث#%#-#.#? #<س#<و#~#.يس#?#^#.ز مثل talafalafil لأنه يؤ#~ي إلى #.نخ#<#.#_ ش#~ي#~ #<ي #_غ#- #.ل#~م. \r\n\r\n–#?جن#% #?#>#.#-ي #.ل#~و#.ء #<ي م#^حلة #.لحمل، لأنه لم يث#%#? ح#?ى #.لآن سل#.مة هذ#. #.ل#~و#.ء #>لى صحة #.لم#^أة #.لح#.مل و#%#.ل#?#.لي ل#. ي#<#_ل #?ن#.وله إل#. #<ي #.لح#.ل#.#? #.لقصوى و#%موج#% نصيحة #.ل#-#%ي#%. \r\n\r\n–يحظ#^ #?ن#.ول #.ل#~و#.ء خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية، لأنه ينزل م#> حلي#% #.لث#~ي و#%#.ل#?#.لي من #.لمح#?مل أن ي#?س#%#% #<ي #_#^#^ #=#%ي#^ لل#-#<ل.", "GI": "About Isosorbide-5-Mononitrate\r\nAlkyl nitrate derivative, a direct vasodilator, Antianginal.\r\nMechanism of Action of Isosorbide-5-Mononitrate\r\nIt is a direct smooth muscle relaxant, which have a prominent action vascular smooth muscles preferentially veins than arteries. It is enzymatically denitrated in the smooth muscle cells to release the reactive free radical nitric oxide which activates cytosolic guanylyl cyclase thus increases cyclic GMP levels which causes dephosphorylation of myosin light chain kinase(MLCK) through a cyclic GMP dependent protein kinase. Reduced availability of phosphorylated (active) MLCK interferes with activation of myosin and myosin fails to interact with actin to cause contraction and consequently relaxation occurs. Elevated levels of cyclic GMP also reduce calcium entry which also contributing to relaxation. It dilates veins more than arteries because veins have greater amount of enzyme that generate nitric oxide from nitrates.", "Composition": "Each 20 mg tablet contains 20 mg isosorbide mononitrate.\r\nEach 40 mg tablet contains 40 mg isosorbide mononitrate.\r\n\r\nProlonged release capsules\r\nEach 25 mg, prolonged release capsule contains 25 mg isosorbide mononitrate.\r\nEach 50 mg, prolonged release capsul", "Route": "ORAL.SOLID" }, { "ID": "299", "Trade_Name": "NETLOOK 20MG 20 SOFT GELATIN CAPS.", "Generic_Name": "ISOTRETINOIN", "Price": "140", "Price_Old": "100", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > ANDALOUS PHARMA", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#>ق#~ي، و#.لش#~ي#~ #.ل#~#^جة أو #.لمس#?#>صى، و#.لذي ل#. يس#?جي#% لل#>ل#.ج #.ل#?قلي#~ي. \r\n\r\n–يس#?خ#~م أحي#.ن#.ً #%ه#~#< #.لوق#.ية من #.لإص#.#%ة من #%#>#_ أنو#.#> #.لس#^#-#.ن #.لذي ق#~ يصي#% #.لجل#~ . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#% #.لش#%#.#% #.ل#%سي#- و#.لم#?#=يس.", "Contraindications": "–ق#%ل #.س#?خ#~#.م #.ل#>ق#.#^ يج#% إج#^#.ء #.ل#=ش#< #.ل#-#%ي لل#?#>#^#< #>لى #.لح#.لة وأس#%#.#% ظهو#^ ح#% #.لش#%#.#% و#>لى هذ#. #.لأس#.س ي#?م #?ح#~ي#~ #.ل#>ق#.#^ #.لمن#.س#%. \r\n\r\n–#<ي ح#.لة #.س#?خ#~#.م #.ل#=#^يم#.#? و#.ل#>ق#.#^#.#? #.لأخ#^ى و#>#~م #<#.#>لي#?ه#. ي#?م #.للجوء إلى هذ#. #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول ج#^#>ة م#%#.لغه أو ز#.ئ#~ة #>ن #.لج#^#>ة #.لمح#~#~ة م جهة #.ل#-#%ي#% ح#?ى ل#. #?أ#?ي #%ن#?#.ئج #>#=سية #>لى #.لجسم. \r\n\r\n–#<ي ح#.لة نسي#.ن #.لج#^#>ة ي#?م أخذه#. إل#. #<ي ح#.لة ق#^#% مي#>#.#~ #.لج#^#>ة #.ل#?#.لية ويحذ#^ #?ن#.ول ج#^#>ة م#_#.#>#<ة. \r\n\r\n–يج#% #>مل #.ل#?ح#.ليل #.ل#~و#^ية و#.لم#?#.#%#>ة م#> #.ل#-#%ي#% لل#?#>#^#< #>لى وظ#.ئ#< #.ل#=#%#~ و#>#~م #?أث#^ه #%#.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.ل#?#>#^#_ لأش#>ة #.لشمس أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يج#% #?ن#.ول #.لم#.ء #%#=مي#.#? #=#.#<ية. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لليز#^ إل#. #%#>#~ م#^و#^ #>#.م #%#>#~ #.ل#>ل#.ج و#.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه#. #?ؤث#^ #>لى صحة #.لجنين. \r\n\r\n–#<ي ح#.لة وجو#~ #^غ#%ة #<ي #.لحمل يج#% #.ل#?وق#< #>ن #.ل#>ل#.ج #%م#~ة ل#. #?قل #>ن ثل#.ث أشه#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.لمقش#^#.#? #.ل#%ش#^ة خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة وجو#~ أي م#^#_ أو مش#.#=ل ن#<سية يج#% إخ#%#.#^ #.ل#-#%ي#% وخ#.صة لمن ي#>#.نون من #_#>#< #<ي #.ل#>ظ#.م وأم#^#.#_ #.لقل#% و#.لس#=#^ و#.ل#=#%#~. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ م#> أي أ#~وية أو مس#?ح#_#^#.#? #-#%ية مثل #.ل#?#?#^#.سي#=لين. \r\n\r\n–ينصح #%إ#?#%#.#> نظ#.م غذ#.ئي ي#>#?م#~ #>لى #.لخ#_#^#.و#.#? و#.ل#<#.#=هة أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "About Isotretinoin\r\nVitamin A isomer, Retinoic Acid Derivative, Anti-acne.\r\n\r\nMechanism of Action of Isotretinoin\r\nIsotretinoin is a 13-cis-retinoic acid and is used in the treatment of severe nodulocystic acne. Isotretinoin decreases sebocyte number and reduces sebum synthesis and therefore used in the treatment of acne.It reduces sebaceous gland size and inhibits sebaceous gland differentiation. \r\nIsotretinoin reduces the production of sebum and shrinks the sebaceous glands. It stabilises keratinization and prevents comedones formation. It alters DNA transcription\r\n\r\nInteractions for Isotretinoin\r\nAlcohol: Etretinate formed in presence of alcohol. \r\nAntibacterials: Possible increased risk of benign intracranial hypertension with tetracyclines. \r\nWarfarin: Possible reduction in anticoagulant effect. \r\nAntiepileptics: Plasma concentration of carbamazepine may be reduced. \r\nCytotoxic drugs: Plasma concentration of methotrexate may be increased.", "Composition": "isotretinoin 10mg or 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "300", "Trade_Name": "AMLOBENZAMIR 5/10MG 10 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "12", "Price_Old": "12", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > MIRA INTERNATIONAL", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "301", "Trade_Name": "NORVAPRIL 5/10MG 30 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "42", "Price_Old": "42", "Company": "MARCYRL CO. > GEOPHARMA-EGYPT", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "Amlodipine 5mg + benazepril 10mg\r\nor : Amlodipine 5mg + benazepril 20mg", "Route": "ORAL.SOLID" }, { "ID": "302", "Trade_Name": "LOADLESS 5/20MG 30 CAP", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "72", "Price_Old": "48", "Company": "ARAB CAPS > ROYAL GROUP-EGYPT", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "amlodipine 2.5mg benazepril 20mg \r\nor amlodipine 2.5mg benazepril 10mg \r\nor amlodipine 5mg benazepril 20mg", "Route": "ORAL.SOLID" }, { "ID": "303", "Trade_Name": "AMLOBENZAMIR 5/20MG 10 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "14", "Price_Old": "14", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > MIRA INTERNATIONAL", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "304", "Trade_Name": "AMOXYCILLIN 250 MG/5 ML SUSP. 80 ML", "Generic_Name": "AMOXICILLIN", "Price": "7", "Price_Old": "7", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "Amoxycillin 250mg", "Route": "ORAL.LIQUID" }, { "ID": "305", "Trade_Name": "NORVAPRIL 5/20MG 30 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "48", "Price_Old": "48", "Company": "MARCYRL CO. > GEOPHARMA-EGYPT", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "Amlodipine 5mg + benazepril 10mg\r\nor : Amlodipine 5mg + benazepril 20mg", "Route": "ORAL.SOLID" }, { "ID": "306", "Trade_Name": "LOADLESS 2.5/10MG 30 CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "54", "Price_Old": "36", "Company": "ARAB CAPS > ROYAL GROUP-EGYPT", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "amlodipine 2.5mg benazepril 20mg \r\nor amlodipine 2.5mg benazepril 10mg \r\nor amlodipine 5mg benazepril 20mg", "Route": "ORAL.SOLID" }, { "ID": "307", "Trade_Name": "AMOXICID 250MG 12 CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "6.25", "Price_Old": "6.25", "Company": "CID", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "amoxicillin 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "308", "Trade_Name": "AMLOZAPRIL 10/20MG 10CAPS.", "Generic_Name": "AMLODIPINE+BENAZEPRIL", "Price": "16", "Price_Old": "16", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "ANTIHYPERTENSIVE.COMBINED ACE WITH CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#~و#.ء م#~#^ لل#%ول . \r\n\r\n–يقلل من #_غ#- #.ل#~م وي#>مل #>لى #?وسي#> #.ل#.و#>ية #.ل#~موية .", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #%وجو#~ حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#>ق#.#^ . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م #=#%سول#.#? لو#~لس أثن#.ء #<#?#^ة #.لحمل حيث إنه ق#~ يس#%#% و#<#.ة #.لجنين .", "GI": "Mechanism of Action of Amlodipine\r\nAmlodipine is a second generation dihydropyridine Ca channel blocker. It exerts it`s antihypertensive, antianginal actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, & reduce myocardial oxygen demand .It markedly relax arterioles and milder effects on veins. They do not compromise haemodynamics and cerebral and renal perfusion.\r\nMechanism of action\tBenazeprilat, the active metabolite of Benazepril, competes with angiotensin I for binding at the angiotensin-converting enzyme, blocking the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in decreased plasma angiotensin II. As angiotensin II is a vasoconstrictor and a negative-feedback mediator for renin activity, lower concentrations result in a decrease in blo", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "309", "Trade_Name": "BIOMOX 250MG 12CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "7.25", "Price_Old": "7.25", "Company": "SEDICO", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "amoxycillin 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "310", "Trade_Name": "CLOXAPEN 500MG 12 CAPS.", "Generic_Name": "AMPICILLIN+DICLOXACILLIN", "Price": "7.84", "Price_Old": "7.84", "Company": "EL NILE.", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #=م#_#.#~ حيوي و#.س#> #.لمج#.ل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.ل#.ن#<يه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ووق#.يه من #.لحمي #.ل#^وم#.#?يزميه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #^وم#.#?يزم #.لقل#%. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.ل#?ه#.#% #.ل#=لوي #.لح#.#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #>#~وي #.لجه#.ز #.ل#?ن#<سي . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #>#~وي #.لجل#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #>#~وي #.ل#.ن#< و#.لحنج#^ه و#.ل#.ذن.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء #<ي ح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?صي#% #.ل#=#%#~ و#.ل#=لي.", "GI": "The mechanism of synergistic activity of a combination of ampicillin and dicloxacillin was studied on beta-lactamase-producing Citrobacter freundii GN346 and its derived beta-lactamaseless mutant GN346/16. The synergistic activity was exhibited against the parent strain but not against the mutant strain. Precultivation of the parent strain with the combination reduced the amount of the subsequent binding of [14C]penicillin G to the membrane fraction from the treated cells, but no reduction was observed in the case of cells treated with ampicillin or dicloxacillin alone. On the other hand, the amount of binding of [14C]penicillin G to the membrane fraction from the mutant strain was reduced by ampicillin treatment alone. These results clearly indicated that dicloxacillin inhibited the beta-lactamase activity produced by the parent strain, and, consequently, ampicillin can penetrate through the outer membrane and periplasmic beta-lactamase barrier into its target sites on the cytoplasmic", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "311", "Trade_Name": "TENOLATE S.R. 20 CAPS.", "Generic_Name": "ATENOLOL+NIFEDIPINE", "Price": "14", "Price_Old": "14", "Company": "SIGMA > HOCHSTER PHARMACEUTICAL INDUSTRIES", "Pharmacology": "HYPERTENSION", "Category": "مش#.#=ل #.لقل#%", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لذ#%حة #.لص#~#^ية #.لو#>#.ئية. \r\n\r\n–#>ل#.ج لح#.ل#.#? #.لذ#%حة #.لص#~#^ية #.لمس#?ق#^ة و#.لمزمنة. \r\n\r\n–ي#>#.لج #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م #.لمص#.ح#% لل#?شنج #.لقص#%ي. \r\n\r\n–#.لذ#%حة #.لص#~#^ية و#.#^#?#<#.#> #_غ#- #.ل#~م لمن ل#. ي#?حملو#. أ#~وية ح#.ص#^#.#? #%ي#?#. #.لأ#~#^ين#.لية أو #.لن#?#^#.#?. \r\n\r\n–يس#?خ#~م لمن هم ي#>#.نون من أ#>#^#.#_ #.لذ#%حة #.لص#~#^ية و#.#^#?#<#.#> #_غ#- #.ل#~م #%#.ل#^غم من #?ن#.ول ج#^#>#.#? #>#.لية من #.ل#>ل#.ج #.ل#>#.#~ي. \r\n\r\n–ظ#.ه#^ة #^ينو#~. \r\n\r\n–ي#>#.لج #.#^#?#<#.#> #_غ#- #.ل#~م #.ل#^ئوي #.لأس#.سي. \r\n\r\n–#<ي #%#>#_ #.لح#.ل#.#? ي#~خل #<ي #>ل#.ج #?شنج #.لم#^ئ و#.#_#-#^#.#%#.#? #.لح#^#=ة ذ#.#? صلة.", "Contraindications": "–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه أ#?ينولول. \r\n\r\n–لمن ي#>#.نون من #?شنج قص#%ي أو ص#<ي#^ أو أزم#.#? #^#%و #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ل#. يس#?خ#~م لم#^#_ي م#?ل#.زمة #.لجيو#% #.لأن#<ية. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ ل#>ل#.ج #.لنو#%#.#? #.لذ#%حة #.لص#~#^ية #.لح#.#~ة. \r\n\r\n–ل#. يس#?خ#~م #<ي #>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م #.لخ#%يث. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ م#>#~ل #.لحمو#_ة #<ي #.ل#~م #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–ل#. يج#% وص#< #.ل#>ق#.#^ للم#^أة #.لم#^#_#>ة حيث إنه ي#>#^#_ #.لجنين للخ#-#^.", "GI": "Tenolat SR is a combination of Atenolol ?beta blocker? and Nifedipine (calcium channel blocker)\r\n\r\nNifedipine is a dihydropyridine derivative (a member of slow calcium channel blocker)\r\n\r\nHas cardioprotective properties due to peripheral vasodialator effect and direct coronary vasodilator effect thus increases blood flow to myocardium and improves oxygen supply to the hear.\r\n\r\nIt inhibits calcium ions diffusion into the cells of muscle fibers thus leading to dilatation of the blood vessels.\r\n\r\nAtenolol is a hydrophilic beta blocker, it reduces the rate and force of contraction of the heart, decreases the rate of conduction of impulses through the conducting system, reduces the response of the heart to stress and evercise, lowers the blood pressure by blocking the action of the nervous system on the heart and reduces the force of the heart muscles\r\n\r\nTenolat SR Is a pioneer combination of beta blocker and Calcium channel blocker which leads potentiate their actions and minimizes their", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "312", "Trade_Name": "HIPRESS-D 20 CAPS.", "Generic_Name": "AMILORIDE+ATENOLOL+HYDROCHLOROTHIAZIDE", "Price": "11", "Price_Old": "11", "Company": "RAMEDA", "Pharmacology": "ANTIHYPERTENSIVE.BETA BLOCKER.SELECTIVE B1", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م #%جمي#> ح#.ل#.#?ه. \r\n\r\n–ي#>#.لج #.ح#?ش#.ء #>#_لة #.لقل#%. \r\n\r\n–قصو#^ #.لقل#% #.ل#.ح#?ق#.ني #.لن#.#?ج #>ن نقص #%و#?#.سيوم #.ل#~م. \r\n\r\n–ي#>#.لج #.#^#?#<#.#> #_غ#- #.ل#~م #.لن#.#?ج #>ن نقص #%و#?#.سيوم #.ل#~م.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ لم#^#_ي #.ل#=#%#~. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ #%ش#=ل م#?ز#.من م#> أ#~وية م#~#^ة لل#%ول. \r\n\r\n–لمن ي#>#.نون من قصو#^ #<ي #.ل#=لي ح#.#~ #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ل#. يس#?خ#~م لم#^#_ي #.لذئ#%ة #.لحم#.مية. \r\n\r\n–يج#% #.ل#?قليل من ش#^#% #.ل#=حول و#.ل#?#~خين. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ #<ي ح#.لة وجو#~ #^#~ #<#>ل #?حسسي من #.ل#>ق#.#^. \r\n\r\n–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.نق#-#.#> #.ل#%ول أو قلة إن#?#.ج #.ل#%ول. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #<#^#- #%و#?#.سيوم #.ل#~م. \r\n\r\n–لمن ي#>#.نون من ص#~مة #.لقل#%ية. \r\n\r\n–يحذ#^ #.س#?خ#~م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ولم#^#_ي #.لس#=#^ و#.ل#<شل #.ل#=لوي و#?سمم #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #.#>#?ل#.ل #.ل#=لية #.لس#=#^ي.", "GI": "About Atenolol\r\nCardioselective Beta(Beta1 )-adrenergic blocking agent, Antihypertensive,anti anginal.\r\nMechanism of Action of Atenolol\r\nAtenolol is a cardio selective beta-1 adrenergic antagonist. It has negative chronotropic and negative inotropic effects on heart. It decreases oxygen consumption- cardiac work and aortic pressure. It decreases nor adrenaline and renin releases. It decreases central sympathetic out flow In sympathetic over activity, it prolongs systole by retarding conduction. It increases oxygen supply and exercise tolerance in angina patients. The drug decreases BP in hypertensive individuals- both systolic and diastolic BP is reduced. \r\nAntimigraine action: Atenolol is useful in migraine due to its beta blockade action. Through beta blockade action it inhibits vasodilation and relieves migraine.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "313", "Trade_Name": "AMPIFLUX 500MG 12 CAPS.", "Generic_Name": "AMPICILLIN+FLUCLOXACILLIN", "Price": "12", "Price_Old": "8", "Company": "PHARCO", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–#>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي (#?شمل #>#~وى #.لأن#< و#.لأذن و#.لحنج#^ة): \r\n\r\n–إل#?ه#.#% #.لجيو#% #.لأن#<ية، إل#?ه#.#% #.للوز#?ين، إل#?ه#.#% #.ل#%ل#>وم، \r\n\r\n–إل#?ه#.#% #.لحنج#^ة، إل#?ه#.#% #.لأذن #.لوس#-ى، #.لخ… . \r\n\r\n–#>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي: \r\n\r\n–إل#?ه#.#% #.لش#>#% #.لهو#.ئية ,#.ل#.ل#?ه#.#% #.لش#>#%ي #.ل#^ئوي و#.ل#<صي. \r\n\r\n–#>#~وي #.لجه#.ز #.ل#%ولي #.ل#?ن#.سلي: \r\n\r\n–#.ل#?ه#.#% #.لمث#.نة, #.ل#?ه#.#% #.ل#.حليل Urethritis, \r\n\r\n–#.ل#?ه#.#% #.ل#=لية وحو#_ه#., #.ل#.جه#.#_ #.ل#.ن#?#.ني Septic Abortion, حمى #.لن#<#.س. \r\n\r\n–#>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة: \r\n\r\n–#.ل#~م#.مل, #.لخ#^#.ج, #.ل#?ه#.#% #.لنسيج #.لخلوي, #>#~وى #.لج#^وح, #>#_#.#? #.لحيو#.ن#.#?. \r\n\r\n–#>#~وى #.لأسن#.ن: \r\n\r\n–خ#^#.ج #.ل#.سن#.ن. \r\n\r\n–#>#~وى #.ل#>ظ#.م و#.لم#<#.صل: \r\n\r\n–#.ل#?ه#.#% #.ل#>ظم و#.لنقي Osteomyelitis.", "Contraindications": "–#<#^#- #.لحس#.سية لل#>ق#.#^ أو لمجمو#>ة #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسلين#.#? #.و #.ل#=ي#<#.لوس#%و#^ين#.#?. \r\n\r\n–#.لم#^#_ى #.لذين ي#?#>#.#-ون م#_#.#~ حيوي من #<ئة #.ل#?#?#^#.سي#=لين لأنه يقلل من #>مل #.ل#%نسلين#.#?. \r\n\r\n–#.لم#^#_ى #%#~#.ء #=ث#^ة #.لوحي#~#.#? #.ل#>#~و#.ئية. \r\n\r\n–#.ل#.شخ#.ص #.لذين #?لقو#. ح#~يث#.ً لق#.ح #.ل#?ي#<وئي#~ #.ل#<موي #.لحي. \r\n\r\n–#.لم#^#_ى #.لس#.#%ق لهم ح#~وث خلل وظ#<ي #=#%#~ي/ي#^ق#.ن #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء.", "GI": "This medicine contains 2 antibiotics called Flucloxacillin and Ampicillin.\r\n\r\nThis combination of Flucloxacillin and Ampicillin is also known as Co-Fluampicil. This medicine belongs to a group of antibiotics called the penicillins.\r\n\r\nCo-Fluampicil is used to treat certain bacterial infections of the ear, nose, throat, lungs, skin or bladder.\r\n\r\ninteraction:\r\nDo not take antacids together with Co-Fluampicil. Antacids could reduce the effectiveness of Co-Fluampicil. If you must take antacids, take them at least 1 hour before or 2 hours after Co-Fluampicil.\r\n\r\nInform your doctor if you are taking birth-control pills that contain oestrogen. Co-Fluampicil may decrease the effectiveness of these pills. You may wish to discuss additional birth-control methods with your doctor or pharmacist.", "Composition": "ampicillin 125mg+flucloxacillin 125mg \r\nor ampicillin 250mg+flucloxacillin 250mg", "Route": "ORAL.SOLID" }, { "ID": "314", "Trade_Name": "ATOMOXAPEX 18MG 30 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "120", "Price_Old": "120", "Company": "MULTI-APEX", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "315", "Trade_Name": "ATOMOXAPEX 10MG 30 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "90", "Price_Old": "90", "Company": "MULTI-APEX", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "316", "Trade_Name": "ROWATINEX 45 SOFT GELATIN CAPS.", "Generic_Name": "ANETHOL+BORNEOL+CAMPHENE+CINEOLE+ETHAVERINE+FENCHONE+PINENE", "Price": "27", "Price_Old": "18", "Company": "ROWA-WAGNER K.G.W GERMANY > AMOUN", "Pharmacology": "URINARY.ANALGESIC.ANTISEPTIC", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#>ل#.ج #?#.م لحصو#.#? #.ل#=لي. \r\n\r\n–#>ل#.ج#.#? #.ل#.ل#?ه#.#%#.#? #.لن#.#?جة من #.ل#.#_#-#^#.#%#.#? #.لجه#.ز #.ل#%ولي. \r\n\r\n–ي#?خلص من #.لمغص #.ل#=لوي #.لذي يصي#% #.ل#>#~ي#~ من #.لأشخ#.ص. \r\n\r\n–ي#>#.لج ح#.ل#.#? #^#=و#~ #.ل#%ول. \r\n\r\n–يس#.#>#~ #<ي #_خ #.لنش#.#- #%#.لجسم ، و#.لق#_#.ء #>لي #.ل#=سل أي#_ً#.. \r\n\r\n–وي#>مل #=#>ل#.ج س#^ي#> لل#?خلص #?م#.مً#. من #.#_#-#^#.#%#.#? #.لم#>#~ة. \r\n\r\n–يم#=نه #.لسي#-#^ة أي#_ً#. #>لى م#>#~ل #.لس#=#^ #%#.ل#~م. \r\n\r\n–يس#.#>#~ #<ي #_ح #.لهو#.ء #%ش#=ل من#?ظم وسليم إلى #.ل#^ئ#?ين. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–يمن#> #.ل#%#=#?ي#^ي#. #.لمس#%#%ة لل#^#%و. \r\n\r\n–#>ل#.ج س#^ي#> و#<#>#.ل ل#.ل#?ه#.#%#.#? #.ل#>يون. \r\n\r\n–له #~و#^ #<#>#.ل ج#~ً#. #<ي #>ل#.ج #.ل#?ه#.#% وأل#.م #.لم#<#.صل. \r\n\r\n–#.لمغص #.ل#=لوي #.لح#.#~.", "Contraindications": "–لمن ي#>#.نون #<ي #.#_#-#^#.#%#.#? #<ي #.لم#>#~ة ل#~يهم، #%س#%#% ج#^ثومة #.ل#%ول. \r\n\r\n–ويمن#> #?ن#.وله أي#_ً#. #>ن #.لأشخ#.ص #.للذين ي#>#.نون من حص#^ #.ل#%ول #%س#%#% حصوة أو غي#^ه من #.لأ#>#^#.#_ #.لأخ#^ى لأس#%#.#% أخ#^ى #<ي حص#^ #.ل#%ول. \r\n\r\n–يمن#> أي#_ً#. #?ن#.وله للحو#.مل و#.لم#^#_#>#.#? إل#. #?ح#? إش#^#.#< #.ل#-#%ي#% و#?#?#%#> إ#^ش#.#~#.#?ه جي#~ً#. ومن #.لأ#<#_ل #>#~م #?ن#.وله #<ي ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة أو #.ل#?خ#-ي#- للحمل ل#=ي ل#. يؤذي #.لجنين. \r\n\r\n–وينصح #%#?جن#% هذ#. #.ل#~و#.ء و#.#%#?#>#.#~ه #>ن م#?ن#.ول أي#~ي أ#-#<#.ل#= لحم#.ي#?هم من #.لأ#_#^#.#^ ووصولهم له.", "GI": "Properties\r\nRowatinex promotes diuresis and relaxes urinary tract spasm. thus assisting the passage of stones. The therapeutic effect of the balanced combination of terpenes reduces urinary tract inflammation stimulating renal blood flow through the kidneys and increasing the output of a less concentrated urine.\r\n \r\nIndications\r\nRowatinex is indicated for the treatment of urinary tract spasm and inflammation associated with urolithiasis. Rowatinex also assists in the dissolution and expulsion of stones in the renal system\r\nPrecautions and Warnings\r\nLiquid intake should be increased during therapy. The product should only be used with caution in patients on anticoagulants or drugs dependent on the liver for metabolism and excretion.\r\n \r\nPregnancy and Lactation\r\nAlthough no teratogenic effects have been reported, it is advisable that pregnant women should not take Rowatinex during the first trimester of pregnancy.", "Composition": "Each Capsule contains;\r\nAlpha Pinene 24.8 mg \r\nBeta Pinene 6.2 mg\r\nCamphene 15 mg \r\nBorneol 10 mg\r\nAnethol 4 mg \r\nFenchone 4 mg\r\nCineol 3 mg \r\nOlive Oil q.s. add to 100 mg", "Route": "ORAL.SOLID" }, { "ID": "317", "Trade_Name": "STRATTERA 10MG 28 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "530", "Price_Old": "530", "Company": "ELI LILLY", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 10mg or 18mg or 25mg or 40mg or 60mg", "Route": "ORAL.SOLID" }, { "ID": "318", "Trade_Name": "THROMBONORM 0.5MG 100 CAPS.", "Generic_Name": "ANAGRELIDE", "Price": "1000", "Price_Old": "1000", "Company": "MARCYRL CO.", "Pharmacology": "THROMBOCYTHEMIA", "Category": "#=ث#^ة #.لص#<يح#.#?", "Use": "–#=ث#^ة #.لص#<يح#.#? \r\n\r\n–ث#.نوية #.#_#-#^#.#%#.#? #.ل#?#=#.ث#^ #.لنقوي ، ل#?قليل #.#^#?#<#.#> #>#~#~ #.لص#<#.ئح #.ل#~موية وخ#-#^ #.لجل#-ة ول#?حسين #.لأ#>#^#.#_ #.لم#^#?#%#-ة #%ه#. #%م#. #<ي ذل#= #.لأح#~#.ث #.لنز#<ية", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.ل#.#? #.لحس#.سية #.لش#~ي#~ة من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.ني من مش#=ل#.#? #<ي #.ل#=#%#~. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.ني من #.نخ#<#.#_ مس#?وي #.ل#%و#?#.سيوم #<ي #.ل#~م. \r\n\r\n–ل#. يس#?خ#~م لمن ل#~يه #?#.#^يخ م#^#_ي خ#.ص #%#>#~م #.ن#?ظ#.م #_#^#%#.#? #.لقل#% أو من ي#?ن#.ول أ#~وية #?ؤ#~ي إلى زي#.#~ة #-ول ” QT ” #%#?خ#-ي#- #.لقل#%. \r\n\r\n–يس#?خ#~م #%حذ#^ لم#^#_ى #.ل#=لى و#.لقل#%. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.ني من مش#=ل#.#? #<ي #.ل#^ئ#?ين أو ص#>و#%#.#? #<ي #.ل#?ن#<س. \r\n\r\n–يج#% #?جن#% #.لإص#.#%#.#? و#.لج#^وح خل#.ل #<#?#^ة #.ل#>ل#.ج لأن هذ#. #.ل#~و#.ء ي#?س#%#% #<ي إ#%#-#.ء س#^#>ة #.ل#?ئ#.م #.لج#^وح. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%#?ن#.ول #.ل#~و#.ء ق#%ل إج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية وخل#> #.لأسن#.ن. \r\n\r\n–ل#. يس#?خ#~م لم#^#_ى #<شل #.لقل#% #.ل#.ح#?ق#.ني. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.ني من مش#=ل#.#? #<ي #=ه#^#%#.ء #.لمخ. \r\n\r\n–يج#% إج#^#.ء #<حوص#.#? #?خ#-ي#- للقل#% ق#%ل #.ل#%#~ء #<ي #?ن#.ول #.ل#~و#.ء. \r\n\r\n–يج#% إج#^#.ء #<حوص#.#? #~و#^ية لل#~م خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "Indication:\r\nFor the treatment of patients with thrombocythemia, secondary to myeloproliferative disorders, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.\r\n\r\ndosage:\r\nAdult- The recommended starting dose is 0.5 mg qid or 1 mg bid (2 capsules of 0.5 mg twice a day) and can be increased to 4 times daily.\r\n\r\nMechanism of action :\r\nThe mechanism by which anagrelide reduces blood platelet count is still under investigation. Studies in patients support a hypothesis of dose-related reduction in platelet production resulting from a decrease in megakaryocyte hypermaturation. In blood withdrawn from normal volunteers treated with anagrelide, a disruption was found in the postmitotic phase of megakaryocyte development and a reduction in megakaryocyte size and ploidy.", "Composition": "anagrelide 0.5mg", "Route": "ORAL.SOLID" }, { "ID": "319", "Trade_Name": "STRATTERA 18MG 28 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "530", "Price_Old": "530", "Company": "ELI LILLY", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 10mg or 18mg or 25mg or 40mg or 60mg", "Route": "ORAL.SOLID" }, { "ID": "320", "Trade_Name": "EPICOCILLIN 250MG 12 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "6.5", "Price_Old": "6.5", "Company": "EIPICO", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "AMPICILLIN (AS SODIUM) 1000 MG or 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "321", "Trade_Name": "AMPICILLIN-ALEX 500MG 12 H.G.CAPS.", "Generic_Name": "AMPICILLIN", "Price": "7.59", "Price_Old": "7.59", "Company": "MISR > ALEXANDRIA", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "322", "Trade_Name": "AMPICILLIN-EL NASR 500MG 12 CAPS.USP 23", "Generic_Name": "AMPICILLIN", "Price": "9", "Price_Old": "9", "Company": "EL NASR", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "323", "Trade_Name": "AMPICILLIN-MISR 500MG 12 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "9.25", "Price_Old": "9.25", "Company": "MISR", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "324", "Trade_Name": "AMPICLOX 500MG 12CAPS.", "Generic_Name": "AMPICILLIN+CLOXACILLIN", "Price": "8.59", "Price_Old": "8.59", "Company": "MUP > SMITHKLINE BEECHAM", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#%ولي و#.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج خ#^#.ج #.لأسن#.ن. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجل#~ية و#.لأنسجة #.ل#^خوة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لمث#.نة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–#?ن#.ول ج#^#>ة ز#.ئ#~ة من أم#%ي#=لو#=س ق#~ يس#%#% #<#^#- #<ي نس#%ة #.ل#%و#?#.سمية و#.ل#?ي #?س#%#% #.#_#-#^#.#%#.#? #<ي #.لقل#% وق#~ يس#%#% #?وق#< #.لقل#%. \r\n\r\n–يحذ#^ #.ل#.س#?خ#~#.م #.لم#?ز#.من م#> أ#~وية (#%#^و#%نيسي#~ و#.ل#=لو#^#.م#<يني#=ول و#.ل#?#?#^#.س#=لين وميثو#?#^و#=سي#?). \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–أثن#.ء #<#?#^ة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ إل#. #<ي ح#.لة #.ل#_#^و#^ة #.لقصوى وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% حيث أن #.لم#.#~ة #.ل#<#>#.لة #?ن#?قل لل#^#_ي#> م#> حلي#% #.لأم وق#~ يؤث#^ #>لى صح#?ه.", "GI": "Indications \r\n1.Respiratory tract infection \r\n2.Urinary tract infection \r\n3.Bone and joint infection \r\n4.Skin infection \r\n5.Soft tissue infection \r\n\r\ndose:\r\nAdult: 250 - 500mg every 6 hours for 7 - 10 days.\r\n\r\nMechanism of Action of Ampicillin\r\nAmpicillin is a bactericidal drug. It is a Beta lactum antibiotic. It binds to the Penicillin binding protein in the cell wall of bacteria and inhibits the enzyme transpeptidase which is responsible for the transpeptidation reaction in peptidoglycan synthesis. It also activates the endogenous enzyme which degrades the peptidoglycan.These results in inhibition of protein synthesis and there by cell wall synthesis. Ampicillin is active against both gram positive and gram negative organism.", "Composition": "ampicillin 250mg+cloxacillin 250mg", "Route": "ORAL.SOLID" }, { "ID": "325", "Trade_Name": "AMPICILLIN FORTE 500MG 12 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "7.59", "Price_Old": "7.59", "Company": "EL NILE.", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "ampicillin 1gm \r\nor Ampicillin 125mg/5ml", "Route": "ORAL.SOLID" }, { "ID": "326", "Trade_Name": "AMPICILLIN 500MG 10 CAPS. USP 28", "Generic_Name": "AMPICILLIN", "Price": "7.15", "Price_Old": "7.15", "Company": "OCTOBER PHARMA", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "Ampicillin 250,500mg", "Route": "ORAL.SOLID" }, { "ID": "327", "Trade_Name": "EPICOCILLIN 500MG 16 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "12.6", "Price_Old": "12.6", "Company": "EIPICO", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "AMPICILLIN (AS SODIUM) 1000 MG or 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "328", "Trade_Name": "AMPICILLIN-CID 500 MG 12 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "10", "Price_Old": "10", "Company": "CID", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "329", "Trade_Name": "RIVACLOX 500MG 20 CAPS.", "Generic_Name": "AMPICILLIN+CLOXACILLIN", "Price": "11", "Price_Old": "11", "Company": "RIVA PHARMA S.A.E.", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#%ولي و#.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج خ#^#.ج #.لأسن#.ن. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجل#~ية و#.لأنسجة #.ل#^خوة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لمث#.نة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–#?ن#.ول ج#^#>ة ز#.ئ#~ة من أم#%ي#=لو#=س ق#~ يس#%#% #<#^#- #<ي نس#%ة #.ل#%و#?#.سمية و#.ل#?ي #?س#%#% #.#_#-#^#.#%#.#? #<ي #.لقل#% وق#~ يس#%#% #?وق#< #.لقل#%. \r\n\r\n–يحذ#^ #.ل#.س#?خ#~#.م #.لم#?ز#.من م#> أ#~وية (#%#^و#%نيسي#~ و#.ل#=لو#^#.م#<يني#=ول و#.ل#?#?#^#.س#=لين وميثو#?#^و#=سي#?). \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل حيث إنه يس#%#% #?شوه #.لأجنة. \r\n\r\n–أثن#.ء #<#?#^ة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ إل#. #<ي ح#.لة #.ل#_#^و#^ة #.لقصوى وي#=ون #?ح#? إش#^#.#< #.ل#-#%ي#% حيث أن #.لم#.#~ة #.ل#<#>#.لة #?ن#?قل لل#^#_ي#> م#> حلي#% #.لأم وق#~ يؤث#^ #>لى صح#?ه.", "GI": "Indications \r\n1.Respiratory tract infection \r\n2.Urinary tract infection \r\n3.Bone and joint infection \r\n4.Skin infection \r\n5.Soft tissue infection \r\n\r\ndose:\r\nAdult: 250 - 500mg every 6 hours for 7 - 10 days.\r\n\r\nMechanism of Action of Ampicillin\r\nAmpicillin is a bactericidal drug. It is a Beta lactum antibiotic. It binds to the Penicillin binding protein in the cell wall of bacteria and inhibits the enzyme transpeptidase which is responsible for the transpeptidation reaction in peptidoglycan synthesis. It also activates the endogenous enzyme which degrades the peptidoglycan.These results in inhibition of protein synthesis and there by cell wall synthesis. Ampicillin is active against both gram positive and gram negative organism.", "Composition": "AMPICILLIN 250 MG or 125mg + CLOXACILLIN 250 MG or 125mg", "Route": "ORAL.SOLID" }, { "ID": "330", "Trade_Name": "HICONCIL 250MG 12CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "6.5", "Price_Old": "6.5", "Company": "PHARCO", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "Amoxicillin 100, 125, 250, 500mg", "Route": "ORAL.SOLID" }, { "ID": "331", "Trade_Name": "AMOXYCILLIN 500MG 12 CAPS B.P.2013", "Generic_Name": "AMOXICILLIN", "Price": "9", "Price_Old": "9", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "Amoxycillin 125mg", "Route": "ORAL.SOLID" }, { "ID": "332", "Trade_Name": "AMOXIL 500MG 12 CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "9", "Price_Old": "9", "Company": "MUP > SMITHKLINE BEECHAM", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "amoxicillin 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "333", "Trade_Name": "IBIAMOX 250MG 12CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "5.7", "Price_Old": "5.7", "Company": "AMOUN", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "Capsules: \r\neach capsule contains amoxycillin trihydrate equivalent to 250 mg or 500 mg amoxycillin.\r\n\r\nPowder for oral suspension: \r\neach 5 ml after reconstitution contains amoxycillin trihydrate equivalent to 200 mg or 400 mg amoxycillin.", "Route": "ORAL.SOLID" }, { "ID": "334", "Trade_Name": "HICONCIL 500MG 12 CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "11.6", "Price_Old": "11.6", "Company": "PHARCO", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "Amoxicillin 100, 125, 250, 500mg", "Route": "ORAL.SOLID" }, { "ID": "335", "Trade_Name": "BIOMOX 500MG 12CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "11", "Price_Old": "11", "Company": "SEDICO", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "amoxycillin 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "336", "Trade_Name": "AMOXICILLIN 500MG 12 CAPS. USP 28", "Generic_Name": "AMOXICILLIN", "Price": "8.09", "Price_Old": "8.09", "Company": "OCTOBER PHARMA", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "amoxicillin 500mg", "Route": "ORAL.SOLID" }, { "ID": "337", "Trade_Name": "E-MOX 500MG 16 CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "15.6", "Price_Old": "15.6", "Company": "EIPICO", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "338", "Trade_Name": "AMOXICID 500 MG 12 CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "9.5", "Price_Old": "9.5", "Company": "CID", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "amoxicillin 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "339", "Trade_Name": "IBIAMOX 500MG 12 CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "10", "Price_Old": "10", "Company": "AMOUN", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "Capsules: \r\neach capsule contains amoxycillin trihydrate equivalent to 250 mg or 500 mg amoxycillin.\r\n\r\nPowder for oral suspension: \r\neach 5 ml after reconstitution contains amoxycillin trihydrate equivalent to 200 mg or 400 mg amoxycillin.", "Route": "ORAL.SOLID" }, { "ID": "340", "Trade_Name": "AZALIDE 500MG 3 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "32.5", "Price_Old": "21.6", "Company": "T3A PHARMA", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "azithromycin 200mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "341", "Trade_Name": "BRONCHO-VAXOM ADULTS 7MG 10 CAPS.", "Generic_Name": "BACTERIAL LYSATE", "Price": "76", "Price_Old": "57", "Company": "MEMPHIS > OM-SWITZERLAND", "Pharmacology": "IMMUNE ENHANCER", "Category": "م#>زز للمن#.#>ة", "Use": "–#.لوق#.ية من #.لإص#.#%ة #%#>#~وى #.لجه#.ز #.ل#?ن#<سى \r\n\r\n–#?قليل #<#^ص #.لإص#.#%ة #%#.ل#>#~وى #.ل#<ي#^وسية و #.ل#%#=#?ي#^ية. \r\n\r\n–#.لإل#?ه#.#% #.ل#^ئوى #.لح#.#~ و #.لمزمن \r\n\r\n–#.ل#^#%و \r\n\r\n–#.لإنس#~#.#~ #.ل#^ئوي #.لمزمن \r\n\r\n–#.ل#>#~وى #.ل#%#=#?ي#^ية #.لمق#.ومة للم#_#.#~#.#? #.لحيوية. \r\n\r\n–#.لم#_#.#>#<#.#? #.ل#%#=#?ي#^ية #.لن#.#?جة #>ن #.ل#>#~وى #.ل#<ي#^وسية للجه#.ز #.ل#?ن#<سي.", "Contraindications": "–#.لحس#.سية #?ج#.ه أى من #.ل#>ن#.ص#^ #.لم#=ونة لل#~و#.ء \r\n\r\n–#<ى ح#.لة #.لحمل و #.ل#^#_#.#>ة إل#. #%#>#~ إس#?ش#.#^ة #.ل#-#%ي#%", "GI": "Bacterial lysates are natural substances secreted by many bacteria in the process of life.These polypeptides inhibit the growth of other microorganisms. Bacterial lysates up-regulate the immune system, maintain it in a state of alert and raise the defense against infections.\r\nThis action provides a significant reduction (or a complete disappearance) in symptoms of microbial infections.\r\n\r\nUses in dermatology\r\nIn dermatology, bacterial lysates have a powerful skin cleansing effect. These preparations protect and restore damaged skin.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "342", "Trade_Name": "BRONCHO-VAXOM CHILDREN 3.5MG 10 CAPS.", "Generic_Name": "BACTERIAL LYSATE", "Price": "60", "Price_Old": "45", "Company": "MEMPHIS > OM-SWITZERLAND", "Pharmacology": "IMMUNE ENHANCER", "Category": "م#>زز للمن#.#>ة", "Use": "–#.لوق#.ية من #.لإص#.#%ة #%#>#~وى #.لجه#.ز #.ل#?ن#<سى \r\n\r\n–#?قليل #<#^ص #.لإص#.#%ة #%#.ل#>#~وى #.ل#<ي#^وسية و #.ل#%#=#?ي#^ية. \r\n\r\n–#.لإل#?ه#.#% #.ل#^ئوى #.لح#.#~ و #.لمزمن \r\n\r\n–#.ل#^#%و \r\n\r\n–#.لإنس#~#.#~ #.ل#^ئوي #.لمزمن \r\n\r\n–#.ل#>#~وى #.ل#%#=#?ي#^ية #.لمق#.ومة للم#_#.#~#.#? #.لحيوية. \r\n\r\n–#.لم#_#.#>#<#.#? #.ل#%#=#?ي#^ية #.لن#.#?جة #>ن #.ل#>#~وى #.ل#<ي#^وسية للجه#.ز #.ل#?ن#<سي.", "Contraindications": "–#.لحس#.سية #?ج#.ه أى من #.ل#>ن#.ص#^ #.لم#=ونة لل#~و#.ء \r\n\r\n–#<ى ح#.لة #.لحمل و #.ل#^#_#.#>ة إل#. #%#>#~ إس#?ش#.#^ة #.ل#-#%ي#% \r\n\r\n–للأ#-#<#.ل أقل من 6 شهو#^", "GI": "Bacterial lysates are natural substances secreted by many bacteria in the process of life.These polypeptides inhibit the growth of other microorganisms. Bacterial lysates up-regulate the immune system, maintain it in a state of alert and raise the defense against infections.\r\nThis action provides a significant reduction (or a complete disappearance) in symptoms of microbial infections.\r\n\r\nUses in dermatology\r\nIn dermatology, bacterial lysates have a powerful skin cleansing effect. These preparations protect and restore damaged skin.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "343", "Trade_Name": "UNIZITHRIN 500MG 3 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "21.75", "Price_Old": "14.4", "Company": "UNIPHARMA CO.", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "-Each 5 ml of Unizithrin suspension contains:-\r\nAzithromycin dihydrate equivalent to 100 mg Azithromycin base.\r\n\r\n-Each Capsule of Unizithrin contains:-\r\nAzithromycin dihydrate equivalent to 500 mg Azithromycin base.", "Route": "ORAL.SOLID" }, { "ID": "344", "Trade_Name": "NO-TUSS 10 SOFT GELATIN CAP.", "Generic_Name": "BENZONATATE+DIPHENHYDRAMINE+GUAIFENESIN+PHENYLEPHRINE", "Price": "7", "Price_Old": "7", "Company": "GRAND PHARMA > DELTA PHARMA", "Pharmacology": "COUGH DRUGS", "Category": "م#_#.#~ لل#=حة", "Use": "–مه#~ئ لل#=حة . \r\n\r\n–مذي#% لل#%لغم . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج أ#>#^#.#_ #.ل#%#^#~ و #.لإن#<لونز#. مثل #.ل#^شح و #.لز#=#.م و إح#?ق#.ن #.لأن#< . \r\n\r\n–#>ل#.ج حس#.سية #.لجيو#% #.لأن#<ية .", "Contraindications": "–ل#. يس#?خ#~م للأ#-#<#.ل أقل من 6 سنو#.#? . \r\n\r\n–ل#. يس#?خ#~م م#> م#^#_ى #.ل#_غ#- #.لم#^#?#<#> . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى إح#?ق#.ن #.ل#%#^وس#?#.#?#. ، م#^#_ى #.لغ#~ة #.ل#~#^قية ، #.لم#^#_ى #.لذين ي#>#.نون من نو#%#.#? #.ل#^#%و ، م#^#_ى #.لص#^#> ، م#^#_ى #.لمي#.ه #.ل#%ي#_#.ء #>لى #.ل#>ين . \r\n\r\n–ق#~ يس#%#% #.لن#>#.س ، لذل#= يج#% #.لحذ#^ أثن#.ء #.لقي#.#~ة . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> ح#.ل#.#? ق#^ح #.لجه#.ز #.له#_مى .", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "345", "Trade_Name": "PROSTAGARD 20 CAPS.", "Generic_Name": "BEAR BERRY EXTRACT+PUMPKIN SEED EXTRACT+PYGEUM AFRICANUM+SAW PALMETTO+VITAMIN B6+ZINC GLUCONATE", "Price": "22", "Price_Old": "22", "Company": "SIGMA", "Pharmacology": "PROSTATE DISORDER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "–#.ل#>ل#.ج و#.لوق#.ية من #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~ \r\n\r\n–ص#>و#%ة #.ل#?#%ول #.لمص#.ح#%ة ل#?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~ #.لم#^حلة #.ل#.ولى و#.لث#.نية \r\n\r\n–#?خ#<ي#< #.ح#?ق#.ن و#.ل#?ه#.#% #.ل#%#^وس#?#.#? \r\n\r\n–م#-ه#^ وم#~#^ لل#%ول", "Contraindications": "–#<#^#- #.ل#?حسس من أي من #.لمو#.#~ #.ل#<#>#.لة", "GI": "COMING SOON ..", "Composition": "SAW PALMETTO160MG+PYGEUM AFRICANUM 25MG", "Route": "ORAL.SOLID" }, { "ID": "346", "Trade_Name": "ZITHROKAN 500 MG 3 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "32.5", "Price_Old": "21.6", "Company": "HIKMA PHARMA", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "azithromycin 100mg or 200mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "347", "Trade_Name": "BRONCHOFREE 20 CAPS.", "Generic_Name": "BENZONATATE+DIPHENHYDRAMINE+GUAIFENESIN+PHENYLEPHRINE", "Price": "14", "Price_Old": "14", "Company": "ADWIA", "Pharmacology": "COUGH DRUGS", "Category": "م#_#.#~ لل#=حة", "Use": "–مه#~ئ لل#=حة . \r\n\r\n–مذي#% لل#%لغم . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج أ#>#^#.#_ #.ل#%#^#~ و #.لإن#<لونز#. مثل #.ل#^شح و #.لز#=#.م و إح#?ق#.ن #.لأن#< . \r\n\r\n–#>ل#.ج حس#.سية #.لجيو#% #.لأن#<ية .", "Contraindications": "–ل#. يس#?خ#~م للأ#-#<#.ل أقل من 6 سنو#.#? . \r\n\r\n–ل#. يس#?خ#~م م#> م#^#_ى #.ل#_غ#- #.لم#^#?#<#> . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى إح#?ق#.ن #.ل#%#^وس#?#.#?#. ، م#^#_ى #.لغ#~ة #.ل#~#^قية ، #.لم#^#_ى #.لذين ي#>#.نون من نو#%#.#? #.ل#^#%و ، م#^#_ى #.لص#^#> ، م#^#_ى #.لمي#.ه #.ل#%ي#_#.ء #>لى #.ل#>ين . \r\n\r\n–ق#~ يس#%#% #.لن#>#.س ، لذل#= يج#% #.لحذ#^ أثن#.ء #.لقي#.#~ة . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> ح#.ل#.#? ق#^ح #.لجه#.ز #.له#_مى .", "GI": "COMING SOON ..", "Composition": "Each capsule contains: \r\nBenzonatate 100 mg. \r\nGuaiphenesin 100 mg. \r\nDiphenhydramine 25 mg. \r\nPhenyl ephrine HCl 10 mg.", "Route": "ORAL.SOLID" }, { "ID": "348", "Trade_Name": "ZISROCIN 500 MG 3 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "32.5", "Price_Old": "21.6", "Company": "EGYPHAR", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "Each Capsule of Zisrocin contains Azithromycin dihydrate equivalent to 500 mg Azithromycin base.\r\n\r\nEach 5 ml of Zisrocin suspension contains Azithromycin dihydrate equivalent to 100 mg Azithromycin base.", "Route": "ORAL.SOLID" }, { "ID": "349", "Trade_Name": "VITA-GUARD 10 CAPS.", "Generic_Name": "BETACAROTENE+CU+MN+SE YEAST+VITAMIN C+VITAMIN E+ZN", "Price": "5", "Price_Old": "5", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "MULTIVIAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–م#=مل م#_#.#~ للأ#=س#~ة و#.س#> #.لن#-#.ق.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "350", "Trade_Name": "ATOMOXAPEX 25MG 30 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "180", "Price_Old": "180", "Company": "MULTI-APEX", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "351", "Trade_Name": "ATOMOXETINE 40MG 10 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "80", "Price_Old": "80", "Company": "SABAA", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 25mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "352", "Trade_Name": "ATOMOXAPEX 40MG 30 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "240", "Price_Old": "240", "Company": "MULTI-APEX", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "353", "Trade_Name": "ATOMOXETINE 25MG 10 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "60", "Price_Old": "60", "Company": "SABAA", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 25mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "354", "Trade_Name": "ATOMOXAPEX 60 MG 30 CAP.", "Generic_Name": "ATOMOXETINE", "Price": "300", "Price_Old": "300", "Company": "MULTI-APEX", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "355", "Trade_Name": "ATTENSERA 40 MG 30 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "240", "Price_Old": "240", "Company": "MASH PREMIERE", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 25mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "356", "Trade_Name": "STRATTERA 25MG 28 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "530", "Price_Old": "530", "Company": "ELI LILLY", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 10mg or 18mg or 25mg or 40mg or 60mg", "Route": "ORAL.SOLID" }, { "ID": "357", "Trade_Name": "STRATTERA 40MG 28 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "530", "Price_Old": "530", "Company": "ELI LILLY", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 10mg or 18mg or 25mg or 40mg or 60mg", "Route": "ORAL.SOLID" }, { "ID": "358", "Trade_Name": "ATTENSERA 25 MG 30 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "180", "Price_Old": "180", "Company": "MASH PREMIERE", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 25mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "359", "Trade_Name": "STRATTERA 60MG 28 CAPS.", "Generic_Name": "ATOMOXETINE", "Price": "530", "Price_Old": "530", "Company": "ELI LILLY", "Pharmacology": "ATTENTION-DEFICIT HYPERACTIVITY DISORDER", "Category": "قصو#^ #.ل#.ن#?#%#.ه و#<#^#- #.لح#^#=ة", "Use": "–يُس#.#>#~ #<ي #>ل#.ج #<#^#- #.لح#^#=ة #.لذي يُص#.#% #%ه #.ل#%#>#_ #<ن هن#.#= #%#>#_ #.لأس#%#.#% #.ل#?ي #?ؤ#~ي إلى #.لإص#.#%ة #%هذ#. #.لم#^#_ #.لذي يُس#%#% مش#.#=ل صحية ومن هذه #.لأس#%#.#% #.ل#?#>#^#_ ل#?سمم#.#? مُزمنة ومن #.لمم#=ن أي#_#.ً أن ين#?ج من ح#~وث #%#>#_ #.لمش#.#=ل #<ي #.ل#~م#.غ. \r\n\r\n–#>ل#.ج س#^ي#> لل#?خلص من #.#_#-#^#.#%#.#? #<ي نقس #.ل#.ن#?#%#.ه ل#~ى #.لأ#-#<#.ل. \r\n\r\n–يُ#>#.لج #<#^#- #.لح#^#=ة #.لذي يُ#>#.ني منه #.ل#%#>#_. \r\n\r\n–#>ل#.ج #<#^#- #.لنش#.#- ل#~ى #.ل#%#>#_.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. حس#.سية من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #~ون #.س#?ش#.#^ة من #.ل#-#%ي#% إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي ل#~يه#. مش#.#=ل #<ي وظ#.ئ#< #.ل#=لى إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#~م إل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.لحو#.مل إل#. #%أس#?ش#.#^ة من #.ل#-#%ي#%. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للأمه#.#? #.لم#^#_#>#.#? #^#_#.#>ة #-#%ي#>ية لأنه ق#~ ين#?قل #.ل#~و#.ء #>#%#^ ل#%ن #.لأم ويس#%#% #.خ#-#.#^ صحية #>لي #.ل#-#<ل #<يج#% م#>#^#<ة #.ل#-#%ي#% #%ذل#=. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.#^#?#<#.#> #<ي #_غ#- #.ل#>ين. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #?ن#.ول #.ل#=#<#.يين لأنه ق#~ #?زي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "Description:\t\r\nAtomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD).\r\n\r\ndose:\r\nDosing of children and adolescents up to 70 kg body weight\r\nInitial: The recommended dose is 0.5 mg/kg and increased after a minimum of 3 days to a target total daily dose of approximately 1.2 mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. The total daily dose in children and adolescents should not exceed 1.4 mg/kg or 100 mg. \r\nDosing of children and adolescents over 70 kg body weight and adults Initial: The recommended dose is 40 mg and increased after a minimum of 3 days to a target total daily dose of approximately 80 mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening. \r\nMaximum: 100mg.", "Composition": "atomoxetine 10mg or 18mg or 25mg or 40mg or 60mg", "Route": "ORAL.SOLID" }, { "ID": "360", "Trade_Name": "FAMOX 500 MG 16 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "29.25", "Price_Old": "19.5", "Company": "SEDICO > TOP PHARM", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "Amoxicillin 125mg or 250mg", "Route": "ORAL.SOLID" }, { "ID": "361", "Trade_Name": "HI-FLUCIL 250/250MG 16 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "20", "Price_Old": "20", "Company": "CID", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "362", "Trade_Name": "FLUMOX 500 MG 16 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "32.4", "Price_Old": "21.6", "Company": "EIPICO", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "363", "Trade_Name": "FLUCAMOX 500MG 12 CAPS", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "24", "Price_Old": "13.8", "Company": "SEDICO", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "364", "Trade_Name": "AMPICILLIN-CID 250MG 12 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "6.5", "Price_Old": "6.5", "Company": "CID", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "365", "Trade_Name": "AMPICILLIN-MISR 250 MG 12 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "6.5", "Price_Old": "6.5", "Company": "MISR", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "366", "Trade_Name": "FLUMOCIN 500MG 8 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "6", "Price_Old": "6", "Company": "T3A PHARMA", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "367", "Trade_Name": "AMPICILLIN-ALEX 250MG 12CAPS", "Generic_Name": "AMPICILLIN", "Price": "5.7", "Price_Old": "5.7", "Company": "ALEXANDRIA", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "Ampicillin 250mg/5ml", "Route": "ORAL.SOLID" }, { "ID": "368", "Trade_Name": "UROXATE EFF. 12 SACHETS", "Generic_Name": "FLAVOXATE HYDROCHLORIDE+LIGHT MAGNESIUM OXIDE", "Price": "8.5", "Price_Old": "8.5", "Company": "SEDICO", "Pharmacology": "ANTIMUSCARINIC.URINARY BLADDER ANTISPASMODIC", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–Uroxate 50 mg Eff يو#^#=س#?#.#? #<و#.#^ يس#?خ#~م ل#>ل#.ج #.مل#.ج #.و#=س#.ل#.#? #.ل#=#.لسيوم #=م#. يس#?خ#~م #=ملين خ#<ي#< \r\n\r\n–يس#?خ#~م #~و#.ء Uroxate 50 mg Eff يو#^#=س#?#.#? #<و#.#^ #<ي #>ل#.ج أ#>#^#.#_ #>س#^ #.ل#%ول ، #=ث#^ة #>#~#~ م#^#.#? #.ل#?#%ول و#.ل#?#%ول #.لل#.#^#.#~ي، #.ل#.حس#.س #%#.لآم #<وق من#-قة #.ل#>#.نة، سلس #.ل#%ول #.لذي ي#=ون ن#.#?ج #>ن #.ل#?ه#.#% #.لمث#.نة ، #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. ، #.ل#?ه#.#%#.#? #.لمث#.نة ومج#^ي #.ل#%ول ، #.ل#?قلص#.#? #.لن#.#?جة #>ن حصو#.#? #.ل#=لي و#.لح#.ل#% ، #.ل#?قلص#.#? #.لن#.#?جة #>ن #.لآم #.ل#~و#^ة #.لشه#^ية #.و زي#.#~ة #.نق#%#.#_ #>#_لة #.ل#^حم .", "Contraindications": "–ل#. يج#% #.س#?خ#~#.م Uroxate 50 mg Eff يو#^#=س#?#.#? #<و#.#^#.ص #<ي ح#.لة #.لحس#.سية ل#.ح#~ي #.لم#=ون#.#? #.و #<ي ح#.ل#.#? #.ل#.نس#~#.#~ #.لم#>وي ، #.نس#~#.#~ #.ل#.ثني #>ش#^ ، نزي#< #.لجه#.ز #.له#_مي #.و #.نس#~#.#~ مج#^ي #.ل#%ول ، #.ل#.م #.ل#%#-ن ، #.ل#?ه#.#% #.لز#.ئ#~ة #.ل#~و#~ية ، #.ل#.لآم #.لش#^جية \r\n\r\n–يس#?خ#~م Uroxate 50 mg Eff يو#^#=س#?#.#? #<و#.#^ #%ح#^ص #<ي م#^#_ي #.لجلو#=وم#. ، #.لقصو#^ #.ل#=لوي ، #.لنزي#< #.لش#^جي \r\n\r\n–يج#% #.ل#?#>#.مل #%حذ#^ م#> #.ل#.ل#.#? #.و قي#.#~ة #.لسي#.#^#.#? و#=ل م#. يح#?#.ج #?#^#=يز #>ن#~ #.س#?خ#~#.م Uroxate 50 mg Eff يو#^#=س#?#.#? #<و#.#^ حيث ي#>مل #.حي#.ن#. #>لي #>#~م و#_وح #.ل#^ؤية ويم#=ن #.ن يس#%#% #.لن#>#.س \r\n\r\n–ل#. يج#% #.س#?خ#~#.م Uroxate 50 mg Eff يو#^#=س#?#.#? #<و#.#^ #<ي #.لحمل وخصوص#. #.لثل#.ثة #.شه#^ #.لأولي من #.لحمل #.ل#. #.ذ#. #=#.ن #.لن#<#> #.#=ث#^ من #.ل#_#^#^ و#?ح#? #.ش#^#.#< #-#%ي \r\n\r\n–ل#. يج#% #.س#?خ#~#.م Uroxate 50 mg Eff يو#^#=س#?#.#? #<و#.#^ #<ي #.لأ#-#<#.ل #.لذين #?قل أ#>م#.#^هم #>ن 12 #>#.م", "GI": "About Flavoxate\r\nMuscarinic antagonist(anticholinergic ) Flavones and their glycosides, Muscle relaxant, systemic urinary tract antispasmodic.\r\nMechanism of Action of Flavoxate\r\nThis is a direct antagonist drug which act on muscarinic acetylcholine receptors in innervated organs especially in bladder. Its anticholinergic-parasympatholytic action reduces the tonus of smooth muscle in the bladder and relaxing the involuntary muscle that is found in the wall of the bladder. This effectively reduce the number of required voids, urge incontinence episodes, urge severity and improving retention, facilitating increased volume per void.", "Composition": "flavoxate 0.05g, mg citrate 2.125g", "Route": "SACHETS" }, { "ID": "369", "Trade_Name": "AMPICILLIN-EL NASR 250MG 12 CAPS.", "Generic_Name": "AMPICILLIN", "Price": "6.5", "Price_Old": "6.5", "Company": "EL NASR", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.لص#<#^#.وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج م#^#_ #.لسيل#.ن. \r\n\r\n–#>ل#.ج #~#.ء #.لليس#?#^ي#.#?. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #>#~وي #.ل#?ي#<وي#~. \r\n\r\n–#>ل#.ج #.لحمى #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #.لن#-ي#^ة #.ل#?ي#<ية. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #>#~وي #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية.", "Contraindications": "–يمن#> #.س#?#>م#.له للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو #<#^#- #.لحس#.سية #.لم#>#^و#< لل#%نسيلين#.#? أو للسي#<#.لوس#%و#^ين#.#?. \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء للذين ي#>#.نون من مش#.#=ل #<ي #.ل#=لى أو #.#^#?#<#.#> #<ي أنزيم#.#? #.ل#=#%#~. \r\n\r\n– #.س#?#>م#.ل #.ل#~و#.ء #>لى #.لم#~ى #.ل#-ويل ق#~ يس#%#% نمو #%#>#_ أنو#.#> #.ل#%#=#?ي#^ية #.لمق#.ومة لل#%نسلين مثل #.ل#<#-#^ي#.#?. \r\n\r\n–ل#. يم#=ن #.س#?#>م#.ل #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل وخ#.صة #<ي #.لأشه#^ #.لثل#.ثة #.لأولى من #.لحمل، حيث من #.لمم#=ن أن يح#~ث #%#>#_ #.ل#?شوه#.#? #.لخلقية للجنين. \r\n\r\n–#>#.#~ة ين#?قل #.ل#~و#.ء من حلي#% #.لأم إلى #.ل#-#<ل #.ل#^#_ي#>، لذل#= ننصح #%#?وخي #.لحذ#^ #>ن#~ #.س#?#>م#.ل #.ل#~و#.ء ح#?ى ل#. ي#_#^ #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n–يج#% سؤ#.ل #.لم#^ي#_ #.ذ#. #=#.ن ل#~يه حس#.سية من #.ل#%نسيلين#.#? من ق#%ل , #<إذ#. حصل م#>ه #.ي #^#~ #<#>ل #?حسسي س#.#%ق لأي نو#> من #.ل#%نسيلين#.#? , #>ن#~ه#. يج#% #?حويله لنو#> #.خ#^ من #.لم#_#.#~#.#? #.لحيوية.", "GI": "Description :\t\r\nSemi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic .\r\n\r\nIndication :\r\nFor treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc\r\n\r\ndosage:\r\nAdult- PO/IM/IV- The recommended dose range is 0.5 to 3gm every 6 hours. \r\nChild- 25 to 50mg/kg/day. \r\n\r\nMechanism of action:\r\nBy binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Ampicillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Ampicillin interferes with an autolysin inhibitor.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "370", "Trade_Name": "LIRIMAR 20 MG 10 CAPS.", "Generic_Name": "ATORVASTATIN", "Price": "15", "Price_Old": "15", "Company": "RIVA PHARMA S.A.E.", "Pharmacology": "ANTIHYPERLIPIDEMIC.STATINS", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–س#?خ#~م #<ي #>ل#.ج ح#.ل#.#? زي#.#~ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#?خ#~م #=#>#.مل مس#.#>#~ م#> إ#?#%#.#> نظ#.م غذ#.ئي صحي لل#?خلص من #.ل#%#^و#?ين#.#? #.ل#~هنية منخ#<#_ة #.ل#=ث#.#<ة و#?قليل #?#^#=يز #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#?خ#~م #<ي #?خ#<ي#_ ثل#.ثي #.لجلس#^ي#~#.#? #.لم#^#?#<#>ة #<ي #.ل#~م #%ج#.ن#% إ#?#%#.#> نظ#.م غذ#.ئي صحي. \r\n\r\n–#>ل#.ج #<#^#- #.ل#=وليس#?#^ول #<ي #.ل#~م ح#.لة م#?ج#.نس #.ل#.ز#~و#.ج #.ل#>#.ئلي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#=م#. يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة #.لإص#.#%ة #%أم#^#.#_ وقصو#^ #%#.ل#=#%#~ و#.#^#?#<#.#> نس#%ة ن#.قل#.#? #.لأمين. \r\n\r\n–غي#^ مسموح #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة #.لحمل. \r\n\r\n–ل#. يس#?خ#~م م#> #.ل#^#_#.#>ة #.ل#-#%ي#>ية إل#. #?ح#? إش#^#.#< #-#%ي. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.#>#?ل#.ل #.ل#>#_ل#.#? أو #.ل#<شل #.ل#=لوي يج#% #.ل#?وق#< #>ن #?ن#.وله #<و#^#.ٌ. \r\n\r\n–يس#?خ#~م #%حذ#^ م#> #=#%#.#^ #.لسن خو#<#. من أص#.#%#?هم #%#.ل#.#>#?ل#.ل #.ل#>#_لي. \r\n\r\n–ويس#?خ#~م #.ل#~و#.ء #%حذ#^ م#> م#?#>#.#-ي #.ل#=حولي#.#?. \r\n\r\n–وأي#_#.ً يس#?خ#~م #%حذ#^ ش#~ي#~ م#> #.لأشخ#.ص ذوى #.ل#?#.#^يخ #.لم#^#_ي م#> #.ل#=#%#~. \r\n\r\n–#=م#. أنه يس#?خ#~م #%حذ#^ أي#_#. م#> من ي#>#.نون من #.ل#<شل #.ل#=لوي. \r\n\r\n–وي#?ن#.ول #%حذ#^ م#> أ#~وية أخ#^ى مثل #.ل#<ي#%#^#.#?، ني#.سين، سي#=لوس#%و#^ين، م#.#=#^ولي#~، #?يل#.#%#^ي#<#^، #^ي#?ون#.#<ي#^، وم#_#.#~#.#? #.ل#<#-#^ي#.#?، وهذ#. خو#<#. من #.ل#?#<#.#>ل #.ل#~و#.ئي #.لذي ق#~ يؤ#~ى أي#_#. إلى #.ل#.#>#?ل#.ل #.ل#>#_لي. \r\n\r\n–ينصح #%وق#< #.س#?خ#~#.مه مؤق#?#.ٌ م#> أي م#^ي#_ يظه#^ #>لية ح#.لة #.#>#?ل#.ل #%#.ل#>#_ل#.#?، #<شل #=لوي أو #.#^#?#<#.#> #<ي نس#%ة ن#.قل#.#? #.لأمين أ#=ث#^ من ثل#.ث م#^#.#? من م#>#~له#. #.ل#-#%ي#>ي. \r\n\r\n–ينصح #.س#?خ#~#.مه مؤق#?#.ٌ أي#_#.ً #<ي #.لج#^#.ح#.#? أو #.لمش#.#=ل #.ل#-#%ية #.ل#?ي ق#~ #?ؤ#~ي إلى #.#>#?ل#.ل #.ل#>#_ل#.#? أو #.ل#<شل #.ل#=لوي ن#?يجة #.نحل#.ل #.ل#>#_ل#.#?. \r\n\r\n–#?جن#% #?ن#.ول #>صي#^ #.لج#^ي#% #<#^و#? م#> #.ل#~و#.ء.", "GI": "Description :\r\nIt is a member of the drug class known as statins.\r\ndose:\r\nAdult PO- Initial- The recommended dose is 10 mg daily. Maximum: 80 mg/day.\r\nIndication\t:S\r\nMay be used as primary prevention in individuals with multiple risk factors for coronary heart disease (CHD) and as secondary prevention in individuals with CHD to reduce the risk of myocardial infarction (MI), stroke, angina, and revascularization procedures. May be used to reduce the risk of cardiovascular events in patients with acute coronary syndrome (ACS). May be used in the treatment of primary hypercholesterolemia and mixed dyslipidemia, homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and/or hypertriglyeridemia as an adjunct to dietary therapy to decrease serum total and low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apoB), and triglyceride concentrations, while increasing high-density lipoprotein cholesterol (HDL-C) levels.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "371", "Trade_Name": "PIASCLEDINE 300MG 15 CAPS.", "Generic_Name": "AVOCADO OIL+SOYA BEAN OIL", "Price": "54", "Price_Old": "36", "Company": "LABORATOIRES EXPANSCIENCE > COPAD PHARMA", "Pharmacology": "JOINTS ARTHRITIS", "Category": "م#_#.#~ ل#.ل#?ه#.#% #.لم#<#.صل", "Use": "–#>ل#.ج هش#.شة #.ل#>ظ#.م. \r\n\r\n–خ#<#_ م#>#~ل #_غ#- #.ل#~م #.لم#^#?#<#>. \r\n\r\n–#.ل#?خلص من مش#.#=ل خشونة #.ل#^#=#%ة. \r\n\r\n–#>ل#.ج #.لأم#^#.#_ #.لخ#.صة #%#~#>#.ئم #.لأسن#.ن. \r\n\r\n–#>ل#.ج أم#^#.#_ #?آ#=ل #.لم#<#.صل #.ل#?ي #?ص#.ح#% م#^حلة #.لشيخوخة. \r\n\r\n–#>ل#.ج إل#?ه#.#% #.لم#<#.صل. \r\n\r\n–#>ل#.ج أم#^#.#_ #.ل#>مو#~ #.ل#<ق#^ي و#.لأ#>#^#.#_ #.لن#.#?جة #>نه#.. \r\n\r\n–#>ل#.ج آل#.م م#<صل #.لحو#_. \r\n\r\n–#>ل#.ج ث#.نوي ل#%#>#_ أنو#.#> أم#^#.#_ #.للثة. \r\n\r\n–يس#.#>#~ #<ي #.لوق#.ية من #.#^#?#<#.#> م#>#~ل #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–صحة #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج أ#>#^#.#_ سن #.ليأس.", "Contraindications": "–ح#.ل#.#? #<#^#- #.لحس#.سية #?ج#.ه أح#~ #.لم#=ون#.#? #.لأس#.سية. \r\n\r\n–#<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية وذل#= لأنه يؤث#^ #>لى ل#%ن #.لأم #.لمُ#^#_#> و#%#.ل#?#.لي يؤث#^ #>لى صحة #.ل#-#<ل. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ ق#%ل قي#.#~ة #.لم#^#=#%#.#? أو #.س#?خ#~#.م أي آل#.#? ح#.#~ة وذل#= لأنه يس#%#% #.لن#>#.س. \r\n\r\n–يحذ#^ للم#^أة #.لح#.مل وخ#.صةً #<ي شهو#^ #.لحمل #.لأولى وذل#= لأنه ي#?س#%#% #<ي ح#~وث #?شوه#.#? خلقية للجنين. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه للأ#-#<#.ل. \r\n\r\n–ل#.#%#~ من #?ن#.ول #.ل#=ثي#^ من #.لسو#.ئل خل#.ل #<#?#^ة #.ل#>ل#.ج #%#.س#?خ#~#.م #%يس#=#.ل#~ين ح#?ى ل#. #?ص#.#% #.لم#>#~ة #%#.ل#?ق#^ح#.#?.", "GI": "Origin: A natural vegetable extract made from one-third avocado oil and two-thirds soybean oil. \r\nWhat we know: ASU blocks pro-inflammatory chemicals, prevents deterioration of synovial cells (which line the joints) and may help regenerate normal connective tissue.\r\n\r\nDosage: Softgel- take 300 mg daily.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "372", "Trade_Name": "ASUTEC 300MG 20 CAPS.", "Generic_Name": "AVOCADO OIL+SOYA BEAN OIL", "Price": "41.5", "Price_Old": "27.6", "Company": "MARCYRL CO. > PHARMA GREEN", "Pharmacology": "JOINTS ARTHRITIS", "Category": "م#_#.#~ ل#.ل#?ه#.#% #.لم#<#.صل", "Use": "–#>ل#.ج هش#.شة #.ل#>ظ#.م. \r\n\r\n–خ#<#_ م#>#~ل #_غ#- #.ل#~م #.لم#^#?#<#>. \r\n\r\n–#.ل#?خلص من مش#.#=ل خشونة #.ل#^#=#%ة. \r\n\r\n–#>ل#.ج #.لأم#^#.#_ #.لخ#.صة #%#~#>#.ئم #.لأسن#.ن. \r\n\r\n–#>ل#.ج أم#^#.#_ #?آ#=ل #.لم#<#.صل #.ل#?ي #?ص#.ح#% م#^حلة #.لشيخوخة. \r\n\r\n–#>ل#.ج إل#?ه#.#% #.لم#<#.صل. \r\n\r\n–#>ل#.ج أم#^#.#_ #.ل#>مو#~ #.ل#<ق#^ي و#.لأ#>#^#.#_ #.لن#.#?جة #>نه#.. \r\n\r\n–#>ل#.ج آل#.م م#<صل #.لحو#_. \r\n\r\n–#>ل#.ج ث#.نوي ل#%#>#_ أنو#.#> أم#^#.#_ #.للثة. \r\n\r\n–يس#.#>#~ #<ي #.لوق#.ية من #.#^#?#<#.#> م#>#~ل #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–صحة #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج أ#>#^#.#_ سن #.ليأس.", "Contraindications": "–ح#.ل#.#? #<#^#- #.لحس#.سية #?ج#.ه أح#~ #.لم#=ون#.#? #.لأس#.سية. \r\n\r\n–#<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية وذل#= لأنه يؤث#^ #>لى ل#%ن #.لأم #.لمُ#^#_#> و#%#.ل#?#.لي يؤث#^ #>لى صحة #.ل#-#<ل. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ ق#%ل قي#.#~ة #.لم#^#=#%#.#? أو #.س#?خ#~#.م أي آل#.#? ح#.#~ة وذل#= لأنه يس#%#% #.لن#>#.س. \r\n\r\n–يحذ#^ للم#^أة #.لح#.مل وخ#.صةً #<ي شهو#^ #.لحمل #.لأولى وذل#= لأنه ي#?س#%#% #<ي ح#~وث #?شوه#.#? خلقية للجنين. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه للأ#-#<#.ل. \r\n\r\n–ل#.#%#~ من #?ن#.ول #.ل#=ثي#^ من #.لسو#.ئل خل#.ل #<#?#^ة #.ل#>ل#.ج #%#.س#?خ#~#.م #%يس#=#.ل#~ين ح#?ى ل#. #?ص#.#% #.لم#>#~ة #%#.ل#?ق#^ح#.#?.", "GI": "Origin: A natural vegetable extract made from one-third avocado oil and two-thirds soybean oil. \r\nWhat we know: ASU blocks pro-inflammatory chemicals, prevents deterioration of synovial cells (which line the joints) and may help regenerate normal connective tissue.\r\n\r\nDosage: Softgel- take 300 mg daily.", "Composition": "avocado+soya ext", "Route": "ORAL.SOLID" }, { "ID": "373", "Trade_Name": "LIRIMAR 80 MG 10 CAPS.", "Generic_Name": "ATORVASTATIN", "Price": "29", "Price_Old": "29", "Company": "RIVA PHARMA S.A.E.", "Pharmacology": "ANTIHYPERLIPIDEMIC.STATINS", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–س#?خ#~م #<ي #>ل#.ج ح#.ل#.#? زي#.#~ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#?خ#~م #=#>#.مل مس#.#>#~ م#> إ#?#%#.#> نظ#.م غذ#.ئي صحي لل#?خلص من #.ل#%#^و#?ين#.#? #.ل#~هنية منخ#<#_ة #.ل#=ث#.#<ة و#?قليل #?#^#=يز #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#?خ#~م #<ي #?خ#<ي#_ ثل#.ثي #.لجلس#^ي#~#.#? #.لم#^#?#<#>ة #<ي #.ل#~م #%ج#.ن#% إ#?#%#.#> نظ#.م غذ#.ئي صحي. \r\n\r\n–#>ل#.ج #<#^#- #.ل#=وليس#?#^ول #<ي #.ل#~م ح#.لة م#?ج#.نس #.ل#.ز#~و#.ج #.ل#>#.ئلي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#=م#. يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة #.لإص#.#%ة #%أم#^#.#_ وقصو#^ #%#.ل#=#%#~ و#.#^#?#<#.#> نس#%ة ن#.قل#.#? #.لأمين. \r\n\r\n–غي#^ مسموح #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة #.لحمل. \r\n\r\n–ل#. يس#?خ#~م م#> #.ل#^#_#.#>ة #.ل#-#%ي#>ية إل#. #?ح#? إش#^#.#< #-#%ي. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.#>#?ل#.ل #.ل#>#_ل#.#? أو #.ل#<شل #.ل#=لوي يج#% #.ل#?وق#< #>ن #?ن#.وله #<و#^#.ٌ. \r\n\r\n–يس#?خ#~م #%حذ#^ م#> #=#%#.#^ #.لسن خو#<#. من أص#.#%#?هم #%#.ل#.#>#?ل#.ل #.ل#>#_لي. \r\n\r\n–ويس#?خ#~م #.ل#~و#.ء #%حذ#^ م#> م#?#>#.#-ي #.ل#=حولي#.#?. \r\n\r\n–وأي#_#.ً يس#?خ#~م #%حذ#^ ش#~ي#~ م#> #.لأشخ#.ص ذوى #.ل#?#.#^يخ #.لم#^#_ي م#> #.ل#=#%#~. \r\n\r\n–#=م#. أنه يس#?خ#~م #%حذ#^ أي#_#. م#> من ي#>#.نون من #.ل#<شل #.ل#=لوي. \r\n\r\n–وي#?ن#.ول #%حذ#^ م#> أ#~وية أخ#^ى مثل #.ل#<ي#%#^#.#?، ني#.سين، سي#=لوس#%و#^ين، م#.#=#^ولي#~، #?يل#.#%#^ي#<#^، #^ي#?ون#.#<ي#^، وم#_#.#~#.#? #.ل#<#-#^ي#.#?، وهذ#. خو#<#. من #.ل#?#<#.#>ل #.ل#~و#.ئي #.لذي ق#~ يؤ#~ى أي#_#. إلى #.ل#.#>#?ل#.ل #.ل#>#_لي. \r\n\r\n–ينصح #%وق#< #.س#?خ#~#.مه مؤق#?#.ٌ م#> أي م#^ي#_ يظه#^ #>لية ح#.لة #.#>#?ل#.ل #%#.ل#>#_ل#.#?، #<شل #=لوي أو #.#^#?#<#.#> #<ي نس#%ة ن#.قل#.#? #.لأمين أ#=ث#^ من ثل#.ث م#^#.#? من م#>#~له#. #.ل#-#%ي#>ي. \r\n\r\n–ينصح #.س#?خ#~#.مه مؤق#?#.ٌ أي#_#.ً #<ي #.لج#^#.ح#.#? أو #.لمش#.#=ل #.ل#-#%ية #.ل#?ي ق#~ #?ؤ#~ي إلى #.#>#?ل#.ل #.ل#>#_ل#.#? أو #.ل#<شل #.ل#=لوي ن#?يجة #.نحل#.ل #.ل#>#_ل#.#?. \r\n\r\n–#?جن#% #?ن#.ول #>صي#^ #.لج#^ي#% #<#^و#? م#> #.ل#~و#.ء.", "GI": "Description :\r\nIt is a member of the drug class known as statins.\r\ndose:\r\nAdult PO- Initial- The recommended dose is 10 mg daily. Maximum: 80 mg/day.\r\nIndication\t:S\r\nMay be used as primary prevention in individuals with multiple risk factors for coronary heart disease (CHD) and as secondary prevention in individuals with CHD to reduce the risk of myocardial infarction (MI), stroke, angina, and revascularization procedures. May be used to reduce the risk of cardiovascular events in patients with acute coronary syndrome (ACS). May be used in the treatment of primary hypercholesterolemia and mixed dyslipidemia, homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and/or hypertriglyeridemia as an adjunct to dietary therapy to decrease serum total and low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apoB), and triglyceride concentrations, while increasing high-density lipoprotein cholesterol (HDL-C) levels.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "374", "Trade_Name": "AZOMYCIN 250MG 6 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "25.2", "Price_Old": "25.2", "Company": "PHARCO", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "azithromycin 200mg or 250mg", "Route": "ORAL.SOLID" }, { "ID": "375", "Trade_Name": "AZALIDE 250MG 6 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "49.5", "Price_Old": "33", "Company": "T3A PHARMA", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "azithromycin 200mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "376", "Trade_Name": "AVOSOYA 30 CAPSULES", "Generic_Name": "AVOCADO OIL+SOYA BEAN OIL", "Price": "60", "Price_Old": "40", "Company": "DEBEIKY > TREND PHARM", "Pharmacology": "JOINTS ARTHRITIS", "Category": "م#_#.#~ ل#.ل#?ه#.#% #.لم#<#.صل", "Use": "–#>ل#.ج هش#.شة #.ل#>ظ#.م. \r\n\r\n–خ#<#_ م#>#~ل #_غ#- #.ل#~م #.لم#^#?#<#>. \r\n\r\n–#.ل#?خلص من مش#.#=ل خشونة #.ل#^#=#%ة. \r\n\r\n–#>ل#.ج #.لأم#^#.#_ #.لخ#.صة #%#~#>#.ئم #.لأسن#.ن. \r\n\r\n–#>ل#.ج أم#^#.#_ #?آ#=ل #.لم#<#.صل #.ل#?ي #?ص#.ح#% م#^حلة #.لشيخوخة. \r\n\r\n–#>ل#.ج إل#?ه#.#% #.لم#<#.صل. \r\n\r\n–#>ل#.ج أم#^#.#_ #.ل#>مو#~ #.ل#<ق#^ي و#.لأ#>#^#.#_ #.لن#.#?جة #>نه#.. \r\n\r\n–#>ل#.ج آل#.م م#<صل #.لحو#_. \r\n\r\n–#>ل#.ج ث#.نوي ل#%#>#_ أنو#.#> أم#^#.#_ #.للثة. \r\n\r\n–يس#.#>#~ #<ي #.لوق#.ية من #.#^#?#<#.#> م#>#~ل #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–صحة #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج أ#>#^#.#_ سن #.ليأس.", "Contraindications": "–ح#.ل#.#? #<#^#- #.لحس#.سية #?ج#.ه أح#~ #.لم#=ون#.#? #.لأس#.سية. \r\n\r\n–#<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية وذل#= لأنه يؤث#^ #>لى ل#%ن #.لأم #.لمُ#^#_#> و#%#.ل#?#.لي يؤث#^ #>لى صحة #.ل#-#<ل. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ ق#%ل قي#.#~ة #.لم#^#=#%#.#? أو #.س#?خ#~#.م أي آل#.#? ح#.#~ة وذل#= لأنه يس#%#% #.لن#>#.س. \r\n\r\n–يحذ#^ للم#^أة #.لح#.مل وخ#.صةً #<ي شهو#^ #.لحمل #.لأولى وذل#= لأنه ي#?س#%#% #<ي ح#~وث #?شوه#.#? خلقية للجنين. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه للأ#-#<#.ل. \r\n\r\n–ل#.#%#~ من #?ن#.ول #.ل#=ثي#^ من #.لسو#.ئل خل#.ل #<#?#^ة #.ل#>ل#.ج #%#.س#?خ#~#.م #%يس#=#.ل#~ين ح#?ى ل#. #?ص#.#% #.لم#>#~ة #%#.ل#?ق#^ح#.#?.", "GI": "Origin: A natural vegetable extract made from one-third avocado oil and two-thirds soybean oil. \r\nWhat we know: ASU blocks pro-inflammatory chemicals, prevents deterioration of synovial cells (which line the joints) and may help regenerate normal connective tissue.\r\n\r\nDosage: Softgel- take 300 mg daily.", "Composition": "* Each hard gelatinous capsule contains:\r\n Avocado/ Soy unsaponifiables extract 300 mg. providing Avocado unsaponifiables 1 part (100 mg)\r\n* Soy unsaponifiables 2 pails (200 mg)", "Route": "ORAL.SOLID" }, { "ID": "377", "Trade_Name": "AZIWOK 250MG 6 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "45", "Price_Old": "30", "Company": "GLOBAL NAPI PHARMACEUTICALS > WOCKHARDT", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "azithromycin 200mg or 250mg", "Route": "ORAL.SOLID" }, { "ID": "378", "Trade_Name": "AVOCAPI 10CAPS.", "Generic_Name": "AVOCADO OIL+SOYA BEAN OIL", "Price": "8.5", "Price_Old": "8.5", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "JOINTS CARE", "Category": "م#_#.#~ ل#.ل#?ه#.#% #.لم#<#.صل", "Use": "–#>ل#.ج هش#.شة #.ل#>ظ#.م. \r\n\r\n–خ#<#_ م#>#~ل #_غ#- #.ل#~م #.لم#^#?#<#>. \r\n\r\n–#.ل#?خلص من مش#.#=ل خشونة #.ل#^#=#%ة. \r\n\r\n–#>ل#.ج #.لأم#^#.#_ #.لخ#.صة #%#~#>#.ئم #.لأسن#.ن. \r\n\r\n–#>ل#.ج أم#^#.#_ #?آ#=ل #.لم#<#.صل #.ل#?ي #?ص#.ح#% م#^حلة #.لشيخوخة. \r\n\r\n–#>ل#.ج إل#?ه#.#% #.لم#<#.صل. \r\n\r\n–#>ل#.ج أم#^#.#_ #.ل#>مو#~ #.ل#<ق#^ي و#.لأ#>#^#.#_ #.لن#.#?جة #>نه#.. \r\n\r\n–#>ل#.ج آل#.م م#<صل #.لحو#_. \r\n\r\n–#>ل#.ج ث#.نوي ل#%#>#_ أنو#.#> أم#^#.#_ #.للثة. \r\n\r\n–يس#.#>#~ #<ي #.لوق#.ية من #.#^#?#<#.#> م#>#~ل #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–صحة #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج أ#>#^#.#_ سن #.ليأس.", "Contraindications": "–ح#.ل#.#? #<#^#- #.لحس#.سية #?ج#.ه أح#~ #.لم#=ون#.#? #.لأس#.سية. \r\n\r\n–#<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية وذل#= لأنه يؤث#^ #>لى ل#%ن #.لأم #.لمُ#^#_#> و#%#.ل#?#.لي يؤث#^ #>لى صحة #.ل#-#<ل. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ ق#%ل قي#.#~ة #.لم#^#=#%#.#? أو #.س#?خ#~#.م أي آل#.#? ح#.#~ة وذل#= لأنه يس#%#% #.لن#>#.س. \r\n\r\n–يحذ#^ للم#^أة #.لح#.مل وخ#.صةً #<ي شهو#^ #.لحمل #.لأولى وذل#= لأنه ي#?س#%#% #<ي ح#~وث #?شوه#.#? خلقية للجنين. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه للأ#-#<#.ل. \r\n\r\n–ل#.#%#~ من #?ن#.ول #.ل#=ثي#^ من #.لسو#.ئل خل#.ل #<#?#^ة #.ل#>ل#.ج #%#.س#?خ#~#.م #%يس#=#.ل#~ين ح#?ى ل#. #?ص#.#% #.لم#>#~ة #%#.ل#?ق#^ح#.#?.", "GI": "Origin: A natural vegetable extract made from one-third avocado oil and two-thirds soybean oil. \r\nWhat we know: ASU blocks pro-inflammatory chemicals, prevents deterioration of synovial cells (which line the joints) and may help regenerate normal connective tissue.\r\n\r\nDosage: Softgel- take 300 mg daily.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "379", "Trade_Name": "ZITHROMAX 250MG 6 CAPS.", "Generic_Name": "AZITHROMYCIN", "Price": "79", "Price_Old": "54", "Company": "PFIZER", "Pharmacology": "ANTIBIOTIC.MACROLIDE", "Category": "م#_#.#~ حيوي م#.#=#^ولي#~", "Use": "–ي#>#.لج أم#^#.#_ #.ل#^ئوية #.ل#.نس#~#.#~ية #.لح#.#~ة ن#?يجة #.لإص#.#%ة #%ج#^ثومة #.لمس#?#~يمة #.لنزلية, #.لمو#^#.#=سلل#. #.لنزلية, #.ل#>ق#~ية #.ل#^ئوية. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.لس#<لي, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية, \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.ل#<صي و#.لش#>#%ي. \r\n\r\n–#>ل#.ج #>#~وى #.لأن#<. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #>#~وى #.لجه#.ز #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #>نق #.ل#^حم. \r\n\r\n–#>ل#.ج #>#~وي #.لجل#~ #.لغي#^ م#?#<#.قمة. \r\n\r\n–#>ل#.ج ق#^حة #.ل#?ن#.سلية.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء لل#.شخ#.ص #.لذي ي#>#.نون من #.لح#.ل#.#? #.لم#^#_ية #.ل#?#.لية : \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ \r\n\r\n–أم#^#.#_ #.لقل#% \r\n\r\n–#.#_#-#^#.#%#.#? #_#^#%#.#? #.لقل#% \r\n\r\n–#<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? \r\n\r\n–مثل #.لم#_#.#~#.#? #.لحيوية #.ل#.خ#^ى من #.لمم#=ن أن يؤث#^ #.ل#>ق#.#^ #>لى #.ل#%#=#?ي#^ي#. #.لم#>وية مم#. يقلل #.م#?ص#.ص ح#%و#% من#> #.لحمل و#?أثي#^ه#.. \r\n\r\n–#<ي #%#>#_ #.ل#.حي#.ن #.ل#.س#?#>م#.ل #.لم#?ز#.من م#> #.لأ#~وية #.لم#_#.#~ة لل#?خث#^ يم#=ن أن يزي#~ من إح#?م#.لية #.لنز#<. لذل#= يج#% قي#.س وم#?#.#%#>ة نس#%ة سيولة #.ل#~م (وق#? #.ل#%#^وث#^وم#%ين ) أو #.لنس#%ة #.ل#-#%ي#>ية #.ل#~ولية international normalized ratio (INR) #>ن#~ #.س#?#>م#.لهم#. م#>#.ً. \r\n\r\n–ينصح #%م#^#.ق#%ة #.لم#^#_ى #.لذين يس#?#>ملون أزي#?#^وم#.يسين #%#.لمز#.منة م#> #.لأ#~وية #.ل#?#.لية: \r\n\r\n–#^ي#?ون#.#<ي#^، #~يجو#=سين، إ#^غو#?#.مين، #?يو#<يللين، #?#^#<ين#.#~ين، \r\n\r\n–سي#=لوس#%و#^ين، هي#=سو#%#.#^#%ي#?#.ل، #<ينو#?ين. \r\n\r\n–أ#~وية #.لحمو#_ة: \r\n\r\n–#?قلل من #?أثي#^ #.ل#~و#.ء #<ي#?ن#.ول #.ل#>ق#.#^ ق#%ل س#.#>ه #.و #%#>#~ س#.#>#?ين من #?ن#.وله#.. \r\n\r\n– #.لحمل و#.ل#^#_#.#>ة: #.لحمل: \r\n\r\n–يصن#< #.ل#>ق#.#^ #<ى #.ل#<ئة ( #% ) #%#.لنس#%ة للسل#.مة #.ثن#.ء #<#?#^ة #.لحمل, \r\n\r\n–لم #?ظه#^ #.ل#~#^#.س#.#? #.ل#?ن#.سلية #>لى #.لحيو#.ن#.#? أن #.س#?خ#~#.م #.ل#>ق#.#^ يس#%#% #?شوه#.#? للجنين, و#=غي#^ه من #.ل#.#~وية يج#% #?جن#% #.س#?#>م#.ل #.ل#~و#.ء \r\n\r\n–#.ثن#.ء #.لحمل وخ#.صة #.ثن#.ء #.لثل#.ثة #.ل#.شه#^ #.ل#.ولى #.ل#. #<ي ح#.لة #.ل#_#^و#^ة #.ل#?ي يق#^#^ه#. #.ل#-#%ي#%. \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–يس#?#>مل #.ألزيث#^وم#.يسين #%حذ#^ #>ن#~ #.ألمه#.#? #.لم#^#_#>#.#? و#?ح#? #.ش#^#.#< #.ل#-#%ي#%, حيث #?#%ين #.#<#^#.ز #=مية #_ئيلة من #.ل#~و#.ء #<ي ل#%ن #.ل#.م.", "GI": "Description:\t\r\nAzithromycin is a semi-synthetic macrolide antibiotic of the azalide class.\r\n\r\ndose:\r\nAdult: PO- Respiratory tract, Skin and soft tissue infections- 500 mg once daily for 3 days. Or 500mg on day 1 followed by 250mg on days 2 to 5. \r\nTyphoid- 500 mg once daily for 7 days. \r\nUncomplicated gonorrhoea- 2 g single dose. \r\nGranuloma inguinale- Initial: 1 g, then 500 mg/day until all lesions has healed completely.\r\nChancroid/Chlamydial urethritis: 1 g single dose Prophylaxis of disseminated MAC infections 1.2 g once weekly. Treatment or secondary prophylaxis: administered along with other antimycobacterials: 500 mg once daily. \r\n\r\nMechanism of action\tAzithromycin binds to the 50S subunit of the 70S bacterial ribosomes, and therefore inhibits RNA-dependent protein synthesis in bacterial cells.\r\n\r\nHalf life :\r\n68 hours", "Composition": "Capsules: Azithromycin dihydrate 262.05 mg equivalent to 250 mg azithromycin base.\r\n\r\nPowder for Oral Suspension: Azithromycin dihydrate 209.64 mg/5ml equivalent to 200mg/5ml of azithromycin base.", "Route": "ORAL.SOLID" }, { "ID": "380", "Trade_Name": "MOXIPEN 500MG 12 CAPS.", "Generic_Name": "AMOXICILLIN", "Price": "8.75", "Price_Old": "8.75", "Company": "MISR", "Pharmacology": "PENICILLINS.MONOCOMPONENT", "Category": "م#_#.#~ حيوي #%نسيلين #.ح#.#~ي", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج نزل#.#? #.لش#>#% #.لهو#.ئية #.لح#.#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.لص#~ي#~ #.لم#?#^#.#=م #>لى #.ل#^ئة. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لس#>#.ل #.ل#~ي#=ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لش#<#.#< #.لج#^ثومي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #.#?ج#.ه مجمو#>ة أ#~وية #.ل#%ي#?#. ل#.#=#?#.م مثل #.ل#%نسيلين#.#? و#.ل#=ي#<#.لوس#%و#^ين#.#?. يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ و#.لي#^ق#.ن. \r\n\r\n–ول#. يج#% #.س#?خ#~#.مه #<ي ح#.لة #.لم#^#_ي #.لذين ي#>#.نون من #<شل #=لوي أو خلل #%#.ل#=#%#~ . \r\n\r\n–#=م#. يحذ#^ أي#_#.ً #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحمل حيث ي#>#%#^ من خل#.ل #.لمشيمة مم#. ق#~ يؤث#^ سل#%#. #>لي #.لجنين وأي#_#.ً ل#. يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#^#_#.#>ة لأنه ي#<#^ز #<ي ل#%ن #.لأم مم#. ق#~ يس#%#% مخ#.#-#^ صحة لل#^#_ي#> .", "GI": "(Indications):\r\n is a penicillin-like , beta-lactam antibiotic. It is used to treat bacterial infections caused by susceptible microorganisms. It prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia, bronchitis, gonorrhea, and infections of the ears, nose, throat, urinary tract, and skin. \r\n(Dosage):\r\nAdult : 250 mg to 500 mg 3 times/day\r\nChild : The recommended dose is 25 mg/kg/day in divided doses every 12 hours.", "Composition": "amoxicillin 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "381", "Trade_Name": "FLUMOX 250 MG 12 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "14.25", "Price_Old": "9.5", "Company": "EIPICO", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "382", "Trade_Name": "AMOFLUX 250/250MG 16 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "18", "Price_Old": "18", "Company": "RAMEDA > PIONEER PHARMACEUTICAL INDUSTRIES", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "amoxicillin 125mg+flucloxacillin 125mg \r\nor amoxicillin 250mg+flucloxacillin 250mg", "Route": "ORAL.SOLID" }, { "ID": "383", "Trade_Name": "MICLOX 500MG 10 CAPS.", "Generic_Name": "AMOXICILLIN+DICLOXACILLIN", "Price": "9", "Price_Old": "9", "Company": "MISR", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–م#_#.#~ حيوي لل#>ل#.ج و#.لوق#.يه من #>#~وى #.ل#.ن#< و#.ل#.ذن و#.لحنج#^ة و#.ل#?ه#.#% #.لجيو#% #.ل#.ن#<ية و#.ل#.ل#?ه#.#% #.لح#.#~ للأذن #.لوس#-ى و#>ل#.ج و#.لوق#.ية من #>#~وى #.لجه#.ز #.ل#?ن#<سى و#>#~وى #.لجل#~ و#>ل#.ج #.لخ#^#.ج و#.ل#~م#.مل ويس#?خ#~م للوق#.يه من #.لحمى #.ل#^وم#.#?يزمية ويس#?خ#~م ل#>ل#.ج #.ل#.م#^#.#_ #.لج#^ثومية و #.ل#?هيج #.ل#>ص#%ي و #^وم#.#?يزم #.لقل#% و #.لإل#?ه#.#% #.ل#=لوي #.لح#.#~", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "About Amoxycillin + Dicloxacillin\r\nAmoxycillin is active against a wide range of Gram-positive and Gramnegative pathogens, and dicloxacillin acts against penicillinase producing Gram-positive pathogens.\r\n\r\nIndications\r\n1.Respiratory tract Infections \r\nTonsillar abscess, otitis media, suppurative sinus infection, acute and chronic bronchitis, bronchi-ectasis, bronchopneumonia, pleu-risy, empyema, lung abscess, emphysema, bronchiolitis. \r\n2.Gynaecological Infections \r\nSeptic abortion, puerperal infections, caesarean sections and other gynaeco-logical surgeries. \r\n3.Urinary tract Infections \r\nAcute and chronic pyelonephritis, cystitis, urethritis. \r\n4.Skin and soft tissue Infections \r\nRecurrent boils, carbuncles, impetigo, cellulitis and other infected dermatoses. \r\n5.Bone Infections \r\nOsteomyelitis and septic arthritis. \r\n6.Serious Infections \r\nSepticaemia, bacterial endocarditis, brain abscess and bacterial meningitis.", "Composition": "amoxicillin 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "384", "Trade_Name": "AMOFLUXIN 500MG 20 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "40", "Price_Old": "40", "Company": "RAMEDA", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "amoxicillin 500mg+flucloxacillin 500mg \r\nor amoxicillin 250mg+flucloxacillin 250mg", "Route": "ORAL.SOLID" }, { "ID": "385", "Trade_Name": "FLUCAMOX 250MG 12CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "8.25", "Price_Old": "8.25", "Company": "SEDICO", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "386", "Trade_Name": "AMOFLUX 125/125MG 12 CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "8.25", "Price_Old": "8.25", "Company": "RAMEDA > DELTA PHARMA", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "amoxicillin 125mg+flucloxacillin 125mg \r\nor amoxicillin 250mg+flucloxacillin 250mg", "Route": "ORAL.SOLID" }, { "ID": "387", "Trade_Name": "FLUMOCIN 250MG 12CAPS.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "6.2", "Price_Old": "6.2", "Company": "T3A PHARMA", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "388", "Trade_Name": "AMOCLOX 500MG 16CAPS.", "Generic_Name": "AMOXICILLIN+DICLOXACILLIN", "Price": "13.5", "Price_Old": "13.5", "Company": "MEMPHIS", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–م#_#.#~ حيوي لل#>ل#.ج و#.لوق#.يه من #>#~وى #.ل#.ن#< و#.ل#.ذن و#.لحنج#^ة و#.ل#?ه#.#% #.لجيو#% #.ل#.ن#<ية و#.ل#.ل#?ه#.#% #.لح#.#~ للأذن #.لوس#-ى و#>ل#.ج و#.لوق#.ية من #>#~وى #.لجه#.ز #.ل#?ن#<سى و#>#~وى #.لجل#~ و#>ل#.ج #.لخ#^#.ج و#.ل#~م#.مل ويس#?خ#~م للوق#.يه من #.لحمى #.ل#^وم#.#?يزمية ويس#?خ#~م ل#>ل#.ج #.ل#.م#^#.#_ #.لج#^ثومية و #.ل#?هيج #.ل#>ص#%ي و #^وم#.#?يزم #.لقل#% و #.لإل#?ه#.#% #.ل#=لوي #.لح#.#~", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "About Amoxycillin + Dicloxacillin\r\nAmoxycillin is active against a wide range of Gram-positive and Gramnegative pathogens, and dicloxacillin acts against penicillinase producing Gram-positive pathogens.\r\n\r\nIndications\r\n1.Respiratory tract Infections \r\nTonsillar abscess, otitis media, suppurative sinus infection, acute and chronic bronchitis, bronchi-ectasis, bronchopneumonia, pleu-risy, empyema, lung abscess, emphysema, bronchiolitis. \r\n2.Gynaecological Infections \r\nSeptic abortion, puerperal infections, caesarean sections and other gynaeco-logical surgeries. \r\n3.Urinary tract Infections \r\nAcute and chronic pyelonephritis, cystitis, urethritis. \r\n4.Skin and soft tissue Infections \r\nRecurrent boils, carbuncles, impetigo, cellulitis and other infected dermatoses. \r\n5.Bone Infections \r\nOsteomyelitis and septic arthritis. \r\n6.Serious Infections \r\nSepticaemia, bacterial endocarditis, brain abscess and bacterial meningitis.", "Composition": "amoxicillin 250mg+dicloxacillin 250mg", "Route": "ORAL.SOLID" }, { "ID": "389", "Trade_Name": "AMOFLUXIN 1 GM VIAL I.M/I.V.", "Generic_Name": "AMOXICILLIN+FLUCLOXACILLIN", "Price": "6", "Price_Old": "6", "Company": "PHARCO > RAMEDA", "Pharmacology": "PENICILLINS.PENICILLIN WITH B-LACTAMASE INHIBITOR", "Category": "#%نسيلين م#> مث#%#-#.#? #.ل#%ي#?#.-ل#.#=#?#.ميز", "Use": "–يس#?خ#~م #>ق#.#^ ل#>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#<سي مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوي وم#^#_ #.ل#.م#<زيم#.. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى و#.لحنج#^ة و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأن#< و#.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.لنزل#.#? #.لم#>وية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#>ل#.ج ح#.ل#.#? حمى #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجه#.ز #.ل#?ن#.سلي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#.. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.لسيل#.ن. \r\n\r\n–#>ل#.ج #.ل#?سمم #.لن#<#.سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=لي و#.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجل#~ و #.لنسيج #.لخلوي. \r\n\r\n–#>ل#.ج #.ل#~م#.مل و#.لخ#^#.ج. \r\n\r\n–#>ل#.ج #.لجم#^#.#?. \r\n\r\n–#.لوق#.ية من #.ل#?لوث أثن#.ء #>مل #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ظ#.م و#?سوس #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#?#>#<نه#.. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#~موي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% غش#.ء #.ل#?#.مو#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لغش#.ء #.ل#%#^ي#?وني. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n–#>ل#.ج #>#~وى #.لقن#.ة #.لم#^#.#^ية.", "Contraindications": "–إذ#. #=#.ن ل#~ي#= حس#.سية لل#%نسلين أو #.لم#_#.#~#.#? #.لحيوية #.لمن#?مية ل#<ئة #.لسي#<#.لوس#%و#^ين \r\n\r\n–ق#~ ي#=ون #=#%#.#^ #.لسن أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م هذ#. #.ل#~و#.ء \r\n\r\n– ح#~يثي #.لول#.#~ة / #.ل#^#_#> ق#~ ي#=ونون أ#=ث#^ #>#^#_ة للأث#.#^ #.لج#.ن#%ية أثن#.ء #.س#?خ#~#.م مش#?ق#.#? #.ل#%نسلين \r\n\r\n–يم#=ن #.ن يس#?#>مل #.ثن#.ء #.لحمل / #.ل#^#_#.#>ة و ل#=ن #<ى #.لح#.ل#.#? #.ل#_#^و#^ية #<ق#- و #?ح#? #.ش#^#.#< #-#%ى مخ#?ص", "GI": "amoxycillin and flucloxacillin - generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination, showing that antagonism does not occur when the two components are combined.\r\nTypical indications include:\r\nAcute and chronic bronchitis\t\r\nPelvic inflammatory disease\r\nPneumonia\t\r\nUrinary tract infections\r\nEar, nose and throat infections\tSkin and soft tissue infections\r\nGynaecological infections", "Composition": "amoxicillin 500mg+flucloxacillin 500mg \r\nor amoxicillin 250mg+flucloxacillin 250mg", "Route": "INJECTION" }, { "ID": "390", "Trade_Name": "BIOTIN FORTE 5MG 60 CAPS.", "Generic_Name": "BIOTIN", "Price": "36", "Price_Old": "24", "Company": "UNIPHARMA CO.", "Pharmacology": "VITAMINS", "Category": "م#=مل #.ل#%يو#?ين", "Use": "–#=م#. ي#~خل #<ي #>ل#.ج مش#.#=ل #.ل#%ش#^ة و#.لجل#~ و#.لش#>#^. \r\n\r\n–ي#>#.لج #?س#.ق#- #.لش#>#^. \r\n\r\n–ي#>مل #>لى #?قوية #.لأظ#.#<#^. \r\n\r\n–يس#.#>#~ #>لى #?ج#~ي#~ خل#.ي#. #.لجسم من خل#.ل زي#.#~ة #?#~#<ق #.ل#~م #%خل#.ي#. #.لجل#~ #<ي#>مل #>لى #?ج#~ي#~ه#..", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.نخ#<#.#_ #<ي مس#?وي #.لس#=#^ #<ي #.لجسم.", "GI": "Mechanism of Action of Biotin\r\nBiotin excerts it`s pharmacological action by influencing metabolic reactions. It acts as a coenzyme for carbohydrate, fat, and protein metabolism. It is required for cell growth and production of fatty acids. It is required for healthy maintenance of hair, skin, sweat glands, nerve tissue, and bone marrow. It also helps in the transfer of carbon dioxide and in the maintenance of a steady blood sugar level.\r\n\r\nIndications for Biotin\r\n1.Biotin deficiency \r\n2 Alopecia \r\n3.Brittle nails \r\n4.Prevent diabetic neuropathy and lower blood glucose levels in diabetic patients \r\n5.Seborrheic dermatitis \r\n6.Dry skin. \r\n\r\nTypical Dosage for Biotin\r\nOral: 30 to 70mcg daily. Increased up to 300mcg/day if required based on the severity of deficiency. \r\nPregnancy: 30mcg daily \r\nLactation: 35mcg daily \r\nPrevent brittle nails: 2.5mg/day.", "Composition": "vit b7 5mg", "Route": "ORAL.SOLID" }, { "ID": "391", "Trade_Name": "MUCLEAR 20 CAPS.", "Generic_Name": "BROMHEXINE+GUAIFENESIN", "Price": "4.75", "Price_Old": "4.75", "Company": "RAMEDA", "Pharmacology": "COUGH DRUGS", "Category": "م#_#.#~ لل#=حة", "Use": "–ل#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–ل#>ل#.ج م#^#_ #.لقص#%#.#? #.ل#^ئوية. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.ل#^#%و #.لقص#%ي. \r\n\r\n–ل#.ذ#.#%ة #.ل#.#<#^#.ز#.#? #.لمخ#.#-ية #%#.لقص#%#.#?.", "Contraindications": "–#.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–ل#. يس#?#>مل #.#=ث#^ من 14 يوم. \r\n\r\n–ل#. يس#?خ#~م لل#.#-#<#.ل #.قل من سن#?ين.", "GI": "(Indications):\r\nThis medication is a mucolytic agent, prescribed for various respiratory diseases such as emphysema with bronchitis pneumoconiosis, chronic inflammatory pulmonary conditions, tracheobronchitis (respiratory tract inflammation), bronchiectasis, bronchitis with bronchospasm asthma. \t\r\n\r\n(dosage) :\r\n The recommended dose is 30-120 mg/day in 2-3 divided doses.\r\n\r\n(Warnings and Precautions) : \r\n Caution needed for pregnant and breastfeeding women.", "Composition": "Caps: bromhexine 8mg, guaifenesin 100mg \r\nsyrup : bromhexine 4mg", "Route": "ORAL.SOLID" }, { "ID": "392", "Trade_Name": "BILICHOL 24 CAPS.", "Generic_Name": "BORNEOL+CAMPHENE+CINEOL+MENTHOL+MENTHONE+PINENE ( ALPHA & BETA )", "Price": "5.9", "Price_Old": "5.9", "Company": "PHARCO", "Pharmacology": "CHOLELITHIASIS", "Category": "#.ل#?ه#.#% #.لم#^#.#^ة و مش#.#=ل #.ل#=#%#~", "Use": "–إل#?ه#.#%#.#? #.لقنو#.#? و#.لحويصل#.#? #.لم#^#.#^ية. \r\n\r\n–#.لوق#.ية و#.ل#>ل#.ج من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–إ#_#-#^#.#%#.#? #.ل#=#%#~.", "Contraindications": "–حس#.سية من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لحمل و#.ل#^#_#.#>ة يج#% إس#?ش#.#^ة #.ل#-#%ي#% ول#. ينصح #%#?ن#.وله #<ي أول 3 شهو#^ من #.لحمل. \r\n\r\n–#?وخي #.لحذ#^ م#> #.لم#^#_ى #.لذين ي#?ن#.ولون أ#~وية #.ل#?جل#-.", "GI": "Bilichol is a collection of highly purified natural active ingredients which restore a healthy balance to the biliary system. Bilichol increases biliary secretion and flow with an additional antispasmodic action that reduces the force and frequency of bile ducts spasm. \r\nIndications\r\nFor the treatment of hepato-biliary disorders including dyskinesia of bite ducts, biliary stasis, inflammatory biliary conditions, cholecystitis and cholelithiasis.", "Composition": "Each Capsule contains:\r\nMenthol 32 mg\r\nMenthone 6 mg\r\nPinene 17 mg\r\nBorneol 5 mg\r\nCineole 2 mg\r\nCamphene 5 mg", "Route": "ORAL.SOLID" }, { "ID": "393", "Trade_Name": "HAIR TONE 40 CAPS.", "Generic_Name": "BIOTIN+CALCIUM PANTOTHENATE+CYSTEINE+KERATIN+P-AMINOBENZOIC ACID+SACCHAROMYCES +VITAMIN(B1+B2+B6+E)", "Price": "38", "Price_Old": "38", "Company": "EVA PHARMA", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#>ل#.ج #?س#.ق#- و #?ل#< #.لش#>#^. \r\n\r\n–#<#>#.ل #<ي زي#.#~ة #-ول #.لش#>#^. \r\n\r\n–#>ل#.ج #_#>#< #.ل#.ظ#.#<#^ و#?قوي#?ه#.. \r\n\r\n–#.ل#?خلص من قش#^ة #<#^وة #.ل#^أس. \r\n\r\n–#.لح#<#.ظ #>لي مس#?وي #.لس#=#^ #<ي #.ل#~م. \r\n\r\n–#>ل#.ج #.ل#.نيمي#. حيث #?ح#?وي #>لي #<ي#?#.مين #%. \r\n\r\n–#>ل#.ج #_#>#< #%صيل#.#? #.لش#>#^ و#?قوية #.لش#>#^.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #.ل#.س#?#>م#.ل لم#^#_ي #.لقس#-#^ة #.لو#^ي#~ية #.لم#^#=زية. \r\n\r\n–يمن#> #.ل#.س#?#>م#.ل لمن ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.ل#=لي و #.ل#=#%#~. \r\n\r\n–يمن#> #.ل#.س#?#>م#.ل لمن ي#>#.ني من #<ق#^ #.ل#~م #.لش#~ي#~ ، ح#.ل#.#? #.لنزي#<.", "GI": "Mechanism of Action of Biotin\r\nBiotin excerts it`s pharmacological action by influencing metabolic reactions. It acts as a coenzyme for carbohydrate, fat, and protein metabolism. It is required for cell growth and production of fatty acids. It is required for healthy maintenance of hair, skin, sweat glands, nerve tissue, and bone marrow. It also helps in the transfer of carbon dioxide and in the maintenance of a steady blood sugar level", "Composition": "Each capsule contains:Thiamine (as HCl) 60 mg\r\nCalcium Pantothenate\r\n60 mg\r\np-Aminobenzoic acid\r\n20 mg\r\nPyridoxine HCl\r\n2.4 mg\r\nRiboflavin Phosphate\r\n2 mg\r\nD-Biotin\r\n0.15 mg\r\nVitamin E acetate\r\n6 mg\r\nMedicinal Yeast\r\n100 mg\r\nL-Cystine\r\n20 mg\r\nKeratin\r\n20 mg", "Route": "ORAL.SOLID" }, { "ID": "394", "Trade_Name": "SUPER ACT 20 CAPS. (CANCELLED)", "Generic_Name": "CAFFEINE+NICOTINIC ACID+VITAMIN E+YOHIMBINE", "Price": "13.2", "Price_Old": "13.2", "Company": "RAMEDA", "Pharmacology": "SEXUAL TONIC", "Category": "منش#- جنسي", "Use": "–#.ل#>نة ن#?يجة قصو#^ #<ي #.ل#~و#^ة #.ل#~موية وم#^#_ى #.لس#=#^ و#.لح#.ل#.#? #.لن#<سية.", "Contraindications": "–ل#. يس#?خ#~م هذ#. #.ل#~و#.ء إذ#. #=ن#? #?#>#.ني من #.لحس#.سية من أح#~ م#=ون#.#?ه. - و#<ي ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة .", "GI": "COMING SOON ..", "Composition": "caffeine 25mg, vit b3 5mg, vit e 15mg, yohimbine 5.4mg", "Route": "ORAL.SOLID" }, { "ID": "395", "Trade_Name": "ANTIFLU 20 CAP.", "Generic_Name": "CAFFEINE+CHLORPHENIRAMINE+IBUPROFEN+PHENYLPROPANOLAMINE", "Price": "12.75", "Price_Old": "8.5", "Company": "ADWIA", "Pharmacology": "COLD & FLU DRUGS", "Category": "لل#%#^#~ و #.ل#^شح", "Use": "– يس#?خ#~م #<ى #>ل#.ج أ#>#^#.#_ نزل#.#? #.ل#%#^#~ و#.لأن#<لونز#.، #=م#. يس#?#>مل #<ى #>ل#.ج #.ل#?ه#.#% #.لأن#< و#>ل#.ج إح#?ق#.ن #.لجيو#% #.لأن#<ية #%#.لأ#_#.#<ة أنه ي#>#.لج أ#^#?#<#.#> #~#^جة ح#^#.#^ة #.لجسم. \r\n\r\n– يس#?#>مل #<ى #>ل#.ج حس#.سية #.ل#.ن#< و#.لنزل#.#? #.لموسمية، #=م#. يس#=ن #.لآل#.م #.لن#.#?جة #>ن نزل#.#? #.ل#%#^#~ و#.لأن#<لونز#. #%#.لأ#_#.#<ة أنه يس#?خ#~م #<ى #>ل#.ج #^شح #.لأن#<.", "Contraindications": "– يحذ#^ أس#?خ#~#.م #.ل#~و#.ء لمن ل#~يهم #<#^#- حس#.سية لأي م#.#~ة من م#=ون#.#? #.ل#~و#.ء #.لمخ#?ل#<ة. \r\n\r\n– يمن#> #.س#?خ#~#.مه م#> #.لم#^#_ي #.لذين ي#?ن#.ولو#. أ#~وية م#_#.#~ة للأ#=#?ئ#.#% أو أ#~وية #>ل#.ج #_غ#- #.ل#~م. \r\n\r\n– #=م#. يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء م#> م#^#_ى #?#_خم #.ل#%#^وس#?#.#?#. ويمن#> #>لى #.لذين ي#>#.نون من أم#^#.#_ #<ي #.لغ#~ة #.ل#~#^قية. \r\n\r\n–4 \r\n\r\n– #<ى ح#.لة وجو#~ قصو#^ #<ى وظ#.ئ#< #.لقل#% أو م#^#_ #.لس#=#^ي يمن#> #.س#?خ#~#.م #.ل#~و#.ء #.ي#_#.ً. \r\n\r\n– يمن#> #.س#?خ#~#.م #.ل#~و#.ء م#> #.لأ#-#<#.ل #.لذين أ#>م#.#^هم #.#=ل من 6 سنو#.#?. \r\n\r\n– #<ى ح#.لة #.لحمل و#.ل#^#_#.#>ة ننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص حيث يحذ#^ #.س#?خ#~#.مه #<ى ثل#.ثة أشه#^ #.لأولي من #.لجمل. \r\n\r\n– ل#. ي#?م #.خذ #.ل#~و#.ء #<ى ح#.لة مم#.#^سة #.لأنش#-ة #.ل#?ى #?#?#-ل#% #.ليقظة مثل #.لقي#.#~ة و#?شغيل #.لآل#.#? ل#.ن #.ل#~و#.ء يس#%#% #.لن#>#.س.", "GI": "COMING SOON ..", "Composition": "Ibuprofen 200 mg\r\nPseudoephedrine hydrochloride 60 mg\r\nChlorpheniramine maleate 3 mg\r\nCaffeine 25 mg", "Route": "ORAL.SOLID" }, { "ID": "396", "Trade_Name": "MEPACURE 30 CAPS.", "Generic_Name": "BIPHENYL DIMETHYL DICARBOXYLATE+SILYMARIN", "Price": "9.5", "Price_Old": "9.5", "Company": "MEPACO", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#>ل#.ج ومن#> #?لي#< #.ل#=#%#~. \r\n\r\n–#?نشي#- خل#.ي#. ووظ#.ئ#< #.ل#=#%#~. \r\n\r\n–#.#>#.#~ة #?#=وين #.لخل#.ي#. #.ل#=#%#~ية. \r\n\r\n–#>ل#.ج #.م#^#.#_ #.ل#=#%#~ مثل : #<ي#^وس#.#? #.ل#=#%#~ #.لو#%#.ئي ، س#^#-#.ن #.ل#=#%#~ ، #?سمم #.ل#=#%#~.", "Contraindications": "–#.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ي #.لس#=#^. \r\n\r\n–#.ل#.#-#<#.ل #.ل#.قل من 12 #>#.م.", "GI": "Biphenyl dimethyl dicarboxylate (DDB) is a hepatoprotectant, which is used as an adjuvant agent in a treatment for chronic hepatitis.", "Composition": "Capsule contains:\r\nDimethyl Dimethoxy Biphenyl Dicarboxylate(D.D.B) 30 mg\r\nSilymarin 50 mg", "Route": "ORAL.SOLID" }, { "ID": "397", "Trade_Name": "COLDACT 16 CAPS.", "Generic_Name": "CAFFEINE+CHLORPHENIRAMINE+PARACETAMOL(ACETAMINOPHEN)+PHENYLPROPANOLAMINE", "Price": "6", "Price_Old": "6", "Company": "MEMPHIS", "Pharmacology": "COLD & FLU DRUGS", "Category": "لل#%#^#~ و #.ل#^شح", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#.ح#?ق#.ن #.لمص#.ح#% لنزل#.#? #.ل#%#^#~ و#.ح#?ق#.ن #.لأن#< و#.لحنج#^ة وسيل#.ن #.لأن#< و#.لجيو#% #.ل#.ن#<ية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج نزل#.#? #.ل#%#^#~ و#%#>#_ #.لأ#>#^#.#_ #.لمص#.ح#%ة له مثل #.ل#>#-س و#.ل#=حة. \r\n\r\n–ي#>مل #>لى #?حسين وظ#.ئ#< #.لقنو#.#? #.ل#?ن#<سية #.ل#>لي#. و#>و#~#?ه#. ل#-#%ي#>#?ه#.. \r\n\r\n–يس#?خ#~م #<ى #?س#=ين و#?خ#<ي#< #.ل#.ل#.م #.لن#.#?جة #>ن #.لص#~#.#> #.لمص#.ح#% لنزل#.#? #.ل#%#^#~. \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.#^#?#<#.#> #~#^جة #.لح#^#.#^ة و حمى #.لقش.", "Contraindications": "–#.ل#?أ#=#~ من #>#~م وجو#~ حس#.سية للم#^ي#_ من #.يً#. م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.وله للأشخ#.ص #.لذين ي#>#.نون من م#^#_ #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–يمن#> #?ن#.وله للأشخ#.ص #.لذين ي#>#.نون من قصو#^ #<ى #.لقل#% . \r\n\r\n–يمن#> #>لى #.لح#.مل #.و #.لم#^#_#> #?ن#.وله. \r\n\r\n–يمن#> من#>ً#. #%#.#?ً#. #?ن#.ول #.ل#=حولي#.#? #.ثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–ل#. ي#?م #?ن#.وله لمن ي#>#.ني من مش#.#=ل صحية #<ي #.ل#=لى #.و #.ل#=#%#~.", "GI": "COMING SOON ..", "Composition": "caffeine 20mg, chlorpheniramine 2mg, ibuprofen 300mg, pseudoephedrine 30mg", "Route": "ORAL.SOLID" }, { "ID": "398", "Trade_Name": "PENNEL 30 CAPS.", "Generic_Name": "BIPHENYL DIMETHYL DICARBOXYLATE+GARLIC OIL", "Price": "45", "Price_Old": "37.5", "Company": "PHARMAKING-KOREA > UNITED PHARMA INTERNATIONAL-EGYPT", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#.ل#?ه#.#% #.ل#=#%#~ #.لمزمن \r\n\r\n–سمية #.لإيث#.نول \r\n\r\n–#?صل#% #.لش#^#.يين \r\n\r\n–س#^#-#.ن #.لقولون \r\n\r\n–س#^#-#.ن #.لمس#?قيم \r\n\r\n–#_غ#- #~م م#^#?#<#> \r\n\r\n–س#^#-#.ن #.ل#%#^وس#?#.#? \r\n\r\n– #>ل#.مة ل#~غ#.#? \r\n\r\n–#.لقو#%#.ء #.لحلقية م#^#_ جل#~ي \r\n\r\n–ق#~م #.ل#^ي#.#_ي", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.ل#?#<#.#>ل#.#? #.ل#~و#.ئية : \r\n\r\n–Antihypertensives \r\n\r\n–Calcium channel blockers \r\n\r\n–Ciprofloxacin \r\n\r\n–Saquinavir \r\n\r\n–Warfarin", "GI": "Biphenyl dimethyl dicarboxylate (DDB) is a hepatoprotectant, which is used as an adjuvant agent in a treatment for chronic hepatitis.", "Composition": "ddb 25mg, garlic oil 50mg", "Route": "ORAL.SOLID" }, { "ID": "399", "Trade_Name": "CEFACET 10 CAPS.", "Generic_Name": "CAFFEINE+PARACETAMOL(ACETAMINOPHEN)", "Price": "5", "Price_Old": "5", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "NSAID", "Category": "مس#=ن وم#_#.#~ لل#.ل#?ه#.#%", "Use": "–#.لص#~#.#> و#.ل#.لم #<ى #.ل#>#_ل#.#? \r\n\r\n–#.ل#.م #.لظه#^ و #.ل#.م #.ل#.سن#.ن \r\n\r\n–مس#=ن لل#.لم سو#.ء #=#.ن ح#.#~ #.و مزمن \r\n\r\n–#.وج#.#> #.ل#?ه#.#% #.لم#<#.صل \r\n\r\n–#.لم #.ل#.سن#.ن \r\n\r\n–#.لم #.ل#^وم#.#?يزم \r\n\r\n–#.وج#.#> #.س#<ل #.لظه#^ \r\n\r\n–#.ل#.ل#.م #%#>#~ #>ملي#.#? #.ل#?لقيح #%ش#=ل #>#.م \r\n\r\n–#.وج#.#> #.لحلق و #.لجسم #%س#%#% نزل#.#? #.ل#%#^#~ و#.ل#.ن#<لونز#. \r\n\r\n–يق#_ى #>لى #.لص#~#.#> #.لنص#<ى \r\n\r\n–#.ل#?ه#.#% #.للوز#?ين و#.لحنج#^ة \r\n\r\n–#.لم #.ل#.ذنين \r\n\r\n–#.لم #.ل#^وم#.#?يزم \r\n\r\n–#.ل#?ه#.#% #.لجيو#% #.ل#.ن#<ية \r\n\r\n–#.ل#.م #.ل#>#_ل#.#? و#.ل#.ل#.م #.ل#>ص#%ية \r\n\r\n–#.ل#.ل#.م #.لمص#.ح#%ة ل#~و#^ة #.ل#-مث \r\n\r\n–#.ل#.ل#.م #<ى م#^#_ى #.لق#^حة", "Contraindications": "–#<#^#- حس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى . \r\n\r\n–م#^#_ ش#~ي#~ #<ى #.ل#=#%#~. \r\n\r\n–قصو#^ #<ى وظ#.ئ#< #.ل#=لي.", "GI": "mechanism:\r\nIt is thought paracetamol reduces fever by affecting an area of the brain that regulates our body temperature (the hypothalamic heat-regulating center).\r\nParacetamol is about as effective as aspirin or ibuprofen at relieving mild to moderate pain and fever, but unlike aspirin and ibuprofen it has no anti-inflammatory effect.\r\nCaffeine is a mild stimulant that helps reduce fatigue. Caffeine is also thought to enhance the painkilling effect of paracetamol.\r\n\r\nWhat is it used for?\r\nMild to moderate pain, such as headache, migraine, toothache, sore throat, muscular and rheumatic pain, nerve pain (neuralgia), backache (lumbago) and period pain.\r\nRelieving aches, pains, sore throat and fever associated with colds and flu.", "Composition": "Acetyl salicylic acid 250mg &Caffeine 65mg&acetaminophen 250mg", "Route": "ORAL.SOLID" }, { "ID": "400", "Trade_Name": "STADIVIR 40MG 10 CAPS.", "Generic_Name": "STAVUDINE", "Price": "50", "Price_Old": "50", "Company": "EVA PHARMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#?", "Use": "–يس#?خ#~م هذ#. #.ل#~و#.ء م#> أ#~وية #<ي#^وس نقص #.لمن#.#>ة #.ل#%ش#^ية #.لأخ#^ى للمس#.#>#~ة #<ي #.لسي#-#^ة #>لى #>#~وى #<ي#^وس نقص #.لمن#.#>ة #.ل#%ش#^ية . \r\n\r\n–يس#.#>#~ #>لى #?قليل #=مية #<ي#^وس نقص #.لمن#.#>ة #.ل#%ش#^ية #<ي #.لجسم ح#?ى ي#>مل #.لجه#.ز #.لمن#.#>ي #%ش#=ل أ#<#_ل. هذ#. يقلل من #<#^ص#?#= #<ي #.لحصول #>لى م#_#.#>#<#.#? #<ي#^وس نقص #.لمن#.#>ة #.ل#%ش#^ية (مثل #.ل#>#~وى #.لج#~ي#~ة و#.لس#^#-#.ن ) ويحسن نو#>ية حي#.#?#=. \r\n\r\n–ين#?مي إلى #<ئة من #.ل#>ق#.قي#^ #?#>#^#< #%#.سم مث#%#-#.#? #.لنسخ #.ل#>#=سي للنيو#=ليوزي#~", "Contraindications": "–أخ#%#^ #-#%ي#%#= أو #.لصي#~لي إذ#. #=ن#? #?#>#.ني من #.لحس#.سية ؛ أو إذ#. #=#.ن ل#~ي#= أي حس#.سية أخ#^ى. ق#~ يح#?وي هذ#. #.لمن#?ج #>لى م#=ون#.#? غي#^ نش#-ة ، و#.ل#?ي يم#=ن أن #?س#%#% #.لحس#.سية أو مش#.#=ل أخ#^ى. للمزي#~ من #.لم#>لوم#.#? #?ح#~ث م#> #.لصي#~لى #.لخ#.ص #%#= \r\n\r\n–ق#%ل #.س#?خ#~#.م هذ#. #.ل#~و#.ء ، أخ#%#^ #-#%ي#%#= أو #.لصي#~لي #?#.#^يخ#= #.ل#-#%ي ، ل#. سيم#.: #.ل#?ه#.#% #.ل#%ن#=#^ي#.س ، ومش#.#=ل #<ي #.ل#=لى ، ومش#.#=ل #<ي #.ل#=#%#~ (مثل #.ل#?ه#.#% #.ل#=#%#~ و#?لي#< #.ل#=#%#~ ) ، ومش#.#=ل #.لأ#>ص#.#% (مثل #.ل#.#>#?ل#.ل #.ل#>ص#%ي #.لمحي#-ي ) ، و#?#>#.#-ي #.ل#=حول ، ومش#.#=ل #.لم#^#.#^ة مثل حصو#.#? #.لم#^#.#^ة \r\n\r\n–#?جن#% #.لمش#^و#%#.#? #.ل#=حولية لأنه#. ق#~ #?زي#~ من خ#-#^ #.لإص#.#%ة #%مش#.#=ل #.ل#=#%#~ و / أو #.ل#?ه#.#% #.ل#%ن#=#^ي#.س \r\n\r\n–ق#%ل إج#^#.ء #.لج#^#.حة ، أخ#%#^ #-#%ي#%#= أو #-#%ي#% #.لأسن#.ن #>ن جمي#> #.لمن#?ج#.#? #.ل#?ي #?س#?خ#~مه#. #%م#. #<ي ذل#= #.لأ#~وية #.لموصو#<ة ، و#.لأ#~وية غي#^ #.لموصو#<ة ، و#.لمن#?ج#.#? #.ل#>ش#%ية \r\n\r\n–#.نخ#<#.#_ وظي#<ة #.ل#=لى م#> #?ق#~م#= #<ي #.لسن. #?#?م إز#.لة هذ#. #.ل#~و#.ء #>ن #-#^يق #.ل#=لى . لذل#= يج#% #?وخي #.لحذ#^ #>ن#~ #.س#?خ#~#.م هذ#. #.ل#~و#.ء ل#~ى #.ل#%#.لغين #.لأ#=#%#^ سنً#. لأنهم ق#~ ي#=ونون أ#=ث#^ حس#.سية ل#?أثي#^#.#? #.ل#>ق#.#^ ، خ#.صةً زي#.#~ة خ#-#^ ح#~وث مش#.#=ل #.لأ#>ص#.#% \r\n\r\n–أخ#%#^ #-#%ي#%#= إذ#. #=ن#? ح#.مل#.ً ق#%ل #.س#?خ#~#.م هذ#. #.ل#~و#.ء. يم#=ن أن يقلل #.ل#>ل#.ج من خ#-#^ #.ن#?ق#.ل #>#~وى #<ي#^وس نقص #.لمن#.#>ة #.ل#%ش#^ية إلى #-#<ل#=. من#.قشة #.لمخ#.#-#^ و#.لمن#.#<#> م#> #-#%ي#%#= \r\n\r\n–هذ#. #.ل#~و#.ء يم#^ #<ي حلي#% #.لث#~ي . لأن حلي#% #.لث#~ي يم#=ن أن ينقل #<ي#^وس نقص #.لمن#.#>ة #.ل#%ش#^ية ، ل#. #?#^#_#>", "GI": "About Stavudine\r\nNucleoside Reverse Transcriptase Inhibitor, Antiretroviral Agent.\r\nMechanism of Action of Stavudine\r\nStavudine is a Thymidine nucleoside analogue. It undergoes phosphorylation in the presence of Kinase enzyme and form Stavudine triphosphate. This Stavudine triphosphate competitively inhibit HIV reverse transcriptase enzyme which is responsible for the conversion of viral RNA to pro viral DNA and is then added to host cell chromosome. Stavudine triphosphate terminates elongation of pro viral DNA and results in inhibition of viral replication.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "401", "Trade_Name": "AMIRON 150MG/3ML 6 I.V. AMP.", "Generic_Name": "AMIODARONE", "Price": "12", "Price_Old": "12", "Company": "SEDICO", "Pharmacology": "ANTIARRHYTHMIAS.CLASS III", "Category": "م#_#.#~ لل#^ج#<#.ن #.ل#.ذيني #.ل#<ئة III", "Use": "–#>ل#.ج #>#~م إن#?ظ#.م #_#^#%#.#? #.لقل#% . \r\n\r\n– #>ل#.ج #^#>شة #.لقل#% . \r\n\r\n– #>ل#.ج #.ل#^ج#<#.ن #.لأذينى . \r\n\r\n– #>ل#.ج خ#<ق#.ن #.لقل#% .", "Contraindications": "–يمن#> #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> #<ي ح#.ل#.#? #.ل#.ص#.#%ة #%ص#~مة قل#%ية \r\n\r\n–يمن#> #<ي ح#.ل#.#? #%#-ء #_#^#%#.#? #.لقل#%", "GI": "Description\t\r\nAn antianginal and antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting Na,K-activated myocardial adenosine triphosphatase. There is a resulting decrease in heart rate and in vascular resistance.\r\n\r\nIndication\t:\r\nIntravenously, for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. Orally, for the treatment of life-threatening recurrent ventricular arrhythmias such as recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia.\r\n\r\nContra-indications :\r\n1.Hypersensitivity to the drug \r\n2.2nd or third degree heart block \r\n3.Congestive Heart failure \r\n4.Cardiogenic shock \r\n5.Severe bradycardia \r\n6.Severe obstructive pulmonary diseases \r\n7.Electrolyte imbalance \r\n8.Severe Hypotension \r\n9.Myasthenia gravis \r\n10.Sinus node dysfunction \r\n11.Atrial conduction defect", "Composition": "amiodarone 200mg", "Route": "INJECTION" }, { "ID": "402", "Trade_Name": "DOGMATIL 50MG 30 CAPS.", "Generic_Name": "SULPIRIDE", "Price": "27", "Price_Old": "18", "Company": "SANOFI", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#>ل#.ج #.ل#<ص#.م #.لن#<سي، و#.ل#.#_#-#^#.#%#.#? #.لسلو#=ية. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#.#=#?ئ#.#%، و#.لقلق و#.ل#?و#?#^. \r\n\r\n–ي#>#.لج أ#>#^#.#_ #.لقولون #.ل#?هيجي، و#.لقولون #.ل#>ص#%ي، وم#. يصح#%ه من #.ل#.ن#?#<#.خ#.#?، و#?شنج#.#? #.ل#%#-ن. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ق#^حة #.لم#>#~ة، وآل#.م #.ل#%#-ن. \r\n\r\n–#>ل#.ج ق#^حة #.لإثنى #>ش#^، و#?شنج#.#? #.لقولون.", "Contraindications": "–#<ي ح#.لة #.لحس#.سية #.لم#<#^#-ة لإح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#=م#. يمن#> #.س#?#>م#.له أثن#.ء #<#?#^#.#? #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#~و#.ء #<ي #.لم#^#_ى #.لمص#.#%ون #%#.نخ#<#.#_ ح#.#~ #<ي #.لجه#.ز #.ل#>ص#%ي، و#.لنخ#.#> #.ل#>ظمي. \r\n\r\n– يمن#> #.س#?خ#~#.مه #<ي #.لمص#.#%ون #%و#^م #<ي #.لقو#.#?م و هو أح#~ أو#^#.م #.لغ#~#~ #.لصم#.ء #.ل#>ص#%ية ينشأ من نخ#.#> #.لغ#~#~ #.ل#=ظ#^ية.", "GI": "About Sulpiride\r\nSynthetic Origin, D2 Antagonist.\r\nMechanism of Action of Sulpiride\r\nSulpride block both dopamine D1 and D2 receptors, Sulpiride is more selective and acts primarily as a dopamine D2 antagonist. Sulpiride appears to lack effects on norepinephrine, acetylcholine, serotonin, histamine, or gamma-aminobutyric acid (GABA) receptors.\r\nIndications for Sulpiride\r\nSchizophrenia\r\nInteractions for Sulpiride\r\n1.Concurrent use with lithium increases the risk of extrapyramidal side effects 2.Concurrent use with antacids or sucralfate may affect sulpiride absorption \r\n3.Efficacy may be reduced by dopamine agonists \r\n4.Increased postural hypotension if used with other antihypertensive drugs", "Composition": "sulpiride 50mg", "Route": "ORAL.SOLID" }, { "ID": "403", "Trade_Name": "ARCA-ZINC 30 CAPS.", "Generic_Name": "SULBUTIAMINE+ZINC SULPHATE", "Price": "18", "Price_Old": "18", "Company": "EGYPHAR", "Pharmacology": "NOOTROPIC", "Category": "منش#- #.لذهن", "Use": "–يس#?#>مل هذ#. #.ل#~و#.ء #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لن#<سي. \r\n\r\n–لمن ي#>#.نون من قلة #.لنش#.#- و#.لإح#%#.#- #.لش#~ي#~. \r\n\r\n–من ي#>#.نون من مش#=لة #.لوهن أي #.ل#.#_#-#^#.#% #.لش#~ي#~ #.لذي يح#~ث ل#%#>#_ #.لأ#<#^#.#~ ن#?يجة #.لإص#.#%ة #%أم#^#.#_ م#>ينة مثل م#?ل#.زمة #.ل#?#>#% #.لمزمن، أو من ل#~يهم #~#.ء #.لس#=#^ي. \r\n\r\n–ي#>#.لج #.#=#?ئ#.#% م#. #%#>#~ #.لول#.#~ة ومن ي#>#.نون من مش#.#=ل #<ي #.ل#=لى. \r\n\r\n–يم#=ن #.س#?خ#~#.مه لل#?قليل من #.لش#>و#^ #%#.ل#_#>#< #>ن #-#^يق زي#.#~ة قوة #.ل#?#^#=يز.", "Contraindications": "–ل#.#%#~ #>لى من ل#~يهم حس#.سية م#<#^#-ة #?ج#.ه م#=ون#.#? #.ل#~و#.ء #.ل#.م#?ن#.#> #>ن #.س#?#>م#.له. \r\n\r\n–ل#. يج#% زي#.#~ة #.لج#^#>ة #>ن #.ل#?ي ح#~#~ه#. #.ل#-#%ي#% ح#?ى ل#. #?ظه#^ #.لأ#>#^#.#_ #.لمز#>جة. \r\n\r\n–إذ#. #=#.ن#? #.لم#^ي#_ة ح#.مل أو من #.لم#^#_#>#.#? ل#.#%#~ من #?جن#% #?ن#.ول هذ#. #.ل#~و#.ء إل#. #%#>#~ إس#?ش#.#^ة #.ل#-#%ي#% لأن هن#.#= ح#.ل#.#? ل#. ين#%غي له#. أن #?#?ن#.وله. \r\n\r\n–ل#. يج#% #>لى #.لأ#-#<#.ل #?ن#.ول هذ#. #.ل#~و#.ء وم#> #.لمسنين ل#.#%#~ من #.لحذ#^ من إس#?خ#~#.مه.", "GI": "About Sulbutiamine\r\nA synthetic derivative of thiamine, a centrally acting cholinergic agent, Nootropic,antiasthenic.\r\nMechanism of Action of Sulbutiamine\r\nSulbutiamine is a centrally acting cholinergic agent. This drug inhibits the enzyme Acetyl cholinesterase and prolongs the action of Acetylcholine- a stimulating hormone in the brain. This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with donepezil. \r\nSulbutiamine is a thiamine derivative. Being lipophilic it crosses the blood brain barrier and leads to increased formation of thiamine triphosphate which regulates the synaptic transmission of many neurotransmission system.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "404", "Trade_Name": "PROGRAF 1MG 100 CAPS.", "Generic_Name": "TACROLIMUS", "Price": "2170", "Price_Old": "1550", "Company": "ASTELLAS TOYOMA CO.LTD-JAPAN > HIKMA PHARMA", "Pharmacology": "IMMUBOSUPPRESSANT", "Category": "مث#%#-#.#? #.لمن#.#>ة", "Use": "–هذ#. #.ل#~و#.ء ي#?م #?ن#.وله #%#>#~ #.لخ#^وج من #>ملي#.#? ز#^#.#>ة #.لأ#>#_#.ء مثل #.لقل#% و#.ل#=#%#~ و#.ل#=لي. \r\n\r\n–ي#?م #?ن#.ول #.ل#~و#.ء لمن#> #.لجسم من #.ل#>#_و #.لج#~ي#~. \r\n\r\n–يس#.#>#~ #.ل#~و#.ء #<ي #>ل#.ج #.لأم#^#.#_ #.لمن#.#>ية #.لذ#.#?ية. \r\n\r\n–ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية.", "Contraindications": "–ل#. ينصح #%#?ن#.ول #.ل#>ق#.#^ #>ن#~ #.لم#>#.ن#.ة من حس#.سية #_#~ م#=ون من م#=ون#.#? #.ل#>ق#.#^. \r\n\r\n–غي#^ مسموح #%#?ن#.ول #.ل#>ق#.#^ #<ي #<#?#^ة #.لحمل و#<#?#^ة #.ل#^#_#.#>ة لأنه ي#?س#%#% #<ي ح#~وث #?شوه#.#? خلقية.", "GI": "About Tacrolimus\r\nCalcineurin Inhibitor, a macrolide, Immunosuppressant for prevention of graft rejection.\r\nMechanism of Action of Tacrolimus\r\nIt binds to specific receptors on T cells. It reduces peptidyl-prolyl isomerase activity by forming a complex with immunophilin FKBP-12 (FK506 binding protein).This leads to an increase in intracellular calcium that, in turn, causes a series of reactions inhibiting the transcription of several genes, mainly the cytokines (IL-2, IL-4, and IL-5). It also decreases the production of IL-8 receptor genes and inhibits the production of receptors for IgE molecules.\r\nIndications for Tacrolimus\r\n1. Prophylaxis of organ rejection in patients receiving allogenic liver or kidney transplants\r\nInteractions for Tacrolimus\r\nIncreased nephrotoxicity may result if tacrolimus is given with other potentially nephrotoxic drugs like cyclosporin. \r\nAvoid concomitant use of potassium-sparing diuretics. Concomitant use of drugs which inhibit the cytochrome P450 (CYP3A)", "Composition": "tracrolimus 0.5mg or 1mg", "Route": "ORAL.SOLID" }, { "ID": "405", "Trade_Name": "TOPMODE 50MG 30 CAPS.", "Generic_Name": "SULPIRIDE", "Price": "8", "Price_Old": "8", "Company": "DELTA PHARMA", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#>ل#.ج #.ل#<ص#.م #.لن#<سي، و#.ل#.#_#-#^#.#%#.#? #.لسلو#=ية. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#.#=#?ئ#.#%، و#.لقلق و#.ل#?و#?#^. \r\n\r\n–ي#>#.لج أ#>#^#.#_ #.لقولون #.ل#?هيجي، و#.لقولون #.ل#>ص#%ي، وم#. يصح#%ه من #.ل#.ن#?#<#.خ#.#?، و#?شنج#.#? #.ل#%#-ن. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ق#^حة #.لم#>#~ة، وآل#.م #.ل#%#-ن. \r\n\r\n–#>ل#.ج ق#^حة #.لإثنى #>ش#^، و#?شنج#.#? #.لقولون.", "Contraindications": "–#<ي ح#.لة #.لحس#.سية #.لم#<#^#-ة لإح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#=م#. يمن#> #.س#?#>م#.له أثن#.ء #<#?#^#.#? #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#~و#.ء #<ي #.لم#^#_ى #.لمص#.#%ون #%#.نخ#<#.#_ ح#.#~ #<ي #.لجه#.ز #.ل#>ص#%ي، و#.لنخ#.#> #.ل#>ظمي. \r\n\r\n– يمن#> #.س#?خ#~#.مه #<ي #.لمص#.#%ون #%و#^م #<ي #.لقو#.#?م و هو أح#~ أو#^#.م #.لغ#~#~ #.لصم#.ء #.ل#>ص#%ية ينشأ من نخ#.#> #.لغ#~#~ #.ل#=ظ#^ية.", "GI": "About Sulpiride\r\nSynthetic Origin, D2 Antagonist.\r\nMechanism of Action of Sulpiride\r\nSulpride block both dopamine D1 and D2 receptors, Sulpiride is more selective and acts primarily as a dopamine D2 antagonist. Sulpiride appears to lack effects on norepinephrine, acetylcholine, serotonin, histamine, or gamma-aminobutyric acid (GABA) receptors.\r\nIndications for Sulpiride\r\nSchizophrenia\r\nInteractions for Sulpiride\r\n1.Concurrent use with lithium increases the risk of extrapyramidal side effects 2.Concurrent use with antacids or sucralfate may affect sulpiride absorption \r\n3.Efficacy may be reduced by dopamine agonists \r\n4.Increased postural hypotension if used with other antihypertensive drugs", "Composition": "Each capsule contains:\r\n (sulpiride) 50 mg\r\n\r\nTopmode fort Tablets \r\nEach tablet contains:\r\n (sulpiride) 200 mg", "Route": "ORAL.SOLID" }, { "ID": "406", "Trade_Name": "DOGMAPRIDE 50MG 30 CAPS.", "Generic_Name": "SULPIRIDE", "Price": "12", "Price_Old": "12", "Company": "AMOUN", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#>ل#.ج #.ل#<ص#.م #.لن#<سي، و#.ل#.#_#-#^#.#%#.#? #.لسلو#=ية. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#.#=#?ئ#.#%، و#.لقلق و#.ل#?و#?#^. \r\n\r\n–ي#>#.لج أ#>#^#.#_ #.لقولون #.ل#?هيجي، و#.لقولون #.ل#>ص#%ي، وم#. يصح#%ه من #.ل#.ن#?#<#.خ#.#?، و#?شنج#.#? #.ل#%#-ن. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ق#^حة #.لم#>#~ة، وآل#.م #.ل#%#-ن. \r\n\r\n–#>ل#.ج ق#^حة #.لإثنى #>ش#^، و#?شنج#.#? #.لقولون.", "Contraindications": "–#<ي ح#.لة #.لحس#.سية #.لم#<#^#-ة لإح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#=م#. يمن#> #.س#?#>م#.له أثن#.ء #<#?#^#.#? #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#~و#.ء #<ي #.لم#^#_ى #.لمص#.#%ون #%#.نخ#<#.#_ ح#.#~ #<ي #.لجه#.ز #.ل#>ص#%ي، و#.لنخ#.#> #.ل#>ظمي. \r\n\r\n– يمن#> #.س#?خ#~#.مه #<ي #.لمص#.#%ون #%و#^م #<ي #.لقو#.#?م و هو أح#~ أو#^#.م #.لغ#~#~ #.لصم#.ء #.ل#>ص#%ية ينشأ من نخ#.#> #.لغ#~#~ #.ل#=ظ#^ية.", "GI": "About Sulpiride\r\nSynthetic Origin, D2 Antagonist.\r\nMechanism of Action of Sulpiride\r\nSulpride block both dopamine D1 and D2 receptors, Sulpiride is more selective and acts primarily as a dopamine D2 antagonist. Sulpiride appears to lack effects on norepinephrine, acetylcholine, serotonin, histamine, or gamma-aminobutyric acid (GABA) receptors.\r\nIndications for Sulpiride\r\nSchizophrenia\r\nInteractions for Sulpiride\r\n1.Concurrent use with lithium increases the risk of extrapyramidal side effects 2.Concurrent use with antacids or sucralfate may affect sulpiride absorption \r\n3.Efficacy may be reduced by dopamine agonists \r\n4.Increased postural hypotension if used with other antihypertensive drugs", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "407", "Trade_Name": "SUTENT 12.5MG 28 CAPSULES", "Generic_Name": "SUNITINIB", "Price": "5750", "Price_Old": "5750", "Company": "PFIZER", "Pharmacology": "ANTINEOPLASTIC", "Category": "م#_#.#~#.#? للأو#^#.م", "Use": "–يس#?خ#~م #<ي #>ل#.ج: \r\n\r\n–أو#^#.م #.لم#>#~ة-#.لأم#>#.ء #.لس#~ّوية \r\n\r\n–س#^#-#.ن #.لخل#.ي#. #.ل#=لوية #.لمن#?ش#^ \r\n\r\n–س#^#-#.ن #.ل#%ن#=#^ي#.س #.ل#>ص#%ي #.لغ#~ي", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج.", "GI": "Sunitinib was approved on January 26, 2006 by FDA for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor (GIST). Sunitinib is a small-molecule which is administered orally and it is multi-targeted receptor tyrosine kinase (RTK) inhibitor. Sunitinib inhibits cellular signaling by targeting multiple RTKs. These include all platelet-derived growth factor receptors (PDGF-R) and vascular endothelial growth factor receptors (VEGF-R). sunitinib also inhibits KIT (CD117), the RTK that drives the majority of GISTs and other RTKs including RET, CSF-1R, and flt3.", "Composition": "sunitinib 12.5mg or 25mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "408", "Trade_Name": "CANGOUT 200MG 10 CAPS.", "Generic_Name": "SULFINPYRAZONE", "Price": "12", "Price_Old": "12", "Company": "MULTI-APEX", "Pharmacology": "ANTIGOUT.ANALGESIC", "Category": "م#_#.#~ للنق#^س و مس#=ن", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.لنق#^سي #.لمزمن. \r\n\r\n–#.لح#~ من مس#?وى حم#_ #.ليو#^ي#= #%#.ل#~م. \r\n\r\n–من#> #?#=ون #%لو#^#.#? حم#_ #.ليو#^ي#=. \r\n\r\n–#~#>م صحة #.ل#=لى.", "Contraindications": "–#<#^#- #.لحس#.سية. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لنز#<ية #<ي #.لم#>#~ة و#.ل#.م#>#.ء، مثل ق#^حة #.لم#>#~ة. \r\n\r\n–أم#^#.#_ #.ل#=لى #.لمزمنة. \r\n\r\n–حصوة حم#_ #.ليو#^ي#= #%#.ل#=لى.", "GI": "About Sulfinpyrazone\r\nUricosuric Agent, Antigout.\r\nMechanism of Action of Sulfinpyrazone\r\nSulfinpyrazone competitively inhibits the tubular reabsorption of uric acid and increases the uric acid excretion. This will help in decrease the amount of uric acid in gouty patients.\r\nIndications for Sulfinpyrazone\r\n1. Gouty arthritis \r\n\r\nTypical Dosage for Sulfinpyrazone\r\nOral \r\nAdult: \r\n100-200mg to be taken 2 times daily with meals. Dose can be gradually increased upto 800mg/day.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "409", "Trade_Name": "PROGRAF 5 MG 100 CAPS.", "Generic_Name": "TACROLIMUS", "Price": "6300", "Price_Old": "6300", "Company": "ASTELLAS TOYOMA CO.LTD-JAPAN > HIKMA PHARMA", "Pharmacology": "IMMUNOSUPPRESSANTS", "Category": "مث#%#-#.#? #.لمن#.#>ة", "Use": "–هذ#. #.ل#~و#.ء ي#?م #?ن#.وله #%#>#~ #.لخ#^وج من #>ملي#.#? ز#^#.#>ة #.لأ#>#_#.ء مثل #.لقل#% و#.ل#=#%#~ و#.ل#=لي. \r\n\r\n–ي#?م #?ن#.ول #.ل#~و#.ء لمن#> #.لجسم من #.ل#>#_و #.لج#~ي#~. \r\n\r\n–يس#.#>#~ #.ل#~و#.ء #<ي #>ل#.ج #.لأم#^#.#_ #.لمن#.#>ية #.لذ#.#?ية. \r\n\r\n–ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية.", "Contraindications": "–ل#. ينصح #%#?ن#.ول #.ل#>ق#.#^ #>ن#~ #.لم#>#.ن#.ة من حس#.سية #_#~ م#=ون من م#=ون#.#? #.ل#>ق#.#^. \r\n\r\n–غي#^ مسموح #%#?ن#.ول #.ل#>ق#.#^ #<ي #<#?#^ة #.لحمل و#<#?#^ة #.ل#^#_#.#>ة لأنه ي#?س#%#% #<ي ح#~وث #?شوه#.#? خلقية.", "GI": "About Tacrolimus\r\nCalcineurin Inhibitor, a macrolide, Immunosuppressant for prevention of graft rejection.\r\nMechanism of Action of Tacrolimus\r\nIt binds to specific receptors on T cells. It reduces peptidyl-prolyl isomerase activity by forming a complex with immunophilin FKBP-12 (FK506 binding protein).This leads to an increase in intracellular calcium that, in turn, causes a series of reactions inhibiting the transcription of several genes, mainly the cytokines (IL-2, IL-4, and IL-5). It also decreases the production of IL-8 receptor genes and inhibits the production of receptors for IgE molecules.\r\nIndications for Tacrolimus\r\n1. Prophylaxis of organ rejection in patients receiving allogenic liver or kidney transplants\r\nInteractions for Tacrolimus\r\nIncreased nephrotoxicity may result if tacrolimus is given with other potentially nephrotoxic drugs like cyclosporin. \r\nAvoid concomitant use of potassium-sparing diuretics. Concomitant use of drugs which inhibit the cytochrome P450 (CYP3A)", "Composition": "tracrolimus 0.5mg or 1mg", "Route": "ORAL.SOLID" }, { "ID": "410", "Trade_Name": "ELIBUTACAND 100 MG 3 VAG. OVULES", "Generic_Name": "BUTOCONAZOLE", "Price": "30", "Price_Old": "30", "Company": "SIGMA", "Pharmacology": "ANTIFUNGAL", "Category": "م#_#.#~ لل#<#-#^ي#.#?", "Use": "–م#^#=#% #~و#.ئي يس#?خ#~م #<ي #>ل#.ج #>#~وى #.لمه#%ل #.ل#<#-#^ية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. #.لحمل. #.لأ#-#<#.ل.", "GI": "Indication: Vulvo-vaginal candidiasis\r\nUse: Once daily intravaginally.", "Composition": "COMING SOON ..", "Route": "VAGINAL" }, { "ID": "411", "Trade_Name": "TRAMAL 50MG 20 CAPS.", "Generic_Name": "TRAMADOL", "Price": "18", "Price_Old": "18", "Company": "MINA PHARM > GRUNENTHAL-GERMANY", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–ين#?مي #>ق#.#^ #?#^#.م#.#~ول إلى مجمو#>ة أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ إس#?ي#^وئي#~ية و#.ل#?ي له#. #<#.#>ليه #=#%ي#^ة #<ي #?س#=ين آل#.م #.لجسم #.لن#.#?جة #>ن #.ل#<ص#.ل #.ل#>ظمي . \r\n\r\n–يوص#< #>ق#.#^ #?#^#.م#.#~ول لم#^#_ي #.لس#^#-#.ن ل#?س#=ين آل#.مهم ول#=ن #<ي #.لغ#.ل#% #%#>#~ #?ن#.ول #>ق#.#^ #?#^#.م#.#~ول ل#>#~ة أس#.#%ي#> ق#~ ي#-ل#% #.ل#-#%ي#% #?غي#^ #.لمخ#~#^ لمخ#~#^ أقوي #<ي #.لم#<#>ول . \r\n\r\n–ي#?ميز #>ق#.#^ #?#^#.م#.#~ول #%أنه ل#. يس#%#% مش#.#=ل #<ي #.لقل#% أو ق#^حة ه#_مية .", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه لل#-#<#.ل #.لأقل من 10 سنو#.#?. \r\n\r\n–ومن ي#>#.نون من #.لأ#~م#.ن. \r\n\r\n–#>#~م #.لسو#.قة أثن#.ء #?ن#.ول هذ#. #.ل#>ق#.#^. \r\n\r\n–#<ى ح#.لة #.لخ#_و#> #.لى #>ملي#.#? ج#^#.حية يج#% أخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–ل#. يوج#~ خ#-#^ منه #>لى م#^#_ى #.لقل#%.", "GI": "(Indications):\r\n This medication is an opioid analgesic, prescribed for moderate to severe pain in adults.It works by changing the way the body senses pain. \r\n\r\n(Contraindications):\r\n acute alcoholism, head injuries, severe kidney impairment, breastfeeding, hypersensitivity\r\n\r\n(Dosage):\r\nThe recommended dose is 50-100 mg (immediate release tablets) every 4-6 hours as needed for pain. The maximum dose is 400 mg/day.\r\nIV/IM-Moderate to severe pain- The recommended dose is 50-100 mg 4-6 hourly.", "Composition": "tramadol 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "412", "Trade_Name": "TRAMADOL 50MG 20CAPS.", "Generic_Name": "TRAMADOL", "Price": "10.7", "Price_Old": "10.7", "Company": "MEMPHIS", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–ين#?مي #>ق#.#^ #?#^#.م#.#~ول إلى مجمو#>ة أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ إس#?ي#^وئي#~ية و#.ل#?ي له#. #<#.#>ليه #=#%ي#^ة #<ي #?س#=ين آل#.م #.لجسم #.لن#.#?جة #>ن #.ل#<ص#.ل #.ل#>ظمي . \r\n\r\n–يوص#< #>ق#.#^ #?#^#.م#.#~ول لم#^#_ي #.لس#^#-#.ن ل#?س#=ين آل#.مهم ول#=ن #<ي #.لغ#.ل#% #%#>#~ #?ن#.ول #>ق#.#^ #?#^#.م#.#~ول ل#>#~ة أس#.#%ي#> ق#~ ي#-ل#% #.ل#-#%ي#% #?غي#^ #.لمخ#~#^ لمخ#~#^ أقوي #<ي #.لم#<#>ول . \r\n\r\n–ي#?ميز #>ق#.#^ #?#^#.م#.#~ول #%أنه ل#. يس#%#% مش#.#=ل #<ي #.لقل#% أو ق#^حة ه#_مية .", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه لل#-#<#.ل #.لأقل من 10 سنو#.#?. \r\n\r\n–ومن ي#>#.نون من #.لأ#~م#.ن. \r\n\r\n–#>#~م #.لسو#.قة أثن#.ء #?ن#.ول هذ#. #.ل#>ق#.#^. \r\n\r\n–#<ى ح#.لة #.لخ#_و#> #.لى #>ملي#.#? ج#^#.حية يج#% أخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–ل#. يوج#~ خ#-#^ منه #>لى م#^#_ى #.لقل#%.", "GI": "(Indications):\r\n This medication is an opioid analgesic, prescribed for moderate to severe pain in adults.It works by changing the way the body senses pain. \r\n\r\n(Contraindications):\r\n acute alcoholism, head injuries, severe kidney impairment, breastfeeding, hypersensitivity\r\n\r\n(Dosage):\r\nThe recommended dose is 50-100 mg (immediate release tablets) every 4-6 hours as needed for pain. The maximum dose is 400 mg/day.\r\nIV/IM-Moderate to severe pain- The recommended dose is 50-100 mg 4-6 hourly.", "Composition": "tramadol 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "413", "Trade_Name": "CONTRAMAL 50 MG 20 CAPS.", "Generic_Name": "TRAMADOL", "Price": "12.7", "Price_Old": "12.7", "Company": "SIGMA", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–ين#?مي #>ق#.#^ #?#^#.م#.#~ول إلى مجمو#>ة أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ إس#?ي#^وئي#~ية و#.ل#?ي له#. #<#.#>ليه #=#%ي#^ة #<ي #?س#=ين آل#.م #.لجسم #.لن#.#?جة #>ن #.ل#<ص#.ل #.ل#>ظمي . \r\n\r\n–يوص#< #>ق#.#^ #?#^#.م#.#~ول لم#^#_ي #.لس#^#-#.ن ل#?س#=ين آل#.مهم ول#=ن #<ي #.لغ#.ل#% #%#>#~ #?ن#.ول #>ق#.#^ #?#^#.م#.#~ول ل#>#~ة أس#.#%ي#> ق#~ ي#-ل#% #.ل#-#%ي#% #?غي#^ #.لمخ#~#^ لمخ#~#^ أقوي #<ي #.لم#<#>ول . \r\n\r\n–ي#?ميز #>ق#.#^ #?#^#.م#.#~ول #%أنه ل#. يس#%#% مش#.#=ل #<ي #.لقل#% أو ق#^حة ه#_مية .", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه لل#-#<#.ل #.لأقل من 10 سنو#.#?. \r\n\r\n–ومن ي#>#.نون من #.لأ#~م#.ن. \r\n\r\n–#>#~م #.لسو#.قة أثن#.ء #?ن#.ول هذ#. #.ل#>ق#.#^. \r\n\r\n–#<ى ح#.لة #.لخ#_و#> #.لى #>ملي#.#? ج#^#.حية يج#% أخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–ل#. يوج#~ خ#-#^ منه #>لى م#^#_ى #.لقل#%.", "GI": "(Indications):\r\n This medication is an opioid analgesic, prescribed for moderate to severe pain in adults.It works by changing the way the body senses pain. \r\n\r\n(Contraindications):\r\n acute alcoholism, head injuries, severe kidney impairment, breastfeeding, hypersensitivity\r\n\r\n(Dosage):\r\nThe recommended dose is 50-100 mg (immediate release tablets) every 4-6 hours as needed for pain. The maximum dose is 400 mg/day.\r\nIV/IM-Moderate to severe pain- The recommended dose is 50-100 mg 4-6 hourly.", "Composition": "tramadol 100mg or 50mg \r\nor tramadol 150mg or 200mg", "Route": "ORAL.SOLID" }, { "ID": "414", "Trade_Name": "NAVOBAN 5MG 5CAPS.", "Generic_Name": "TROPISETRON", "Price": "391.8", "Price_Old": "391.8", "Company": "NOVARTIS", "Pharmacology": "COMING SOON ..", "Category": "COMING SOON ..", "Use": "–يس#?خ#~م ل#?قليل #.لغثي#.ن و#.لقئ #.لمص#.ح#% لل#>ل#.ج #.ل#=يمي#.ئي ، #.ل#>ل#.ج #.ل#.ش#>#.#>ي ، #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لحس#.سية #?ج#.ه م#_#.#~#.#? مس#?ق#%ل#.#? 5-إ#?ش #?ي-3.", "GI": "COMING SOON ..", "Composition": "tropisetron 5mg", "Route": "ORAL.SOLID" }, { "ID": "415", "Trade_Name": "TRAMAX 50 MG 30 CAPS.", "Generic_Name": "TRAMADOL", "Price": "14.4", "Price_Old": "14.4", "Company": "HI-PHARM", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–ين#?مي #>ق#.#^ #?#^#.م#.#~ول إلى مجمو#>ة أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ إس#?ي#^وئي#~ية و#.ل#?ي له#. #<#.#>ليه #=#%ي#^ة #<ي #?س#=ين آل#.م #.لجسم #.لن#.#?جة #>ن #.ل#<ص#.ل #.ل#>ظمي . \r\n\r\n–يوص#< #>ق#.#^ #?#^#.م#.#~ول لم#^#_ي #.لس#^#-#.ن ل#?س#=ين آل#.مهم ول#=ن #<ي #.لغ#.ل#% #%#>#~ #?ن#.ول #>ق#.#^ #?#^#.م#.#~ول ل#>#~ة أس#.#%ي#> ق#~ ي#-ل#% #.ل#-#%ي#% #?غي#^ #.لمخ#~#^ لمخ#~#^ أقوي #<ي #.لم#<#>ول . \r\n\r\n–ي#?ميز #>ق#.#^ #?#^#.م#.#~ول #%أنه ل#. يس#%#% مش#.#=ل #<ي #.لقل#% أو ق#^حة ه#_مية .", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه لل#-#<#.ل #.لأقل من 10 سنو#.#?. \r\n\r\n–ومن ي#>#.نون من #.لأ#~م#.ن. \r\n\r\n–#>#~م #.لسو#.قة أثن#.ء #?ن#.ول هذ#. #.ل#>ق#.#^. \r\n\r\n–#<ى ح#.لة #.لخ#_و#> #.لى #>ملي#.#? ج#^#.حية يج#% أخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–ل#. يوج#~ خ#-#^ منه #>لى م#^#_ى #.لقل#%.", "GI": "(Indications):\r\n This medication is an opioid analgesic, prescribed for moderate to severe pain in adults.It works by changing the way the body senses pain. \r\n\r\n(Contraindications):\r\n acute alcoholism, head injuries, severe kidney impairment, breastfeeding, hypersensitivity\r\n\r\n(Dosage):\r\nThe recommended dose is 50-100 mg (immediate release tablets) every 4-6 hours as needed for pain. The maximum dose is 400 mg/day.\r\nIV/IM-Moderate to severe pain- The recommended dose is 50-100 mg 4-6 hourly.", "Composition": "tramadol 50mg", "Route": "ORAL.SOLID" }, { "ID": "416", "Trade_Name": "OCTOTRAMADOL 50MG 12 CAPS.", "Generic_Name": "TRAMADOL", "Price": "13", "Price_Old": "13", "Company": "OCTOBER PHARMA", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–ين#?مي #>ق#.#^ #?#^#.م#.#~ول إلى مجمو#>ة أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ إس#?ي#^وئي#~ية و#.ل#?ي له#. #<#.#>ليه #=#%ي#^ة #<ي #?س#=ين آل#.م #.لجسم #.لن#.#?جة #>ن #.ل#<ص#.ل #.ل#>ظمي . \r\n\r\n–يوص#< #>ق#.#^ #?#^#.م#.#~ول لم#^#_ي #.لس#^#-#.ن ل#?س#=ين آل#.مهم ول#=ن #<ي #.لغ#.ل#% #%#>#~ #?ن#.ول #>ق#.#^ #?#^#.م#.#~ول ل#>#~ة أس#.#%ي#> ق#~ ي#-ل#% #.ل#-#%ي#% #?غي#^ #.لمخ#~#^ لمخ#~#^ أقوي #<ي #.لم#<#>ول . \r\n\r\n–ي#?ميز #>ق#.#^ #?#^#.م#.#~ول #%أنه ل#. يس#%#% مش#.#=ل #<ي #.لقل#% أو ق#^حة ه#_مية .", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه لل#-#<#.ل #.لأقل من 10 سنو#.#?. \r\n\r\n–ومن ي#>#.نون من #.لأ#~م#.ن. \r\n\r\n–#>#~م #.لسو#.قة أثن#.ء #?ن#.ول هذ#. #.ل#>ق#.#^. \r\n\r\n–#<ى ح#.لة #.لخ#_و#> #.لى #>ملي#.#? ج#^#.حية يج#% أخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–ل#. يوج#~ خ#-#^ منه #>لى م#^#_ى #.لقل#%.", "GI": "(Indications):\r\n This medication is an opioid analgesic, prescribed for moderate to severe pain in adults.It works by changing the way the body senses pain. \r\n\r\n(Contraindications):\r\n acute alcoholism, head injuries, severe kidney impairment, breastfeeding, hypersensitivity\r\n\r\n(Dosage):\r\nThe recommended dose is 50-100 mg (immediate release tablets) every 4-6 hours as needed for pain. The maximum dose is 400 mg/day.\r\nIV/IM-Moderate to severe pain- The recommended dose is 50-100 mg 4-6 hourly.", "Composition": "tramadol 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "417", "Trade_Name": "DIAGUARD 30 CAPS.", "Generic_Name": "CHROMIUM+VANDYL+MAGNESIUM+FLOC ACID+VITAMIN B6+VITAMIN B12", "Price": "25.5", "Price_Old": "25.5", "Company": "SAFE PHARMA > EPCI", "Pharmacology": "DIETARY SUPPLEMENT", "Category": "م#=مل غذ#.ئي", "Use": "–يس#.#>#~ #>لى #.ل#?خسيس . \r\n\r\n–يس#.#>#~ #>لى #?قليل #.لشهية . \r\n\r\n–م#=مل غذ#.ئي أثن#.ء #.ل#^يجيم .", "Contraindications": "–#.لحمل و #.ل#^#_#.#>ة : \r\n\r\n–#.لحمل : ل#. ي#<#_ل إس#?خ#~#.مه أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : ل#. ي#<#_ل إس#?خ#~#.مه أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–#?حذي#^#.#? : \r\n\r\n–يس#?خ#~م #%حذ#^ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.لقل#% ، #.ل#=#%#~ ، #.ل#=لى .", "GI": "*Composition: Each capsule contains:\r\n Chromium picolinate 1mg + Vanadyl sulphate 100mg + Magnesium oxide 350mg + Folic acid 0.8mg + Vitamin B6 25mg + Vitamin B12 0.5mg\r\n* Indications: Multivitamins formula used especially for diabetic patients against diabetes complications.\r\n* Dosage & Administration: one capsule to be taken once daily, preferably with meals", "Composition": "chromium picolinate, folic acid 0.8mg, magnesium 350mg, vanadium 100mg, vit b12 0.5mcg, vit b6 25mg", "Route": "ORAL.SOLID" }, { "ID": "418", "Trade_Name": "OCTOTRAMADOL 50MG 6CAPS.", "Generic_Name": "TRAMADOL", "Price": "4.5", "Price_Old": "4.5", "Company": "OCTOBER PHARMA", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–ين#?مي #>ق#.#^ #?#^#.م#.#~ول إلى مجمو#>ة أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ إس#?ي#^وئي#~ية و#.ل#?ي له#. #<#.#>ليه #=#%ي#^ة #<ي #?س#=ين آل#.م #.لجسم #.لن#.#?جة #>ن #.ل#<ص#.ل #.ل#>ظمي . \r\n\r\n–يوص#< #>ق#.#^ #?#^#.م#.#~ول لم#^#_ي #.لس#^#-#.ن ل#?س#=ين آل#.مهم ول#=ن #<ي #.لغ#.ل#% #%#>#~ #?ن#.ول #>ق#.#^ #?#^#.م#.#~ول ل#>#~ة أس#.#%ي#> ق#~ ي#-ل#% #.ل#-#%ي#% #?غي#^ #.لمخ#~#^ لمخ#~#^ أقوي #<ي #.لم#<#>ول . \r\n\r\n–ي#?ميز #>ق#.#^ #?#^#.م#.#~ول #%أنه ل#. يس#%#% مش#.#=ل #<ي #.لقل#% أو ق#^حة ه#_مية .", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه لل#-#<#.ل #.لأقل من 10 سنو#.#?. \r\n\r\n–ومن ي#>#.نون من #.لأ#~م#.ن. \r\n\r\n–#>#~م #.لسو#.قة أثن#.ء #?ن#.ول هذ#. #.ل#>ق#.#^. \r\n\r\n–#<ى ح#.لة #.لخ#_و#> #.لى #>ملي#.#? ج#^#.حية يج#% أخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–ل#. يوج#~ خ#-#^ منه #>لى م#^#_ى #.لقل#%.", "GI": "(Indications):\r\n This medication is an opioid analgesic, prescribed for moderate to severe pain in adults.It works by changing the way the body senses pain. \r\n\r\n(Contraindications):\r\n acute alcoholism, head injuries, severe kidney impairment, breastfeeding, hypersensitivity\r\n\r\n(Dosage):\r\nThe recommended dose is 50-100 mg (immediate release tablets) every 4-6 hours as needed for pain. The maximum dose is 400 mg/day.\r\nIV/IM-Moderate to severe pain- The recommended dose is 50-100 mg 4-6 hourly.", "Composition": "tramadol 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "419", "Trade_Name": "URO-VAXOM 60MG 10 CAPS.", "Generic_Name": "URO-VAXOM LYOPHILIZATE", "Price": "30", "Price_Old": "30", "Company": "MINA PHARM > OM-SWITZERLAND", "Pharmacology": "UTI INFECTIONS", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–لل#>ل#.ج و#.لوق#.ية من #.خم#.ج #.لمس#.ل#= #.ل#%ولية #.لس#<لي و#.لح#.#~ة \r\n\r\n–#.لوق#.ية من #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية (#%#.ل#.نجليزية: Urinary tract infection) #.لم#?#=#^#^ة. \r\n\r\n–#>ل#.ج مس#.#>#~ للم#_#.#~#.#? #.لحيوية #.ل#?قلي#~ية #.لمس#?#>ملة #<ي ح#.ل#.#? #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية #.لح#.#~ة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه#. #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه #.ي من م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل #<#?#^#?ي #.ل#^#_#.#>ة و#.لحمل", "GI": "is an extract of Escherichia coli, a germ responsible for the majority of urinary infections. It stimulates the immune system in order to increase the body?s natural defences against a wide spectrum of urinary pathogens. Uro-Vaxom? prevents recurrent urinary tract infections, in particular cystitis.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "420", "Trade_Name": "TOLMETIN 200MG 10CAPS.", "Generic_Name": "TOLMETIN", "Price": "18", "Price_Old": "18", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ ل#?خ#<ي#< ش#~َّة #.لألم و#.ل#.ل#?ه#.#%.", "Contraindications": "– إذ#. #=#.ن ل#~ى #.لم#^ي#_ #?َحَسُّسٌ #?ج#.ه #.ل#?ُّولمي#?ين أو أيِّ مُ#=َوِّن آخ#^ من هذ#. #.ل#~َّو#.ء. \r\n\r\n– يج#% إِ#-ل#.#>ُ مُق#~ِّم #.ل#^ِّ#>#.ية #.لصحِّية إذ#. #=#.ن ل#~ى #.لم#^ي#_ #?َحَسُّسٌ لأيِّ #~َو#.ءٍ آخ#^. \r\n\r\n– يج#% #.لإ#%ل#.غُ #>ن #.ل#?َّحسُّس #.لذي أص#.#% #.لم#^ي#_َ و#.ل#=ي#<يَّة #.ل#?ي أثَّ#^ #%ه#. #<يه. وي#?#_مَّن ذل#= #.ل#=ش#<َ #>ن وجو#~ #-#<ح أو #%ثو#^ أو ح#=َّة جل#~يَّة أو #_يق #<ي #.ل#?ن#<ُّس أو صَ#<ي#^ #>ن#~َ #.لشَّهيق أو سُ#>#.ل أو #?َو#^ُّم #.لوجه أو #.لشَّ#<#?ين أو #.للِّس#.ن أو #.لحَلق، أو أيَّة أ#>#^#.#_ أخ#^ى مُص#.ح#%َة ل#.ِس#?ِ#>م#.ل #.ل#~َّو#.ء. \r\n\r\n– إذ#. #=#.ن#? #.لمَ#^ي#_ةُ ح#.مل#.ً #%أ#=ث#^ من أ#^#%#>َة و#>ش#^ين أس#%و#>#.ً.", "GI": "About Tolmetin\r\nNSAID, arylalkanoic acid derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Tolmetin\r\nTolmetin is a nonsteroidal compound having anti-inflammatory, analgesics and antipyretic activities. It produces its actions by inhibiting Prostaglandin synthesis.\r\nIndications for Tolmetin\r\n1.Rheumatoid arthritis \r\n2.Osteoarthritis \r\n3.Juvanile rheumatoid arthritis \r\nTypical Dosage for Tolmetin\r\nAdult:200 - 400 mg three times a day- maximum daily dose:1800mg \r\nChildren above 2 years: 15- 30 mg/kg/day in 3 - 4 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "421", "Trade_Name": "TOPAMAX 15 MG SPRINKLE 60 CAPS.", "Generic_Name": "TOPIRAMATE", "Price": "84", "Price_Old": "84", "Company": "JANSSEN CILAG", "Pharmacology": "ANTI-EPILEPTIC.FRUCTOSE DERIVATIVE", "Category": "م#_#.#~ للص#^#> و #.لص#~#.#> #.لنص#<ي", "Use": "–#>ل#.ج #.لص#^#> #.لجزئي و#.ل#=#%ي#^. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#>ص#%ية. \r\n\r\n–#.لص#~#.#> #.لنص#<ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج إ#~م#.ن #.ل#=حول. \r\n\r\n–#.ل#=ه#^#%#.ء #.لز#.ئ#~ة #<ي #.ل#~م#.غ. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#?شنج.", "Contraindications": "–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل أو #<ي ح#.لة #.ل#?خ#-ي#- لحمل. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–ل#. يج#% #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%أ#<#=#.#^ #.ن#?ح#.#^ية يج#% #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#?ن#.ول #=مية #=#%ي#^ة من #.لسو#.ئل أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "A sulfamate-substituted monosaccharide, Carbonic anhydrase inhibitor, Anticonvulsant,antimigraine.\r\n\r\nYou may swallow this medication whole, or you may open the capsule and sprinkle the contents on a teaspoonful of soft food (such as applesauce, yogurt). Swallow the drug/food mixture right away. Do not chew the mixture. Do not prepare the mixture ahead of time for later use. \r\n\r\nMechanism of Action of Topiramate\r\nTopiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency neuronal discharge. It enhances the inhibitory neurotransmitter GABA and inhibits the excitatory glutamate receptors. Topiramate is also used in migraine prophylaxis. \r\nTopiramate also has weak carbonic anhydrase inhibitory activity.", "Composition": "topiramate 100mg or 25mg", "Route": "ORAL.SOLID" }, { "ID": "422", "Trade_Name": "DETRUSITOL RETARD 4MG 14 PROLONGED RELEASE CAPS.", "Generic_Name": "TOLTERODINE L TARTARATE", "Price": "130", "Price_Old": "65", "Company": "PFIZER", "Pharmacology": "URINARY INCONTINENCE.ANTISPASMODICS.MUSCARINIC ANTAGONISTS", "Category": "#.ل#?#%ول #.لل#.إ#^#.#~ي و سلس #.ل#%ول", "Use": "–ح#.ل#.#? #<#^#- نش#.#- #.لمث#.نة \r\n\r\n–#.ل#?#%ول #.لل#.إ#^#.#~ي \r\n\r\n–سلس #.ل#%ول \r\n\r\n–#>#~م #.لق#~#^ة #>لى #.لإح#?#<#.ظ #%#.ل#%ول #<ي #.لمث#.نة", "Contraindications": "–حس#.سية من #.ل#~و#.ء \r\n\r\n–#.لحمل و#.ل#^#_#.#>ة \r\n\r\n–إنس#~#.#~ #.لأم#>#.ء و مش#.#=ل #%#.لقولون \r\n\r\n–#?#_خم #.ل#%#^وس#?#.#?#. وإح#?#%#.س #.ل#%ول \r\n\r\n–م#^#_ى #.لقل#% \r\n\r\n–م#^#_ى #.ل#_غ#- #.لم#^#?#<#> و#.لجلو#=وم#.", "GI": "About Tolterodine Tartarate\r\nAnticholinergic ( antimuscarinic), Treat urinary incontinence.\r\nMechanism of Action of Tolterodine Tartarate\r\nTolterodine tartrate is a specific muscarinic receptor (M3 receptor) antagonist. It blocks muscarinic receptors which can be found on the muscle cells of the bladder wall. It prevents the action of acetyl choline on these receptors. Acetylcholine acting on these receptors causes the muscle in the bladder wall to contract, and the bladder to empty. By preventing this, Tolterodine helps the muscle in the bladder wall to relax. This reduces unstable, involuntary contractions of the bladder, and thereby increases the capacity of the bladder to hold urine. This in turn reduces the need to pass urine. \r\nStimulation of muscarinic receptors causes the bladder to contract and empty. Tolterodine relax the involuntary muscle in the wall of the bladder.", "Composition": "tolterodine l tartarate 4mg", "Route": "ORAL.SOLID" }, { "ID": "423", "Trade_Name": "TOLMETIN 400MG 10CAPS.", "Generic_Name": "TOLMETIN", "Price": "26.4", "Price_Old": "26.4", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ ل#?خ#<ي#< ش#~َّة #.لألم و#.ل#.ل#?ه#.#%.", "Contraindications": "– إذ#. #=#.ن ل#~ى #.لم#^ي#_ #?َحَسُّسٌ #?ج#.ه #.ل#?ُّولمي#?ين أو أيِّ مُ#=َوِّن آخ#^ من هذ#. #.ل#~َّو#.ء. \r\n\r\n– يج#% إِ#-ل#.#>ُ مُق#~ِّم #.ل#^ِّ#>#.ية #.لصحِّية إذ#. #=#.ن ل#~ى #.لم#^ي#_ #?َحَسُّسٌ لأيِّ #~َو#.ءٍ آخ#^. \r\n\r\n– يج#% #.لإ#%ل#.غُ #>ن #.ل#?َّحسُّس #.لذي أص#.#% #.لم#^ي#_َ و#.ل#=ي#<يَّة #.ل#?ي أثَّ#^ #%ه#. #<يه. وي#?#_مَّن ذل#= #.ل#=ش#<َ #>ن وجو#~ #-#<ح أو #%ثو#^ أو ح#=َّة جل#~يَّة أو #_يق #<ي #.ل#?ن#<ُّس أو صَ#<ي#^ #>ن#~َ #.لشَّهيق أو سُ#>#.ل أو #?َو#^ُّم #.لوجه أو #.لشَّ#<#?ين أو #.للِّس#.ن أو #.لحَلق، أو أيَّة أ#>#^#.#_ أخ#^ى مُص#.ح#%َة ل#.ِس#?ِ#>م#.ل #.ل#~َّو#.ء. \r\n\r\n– إذ#. #=#.ن#? #.لمَ#^ي#_ةُ ح#.مل#.ً #%أ#=ث#^ من أ#^#%#>َة و#>ش#^ين أس#%و#>#.ً.", "GI": "About Tolmetin\r\nNSAID, arylalkanoic acid derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Tolmetin\r\nTolmetin is a nonsteroidal compound having anti-inflammatory, analgesics and antipyretic activities. It produces its actions by inhibiting Prostaglandin synthesis.\r\nIndications for Tolmetin\r\n1.Rheumatoid arthritis \r\n2.Osteoarthritis \r\n3.Juvanile rheumatoid arthritis \r\nTypical Dosage for Tolmetin\r\nAdult:200 - 400 mg three times a day- maximum daily dose:1800mg \r\nChildren above 2 years: 15- 30 mg/kg/day in 3 - 4 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "424", "Trade_Name": "TOPAMAX 50 MG SPRINKLE 60 CAPS.", "Generic_Name": "TOPIRAMATE", "Price": "200", "Price_Old": "200", "Company": "JANSSEN CILAG", "Pharmacology": "ANTI-EPILEPTIC.FRUCTOSE DERIVATIVE", "Category": "م#_#.#~ للص#^#> و #.لص#~#.#> #.لنص#<ي", "Use": "–#>ل#.ج #.لص#^#> #.لجزئي و#.ل#=#%ي#^. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#>ص#%ية. \r\n\r\n–#.لص#~#.#> #.لنص#<ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج إ#~م#.ن #.ل#=حول. \r\n\r\n–#.ل#=ه#^#%#.ء #.لز#.ئ#~ة #<ي #.ل#~م#.غ. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#?شنج.", "Contraindications": "–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل أو #<ي ح#.لة #.ل#?خ#-ي#- لحمل. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–ل#. يج#% #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%أ#<#=#.#^ #.ن#?ح#.#^ية يج#% #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#?ن#.ول #=مية #=#%ي#^ة من #.لسو#.ئل أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "A sulfamate-substituted monosaccharide, Carbonic anhydrase inhibitor, Anticonvulsant,antimigraine.\r\n\r\nYou may swallow this medication whole, or you may open the capsule and sprinkle the contents on a teaspoonful of soft food (such as applesauce, yogurt). Swallow the drug/food mixture right away. Do not chew the mixture. Do not prepare the mixture ahead of time for later use. \r\n\r\nMechanism of Action of Topiramate\r\nTopiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency neuronal discharge. It enhances the inhibitory neurotransmitter GABA and inhibits the excitatory glutamate receptors. Topiramate is also used in migraine prophylaxis. \r\nTopiramate also has weak carbonic anhydrase inhibitory activity.", "Composition": "topiramate 100mg or 25mg", "Route": "ORAL.SOLID" }, { "ID": "425", "Trade_Name": "SPRINKAZEN 25MG SPRINKLE 10 CAPS.", "Generic_Name": "TOPIRAMATE", "Price": "10", "Price_Old": "10", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "ANTI-EPILEPTIC.FRUCTOSE DERIVATIVE", "Category": "م#_#.#~ للص#^#> و #.لص#~#.#> #.لنص#<ي", "Use": "–#>ل#.ج #.لص#^#> #.لجزئي و#.ل#=#%ي#^. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#>ص#%ية. \r\n\r\n–#.لص#~#.#> #.لنص#<ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج إ#~م#.ن #.ل#=حول. \r\n\r\n–#.ل#=ه#^#%#.ء #.لز#.ئ#~ة #<ي #.ل#~م#.غ. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#?شنج.", "Contraindications": "–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل أو #<ي ح#.لة #.ل#?خ#-ي#- لحمل. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–ل#. يج#% #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%أ#<#=#.#^ #.ن#?ح#.#^ية يج#% #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#?ن#.ول #=مية #=#%ي#^ة من #.لسو#.ئل أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "A sulfamate-substituted monosaccharide, Carbonic anhydrase inhibitor, Anticonvulsant,antimigraine.\r\n\r\nYou may swallow this medication whole, or you may open the capsule and sprinkle the contents on a teaspoonful of soft food (such as applesauce, yogurt). Swallow the drug/food mixture right away. Do not chew the mixture. Do not prepare the mixture ahead of time for later use. \r\n\r\nMechanism of Action of Topiramate\r\nTopiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency neuronal discharge. It enhances the inhibitory neurotransmitter GABA and inhibits the excitatory glutamate receptors. Topiramate is also used in migraine prophylaxis. \r\nTopiramate also has weak carbonic anhydrase inhibitory activity.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "426", "Trade_Name": "TOLMET DS 400MG 12 CAPS", "Generic_Name": "TOLMETIN SODIUM", "Price": "26.4", "Price_Old": "26.4", "Company": "BIOPHARM EGYPT", "Pharmacology": "NSAID", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#?آ#=ل #.لم#<#.صل \r\n\r\n–#.ل#.م م#<#.صل #.ل#^#=#%ة \r\n\r\n–إل#?ه#.#% #.لحو#_ \r\n\r\n–#.لإنزل#.ق #.لغ#_#^و#<ي \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل: \r\n\r\n–#.ل#.م #.لم#<#.صل #.ل#^وم#.#?يزمية \r\n\r\n–#.ل#.م #.ل#^ق#%ة و#.ل#<ق#^#.#? \r\n\r\n–#.ل#^وم#.#?يزم غي#^ #.لم#<صلي: \r\n\r\n–إل#?ه#.#% #.ل#>#_#~ ولوحة #.ل#=#?#< \r\n\r\n–م#.#%#>#~ #.لإل#?ه#.#%#.#? #.ل#^وم#.#?يزمية \r\n\r\n–#.ل#?و#^م و#.ل#=#~م#.#? و#.لص#~م#.#?", "Contraindications": "–ألم ش#%ه #.لمن#-وق #<ي #?ح#~ي#~ #.لش#^ي#.ن #.ل#?#.جي سيخ#_#> ل#>ملية ج#^#.حية \r\n\r\n–#.ل#^#%و \r\n\r\n–#.لش#^ى \r\n\r\n–#<#^#- #.لحس#.سية", "GI": "About Tolmetin\r\nNSAID, arylalkanoic acid derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Tolmetin\r\nTolmetin is a nonsteroidal compound having anti-inflammatory, analgesics and antipyretic activities. It produces its actions by inhibiting Prostaglandin synthesis.\r\nIndications for Tolmetin\r\n1.Rheumatoid arthritis \r\n2.Osteoarthritis \r\n3.Juvanile rheumatoid arthritis \r\nTypical Dosage for Tolmetin\r\nAdult:200 - 400 mg three times a day- maximum daily dose:1800mg \r\nChildren above 2 years: 15- 30 mg/kg/day in 3 - 4 divided doses", "Composition": "tolmetin 400mg", "Route": "ORAL.SOLID" }, { "ID": "427", "Trade_Name": "SPRINKAZEN 50MG SPRINKLE 10 CAPS.", "Generic_Name": "TOPIRAMATE", "Price": "13", "Price_Old": "13", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "ANTI-EPILEPTIC.FRUCTOSE DERIVATIVE", "Category": "م#_#.#~ للص#^#> و #.لص#~#.#> #.لنص#<ي", "Use": "–#>ل#.ج #.لص#^#> #.لجزئي و#.ل#=#%ي#^. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#>ص#%ية. \r\n\r\n–#.لص#~#.#> #.لنص#<ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج إ#~م#.ن #.ل#=حول. \r\n\r\n–#.ل#=ه#^#%#.ء #.لز#.ئ#~ة #<ي #.ل#~م#.غ. \r\n\r\n–ي#>#.لج نو#%#.#? #.ل#?شنج.", "Contraindications": "–ل#. يج#% #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل أو #<ي ح#.لة #.ل#?خ#-ي#- لحمل. \r\n\r\n–يمن#> #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–ل#. يج#% #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%أ#<#=#.#^ #.ن#?ح#.#^ية يج#% #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–ينصح #%#?ن#.ول #=مية #=#%ي#^ة من #.لسو#.ئل أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "A sulfamate-substituted monosaccharide, Carbonic anhydrase inhibitor, Anticonvulsant,antimigraine.\r\n\r\nYou may swallow this medication whole, or you may open the capsule and sprinkle the contents on a teaspoonful of soft food (such as applesauce, yogurt). Swallow the drug/food mixture right away. Do not chew the mixture. Do not prepare the mixture ahead of time for later use. \r\n\r\nMechanism of Action of Topiramate\r\nTopiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency neuronal discharge. It enhances the inhibitory neurotransmitter GABA and inhibits the excitatory glutamate receptors. Topiramate is also used in migraine prophylaxis. \r\nTopiramate also has weak carbonic anhydrase inhibitory activity.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "428", "Trade_Name": "RUMATOL 400 MG 10 CAPS.", "Generic_Name": "TOLMETIN SODIUM", "Price": "26.4", "Price_Old": "26.4", "Company": "SIGMA", "Pharmacology": "NSAID", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#?آ#=ل #.لم#<#.صل \r\n\r\n–#.ل#.م م#<#.صل #.ل#^#=#%ة \r\n\r\n–إل#?ه#.#% #.لحو#_ \r\n\r\n–#.لإنزل#.ق #.لغ#_#^و#<ي \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل: \r\n\r\n–#.ل#.م #.لم#<#.صل #.ل#^وم#.#?يزمية \r\n\r\n–#.ل#.م #.ل#^ق#%ة و#.ل#<ق#^#.#? \r\n\r\n–#.ل#^وم#.#?يزم غي#^ #.لم#<صلي: \r\n\r\n–إل#?ه#.#% #.ل#>#_#~ ولوحة #.ل#=#?#< \r\n\r\n–م#.#%#>#~ #.لإل#?ه#.#%#.#? #.ل#^وم#.#?يزمية \r\n\r\n–#.ل#?و#^م و#.ل#=#~م#.#? و#.لص#~م#.#?", "Contraindications": "–ألم ش#%ه #.لمن#-وق #<ي #?ح#~ي#~ #.لش#^ي#.ن #.ل#?#.جي سيخ#_#> ل#>ملية ج#^#.حية \r\n\r\n–#.ل#^#%و \r\n\r\n–#.لش#^ى \r\n\r\n–#<#^#- #.لحس#.سية", "GI": "About Tolmetin\r\nNSAID, arylalkanoic acid derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Tolmetin\r\nTolmetin is a nonsteroidal compound having anti-inflammatory, analgesics and antipyretic activities. It produces its actions by inhibiting Prostaglandin synthesis.\r\nIndications for Tolmetin\r\n1.Rheumatoid arthritis \r\n2.Osteoarthritis \r\n3.Juvanile rheumatoid arthritis \r\nTypical Dosage for Tolmetin\r\nAdult:200 - 400 mg three times a day- maximum daily dose:1800mg \r\nChildren above 2 years: 15- 30 mg/kg/day in 3 - 4 divided doses", "Composition": "tolmetin 200mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "429", "Trade_Name": "AMADOL 50MG 20 CAPS.", "Generic_Name": "TRAMADOL", "Price": "12.7", "Price_Old": "12.7", "Company": "ADWIA", "Pharmacology": "ANALGESICS.NARCOTIC OPIOID", "Category": "مس#=ن و مخ#~#^ أ#<يوني", "Use": "–ين#?مي #>ق#.#^ #?#^#.م#.#~ول إلى مجمو#>ة أ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#% #.لغي#^ إس#?ي#^وئي#~ية و#.ل#?ي له#. #<#.#>ليه #=#%ي#^ة #<ي #?س#=ين آل#.م #.لجسم #.لن#.#?جة #>ن #.ل#<ص#.ل #.ل#>ظمي . \r\n\r\n–يوص#< #>ق#.#^ #?#^#.م#.#~ول لم#^#_ي #.لس#^#-#.ن ل#?س#=ين آل#.مهم ول#=ن #<ي #.لغ#.ل#% #%#>#~ #?ن#.ول #>ق#.#^ #?#^#.م#.#~ول ل#>#~ة أس#.#%ي#> ق#~ ي#-ل#% #.ل#-#%ي#% #?غي#^ #.لمخ#~#^ لمخ#~#^ أقوي #<ي #.لم#<#>ول . \r\n\r\n–ي#?ميز #>ق#.#^ #?#^#.م#.#~ول #%أنه ل#. يس#%#% مش#.#=ل #<ي #.لقل#% أو ق#^حة ه#_مية .", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه لل#-#<#.ل #.لأقل من 10 سنو#.#?. \r\n\r\n–ومن ي#>#.نون من #.لأ#~م#.ن. \r\n\r\n–#>#~م #.لسو#.قة أثن#.ء #?ن#.ول هذ#. #.ل#>ق#.#^. \r\n\r\n–#<ى ح#.لة #.لخ#_و#> #.لى #>ملي#.#? ج#^#.حية يج#% أخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء. \r\n\r\n–ل#. يوج#~ خ#-#^ منه #>لى م#^#_ى #.لقل#%.", "GI": "(Indications):\r\n This medication is an opioid analgesic, prescribed for moderate to severe pain in adults.It works by changing the way the body senses pain. \r\n\r\n(Contraindications):\r\n acute alcoholism, head injuries, severe kidney impairment, breastfeeding, hypersensitivity\r\n\r\n(Dosage):\r\nThe recommended dose is 50-100 mg (immediate release tablets) every 4-6 hours as needed for pain. The maximum dose is 400 mg/day.\r\nIV/IM-Moderate to severe pain- The recommended dose is 50-100 mg 4-6 hourly.", "Composition": "Each 2ml Ampoule contains Tramadol Hcl 100 mg.", "Route": "ORAL.SOLID" }, { "ID": "430", "Trade_Name": "CUREPRO XR 0.4 MG 10 CAPS.", "Generic_Name": "TAMSULOSIN", "Price": "21.6", "Price_Old": "21.6", "Company": "DEBEIKY > NOVELL PHARMA", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "tamsulosin 0.4mg", "Route": "ORAL.SOLID" }, { "ID": "431", "Trade_Name": "OMNIC 0.4MG 30 MODIFIED RELEASE CAPS.", "Generic_Name": "TAMSULOSIN", "Price": "147", "Price_Old": "35", "Company": "YAMANOUCHI EUROPE B.V.NETHERLANDS. > AL GAURISM SCIENTIFIC OFFICE", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "Omnic 0,4 capsules contain 0,4 mg tamsulosin hydrochloride", "Route": "ORAL.SOLID" }, { "ID": "432", "Trade_Name": "LOSIPROST 0.4 MG 30 CAP.", "Generic_Name": "TAMSULOSIN", "Price": "60", "Price_Old": "60", "Company": "EUROPEAN EGYPTIAN PHARM. IND. > PHARMA-TECH", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "tamsulosin 0.4mg", "Route": "ORAL.SOLID" }, { "ID": "433", "Trade_Name": "BLOCK ALPHA 0.4 MG MR 30 CAPS.", "Generic_Name": "TAMSULOSIN", "Price": "81", "Price_Old": "81", "Company": "ADWIA", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "Each Block Alpha MR capsule contains:\r\nTamsulosin HCI 0.4 mg.", "Route": "ORAL.SOLID" }, { "ID": "434", "Trade_Name": "TAMSULIN 0.4MG 28 CAPS.", "Generic_Name": "TAMSULOSIN", "Price": "70", "Price_Old": "70", "Company": "MARCYRL CO.", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "Tamsulosin Hydrochloride 0.4 mg", "Route": "ORAL.SOLID" }, { "ID": "435", "Trade_Name": "TAMIC 0.4MG M.R 10 CAP.", "Generic_Name": "TAMSULOSIN", "Price": "33.6", "Price_Old": "33.6", "Company": "SIGMA", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "Each capsule contains:\r\nTamsulosin hydrochloride 0.4 mg", "Route": "ORAL.SOLID" }, { "ID": "436", "Trade_Name": "KEMPROST 0.4MG 20 CAPS.", "Generic_Name": "TAMSULOSIN", "Price": "56", "Price_Old": "56", "Company": "CHEMIPHARM", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "tamsulosin 0.4mg", "Route": "ORAL.SOLID" }, { "ID": "437", "Trade_Name": "TAMSUL 0.4MG 30 CAPSULE", "Generic_Name": "TAMSULOSIN", "Price": "105", "Price_Old": "105", "Company": "AMOUN", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "tamsulosin 0.4mg", "Route": "ORAL.SOLID" }, { "ID": "438", "Trade_Name": "FIRAMAZIN 0.4MG 30 H.G.CAPS.", "Generic_Name": "TAMSULOSIN", "Price": "54", "Price_Old": "54", "Company": "EVA PHARMA", "Pharmacology": "URINATION-DIFFICULTY.ALPHA BLOCKER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "– يُس#?خ#~م ل#>ل#.ج أ#>#^#.#_ و#>ل#.م#.#? #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ومن أ#>#^#.#_ #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~: \r\n\r\n–ص#>و#%ة #.ل#?#%ول. \r\n\r\n–#.لح#.جة #.لم#?#=#^#^ة أو #.لمُلّحة لل#?#%ول، #.ل#?ي #?ح#~ث غ#.ل#%ً#. #<ي #.لليل. \r\n\r\n– #?خ#<ي#< أ#>#^#.#_ #.نس#~#.#~ #.لمث#.نة. \r\n\r\n– #?سهيل #-#^#~ حصو#.#? #.لح#.ل#%.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م.", "GI": "About Tamsulosin\r\nSelective Alpha1a Adrenergic Antagonist , For benign prostatic hyperplasia.\r\nMechanism of Action of Tamsulosin\r\nTamsulosin is adrenergic alpha receptor antagonist. It inhibits alpha 1A and alpha 1D subtype receptors. Tamsulosin selectively inhibits alpha 1A receptor in the prostate and leads to relaxation of smooth muscles in the bladder neck and prostate. This will improve urine flow and reduces BPH symptoms. \r\nAdrenergic nerves releases adrenalin which produces contraction of muscles. Tamsulosin is selectively inhibit alpha 1A receptor in the prostate and bladder neck and relaxes the muscles and decrease the obstruction to the flow of urine in prostate hypertrophy. \r\nIndications for Tamsulosin\r\n1. Benign Prostatic hyperplasia (BPH) \r\n\r\n\r\nInteractions for Tamsulosin\r\nCimetidine: Results in significant decrease in clearance of tamsulosin AUC. \r\nAlpha adrenergic blocking agents: Tamsulosin should not be used in combination with other alpha adrenergics.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "439", "Trade_Name": "UFT 28 CAPSULES", "Generic_Name": "TEGAFUR+URACIL", "Price": "650", "Price_Old": "650", "Company": "MERCK KGAA F.R.GERMANY > MERCK KGAA F.R-EGYPT", "Pharmacology": "ANTINEOPLASTIC", "Category": "م#_#.#~#.#? للأو#^#.م", "Use": "–يش#.#^ إلى UFT ل#>ل#.ج #.لخ#- #.لأول #<ي س#^#-#.ن #.لقولون و#.لمس#?قيم #.لمن#?ش#^، #<ي #?#^#=ي#%ة م#> حم#_ #.ل#<وليني#=.", "Contraindications": "–#<#^#- #.لحس#.سية \r\n\r\n–#.لحمل \r\n\r\n–غي#.#% وس#.ئل من#> #.لحمل #.لأنثوية #.ل#<#>#.لة \r\n\r\n–غي#.#% مو#.ن#> #.لحمل #.لذ#=#^ية \r\n\r\n–#.لم#^#.هقين \r\n\r\n–#.ل#.#-#<#.ل \r\n\r\n–ح#.ل#.#? #.لقصو#^ #.ل#=#%#~ي #.لح#.#~ \r\n\r\n–#=#%#? #.لنقى #%#>#~ #.ل#>ل#.ج #.لإش#>#.#>ي \r\n\r\n–#=#%#? #.لنقى #%#>#~ إ#>#-#.ء #>و#.مل م#_#.#~ة للو#^م", "GI": "UFT is an anticancer medication composed of a fixed molar ration (1:4) of tegafur and uracil to be administered with calcium folinate. In the body, tegafur is converted into 5-fluorouracil (5-FU), the active antineoplastic metabolite. The mechanism of cytotoxicity of 5-FU is thought to be derived from the fact that 5-fluoro-deoxyuridine-monophosphate (FdUMP), the active metabolite of 5-FU, competes with deoxyuridine-monophosphate (dUMP), thereby inhibiting thymidylate synthase and subsequently DNA synthesis. Another active metabolite of 5-FU, 5-fluorouridine-triphosphate (FUTP) is integrated into cellular RNA, inhibiting RNA function. Uracil, when combined with tegafur, enhances the antitumor activity of 5-FU due to higher 5-FU concentrations in the tumor tissue versus normal surrounding tissue compared with tegafur alone.\r\nCalcium folinate enhances the cytotoxicity of 5-FU. The independent actions of uracil and leucovorin calcium provide for dual biomodulation of tegafur.", "Composition": "tegafur 100mg, uracil 224", "Route": "ORAL.SOLID" }, { "ID": "440", "Trade_Name": "VEXAMOD 150MG SR 10 CAPS.", "Generic_Name": "VENLAFAXINE", "Price": "39", "Price_Old": "39", "Company": "SIGMA", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–ي#?م #.س#?خ#~#.مه #<ي #>ل#.ج ح#.ل#.#? #.ل#.#=#?ئ#.#%. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.#_#-#^#.#%#.#? #.لهل#>. \r\n\r\n–ي#?م #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لقلق و#.ل#?و#?#^. \r\n\r\n–يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لهل#> #.ل#.ج#?م#.#>ي. \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? #.له#%#.#? #.لس#.خنة. \r\n\r\n–وأ#>#^#.#_ #.نق#-#.#> #.ل#-مث ل#~ى #.لسي#~#.#?. \r\n\r\n–ل#>ل#.ج ح#.ل#.#? س#^#-#.ن #.لث#~ي.", "Contraindications": "–1. ل#. يج#% #.س#?خ#~#.مه للم#^#_ى #.ل#?ي #?#>#.ني من أي حس#.سية من أي م#^#=#% من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–2. من #.لممنو#> #.س#?خ#~#.مه م#> #?ن#.ول مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين، وإذ#. ل#. #%#~ من #?ن#.وله ي#?م #?ن#.وله #%#>#~ 14 يوم من #?وق#< #.ل#>ل#.ج #>ن #?ن#.وله. \r\n\r\n–3. أم#. #%#.لنس#%ة للأ#-#<#.ل و#.لم#^#.هقين #.لذين ل#. ي#%لغون من #.ل#>م#^ 18 #>#.م ممنو#> #.س#?خ#~#.مه نه#.ئي#.ً.", "GI": "About Venlafaxine\r\nAn arylalkanolamine derivative,Serotonin\r\norepinephrine ReuptakeInhibitor, Antidepressant,anxiolytic.\r\nMechanism of Action of Venlafaxine\r\nVenlafaxine and its metabolite block the re-uptake of neurotransmitter Serotonin and Noradrenaline from the synapse in to the presynaptic nerve terminal in the CNS. In high doses it weakly inhibits the reuptake of Dopamine. Venlafaxine potentiates the neurotransmitter`s activity and produces antidepressant action.\r\nIndications for Venlafaxine\r\n1. Depression \r\n2. Generalised anxiety disorder \r\n3. Social anxiety disorder", "Composition": "venlafaxine 150mg or 37.5mg or 75mg", "Route": "ORAL.SOLID" }, { "ID": "441", "Trade_Name": "A-VITON 50.000 I.U. 20 CAPS.", "Generic_Name": "VITAMIN A", "Price": "9", "Price_Old": "5", "Company": "KAHIRA", "Pharmacology": "VITAMIN A", "Category": "#<ي#?#.مين أ", "Use": "–#.لوق#.ية و#.ل#>ل#.ج #<ي ح#.ل#.#? نقص #<ي#?#.مين أ. \r\n\r\n– ح#.ل#.#? خلل إم#?ص#.ص #<ي#?#.مين أ من #.لأم#>#.ء مثل م#^#_ #.لص#<#^#.ء #.لإنس#~#.#~ي. \r\n\r\n– زي#.#~ة #.ل#?#>#^#_ للإص#.#%#.#? #%#.ل#>#~وى. \r\n\r\n– #<ي أم#^#.#_ #.ل#>ين مثل ق#^ح #.ل#>ين وج#<#.#< #.لق#^نية. \r\n\r\n– #.لأم#^#.#_ #.لجل#~ية. \r\n\r\n– #<ي ح#.ل#.#? #.ل#?سنين.", "Contraindications": "–#.لحس#.سية #.ل#>#.لية ل#<ي#?#.مين أ. \r\n\r\n–#.لحمل. \r\n\r\n–#.لأ#=زيم#. #.لح#.#~ة \r\n\r\n–#.ل#?ه#.#% #.لجل#~ #.لح#.#~ \r\n\r\n–#.ل#^#_#.#>ة #.ل#-#%ي#>ية \r\n\r\n–#.لو#^#~ية", "GI": "About Vitamin A\r\nFat-soluble vitamin, Treatment of vitamin A deficiency.\r\nMechanism of Action of Vitamin A\r\nVitamin A is required for a variety of physiological functions in the body such as: - 1).Proper functioning of retina and formation of pigment Rhodopsin during dark adaptation. 2).promotes differentiation and maintains structural integrity of epithelia over the body and also retard the malignancies of epithelial structures.3).Promotes mucous secretion. 4).Inhibits keratinization, 5). Maintains proper bone growth, 6).Maintenance of spermatogenesis, 7).Supports foetal development, 8).Improves resistance to infection. It is required for proper antibody response, normal lymphocyte proliferation and killer cell function.\r\nIndications for Vitamin A\r\n1. Vitamin A deficiency \r\n2. Xerophthalmia \r\n3. Acne \r\n4. Ichthyosis \r\n5. Bitot`s spots \r\n6. Night blindness", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "442", "Trade_Name": "VITAMIN A 25000 I.U.SOFT GELATIN 24CAPS.", "Generic_Name": "VITAMIN A", "Price": "3.59", "Price_Old": "3.59", "Company": "SAFE PHARMA > PHARCO", "Pharmacology": "VITAMIN A", "Category": "#<ي#?#.مين أ", "Use": "–#.لوق#.ية و#.ل#>ل#.ج #<ي ح#.ل#.#? نقص #<ي#?#.مين أ. \r\n\r\n– ح#.ل#.#? خلل إم#?ص#.ص #<ي#?#.مين أ من #.لأم#>#.ء مثل م#^#_ #.لص#<#^#.ء #.لإنس#~#.#~ي. \r\n\r\n– زي#.#~ة #.ل#?#>#^#_ للإص#.#%#.#? #%#.ل#>#~وى. \r\n\r\n– #<ي أم#^#.#_ #.ل#>ين مثل ق#^ح #.ل#>ين وج#<#.#< #.لق#^نية. \r\n\r\n– #.لأم#^#.#_ #.لجل#~ية. \r\n\r\n– #<ي ح#.ل#.#? #.ل#?سنين.", "Contraindications": "–#.لحس#.سية #.ل#>#.لية ل#<ي#?#.مين أ. \r\n\r\n–#.لحمل. \r\n\r\n–#.لأ#=زيم#. #.لح#.#~ة \r\n\r\n–#.ل#?ه#.#% #.لجل#~ #.لح#.#~ \r\n\r\n–#.ل#^#_#.#>ة #.ل#-#%ي#>ية \r\n\r\n–#.لو#^#~ية", "GI": "About Vitamin A\r\nFat-soluble vitamin, Treatment of vitamin A deficiency.\r\nMechanism of Action of Vitamin A\r\nVitamin A is required for a variety of physiological functions in the body such as: - 1).Proper functioning of retina and formation of pigment Rhodopsin during dark adaptation. 2).promotes differentiation and maintains structural integrity of epithelia over the body and also retard the malignancies of epithelial structures.3).Promotes mucous secretion. 4).Inhibits keratinization, 5). Maintains proper bone growth, 6).Maintenance of spermatogenesis, 7).Supports foetal development, 8).Improves resistance to infection. It is required for proper antibody response, normal lymphocyte proliferation and killer cell function.\r\nIndications for Vitamin A\r\n1. Vitamin A deficiency \r\n2. Xerophthalmia \r\n3. Acne \r\n4. Ichthyosis \r\n5. Bitot`s spots \r\n6. Night blindness", "Composition": "vit a 25000i.u. or 50000i.u", "Route": "ORAL.SOLID" }, { "ID": "443", "Trade_Name": "CEREBRINE 20MG 20 CAPS.", "Generic_Name": "VINBURNINE", "Price": "31.5", "Price_Old": "21", "Company": "OCTOBER PHARMA > PHARMAGIN-EGYPT", "Pharmacology": "CEREBRAL VASODILATOR", "Category": "موس#> #.لأو#>ية #.ل#~م#.غية", "Use": "–أم#^#.#_ #.لأو#>ية #.ل#~موية \r\n\r\n–#_#>#< #.لذ#.#=#^ة \r\n\r\n–قلة #.ل#?#^#=يز \r\n\r\n–#.#^#?#<#.#> #_غ#- #.ل#~م \r\n\r\n–#.ل#~وخة و#.ل#~و#.#^ و#.لص#~#.#> #.لو#>#.ئي و#.لص#~#.#> #.لنص#<ى \r\n\r\n–#?حسين #.لق#~#^ة #.لذهنية ل#~ى #.ل#.#-#<#.ل و#.لم#^#.هقين", "Contraindications": "–#.ح#?ي#.#-#.#? : \r\n\r\n–#.#_#-#^#.#%#.#? #.لنزي#< \r\n\r\n–#_#>#< #.لجه#.ز #.لمن#.#>ي \r\n\r\n–#.لج#^#.حة \r\n\r\n–#.لحمل و#.ل#^#_#.#>ة : \r\n\r\n–ل#.يس#?خ#~م #.ثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة", "GI": "COMING SOON ..", "Composition": "vinbunine 20mg", "Route": "ORAL.SOLID" }, { "ID": "444", "Trade_Name": "VITAZINC 30 SOFT GELATIN CAPS.", "Generic_Name": "VITAMIN A+VITAMIN E+ZINC GLUCONATE", "Price": "6.75", "Price_Old": "6.75", "Company": "EIPICO", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–مقوى #>#.م للجسم . \r\n\r\n–يس#.#>#~ #>لى #?حسين و ظ#.ئ#< #.لجسم . \r\n\r\n–م#_#.#~ للأ#=س#~ة و يس#.#>#~ #>لى حم#.ية خل#.ي#. #.لجسم من #.ل#?ل#< . \r\n\r\n–#.لح#<#.ظ #>لى سل#.مة #.لجل#~ و #.لأظ#.#<#^ و #.لش#>#^ . \r\n\r\n–م#=مل غذ#.ئى أثن#.ء #.ل#^يجيم . \r\n\r\n–#>ل#.ج #.ل#_#>#< #.ل#>#.م و #.لإ#^ه#.ق و #_#>#< #.ل#?#^#=يز .", "Contraindications": "–يمن#> #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء.", "GI": "COMING SOON ..", "Composition": "vit a, vit e, zinc 102.7mg", "Route": "ORAL.SOLID" }, { "ID": "445", "Trade_Name": "VITAMIN A 50.000 I.U. 24CAPS.", "Generic_Name": "VITAMIN A", "Price": "3.8", "Price_Old": "3.8", "Company": "PHARCO", "Pharmacology": "VITAMIN A", "Category": "#<ي#?#.مين أ", "Use": "–#.لوق#.ية و#.ل#>ل#.ج #<ي ح#.ل#.#? نقص #<ي#?#.مين أ. \r\n\r\n– ح#.ل#.#? خلل إم#?ص#.ص #<ي#?#.مين أ من #.لأم#>#.ء مثل م#^#_ #.لص#<#^#.ء #.لإنس#~#.#~ي. \r\n\r\n– زي#.#~ة #.ل#?#>#^#_ للإص#.#%#.#? #%#.ل#>#~وى. \r\n\r\n– #<ي أم#^#.#_ #.ل#>ين مثل ق#^ح #.ل#>ين وج#<#.#< #.لق#^نية. \r\n\r\n– #.لأم#^#.#_ #.لجل#~ية. \r\n\r\n– #<ي ح#.ل#.#? #.ل#?سنين.", "Contraindications": "–#.لحس#.سية #.ل#>#.لية ل#<ي#?#.مين أ. \r\n\r\n–#.لحمل. \r\n\r\n–#.لأ#=زيم#. #.لح#.#~ة \r\n\r\n–#.ل#?ه#.#% #.لجل#~ #.لح#.#~ \r\n\r\n–#.ل#^#_#.#>ة #.ل#-#%ي#>ية \r\n\r\n–#.لو#^#~ية", "GI": "About Vitamin A\r\nFat-soluble vitamin, Treatment of vitamin A deficiency.\r\nMechanism of Action of Vitamin A\r\nVitamin A is required for a variety of physiological functions in the body such as: - 1).Proper functioning of retina and formation of pigment Rhodopsin during dark adaptation. 2).promotes differentiation and maintains structural integrity of epithelia over the body and also retard the malignancies of epithelial structures.3).Promotes mucous secretion. 4).Inhibits keratinization, 5). Maintains proper bone growth, 6).Maintenance of spermatogenesis, 7).Supports foetal development, 8).Improves resistance to infection. It is required for proper antibody response, normal lymphocyte proliferation and killer cell function.\r\nIndications for Vitamin A\r\n1. Vitamin A deficiency \r\n2. Xerophthalmia \r\n3. Acne \r\n4. Ichthyosis \r\n5. Bitot`s spots \r\n6. Night blindness", "Composition": "rose hips 25mg, vit c 1000mg", "Route": "ORAL.SOLID" }, { "ID": "446", "Trade_Name": "CAVALPHA 5 MG 30 CAPS.", "Generic_Name": "VINPOCETINE", "Price": "22.5", "Price_Old": "22.5", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "NOOTROPIC", "Category": "#.لزه#.يم#^ و #.لخ#^#<", "Use": "–#>ل#.ج #.لزه#.يم#^ و#.لخ#^#<. \r\n\r\n–#?قوية #.لذ#.#=#^ة و زي#.#~ة #.ل#?#^#=يز. \r\n\r\n–#?قليل #.ل#_#>#< #.لجس#~ي. \r\n\r\n–#>ل#.ج #.#_#-#^#.#%#.#? #.لأو#>ية #.ل#~موية #.ل#~م#.غية من خل#.ل زي#.#~ة #?غذية #.ل#~م#.غ.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "447", "Trade_Name": "VITAMIN A & E SOFT GELATIN 24CAPS.", "Generic_Name": "VITAMIN A+VITAMIN E", "Price": "4", "Price_Old": "4", "Company": "PHARCO", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ل#>ل#.ج نقص #<ي#?#.من E ول#>ل#.ج و#.لوق#.ية من #.م#^#.#_ #.لقل#% و#.ل#.و#>ية #.ل#~مويه و#?صل#% #.لش#^#.يين و#.لنو#%#.#? #.لقل#%يه ويس#?خ#~م #=#>ل#.ج مس#.#>#~ #<ى م#>#.لجة م#^#_ #.لس#=#^ى وم#_#.#>#<#.#?ه ويس#?خ#~م للوق#.ية من #%#>#_ #.نو#.#> #.لس#^#-#.ن ويس#?خ#~م #.حي#.ن#. #<ى #.لم#^#.حل #.ل#.خي#^ة #<ى #.لحمل.", "Contraindications": "–يمن#> #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Vitamin A\r\nFat-soluble vitamin, Treatment of vitamin A deficiency.\r\nMechanism of Action of Vitamin A\r\nVitamin A is required for a variety of physiological functions in the body such as: - 1).Proper functioning of retina and formation of pigment Rhodopsin during dark adaptation. 2).promotes differentiation and maintains structural integrity of epithelia over the body and also retard the malignancies of epithelial structures.3).Promotes mucous secretion. 4).Inhibits keratinization, 5). Maintains proper bone growth, 6).Maintenance of spermatogenesis, 7).Supports foetal development, 8).Improves resistance to infection. It is required for proper antibody response, normal lymphocyte proliferation and killer cell function.", "Composition": "vit a 30000i.u., vit e 70mg", "Route": "ORAL.SOLID" }, { "ID": "448", "Trade_Name": "CIRCUFIT 10MG 20 CAPS.", "Generic_Name": "VINPOCETINE", "Price": "22", "Price_Old": "22", "Company": "PHAROPHARMA", "Pharmacology": "NOOTROPIC", "Category": "#.لزه#.يم#^ و #.لخ#^#<", "Use": "–#>ل#.ج #.لزه#.يم#^ و#.لخ#^#<. \r\n\r\n–#?قوية #.لذ#.#=#^ة و زي#.#~ة #.ل#?#^#=يز. \r\n\r\n–#?قليل #.ل#_#>#< #.لجس#~ي. \r\n\r\n–#>ل#.ج #.#_#-#^#.#%#.#? #.لأو#>ية #.ل#~موية #.ل#~م#.غية من خل#.ل زي#.#~ة #?غذية #.ل#~م#.غ.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Vinpocetine\r\nPhosphodiesterase 1 inhibitor, a semisynthetic vincamine derivative, Nootropic, Vasodilator.\r\nMechanism of Action of Vinpocetine\r\nVinpocetine is a semi synthetic derivative of Vincamine. It is a phosphodiesterases inhibitor. It produces vasodilator action and improves blood flow. Vinpocetine facilitates cerebral metabolism by improving blood flow to the brain. It increases the production of ATP in the brain cell and increasing utilization of glucose and oxygen by neurons. Vinpocetine increases the production of Noradrenaline and Dopamine. It prevents strokes, senile dementia and memory disturbances. It is a cerebral metabolic activator and a neuronal protector. It produces an immediate increase in the cerebral oxygenation and results in the activation of the cerebral metabolism.\r\nIndications for Vinpocetine\r\nDementia\r\nTypical Dosage for Vinpocetine\r\nAdult: 5 -15 mg /day and dose can be increased to 30 mg / day", "Composition": "Each capsule contains:\r\nVinpocetine 10 mg", "Route": "ORAL.SOLID" }, { "ID": "449", "Trade_Name": "ADWINERVE PLUS 20 CAPS.", "Generic_Name": "VITAMIN B1+VITAMIN B6+VITAMIN B12", "Price": "8.5", "Price_Old": "8.5", "Company": "ADWIA", "Pharmacology": "VITAMIN B", "Category": "#<ي#?#.مين #%", "Use": "–#.#_#-#^#.#% #.ل#?مثيل #.لغذ#.ئي للأحم#.#_ #.لنووية و#.ل#%#^و#?ين#.#? (Proteins) #<ي أنسجة #.لأ#>ص#.#%.\r\n\r\n–#?ج#~ي#~ أنسجة #.لأ#>ص#.#%. \r\n\r\n–خلل #.لأ#>ص#.#% #.لحسي و#.لح#^#=ي. \r\n\r\n–إل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية #.لن#.#?ج #>ن #.ل#%ول #.لس#=#^ (Diabetes) إ#~م#.ن #.ل#=حولي#.#? #%#>#_ #.لم#^#=#%#.#? #.ل#~و#.ئية #<ي ح#.ل#.#? #.للوم#%#.جو و#.لآل#.م #.ل#>ص#%ية للق#<ص #.لص#~#^ي وإل#?ه#.#% #.لش#%#=ية #<ي م#^#_ #.ل#%ول #.لس#=#^ (Diabetes). #.لحمل و#.ل#^#_#.#>ة.\r\n\r\n–#<ي ح#.ل#.#? زي#.#~ة #.لح#.جة ل#<ي#?#.مين #%1، #%6، #%12.", "Contraindications": "–#.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#-#%ي#%. \r\n\r\n–يمن#> #.ل#.س#?خ#~#.م لل#.#-#<#.ل #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#%.", "GI": "About Vit B1\r\n\r\nPhysiological functions: Thiamine pyrophosphate is a coenzyme and the active form of vitamin B. It functions as coenzyme in decarboxylation of a-keto acid and in Hexose Monophosphate shunt. \r\nDeficiency symptoms: In severe vitamin B1 deficiency beriberi develops. It is of two types: \r\na) Wet beriberi \r\nb) Dry beriberi \r\nWet beriberi: In this the symptoms are related to the cardiovascular system and they are palpitations, tachycardia, dyspnoea, ECG changes, oedema, and high output cardiac failure. \r\nDry beriberi: The symptoms and signs are related to the Nervous system. The main features are peripheral neuritis, hyperaesthesia (localized areas) or anaesthesia, there is gradual loss in muscle strength, wrist drop, poor memory, depression, lack of initiative and anorexia.\r\nMechanism of Action of Vit B2\r\nRiboflavin exerts it`s action by influencing metabolic reactions. Riboflavin functions in the forms of flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) wh", "Composition": "Each capsule contains:\r\nMecobalamin (Vit. B,..) 500 meg. \r\nThiamine HCI (Vit. B,) 100 mg. \r\nPyridoxine HCI (Vit B.) 150 mg.", "Route": "ORAL.SOLID" }, { "ID": "450", "Trade_Name": "EGYRESOLVE 250MG SOFT GELATIN 10CAPSULES", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "9", "Price_Old": "9", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > EGYGEL PHARMA FOR PHARMACEUTICAL INDUSTRIES-EGYPT", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "451", "Trade_Name": "URSOGALL 300MG 30 CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "52.5", "Price_Old": "52.5", "Company": "SIGMA", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "ursodeoxycholic acid 450mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "452", "Trade_Name": "URSOFALK 250MG 20 CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "78", "Price_Old": "54", "Company": "MINA PHARM > DR.FALK-GERMANY", "Pharmacology": "HEPATITIS", "Category": "#.ل#?ه#.#% #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "Each capsule contains:\r\nUrsodeoxycholic add 250 mg", "Route": "ORAL.SOLID" }, { "ID": "453", "Trade_Name": "URSOCHOL 250MG 20 CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "28.8", "Price_Old": "28.8", "Company": "MUP", "Pharmacology": "HEPATITIS", "Category": "#.ل#?ه#.#% #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "ursodeoxycholic acid 250mg", "Route": "ORAL.SOLID" }, { "ID": "454", "Trade_Name": "LIVAGOAL 450MG 20CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "75", "Price_Old": "44", "Company": "MARCYRL CO.", "Pharmacology": "HEPATITIS", "Category": "#.ل#?ه#.#% #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "Each capsule contains\r\nUrsodeoxycholic acid 450 mg", "Route": "ORAL.SOLID" }, { "ID": "455", "Trade_Name": "URSOCHOLIC 400 MG 20 CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "34", "Price_Old": "34", "Company": "MARCYRL CO. > PHARMACARE", "Pharmacology": "HEPATITIS", "Category": "#.ل#?ه#.#% #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "456", "Trade_Name": "URSODOL 250MG 10CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "11", "Price_Old": "11", "Company": "MEMPHIS", "Pharmacology": "HEPATITIS", "Category": "#.ل#?ه#.#% #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "457", "Trade_Name": "BILIVER 450MG 20 CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "82", "Price_Old": "42", "Company": "WESTERN PHARMACEUTICALS INDUSTRIES", "Pharmacology": "HEPATITIS", "Category": "#.ل#?ه#.#% #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "ursodeoxycholic acid 450mg", "Route": "ORAL.SOLID" }, { "ID": "458", "Trade_Name": "URSODIOL 250 MG 20 CAPS", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "22", "Price_Old": "22", "Company": "SEDICO", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "Each Micronized Active ingredient:\r\nUrsodeoxycholic acid 250 mg", "Route": "ORAL.SOLID" }, { "ID": "459", "Trade_Name": "URSOGALL 450MG SR 10 CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "20", "Price_Old": "20", "Company": "SIGMA", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "ursodeoxycholic acid 450mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "460", "Trade_Name": "TETRACYCLINE 250 MG 20*12 CAPS. B.P 2012", "Generic_Name": "TETRACYCLINE", "Price": "86", "Price_Old": "3.05", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–يس#?خ#~م ل#>ل#.ج ح#% #.لش#%#.#%. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمث#.نة و#.ل#=لي. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لج#^ثومية #.ل#?ي #?صي#% #.ل#>ينين. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.ل#=ولي#^#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#=ز#.ز. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.لغ#^غ#^ين#. #.لغ#.زية. \r\n\r\n–#>ل#.ج #.ل#=ل#.مي#~ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#>ل#.ج #>#~وي #.لم#>#~ة و#.لمس#%#%ة #.لإسه#.ل.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء.\r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.#_#-#^#.#%#.#? #%#.ل#~م و#^#.ثية.", "GI": "About Tetracycline\r\nA broad-spectrum polyketide antibiotic,Tetracycline Derivative.\r\nMechanism of Action of Tetracycline\r\nTetracycline is a broad spectrum antibiotic which has more specific action against gram positive organisms than gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals). It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. It is used in some areas for the treatment of Chloroquine-resistant falciparum malaria", "Composition": "Tetracycline 250mg", "Route": "ORAL.SOLID" }, { "ID": "461", "Trade_Name": "THIOTEX FORTE 600MG 20 CAPS.", "Generic_Name": "THIOCTIC ACID(ALPHA LIPOIC ACID)", "Price": "54", "Price_Old": "36", "Company": "MARCYRL CO.", "Pharmacology": "ANTIOXIDANT", "Category": "ل#.#>#?ل#.ل #.لأ#>ص#.#%", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>ص#.#%ِ #.ل#?ي #?ظه#^ #%س#%#% #.لس#=#^ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.ل#>ص#% #.ل#%ص#^يِ. \r\n\r\n–ي#>#.لج ح#.ل#.#? #_#>#< #.لخصو#%ة و#.ل#.ن#?ص#.#%ِ #>ن#~ #.ل#^ج#.ل.", "Contraindications": "–يمن#> #.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة #.#?ج#.ه م#=ون#.#? #.ل#>ق#.#^ من إس#?خ#~#.مه . \r\n\r\n–يمن#> إس#?خ#~#.مه أثن#.ء #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة لأنه يس#%#% خ#-و#^ة #>لى #.لجنين أو #.ل#^#_ي#> .يج#% #>لى م#^ي#_ #.لس#=#^ #>مل #<حص نس#%ة #.لس#=#^ #%صو#^ة مس#?م#^ة لأن #>ق#.#^ ثيو#?#.سي#~ ي#?س#%#% #<ي إنخ#<#.#_ نس#%ة #.لس#=#^ #<ي #.ل#~م . \r\n\r\n–يج#% #>لى مس#?خ#~مي #>ق#.#^ ثيو#?#.سي#~ #.لإ#%#?#>#.#~ #>ن #.لقي#.#~ة أو أي #>مل ي#?#-ل#% #.ل#?#^#=يز #.ل#=#.مل من #.لم#^ي#_ لأن هذ#. #.ل#>ق#.#^ ي#?س#%#% #<ي #_#>#< #.ل#^ؤية و#.لإص#.#%ة #%#>#~م #.ل#?#^#=يز .", "GI": "Indication\t\r\nFor nutritional supplementation, also for treating dietary shortage or imbalance.\r\nMechanism of action\tLipoic Acid is generally involved in oxidative decarboxylations of keto acids and is presented as a growth factor for some organisms. Lipoic acid exists as two enantiomers, the R-enantiomer and the S-enantiomer. Normally only the R-enantiomer of an amino acid is biologically active, but for lipoic acid the S-enantiomer assists in the reduction of the R-enantiomer when a racemic mixture is given. Some recent studies have suggested that the S-enantiomer in fact has an inhibiting effect on the R-enantiomer, reducing its biological activity substantially and actually adding to oxidative stress rather than reducing it. Furthermore, the S-enantiomer has been found to reduce the expression of GLUT-4s in cells, responsible for glucose uptake, and hence reduce insulin sensitivity.", "Composition": "thioctic acid 600mg", "Route": "ORAL.SOLID" }, { "ID": "462", "Trade_Name": "THIOTEX 300MG 30 CAPS.", "Generic_Name": "THIOCTIC ACID(ALPHA LIPOIC ACID)", "Price": "49.5", "Price_Old": "33", "Company": "MARCYRL CO.", "Pharmacology": "ANTIOXIDANT", "Category": "ل#.#>#?ل#.ل #.لأ#>ص#.#%", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>ص#.#%ِ #.ل#?ي #?ظه#^ #%س#%#% #.لس#=#^ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.ل#>ص#% #.ل#%ص#^يِ. \r\n\r\n–ي#>#.لج ح#.ل#.#? #_#>#< #.لخصو#%ة و#.ل#.ن#?ص#.#%ِ #>ن#~ #.ل#^ج#.ل.", "Contraindications": "–يمن#> #.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة #.#?ج#.ه م#=ون#.#? #.ل#>ق#.#^ من إس#?خ#~#.مه . \r\n\r\n–يمن#> إس#?خ#~#.مه أثن#.ء #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة لأنه يس#%#% خ#-و#^ة #>لى #.لجنين أو #.ل#^#_ي#> .يج#% #>لى م#^ي#_ #.لس#=#^ #>مل #<حص نس#%ة #.لس#=#^ #%صو#^ة مس#?م#^ة لأن #>ق#.#^ ثيو#?#.سي#~ ي#?س#%#% #<ي إنخ#<#.#_ نس#%ة #.لس#=#^ #<ي #.ل#~م . \r\n\r\n–يج#% #>لى مس#?خ#~مي #>ق#.#^ ثيو#?#.سي#~ #.لإ#%#?#>#.#~ #>ن #.لقي#.#~ة أو أي #>مل ي#?#-ل#% #.ل#?#^#=يز #.ل#=#.مل من #.لم#^ي#_ لأن هذ#. #.ل#>ق#.#^ ي#?س#%#% #<ي #_#>#< #.ل#^ؤية و#.لإص#.#%ة #%#>#~م #.ل#?#^#=يز .", "GI": "Indication\t\r\nFor nutritional supplementation, also for treating dietary shortage or imbalance.\r\nMechanism of action\tLipoic Acid is generally involved in oxidative decarboxylations of keto acids and is presented as a growth factor for some organisms. Lipoic acid exists as two enantiomers, the R-enantiomer and the S-enantiomer. Normally only the R-enantiomer of an amino acid is biologically active, but for lipoic acid the S-enantiomer assists in the reduction of the R-enantiomer when a racemic mixture is given. Some recent studies have suggested that the S-enantiomer in fact has an inhibiting effect on the R-enantiomer, reducing its biological activity substantially and actually adding to oxidative stress rather than reducing it. Furthermore, the S-enantiomer has been found to reduce the expression of GLUT-4s in cells, responsible for glucose uptake, and hence reduce insulin sensitivity.", "Composition": "Thioctic acid (a-lipoic acid) 300 mg OR 600 mg", "Route": "ORAL.SOLID" }, { "ID": "463", "Trade_Name": "TETRACYCLINE 250MG 12CAPS.", "Generic_Name": "TETRACYCLINE", "Price": "1.5", "Price_Old": "1.5", "Company": "HI-PHARM > PYRAMIDS FOR TRADING PHARMACEUTICALS-EGYPT", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–يس#?خ#~م ل#>ل#.ج ح#% #.لش#%#.#%. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمث#.نة و#.ل#=لي. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لج#^ثومية #.ل#?ي #?صي#% #.ل#>ينين. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.ل#=ولي#^#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#=ز#.ز. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.لغ#^غ#^ين#. #.لغ#.زية. \r\n\r\n–#>ل#.ج #.ل#=ل#.مي#~ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#>ل#.ج #>#~وي #.لم#>#~ة و#.لمس#%#%ة #.لإسه#.ل.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–ل#. يس#?خ#~م م#^هم #.ل#>ينين للأ#-#<#.ل أقل من 6 سنو#.#?. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.#_#-#^#.#%#.#? #%#.ل#~م و#^#.ثية.", "GI": "About Tetracycline\r\nA broad-spectrum polyketide antibiotic,Tetracycline Derivative.\r\nMechanism of Action of Tetracycline\r\nTetracycline is a broad spectrum antibiotic which has more specific action against gram positive organisms than gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals). It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. It is used in some areas for the treatment of Chloroquine-resistant falciparum malaria", "Composition": "Tetracycline 250mg", "Route": "ORAL.SOLID" }, { "ID": "464", "Trade_Name": "EPCIDIN S.R. 6 MG 10 CAPS.", "Generic_Name": "TIZANIDINE", "Price": "8", "Price_Old": "8", "Company": "EPCI", "Pharmacology": "CNS.ANALGESIC.SKELETAL MUSCLE RELAXANT.ALPHA2 AGONIST", "Category": "#%#.س#- لل#>#_ل#.#? #%و#.س#-ة #.لجه#.ز #.ل#>ص#%ي #.لم#^#=زي", "Use": "–مس#=ن لآل#.م #.ل#>#_ل#.#? . \r\n\r\n–#%#.س#- لل#>#_ل#.#? . \r\n\r\n–#>ل#.ج #?قلص#.#? و #?شنج#.#? #.ل#>#_ل#.#? . \r\n\r\n–مس#=ن لآل#.م #.لظه#^ . \r\n\r\n–#>ل#.ج ح#.ل#.#? إص#.#%ة #.لح#%ل #.لشو#=ى أو ح#~وث #_مو#^ #<ى #.لح#%ل #.لشو#=ى . \r\n\r\n–#>ل#.ج ح#.ل#.#? #?شنج #.ل#>#_ل#.#? #.لمص#.ح#% لم#^#_ #.ل#?صل#% #.ل#>ص#%ى #.لم#?#>#~#~ .", "Contraindications": "–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.ل#=#%#~ و #.ل#=لى : يج#% #?ظ#%ي#- #.لج#^#>ة #%و#.س#-ة #.ل#-#%ي#% #.لم#>#.لج . \r\n\r\n–ق#~ يس#%#% #~وخة و #.لإحس#.س #%#.لن#>#.س لذل#= يج#% #.لحذ#^ أثن#.ء #.لقي#.#~ة أو #.لقي#.م #%#.لأ#>م#.ل #.لخ#-ي#^ة . \r\n\r\n–#.ل#?#~خين يقلل من #<#.#>لية #.ل#~و#.ء .", "GI": "About Tizanidine\r\nA centrally acting a-2 adrenergic agonist, Centrally acting muscle relaxant (short-acting).\r\nMechanism of Action of Tizanidine\r\nThis drug is a centrally acting alpha2 agonist at alpha2-adrenergic receptor sites and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. This results the blocking of nerve impulses (or pain sensations) that are sent to your brain.\r\nIndications for Tizanidine\r\n1. Painful muscle spasm associated with static and functional disorders of the spine \r\n2. Following surgery for disc prolapse/osteoarthritis of the hip\r\nInteractions for Tizanidine\r\nAlcohol & other CNS depressants : CNS effects of tizanidine potentiated.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "465", "Trade_Name": "THIOTACID COMPOUND 300 MG 30 CAPS.", "Generic_Name": "THIOCTIC ACID(ALPHA LIPOIC ACID)+VITAMIN B1+VITAMIN B12", "Price": "67.5", "Price_Old": "45", "Company": "EVA PHARMA", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–#.ل#?ه#.#% #.لأ#>ص#.#% #.لن#.#?ج #>ن م#^#_ #.ل#%ول #.لس#=#^ي . \r\n\r\n–#.ل#?ه#.#% #.ل#>ص#% #.ل#%ص#^ي . \r\n\r\n–مش#=ل#.#? #.لخصو#%ة #>ن#~ #.ل#^ج#.ل . \r\n\r\n–#_#>#< #.ل#.ن#?ص#.#% . \r\n\r\n–م#^#_ ألزه#.يم#^ . \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل #.لن#.#?جة #>ن م#^#_ #.ل#^وم#.#?وي#~ . \r\n\r\n–أم#^#.#_ #.ل#=#%#~ #.لن#.#?جة #>ن #?ن#.ول #.ل#=حولي#.#? . \r\n\r\n–أم#^#.#_ #.لأ#>ص#.#% #.لم#?#>لقة #%#.لقل#% . \r\n\r\n–#.لمش#=ل#.#? #.لم#^#?#%#-ة #%#<ي#^وس نقص #.لمن#.#>ة . \r\n\r\n–أم#^#.#_ #.ل#>يون #.ل#?ي يس#%#%ه#. م#^#_ #.لس#=#^ي .", "Contraindications": "–#.لحس#.سية #.لش#~ي#~ة من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–م#^#_ى #.لس#=#^ي حيث يس#%#% هذ#. #.ل#~و#.ء #.نخ#<#.#_ نس#%ة #.لس#=#^ #<ي #.ل#~م، لذ#. يج#% #.لقي#.م #%#.ل#<حص #.لمس#?م#^ . \r\n\r\n–م#^#_ي قصو#^ #.ل#=#%#~ . \r\n\r\n–#.لم#^#_ى #.لمص#.#%ون #%#.#_#-#^#.#%#.#? #.لغ#~ة #.ل#~#^قية . \r\n\r\n–إذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من نقص نس#%ة #.لثي#.مين . \r\n\r\n–ل#. يس#?خ#~م #.ل#~و#.ء م#> #.لمش#^و#%#.#? #.ل#=حولية . \r\n\r\n–ل#. يس#?خ#~م هذ#. #.ل#~و#.ء أثن#.ء #<#?#^ة #.لحمل ل#.ن حم#_ #.لثيو#=#?ي#= يم#=ن أن يس#%#% أ#_#^#.#^ #=#%ي#^ة للجنين . \r\n\r\n–ل#. يج#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.ل#^#_#.#>ة لأنه يم#=ن #.ن يؤث#^ #>لى نمو #.ل#-#<ل و#=مية حلي#% #.ل#^#_#.#>ة ل#~ي #.لأم .", "GI": "Alpha-Lipoic Acid is a naturally occurring micronutrient, synthesized in small amounts by plants and animals (including humans), with antioxidant and potential chemopreventive activities. Alpha-lipoic acid acts as a free radical scavenger and assists in repairing oxidative damage and regenerates endogenous antioxidants, including vitamins C and E and glutathione. This agent also promotes glutathione synthesis. In addition, alpha-lipoic acid exerts metal chelating capacities and functions as a cofactor in various mitochondrial enzyme complexes involved in the decarboxylation of alpha-keto acids.", "Composition": "Each capsule contains:Thioctic acid (alpha lipoic acid) 300 mg\r\nBenfotiamine 40 mg\r\nCyanocobalamin\r\n250 mcg\r\n\r\nThiotacid compound 600 mg:\r\nThioctic acid (alpha lipoic acid) 600mg Benfotiamine (Vit. Bt) 80 mg\r\nCyanocobalamin (Vit. BI2) 500 mcg", "Route": "ORAL.SOLID" }, { "ID": "466", "Trade_Name": "THIAMPHENICOL 250MG 12CAPS.", "Generic_Name": "THIAMPHENICOL", "Price": "4", "Price_Old": "4", "Company": "EL NASR", "Pharmacology": "ANTIBIOTIC", "Category": "م#_#.#~ حيوي", "Use": "–أم#^#.#_ #.لجه#.ز #.ل#?ن#<سي #.لح#.#~ة و#.لن#.#?جة #>ن #.لمي#=#^و#%#.#? #.لمق#.ومة للم#_#.#~#.#? #.لحيوية #.لأخ#^ى. \r\n\r\n– أم#^#.#_ #.لجه#.ز #.له#_مي مثل #.ل#?ي#<وي#~ و #.لس#.لمونيل#.. \r\n\r\n– أم#^#.#_ #.ل#=#%#~ مثل إل#?ه#.#% #.لم#^#.#^ة #.لح#.#~. \r\n\r\n– إل#?ه#.#% مج#^ى #.ل#%ول #%م#=و#^#.#? #.لسيل#.ن.", "Contraindications": "– #.لم#^#_ى #.لذين لهم #?#.#^يخ س#.#%ق م#> قصو#^ نخ#.#> #.ل#>ظ#.م. \r\n\r\n– #.لمو#.لي#~ و #.ل#^#_#> أقل من 6 أشه#^. \r\n\r\n– #.لقصو#^ #.ل#=لوي #.لح#.#~. \r\n\r\n– #.لحس#.سية لل#<ينول#.#?. \r\n\r\n– #.ل#^#_#.#>ة (#.نظ#^ #.لحمل و #.ل#^#_#.#>ة).", "GI": "Thiamphenicol (also known as thiophenicol and dextrosulphenidol) is an antibiotic & immunosuppressive agent. It is the methyl-sulfonyl analogue of chloramphenicol and has a similar spectrum of activity, but is 2.5 to 5 times as potent. Like chloramphenicol, it is insoluble in water, but highly soluble in lipids. It is used in many countries as a veterinary antibiotic.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "467", "Trade_Name": "INTETRIX 20 CAPS", "Generic_Name": "TILBROQUINOL+TILIQUINOL+TILIQUINOL LAURYL SULPHATE", "Price": "14.4", "Price_Old": "14.4", "Company": "ARAB DRUG COMPANY. > BEAUFOUR IPSEN-FRANCE", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#-#<يلي#.#?", "Use": "–م#_#.#~ لل#~ي#~#.ن و#.ل#.م#^#.#_ #.ل#-#<يليه. \r\n\r\n–يس#?خ#~مIntetrix capsule #<ي #.ل#>ل#.ج و#.لسي#-#^ة و#.لوق#.ية، و#?حسين #.لأم#^#.#_ و#.لظ#^و#< و#.لأ#>#^#.#_ #.ل#?#.لية: \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لج#^ثومية. \r\n\r\n–#.لأمي#%ية. \r\n\r\n–#.لأم#^#.#_ #.ل#-#<يلية. \r\n\r\n–#.ل#>#~وى #.ل#-#<يلية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.", "GI": "Intetrix? is commonly used in the treatment of amoebiasis, protozoal diseases, microbial infections, protozoal diseases and other conditions.\r\n\r\nTake Intetrix? by mouth right before a meal, do not chew or break it, swallow the whole capsule. Do not take this medicine in larger or smaller amounts or for longer than recommended.", "Composition": "tilbroquinol 200mg, tiliquinol 50mg, tiliquinol n dodecyl sulphate 50mg", "Route": "ORAL.SOLID" }, { "ID": "468", "Trade_Name": "TETRACYCLINE HYDROCHLORIDE 250MG 16CAPS. USP24", "Generic_Name": "TETRACYCLINE", "Price": "4.5", "Price_Old": "4.5", "Company": "EL NASR", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–يس#?خ#~م ل#>ل#.ج ح#% #.لش#%#.#%. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمث#.نة و#.ل#=لي. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لج#^ثومية #.ل#?ي #?صي#% #.ل#>ينين. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.ل#=ولي#^#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#=ز#.ز. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.لغ#^غ#^ين#. #.لغ#.زية. \r\n\r\n–#>ل#.ج #.ل#=ل#.مي#~ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#>ل#.ج #>#~وي #.لم#>#~ة و#.لمس#%#%ة #.لإسه#.ل.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–ل#. يس#?خ#~م م#^هم #.ل#>ينين للأ#-#<#.ل أقل من 6 سنو#.#?. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.#_#-#^#.#%#.#? #%#.ل#~م و#^#.ثية.", "GI": "About Tetracycline\r\nA broad-spectrum polyketide antibiotic,Tetracycline Derivative.\r\nMechanism of Action of Tetracycline\r\nTetracycline is a broad spectrum antibiotic which has more specific action against gram positive organisms than gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals). It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. It is used in some areas for the treatment of Chloroquine-resistant falciparum malaria", "Composition": "Tetracycline 250mg", "Route": "ORAL.SOLID" }, { "ID": "469", "Trade_Name": "RUMATOL 200 MG 10 CAPS.", "Generic_Name": "TOLMETIN", "Price": "15", "Price_Old": "15", "Company": "SIGMA", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يُس#?خ#~َم هذ#. #.ل#~َّو#.ءُ ل#?خ#<ي#< ش#~َّة #.لألم و#.ل#.ل#?ه#.#%.", "Contraindications": "– إذ#. #=#.ن ل#~ى #.لم#^ي#_ #?َحَسُّسٌ #?ج#.ه #.ل#?ُّولمي#?ين أو أيِّ مُ#=َوِّن آخ#^ من هذ#. #.ل#~َّو#.ء. \r\n\r\n– يج#% إِ#-ل#.#>ُ مُق#~ِّم #.ل#^ِّ#>#.ية #.لصحِّية إذ#. #=#.ن ل#~ى #.لم#^ي#_ #?َحَسُّسٌ لأيِّ #~َو#.ءٍ آخ#^. \r\n\r\n– يج#% #.لإ#%ل#.غُ #>ن #.ل#?َّحسُّس #.لذي أص#.#% #.لم#^ي#_َ و#.ل#=ي#<يَّة #.ل#?ي أثَّ#^ #%ه#. #<يه. وي#?#_مَّن ذل#= #.ل#=ش#<َ #>ن وجو#~ #-#<ح أو #%ثو#^ أو ح#=َّة جل#~يَّة أو #_يق #<ي #.ل#?ن#<ُّس أو صَ#<ي#^ #>ن#~َ #.لشَّهيق أو سُ#>#.ل أو #?َو#^ُّم #.لوجه أو #.لشَّ#<#?ين أو #.للِّس#.ن أو #.لحَلق، أو أيَّة أ#>#^#.#_ أخ#^ى مُص#.ح#%َة ل#.ِس#?ِ#>م#.ل #.ل#~َّو#.ء. \r\n\r\n– إذ#. #=#.ن#? #.لمَ#^ي#_ةُ ح#.مل#.ً #%أ#=ث#^ من أ#^#%#>َة و#>ش#^ين أس#%و#>#.ً.", "GI": "About Tolmetin\r\nNSAID, arylalkanoic acid derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Tolmetin\r\nTolmetin is a nonsteroidal compound having anti-inflammatory, analgesics and antipyretic activities. It produces its actions by inhibiting Prostaglandin synthesis.\r\nIndications for Tolmetin\r\n1.Rheumatoid arthritis \r\n2.Osteoarthritis \r\n3.Juvanile rheumatoid arthritis \r\nTypical Dosage for Tolmetin\r\nAdult:200 - 400 mg three times a day- maximum daily dose:1800mg \r\nChildren above 2 years: 15- 30 mg/kg/day in 3 - 4 divided doses", "Composition": "tolmetin 200mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "470", "Trade_Name": "URSOTWIN 500MG 20 CAPS.", "Generic_Name": "URSODEOXYCHOLIC ACID", "Price": "50", "Price_Old": "50", "Company": "MINA PHARM", "Pharmacology": "HEPATITIS", "Category": "#.ل#?ه#.#% #.ل#=#%#~", "Use": "–يس#?خ#~م #<ي #>ل#.ج حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=#%#~ي #.لص#<#^#.وي #.لأولي و#.لم#>#^و#< #%#.سم #.ل#?شم#> #.لص#<#^#.وي. \r\n\r\n– يس#?خ#~م للوق#.ية من حصو#.#? #.لم#^#.#^ة. \r\n\r\n–ي#>#.لج ح#.ل#.#? #?لي#< #.ل#=يسي #%#.ل#=#%#~.", "Contraindications": "–#.لح#.ل#.#? #.لم#>ق#~ة #.ل#?ي #?ح#?#.ج #.ل#?#~خل #.لج#^#.حي \r\n\r\n–#<ي ح#.ل#.#? #.م#^#.#_ خل#.ي#. #.ل#=#%#~ أو وجو#~ قن#.ة م#^#.#^ية غي#^ #-#%ي#>ية #.ل#?ش#^يح أو أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية inflammatory bowel disease. \r\n\r\n–وجو#~ حصو#.#? م#^#.#^ية م#?#=لسة #.ل#?ى #?ظه#^ #<ى #.لأش#>ة أو حس#.سية لأحم#.#_ #.لم#^#.#^ة وأم#^#.#_ #=#%#~ية مزمنة \r\n\r\n–#<ي وجو#~ ن#.سو#^ م#^#.#^ي م#>وي \r\n\r\n–#.لم#^#_ى #.لذين يح#?#.جون لإج#^#.ء ج#^#.حة #.س#?ئص#.ل #.لم#^#.#^ة مثل #.لإل#?ه#.#% #.لح#.#~ للم#^#.#^ة وإل#?ه#.#% #.لقن#.ة #.لم#^#.#^ية وجو#~ #.نس#~#.#~ م#^#.#^ي #=#.مل.", "GI": "About Ursodeoxycholic Acid\r\nGallstone Dissolution Agent, a bile acid, Prophylaxis and treatment of gall stones, chronic hepatitis, liver transplant rejection.\r\nMechanism of Action of Ursodeoxycholic Acid\r\nUrsodeoxycholic acid is a bile acid. Normally there is a balance between cholesterol and bile acids in the liver. When there is an excess in cholesterol level, cholesterols are separated out from bile and form stones. Ursodeoxycholic acid is a bile acid itself, it increase the level of bile acids within the bile. It also reduces the synthesis and release of cholesterol from liver and also reduces the absorption of cholesterol from the gut. All these reverse the imbalance and prevent the separation of cholesterol from the bile acids and the bile acids also help to dissolve gall stones.\r\nIndications for Ursodeoxycholic Acid\r\n1. Primary Biliary cirrhosis \r\n2. Gall stone disease \r\n3. Chronic hepatitis \r\n4. Cystic fibrosis", "Composition": "ursodeoxycholic acid 500mg", "Route": "ORAL.SOLID" }, { "ID": "471", "Trade_Name": "VALSAR 80MG 7 CAPS.", "Generic_Name": "VALSARTAN", "Price": "18", "Price_Old": "18", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHYPERTENSIVE.ANGIOTENSIN BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#.ل#?#>#^#_ ل#.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#<ي ح#.ل#.#? قصو#^ #.لقل#% #.ل#.ح#?ق#.ني. \r\n\r\n–#.ل#?#>#^#_ لقصو#^ #.لقل#%. \r\n\r\n–#.ل#?#>#^#_ للنو#%#.#? #.لقل#%ية. \r\n\r\n–#.ل#.ص#.#%ه #%#.لجل#-#.#? #.لقل#%ية.", "Contraindications": "–خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية، يحظ#^ #.س#?خ#~#.م هذ#. #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة م#^ي#_ ي#>#.ني من م#^#_ #.لس#=#^ي. \r\n\r\n–#%#.لنس#%ة #.لذين ل#~يهم حس#.سية لأح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يحظ#^ #>لى #.لأ#-#<#.ل #~ون سن 6 سنو#.#?. \r\n\r\n–ي#>#.ني #.لم#^ي#_ من #?#_يق #.لش#^ي#.ن #.ل#=لوي. \r\n\r\n–ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ق#- #?ح#? إش#^#.#< #-#%ي خو#<#. من #.ل#?#<#.#>ل#.#? #%ين #.ل#>ل#.ج و#.لأ#~وية #.لأخ#^ى #.ل#?ي يأخذه#. #.لم#^ي#_. \r\n\r\n–#.لذي ي#>#.ني من #=ث#^ة إ#<#^#.ز #.لغ#~ة #.ل#~#^قية.", "GI": "About Valsartan\r\nAngiotensin II receptor antagonist, Antihypertensive.\r\nMechanism of Action of Valsartan\r\nIt is a competitive antagonist of angiotensin-2 at AT-1 receptor. It decreases peripheral resistance and lowers BP in hypertensive individuals. It blocks all overt actions of angiotensin-2 such as: - 1. Vasoconstriction, 2. Central & Peripheral sympathetic stimulus, 3. Release of aldosterone and adrenaline, 4. Salt and water reabsorption, 5. Central actions like thirst, vasopressin release, and growth promoting actions on heart and blood vessels.\r\nIndications for Valsartan\r\n1. Hypertension\r\nInteractions for Valsartan\r\nPotassium-sparing diuretics (e.g., Spironolactone, Triamterene, Amiloride), Potassium supplements, or Salt substitutes containing potassium: Concomitant use of Valsartan with these drugs will result in hyperkalaemia and in heart failure patients it increases serum creatinine.", "Composition": "valsartan 80mg", "Route": "ORAL.SOLID" }, { "ID": "472", "Trade_Name": "IDISARTAN 80MG 7 CAPS.", "Generic_Name": "VALSARTAN", "Price": "16.8", "Price_Old": "16.8", "Company": "INTERNATIONAL DRUG AGENCY (IDI) > NOVELL PHARMA", "Pharmacology": "ANTIHYPERTENSIVE.ANGIOTENSIN BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#.ل#?#>#^#_ ل#.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#<ي ح#.ل#.#? قصو#^ #.لقل#% #.ل#.ح#?ق#.ني. \r\n\r\n–#.ل#?#>#^#_ لقصو#^ #.لقل#%. \r\n\r\n–#.ل#?#>#^#_ للنو#%#.#? #.لقل#%ية. \r\n\r\n–#.ل#.ص#.#%ه #%#.لجل#-#.#? #.لقل#%ية.", "Contraindications": "–خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية، يحظ#^ #.س#?خ#~#.م هذ#. #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة م#^ي#_ ي#>#.ني من م#^#_ #.لس#=#^ي. \r\n\r\n–#%#.لنس#%ة #.لذين ل#~يهم حس#.سية لأح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يحظ#^ #>لى #.لأ#-#<#.ل #~ون سن 6 سنو#.#?. \r\n\r\n–ي#>#.ني #.لم#^ي#_ من #?#_يق #.لش#^ي#.ن #.ل#=لوي. \r\n\r\n–ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ق#- #?ح#? إش#^#.#< #-#%ي خو#<#. من #.ل#?#<#.#>ل#.#? #%ين #.ل#>ل#.ج و#.لأ#~وية #.لأخ#^ى #.ل#?ي يأخذه#. #.لم#^ي#_. \r\n\r\n–#.لذي ي#>#.ني من #=ث#^ة إ#<#^#.ز #.لغ#~ة #.ل#~#^قية.", "GI": "About Valsartan\r\nAngiotensin II receptor antagonist, Antihypertensive.\r\nMechanism of Action of Valsartan\r\nIt is a competitive antagonist of angiotensin-2 at AT-1 receptor. It decreases peripheral resistance and lowers BP in hypertensive individuals. It blocks all overt actions of angiotensin-2 such as: - 1. Vasoconstriction, 2. Central & Peripheral sympathetic stimulus, 3. Release of aldosterone and adrenaline, 4. Salt and water reabsorption, 5. Central actions like thirst, vasopressin release, and growth promoting actions on heart and blood vessels.\r\nIndications for Valsartan\r\n1. Hypertension\r\nInteractions for Valsartan\r\nPotassium-sparing diuretics (e.g., Spironolactone, Triamterene, Amiloride), Potassium supplements, or Salt substitutes containing potassium: Concomitant use of Valsartan with these drugs will result in hyperkalaemia and in heart failure patients it increases serum creatinine.", "Composition": "valsartan 80mg", "Route": "ORAL.SOLID" }, { "ID": "473", "Trade_Name": "CONVULEX 150MG 40 CAPS.", "Generic_Name": "VALPROIC ACID", "Price": "45", "Price_Old": "45", "Company": "GEROT PHARMA > B.P PHARMA", "Pharmacology": "ANTICONVULSANT", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–يس#?خ#~م #<ي #>ل#.ج نو#%#.#? #.لص#^#> #.لح#.#~ه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#.ل#.#? #.لص#~#.#> #.لنص#<ي #.لح#.#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#>#~و#.نيه #>ن#~ #.ل#.#-#<#.ل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج مش#.#=ل #.لنش#.#- #.لم#<#^#- و#.لن#-ق #>ن#~ #%#>#_ #.ل#.#-#<#.ل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.#=#?ئ#.#% #.لح#.#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.#_#-#^#.#%#.#? #.لهوسيه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لخو#< و#.ل#?و#?#^ #.لم#^#_ي. \r\n\r\n–يس#?خ#~م #<ي #?ه#~ئه #.ل#.#>ص#.#%.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.م#^#.#_ #.ل#=#%#~ و#.ل#%ن#=#^ي#.س. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء لل#.#-#<#.ل #.قل من #>#.مين. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.م#^#.#_ #.ليو#^ي#..", "GI": "About Valproic Acid\r\nHistone Deacetylase Inhibitor ,a GABA transaminase inhibitor, Anticonvulsant, Antimanic,migraine prophylactic.\r\nMechanism of Action of Valproic Acid\r\nValproic acid prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or by decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency neuronal discharge. It blocks the propagation of neuronal impulses. It also modulates neurotransmitter release and neuronal bursting through an effect on voltage gated and receptor gated calcium channels. SValproic acid enhances the release and synthesis of inhibitory neurotransmitter GABA and inhibits its degradation. This will result in an increased concentration of GABA and is used as antiepileptic agent. Valproate is also used to treat the acute manic phase of bipolar disorder and for the prophylaxis of migraine.", "Composition": "1 capsule contains 300 mg valproic acid", "Route": "ORAL.SOLID" }, { "ID": "474", "Trade_Name": "VENLAFAXINE 75MG SR 7 CAPS.", "Generic_Name": "VENLAFAXINE", "Price": "21", "Price_Old": "21", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–ي#?م #.س#?خ#~#.مه #<ي #>ل#.ج ح#.ل#.#? #.ل#.#=#?ئ#.#%. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.#_#-#^#.#%#.#? #.لهل#>. \r\n\r\n–ي#?م #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لقلق و#.ل#?و#?#^. \r\n\r\n–يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لهل#> #.ل#.ج#?م#.#>ي. \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? #.له#%#.#? #.لس#.خنة. \r\n\r\n–وأ#>#^#.#_ #.نق#-#.#> #.ل#-مث ل#~ى #.لسي#~#.#?. \r\n\r\n–ل#>ل#.ج ح#.ل#.#? س#^#-#.ن #.لث#~ي.", "Contraindications": "–1. ل#. يج#% #.س#?خ#~#.مه للم#^#_ى #.ل#?ي #?#>#.ني من أي حس#.سية من أي م#^#=#% من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–2. من #.لممنو#> #.س#?خ#~#.مه م#> #?ن#.ول مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين، وإذ#. ل#. #%#~ من #?ن#.وله ي#?م #?ن#.وله #%#>#~ 14 يوم من #?وق#< #.ل#>ل#.ج #>ن #?ن#.وله. \r\n\r\n–3. أم#. #%#.لنس#%ة للأ#-#<#.ل و#.لم#^#.هقين #.لذين ل#. ي#%لغون من #.ل#>م#^ 18 #>#.م ممنو#> #.س#?خ#~#.مه نه#.ئي#.ً.", "GI": "About Venlafaxine\r\nAn arylalkanolamine derivative,Serotonin\r\norepinephrine ReuptakeInhibitor, Antidepressant,anxiolytic.\r\nMechanism of Action of Venlafaxine\r\nVenlafaxine and its metabolite block the re-uptake of neurotransmitter Serotonin and Noradrenaline from the synapse in to the presynaptic nerve terminal in the CNS. In high doses it weakly inhibits the reuptake of Dopamine. Venlafaxine potentiates the neurotransmitter`s activity and produces antidepressant action.\r\nIndications for Venlafaxine\r\n1. Depression \r\n2. Generalised anxiety disorder \r\n3. Social anxiety disorder", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "475", "Trade_Name": "DISARTAN 160MG 14 CAPS.", "Generic_Name": "VALSARTAN", "Price": "42", "Price_Old": "42", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIHYPERTENSIVE.ANGIOTENSIN BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#.ل#?#>#^#_ ل#.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#<ي ح#.ل#.#? قصو#^ #.لقل#% #.ل#.ح#?ق#.ني. \r\n\r\n–#.ل#?#>#^#_ لقصو#^ #.لقل#%. \r\n\r\n–#.ل#?#>#^#_ للنو#%#.#? #.لقل#%ية. \r\n\r\n–#.ل#.ص#.#%ه #%#.لجل#-#.#? #.لقل#%ية.", "Contraindications": "–خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية، يحظ#^ #.س#?خ#~#.م هذ#. #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة م#^ي#_ ي#>#.ني من م#^#_ #.لس#=#^ي. \r\n\r\n–#%#.لنس#%ة #.لذين ل#~يهم حس#.سية لأح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يحظ#^ #>لى #.لأ#-#<#.ل #~ون سن 6 سنو#.#?. \r\n\r\n–ي#>#.ني #.لم#^ي#_ من #?#_يق #.لش#^ي#.ن #.ل#=لوي. \r\n\r\n–ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ق#- #?ح#? إش#^#.#< #-#%ي خو#<#. من #.ل#?#<#.#>ل#.#? #%ين #.ل#>ل#.ج و#.لأ#~وية #.لأخ#^ى #.ل#?ي يأخذه#. #.لم#^ي#_. \r\n\r\n–#.لذي ي#>#.ني من #=ث#^ة إ#<#^#.ز #.لغ#~ة #.ل#~#^قية.", "GI": "About Valsartan\r\nAngiotensin II receptor antagonist, Antihypertensive.\r\nMechanism of Action of Valsartan\r\nIt is a competitive antagonist of angiotensin-2 at AT-1 receptor. It decreases peripheral resistance and lowers BP in hypertensive individuals. It blocks all overt actions of angiotensin-2 such as: - 1. Vasoconstriction, 2. Central & Peripheral sympathetic stimulus, 3. Release of aldosterone and adrenaline, 4. Salt and water reabsorption, 5. Central actions like thirst, vasopressin release, and growth promoting actions on heart and blood vessels.\r\nIndications for Valsartan\r\n1. Hypertension\r\nInteractions for Valsartan\r\nPotassium-sparing diuretics (e.g., Spironolactone, Triamterene, Amiloride), Potassium supplements, or Salt substitutes containing potassium: Concomitant use of Valsartan with these drugs will result in hyperkalaemia and in heart failure patients it increases serum creatinine.", "Composition": "Each Disartan capsule contains 80 mg valsartan.\r\n\r\nEach Disartan capsule contains 160 mg valsartan.", "Route": "ORAL.SOLID" }, { "ID": "476", "Trade_Name": "DISARTAN 80MG 14 CAPS.", "Generic_Name": "VALSARTAN", "Price": "36", "Price_Old": "36", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIHYPERTENSIVE.ANGIOTENSIN BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#.ل#?#>#^#_ ل#.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#<ي ح#.ل#.#? قصو#^ #.لقل#% #.ل#.ح#?ق#.ني. \r\n\r\n–#.ل#?#>#^#_ لقصو#^ #.لقل#%. \r\n\r\n–#.ل#?#>#^#_ للنو#%#.#? #.لقل#%ية. \r\n\r\n–#.ل#.ص#.#%ه #%#.لجل#-#.#? #.لقل#%ية.", "Contraindications": "–خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية، يحظ#^ #.س#?خ#~#.م هذ#. #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة م#^ي#_ ي#>#.ني من م#^#_ #.لس#=#^ي. \r\n\r\n–#%#.لنس#%ة #.لذين ل#~يهم حس#.سية لأح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يحظ#^ #>لى #.لأ#-#<#.ل #~ون سن 6 سنو#.#?. \r\n\r\n–ي#>#.ني #.لم#^ي#_ من #?#_يق #.لش#^ي#.ن #.ل#=لوي. \r\n\r\n–ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ق#- #?ح#? إش#^#.#< #-#%ي خو#<#. من #.ل#?#<#.#>ل#.#? #%ين #.ل#>ل#.ج و#.لأ#~وية #.لأخ#^ى #.ل#?ي يأخذه#. #.لم#^ي#_. \r\n\r\n–#.لذي ي#>#.ني من #=ث#^ة إ#<#^#.ز #.لغ#~ة #.ل#~#^قية.", "GI": "About Valsartan\r\nAngiotensin II receptor antagonist, Antihypertensive.\r\nMechanism of Action of Valsartan\r\nIt is a competitive antagonist of angiotensin-2 at AT-1 receptor. It decreases peripheral resistance and lowers BP in hypertensive individuals. It blocks all overt actions of angiotensin-2 such as: - 1. Vasoconstriction, 2. Central & Peripheral sympathetic stimulus, 3. Release of aldosterone and adrenaline, 4. Salt and water reabsorption, 5. Central actions like thirst, vasopressin release, and growth promoting actions on heart and blood vessels.\r\nIndications for Valsartan\r\n1. Hypertension\r\nInteractions for Valsartan\r\nPotassium-sparing diuretics (e.g., Spironolactone, Triamterene, Amiloride), Potassium supplements, or Salt substitutes containing potassium: Concomitant use of Valsartan with these drugs will result in hyperkalaemia and in heart failure patients it increases serum creatinine.", "Composition": "Each Disartan capsule contains 80 mg valsartan.\r\n\r\nEach Disartan capsule contains 160 mg valsartan.", "Route": "ORAL.SOLID" }, { "ID": "477", "Trade_Name": "VENLAFAXINE 37.5 MG SR 7 CAPS.", "Generic_Name": "VENLAFAXINE", "Price": "14", "Price_Old": "14", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–ي#?م #.س#?خ#~#.مه #<ي #>ل#.ج ح#.ل#.#? #.ل#.#=#?ئ#.#%. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.#_#-#^#.#%#.#? #.لهل#>. \r\n\r\n–ي#?م #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لقلق و#.ل#?و#?#^. \r\n\r\n–يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لهل#> #.ل#.ج#?م#.#>ي. \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? #.له#%#.#? #.لس#.خنة. \r\n\r\n–وأ#>#^#.#_ #.نق#-#.#> #.ل#-مث ل#~ى #.لسي#~#.#?. \r\n\r\n–ل#>ل#.ج ح#.ل#.#? س#^#-#.ن #.لث#~ي.", "Contraindications": "–1. ل#. يج#% #.س#?خ#~#.مه للم#^#_ى #.ل#?ي #?#>#.ني من أي حس#.سية من أي م#^#=#% من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–2. من #.لممنو#> #.س#?خ#~#.مه م#> #?ن#.ول مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين، وإذ#. ل#. #%#~ من #?ن#.وله ي#?م #?ن#.وله #%#>#~ 14 يوم من #?وق#< #.ل#>ل#.ج #>ن #?ن#.وله. \r\n\r\n–3. أم#. #%#.لنس#%ة للأ#-#<#.ل و#.لم#^#.هقين #.لذين ل#. ي#%لغون من #.ل#>م#^ 18 #>#.م ممنو#> #.س#?خ#~#.مه نه#.ئي#.ً.", "GI": "About Venlafaxine\r\nAn arylalkanolamine derivative,Serotonin\r\norepinephrine ReuptakeInhibitor, Antidepressant,anxiolytic.\r\nMechanism of Action of Venlafaxine\r\nVenlafaxine and its metabolite block the re-uptake of neurotransmitter Serotonin and Noradrenaline from the synapse in to the presynaptic nerve terminal in the CNS. In high doses it weakly inhibits the reuptake of Dopamine. Venlafaxine potentiates the neurotransmitter`s activity and produces antidepressant action.\r\nIndications for Venlafaxine\r\n1. Depression \r\n2. Generalised anxiety disorder \r\n3. Social anxiety disorder", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "478", "Trade_Name": "CONVULEX 300MG 40 CAPS.", "Generic_Name": "VALPROIC ACID", "Price": "63", "Price_Old": "63", "Company": "GEROT PHARMA > B.P PHARMA", "Pharmacology": "ANTICONVULSANT", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–يس#?خ#~م #<ي #>ل#.ج نو#%#.#? #.لص#^#> #.لح#.#~ه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج م#^#_ #.لص#^#>. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#.ل#.#? #.لص#~#.#> #.لنص#<ي #.لح#.#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#>#~و#.نيه #>ن#~ #.ل#.#-#<#.ل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج مش#.#=ل #.لنش#.#- #.لم#<#^#- و#.لن#-ق #>ن#~ #%#>#_ #.ل#.#-#<#.ل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.#=#?ئ#.#% #.لح#.#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.#_#-#^#.#%#.#? #.لهوسيه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لخو#< و#.ل#?و#?#^ #.لم#^#_ي. \r\n\r\n–يس#?خ#~م #<ي #?ه#~ئه #.ل#.#>ص#.#%.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.م#^#.#_ #.ل#=#%#~ و#.ل#%ن#=#^ي#.س. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء لل#.#-#<#.ل #.قل من #>#.مين. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.م#^#.#_ #.ليو#^ي#..", "GI": "About Valproic Acid\r\nHistone Deacetylase Inhibitor ,a GABA transaminase inhibitor, Anticonvulsant, Antimanic,migraine prophylactic.\r\nMechanism of Action of Valproic Acid\r\nValproic acid prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or by decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency neuronal discharge. It blocks the propagation of neuronal impulses. It also modulates neurotransmitter release and neuronal bursting through an effect on voltage gated and receptor gated calcium channels. SValproic acid enhances the release and synthesis of inhibitory neurotransmitter GABA and inhibits its degradation. This will result in an increased concentration of GABA and is used as antiepileptic agent. Valproate is also used to treat the acute manic phase of bipolar disorder and for the prophylaxis of migraine.", "Composition": "1 capsule contains 300 mg valproic acid", "Route": "ORAL.SOLID" }, { "ID": "479", "Trade_Name": "VENLAFAXINE 150 MG SR 7 CAPS.", "Generic_Name": "VENLAFAXINE", "Price": "27", "Price_Old": "27", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–ي#?م #.س#?خ#~#.مه #<ي #>ل#.ج ح#.ل#.#? #.ل#.#=#?ئ#.#%. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.#_#-#^#.#%#.#? #.لهل#>. \r\n\r\n–ي#?م #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لقلق و#.ل#?و#?#^. \r\n\r\n–يج#% #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لهل#> #.ل#.ج#?م#.#>ي. \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? #.له#%#.#? #.لس#.خنة. \r\n\r\n–وأ#>#^#.#_ #.نق#-#.#> #.ل#-مث ل#~ى #.لسي#~#.#?. \r\n\r\n–ل#>ل#.ج ح#.ل#.#? س#^#-#.ن #.لث#~ي.", "Contraindications": "–1. ل#. يج#% #.س#?خ#~#.مه للم#^#_ى #.ل#?ي #?#>#.ني من أي حس#.سية من أي م#^#=#% من م#^#=#%#.#? #.ل#~و#.ء. \r\n\r\n–2. من #.لممنو#> #.س#?خ#~#.مه م#> #?ن#.ول مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين، وإذ#. ل#. #%#~ من #?ن#.وله ي#?م #?ن#.وله #%#>#~ 14 يوم من #?وق#< #.ل#>ل#.ج #>ن #?ن#.وله. \r\n\r\n–3. أم#. #%#.لنس#%ة للأ#-#<#.ل و#.لم#^#.هقين #.لذين ل#. ي#%لغون من #.ل#>م#^ 18 #>#.م ممنو#> #.س#?خ#~#.مه نه#.ئي#.ً.", "GI": "About Venlafaxine\r\nAn arylalkanolamine derivative,Serotonin\r\norepinephrine ReuptakeInhibitor, Antidepressant,anxiolytic.\r\nMechanism of Action of Venlafaxine\r\nVenlafaxine and its metabolite block the re-uptake of neurotransmitter Serotonin and Noradrenaline from the synapse in to the presynaptic nerve terminal in the CNS. In high doses it weakly inhibits the reuptake of Dopamine. Venlafaxine potentiates the neurotransmitter`s activity and produces antidepressant action.\r\nIndications for Venlafaxine\r\n1. Depression \r\n2. Generalised anxiety disorder \r\n3. Social anxiety disorder", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "480", "Trade_Name": "SORAL 20 MG 20 CAPS.", "Generic_Name": "TENOXICAM", "Price": "36", "Price_Old": "36", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?س#=ين #.ل#.لم وم#_#.#~ لل#.ل#?ه#.#% وي#>مل #>لى خ#<#_ #.لح#^#.#^ة. \r\n\r\n–يس#.#>#~ #<ي م#>#.لجة #.ل#.ل#?ه#.#%#.#? و#.لألم #.لذي يوج#~ #<ي #.لجه#.ز #.لح#^#=ي #%ش#=ل #<#>#.ل. \r\n\r\n–ي#?م #.س#?خ#~#.مه #<ي م#>#.لجة #.ل#?ه#.#% #.ل#>#_ل#.#? و#.لأ#^#%#-ة ويقوم م#_#.#~ لل#.ل#?ه#.#%#.#? #%#.ل#.#_#.#<ة #.لى م#>#.لجة #.لآل#.م #.ل#?ي #?ح#~ث #%س#%#% #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يس#.#>#~ #<ي م#>#.لجة #.ل#?و#^م#.#? #.ل#?ي #?ظه#^ #%#>#~ #.ج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ل#.ج #<ي م#>#.لجة هش#.شة #.ل#>ظ#.م وآل#.م #.لم#<#.صل و#.ل#>#_ل#.#? #%#.ل#.#_#.#<ة إلى م#>#.لجة #.ل#?ه#.#% #.ل#=#?#<ين و#.لأو#?#.#^ وي#>مل #>لى #?س#=ين آل#.م #.لظه#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ حس#.سية من إح#~ى م#=ون#.#?ه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأ#-#<#.ل أقل من #>م#^ 18 سنه. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ل#.ج #>ن#~ وجو#~ نزي#< نش#- أو #>ني#<. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ل#.ج #%ح#^ص #>ن#~ وجو#~ نقص #<ي #>#~#~ #.لص#<#.ئح #.ل#~موية أو #>ن#~ وجو#~ نزي#< أو #%#>#_ #.لمش#.#=ل #<ي #.ل#^ؤية #%#.ل#.#_#.#<ة #>ن#~ وجو#~ مش#.#=ل #<ي #.ل#=#%#~ أو #.ل#=لى. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل و#.لم#^#_#>#.#? لأنه ي#_#^ #%صحة #.لجنين و#=ذل#= #.ل#-#<ل #.ل#^#_ي#> لأنه ي#<#^ز #<ي #.لل#%ن. \r\n\r\n–#>#~م #?ن#.ول هذ#. #.ل#~و#.ء لم#^#_ي #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#>ن#~ وجو#~ #<شل #<ي #.لقل#% و#%#>#_ أم#^#.#_ #.لقل#% و#.لش#^#.يين. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#?ن#.ولون #.لأ#~وية #.لم#_#.#~ لل#?خث#^ مثل #~و#.ء #.لو#.#^#<#.#^ين.", "GI": "Mechanism of Action of Tenoxicam\r\nThe anti-inflammatory effects of Tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam). Antipyresis may occur due to its central action on the hypothalamus (resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss).Drug inhibits platelet aggregation (prolongs bleeding time) .It act as a scavenger for active oxygen at the site of inflammation. It also inhibits human metalloproteinases (stromelysin and collagenase) which induce cartilage breakdown.", "Composition": "Each Soral capsule contains 20 mg tenoxicam\r\nEach Soral suppository contains 20 mg tenoxicam\r\nEach Soral lyophilized vial contains 20 mg tenoxicam.", "Route": "ORAL.SOLID" }, { "ID": "481", "Trade_Name": "TERACIN 2MG 10 CAPS.", "Generic_Name": "TERAZOCIN", "Price": "9.5", "Price_Old": "9.5", "Company": "TECHNOPHARM", "Pharmacology": "ALPHA1 BLOCKER", "Category": "#?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~", "Use": "–#>ل#.ج #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–يس#.#>#~ #<ي #?حسين #>ملية #.ل#?#%ول #>ن#~ #.ل#^ج#.ل.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية م#<#^#-ة #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #?حسسي للإص#.#%ة #%حس#.سية #.#?ج#.ه أ#~وية #?ح#?وى #>لى م#.#~ة #?ي#^#.زوسين. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ للم#^أة #.لح#.مل حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ #.لمشيمة و#?س#%#% #?شوه #.لأجنة. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه. \r\n\r\n–يحذ#^ #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? #>ن#~ #?ن#.ول #.ل#>ق#.#^ حيث يس#%#% #.ل#~وخة و#>#~م و#_وح #.ل#^ؤية. \r\n\r\n–ينصح #%#?ن#.ول #.لج#^#>ة #.لأولي ق#%ل #.لنوم حيث يس#%#% #.ل#~وخة و#.ل#~و#.#^ #.لخ#<ي#<. \r\n\r\n–يحذ#^ #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية م#> #.ل#>ق#.#^ حيث #?زي#~ من #.نخ#<#.#_ #_غ#- #.ل#~م.", "GI": "Indication\t\r\nFor the treatment of symptomatic BPH and mild to moderate hypertension.\r\nMechanism of action\tIn general, a1-adrenergic receptors mediate contraction and hypertrophic growth of smooth muscle cells. a1-Receptors are 7-transmembrane domain receptors coupled to G proteins, Gq/11. Three a1-receptor subtypes, which share approximately 75% homology in their transmembrane domains, have been identified: a1A (chromosome 8), a1B (chromosome 5), and a1D (chromosome 20). Terazosin is the first a1-receptor antagonist to demonstrate selectivity for the a1A-receptor. All three receptor subtypes appear to be involved in maintaining vascular tone. The a1A-receptor maintains basal vascular tone while the a1B-receptor mediates the vasocontrictory effects of exogenous a1-agonists. Activation of a1-receptors activates Gq-proteins, which results in intracellular stimulation of phospholipases C, A2, and", "Composition": "terazosin hcl 2mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "482", "Trade_Name": "TENOXICAM 20MG 20 CAPS.", "Generic_Name": "TENOXICAM", "Price": "27", "Price_Old": "27", "Company": "EL-OBOUR", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?س#=ين #.ل#.لم وم#_#.#~ لل#.ل#?ه#.#% وي#>مل #>لى خ#<#_ #.لح#^#.#^ة. \r\n\r\n–يس#.#>#~ #<ي م#>#.لجة #.ل#.ل#?ه#.#%#.#? و#.لألم #.لذي يوج#~ #<ي #.لجه#.ز #.لح#^#=ي #%ش#=ل #<#>#.ل. \r\n\r\n–ي#?م #.س#?خ#~#.مه #<ي م#>#.لجة #.ل#?ه#.#% #.ل#>#_ل#.#? و#.لأ#^#%#-ة ويقوم م#_#.#~ لل#.ل#?ه#.#%#.#? #%#.ل#.#_#.#<ة #.لى م#>#.لجة #.لآل#.م #.ل#?ي #?ح#~ث #%س#%#% #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يس#.#>#~ #<ي م#>#.لجة #.ل#?و#^م#.#? #.ل#?ي #?ظه#^ #%#>#~ #.ج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ل#.ج #<ي م#>#.لجة هش#.شة #.ل#>ظ#.م وآل#.م #.لم#<#.صل و#.ل#>#_ل#.#? #%#.ل#.#_#.#<ة إلى م#>#.لجة #.ل#?ه#.#% #.ل#=#?#<ين و#.لأو#?#.#^ وي#>مل #>لى #?س#=ين آل#.م #.لظه#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ حس#.سية من إح#~ى م#=ون#.#?ه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأ#-#<#.ل أقل من #>م#^ 18 سنه. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ل#.ج #>ن#~ وجو#~ نزي#< نش#- أو #>ني#<. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ل#.ج #%ح#^ص #>ن#~ وجو#~ نقص #<ي #>#~#~ #.لص#<#.ئح #.ل#~موية أو #>ن#~ وجو#~ نزي#< أو #%#>#_ #.لمش#.#=ل #<ي #.ل#^ؤية #%#.ل#.#_#.#<ة #>ن#~ وجو#~ مش#.#=ل #<ي #.ل#=#%#~ أو #.ل#=لى. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل و#.لم#^#_#>#.#? لأنه ي#_#^ #%صحة #.لجنين و#=ذل#= #.ل#-#<ل #.ل#^#_ي#> لأنه ي#<#^ز #<ي #.لل#%ن. \r\n\r\n–#>#~م #?ن#.ول هذ#. #.ل#~و#.ء لم#^#_ي #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#>ن#~ وجو#~ #<شل #<ي #.لقل#% و#%#>#_ أم#^#.#_ #.لقل#% و#.لش#^#.يين. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#?ن#.ولون #.لأ#~وية #.لم#_#.#~ لل#?خث#^ مثل #~و#.ء #.لو#.#^#<#.#^ين.", "GI": "Mechanism of Action of Tenoxicam\r\nThe anti-inflammatory effects of Tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam). Antipyresis may occur due to its central action on the hypothalamus (resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss).Drug inhibits platelet aggregation (prolongs bleeding time) .It act as a scavenger for active oxygen at the site of inflammation. It also inhibits human metalloproteinases (stromelysin and collagenase) which induce cartilage breakdown.", "Composition": "Each TENOXICAM 20 Capsule contains 20 mg of Tenoxicam.", "Route": "ORAL.SOLID" }, { "ID": "483", "Trade_Name": "TENOCAM 20MG 10 CAPS.", "Generic_Name": "TENOXICAM", "Price": "9", "Price_Old": "9", "Company": "KAHIRA", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?س#=ين #.ل#.لم وم#_#.#~ لل#.ل#?ه#.#% وي#>مل #>لى خ#<#_ #.لح#^#.#^ة. \r\n\r\n–يس#.#>#~ #<ي م#>#.لجة #.ل#.ل#?ه#.#%#.#? و#.لألم #.لذي يوج#~ #<ي #.لجه#.ز #.لح#^#=ي #%ش#=ل #<#>#.ل. \r\n\r\n–ي#?م #.س#?خ#~#.مه #<ي م#>#.لجة #.ل#?ه#.#% #.ل#>#_ل#.#? و#.لأ#^#%#-ة ويقوم م#_#.#~ لل#.ل#?ه#.#%#.#? #%#.ل#.#_#.#<ة #.لى م#>#.لجة #.لآل#.م #.ل#?ي #?ح#~ث #%س#%#% #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–يس#.#>#~ #<ي م#>#.لجة #.ل#?و#^م#.#? #.ل#?ي #?ظه#^ #%#>#~ #.ج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ل#.ج #<ي م#>#.لجة هش#.شة #.ل#>ظ#.م وآل#.م #.لم#<#.صل و#.ل#>#_ل#.#? #%#.ل#.#_#.#<ة إلى م#>#.لجة #.ل#?ه#.#% #.ل#=#?#<ين و#.لأو#?#.#^ وي#>مل #>لى #?س#=ين آل#.م #.لظه#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ حس#.سية من إح#~ى م#=ون#.#?ه. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأ#-#<#.ل أقل من #>م#^ 18 سنه. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ل#.ج #>ن#~ وجو#~ نزي#< نش#- أو #>ني#<. \r\n\r\n–يس#?خ#~م هذ#. #.ل#>ل#.ج #%ح#^ص #>ن#~ وجو#~ نقص #<ي #>#~#~ #.لص#<#.ئح #.ل#~موية أو #>ن#~ وجو#~ نزي#< أو #%#>#_ #.لمش#.#=ل #<ي #.ل#^ؤية #%#.ل#.#_#.#<ة #>ن#~ وجو#~ مش#.#=ل #<ي #.ل#=#%#~ أو #.ل#=لى. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل و#.لم#^#_#>#.#? لأنه ي#_#^ #%صحة #.لجنين و#=ذل#= #.ل#-#<ل #.ل#^#_ي#> لأنه ي#<#^ز #<ي #.لل#%ن. \r\n\r\n–#>#~م #?ن#.ول هذ#. #.ل#~و#.ء لم#^#_ي #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–#>ن#~ وجو#~ #<شل #<ي #.لقل#% و#%#>#_ أم#^#.#_ #.لقل#% و#.لش#^#.يين. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#?ن#.ولون #.لأ#~وية #.لم#_#.#~ لل#?خث#^ مثل #~و#.ء #.لو#.#^#<#.#^ين.", "GI": "Mechanism of Action of Tenoxicam\r\nThe anti-inflammatory effects of Tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam). Antipyresis may occur due to its central action on the hypothalamus (resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss).Drug inhibits platelet aggregation (prolongs bleeding time) .It act as a scavenger for active oxygen at the site of inflammation. It also inhibits human metalloproteinases (stromelysin and collagenase) which induce cartilage breakdown.", "Composition": "tenoxicam 20mg", "Route": "ORAL.SOLID" }, { "ID": "484", "Trade_Name": "ANDROMEN 40MG 20 SOFT GELATIN CAPS.", "Generic_Name": "TESTOSTERONE UNDECANOATE", "Price": "26.4", "Price_Old": "26.4", "Company": "DELTA PHARMA", "Pharmacology": "ANDROGEN", "Category": "#.#>#^#.#_ #.نخ#<#.#_ ه#^مون #?س#?وس#?ي#^ون", "Use": "–يس#?#>مل ه#^مون #.ل#?س#?وس#?ي#^ون #<ي #.ل#^ج#.ل لم#~#.و#.ة #.لأم#^#.#_ #.ل#?ي يس#%#%ه#. ن#~#^ة ذل#= #.له#^مون مثل : \r\n\r\n–#?أخي#^ #<ي سن #.ل#%لوغ أو #.ل#>جز #.لجنسي أو #.ل#.خ#?ل#.ل#.#? #.له#^مونية #.لأخ#^ى. \r\n\r\n–#=م#. #.نه يس#?#>مل #<ي #.لم#^أة لم#~#.و#.ة س#^#-#.ن #.لث#~ي #.لش#.ئ#> وغي#^ ق#.#%ل للج#^#.حة.", "Contraindications": "–#<#^#- #.لحس#.سية لل#~و#.ء. \r\n\r\n–س#^#-#.ن #.ل#%#^وس#?#.#?#.. \r\n\r\n–س#^#-#.ن #.لث#~ي #<ي #.لذ#=و#^. \r\n\r\n–#%#>#_ #.لأش#=#.ل ل#. #?س#?خ#~م #<ي #.لإن#.ث. \r\n\r\n–أم#^#.#_ #.ل#=#%#~ ، #.ل#=لى و #.لقل#% #.لح#.#~ة.", "GI": "COMING SOON ..", "Composition": "testosterone 40mg", "Route": "ORAL.SOLID" }, { "ID": "485", "Trade_Name": "TERACIN 5MG 10 CAPS.", "Generic_Name": "TERAZOCIN", "Price": "14.4", "Price_Old": "14.4", "Company": "TECHNOPHARM", "Pharmacology": "ALPHA1 BLOCKER", "Category": "#?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~", "Use": "–#>ل#.ج #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–يس#.#>#~ #<ي #?حسين #>ملية #.ل#?#%ول #>ن#~ #.ل#^ج#.ل.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية م#<#^#-ة #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #?حسسي للإص#.#%ة #%حس#.سية #.#?ج#.ه أ#~وية #?ح#?وى #>لى م#.#~ة #?ي#^#.زوسين. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ للم#^أة #.لح#.مل حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ #.لمشيمة و#?س#%#% #?شوه #.لأجنة. \r\n\r\n–يحذ#^ #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه. \r\n\r\n–يحذ#^ #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? #>ن#~ #?ن#.ول #.ل#>ق#.#^ حيث يس#%#% #.ل#~وخة و#>#~م و#_وح #.ل#^ؤية. \r\n\r\n–ينصح #%#?ن#.ول #.لج#^#>ة #.لأولي ق#%ل #.لنوم حيث يس#%#% #.ل#~وخة و#.ل#~و#.#^ #.لخ#<ي#<. \r\n\r\n–يحذ#^ #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية م#> #.ل#>ق#.#^ حيث #?زي#~ من #.نخ#<#.#_ #_غ#- #.ل#~م.", "GI": "Indication\t\r\nFor the treatment of symptomatic BPH and mild to moderate hypertension.\r\nMechanism of action\tIn general, a1-adrenergic receptors mediate contraction and hypertrophic growth of smooth muscle cells. a1-Receptors are 7-transmembrane domain receptors coupled to G proteins, Gq/11. Three a1-receptor subtypes, which share approximately 75% homology in their transmembrane domains, have been identified: a1A (chromosome 8), a1B (chromosome 5), and a1D (chromosome 20). Terazosin is the first a1-receptor antagonist to demonstrate selectivity for the a1A-receptor. All three receptor subtypes appear to be involved in maintaining vascular tone. The a1A-receptor maintains basal vascular tone while the a1B-receptor mediates the vasocontrictory effects of exogenous a1-agonists. Activation of a1-receptors activates Gq-proteins, which results in intracellular stimulation of phospholipases C, A2, and", "Composition": "terazosin hcl 2mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "486", "Trade_Name": "TORASTATIN 40MG 7 F.C.TAB.", "Generic_Name": "ATORVASTATIN", "Price": "27", "Price_Old": "27", "Company": "EL-OBOUR", "Pharmacology": "ANTIHYPERLIPIDEMIC.STATINS", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–س#?خ#~م #<ي #>ل#.ج ح#.ل#.#? زي#.#~ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#?خ#~م #=#>#.مل مس#.#>#~ م#> إ#?#%#.#> نظ#.م غذ#.ئي صحي لل#?خلص من #.ل#%#^و#?ين#.#? #.ل#~هنية منخ#<#_ة #.ل#=ث#.#<ة و#?قليل #?#^#=يز #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#?خ#~م #<ي #?خ#<ي#_ ثل#.ثي #.لجلس#^ي#~#.#? #.لم#^#?#<#>ة #<ي #.ل#~م #%ج#.ن#% إ#?#%#.#> نظ#.م غذ#.ئي صحي. \r\n\r\n–#>ل#.ج #<#^#- #.ل#=وليس#?#^ول #<ي #.ل#~م ح#.لة م#?ج#.نس #.ل#.ز#~و#.ج #.ل#>#.ئلي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–#=م#. يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة #.لإص#.#%ة #%أم#^#.#_ وقصو#^ #%#.ل#=#%#~ و#.#^#?#<#.#> نس#%ة ن#.قل#.#? #.لأمين. \r\n\r\n–غي#^ مسموح #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة #.لحمل. \r\n\r\n–ل#. يس#?خ#~م م#> #.ل#^#_#.#>ة #.ل#-#%ي#>ية إل#. #?ح#? إش#^#.#< #-#%ي. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.#>#?ل#.ل #.ل#>#_ل#.#? أو #.ل#<شل #.ل#=لوي يج#% #.ل#?وق#< #>ن #?ن#.وله #<و#^#.ٌ. \r\n\r\n–يس#?خ#~م #%حذ#^ م#> #=#%#.#^ #.لسن خو#<#. من أص#.#%#?هم #%#.ل#.#>#?ل#.ل #.ل#>#_لي. \r\n\r\n–ويس#?خ#~م #.ل#~و#.ء #%حذ#^ م#> م#?#>#.#-ي #.ل#=حولي#.#?. \r\n\r\n–وأي#_#.ً يس#?خ#~م #%حذ#^ ش#~ي#~ م#> #.لأشخ#.ص ذوى #.ل#?#.#^يخ #.لم#^#_ي م#> #.ل#=#%#~. \r\n\r\n–#=م#. أنه يس#?خ#~م #%حذ#^ أي#_#. م#> من ي#>#.نون من #.ل#<شل #.ل#=لوي. \r\n\r\n–وي#?ن#.ول #%حذ#^ م#> أ#~وية أخ#^ى مثل #.ل#<ي#%#^#.#?، ني#.سين، سي#=لوس#%و#^ين، م#.#=#^ولي#~، #?يل#.#%#^ي#<#^، #^ي#?ون#.#<ي#^، وم#_#.#~#.#? #.ل#<#-#^ي#.#?، وهذ#. خو#<#. من #.ل#?#<#.#>ل #.ل#~و#.ئي #.لذي ق#~ يؤ#~ى أي#_#. إلى #.ل#.#>#?ل#.ل #.ل#>#_لي. \r\n\r\n–ينصح #%وق#< #.س#?خ#~#.مه مؤق#?#.ٌ م#> أي م#^ي#_ يظه#^ #>لية ح#.لة #.#>#?ل#.ل #%#.ل#>#_ل#.#?، #<شل #=لوي أو #.#^#?#<#.#> #<ي نس#%ة ن#.قل#.#? #.لأمين أ#=ث#^ من ثل#.ث م#^#.#? من م#>#~له#. #.ل#-#%ي#>ي. \r\n\r\n–ينصح #.س#?خ#~#.مه مؤق#?#.ٌ أي#_#.ً #<ي #.لج#^#.ح#.#? أو #.لمش#.#=ل #.ل#-#%ية #.ل#?ي ق#~ #?ؤ#~ي إلى #.#>#?ل#.ل #.ل#>#_ل#.#? أو #.ل#<شل #.ل#=لوي ن#?يجة #.نحل#.ل #.ل#>#_ل#.#?. \r\n\r\n–#?جن#% #?ن#.ول #>صي#^ #.لج#^ي#% #<#^و#? م#> #.ل#~و#.ء.", "GI": "Description :\r\nIt is a member of the drug class known as statins.\r\ndose:\r\nAdult PO- Initial- The recommended dose is 10 mg daily. Maximum: 80 mg/day.\r\nIndication\t:S\r\nMay be used as primary prevention in individuals with multiple risk factors for coronary heart disease (CHD) and as secondary prevention in individuals with CHD to reduce the risk of myocardial infarction (MI), stroke, angina, and revascularization procedures. May be used to reduce the risk of cardiovascular events in patients with acute coronary syndrome (ACS). May be used in the treatment of primary hypercholesterolemia and mixed dyslipidemia, homozygous familial hypercholesterolemia, primary dysbetalipoproteinemia, and/or hypertriglyeridemia as an adjunct to dietary therapy to decrease serum total and low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (apoB), and triglyceride concentrations, while increasing high-density lipoprotein cholesterol (HDL-C) levels.", "Composition": "Each Torastatin 20,40 Film Coated Tablet contains Atorvastatin 20 and 40 mg respectively.", "Route": "ORAL.SOLID" }, { "ID": "487", "Trade_Name": "ANDRIOL 40MG 20 CAPS", "Generic_Name": "TESTOSTERONE", "Price": "40", "Price_Old": "40", "Company": "SEDICO > SCHERING PLOUGH", "Pharmacology": "ANDROGEN", "Category": "#.#>#^#.#_ #.نخ#<#.#_ ه#^مون #?س#?وس#?ي#^ون", "Use": "– يس#?خ#~م ل#>ل#.ج #.#>#^#.#_ #.نخ#<#.#_ ه#^مون #?س#?وس#?ي#^ون ل#~ى #.ل#^ج#.ل وذل#= #>ن#~م#. ي#=ون #.لجسم ل#. يم#=نه #.ن#?#.ج #.ل#?س#?وس#?ي#^ون نه#.ئي#. #.و ل#. ين#?جه #%م#. ي#=#<ي . \r\n\r\n– يم#=ن #.س#?خ#~#.مه ل#>ل#.ج #.م#^#.#_ #.خ#^ى #>لى #.لنحو #.لذي يح#~#~ه #.ل#-#%ي#% . \r\n\r\n– #?س#^ي#> #.لنمو #.لجنسي ل#~ى #.لش#%#.#% #<ي سن #.ل#%لوغ #>ن#~ #?أخ#^ #%لوغهم #.لجنسي #%س#%#% نقص #%هذ#. #.لهو#^مون \r\n\r\n– #.لمس#.همة #<ي زي#.#~ة #.لخصو#%ة ل#~ى #.ل#^ج#.ل #.لذين ي#>#.نون من #.#_#-#^#.#% #<ي #.لغ#~ة #.ل#=ُظ#^ية (Adrenal gland) أو #<ي #.لخصي#?ين. \r\n\r\n– يس#?#>مل #.ل#?يس#?وسْ#?ي#^ون #<ي أحي#.ن ن#.#~#^ة ل#>ل#.ج س#^#-#.ن #.لث#~ي. \r\n\r\n– يم#=ن إ#>#-#.ء #.ل#^ج#.ل #.لذين ي#>#.نون من مس#?وي#.#? منخ#<#_ة من #.ل#?يس#?وسْ#?ي#^ون إ#_#.#<ة من #.لهو#^مون #%و#.س#-ة #~هن هُل#.مَة (جِل) #?ح#?وي #>لى #.ل#?يس#?وسْ#?ي#^ون.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–س#^#-#.ن #.ل#%#^وس#?#.#?#.. \r\n\r\n–س#^#-#.ن #.لث#~ي #<ي #.لذ#=و#^. \r\n\r\n–#%#>#_ #.لأنو#.#> ل#. #?س#?خ#~م #<ي #.لإن#.ث. \r\n\r\n–أم#^#.#_ #.ل#=#%#~. \r\n\r\n–أم#^#.#_ #.ل#=لى. \r\n\r\n–أم#^#.#_ #.لقل#%. \r\n\r\n–#.ثن#.ء #.لحمل: \r\n\r\n–ل#. يُ#>#-ى (X) \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–لم يث#%#? #.ن #.س#?#>م#.ل #.ل#~و#.ء آمن للم#^#_#>#.#?. ل#. ينصح #%#?ن#.وله. \r\n\r\n–#.لأ#-#<#.ل و#.ل#^#_#> : \r\n\r\n–ل#. ينصح #%#.س#?#>م#.له لل#.#-#<#.ل #?ح#? جيل 12 سنه، #.ل#. #%#?وصيه من #.ل#-#%ي#%. \r\n\r\n–#=#%#.#^ #.لسن: \r\n\r\n–من #.لمح#?مل #.ن #?#=ون هن#.ل#= ح#.جه ل#?قليل #.لج#^#>ه #.لم#>#-#.ه. \r\n\r\n–#.لسي#.قة: \r\n\r\n–ل#. #?وج#~ مش#.#=ل م#>#^و#<ه.", "GI": "About Testosterone\r\nA steroid hormone, Androgen.\r\nMechanism of Action of Testosterone\r\nTestosterone and it`s reduced form- dihydrotestosterone binds with cytoplasmic testosterone receptors in androgen responsive organs and tissues and forms hormone receptor complex. This hormone-receptor complex binds with DNA and enhances DNA transcription and formation of mRNA which ultimately leads to modification of protein synthesis. It promotes growth and development of male sex organs and secondary sexual characters and maintains proper sexual functioning. It also exerts anabolic effect on skeleton and skeletal muscles and accelerates erythropoiesis. It also excerts inhibitory, antiestrogenic effects on hormone responsive breast tumors and metastases.", "Composition": "Each capsule contains:\r\nTestosterone (as undecanoate dissolved in oleic acid) 40 mg", "Route": "ORAL.SOLID" }, { "ID": "488", "Trade_Name": "NAGLOVIC 750MG 10 F.C. TABS.", "Generic_Name": "LEVOFLOXACIN", "Price": "25.2", "Price_Old": "25.2", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS > ELRAZY PHARMACEUTICALS-EGYPT", "Pharmacology": "ANTIBIOTIC.QUINOLONE", "Category": "م#_#.#~ حيوي #=ينولون", "Use": "–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية و#.ل#?ه#.#%#.#? #.ل#.نسجة . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#=لي و#.لمث#.نة . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#%#^وس#?#.#?#. . \r\n\r\n–ي#>#.لج #.ل#.ل#?ه#.#% #.ل#^ئوي #.لح#.#~ . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجيو#% #.ل#.ن#<ية . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحوي#_ة و#.ل#=لية #.ل#%#=#?ي#^ي #.لح#.#~. \r\n\r\n–ي#>#.لج #.ل#?#<#.قم #.ل#%#=#?ي#^ي #.لح#.#~ لإل#?ه#.#% #.لش#>#% #.لهو#.ئية #.لمزمن. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#.ذن #.لوس#-ي . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#%ل#>وم و#.لحلق و#.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي . \r\n\r\n–ي#>#.لج #>#~وي #.لجه#.ز #.ل#%ولي #.ل#?ن#.سلي و#.ل#?ه#.#%#.#? #>نق #.ل#^حم و#.ل#?ه#.#% #.ل#.حليل و#.ل#?ه#.#% #.ل#=لي وحو#_ه#. .", "Contraindications": "–يمن#> خل#.ل قي#.#~ة #.لسي#.#^#.#? أو #.س#?خ#~#.م #.لم#.#=ين#.#? #.لثقيلة #.و #.لح#.#~ة، لأنه ق#~ يس#%#% #.لش#>و#^ #%#.ل#~وخة و#.لن#>#.س و#>#~م #.لق#~#^ة #>لي #.ل#?#^#=يز . \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#>ق#.#^ لل#.#-#<#.ل #.قل من 12 #>#.م . \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#.م#^#.#_ #.ل#>قلية وم#^#_ي قصو#^ وظ#.ئ#< #.ل#=#%#~ . \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.ل#.ص#.#%ة #%#.م#^#.#_ #.لقل#% وجل#-#.#? #.لمخ . \r\n\r\n–يمن#> #.س#?#>م#.له لم#^#_ي #.ل#.نيمي#. #.و #<ق#^ #.ل#~م . \r\n\r\n–يمن#> #.س#?#>م#.له خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لل#.شخ#.ص #.لمص#.#%ون #%#~#.ء #.لس#=#^ي و#.نيمي#. #.ل#<ول .", "GI": "About Levofloxacin\r\nThird generation fluoroquinolone (or quinolone), A broad spectrum antiinfective.\r\n\r\nMechanism of Action of Levofloxacin\r\nLevofloxacin is a broad spectrum antibacterial agent. It act by inhibiting the enzyme DNA gyrase (Topoisomerase 2) and Topoisomerase 4.DNA gyrase helps in the formation of a highly condensed three dimensional structure of the DNA by its nicking and closing activity and also by introducing negative supercoil in to the DNA double helix. Levofloxacin inhibits DNA gyrase which results in abnormal linkage between opened DNA and gyrase and negative supercoiling is also impaired. This will inhibits transcription of DNA in to RNA and subsequent protein synthesis.\r\n\r\nIndications for Levofloxacin\r\n1.Sinusitis \r\n2.Bronchitis \r\n3.Pneumonia \r\n4.Urinary tract infection \r\n5.Traveler`s diarrhoea \r\n6.Skin and soft tissue infections \r\n7.Urethritis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "489", "Trade_Name": "TETRACID 250 MG 16 CAP.", "Generic_Name": "TETRACYCLINE", "Price": "11", "Price_Old": "5.5", "Company": "CID", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–يس#?خ#~م ل#>ل#.ج ح#% #.لش#%#.#%. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحو#_. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمث#.نة و#.ل#=لي. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لج#^ثومية #.ل#?ي #?صي#% #.ل#>ينين. \r\n\r\n–#>ل#.ج ح#.ل#.#? #.ل#=ولي#^#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#=ز#.ز. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.لغ#^غ#^ين#. #.لغ#.زية. \r\n\r\n–#>ل#.ج #.ل#=ل#.مي#~ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#>ل#.ج #>#~وي #.لم#>#~ة و#.لمس#%#%ة #.لإسه#.ل.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء. \r\n\r\n–ل#. يس#?خ#~م م#^هم #.ل#>ينين للأ#-#<#.ل أقل من 6 سنو#.#?. \r\n\r\n–ل#. يس#?خ#~م #<ي ح#.لة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#~و#.ء لمن ي#>#.نون من مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.#_#-#^#.#%#.#? #%#.ل#~م و#^#.ثية.", "GI": "About Tetracycline\r\nA broad-spectrum polyketide antibiotic,Tetracycline Derivative.\r\nMechanism of Action of Tetracycline\r\nTetracycline is a broad spectrum antibiotic which has more specific action against gram positive organisms than gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals). It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. It is used in some areas for the treatment of Chloroquine-resistant falciparum malaria", "Composition": "TETRACYCLINE (AS HCL) 250 MG", "Route": "ORAL.SOLID" }, { "ID": "490", "Trade_Name": "MEDVITAZEN 30 SOFT GELATIN CAPS.", "Generic_Name": "VITAMIN B1+VITAMIN B6+VITAMIN B12", "Price": "15", "Price_Old": "15", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "VITAMIN B", "Category": "#<ي#?#.مين #%", "Use": "–#?حسين #>ملي#.#? #.ل#?مثيل #.لغذ#.ئي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#.#>ص#.#% #.ل#-#^#<ية. \r\n\r\n–ي#>مل #>لي #.لح#~ من #?س#.ق#- #.لش#>#^. \r\n\r\n–#.ل#>ل#.ج و#.لوق#.ية من #.ل#.نيمي#. و#<ق#^ #.ل#~م. \r\n\r\n–#?حسين #.لح#.لة #.لمز#.جية و#.لح#~ من #.ل#.#=#?ئ#.#%. \r\n\r\n–#.ل#?ه#.#% #.ل#.#>ص#.#% #.لن#.#?ج #>ن م#^#_ #.لس#=#^ي.", "Contraindications": "–#.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#-#%ي#%. \r\n\r\n–يمن#> #.ل#.س#?خ#~#.م لل#.#-#<#.ل #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#%.", "GI": "About Vit B1\r\n\r\nPhysiological functions: Thiamine pyrophosphate is a coenzyme and the active form of vitamin B. It functions as coenzyme in decarboxylation of a-keto acid and in Hexose Monophosphate shunt. \r\nDeficiency symptoms: In severe vitamin B1 deficiency beriberi develops. It is of two types: \r\na) Wet beriberi \r\nb) Dry beriberi \r\nWet beriberi: In this the symptoms are related to the cardiovascular system and they are palpitations, tachycardia, dyspnoea, ECG changes, oedema, and high output cardiac failure. \r\nDry beriberi: The symptoms and signs are related to the Nervous system. The main features are peripheral neuritis, hyperaesthesia (localized areas) or anaesthesia, there is gradual loss in muscle strength, wrist drop, poor memory, depression, lack of initiative and anorexia.\r\nMechanism of Action of Vit B2\r\nRiboflavin exerts it`s action by influencing metabolic reactions. Riboflavin functions in the forms of flavin adenine dinucleotide (FAD), and flavin mononucleotide (FMN) wh", "Composition": "vit b1 250mg, vit b12 250mcg, vit b6 100mg", "Route": "ORAL.SOLID" }, { "ID": "491", "Trade_Name": "ACTIMAXVIT 15 CAPS.", "Generic_Name": "VITAMINS", "Price": "12", "Price_Old": "12", "Company": "VITABIOTICS", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "492", "Trade_Name": "VITAMIN E 1000MG 24 CAPS.", "Generic_Name": "VITAMIN E", "Price": "36", "Price_Old": "36", "Company": "PHARCO", "Pharmacology": "VITAMIN E", "Category": "#<ي#?#.مين هـ", "Use": "–م#_#.#~ للأ#=س#~ة حيث ي#>مل #>لى حم#.ية #.لخل#.ي#. من #.ل#?ل#< . \r\n\r\n–يس#.#>#~ #>لى #?حسين وظ#.ئ#< و حيوية خل#.ي#. #.لجسم . \r\n\r\n–#?قلل من إص#.#%#.#? #.ل#>ظ#.م مثل إل#?ه#.#%#.#? #.لم#<#.صل و هش#.شة #.ل#>ظ#.م . \r\n\r\n–#?س#.#>#~ #>لى م#=#.#<حة أ#>#^#.#_ #.لشيخوخة . \r\n\r\n–#?س#?خ#~م #=#>ل#.ج مس#.#>#~ #<ى ح#.ل#.#? #_#>#< #.لخصو#%ة #>ن#~ #.ل#^ج#.ل . \r\n\r\n–#?س#.#>#~ #>لى #>ل#.ج #?ل#< و #?س#.ق#- #.لش#>#^ و إ#=س#.#% #.لش#>#^ #.لقوة و #.لحيوية و #.للم#>#.ن . \r\n\r\n–#?س#.#>#~ #>لى ن#_#.#^ة و حيوية #.ل#%ش#^ة ، و #>ل#.ج مش#.#=ل #.ل#%ش#^ة . \r\n\r\n–#?قلل من خ#-#^ #.لإص#.#%ة #%#.لجل#-#.#? . \r\n\r\n–#?س#.#>#~ #>لى #?قوية #.ل#%ص#^ و #>ل#.ج أم#^#.#_ #.ل#>يون . \r\n\r\n–#?قلل من مس#?وى #.ل#=وليس#?#^ول #.لم#^#?#<#> #<ى #.لجسم . \r\n\r\n–#?قلل من خ#-#^ #.لإص#.#%ة #%م#^#_ #.لمي#.ه #.ل#%ي#_#.ء #>لى #.ل#>ين .", "Contraindications": "–#.لحمل و #.ل#^#_#.#>ة : \r\n\r\n–#.لحمل : أمن للإس#?خ#~#.م أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–#?حذي#^#.#? : \r\n\r\n–ق#~ #?زي#~ من خ#-#^ #.لإص#.#%ة #%#.لنزي#< لذل#= #?س#?خ#~م #%حذ#^ و #?ح#? إش#^#.#< #.ل#-#%ي#% ق#%ل #.ل#>ملي#.#? #.لج#^#.حية . \r\n\r\n–ي#<#_ل #>#~م إس#?خ#~#.م #.ل#~و#.ء ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%إس#%و#>ين .", "GI": "Mechanism of Action of Vitamin E\r\nVitamin E acts as an antioxidant and protecting unsaturated lipids in the cell membrane, coenzyme Q, vitamin A, vitamin C etc. from free radical oxidation damage and generation of toxic peroxidation products. It also decreases platelet aggregation.\r\nIndications for Vitamin E\r\n1. Vitamin E deficiency \r\n2. Intermittent claudication \r\n3. Nocturnal muscle cramps \r\n4. Coronary artery disease \r\n5. Fibrocystic breast disease \r\n6. Cystic fibrosis \r\n7. In premature infants exposed to high concentration of oxygen \r\n8. As antioxidant \r\n\r\n\r\nInteractions for Vitamin E\r\nOral anticoagulants : Hypoprothrombinemic effect may be increased with possibility of bleeding.", "Composition": "Vit C 1000mg", "Route": "ORAL.SOLID" }, { "ID": "493", "Trade_Name": "C-RETARD 500MG 10 CAPS.", "Generic_Name": "VITAMIN C", "Price": "13.5", "Price_Old": "13.5", "Company": "HIKMA PHARMA", "Pharmacology": "VITAMIN C", "Category": "#<ي#?#.مين ج", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لحمي. \r\n\r\n–يس#?خ#~م #<ي #.ل#?#=وين #.للثه و#.ل#.سن#.ن. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج و#?ج#~ي#~ #.لخل#.ي#. #<ي #.لجسم. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.نيمي#.. \r\n\r\n–يس#?خ#~م #<ي #.ل#?قليل من #.ل#.ث#.#^ #.لسل#%يه #.ل#?ي #?ن#?ج #>ن#~ #.ل#.قل#.#> #>ن #.ل#?#~خين. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.م#^#.#_ #.ل#%#=#?ي#^يه و#.ل#<ي#^وسيه. \r\n\r\n–يس#?خ#~م #<ي #.ل#?ئ#.م #.لج#^وح #%#>#~ #.ل#>ملي#.#? #.لج#^#.حيه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.ن#<لونز#. ونزل#.#? #.ل#%#^#~. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج نقص #<ي#?#.مين سي #<ي #.لجسم. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج نقص #<ي#?#.مين ج #<ي #.لجسم.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء لم#^#_ي #.لس#^#-#.ن ويج#% #.س#?ش#.#^ه #.ل#-#%ي#%. \r\n\r\n–يمن#> #?ن#.ول #=مي#.#? #=#%ي#^ه من #.ل#~و#.ء ل#.نه#. #?#~م#^ خل#.ي#. #.لجسم. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء لح#.ل#.#? #.ل#.ص#.#%ه #%م#^#_ #.نيمي#. #.ل#%ح#^ #.لم#?وس#-.", "GI": "About Vitamin C\r\nWater soluble vitamin, antioxidant.\r\nMechanism of Action of Vitamin C\r\nVitamin C exerts it`s action by influencing the biologic oxidations and reductions used in cellular respirations. It directly stimulates collagen synthesis and maintains intracellular connective tissue. It involves in various metabolic reactions such as 1).Hydroxylation of praline and lysine residues of protocollagen which is essential for formation and stabilization of collagen triple helix, 2).hydroxylation of carnitine, 3).Conversion of folic acid to folinic acid, 4).biosynthesis of adrenal steroids, catecholamines, oxytocin, and ADH, 5).Metabolism of cyclic nucleotides and prostaglandins. Vitamin C is important in resistance to infections.\r\nInteractions for Vitamin C\r\nOral contraceptives and estrogens: Vitamin C increases serum levels of oestrogen resulting in adverse reactions . \r\nWarfarin: The anticoagulant effects of warfarin is reduced. \r\nLab Tests: Large doses (>500 mg) of vitamin C may ca", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "494", "Trade_Name": "HIVIT 21 - 20 CAPS.", "Generic_Name": "MULTIVITAMINS", "Price": "10", "Price_Old": "10", "Company": "MUP", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–يس#?خ#~م #.ل#~و#.ء #=مص#~#^ #-#%ي#>ي لل#-#.قة مس#?خلص من #.لزيو#? #.لأس#.سية #.لغي#^ مش#%#>ة وهو م#. ي#>#^#< #%زي#? #%ذ#^ #.لق#^#-م.\r\n\r\n–يس#?خ#~م ه#.ي #<ي#? 21 #<ي #>ل#.ج جمي#> ح#.ل#.#? نقص #.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.لمص#.ح#%ة للأم#^#.#_ #.لمزمنة و#.لح#.#~م.\r\n\r\n–#~و#.ء ه#.ي #<ي#? 21 يس#?#>مل أثن#.ء و#%#>#~ #.ل#>ل#.ج #%#.لم#_#.#~#.#? #.لحيوية #.لقوية.\r\n\r\n–يس#?خ#~م #<ي #.ل#>#~ي#~ من ح#.ل#.#? #.خ#?ل#.ل #>ملي#.#? #.ل#?مثيل #.لغذ#.ئي وهذ#. ي#=ون مثل #<#?#^#.#? #.لنق#.هة و#.لحمل و#.ل#^#_#.#>ة وجمي#> أ#>#^#.#_ #.نق#-#.#> #.ل#-مث.\r\n\r\n–يس#?خ#~م #<ي زي#.#~ة من#.#>ة #.لجسم #_#~ #.لأم#^#.#_.\r\n\r\n–يس#?#>مل #<ي #>ل#.ج #.ل#.#_#-#^#.#%#.#? #.لجسم#.نية #.ل#?ي #?ص#.ح#% #.لشيخوخة #.لم#%#=#^ة.\r\n\r\n–ه#.ي #<ي#? 21 يس#?خ#~م #<ي #>ل#.ج #?أخ#^ #.ل#?ئ#.م #.لخل#.ي#. و#.لأنسجة #.ل#?ي #?وج#~ #<ي #.لجسم.\r\n\r\n–يس#?خ#~م ه#.ي #<ي#? 21 #>ل#.ج م#=مل #<ي #%#>#_ ح#.ل#.#? زي#.#~ة #.ل#=وليس#?ي#^ول #<ي #%ل#.زم#. #.ل#~م.", "Contraindications": "–ي#?م من#> #.س#?خ#~#.م #.ل#~و#.ء لمن ل#~يهم #<#^#- حس#.سية من م#=ون#.#? #.ل#~و#.ء #.لأس#.سية و#.لأخ#^ى.\r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص ق#%ل #.س#?خ#~#.م #.ل#~و#.ء لجمي#> #.لنس#.ء #.لحو#.مل و#.لم#^#_#>#.#?.\r\n\r\n–ي#?م من#> #.س#?خ#~#.م #.ل#~و#.ء لجمي#> #.لم#^#_ي #.لذين ي#>#.نون من وجو#~ قصو#^ #<ي وظ#.ئ#< #.ل#=لى و#.ل#=#%#~.\r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لجمي#> #.لأ#-#<#.ل لأنه من #.لمم#=ن أن يؤث#^ #>ليهم.\r\n\r\n–و#=#%#.#^ #.لسن ينصح #%#.س#?#>م#.ل #.ل#~و#.ء #%ش#=ل قوي لأنه من #.ل#<ي#?#.مين#.#? #.له#.مة و#.لم#<ي#~ة لجسم #=#%#.#^ #.لسن.\r\n\r\n–ل#.#%#~ من #.س#?خ#~#.م #.ل#~و#.ء #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج و#.لمخ#?ص.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "495", "Trade_Name": "GR SIX 16 CAPS.", "Generic_Name": "GINSENG+ROYAL JELLY+WHEAT GERM OIL+SAFFLOWER OIL+YEAST+BIOFLAVONOIDS", "Price": "19.2", "Price_Old": "19.2", "Company": "MUP", "Pharmacology": "MULTIVITAMINS", "Category": "م#=مل غذ#.ئي", "Use": "–يزي#~ #-#.قة #.لجسم وحيوي#?ه. \r\n\r\n–يغذي وينش#- خل#.ي#. #.لجسم. \r\n\r\n–يقي من أم#^#.#_ #?ق#~م #.لسن. \r\n\r\n–يقوي جه#.ز #.لمن#.#>ة ومق#.ومة #.لأم#^#.#_. \r\n\r\n–#<و#.ئ#~ زي#? #.لق#^#-م (#.ل#>ص#<#^): \r\n\r\n–يح#?وي #>لى #.لأحم#.#_ #.ل#~هنية #.لغي#^ مش#%#>ة #.ل#?ي #?م#~ #.لجسم #%#.ل#-#.قة و#.لحيوية. \r\n\r\n–يقي #.لجسم من أم#^#.#_ #.ل#~و#^ة #.ل#~موية. \r\n\r\n–ي#>مل #>لى خ#<#_ نس#%ة #.ل#=وليس#?#^ول #<ي #.ل#~م. \r\n\r\n–ينش#- #.ل#~و#^ة #.ل#~موية ويؤ#~ي إلى وصول #.ل#~م ل#=#.#<ة #.لأ#>#_#.ء #%س#%#% #.ح#?و#.ئه #>لى #.لجينسنج. \r\n\r\n–يقوي ويغذي #.لجه#.ز #.ل#>ص#%ي و#.لأ#>ص#.#% #.ل#-#^#<ية #%س#%#% غذ#.ء مل#=#.#? #.لنحل. \r\n\r\n–يقي #.لجسم من نزل#.#? #.ل#%#^#~ و#.لز#=#.م #.لمز#>جة #%س#%#% #.ح#?و#.ئه #>لى م#.#~ة #.ل#%ي#?#. جلو#=#.ن #.ل#?ي #?قوي #.لمن#.#>ة. \r\n\r\n–يق#.وم #?س#.ق#- #.لش#>#^ ويقوي #.ل#%صيل#.#? ويمنحه #.ل#=ث#.#<ة و#.لحيوية #%س#%#% #.لأنيمي#. أو #.لمو#.#~ #.ل#_#.#^ة #.ل#?ي #?ؤث#^ #>لى #.لش#>#^ مثل #.لص#%غ#.#?. \r\n\r\n–#>ل#.ج وق#.ئي يقلل من مخ#.#-#^ #.لإص#.#%ة #%#.ل#?ه#.#% #.لأ#>ص#.#% و#_#>#< #.ل#%ص#^ و#.لق#~ #.لس#=#^ي وأم#^#.#_ #.لقل#% و#.ل#=لى", "Contraindications": "–ل#. #?#?ن#.ول #.لم#=مل إن #=#.ن ل#~ي#= حس#.سية من #.ل#>سل أو حس#.سية من أي من#?ج من من#?ج#.#? #.لنحل #.لأخ#^ى. \r\n\r\n–#%#.لنس#%ة للم#^أة #.لح#.مل و#.لم#^#_#>ة ل#. يج#% #>ليه#. أن #?#?ن#.ول #.لم#=مل إل#. #%#.س#?ش#.#^ة من #-#%ي#% مخ#?ص. \r\n\r\n–يج#% #>#~م #.لإ#<#^#.#- #<ي ش#^#% #.ل#=حول أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–ل#. ين#%غي أن يؤخذ أي م#=مل يح#?وي #>لى #<ي#?#.مين (أ) من ق#%ل #.لأشخ#.ص #.لذين ي#>#.نون من أم#^#.#_ #<ي #.ل#=#%#~، لأن هذ#. من #.لمم#=ن أن يس#%#% #?سمم #.ل#=#%#~، ومن #.لمم#=ن أي#_#.ً أن يس#%#% #?وق#< #?#~#<ق #.لص#<#^#.ء من #.ل#=#%#~ للأم#>#.ء، #<إن #=ن#? م#^ي#_ #=#%#~ #<يج#% أن #?#^#.ج#> #-#%ي#%#= ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–من #.لمم#=ن أن #?زي#~ #.ل#=#%سول#.#? من #<#^ص #.لنزي#<، لذ#. يج#% أن ي#?م #.س#?#>م#.ل #%ح#^ص من #.لذين ي#?#>#.#-ون مسيل#.#? لل#~م. \r\n\r\n–من #.لمم#=ن أن #?س#%#% #.ل#=#%سول#.#? #?هيج #.لجه#.ز #.له#_مي وي#^ج#> ذل#= لأنه#. #?ح#?وي #>لى #%و#~#^ة #.لثوم، لهذ#. يج#% أن ي#?م #.س#?#>م#.له #%حذ#^ من ق#%ل #.لأشخ#.ص #.لذين ل#~يهم مش#.#=ل #<ي #.له#_م أو #<ي #.لم#>#~ة #>موم#.ً. \r\n\r\n–من #.لمم#=ن أي#_#.ً أن #?س#%#% #.ل#=#%سول#.#? #.نخ#<#.#_ #_غ#- #.ل#~م، #<إن #=ن#? ممن ي#>#.نون من #.نخ#<#.#_ #_غ#- #.ل#~م #<يج#% أن #?س#?شي#^ #-#%ي#%#= أول#.ً ق#%ل #?ن#.ول #.ل#=#%سول#.#?. \r\n\r\n–يوج#~ #<ي #.ل#=#%سول#.#? (ثوم) #%إم#=#.نه أن ي#-يل من م#~ة #.لنزي#<، #<إن #=ن#? #?نوي #>مل ج#^#.حة #<يج#% أن #?#?وق#< #>لى #.لأقل أس#%و#>ين #>ن #?ن#.وله ومن ثم #?ج#^ي #.ل#>ملية #.لج#^#.حية.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "Each Capsule contains:\r\nDry Ginseng Roots Extract 3.5% 40 mg\r\n(Royal Jelly Lyophilized 5.4 % - 33 mg)\r\n\r\nEquivalent to pure Royal Jelly 90 mg\r\n\r\nWheat Germ Oil 200 mg\r\nSafflower Oil 300 mg\r\n\r\nYeast Concentrate 200 mg\r\nBioflavonoids 100 mg", "Route": "ORAL.SOLID" }, { "ID": "496", "Trade_Name": "VITAMIN E 100MG 24 SOFT GELATIN CAPS.", "Generic_Name": "VITAMIN E", "Price": "5.75", "Price_Old": "5.75", "Company": "PHARCO", "Pharmacology": "VITAMIN E", "Category": "#<ي#?#.مين هـ", "Use": "–م#_#.#~ للأ#=س#~ة حيث ي#>مل #>لى حم#.ية #.لخل#.ي#. من #.ل#?ل#< . \r\n\r\n–يس#.#>#~ #>لى #?حسين وظ#.ئ#< و حيوية خل#.ي#. #.لجسم . \r\n\r\n–#?قلل من إص#.#%#.#? #.ل#>ظ#.م مثل إل#?ه#.#%#.#? #.لم#<#.صل و هش#.شة #.ل#>ظ#.م . \r\n\r\n–#?س#.#>#~ #>لى م#=#.#<حة أ#>#^#.#_ #.لشيخوخة . \r\n\r\n–#?س#?خ#~م #=#>ل#.ج مس#.#>#~ #<ى ح#.ل#.#? #_#>#< #.لخصو#%ة #>ن#~ #.ل#^ج#.ل . \r\n\r\n–#?س#.#>#~ #>لى #>ل#.ج #?ل#< و #?س#.ق#- #.لش#>#^ و إ#=س#.#% #.لش#>#^ #.لقوة و #.لحيوية و #.للم#>#.ن . \r\n\r\n–#?س#.#>#~ #>لى ن#_#.#^ة و حيوية #.ل#%ش#^ة ، و #>ل#.ج مش#.#=ل #.ل#%ش#^ة . \r\n\r\n–#?قلل من خ#-#^ #.لإص#.#%ة #%#.لجل#-#.#? . \r\n\r\n–#?س#.#>#~ #>لى #?قوية #.ل#%ص#^ و #>ل#.ج أم#^#.#_ #.ل#>يون . \r\n\r\n–#?قلل من مس#?وى #.ل#=وليس#?#^ول #.لم#^#?#<#> #<ى #.لجسم . \r\n\r\n–#?قلل من خ#-#^ #.لإص#.#%ة #%م#^#_ #.لمي#.ه #.ل#%ي#_#.ء #>لى #.ل#>ين .", "Contraindications": "–#.لحمل و #.ل#^#_#.#>ة : \r\n\r\n–#.لحمل : أمن للإس#?خ#~#.م أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–#?حذي#^#.#? : \r\n\r\n–ق#~ #?زي#~ من خ#-#^ #.لإص#.#%ة #%#.لنزي#< لذل#= #?س#?خ#~م #%حذ#^ و #?ح#? إش#^#.#< #.ل#-#%ي#% ق#%ل #.ل#>ملي#.#? #.لج#^#.حية . \r\n\r\n–ي#<#_ل #>#~م إس#?خ#~#.م #.ل#~و#.ء ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%إس#%و#>ين .", "GI": "Mechanism of Action of Vitamin E\r\nVitamin E acts as an antioxidant and protecting unsaturated lipids in the cell membrane, coenzyme Q, vitamin A, vitamin C etc. from free radical oxidation damage and generation of toxic peroxidation products. It also decreases platelet aggregation.\r\nIndications for Vitamin E\r\n1. Vitamin E deficiency \r\n2. Intermittent claudication \r\n3. Nocturnal muscle cramps \r\n4. Coronary artery disease \r\n5. Fibrocystic breast disease \r\n6. Cystic fibrosis \r\n7. In premature infants exposed to high concentration of oxygen \r\n8. As antioxidant \r\n\r\n\r\nInteractions for Vitamin E\r\nOral anticoagulants : Hypoprothrombinemic effect may be increased with possibility of bleeding.", "Composition": "Each soft gelatin capsule contains:\r\nVitamin E 1000 mg", "Route": "ORAL.SOLID" }, { "ID": "497", "Trade_Name": "HAEMA-CAPS 14 CAPS.", "Generic_Name": "VITAMINS+IRON", "Price": "18", "Price_Old": "18", "Company": "AMOUN", "Pharmacology": "ANEMIA.IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~ ل#<ق#^ #.ل#~م #.ل#.نيمي#.", "Use": "–#>ل#.ج #.ل#.نيمي#. و#<ق#^ #.ل#~م. \r\n\r\n–#?#>وي#_ نقص #.لح#~ي#~ #.لش#~ي#~. \r\n\r\n–يس#?خ#~م #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–يس#?خ#~م #.ثن#.ء نزي#< #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–للح#~ من #?س#.ق#- #.لش#>#^ #.لمص#.ح#% لح#.ل#.#? #.ل#.نيمي#.. \r\n\r\n–#?#>وي#_ نقص #.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #<ي #<#?#^ة #.لحمل و#.ل#^#_#.#>ة.", "Contraindications": "–يمن#> #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "498", "Trade_Name": "E-VITON 100 MG 20 CAPS.", "Generic_Name": "VITAMIN E", "Price": "3.2", "Price_Old": "3.2", "Company": "KAHIRA", "Pharmacology": "VITAMIN E", "Category": "#<ي#?#.مين هـ", "Use": "–م#_#.#~ للأ#=س#~ة حيث ي#>مل #>لى حم#.ية #.لخل#.ي#. من #.ل#?ل#< . \r\n\r\n–يس#.#>#~ #>لى #?حسين وظ#.ئ#< و حيوية خل#.ي#. #.لجسم . \r\n\r\n–#?قلل من إص#.#%#.#? #.ل#>ظ#.م مثل إل#?ه#.#%#.#? #.لم#<#.صل و هش#.شة #.ل#>ظ#.م . \r\n\r\n–#?س#.#>#~ #>لى م#=#.#<حة أ#>#^#.#_ #.لشيخوخة . \r\n\r\n–#?س#?خ#~م #=#>ل#.ج مس#.#>#~ #<ى ح#.ل#.#? #_#>#< #.لخصو#%ة #>ن#~ #.ل#^ج#.ل . \r\n\r\n–#?س#.#>#~ #>لى #>ل#.ج #?ل#< و #?س#.ق#- #.لش#>#^ و إ#=س#.#% #.لش#>#^ #.لقوة و #.لحيوية و #.للم#>#.ن . \r\n\r\n–#?س#.#>#~ #>لى ن#_#.#^ة و حيوية #.ل#%ش#^ة ، و #>ل#.ج مش#.#=ل #.ل#%ش#^ة . \r\n\r\n–#?قلل من خ#-#^ #.لإص#.#%ة #%#.لجل#-#.#? . \r\n\r\n–#?س#.#>#~ #>لى #?قوية #.ل#%ص#^ و #>ل#.ج أم#^#.#_ #.ل#>يون . \r\n\r\n–#?قلل من مس#?وى #.ل#=وليس#?#^ول #.لم#^#?#<#> #<ى #.لجسم . \r\n\r\n–#?قلل من خ#-#^ #.لإص#.#%ة #%م#^#_ #.لمي#.ه #.ل#%ي#_#.ء #>لى #.ل#>ين .", "Contraindications": "–#.لحمل و #.ل#^#_#.#>ة : \r\n\r\n–#.لحمل : أمن للإس#?خ#~#.م أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–#?حذي#^#.#? : \r\n\r\n–ق#~ #?زي#~ من خ#-#^ #.لإص#.#%ة #%#.لنزي#< لذل#= #?س#?خ#~م #%حذ#^ و #?ح#? إش#^#.#< #.ل#-#%ي#% ق#%ل #.ل#>ملي#.#? #.لج#^#.حية . \r\n\r\n–ي#<#_ل #>#~م إس#?خ#~#.م #.ل#~و#.ء ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%إس#%و#>ين .", "GI": "Mechanism of Action of Vitamin E\r\nVitamin E acts as an antioxidant and protecting unsaturated lipids in the cell membrane, coenzyme Q, vitamin A, vitamin C etc. from free radical oxidation damage and generation of toxic peroxidation products. It also decreases platelet aggregation.\r\nIndications for Vitamin E\r\n1. Vitamin E deficiency \r\n2. Intermittent claudication \r\n3. Nocturnal muscle cramps \r\n4. Coronary artery disease \r\n5. Fibrocystic breast disease \r\n6. Cystic fibrosis \r\n7. In premature infants exposed to high concentration of oxygen \r\n8. As antioxidant \r\n\r\n\r\nInteractions for Vitamin E\r\nOral anticoagulants : Hypoprothrombinemic effect may be increased with possibility of bleeding.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "499", "Trade_Name": "KEROVIT 15 SOFT GELATIN CAPS.", "Generic_Name": "VITAMINS", "Price": "54", "Price_Old": "54", "Company": "AMOUN", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "arginine 10mg, bee pollen 25mg, boron 130mcg, calcium 30mg, carnitine 10mg, choline 10mg, chromium picolinate 120mcg, co enzyme q10 5mg, copper 2mg, dha(docosahexaenoic acid) 20mg, epa(eicosapentaenoic acid) 30mg, folic acid 600mcg, ginkgo biloba 20mg, gi", "Route": "ORAL.SOLID" }, { "ID": "500", "Trade_Name": "RECEPTOLOC 300MG 20 CAPS.", "Generic_Name": "NIZATIDINE", "Price": "30", "Price_Old": "30", "Company": "ALEXANDRIA", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–يس#?خ#~م #<ى #.م#^#.#_ #.#^#?ج#.#> #.لح#.م#_ #%#.لم#^ئ . \r\n\r\n–يس#?خ#~م #<ى ق#^حة #.لم#>#~ة وق#^حة #.لأثني #>ش#^ (#.لنش#-ة ولمن#>ه#.) . \r\n\r\n–يس#?خ#~م #<ى #.لحمو#_ة #.لم#>وية و#>س#^ #.له#_م #.لحم#_ي .", "Contraindications": "–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن ل#~ي#= حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#.#>له للنيز#.ني#~ين #.و #.ي من م#=ون#.#? #.لمس#?ح#_#^ #.و #^#.ن#?ي#~ين ، #<#.مو#?ي#~ين #.و سيمي#?#~ين . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #<ى ح#.ل#.#? #.ل#^#_#.#>ة ل#.نة ي#<#^ز #<ى ل#%ن #.ل#.م . \r\n\r\n–يس#?خ#~م #.ثن#.ء #.لحمل #.ذ#. #=#.ن#? هن#.#= ح#.جة و#.#_حة #.لي #.س#?خ#~#.مه . \r\n\r\n–ممنو#> #.س#?خ#~#.مه لم#^#_ى #.ل#=#%#~ #.و #.ل#=لى . \r\n\r\n–ممنو#> #.س#?خ#~#.مه #.ذ#. #=#.ن #.لم#^#_ م#~خن .", "GI": "Indication\t\r\nFor the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer.\r\nPharmacodynamics\t\r\nNizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.\r\n\r\nMechanism of action\t\r\nNizatidine competes with histamine for binding at the H2-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions.", "Composition": "nizatidine 300mg", "Route": "ORAL.SOLID" }, { "ID": "501", "Trade_Name": "OMEPAK 10MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "14.4", "Price_Old": "14.4", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "502", "Trade_Name": "HEALSEC 10MG 14 CAPS", "Generic_Name": "OMEPRAZOLE", "Price": "18", "Price_Old": "12", "Company": "BORG", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each nard gelatin capsule contains:\r\n- Active ingredients:\r\nHealsec 10 mg Hard Gelatin Capsules\r\nOmeprazole 10 mg\r\n\r\nHealsec 20 mg Hard Gelatin Capsules\r\nOmeprazole 20 mg\r\n\r\nHealsec 40 mg Hard Gelatin Capsules Omeprazole 40 mg", "Route": "ORAL.SOLID" }, { "ID": "503", "Trade_Name": "MIRAPRO N 20MG 20CAPS. (N/A)", "Generic_Name": "NORPSEUDOEPHEDRINE", "Price": "24", "Price_Old": "24", "Company": "OCTOBER PHARMA", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يل#>#% #>لي مس#?ق#%ل#.#? #.ل#-#>#.م #<ي #.ل#~م#.غ ويح#~ من #.لشهية. \r\n\r\n–يس#.#>#~ #>لي #.ل#?خسيس و #.لح#~ من #.لسمنة #.لم#<#^#-ة. \r\n\r\n–يس#.#>#~ #>لي ح#^ق #.ل#~هون #.لم#?#^#.#=مة #<ي #.لجسم. \r\n\r\n–يس#.#>#~ #>لي #?#_ييق #.ل#.و#>ية #.ل#~موية #%#.ل#.ن#<.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #~و#.ء مي#^#.#%#^و-#.ن.", "GI": "Indication\tUsed to decrease appetite.\r\nPharmacodynamics\tClosely related to ephedrine, cathinone and other amphetamines, it may contribute to the stimulant effect of Catha edulis, although another constituent, cathinone appears to show stronger activity.", "Composition": "giger 150g, triticum aestivum fiber 200g , yeast 50g", "Route": "ORAL.SOLID" }, { "ID": "504", "Trade_Name": "PRAVOTIN 100 MG 14 SACHETS", "Generic_Name": "LACTOFERRIN", "Price": "85", "Price_Old": "79", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > HYGINT PHARMACEUTICALS-EGYPT", "Pharmacology": "IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~", "Use": "–#.لسي#~#.#? #.لحو#.مل يح#?جن لم#>#~ل#.#? من #.لح#~ي#~ أ#>لى للح#<#.ظ #>لى صحة #.لجنين \r\n\r\n–م#^#_ى #.لغسيل #.ل#=لوي \r\n\r\n–م#^#_ى #.لأنيمي#. \r\n\r\n–م#^#_ي #.لقل#% و#.لأو#>ية #.ل#~موية \r\n\r\n–#>ل#.ج ق#^حة #.لأم#>#.ء و#.لإسه#.ل و#.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي و#<ي#^وس #.ل#^و#?#. \r\n\r\n–م#_#.#~ للأ#=س#~ة . \r\n\r\n–يس#.#>#~ #>لى #?قوية #.لمن#.#>ة . \r\n\r\n–يس#?خ#~م ل#>ل#.ج #.ل#.سه#.ل . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.لإل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئى . \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? آل#.م #.لم#>#~ة . \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? ق#^ح #.لم#>#~ة و#.لأم#>#.ء . \r\n\r\n–م#<ي#~ ج#~#. #<ي #.ل#?خلص من مش#=لة #.ل#_#>#< و#.لوهن #.ل#>#.م #<ي #.لجسم . \r\n\r\n–من #.لأ#~وية #.ل#<#>#.لة لم#^#_ي #.لقل#% ومن#.س#% ج#~#. لمم#.#^سي #.ل#^ي#.#_#.#?.", "Contraindications": "–ق#~ يس#%#% ح#~وث إمس#.#= أو #<ق#~#.ن #.لشهية #>ن#~ #%#>#_ #.لم#^#_ى .", "GI": "Lactoferrin is a bioactive 80-kDa iron binding glycoprotein.\r\nDosage: 1 sachet to be dissolved in quarter glass of water and taken twice daily before meals.", "Composition": "lactoferrin 100mg", "Route": "SACHETS" }, { "ID": "505", "Trade_Name": "RISEK 10 MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "13.2", "Price_Old": "13.2", "Company": "JULPHAR", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each capsule contains:\r\nRisek 10mg: Omeprazole 10mg\r\nRisek 20mg: Omeprazole 20mg\r\nRisek 40mg: Omeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "506", "Trade_Name": "ACNESEPT 80 GRAM SOAP", "Generic_Name": "TRICLOSAN(IRGASAN)+TEGOBETAIN+CITRIC ACID+SULPHUR PPT.+SALICYLIC ACID+MENTHOL+ZINC OXIDE+LEMON OIL", "Price": "4.75", "Price_Old": "4.75", "Company": "ZAYTONA EGYPT", "Pharmacology": "ANTI-ACNE", "Category": "م#_#.#~ لح#% #.لش#%#.#%", "Use": "–#.لق#_#.ء #>لى مش#=لة ح#% #.لش#%#.#% #.ل#?ي #?و#.جه #.ل#=ثي#^ ج#~#. من #.لش#%#.#% من #.لجنسين #<هي من#.س#%ة ج#~#. لذوي #.ل#%ش#^ة #.ل#~هنية حيث #?#>مل #>لى #?قليل إ#<#^#.ز #.لم#.#~ة #.ل#~هنية و#.ل#?خلص من ح#% #.لش#%#.#% وآث#.#^ه.\r\n\r\n–#?منح #.ل#%ش#^ة #.لص#<#.ء و#.لنق#.ء #.لم#-لو#% و#?قوم هذه #.لص#.#%ونة #%#.ل#?خلص #?م#.م#. من أنو#.#> ح#% #.لش#%#.#% #.لموجو#~ة #>لى #.ل#%ش#^ة و#?حميه#. أي#_#. من ظهو#^ه م#^ة أخ#^ى. \r\n\r\n–#?#>مل #>لى منح #.ل#%ش#^ة #.ل#?#^#-ي#% #.ل#<#>#.ل و#<ي ن#<س #.لوق#? #?ح#.#<ظ #>لى إ#<#^#.ز #.ل#~هون مم#. يمن#> ظهو#^ #.لح#%و#% م#^ة أخ#^ى ل#?#?#^#= #.ل#%ش#^ة خ#.لية من أي آث#.#^ للح#%و#%.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.", "GI": "For all forms of acne.", "Composition": "COMING SOON ..", "Route": "SOAP" }, { "ID": "507", "Trade_Name": "RISEK 10 MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "19.2", "Price_Old": "19.2", "Company": "JULPHAR", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each capsule contains:\r\nRisek 10mg: Omeprazole 10mg\r\nRisek 20mg: Omeprazole 20mg\r\nRisek 40mg: Omeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "508", "Trade_Name": "SEKEM BABY CALM HERBS 15 FILTER BAGS", "Generic_Name": "CARAWAY+ANISE+FENNEL+LIQUORICE+CHAMOMILE", "Price": "14.5", "Price_Old": "12.5", "Company": "ATOS PHARMA > SEKEM", "Pharmacology": "BABY CARE", "Category": "#.ل#>ن#.ية #%#.ل#-#<ل", "Use": "–مه#~ئ لل#^#_#> \r\n\r\n–#-#.#^#~ للغ#.ز#.#? \r\n\r\n–#?ه#~ئة م#>#~ة #.ل#-#<ل \r\n\r\n–منوم للأ#-#<#.ل و#.ل#^#_#> \r\n\r\n–يس#.#>#~ #>لى #.له#_م \r\n\r\n–يه#~ئ #?و#?#^ أ#>ص#.#% #.ل#^#_ي#> #>ن#~ #.لألم أو #%زوغ #.لأسن#.ن", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء.", "GI": "COMING SOON ..", "Composition": "olive oil 10%, zinc oxide 20%", "Route": "SACHETS" }, { "ID": "509", "Trade_Name": "EPIRAZOLE 20MG 14CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "44", "Price_Old": "44", "Company": "EIPICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg", "Route": "ORAL.SOLID" }, { "ID": "510", "Trade_Name": "ORLY 120MG 30 CAPS.", "Generic_Name": "ORLISTAT", "Price": "97.5", "Price_Old": "97.5", "Company": "EVA PHARMA", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "Each hard capsule contains:Active ingredient: Orlistat 120 mg\r\nInactive ingredient: Microcrystalline cellulose, PVP, sodium starch glycollate, sodium lauryl sulphate, purified talc, gelatin, titanium dioxide, brilliant blue & erythrosine.", "Route": "ORAL.SOLID" }, { "ID": "511", "Trade_Name": "HEPATIC FORTE 30 SOFT GELATIN CAPS.", "Generic_Name": "OROTIC ACID+PHOSPHOLIPIDS+SILYMARIN", "Price": "21", "Price_Old": "21", "Company": "ADWIA", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–حم#.سة خل#.ي#. #.ل#=#%#~ من #.ل#?ل#<. \r\n\r\n–#.#>#.#~ة #?#=وين #.لخل#.ي#. #.ل#=#%#~ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي. \r\n\r\n–#.م#^#.#_ #.ل#=#%#~ #.ل#?سممية. \r\n\r\n–#?نشي#- وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–#>ل#.ج #?لي#< #.ل#=#%#~.", "Contraindications": "–يس#?خ#~م #%حذ#^ م#> م#^#_ي #.لس#=#^. \r\n\r\n–ل#. يس#?خ#~م لل#.#-#<#.ل #.قل من 12 #>#.م. \r\n\r\n–يمن#> لمن #?#>#.ني من خلل ه#^موني.", "GI": "About Silymarin\r\nA polyphenolic flavonoid, Hepatoprotective(antihepatotoxic),antioxidant.\r\nMechanism of Action of Silymarin\r\nSilymarin stimulates RNA polymerase A and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepatocytes and also increase the regenerative ability of the liver. \r\nIt stabilizes the hepatic cell membrane and prevents the penetration of toxin in to the cell and also slows the absorption of harmful substances in to the liver. \r\nSilymarin contains antioxidant flavanoid. It combines with free radicals formed from metabolic process and also from breakdown of toxic substances and neutralizes them. Because of its antioxidant action it has anti-inflammatory property and it is used in ulcerative colitis and in ulcers. \r\nIt increases the glutathione content in the liver and intestine and also increases the activity of super oxide dismutase enzymes and is helpful in detoxifying actions of liver.", "Composition": "? Each capsule contains: \r\nSilymarin 70 mg\r\nEssential Phospholipids 300 mg\r\nOrotic Acid (Vit. B13) 10 mg", "Route": "ORAL.SOLID" }, { "ID": "512", "Trade_Name": "XENICAL 120MG 84 CAP.", "Generic_Name": "ORLISTAT", "Price": "280", "Price_Old": "280", "Company": "F.HOFFMAN LA ROCHE > EGYPTIAN PHARMACEUTICAL TRADING COMPANY", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "orlistat 120mg", "Route": "ORAL.SOLID" }, { "ID": "513", "Trade_Name": "QUICK-SLIM 120 MG 30 CAPS.", "Generic_Name": "ORLISTAT", "Price": "100", "Price_Old": "87", "Company": "MARCYRL CO.", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "514", "Trade_Name": "OXEPAM 15 MG 20 CAP.", "Generic_Name": "OXAZEPAM", "Price": "16", "Price_Old": "16", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "PSYCHIATRIC.ANXIOLYTICS-HYPNOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#.لقلق #.لن#.جم #>ن #.نسح#.#% #.ل#=حول \r\n\r\n–#.لقلق و#.ل#?و#?#^ #.لمص#.ح#% ل#_غو#- #.لحي#.ة #.ليومية \r\n\r\n–#.ل#?غل#% #>لى #.لقلق #.لمص#.ح#% لل#.#=#?ئ#.#% \r\n\r\n–#.ل#?غل#% #>لى #.لقلق وس#^#>ة #.ل#.س#?ث#.#^ة و#.ل#?هيج ل#~ى #=#%#.#^ #.لسن", "Contraindications": "–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=#%#~ أو #.ل#=لي #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#?ن#<س أو #.لز#^ق أو #.ل#%و#^#<ي#^ي#. #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ #<ي ح#.لة #.لحس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–ل#. ينصح #%#.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? ثقيلة ق#~ #?#?#-ل#% يقظة ذهنية. \r\n\r\n–يحذ#^ #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%مش#.#=ل #<ي #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n– لمن ي#>#.نون من أم#^#.#_ #.لقل#% و#.لأو#>ية #.ل#~موية. \r\n\r\n– لمن ي#>#.نون من م#^#_ #.ل#%و#^#<ي#^ي#.. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#_يق #<ي #.لزو#.ية. \r\n\r\n–#<ي ح#.لة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~ أو #.ل#=لي. \r\n\r\n– #<ي ح#.لة #.لحس#.سية #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من م#^#_ #.لوهن.", "GI": "About Oxazepam\r\nAnxiolytic,benzodiazepines\r\n\r\nMechanism of Action of Oxazepam\r\nSimilar to other benzodiazepines, oxazepam exerts its anxiolytic effects by potentiating the effect of gamma-aminobutyric acid (GABA) on GABA-A receptors through a cooperative mechanism of action. GABA receptors are ionotropic chloride-linked channel receptors that produce inhibitory postsynaptic potentials. Benzodiazepine binding increases chloride conductance in the presence of GABA by increasing the frequency at which the channel opens.\r\nIndications for Oxazepam\r\nFor the treatment of anxiety disorders and alcohol withdrawal.\r\nInteractions for Oxazepam\r\n1.Reduced sedative effects with theophylline and other CNS stimulants. \r\n2.Increased incidence of headache with zidovudine. \r\n3.May reduce effects of levodopa. \r\n4.Potentially Fatal: Additive CNS depression with alcohol and other CNS depressants.", "Composition": "oxazepam 15mg", "Route": "ORAL.SOLID" }, { "ID": "515", "Trade_Name": "TAMIFLU 75MG 10CAPS.", "Generic_Name": "OSELTAMIVIR", "Price": "120", "Price_Old": "120", "Company": "F.HOFFMAN LA ROCHE > MULTIPHARMA", "Pharmacology": "ANTIVIRAL.RELEASE PHASE", "Category": "م#_#.#~ لل#<ي#^وس#.#?", "Use": "–م#>#.لجة مش#=لة #.لإن#<لونز#. سو#.ء #%#.لنس#%ة لل#%#.لغين أو لل#=#%#.#^ #%#.ل#>ل#.وة إلى #.لأ#-#<#.ل، و#%#.ل#?ح#~ي#~ #.لذين ق#~ #%لغو#. #>#.مهم #.لأول . \r\n\r\n–من#> ح#~وث #.لإص#.#%ة #%مش#=لة #.لإن#<لونز#. سو#.ء #<ي #.ل#%#.لغين أو #%#.لنس#%ة ل#<ئوة #.لأ#-#<#.ل #<وق سن #.لسنة #.لو#.ح#~ة، و#%#.ل#?ح#~ي#~ مم#=ن #=#.نو#. #>لى #.#?ص#.ل م#%#.ش#^ م#> شخص مص#.#% #%#.لإن#<لونز#. . \r\n\r\n–#.لوق#.ية من #.لإص#.#%ة #%مش#=لة #.لإن#<لونز#. لأولئ#= #.لأ#-#<#.ل #.لأقل من #>م#^ “12” شه#^#.ً #<ي أثن#.ء #?#<شي #.لإص#.#%ة #%و#%#.ء #.لإن#<لونز#. .", "Contraindications": "–يوج#~ #>#~#~ من #.ح#?ي#.#-ي#.#? #.لسل#.مة أو مو#.ن#> #.ل#.س#?#>م#.ل #.لخ#.صة #%#.ل#>ق#.#^، و#.ل#?ي من #.ل#_#^و#^ي #.ل#.ل#?ز#.م #%ه#.، وهي :- \r\n\r\n–نظ#^#.ً ل#.ح#?و#.ء #.ل#>ق#.#^ #>لى م#.#~ة #.لسو#^#%ي#?ول، و#.ل#?ي #^#%م#. ق#~ ل#. #?#=ون من#.س#%ة #%ش#=ل مث#.لي لأولئ#= #.لأشخ#.ص #.لذين ي#>#.نون #<ي #.لأصل من #.ل#?#>ص#% #.لو#^#.ثي #.لن#.#~#^ لل#<#^#=#?وز #<إنه ي#<#_ل #>#~م #.س#?خ#~#.مه #>ل#.جي#.ً #%#.لنس#%ة لهم . \r\n\r\n–يمن#> من #.س#?خ#~#.م #.ل#>ق#.#^ #.لمص#.#%ين #%مش#=لة #.لحس#.سية لل#~و#.ء أو لمش#?ق#.#?ه . \r\n\r\n–ين#%غي #>#~م #.ل#.س#?خ#~#.م #.ل#>ل#.جي لل#>ق#.#^ لأولئ#= #.لأ#-#<#.ل #.لذين لم ي#%لغو#. #>م#^ #.ل#>#.م . \r\n\r\n–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #%#=ل حذ#^، وح#^ص لأولئ#= #.لمص#.#%ين #%#.ح#?ل#.ل #<ي #.لوظ#.ئ#< #.لم#?#>لقة #%#.ل#=لى أو #%#.ل#=#%#~ #%#.ل#>ل#.وة إلى م#^#_ #.لقل#% أو #.لجه#.ز #.ل#?ن#<س #%#.لإ#_#.#<ة أي#_#.ً إلى #.لمص#.#%ين #%#.خ#?ل#.ل #<ي #.لجه#.ز #.لمن#.#>ي . \r\n\r\n–#%#.لإم#=#.ن #?ن#.ول أو آخذ #.ل#>ق#.#^ م#> #.ل#-#>#.م أو #%#~ونه . \r\n\r\n–ي#^#.#>ى #>#~م #.لقي#.م #%#?ن#.ول أو آخذ ج#^#>ة ز#.ئ#~ة #>ن #.لج#^#>ة #.لأس#.سية من #.ل#>ق#.#^ #<ي ح#.لة #.لنسي#.ن . \r\n\r\n–ي#^#.#>ى #.لحصول أول#.ً #>لى #.ل#.س#?ش#.#^ة #.ل#-#%ية #.لل#.زمة ل#?ن#.ول #.ل#>ق#.#^ من ج#.ن#% #.لحو#.مل أو من يقمن #%#.ل#^#_#.#>ة #.ل#-#%ية، وذل#= ي#^ج#> إلى أنه ل#. ز#.ل من غي#^ #.لم#>#^و#< إلى أي م#~ى ق#~ ي#<#^ز #.ل#>ق#.#^ #<ي حلي#% #.لث#~ي #.لخ#.ص #%#.لم#^#_#> أو م#~ى #?أثي#^ه #.لسل#%ي #%#.لنس#%ة للحو#.مل سو#.ء #%#.لنس#%ة للأم أو للجنين . \r\n\r\n–ي#?#<#.#>ل #.ل#>ق#.#^، و#%ش#=ل قوي م#> #.لمصل #.لخ#.ص #%#.لإن#<لونز#.، و#.لذي يؤخذ #>ن #-#^يق #.لأن#<، ولذل#= #<إنه ي#^#.#>ى إخ#%#.#^ #.ل#-#%ي#% #.لم#>#.لج أول#.ً #%نو#>ية #.لأ#~وية #.ل#?ي ي#?ن#.وله#. أو يس#?خ#~مه#. #.لمص#.#% #%مش#=لة #.لإن#<لونز#. #<ي ح#.ل ذل#=، وق#%ل #.ل#.س#?خ#~#.م #.ل#<#>لي لل#>ق#.#^ . \r\n\r\n–ي#^#.#>ى #.ل#.ح#?#<#.ظ #%#.لمس#?ح#_#^ #%#>ي#~#.ً #>ن #.ل#^#-و#%ة #.ل#>#.لية #.ل#~#^جة، و#<ي #~#.خل #>#%و#?ه #.لأصلية #=م#. ي#?وج#% ح#<ظه #<ي #~#^جة ح#^#.#^ة #.لغ#^#<ة، و#%#>ي#~#.ً #>ن #~#^ج#.#? #.لح#^#.#^ة #.ل#>#.لية . \r\n\r\n–#%#.لنس#%ة لل#>ق#.#^ #>لى ش#=ل ش#^#.#% #<إنه يج#^ى #.ل#.ح#?#<#.ظ #%ه #<ي #~#.خل #.لثل#.جة #%#>#~ م#^#.#>#.ة #?خ#<ي#<ه #%#.س#?خ#~#.م #.لم#.ء #>لى أن ي#?م #.س#?خ#~#.مه #<ي خل#.ل م#. م#~#?ه #.لزمنية ” #>ش#^ة أي#.م ” #<ق#-، و#>لى #.لأ#=ث#^ . \r\n\r\n–ي#?وج#% #.ل#.ل#?ز#.م #%#.لج#^#>#.#? #.ل#>ل#.جية #.لمق#^#^ة من ج#.ن#% #.ل#-#%ي#% #.لم#>#.لج من #.ل#>ق#.#^، وذل#= للحصول #>لى أ#<#_ل #.لن#?#.ئج #.ل#>ل#.جية، ةل#?جن#% #.لإص#.#%ة #%أي#.ً من #.لآث#.#^ #.لج#.ن#%ية #.لخ#.صة #%ــ #.ل#>ق#.#^ .", "GI": "About Oseltamivir\r\nAntiviral,Neuraminidase inhibitor\r\nMechanism of Action of Oseltamivir\r\nOseltamivir is an ethyl ester prodrug requiring ester hydrolysis for conversion to active form oseltamivir carboxylate. Oseltamivir is a neuraminidase inhibitor, serving as a competitive inhibitor towards sialic acid, found on the surface proteins of normal host cells. By blocking the activity of the viral neuraminidase (NA) enzyme, oseltamivir prevents new viral particles from being released by infected cells.\r\nIndications for Oseltamivir\r\nTreatment and prevention of infections due to influenza A and B viruses.\r\nInteractions for Oseltamivir\r\nOseltamivir+Probenecid: Oseltamivir has its toxicity increased by probenecid.", "Composition": "oseltamivir 75mg", "Route": "ORAL.SOLID" }, { "ID": "516", "Trade_Name": "SLIM SAFE 120MG 30 CAPS.", "Generic_Name": "ORLISTAT", "Price": "102", "Price_Old": "102", "Company": "AMOUN", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "orlistat 120mg", "Route": "ORAL.SOLID" }, { "ID": "517", "Trade_Name": "TAMINIL-N 75 MG 10 CAPS.", "Generic_Name": "OSELTAMIVIR", "Price": "189", "Price_Old": "70", "Company": "EL NILE.", "Pharmacology": "ANTIVIRAL.RELEASE PHASE", "Category": "م#_#.#~ لل#<ي#^وس#.#?", "Use": "–م#>#.لجة مش#=لة #.لإن#<لونز#. سو#.ء #%#.لنس#%ة لل#%#.لغين أو لل#=#%#.#^ #%#.ل#>ل#.وة إلى #.لأ#-#<#.ل، و#%#.ل#?ح#~ي#~ #.لذين ق#~ #%لغو#. #>#.مهم #.لأول . \r\n\r\n–من#> ح#~وث #.لإص#.#%ة #%مش#=لة #.لإن#<لونز#. سو#.ء #<ي #.ل#%#.لغين أو #%#.لنس#%ة ل#<ئوة #.لأ#-#<#.ل #<وق سن #.لسنة #.لو#.ح#~ة، و#%#.ل#?ح#~ي#~ مم#=ن #=#.نو#. #>لى #.#?ص#.ل م#%#.ش#^ م#> شخص مص#.#% #%#.لإن#<لونز#. . \r\n\r\n–#.لوق#.ية من #.لإص#.#%ة #%مش#=لة #.لإن#<لونز#. لأولئ#= #.لأ#-#<#.ل #.لأقل من #>م#^ “12” شه#^#.ً #<ي أثن#.ء #?#<شي #.لإص#.#%ة #%و#%#.ء #.لإن#<لونز#. .", "Contraindications": "–يوج#~ #>#~#~ من #.ح#?ي#.#-ي#.#? #.لسل#.مة أو مو#.ن#> #.ل#.س#?#>م#.ل #.لخ#.صة #%#.ل#>ق#.#^، و#.ل#?ي من #.ل#_#^و#^ي #.ل#.ل#?ز#.م #%ه#.، وهي :- \r\n\r\n–نظ#^#.ً ل#.ح#?و#.ء #.ل#>ق#.#^ #>لى م#.#~ة #.لسو#^#%ي#?ول، و#.ل#?ي #^#%م#. ق#~ ل#. #?#=ون من#.س#%ة #%ش#=ل مث#.لي لأولئ#= #.لأشخ#.ص #.لذين ي#>#.نون #<ي #.لأصل من #.ل#?#>ص#% #.لو#^#.ثي #.لن#.#~#^ لل#<#^#=#?وز #<إنه ي#<#_ل #>#~م #.س#?خ#~#.مه #>ل#.جي#.ً #%#.لنس#%ة لهم . \r\n\r\n–يمن#> من #.س#?خ#~#.م #.ل#>ق#.#^ #.لمص#.#%ين #%مش#=لة #.لحس#.سية لل#~و#.ء أو لمش#?ق#.#?ه . \r\n\r\n–ين#%غي #>#~م #.ل#.س#?خ#~#.م #.ل#>ل#.جي لل#>ق#.#^ لأولئ#= #.لأ#-#<#.ل #.لذين لم ي#%لغو#. #>م#^ #.ل#>#.م . \r\n\r\n–يج#^ى #.س#?خ#~#.م #.ل#>ق#.#^ #%#=ل حذ#^، وح#^ص لأولئ#= #.لمص#.#%ين #%#.ح#?ل#.ل #<ي #.لوظ#.ئ#< #.لم#?#>لقة #%#.ل#=لى أو #%#.ل#=#%#~ #%#.ل#>ل#.وة إلى م#^#_ #.لقل#% أو #.لجه#.ز #.ل#?ن#<س #%#.لإ#_#.#<ة أي#_#.ً إلى #.لمص#.#%ين #%#.خ#?ل#.ل #<ي #.لجه#.ز #.لمن#.#>ي . \r\n\r\n–#%#.لإم#=#.ن #?ن#.ول أو آخذ #.ل#>ق#.#^ م#> #.ل#-#>#.م أو #%#~ونه . \r\n\r\n–ي#^#.#>ى #>#~م #.لقي#.م #%#?ن#.ول أو آخذ ج#^#>ة ز#.ئ#~ة #>ن #.لج#^#>ة #.لأس#.سية من #.ل#>ق#.#^ #<ي ح#.لة #.لنسي#.ن . \r\n\r\n–ي#^#.#>ى #.لحصول أول#.ً #>لى #.ل#.س#?ش#.#^ة #.ل#-#%ية #.لل#.زمة ل#?ن#.ول #.ل#>ق#.#^ من ج#.ن#% #.لحو#.مل أو من يقمن #%#.ل#^#_#.#>ة #.ل#-#%ية، وذل#= ي#^ج#> إلى أنه ل#. ز#.ل من غي#^ #.لم#>#^و#< إلى أي م#~ى ق#~ ي#<#^ز #.ل#>ق#.#^ #<ي حلي#% #.لث#~ي #.لخ#.ص #%#.لم#^#_#> أو م#~ى #?أثي#^ه #.لسل#%ي #%#.لنس#%ة للحو#.مل سو#.ء #%#.لنس#%ة للأم أو للجنين . \r\n\r\n–ي#?#<#.#>ل #.ل#>ق#.#^، و#%ش#=ل قوي م#> #.لمصل #.لخ#.ص #%#.لإن#<لونز#.، و#.لذي يؤخذ #>ن #-#^يق #.لأن#<، ولذل#= #<إنه ي#^#.#>ى إخ#%#.#^ #.ل#-#%ي#% #.لم#>#.لج أول#.ً #%نو#>ية #.لأ#~وية #.ل#?ي ي#?ن#.وله#. أو يس#?خ#~مه#. #.لمص#.#% #%مش#=لة #.لإن#<لونز#. #<ي ح#.ل ذل#=، وق#%ل #.ل#.س#?خ#~#.م #.ل#<#>لي لل#>ق#.#^ . \r\n\r\n–ي#^#.#>ى #.ل#.ح#?#<#.ظ #%#.لمس#?ح#_#^ #%#>ي#~#.ً #>ن #.ل#^#-و#%ة #.ل#>#.لية #.ل#~#^جة، و#<ي #~#.خل #>#%و#?ه #.لأصلية #=م#. ي#?وج#% ح#<ظه #<ي #~#^جة ح#^#.#^ة #.لغ#^#<ة، و#%#>ي#~#.ً #>ن #~#^ج#.#? #.لح#^#.#^ة #.ل#>#.لية . \r\n\r\n–#%#.لنس#%ة لل#>ق#.#^ #>لى ش#=ل ش#^#.#% #<إنه يج#^ى #.ل#.ح#?#<#.ظ #%ه #<ي #~#.خل #.لثل#.جة #%#>#~ م#^#.#>#.ة #?خ#<ي#<ه #%#.س#?خ#~#.م #.لم#.ء #>لى أن ي#?م #.س#?خ#~#.مه #<ي خل#.ل م#. م#~#?ه #.لزمنية ” #>ش#^ة أي#.م ” #<ق#-، و#>لى #.لأ#=ث#^ . \r\n\r\n–ي#?وج#% #.ل#.ل#?ز#.م #%#.لج#^#>#.#? #.ل#>ل#.جية #.لمق#^#^ة من ج#.ن#% #.ل#-#%ي#% #.لم#>#.لج من #.ل#>ق#.#^، وذل#= للحصول #>لى أ#<#_ل #.لن#?#.ئج #.ل#>ل#.جية، ةل#?جن#% #.لإص#.#%ة #%أي#.ً من #.لآث#.#^ #.لج#.ن#%ية #.لخ#.صة #%ــ #.ل#>ق#.#^ .", "GI": "About Oseltamivir\r\nAntiviral,Neuraminidase inhibitor\r\nMechanism of Action of Oseltamivir\r\nOseltamivir is an ethyl ester prodrug requiring ester hydrolysis for conversion to active form oseltamivir carboxylate. Oseltamivir is a neuraminidase inhibitor, serving as a competitive inhibitor towards sialic acid, found on the surface proteins of normal host cells. By blocking the activity of the viral neuraminidase (NA) enzyme, oseltamivir prevents new viral particles from being released by infected cells.\r\nIndications for Oseltamivir\r\nTreatment and prevention of infections due to influenza A and B viruses.\r\nInteractions for Oseltamivir\r\nOseltamivir+Probenecid: Oseltamivir has its toxicity increased by probenecid.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "518", "Trade_Name": "REGIMAX 120MG 30 CAPS.", "Generic_Name": "ORLISTAT", "Price": "100.14", "Price_Old": "69", "Company": "GLOBAL NAPI PHARMACEUTICALS > PENTA PHARMA-EGYPT", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "519", "Trade_Name": "PAXELADINE 40 MG 20 CAPS.", "Generic_Name": "OXELADIN", "Price": "20", "Price_Old": "20", "Company": "ARAB DRUG COMPANY. > BEAUFOUR IPSEN-FRANCE", "Pharmacology": "COUGH DRUGS", "Category": "م#_#.#~ لل#=حة", "Use": "– #.ل#=حة #.لج#.#<ة و م#. يص#.ح#%ه#. من #.#>#^#.#_ \r\n\r\n–س#>#.ل مهيج \r\n\r\n–#.ل#.ل#?ه#.#% #.ل#^ئوي \r\n\r\n–#.لس#>#.ل #.ل#?حسسي \r\n\r\n–#.لس#>#.ل #.لن#<سي \r\n\r\n–#.لس#>#.ل #<ي #.لم#^#_ى #.لذين ي#>#.نون من أم#^#.#_ #.لقل#% \r\n\r\n–#.لقص#%#.#? \r\n\r\n–#.ل#?ه#.#% ش#>#%ي", "Contraindications": "–#.لحس#.سية ل#.ح#~ي #.لم#=ون#.#? #.ل#<#>#.لة #.و غي#^ #.ل#<#>#.لة #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء \r\n\r\n–ل#. يج#% #.ل#.س#?#>م#.ل #<ي #.لأ#-#<#.ل #.لذين #?قل #.#>م#.#^هم #>ن 30 شه#^ ( #>#.مين ) #.و #?قل #.وز#.نهم #>ن 15 #=جم", "GI": "Oxeladin is a cough suppressant. It is a highly potent and effective drug used to treat all types of cough of various etiologies. It is not related to opium or its derivatives, so treatment with oxeladin is free of risk of dependence or addiction. Oxeladin has none of the side effects (such as hypnosis, respiratory depression, tolerance, constipation and analgesia) which are present when common antitussives, such as codeine and its derivatives, are used. It may be used at every age, as well as in patients with heart disease, since it has a high level of safety and a great selectivity to act on the bulbar centre of cough.", "Composition": "oxeladine citrate 0.2% or 40mg", "Route": "ORAL.SOLID" }, { "ID": "520", "Trade_Name": "DOWNOPRAZOL 40MG/1100 14 CAPS.", "Generic_Name": "OMEPRAZOLE+SODIUM BICARBONATE", "Price": "45", "Price_Old": "30", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > UTOPIA PHARMACEUTICALS COMPANY", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة و#.ل#.ثنى #>ش#^ #=م#. يقوم #%#>ل#.ج ق#^حة #.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.لحمو#_ة. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ىء #=م#. ي#>#.لج ح#^ق#.ن #.لم#^ئ و#.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #.ل#>ل#.ج و #.لوق#.ية من #.لق#^حة #.لن#.#?جة #>ن #.س#?#>م#.ل #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#^غ#%ة #<ى #.لوق#.ية من ق#^حة #.لم#>#~ة #<ى ح#.ل#.#? #.س#?خ#~#.م #.ل#=و#^#?يزون #=م#. ي#>#.لج #.ل#?ه#.#% #.لقولون #.ل#?ق#^حى ، #%#.ل#.#_#.#<ة #.نه ي#>مل #>لى #?قليل مخ#.#-#^ #.لنزي#< #%#.لجه#.ز #.له#_مى . \r\n\r\n–#<#>#.ل #<ي ح#.ل#.#? #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي #=م#. يس#.#>#~ #>لي #?قليل مخ#.#-#^ #.لنزي#< #<ي #.لجه#.ز #.له#_مي .", "Contraindications": "–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة يؤ#~ى إلى سوء إم#?ص#.ص #<ي#?#.مين B12 مم#. يقلل من #?#^#=يزه #%#.لجسم لذل#= ي#<#_ل #?ن#.ول أ#~وية #?ح#?وى #>لى #<ي#?#.مين B12 أثن#.ء #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة . \r\n\r\n–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة ( أ#=ث#^ من #>#.م ) ق#~ يؤ#~ى إلى نقص نس#%ة #.لم#.غنيسيوم #%#.ل#~م ( HYPOMAGNESEMIA ) . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=لى . \r\n\r\n–يقلل #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى : \r\n\r\n–KETOCONAZOLE \r\n\r\n– ITRACONAZOLE \r\n\r\n– MESALAZINE لذل#= يج#% #.س#?خ#~#.م #.#~ويه أخ#^ى . \r\n\r\n–يزي#~ من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى م#.#~ة #.ل DIGOXIN لذل#= يج#% #.لحذ#^ : ق#~ #?س#%#% #.لو#<#.ة . \r\n\r\n–يقلل من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى SOFOSBUVIR / VELPATASVIR #.لمس#?خ#~م ل#>ل#.ج #<ي#^وس C لذل#= يج#% #.س#?خ#~#.م #>ل#.ج أخ#^ . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لجل#-ة #.ل#?ى #?ح#?وى #>لى م#.#~ة CLOPIDOGREL : لذل#= يج#% #?غيي#^ #.ل#>ل#.ج . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لأم#^#.#_ #.لن#<سية #.ل#?ى #?ح#?وى #>لى م#.#~ة DULOXETINE \r\n\r\n–#<ى ح#.لة #.لحمل ل#.يوج#~ #~#^#.سة #=#.#<ية #>ن #.س#?خ#~#.م #.ل#~و#.ء، أم#. #<ى ح#.لة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.مة وننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص #<ى ذل#=.يمن#> #?ن#.ول #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لح#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى .", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.\r\nIndications for Omeprazole\r\n1. Duodenal ulcer \r\n2. Gastric ulcer \r\n3. Zollinger- Ellison syndrome \r\n4. Gastroesophageal reflux disease \r\n5. Oesophagitis \r\n6. Acid related dyspepsia \r\n7. NSAID associated ulceration \r\n8. Prophylaxis of acid aspiration during anesthesia \r\nInteractions for Omeprazole\r\nDiazepam: Half life of diazepam is increased. \r\nPhenytoin: Increased", "Composition": "Each hard gelatin capsule contains:\r\nOmeprazole (20 or 40) mg.\r\nSodium bicarbonate 1100 mg.\r\n\r\nEach Packet of 3 gm powder for oral suspension contains:\r\nOmeprazole 20 mg + Sodium bicarbonate 1680 mg.", "Route": "ORAL.SOLID" }, { "ID": "521", "Trade_Name": "CUT DOWN 120 MG 20 CAPS.", "Generic_Name": "ORLISTAT", "Price": "57", "Price_Old": "38", "Company": "SABAA > NOVELL PHARMA", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "1 gm cutacort cream contains\r\n 10 mg isoconazole nitrate and 1 mg diflucortolone valerate in an easy to remove low fat base (o/w emulsion ).", "Route": "ORAL.SOLID" }, { "ID": "522", "Trade_Name": "CHEMITRIJULIE 120 MG 30 CAPS.", "Generic_Name": "ORLISTAT", "Price": "99.75", "Price_Old": "33.75", "Company": "EGPI > CHEMIDICA-EGYPT", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "523", "Trade_Name": "OMEHEALTH 40/1100 MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE+SODIUM BICARBONATE", "Price": "27", "Price_Old": "18", "Company": "EGPI > HEALTHY POINT THERAPEUTICS", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة و#.ل#.ثنى #>ش#^ #=م#. يقوم #%#>ل#.ج ق#^حة #.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.لحمو#_ة. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ىء #=م#. ي#>#.لج ح#^ق#.ن #.لم#^ئ و#.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #.ل#>ل#.ج و #.لوق#.ية من #.لق#^حة #.لن#.#?جة #>ن #.س#?#>م#.ل #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#^غ#%ة #<ى #.لوق#.ية من ق#^حة #.لم#>#~ة #<ى ح#.ل#.#? #.س#?خ#~#.م #.ل#=و#^#?يزون #=م#. ي#>#.لج #.ل#?ه#.#% #.لقولون #.ل#?ق#^حى ، #%#.ل#.#_#.#<ة #.نه ي#>مل #>لى #?قليل مخ#.#-#^ #.لنزي#< #%#.لجه#.ز #.له#_مى . \r\n\r\n–#<#>#.ل #<ي ح#.ل#.#? #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي #=م#. يس#.#>#~ #>لي #?قليل مخ#.#-#^ #.لنزي#< #<ي #.لجه#.ز #.له#_مي .", "Contraindications": "–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة يؤ#~ى إلى سوء إم#?ص#.ص #<ي#?#.مين B12 مم#. يقلل من #?#^#=يزه #%#.لجسم لذل#= ي#<#_ل #?ن#.ول أ#~وية #?ح#?وى #>لى #<ي#?#.مين B12 أثن#.ء #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة . \r\n\r\n–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة ( أ#=ث#^ من #>#.م ) ق#~ يؤ#~ى إلى نقص نس#%ة #.لم#.غنيسيوم #%#.ل#~م ( HYPOMAGNESEMIA ) . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=لى . \r\n\r\n–يقلل #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى : \r\n\r\n–KETOCONAZOLE \r\n\r\n– ITRACONAZOLE \r\n\r\n– MESALAZINE لذل#= يج#% #.س#?خ#~#.م #.#~ويه أخ#^ى . \r\n\r\n–يزي#~ من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى م#.#~ة #.ل DIGOXIN لذل#= يج#% #.لحذ#^ : ق#~ #?س#%#% #.لو#<#.ة . \r\n\r\n–يقلل من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى SOFOSBUVIR / VELPATASVIR #.لمس#?خ#~م ل#>ل#.ج #<ي#^وس C لذل#= يج#% #.س#?خ#~#.م #>ل#.ج أخ#^ . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لجل#-ة #.ل#?ى #?ح#?وى #>لى م#.#~ة CLOPIDOGREL : لذل#= يج#% #?غيي#^ #.ل#>ل#.ج . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لأم#^#.#_ #.لن#<سية #.ل#?ى #?ح#?وى #>لى م#.#~ة DULOXETINE \r\n\r\n–#<ى ح#.لة #.لحمل ل#.يوج#~ #~#^#.سة #=#.#<ية #>ن #.س#?خ#~#.م #.ل#~و#.ء، أم#. #<ى ح#.لة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.مة وننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص #<ى ذل#=.يمن#> #?ن#.ول #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لح#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى .", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.\r\nIndications for Omeprazole\r\n1. Duodenal ulcer \r\n2. Gastric ulcer \r\n3. Zollinger- Ellison syndrome \r\n4. Gastroesophageal reflux disease \r\n5. Oesophagitis \r\n6. Acid related dyspepsia \r\n7. NSAID associated ulceration \r\n8. Prophylaxis of acid aspiration during anesthesia \r\nInteractions for Omeprazole\r\nDiazepam: Half life of diazepam is increased. \r\nPhenytoin: Increased", "Composition": "omeprazole 40mg, sod. Bicarbonate 1100 mg", "Route": "ORAL.SOLID" }, { "ID": "524", "Trade_Name": "ORGANO-ORLISTAT 120MG 20 CAPS.", "Generic_Name": "ORLISTAT", "Price": "46", "Price_Old": "46", "Company": "ORGANOPHARMA", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "525", "Trade_Name": "EASY SLIM 120MG 10 CAPS.", "Generic_Name": "ORLISTAT", "Price": "30", "Price_Old": "30", "Company": "EUROPEAN EGYPTIAN PHARM. IND.", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "orlistat 120mg", "Route": "ORAL.SOLID" }, { "ID": "526", "Trade_Name": "STOMIGAS 40/1100 MG 20 CAPS.", "Generic_Name": "OMEPRAZOLE+SODIUM BICARBONATE", "Price": "54", "Price_Old": "36", "Company": "INTERNATIONAL DRUG AGENCY (IDI) > NOVELL PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة و#.ل#.ثنى #>ش#^ #=م#. يقوم #%#>ل#.ج ق#^حة #.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.لحمو#_ة. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ىء #=م#. ي#>#.لج ح#^ق#.ن #.لم#^ئ و#.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #.ل#>ل#.ج و #.لوق#.ية من #.لق#^حة #.لن#.#?جة #>ن #.س#?#>م#.ل #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#^غ#%ة #<ى #.لوق#.ية من ق#^حة #.لم#>#~ة #<ى ح#.ل#.#? #.س#?خ#~#.م #.ل#=و#^#?يزون #=م#. ي#>#.لج #.ل#?ه#.#% #.لقولون #.ل#?ق#^حى ، #%#.ل#.#_#.#<ة #.نه ي#>مل #>لى #?قليل مخ#.#-#^ #.لنزي#< #%#.لجه#.ز #.له#_مى . \r\n\r\n–#<#>#.ل #<ي ح#.ل#.#? #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي #=م#. يس#.#>#~ #>لي #?قليل مخ#.#-#^ #.لنزي#< #<ي #.لجه#.ز #.له#_مي .", "Contraindications": "–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة يؤ#~ى إلى سوء إم#?ص#.ص #<ي#?#.مين B12 مم#. يقلل من #?#^#=يزه #%#.لجسم لذل#= ي#<#_ل #?ن#.ول أ#~وية #?ح#?وى #>لى #<ي#?#.مين B12 أثن#.ء #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة . \r\n\r\n–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة ( أ#=ث#^ من #>#.م ) ق#~ يؤ#~ى إلى نقص نس#%ة #.لم#.غنيسيوم #%#.ل#~م ( HYPOMAGNESEMIA ) . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=لى . \r\n\r\n–يقلل #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى : \r\n\r\n–KETOCONAZOLE \r\n\r\n– ITRACONAZOLE \r\n\r\n– MESALAZINE لذل#= يج#% #.س#?خ#~#.م #.#~ويه أخ#^ى . \r\n\r\n–يزي#~ من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى م#.#~ة #.ل DIGOXIN لذل#= يج#% #.لحذ#^ : ق#~ #?س#%#% #.لو#<#.ة . \r\n\r\n–يقلل من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى SOFOSBUVIR / VELPATASVIR #.لمس#?خ#~م ل#>ل#.ج #<ي#^وس C لذل#= يج#% #.س#?خ#~#.م #>ل#.ج أخ#^ . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لجل#-ة #.ل#?ى #?ح#?وى #>لى م#.#~ة CLOPIDOGREL : لذل#= يج#% #?غيي#^ #.ل#>ل#.ج . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لأم#^#.#_ #.لن#<سية #.ل#?ى #?ح#?وى #>لى م#.#~ة DULOXETINE \r\n\r\n–#<ى ح#.لة #.لحمل ل#.يوج#~ #~#^#.سة #=#.#<ية #>ن #.س#?خ#~#.م #.ل#~و#.ء، أم#. #<ى ح#.لة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.مة وننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص #<ى ذل#=.يمن#> #?ن#.ول #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لح#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى .", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.\r\nIndications for Omeprazole\r\n1. Duodenal ulcer \r\n2. Gastric ulcer \r\n3. Zollinger- Ellison syndrome \r\n4. Gastroesophageal reflux disease \r\n5. Oesophagitis \r\n6. Acid related dyspepsia \r\n7. NSAID associated ulceration \r\n8. Prophylaxis of acid aspiration during anesthesia \r\nInteractions for Omeprazole\r\nDiazepam: Half life of diazepam is increased. \r\nPhenytoin: Increased", "Composition": "STOMIGAS 20/1100 mg Capsules: Each hard gelatin capsule, contains 20 mg omeprazole and 1100 mg sodium bicarbonate.\r\n\r\nSTOMIGAS 40/1100 mg Capsules: Each hard gelatin capsule, contains 40 mg omeprazole and 1100 mg sodium bicarbonate.\r\n\r\nSTOMIGAS powder in pack", "Route": "ORAL.SOLID" }, { "ID": "527", "Trade_Name": "FATLOSE 120 MG 10 CAP.", "Generic_Name": "ORLISTAT", "Price": "20", "Price_Old": "20", "Company": "EL-OBOUR > REPHARMA PHARMACEUTICALS", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "528", "Trade_Name": "STOMIGAS 20/1100 MG 20 CAPS.", "Generic_Name": "OMEPRAZOLE+SODIUM BICARBONATE", "Price": "54", "Price_Old": "36", "Company": "INTERNATIONAL DRUG AGENCY (IDI) > NOVELL PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة و#.ل#.ثنى #>ش#^ #=م#. يقوم #%#>ل#.ج ق#^حة #.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.لحمو#_ة. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ىء #=م#. ي#>#.لج ح#^ق#.ن #.لم#^ئ و#.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #.ل#>ل#.ج و #.لوق#.ية من #.لق#^حة #.لن#.#?جة #>ن #.س#?#>م#.ل #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#^غ#%ة #<ى #.لوق#.ية من ق#^حة #.لم#>#~ة #<ى ح#.ل#.#? #.س#?خ#~#.م #.ل#=و#^#?يزون #=م#. ي#>#.لج #.ل#?ه#.#% #.لقولون #.ل#?ق#^حى ، #%#.ل#.#_#.#<ة #.نه ي#>مل #>لى #?قليل مخ#.#-#^ #.لنزي#< #%#.لجه#.ز #.له#_مى . \r\n\r\n–#<#>#.ل #<ي ح#.ل#.#? #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي #=م#. يس#.#>#~ #>لي #?قليل مخ#.#-#^ #.لنزي#< #<ي #.لجه#.ز #.له#_مي .", "Contraindications": "–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة يؤ#~ى إلى سوء إم#?ص#.ص #<ي#?#.مين B12 مم#. يقلل من #?#^#=يزه #%#.لجسم لذل#= ي#<#_ل #?ن#.ول أ#~وية #?ح#?وى #>لى #<ي#?#.مين B12 أثن#.ء #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة . \r\n\r\n–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة ( أ#=ث#^ من #>#.م ) ق#~ يؤ#~ى إلى نقص نس#%ة #.لم#.غنيسيوم #%#.ل#~م ( HYPOMAGNESEMIA ) . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=لى . \r\n\r\n–يقلل #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى : \r\n\r\n–KETOCONAZOLE \r\n\r\n– ITRACONAZOLE \r\n\r\n– MESALAZINE لذل#= يج#% #.س#?خ#~#.م #.#~ويه أخ#^ى . \r\n\r\n–يزي#~ من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى م#.#~ة #.ل DIGOXIN لذل#= يج#% #.لحذ#^ : ق#~ #?س#%#% #.لو#<#.ة . \r\n\r\n–يقلل من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى SOFOSBUVIR / VELPATASVIR #.لمس#?خ#~م ل#>ل#.ج #<ي#^وس C لذل#= يج#% #.س#?خ#~#.م #>ل#.ج أخ#^ . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لجل#-ة #.ل#?ى #?ح#?وى #>لى م#.#~ة CLOPIDOGREL : لذل#= يج#% #?غيي#^ #.ل#>ل#.ج . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لأم#^#.#_ #.لن#<سية #.ل#?ى #?ح#?وى #>لى م#.#~ة DULOXETINE \r\n\r\n–#<ى ح#.لة #.لحمل ل#.يوج#~ #~#^#.سة #=#.#<ية #>ن #.س#?خ#~#.م #.ل#~و#.ء، أم#. #<ى ح#.لة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.مة وننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص #<ى ذل#=.يمن#> #?ن#.ول #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لح#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى .", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.\r\nIndications for Omeprazole\r\n1. Duodenal ulcer \r\n2. Gastric ulcer \r\n3. Zollinger- Ellison syndrome \r\n4. Gastroesophageal reflux disease \r\n5. Oesophagitis \r\n6. Acid related dyspepsia \r\n7. NSAID associated ulceration \r\n8. Prophylaxis of acid aspiration during anesthesia \r\nInteractions for Omeprazole\r\nDiazepam: Half life of diazepam is increased. \r\nPhenytoin: Increased", "Composition": "STOMIGAS 20/1100 mg Capsules: Each hard gelatin capsule, contains 20 mg omeprazole and 1100 mg sodium bicarbonate.\r\n\r\nSTOMIGAS 40/1100 mg Capsules: Each hard gelatin capsule, contains 40 mg omeprazole and 1100 mg sodium bicarbonate.\r\n\r\nSTOMIGAS powder in pack", "Route": "ORAL.SOLID" }, { "ID": "529", "Trade_Name": "ORLISMART 120MG 10 CAPS.", "Generic_Name": "ORLISTAT", "Price": "32.4", "Price_Old": "32.4", "Company": "PHAROPHARMA", "Pharmacology": "WEIGHT LOSS", "Category": "#<ق#~#.ن #.لوزن", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لسمنة #.لم#<#^#-ة وزي#.#~ة #.لوزن #.لمَ#^#_ية، #=م#. يق#_ي #>لي #.ل#~هون #<ي #.لجسم .", "Contraindications": "–يمن#> #.س#?خ#~#.مه لل#.شخ#.ص #.لذين ي#>#.نون من م#?ل#.زمة سوء #.ل#.م#?ص#.ص #.له#_مي . \r\n\r\n–يمن#> #.س#?خ#~#.م #.ل#>ق#.#^ خل#.ل #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي ح#.لة #?وق#< #?#~#<ق #.ل#>ص#.#^ة #.لص#<#^#.وية #<ي جسم #.لم#^ي#_ . \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ للأ#-#<#.ل . \r\n\r\n–يج#% #>#~م #?ن#.ول ج#^#>ة ز#.ئ#~ة حيث أنه#. #?ؤث#^ #>لي مس#?وي #.لس#=#^ و#.ل#=وليس#?#^ول #<ي #.لجسم . \r\n\r\n–#?ن#.وله ق#~ يؤ#~ي #.لي #.ل#.ص#.#%ة #%حصو#.#? #.ل#=لي، ولذل#= يمن#> #.س#?خ#~مه#. لل#.شخ#.ص #.لمص#.#%ون #%مش#.#=ل #<ي وظ#.ئ#< #.ل#=لي . \r\n\r\n–ي#<#_ل #>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه يقلل من إ#<#^#.ز #.لحلي#% #>ن#~ #.لأم وين#?قل #.لم#.#~ة #.ل#<#>#.لة #>#%#^ حلي#% #.لث#~ي.", "GI": "About Orlistat\r\nAnti-obese drug. Saturated derivative of lipstatin.\r\n\r\nMechanism of Action of Orlistat\r\nIts primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.Orlistat works by inhibiting gastric and pancreatic lipases, the enzymes that break down triglycerides in the intestine. When lipase activity is blocked, triglycerides from the diet are not hydrolyzed into absorbable free fatty acids, and are excreted undigested instead.", "Composition": "orlistat 120mg", "Route": "ORAL.SOLID" }, { "ID": "530", "Trade_Name": "GASEC 20 MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "37.7", "Price_Old": "37.7", "Company": "MUP > ACINO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg", "Route": "ORAL.SOLID" }, { "ID": "531", "Trade_Name": "HYPOSEC 20MG 14CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "42", "Price_Old": "42", "Company": "AMOUN", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg", "Route": "ORAL.SOLID" }, { "ID": "532", "Trade_Name": "ROSUVASTATIN 20MG 14 F.C. TAB.", "Generic_Name": "ROSUVASTATIN", "Price": "24", "Price_Old": "24", "Company": "BORG", "Pharmacology": "ANTIHYPERLIPIDEMIC.STATINS", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "– ح#.ل#.#? #.#^#?#<#.#> نس#%ة #.ل#~هون #<ي #.ل#~م . \r\n\r\n– #.#^#?#<#.#> #.ل#=ولس#?#^ول #.ل#_#.#^ . \r\n\r\n– #.#^#?#<#.#> نس#%ة #.ل#~هون #.ل#%#^و#?ينية . \r\n\r\n– زي#.#~ة نس#%ة #.ل#~هون #.لثل#.ثية . \r\n\r\n– #?صل#% #.لش#^#.يين . \r\n\r\n– ح#.ل#.#? #.ل#=ولس#?#^ول #.لو#^#.ثي #>ن#~ #.لأ#-#<#.ل . \r\n\r\n– للوق#.ية من أم#^#.#_ #.لقل#% . \r\n\r\n– #.لوق#.ية من أم#^#.#_ ش#^#.يين #.لقل#% #.ل#?#.جية من خل#.ل منه #?#^#.#=م #.ل#~هون #>لى ج#~#.#^ #.لأو#>ية #.ل#~موية . \r\n\r\n– #.لوق#.ية من #.لذ#%حة #.لص#~#^ية . \r\n\r\n– #.لوق#.ية من #.لأزم#.#? #.لقل#%ية . \r\n\r\n– لوق#.ية م#^#_ى #.#^#?#<#.#> #.ل#=ولس#?#^ول #<ي #.ل#~م من #.لإص#.#%ة #%#.لجل#-#.#? . \r\n\r\n– #.لحم#.ية من خ#-#^ #.لس#=#?ة #.ل#~م#.غية من خل#.ل من#> #?#^#.#=م #.ل#~هون #>لى #.لأو#>ية #.ل#~موية #.ل#?ي #?غذي #.لمخ ومن#>ه#. من #.ل#.نس#~#.#~ .", "Contraindications": "– #.لحس#.سية #.لش#~ي#~ة من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n– م#^#_ى #.ل#=#%#~ و#.#^#?#<#.#> م#>#~ل ن#.قل#.#? #.لأمين، لذ#. يج#% م#?#.#%#>ة وظ#.ئ#< #.ل#=#%#~ #%ش#=ل #~و#^ي خل#.ل #<#?#^ة #.ل#>ل#.ج . \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لحمل لأنه يؤث#^ #>لى وزن #.لجنين و#?#-و#^ نموه . \r\n\r\n– ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء خل#.ل م#^حلة #.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه ين#?قل لل#-#<ل #>#%#^ ل#%ن #.لأم ويس#%#% #.نخ#<#.#_ وزنه . \r\n\r\n– هذ#. #.ل#~و#.ء يس#?خ#~م #%حذ#^ م#> #=#%#.#^ #.لسن . \r\n\r\n– ل#. يج#% #?ن#.ول هذ#. #.ل#~و#.ء #%#.ل#?ز#.من م#> #.لمش#^و#%#.#? #.ل#=حولية . \r\n\r\n– يس#?خ#~م #%حذ#^ م#> م#^#_ى #.لقصو#^ #.ل#=لوي . \r\n\r\n– يس#?خ#~م #%حذ#^ م#> م#^#_ى #.لس#=#^ي .", "GI": "About Rosuvastatin\r\nStatin, HMG-CoA Reductase Inhibitor, Antilipemic.\r\nMechanism of Action of Rosuvastatin\r\nIt is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG CoA) to mevalonate. The drug exerts it`s action by specific inhibition of enzyme- 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMG CoA reductase) and reduces cholesterol synthesis up to 50% at therapeutic doses. This results in compensatory increase in low density lipoprotein (LDL) receptor expression in liver which ultimately leads to increased receptor mediated uptake and catabolism of intermediate density lipoprotein(IDL) and low density lipoprotein (LDL). It causes dose dependent lowering of LDL cholesterol and reduces hepatic synthesis of very low density lipoprotein (VLDL) and lowers plasma triglyceride levels. It also increases high density lipoprotein (HDL) levels.", "Composition": "Rosuvastatin 10mg", "Route": "ORAL.SOLID" }, { "ID": "533", "Trade_Name": "GASEC 20 MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "26.4", "Price_Old": "26.4", "Company": "MUP > ACINO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg", "Route": "ORAL.SOLID" }, { "ID": "534", "Trade_Name": "OMEPAK 20MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "19.8", "Price_Old": "19.8", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "535", "Trade_Name": "LOSEC 20MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "32.4", "Price_Old": "32.4", "Company": "ASTRA ZENECA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "536", "Trade_Name": "HEALSEC 20 MG 14 CAPS", "Generic_Name": "OMEPRAZOLE", "Price": "21.75", "Price_Old": "14.4", "Company": "BORG", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each nard gelatin capsule contains:\r\n- Active ingredients:\r\nHealsec 10 mg Hard Gelatin Capsules\r\nOmeprazole 10 mg\r\n\r\nHealsec 20 mg Hard Gelatin Capsules\r\nOmeprazole 20 mg\r\n\r\nHealsec 40 mg Hard Gelatin Capsules Omeprazole 40 mg", "Route": "ORAL.SOLID" }, { "ID": "537", "Trade_Name": "NAPIZOLE 20MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "41.5", "Price_Old": "27.6", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Omeprazole 20 mg", "Route": "ORAL.SOLID" }, { "ID": "538", "Trade_Name": "GASTRAZOLE 20 MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "42.4", "Price_Old": "42.4", "Company": "EUROPEAN EGYPTIAN PHARM. IND.", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Active ingredient: Omeprazole 20 mg.", "Route": "ORAL.SOLID" }, { "ID": "539", "Trade_Name": "OMEPAK 20MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "33", "Price_Old": "33", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "540", "Trade_Name": "CERVITAM 20 CAPS.", "Generic_Name": "PIRACETAM+VINCAMINE", "Price": "31.5", "Price_Old": "21", "Company": "EGYPHAR", "Pharmacology": "CEREBRAL CIRCULATORY INHANCER", "Category": "محسن #.ل#~و#^ة #.ل#~موية #.ل#~م#.غية", "Use": "–#?نشي#- وصول #.ل#~و#^ة #.ل#~موية و #.لأ#=سجين للمخ خصوص#. #%#>#~ #.ل#?#>#^#_ للس#=#?ة #.ل#~م#.غية .\r\n\r\n–يس#.#>#~ #>لى #?نشي#- #.لذ#.#=#^ة و #>ل#.ج #.لنسي#.ن و #.لزه#.يم#^ و #.لخ#^#< و #_#>#< #.ل#?#^#=يز ل#~ى #=#%#.#^ #.لسن .\r\n\r\n–يس#.#>#~ #>لى #?حسين #.لق#~#^#.#? #.ل#>قلية خصوص#. ل#~ى #=#%#.#^ #.لسن و #%#>#~ #.لإص#.#%ة #%#.لس#=#?ة #.ل#~م#.غية و ل#~ى #.لأ#-#<#.ل .\r\n\r\n–#>ل#.ج إ#_#-#^#.#% #.لإذنين و #.ل#~وخة و #.ل#~و#.#^ .", "Contraindications": "–ل#. يس#?خ#~م #<ى ح#.لة وجو#~ نزي#< #%#.لمخ .\r\n\r\n–ل#. يس#?خ#~م م#> ح#.ل#.#? م#^#_ى #.ل#=لى #.لم#?أخ#^ة ، و ح#.ل#.#? م#^#_ى #.ل#=#%#~ .\r\n\r\n–#>ن#~ #.ل#?وق#< #>ن #?ن#.ول #.ل#~و#.ء يج#% #.ل#?وق#< #?#~#^يجي#. .\r\n\r\n–ل#. ي#<#_ل إس#?خ#~#.مه للأ#-#<#.ل أقل من 16 سنة .", "GI": "Piracetam: It is neotropic, known as intelligence booster. It facilitates the oxygen supply to the brain and enhances communication between the left and right parts of the brain. It also enhances the memory.\r\n\r\nVincamine: It has been proven that it is very effective in increasing concentration and attention. It is vasodilator, it increases blood flow and circulation specially in cases of cerebral insufficiency of various types. More and above Vincamine has very low toxicity, as it is an extract of plant origin.\r\n\r\nINDICATIONS:\r\n\r\n-Symptomatic improvement of vertigoes.\r\n-Improvement of certain symptoms of pathological intellectual deficiency of geriatrics (troubles of concentration, memory ...... etc.).\r\n-Treatment of constituted cerebral infarction.\r\n-Complementary treatment to remedy symptoms of pathologic cognitive deficiency and chronic neurosensorial for geriatrics (excluding Alzheimer and other mental disturbances).", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "541", "Trade_Name": "INFLACAM 20MG 10 CAPS.", "Generic_Name": "PIROXICAM", "Price": "7", "Price_Old": "7", "Company": "MEPACO", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#>ل#.ج #.ل#<ص#.ل #.ل#>ظمي. \r\n\r\n–ي#=ون ذ#.#? #?أثي#^ #<#>#.ل وس#^ي#> لل#?خلص من #.ل#^وم#.#?يزم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لنق#^س. \r\n\r\n–#>ل#.ج س#^ي#> ل#.ل#?ه#.#% #.ل#<ق#^#.#?. \r\n\r\n–#>ل#.ج آل#.م #.ل#-مث. \r\n\r\n–يق#_ي #>لى #.ل#?و#^م#.#? #.لن#.#?جة من #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من حس#.سية #?ج#.ه #.لأس#%#^ين. \r\n\r\n–ي#=ون ممنو#> #<ي ح#.لة #.لإص#.#%ة #%أي أم#^#.#_ قل#%ية. \r\n\r\n–يمن#> #?ن#.ول إن#<ل#.#=#.م #>ن م#^#_ى #.لقصو#^ #.ل#=#%#~ي. \r\n\r\n–ي#?م #?ن#.وله #%حذ#^ #<ي ح#.لة #.لإص#.#%ة #.ل#%#^#<ي#^ية #.ل#=#%#~ية. \r\n\r\n–يحذ#^ منه #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يمن#> #>ن #.لم#^أة #.لح#.مل #-و#.ل شهو#^ #.لحمل ح#?ى ل#. #?#=ون س#%#%#.ً #<ي أي أ#_#^#.#^ #>لى #.لجنين. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.لص#~#.#> #.لن#.#?جة #>ن #?ن#.ول #.لمس#=ن#.#?.", "GI": "About Piroxicam\r\nNSAID,Oxicam derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Piroxicam\r\nDrug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. In this way it reduces the PG (Prostaglandin) concentration in the synovial fluid. It also reduces platelet aggregation (prolong bleeding time), production of IgM rheumatoid factor, chemotaxis of leukocytes and ratio of T-helper to T- suppressor lymphocytes.\r\nIndications for Piroxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute musculo-skeletal disorders \r\n5. Acute gout \r\n6. Post-operative & post-traumatic pain \r\n7. Primary dysmenorrhea \r\nInteractions for Piroxicam\r\nAnticoagulants: May prolong prothrombin time. \r\nBeta-Blockers: Antihypertensive effect may be impaired. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nLithium: Serum lithium levels may be increased. \r\nHydantoins: Serum hydantoin levels increase", "Composition": "Each dispersible tablet contains:\r\nPiroxicam 10 mg or 20 mg\r\n\r\nEach capsule contains:\r\n10 mg or 20 mg Piroxicam\r\n\r\nEach suppository contains:\r\n20mg Piroxicam\r\n\r\nEach 1ml ampoule contains:\r\n20mg Piroxicam", "Route": "ORAL.SOLID" }, { "ID": "542", "Trade_Name": "FELDORAL 20MG 10 CAPS.", "Generic_Name": "PIROXICAM", "Price": "8", "Price_Old": "8", "Company": "SEDICO", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#>ل#.ج #.ل#<ص#.ل #.ل#>ظمي. \r\n\r\n–ي#=ون ذ#.#? #?أثي#^ #<#>#.ل وس#^ي#> لل#?خلص من #.ل#^وم#.#?يزم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لنق#^س. \r\n\r\n–#>ل#.ج س#^ي#> ل#.ل#?ه#.#% #.ل#<ق#^#.#?. \r\n\r\n–#>ل#.ج آل#.م #.ل#-مث. \r\n\r\n–يق#_ي #>لى #.ل#?و#^م#.#? #.لن#.#?جة من #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من حس#.سية #?ج#.ه #.لأس#%#^ين. \r\n\r\n–ي#=ون ممنو#> #<ي ح#.لة #.لإص#.#%ة #%أي أم#^#.#_ قل#%ية. \r\n\r\n–يمن#> #?ن#.ول إن#<ل#.#=#.م #>ن م#^#_ى #.لقصو#^ #.ل#=#%#~ي. \r\n\r\n–ي#?م #?ن#.وله #%حذ#^ #<ي ح#.لة #.لإص#.#%ة #.ل#%#^#<ي#^ية #.ل#=#%#~ية. \r\n\r\n–يحذ#^ منه #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يمن#> #>ن #.لم#^أة #.لح#.مل #-و#.ل شهو#^ #.لحمل ح#?ى ل#. #?#=ون س#%#%#.ً #<ي أي أ#_#^#.#^ #>لى #.لجنين. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.لص#~#.#> #.لن#.#?جة #>ن #?ن#.ول #.لمس#=ن#.#?.", "GI": "About Piroxicam\r\nNSAID,Oxicam derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Piroxicam\r\nDrug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. In this way it reduces the PG (Prostaglandin) concentration in the synovial fluid. It also reduces platelet aggregation (prolong bleeding time), production of IgM rheumatoid factor, chemotaxis of leukocytes and ratio of T-helper to T- suppressor lymphocytes.\r\nIndications for Piroxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute musculo-skeletal disorders \r\n5. Acute gout \r\n6. Post-operative & post-traumatic pain \r\n7. Primary dysmenorrhea \r\nInteractions for Piroxicam\r\nAnticoagulants: May prolong prothrombin time. \r\nBeta-Blockers: Antihypertensive effect may be impaired. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nLithium: Serum lithium levels may be increased. \r\nHydantoins: Serum hydantoin levels increase", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "543", "Trade_Name": "FELDENE 10MG 20 CAPS.", "Generic_Name": "PIROXICAM", "Price": "26.25", "Price_Old": "17.4", "Company": "PFIZER", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#>ل#.ج #.ل#<ص#.ل #.ل#>ظمي. \r\n\r\n–ي#=ون ذ#.#? #?أثي#^ #<#>#.ل وس#^ي#> لل#?خلص من #.ل#^وم#.#?يزم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لنق#^س. \r\n\r\n–#>ل#.ج س#^ي#> ل#.ل#?ه#.#% #.ل#<ق#^#.#?. \r\n\r\n–#>ل#.ج آل#.م #.ل#-مث. \r\n\r\n–يق#_ي #>لى #.ل#?و#^م#.#? #.لن#.#?جة من #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من حس#.سية #?ج#.ه #.لأس#%#^ين. \r\n\r\n–ي#=ون ممنو#> #<ي ح#.لة #.لإص#.#%ة #%أي أم#^#.#_ قل#%ية. \r\n\r\n–يمن#> #?ن#.ول إن#<ل#.#=#.م #>ن م#^#_ى #.لقصو#^ #.ل#=#%#~ي. \r\n\r\n–ي#?م #?ن#.وله #%حذ#^ #<ي ح#.لة #.لإص#.#%ة #.ل#%#^#<ي#^ية #.ل#=#%#~ية. \r\n\r\n–يحذ#^ منه #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يمن#> #>ن #.لم#^أة #.لح#.مل #-و#.ل شهو#^ #.لحمل ح#?ى ل#. #?#=ون س#%#%#.ً #<ي أي أ#_#^#.#^ #>لى #.لجنين. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.لص#~#.#> #.لن#.#?جة #>ن #?ن#.ول #.لمس#=ن#.#?.", "GI": "About Piroxicam\r\nNSAID,Oxicam derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Piroxicam\r\nDrug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. In this way it reduces the PG (Prostaglandin) concentration in the synovial fluid. It also reduces platelet aggregation (prolong bleeding time), production of IgM rheumatoid factor, chemotaxis of leukocytes and ratio of T-helper to T- suppressor lymphocytes.\r\nIndications for Piroxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute musculo-skeletal disorders \r\n5. Acute gout \r\n6. Post-operative & post-traumatic pain \r\n7. Primary dysmenorrhea \r\nInteractions for Piroxicam\r\nAnticoagulants: May prolong prothrombin time. \r\nBeta-Blockers: Antihypertensive effect may be impaired. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nLithium: Serum lithium levels may be increased. \r\nHydantoins: Serum hydantoin levels increase", "Composition": "5 mg piroxicam per gram of gel", "Route": "ORAL.SOLID" }, { "ID": "544", "Trade_Name": "TRANEXENE 5 MG 30 CAPS. (N/A)", "Generic_Name": "POTASSIUM CLORAZEPATE", "Price": "1.65", "Price_Old": "1.65", "Company": "EL NILE. > SANOFI AVENTIS", "Pharmacology": "ANTI-EPILEPTIC.BENZODIAZEPINES", "Category": "مه#~ئ و م#_#.#~ للص#^#>", "Use": "–يس#?خ#~م #<ي #>ل#.ج: #.#_#-#^#.#%#.#? #.لقلق (#>لى #.لم#~ى #.لقصي#^) #.#>#^#.#_ #.نسح#.#% #.ل#=حول #<ي #.للم#~منين (م#?ل#.زمة #.لم#?ن#.#> #>ن #.ل#=حول) #=#~و#.ء مس#.#>#~ #<ي #>ل#.ج نو#%#.#? #.لص#^#> #.لجزئية", "Contraindications": "–#<#^#- #.لحس#.سية من أي من #.لم#=ون#.#?.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "545", "Trade_Name": "PIROXIDEN 20MG 12CAPS.", "Generic_Name": "PIROXICAM", "Price": "6.75", "Price_Old": "6.75", "Company": "EL NASR", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#>ل#.ج #.ل#<ص#.ل #.ل#>ظمي. \r\n\r\n–ي#=ون ذ#.#? #?أثي#^ #<#>#.ل وس#^ي#> لل#?خلص من #.ل#^وم#.#?يزم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لنق#^س. \r\n\r\n–#>ل#.ج س#^ي#> ل#.ل#?ه#.#% #.ل#<ق#^#.#?. \r\n\r\n–#>ل#.ج آل#.م #.ل#-مث. \r\n\r\n–يق#_ي #>لى #.ل#?و#^م#.#? #.لن#.#?جة من #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من حس#.سية #?ج#.ه #.لأس#%#^ين. \r\n\r\n–ي#=ون ممنو#> #<ي ح#.لة #.لإص#.#%ة #%أي أم#^#.#_ قل#%ية. \r\n\r\n–يمن#> #?ن#.ول إن#<ل#.#=#.م #>ن م#^#_ى #.لقصو#^ #.ل#=#%#~ي. \r\n\r\n–ي#?م #?ن#.وله #%حذ#^ #<ي ح#.لة #.لإص#.#%ة #.ل#%#^#<ي#^ية #.ل#=#%#~ية. \r\n\r\n–يحذ#^ منه #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يمن#> #>ن #.لم#^أة #.لح#.مل #-و#.ل شهو#^ #.لحمل ح#?ى ل#. #?#=ون س#%#%#.ً #<ي أي أ#_#^#.#^ #>لى #.لجنين. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.لص#~#.#> #.لن#.#?جة #>ن #?ن#.ول #.لمس#=ن#.#?.", "GI": "About Piroxicam\r\nNSAID,Oxicam derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Piroxicam\r\nDrug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. In this way it reduces the PG (Prostaglandin) concentration in the synovial fluid. It also reduces platelet aggregation (prolong bleeding time), production of IgM rheumatoid factor, chemotaxis of leukocytes and ratio of T-helper to T- suppressor lymphocytes.\r\nIndications for Piroxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute musculo-skeletal disorders \r\n5. Acute gout \r\n6. Post-operative & post-traumatic pain \r\n7. Primary dysmenorrhea \r\nInteractions for Piroxicam\r\nAnticoagulants: May prolong prothrombin time. \r\nBeta-Blockers: Antihypertensive effect may be impaired. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nLithium: Serum lithium levels may be increased. \r\nHydantoins: Serum hydantoin levels increase", "Composition": "piroxicam 20mg", "Route": "ORAL.SOLID" }, { "ID": "546", "Trade_Name": "FELDENE 20MG 10 CAPS.", "Generic_Name": "PIROXICAM", "Price": "26.25", "Price_Old": "17.4", "Company": "PFIZER", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#>ل#.ج #.ل#<ص#.ل #.ل#>ظمي. \r\n\r\n–ي#=ون ذ#.#? #?أثي#^ #<#>#.ل وس#^ي#> لل#?خلص من #.ل#^وم#.#?يزم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لنق#^س. \r\n\r\n–#>ل#.ج س#^ي#> ل#.ل#?ه#.#% #.ل#<ق#^#.#?. \r\n\r\n–#>ل#.ج آل#.م #.ل#-مث. \r\n\r\n–يق#_ي #>لى #.ل#?و#^م#.#? #.لن#.#?جة من #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من حس#.سية #?ج#.ه #.لأس#%#^ين. \r\n\r\n–ي#=ون ممنو#> #<ي ح#.لة #.لإص#.#%ة #%أي أم#^#.#_ قل#%ية. \r\n\r\n–يمن#> #?ن#.ول إن#<ل#.#=#.م #>ن م#^#_ى #.لقصو#^ #.ل#=#%#~ي. \r\n\r\n–ي#?م #?ن#.وله #%حذ#^ #<ي ح#.لة #.لإص#.#%ة #.ل#%#^#<ي#^ية #.ل#=#%#~ية. \r\n\r\n–يحذ#^ منه #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يمن#> #>ن #.لم#^أة #.لح#.مل #-و#.ل شهو#^ #.لحمل ح#?ى ل#. #?#=ون س#%#%#.ً #<ي أي أ#_#^#.#^ #>لى #.لجنين. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.لص#~#.#> #.لن#.#?جة #>ن #?ن#.ول #.لمس#=ن#.#?.", "GI": "About Piroxicam\r\nNSAID,Oxicam derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Piroxicam\r\nDrug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. In this way it reduces the PG (Prostaglandin) concentration in the synovial fluid. It also reduces platelet aggregation (prolong bleeding time), production of IgM rheumatoid factor, chemotaxis of leukocytes and ratio of T-helper to T- suppressor lymphocytes.\r\nIndications for Piroxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute musculo-skeletal disorders \r\n5. Acute gout \r\n6. Post-operative & post-traumatic pain \r\n7. Primary dysmenorrhea \r\nInteractions for Piroxicam\r\nAnticoagulants: May prolong prothrombin time. \r\nBeta-Blockers: Antihypertensive effect may be impaired. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nLithium: Serum lithium levels may be increased. \r\nHydantoins: Serum hydantoin levels increase", "Composition": "5 mg piroxicam per gram of gel", "Route": "ORAL.SOLID" }, { "ID": "547", "Trade_Name": "VENDOCID 20MG 10 CAP.", "Generic_Name": "PIROXICAM", "Price": "9.4", "Price_Old": "9.4", "Company": "CID", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#>ل#.ج #.ل#<ص#.ل #.ل#>ظمي. \r\n\r\n–ي#=ون ذ#.#? #?أثي#^ #<#>#.ل وس#^ي#> لل#?خلص من #.ل#^وم#.#?يزم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لنق#^س. \r\n\r\n–#>ل#.ج س#^ي#> ل#.ل#?ه#.#% #.ل#<ق#^#.#?. \r\n\r\n–#>ل#.ج آل#.م #.ل#-مث. \r\n\r\n–يق#_ي #>لى #.ل#?و#^م#.#? #.لن#.#?جة من #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من حس#.سية #?ج#.ه #.لأس#%#^ين. \r\n\r\n–ي#=ون ممنو#> #<ي ح#.لة #.لإص#.#%ة #%أي أم#^#.#_ قل#%ية. \r\n\r\n–يمن#> #?ن#.ول إن#<ل#.#=#.م #>ن م#^#_ى #.لقصو#^ #.ل#=#%#~ي. \r\n\r\n–ي#?م #?ن#.وله #%حذ#^ #<ي ح#.لة #.لإص#.#%ة #.ل#%#^#<ي#^ية #.ل#=#%#~ية. \r\n\r\n–يحذ#^ منه #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يمن#> #>ن #.لم#^أة #.لح#.مل #-و#.ل شهو#^ #.لحمل ح#?ى ل#. #?#=ون س#%#%#.ً #<ي أي أ#_#^#.#^ #>لى #.لجنين. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.لص#~#.#> #.لن#.#?جة #>ن #?ن#.ول #.لمس#=ن#.#?.", "GI": "About Piroxicam\r\nNSAID,Oxicam derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Piroxicam\r\nDrug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. In this way it reduces the PG (Prostaglandin) concentration in the synovial fluid. It also reduces platelet aggregation (prolong bleeding time), production of IgM rheumatoid factor, chemotaxis of leukocytes and ratio of T-helper to T- suppressor lymphocytes.\r\nIndications for Piroxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute musculo-skeletal disorders \r\n5. Acute gout \r\n6. Post-operative & post-traumatic pain \r\n7. Primary dysmenorrhea \r\nInteractions for Piroxicam\r\nAnticoagulants: May prolong prothrombin time. \r\nBeta-Blockers: Antihypertensive effect may be impaired. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nLithium: Serum lithium levels may be increased. \r\nHydantoins: Serum hydantoin levels increase", "Composition": "piroxicam 20mg", "Route": "ORAL.SOLID" }, { "ID": "548", "Trade_Name": "INFLACAM 10MG 20 CAPS.", "Generic_Name": "PIROXICAM", "Price": "9", "Price_Old": "9", "Company": "MEPACO", "Pharmacology": "NSAID.OXICAM", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية", "Use": "–#>ل#.ج #.ل#<ص#.ل #.ل#>ظمي. \r\n\r\n–ي#=ون ذ#.#? #?أثي#^ #<#>#.ل وس#^ي#> لل#?خلص من #.ل#^وم#.#?يزم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لنق#^س. \r\n\r\n–#>ل#.ج س#^ي#> ل#.ل#?ه#.#% #.ل#<ق#^#.#?. \r\n\r\n–#>ل#.ج آل#.م #.ل#-مث. \r\n\r\n–يق#_ي #>لى #.ل#?و#^م#.#? #.لن#.#?جة من #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من حس#.سية #?ج#.ه #.لأس#%#^ين. \r\n\r\n–ي#=ون ممنو#> #<ي ح#.لة #.لإص#.#%ة #%أي أم#^#.#_ قل#%ية. \r\n\r\n–يمن#> #?ن#.ول إن#<ل#.#=#.م #>ن م#^#_ى #.لقصو#^ #.ل#=#%#~ي. \r\n\r\n–ي#?م #?ن#.وله #%حذ#^ #<ي ح#.لة #.لإص#.#%ة #.ل#%#^#<ي#^ية #.ل#=#%#~ية. \r\n\r\n–يحذ#^ منه #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية. \r\n\r\n–يمن#> #>ن #.لم#^أة #.لح#.مل #-و#.ل شهو#^ #.لحمل ح#?ى ل#. #?#=ون س#%#%#.ً #<ي أي أ#_#^#.#^ #>لى #.لجنين. \r\n\r\n–يمن#> #<ي ح#.لة #.لإص#.#%ة #%#.لص#~#.#> #.لن#.#?جة #>ن #?ن#.ول #.لمس#=ن#.#?.", "GI": "About Piroxicam\r\nNSAID,Oxicam derivative, Analgesic,antiinflammatory.\r\nMechanism of Action of Piroxicam\r\nDrug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. In this way it reduces the PG (Prostaglandin) concentration in the synovial fluid. It also reduces platelet aggregation (prolong bleeding time), production of IgM rheumatoid factor, chemotaxis of leukocytes and ratio of T-helper to T- suppressor lymphocytes.\r\nIndications for Piroxicam\r\n1. Rheumatoid arthritis \r\n2. Osteoarthritis \r\n3. Ankylosing spondylitis \r\n4. Acute musculo-skeletal disorders \r\n5. Acute gout \r\n6. Post-operative & post-traumatic pain \r\n7. Primary dysmenorrhea \r\nInteractions for Piroxicam\r\nAnticoagulants: May prolong prothrombin time. \r\nBeta-Blockers: Antihypertensive effect may be impaired. \r\nCyclosporine: Nephrotoxicity of both agents may be increased. \r\nLithium: Serum lithium levels may be increased. \r\nHydantoins: Serum hydantoin levels increase", "Composition": "Each dispersible tablet contains:\r\nPiroxicam 10 mg or 20 mg\r\n\r\nEach capsule contains:\r\n10 mg or 20 mg Piroxicam\r\n\r\nEach suppository contains:\r\n20mg Piroxicam\r\n\r\nEach 1ml ampoule contains:\r\n20mg Piroxicam", "Route": "ORAL.SOLID" }, { "ID": "549", "Trade_Name": "ZEPEXENE 5 MG 10 CAPS. (N/A)", "Generic_Name": "POTASSIUM CLORAZEPATE", "Price": "1.75", "Price_Old": "1.75", "Company": "HI-PHARM", "Pharmacology": "ANTI-EPILEPTIC.BENZODIAZEPINES", "Category": "مه#~ئ و م#_#.#~ للص#^#>", "Use": "–يس#?خ#~م #<ي #>ل#.ج: #.#_#-#^#.#%#.#? #.لقلق (#>لى #.لم#~ى #.لقصي#^) #.#>#^#.#_ #.نسح#.#% #.ل#=حول #<ي #.للم#~منين (م#?ل#.زمة #.لم#?ن#.#> #>ن #.ل#=حول) #=#~و#.ء مس#.#>#~ #<ي #>ل#.ج نو#%#.#? #.لص#^#> #.لجزئية", "Contraindications": "–#<#^#- #.لحس#.سية من أي من #.لم#=ون#.#?.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "550", "Trade_Name": "DRY TROPAN 5MG MR 10 CAPS.", "Generic_Name": "OXYBUTYNIN", "Price": "11", "Price_Old": "11", "Company": "BORG", "Pharmacology": "URINARY INCONTINENCE.ANTISPASMODICS.MUSCARINIC ANTAGONISTS", "Category": "#.ل#?#%ول #.لل#.إ#^#.#~ي و سلس #.ل#%ول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?#%ول #.لل#.#^#.#~ي #.لليلي . \r\n\r\n–#>ل#.ج ح#.ل#.#? #?ل#< #.لخل#.ي#. #.ل#>ص#%ية #<ي #.ل#~م#.غ . \r\n\r\n–يس#.#>#~ هذ#. #.ل#~و#.ء #>لي #.لسي#-#^ة و#.ل#?ح#=م #<ي #.ل#%ول . \r\n\r\n–#>ل#.ج #<#>#.ل ل#.نق#%#.#_ #>#_ل#.#? #.لمث#.نة . \r\n\r\n–يس#?خ#~م #.ي#_#.ً #<ي #>ل#.ج #.ل#>يو#% #.لخل#<ية #.لموجو#~ة #%#.ل#>مو#~ #.ل#<ق#^ي . \r\n\r\n–#>ل#.ج #?ل#< #.لح#%ل #.لشو#=ي و#?ل#< #.لخل#.ي#. #.ل#>ص#%ية . \r\n\r\n–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي ح#~وث #.#^#?خ#.ء و#.#^#?ي#.ح #<ي #>#_ل#.#? #.لمث#.نة ح#?ي #?#?حسن ح#.لة #.لم#^ي#_ وي#?م #>ل#.ج #.لمش#=لة .", "Contraindications": "–يحظ#^ لل#.شخ#.ص #.لمص#.#%ون #%حس#.سية م#<#^#-ة #?ج#.ة م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لمص#.#%ون #%#.م#^#.#_ #.لقل#% و#.ل#=#%#~ و#.ل#=لي . \r\n\r\n–يجظ#^ #.س#?#>م#.له #.ي#_#. لم#^#_ي #.لقولون . \r\n\r\n–يحظ#^ خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية #.ل#. #>ن#~ #.ل#_#^و#^ة #.لقصوي #?ح#? #.ش#^#.#< #.ل#-#%ي #.لم#>#.لج .", "GI": "About Oxybutynin\r\nAntimuscarinic agent, Urinary Antispasmodic Agent.\r\n\r\nMechanism of Action of Oxybutynin\r\nThis drug decreases muscle spasms of the bladder by competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth muscle as a calcium antagonist and local anesthetic action at high concentrations.\r\nIndications for Oxybutynin\r\n1. Urinary incontinence \r\n2. Urgency and frequency in the unstable bladder \r\n3. Nocturnal enuresis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "551", "Trade_Name": "COLOMINT 24 CAPS.", "Generic_Name": "PEPPERMINT OIL", "Price": "5.5", "Price_Old": "5.5", "Company": "PHARCO", "Pharmacology": "GIT DISTURBANCES", "Category": "مش#.#=ل #.لجه#.ز #.له#_مي", "Use": "–#.ل#?ه#.#%#.#? #.لقولون #.ل#>ص#%ي . \r\n\r\n–م#_#.#~ لل#?قلص#.#? و#.ل#.ن#?#<#.خ#.#? . \r\n\r\n–#-#.#^#~ للغ#.ز#.#? #%#~#.خل #.ل#.م#>#.ء . \r\n\r\n–#.لمغص #.لم#>وي . \r\n\r\n–#.#>#^#.#_ #.ل#?ه#.#% #.لقولون .", "Contraindications": "–يج#% #.ل#. #?م#_غ #.و #?#=س#^ #.ل#=#%سولة ق#%ل #.ل#%ل#> ح#?ي ل#. #?س#%#% #?هيج #<ي #.لم#>#~ة . \r\n\r\n–يج#% #.ل#. #?#?ن#.ول #.ل#~و#.ء م#> #.ل#=حول ح#?ي ل#. يس#%#% #.#>#^#.#_ حس#.سية . \r\n\r\n–ل#. #?#?ن#.ول #.ل#~و#.ء #%#>#~ #.ل#.#=ل م#%#.ش#^ة . \r\n\r\n–ل#. #?#?ن#.ول #.ل#~و#.ء م#> #.#~وية سوء #.له#_م ح#?ي ل#. #?#%#-ل م#<#>ول #.ل#=#%سول#.#? .", "GI": "Peppermint oil is derived from the peppermint plant -- a cross between water mint and spearmint -- that thrives in Europe and North America.\r\n\r\nPeppermint oil is commonly used as flavoring in foods and beverages and as a fragrance in soaps and cosmetics. Peppermint oil also is used for a variety of health conditions and can be taken orally in dietary supplements or topically as a skin cream or ointment.", "Composition": "Peppermint Oil 0.2 ml", "Route": "ORAL.SOLID" }, { "ID": "552", "Trade_Name": "RETADEL 250MG 20 CAPS.", "Generic_Name": "PENICILLAMINE", "Price": "26.4", "Price_Old": "26.4", "Company": "DELTA PHARMA", "Pharmacology": "ANTIRHEUMATIC AGENT.WILSON S DISEASE.ANTIDOTE CHELATING AGENT", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي \r\n\r\n–#?#^#.#=م #.لنح#.س #<ي #.لأنسجة \r\n\r\n–#.لحج#.#^ة سيس#?ين #.ل#=لى", "Contraindications": "–#.ل#%ول #.ل#~موي \r\n\r\n–#%يلة سيس#?ينية \r\n\r\n–حمل \r\n\r\n–ظهو#^ #?ق#^ح#.#? #<ي #.لأم#^#.#_ #.لجل#~ية \r\n\r\n–م#?ل#.زمة مثل #.لذئ#%ة \r\n\r\n–م#^#_ #.ل#=لية", "GI": "Indication\tFor treatment of Wilson s disease, cystinuria and active rheumatoid arthritis.\r\nMechanism of action\tPenicillamine is a chelating agent recommended for the removal of excess copper in patients with Wilson s disease. From in vitro studies which indicate that one atom of copper combines with two molecules of penicillamine. Penicillamine also reduces excess cystine excretion in cystinuria. This is done, at least in part, by disulfide interchange between penicillamine and cystine, resulting in formation of penicillamine-cysteine disulfide, a substance that is much more soluble than cystine and is excreted readily. Penicillamine interferes with the formation of cross-links between tropocollagen molecules and cleaves them when newly formed. The mechanism of action of penicillamine in rheumatoid arthritis is unknown although it appears to suppress disease activity. Unlike cytotoxic immunosuppressants,", "Composition": "penicillamine 250mg", "Route": "ORAL.SOLID" }, { "ID": "553", "Trade_Name": "DRY TROPAN 10MG MR 10 CAPS.", "Generic_Name": "OXYBUTYNIN", "Price": "13.2", "Price_Old": "13.2", "Company": "BORG", "Pharmacology": "URINARY INCONTINENCE.ANTISPASMODICS.MUSCARINIC ANTAGONISTS", "Category": "#.ل#?#%ول #.لل#.إ#^#.#~ي و سلس #.ل#%ول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?#%ول #.لل#.#^#.#~ي #.لليلي . \r\n\r\n–#>ل#.ج ح#.ل#.#? #?ل#< #.لخل#.ي#. #.ل#>ص#%ية #<ي #.ل#~م#.غ . \r\n\r\n–يس#.#>#~ هذ#. #.ل#~و#.ء #>لي #.لسي#-#^ة و#.ل#?ح#=م #<ي #.ل#%ول . \r\n\r\n–#>ل#.ج #<#>#.ل ل#.نق#%#.#_ #>#_ل#.#? #.لمث#.نة . \r\n\r\n–يس#?خ#~م #.ي#_#.ً #<ي #>ل#.ج #.ل#>يو#% #.لخل#<ية #.لموجو#~ة #%#.ل#>مو#~ #.ل#<ق#^ي . \r\n\r\n–#>ل#.ج #?ل#< #.لح#%ل #.لشو#=ي و#?ل#< #.لخل#.ي#. #.ل#>ص#%ية . \r\n\r\n–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي ح#~وث #.#^#?خ#.ء و#.#^#?ي#.ح #<ي #>#_ل#.#? #.لمث#.نة ح#?ي #?#?حسن ح#.لة #.لم#^ي#_ وي#?م #>ل#.ج #.لمش#=لة .", "Contraindications": "–يحظ#^ لل#.شخ#.ص #.لمص#.#%ون #%حس#.سية م#<#^#-ة #?ج#.ة م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لمص#.#%ون #%#.م#^#.#_ #.لقل#% و#.ل#=#%#~ و#.ل#=لي . \r\n\r\n–يجظ#^ #.س#?#>م#.له #.ي#_#. لم#^#_ي #.لقولون . \r\n\r\n–يحظ#^ خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية #.ل#. #>ن#~ #.ل#_#^و#^ة #.لقصوي #?ح#? #.ش#^#.#< #.ل#-#%ي #.لم#>#.لج .", "GI": "About Oxybutynin\r\nAntimuscarinic agent, Urinary Antispasmodic Agent.\r\n\r\nMechanism of Action of Oxybutynin\r\nThis drug decreases muscle spasms of the bladder by competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth muscle as a calcium antagonist and local anesthetic action at high concentrations.\r\nIndications for Oxybutynin\r\n1. Urinary incontinence \r\n2. Urgency and frequency in the unstable bladder \r\n3. Nocturnal enuresis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "554", "Trade_Name": "PHAROTOIN 50MG 10 CAPS.", "Generic_Name": "PHENYTOIN", "Price": "2", "Price_Old": "2", "Company": "PHAROPHARMA", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "555", "Trade_Name": "MENTHOLAX HERBAL 24 CAPS.", "Generic_Name": "PEPPERMINT+SENNA", "Price": "6.5", "Price_Old": "6.5", "Company": "PHARCO", "Pharmacology": "GIT DISTURBANCES", "Category": "مش#.#=ل #.لجه#.ز #.له#_مي", "Use": "–يس#?خ#~م #<ي #>ل#.ج ح#.ل#.#? #.لإمس#.#=. \r\n\r\n–ي#>#.لج ص#>و#%ة إخ#^#.ج #.ل#<#_ل#.#? من #.لش#^ج. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإمس#.#= #.لمزمنة و#.ل#-#.#^ئة. \r\n\r\n–يس#?خ#~م ل#?#<#^يغ #.لم#>#~ة ق#%ل إج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية وإج#^#.ء #<حصل #-#%ي أو منظ#.#^ إو #.لخ#_و#> لأش#>ة #%#.لص#%غة. \r\n\r\n–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? #.لإمس#.#= #.ل#?ي #?ح#~ث #%#>#~ #>ملي#.#? #.لج#^#.حية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.", "GI": "Peppermint oil is derived from the peppermint plant -- a cross between water mint and spearmint -- that thrives in Europe and North America.\r\n\r\nPeppermint oil is commonly used as flavoring in foods and beverages and as a fragrance in soaps and cosmetics. Peppermint oil also is used for a variety of health conditions and can be taken orally in dietary supplements or topically as a skin cream or ointment.", "Composition": "peppermint 100mg, senna 20mg", "Route": "ORAL.SOLID" }, { "ID": "556", "Trade_Name": "ARTAMINE 250MG 50CAPS.", "Generic_Name": "PENICILLAMINE", "Price": "184", "Price_Old": "110", "Company": "SANDOZ > EGYPTIAN PHARMACEUTICAL TRADING COMPANY", "Pharmacology": "ANTIRHEUMATIC AGENT.WILSON S DISEASE.ANTIDOTE CHELATING AGENT", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–#.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي \r\n\r\n–#?#^#.#=م #.لنح#.س #<ي #.لأنسجة \r\n\r\n–#.لحج#.#^ة سيس#?ين #.ل#=لى", "Contraindications": "–#.ل#%ول #.ل#~موي \r\n\r\n–#%يلة سيس#?ينية \r\n\r\n–حمل \r\n\r\n–ظهو#^ #?ق#^ح#.#? #<ي #.لأم#^#.#_ #.لجل#~ية \r\n\r\n–م#?ل#.زمة مثل #.لذئ#%ة \r\n\r\n–م#^#_ #.ل#=لية", "GI": "Indication\tFor treatment of Wilson s disease, cystinuria and active rheumatoid arthritis.\r\nMechanism of action\tPenicillamine is a chelating agent recommended for the removal of excess copper in patients with Wilson s disease. From in vitro studies which indicate that one atom of copper combines with two molecules of penicillamine. Penicillamine also reduces excess cystine excretion in cystinuria. This is done, at least in part, by disulfide interchange between penicillamine and cystine, resulting in formation of penicillamine-cysteine disulfide, a substance that is much more soluble than cystine and is excreted readily. Penicillamine interferes with the formation of cross-links between tropocollagen molecules and cleaves them when newly formed. The mechanism of action of penicillamine in rheumatoid arthritis is unknown although it appears to suppress disease activity. Unlike cytotoxic immunosuppressants,", "Composition": "penicillamine 250mg", "Route": "ORAL.SOLID" }, { "ID": "557", "Trade_Name": "IPANTEN 50MG 50 CAPS.", "Generic_Name": "PHENYTOIN", "Price": "18", "Price_Old": "12", "Company": "ARAB CAPS > ACDIMA INTERNATIONAL TRADING", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "Each 1 Capsule contains:\r\n 100mg Phenytoin sodium or Each 1 Capsule contains 50mg Phenytoin sodium", "Route": "ORAL.SOLID" }, { "ID": "558", "Trade_Name": "DRY TROPAN 15MG MR 10 CAPS.", "Generic_Name": "OXYBUTYNIN", "Price": "16.2", "Price_Old": "16.2", "Company": "BORG", "Pharmacology": "URINARY INCONTINENCE.ANTISPASMODICS.MUSCARINIC ANTAGONISTS", "Category": "#.ل#?#%ول #.لل#.إ#^#.#~ي و سلس #.ل#%ول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?#%ول #.لل#.#^#.#~ي #.لليلي . \r\n\r\n–#>ل#.ج ح#.ل#.#? #?ل#< #.لخل#.ي#. #.ل#>ص#%ية #<ي #.ل#~م#.غ . \r\n\r\n–يس#.#>#~ هذ#. #.ل#~و#.ء #>لي #.لسي#-#^ة و#.ل#?ح#=م #<ي #.ل#%ول . \r\n\r\n–#>ل#.ج #<#>#.ل ل#.نق#%#.#_ #>#_ل#.#? #.لمث#.نة . \r\n\r\n–يس#?خ#~م #.ي#_#.ً #<ي #>ل#.ج #.ل#>يو#% #.لخل#<ية #.لموجو#~ة #%#.ل#>مو#~ #.ل#<ق#^ي . \r\n\r\n–#>ل#.ج #?ل#< #.لح#%ل #.لشو#=ي و#?ل#< #.لخل#.ي#. #.ل#>ص#%ية . \r\n\r\n–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي ح#~وث #.#^#?خ#.ء و#.#^#?ي#.ح #<ي #>#_ل#.#? #.لمث#.نة ح#?ي #?#?حسن ح#.لة #.لم#^ي#_ وي#?م #>ل#.ج #.لمش#=لة .", "Contraindications": "–يحظ#^ لل#.شخ#.ص #.لمص#.#%ون #%حس#.سية م#<#^#-ة #?ج#.ة م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#~و#.ء لل#.شخ#.ص #.لمص#.#%ون #%#.م#^#.#_ #.لقل#% و#.ل#=#%#~ و#.ل#=لي . \r\n\r\n–يجظ#^ #.س#?#>م#.له #.ي#_#. لم#^#_ي #.لقولون . \r\n\r\n–يحظ#^ خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية #.ل#. #>ن#~ #.ل#_#^و#^ة #.لقصوي #?ح#? #.ش#^#.#< #.ل#-#%ي #.لم#>#.لج .", "GI": "About Oxybutynin\r\nAntimuscarinic agent, Urinary Antispasmodic Agent.\r\n\r\nMechanism of Action of Oxybutynin\r\nThis drug decreases muscle spasms of the bladder by competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth muscle as a calcium antagonist and local anesthetic action at high concentrations.\r\nIndications for Oxybutynin\r\n1. Urinary incontinence \r\n2. Urgency and frequency in the unstable bladder \r\n3. Nocturnal enuresis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "559", "Trade_Name": "PHENYTIN 50MG 50 CAPS.", "Generic_Name": "PHENYTOIN", "Price": "10", "Price_Old": "10", "Company": "EL NILE.", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "Capsule: 50 mg Capsule 100 mg Capsule\r\nPhenytoin sodium 50 mg/ cap. & Phenytoin sodium 100 mg/ cap.\r\n\r\n-Suspension:\r\nPhenytoin (micronized) 30 mg/5ml\r\n\r\n-Ampoule:\r\nEach 1 ml contains :\r\nPhenytoin sodium 50 mg", "Route": "ORAL.SOLID" }, { "ID": "560", "Trade_Name": "ADRENAMAX 1 MG/1ML 10 AMP.", "Generic_Name": "ADRENALINE", "Price": "26", "Price_Old": "26", "Company": "CHEMIPHARM", "Pharmacology": "ALPHA AND BETA ADRENERGIC AGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? #.ل#^#%و #.لح#.#~ة، حيث ي#>مل #.ل#~و#.ء #>لى #?خ#<ي#< #.ل#?قلص#.#? #<ي #>#_ل#.#? #.لقص#%#.#? #.لملس#.ء من خل#.ل #?ح#<يز #>ملي مُس#?ق#%ل#.#? #.ل#%ي#?#.، وي#>مل #>لى #?خ#<ي#< #.ل#?شنج#.#? #.ل#^ئوية، حيث يُ#=#.#<ح ح#.ل#.#? #.ل#?شنج #.لقص#%ي. \r\n\r\n–يس#?#>مل #<ي #.ل#>ل#.ج من #.خ#-#.#^ #?جم#> #.لسو#.ئل #~#.خل #.لش#^#.يين #%ش#=ل #<#>#.ل. \r\n\r\n–يُ#>#.لج #%ش#=ل #<#>#.ل ح#.ل#.#? #?شنج#.#? #.لقص#%ة #.ل#^ئوية و#=ذل#= #.لخ#.نوق. \r\n\r\n–يُم#=نه #>ل#.ج ح#.ل#.#? #?وق#< #.لقل#% #%ش#=ل #<#>#.ل وجي#~. \r\n\r\n–#<ي #.لغ#.ل#% ي#?م إ#_#.#<ة #.ل#~و#.ء إلى #.ل#?خ#~ي#^ #.لمو#_#>ي وحينه#. ين#?ش#^ #.ل#~و#.ء ويح#~ُ من إم#?ص#.ص هذ#. #.لمخ#~#^، ومن ثم يُقلل أخ#-#.#^ زي#.#~ة #.لج#^#>ة. \r\n\r\n–ويًم#=ن #.س#?#>م#.له #<ي أغ#^#.#_ #-#%ية أخ#^ى يح#~#~ه#. #.ل#-#%ي#% ن#<سه.", "Contraindications": "–#.لحس#.سية لل#.#%ن#<#^ين, #.و للمو#.#~ #.لمس#?خ#~مة #<ي #.لم#^#=#%. \r\n\r\n–#.#_#-#^#.#% نظم #.لقل#% م#.ن#> ل#.س#?#>م#.له. \r\n\r\n– و يمن#> #.س#?#>م#.ل ق#-#^ة #.ل#.#%ن#<#^ين لل#>ين #<ي ح#.لة ز#^ق #.ل#>ين", "GI": "About Adrenaline\r\nAlpha and Beta adrenergic agonist, catecholamine, Vasoconstrictor., Anti asthma, inanaphylatic shock.\r\nMechanism of Action of Adrenaline\r\nAdrenaline is an alpha and beta adrenergic agonist which exerts it`s therapeutic actions through predominant beta receptor agonistic action. It is a positive inotropic and chronotropic drug and it increases stroke volume, cardiac output and improves coronary blood flow. It increases systolic and mean blood pressure. It increases blood flow to skeletal muscles. It is a powerful bronchial smooth muscle relaxant and antagonizes spasm of bronchial muscle. It acts through alpha receptors in skin, mucous membrane, and viscera and causes vasoconstriction and which reduces absorption of local anaesthetics localizes and prolongs the duration of anaesthesia. Local vasoconstrictor action also produces haemostasis.Role in local anaesthesia:", "Composition": "epinephrine 1mg", "Route": "INJECTION" }, { "ID": "561", "Trade_Name": "RISEK 40 MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "30", "Price_Old": "30", "Company": "JULPHAR", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each capsule contains:\r\nRisek 10mg: Omeprazole 10mg\r\nRisek 20mg: Omeprazole 20mg\r\nRisek 40mg: Omeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "562", "Trade_Name": "PEPZOL 40MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "29", "Price_Old": "19.2", "Company": "HIKMA PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Omeprazole 20 mg or 40 mg", "Route": "ORAL.SOLID" }, { "ID": "563", "Trade_Name": "OMEPAK 40MG 14CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "30", "Price_Old": "30", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "564", "Trade_Name": "AZGOVANC 40MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE+SODIUM BICARBONATE", "Price": "27", "Price_Old": "18", "Company": "SABAA > APIC", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة و#.ل#.ثنى #>ش#^ #=م#. يقوم #%#>ل#.ج ق#^حة #.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.لحمو#_ة. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ىء #=م#. ي#>#.لج ح#^ق#.ن #.لم#^ئ و#.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #.ل#>ل#.ج و #.لوق#.ية من #.لق#^حة #.لن#.#?جة #>ن #.س#?#>م#.ل #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#^غ#%ة #<ى #.لوق#.ية من ق#^حة #.لم#>#~ة #<ى ح#.ل#.#? #.س#?خ#~#.م #.ل#=و#^#?يزون #=م#. ي#>#.لج #.ل#?ه#.#% #.لقولون #.ل#?ق#^حى ، #%#.ل#.#_#.#<ة #.نه ي#>مل #>لى #?قليل مخ#.#-#^ #.لنزي#< #%#.لجه#.ز #.له#_مى . \r\n\r\n–#<#>#.ل #<ي ح#.ل#.#? #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي #=م#. يس#.#>#~ #>لي #?قليل مخ#.#-#^ #.لنزي#< #<ي #.لجه#.ز #.له#_مي .", "Contraindications": "–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة يؤ#~ى إلى سوء إم#?ص#.ص #<ي#?#.مين B12 مم#. يقلل من #?#^#=يزه #%#.لجسم لذل#= ي#<#_ل #?ن#.ول أ#~وية #?ح#?وى #>لى #<ي#?#.مين B12 أثن#.ء #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة . \r\n\r\n–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة ( أ#=ث#^ من #>#.م ) ق#~ يؤ#~ى إلى نقص نس#%ة #.لم#.غنيسيوم #%#.ل#~م ( HYPOMAGNESEMIA ) . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=لى . \r\n\r\n–يقلل #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى : \r\n\r\n–KETOCONAZOLE \r\n\r\n– ITRACONAZOLE \r\n\r\n– MESALAZINE لذل#= يج#% #.س#?خ#~#.م #.#~ويه أخ#^ى . \r\n\r\n–يزي#~ من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى م#.#~ة #.ل DIGOXIN لذل#= يج#% #.لحذ#^ : ق#~ #?س#%#% #.لو#<#.ة . \r\n\r\n–يقلل من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى SOFOSBUVIR / VELPATASVIR #.لمس#?خ#~م ل#>ل#.ج #<ي#^وس C لذل#= يج#% #.س#?خ#~#.م #>ل#.ج أخ#^ . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لجل#-ة #.ل#?ى #?ح#?وى #>لى م#.#~ة CLOPIDOGREL : لذل#= يج#% #?غيي#^ #.ل#>ل#.ج . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لأم#^#.#_ #.لن#<سية #.ل#?ى #?ح#?وى #>لى م#.#~ة DULOXETINE \r\n\r\n–#<ى ح#.لة #.لحمل ل#.يوج#~ #~#^#.سة #=#.#<ية #>ن #.س#?خ#~#.م #.ل#~و#.ء، أم#. #<ى ح#.لة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.مة وننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص #<ى ذل#=.يمن#> #?ن#.ول #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لح#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى .", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.\r\nIndications for Omeprazole\r\n1. Duodenal ulcer \r\n2. Gastric ulcer \r\n3. Zollinger- Ellison syndrome \r\n4. Gastroesophageal reflux disease \r\n5. Oesophagitis \r\n6. Acid related dyspepsia \r\n7. NSAID associated ulceration \r\n8. Prophylaxis of acid aspiration during anesthesia \r\nInteractions for Omeprazole\r\nDiazepam: Half life of diazepam is increased. \r\nPhenytoin: Increased", "Composition": "Omeprazole 20 mg or 40 mg\r\nSodium Bicarbonate 1100 mg", "Route": "ORAL.SOLID" }, { "ID": "565", "Trade_Name": "RISEK 40 MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "60", "Price_Old": "60", "Company": "JULPHAR", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each capsule contains:\r\nRisek 10mg: Omeprazole 10mg\r\nRisek 20mg: Omeprazole 20mg\r\nRisek 40mg: Omeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "566", "Trade_Name": "PEPZOL 40MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "47.25", "Price_Old": "31.5", "Company": "HIKMA PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Omeprazole 20 mg or 40 mg", "Route": "ORAL.SOLID" }, { "ID": "567", "Trade_Name": "AZGOVANC 20MG 7 CAPS.", "Generic_Name": "OMEPRAZOLE+SODIUM BICARBONATE", "Price": "19", "Price_Old": "12.6", "Company": "SABAA > APIC", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة و#.ل#.ثنى #>ش#^ #=م#. يقوم #%#>ل#.ج ق#^حة #.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.لحمو#_ة. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ىء #=م#. ي#>#.لج ح#^ق#.ن #.لم#^ئ و#.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #.ل#>ل#.ج و #.لوق#.ية من #.لق#^حة #.لن#.#?جة #>ن #.س#?#>م#.ل #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#^غ#%ة #<ى #.لوق#.ية من ق#^حة #.لم#>#~ة #<ى ح#.ل#.#? #.س#?خ#~#.م #.ل#=و#^#?يزون #=م#. ي#>#.لج #.ل#?ه#.#% #.لقولون #.ل#?ق#^حى ، #%#.ل#.#_#.#<ة #.نه ي#>مل #>لى #?قليل مخ#.#-#^ #.لنزي#< #%#.لجه#.ز #.له#_مى . \r\n\r\n–#<#>#.ل #<ي ح#.ل#.#? #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي #=م#. يس#.#>#~ #>لي #?قليل مخ#.#-#^ #.لنزي#< #<ي #.لجه#.ز #.له#_مي .", "Contraindications": "–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة يؤ#~ى إلى سوء إم#?ص#.ص #<ي#?#.مين B12 مم#. يقلل من #?#^#=يزه #%#.لجسم لذل#= ي#<#_ل #?ن#.ول أ#~وية #?ح#?وى #>لى #<ي#?#.مين B12 أثن#.ء #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة . \r\n\r\n–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة ( أ#=ث#^ من #>#.م ) ق#~ يؤ#~ى إلى نقص نس#%ة #.لم#.غنيسيوم #%#.ل#~م ( HYPOMAGNESEMIA ) . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=لى . \r\n\r\n–يقلل #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى : \r\n\r\n–KETOCONAZOLE \r\n\r\n– ITRACONAZOLE \r\n\r\n– MESALAZINE لذل#= يج#% #.س#?خ#~#.م #.#~ويه أخ#^ى . \r\n\r\n–يزي#~ من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى م#.#~ة #.ل DIGOXIN لذل#= يج#% #.لحذ#^ : ق#~ #?س#%#% #.لو#<#.ة . \r\n\r\n–يقلل من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى SOFOSBUVIR / VELPATASVIR #.لمس#?خ#~م ل#>ل#.ج #<ي#^وس C لذل#= يج#% #.س#?خ#~#.م #>ل#.ج أخ#^ . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لجل#-ة #.ل#?ى #?ح#?وى #>لى م#.#~ة CLOPIDOGREL : لذل#= يج#% #?غيي#^ #.ل#>ل#.ج . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لأم#^#.#_ #.لن#<سية #.ل#?ى #?ح#?وى #>لى م#.#~ة DULOXETINE \r\n\r\n–#<ى ح#.لة #.لحمل ل#.يوج#~ #~#^#.سة #=#.#<ية #>ن #.س#?خ#~#.م #.ل#~و#.ء، أم#. #<ى ح#.لة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.مة وننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص #<ى ذل#=.يمن#> #?ن#.ول #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لح#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى .", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.\r\nIndications for Omeprazole\r\n1. Duodenal ulcer \r\n2. Gastric ulcer \r\n3. Zollinger- Ellison syndrome \r\n4. Gastroesophageal reflux disease \r\n5. Oesophagitis \r\n6. Acid related dyspepsia \r\n7. NSAID associated ulceration \r\n8. Prophylaxis of acid aspiration during anesthesia \r\nInteractions for Omeprazole\r\nDiazepam: Half life of diazepam is increased. \r\nPhenytoin: Increased", "Composition": "Omeprazole 20 mg or 40 mg\r\nSodium Bicarbonate 1100 mg", "Route": "ORAL.SOLID" }, { "ID": "568", "Trade_Name": "OMEPAK 40MG 7CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "15", "Price_Old": "15", "Company": "SEDICO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 10mg or 20mg", "Route": "ORAL.SOLID" }, { "ID": "569", "Trade_Name": "DOWNOPRAZOL 20MG/1100 14 CAPS.", "Generic_Name": "OMEPRAZOLE+SODIUM BICARBONATE", "Price": "38", "Price_Old": "25.2", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > UTOPIA PHARMACEUTICALS COMPANY", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#?ه#.#% #.لم#>#~ة و#.ل#.ثنى #>ش#^ #=م#. يقوم #%#>ل#.ج ق#^حة #.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.لحمو#_ة. \r\n\r\n–يس#?#>مل #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ىء #=م#. ي#>#.لج ح#^ق#.ن #.لم#^ئ و#.لم#>#~ة ، #%#.ل#.#_#.#<ة #.لى #.ل#>ل#.ج و #.لوق#.ية من #.لق#^حة #.لن#.#?جة #>ن #.س#?#>م#.ل #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ح#.ل#.#? #.ل#^غ#%ة #<ى #.لوق#.ية من ق#^حة #.لم#>#~ة #<ى ح#.ل#.#? #.س#?خ#~#.م #.ل#=و#^#?يزون #=م#. ي#>#.لج #.ل#?ه#.#% #.لقولون #.ل#?ق#^حى ، #%#.ل#.#_#.#<ة #.نه ي#>مل #>لى #?قليل مخ#.#-#^ #.لنزي#< #%#.لجه#.ز #.له#_مى . \r\n\r\n–#<#>#.ل #<ي ح#.ل#.#? #.ل#?ه#.#% #.لقولون #.ل#?ق#^حي #=م#. يس#.#>#~ #>لي #?قليل مخ#.#-#^ #.لنزي#< #<ي #.لجه#.ز #.له#_مي .", "Contraindications": "–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة يؤ#~ى إلى سوء إم#?ص#.ص #<ي#?#.مين B12 مم#. يقلل من #?#^#=يزه #%#.لجسم لذل#= ي#<#_ل #?ن#.ول أ#~وية #?ح#?وى #>لى #<ي#?#.مين B12 أثن#.ء #.ل#>ل#.ج ل#<#?#^#.#? #-ويلة . \r\n\r\n–#.لإس#?خ#~#.م ل#<#?#^#.#? #-ويلة ( أ#=ث#^ من #>#.م ) ق#~ يؤ#~ى إلى نقص نس#%ة #.لم#.غنيسيوم #%#.ل#~م ( HYPOMAGNESEMIA ) . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ و #?ح#? إش#^#.#< #.ل#-#%ي#% م#> م#^#_ى #.ل#=لى . \r\n\r\n–يقلل #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى : \r\n\r\n–KETOCONAZOLE \r\n\r\n– ITRACONAZOLE \r\n\r\n– MESALAZINE لذل#= يج#% #.س#?خ#~#.م #.#~ويه أخ#^ى . \r\n\r\n–يزي#~ من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى م#.#~ة #.ل DIGOXIN لذل#= يج#% #.لحذ#^ : ق#~ #?س#%#% #.لو#<#.ة . \r\n\r\n–يقلل من #<#.#>لية #.لأ#~وية #.ل#?ى #?ح#?وى #>لى SOFOSBUVIR / VELPATASVIR #.لمس#?خ#~م ل#>ل#.ج #<ي#^وس C لذل#= يج#% #.س#?خ#~#.م #>ل#.ج أخ#^ . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لجل#-ة #.ل#?ى #?ح#?وى #>لى م#.#~ة CLOPIDOGREL : لذل#= يج#% #?غيي#^ #.ل#>ل#.ج . \r\n\r\n–يقلل من #<#.#>لية أ#~وية #.لأم#^#.#_ #.لن#<سية #.ل#?ى #?ح#?وى #>لى م#.#~ة DULOXETINE \r\n\r\n–#<ى ح#.لة #.لحمل ل#.يوج#~ #~#^#.سة #=#.#<ية #>ن #.س#?خ#~#.م #.ل#~و#.ء، أم#. #<ى ح#.لة #.ل#^#_#.#>ة يحذ#^ #.س#?خ#~#.مة وننصح #%م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص #<ى ذل#=.يمن#> #?ن#.ول #.ل#~و#.ء لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لح#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى .", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.\r\nIndications for Omeprazole\r\n1. Duodenal ulcer \r\n2. Gastric ulcer \r\n3. Zollinger- Ellison syndrome \r\n4. Gastroesophageal reflux disease \r\n5. Oesophagitis \r\n6. Acid related dyspepsia \r\n7. NSAID associated ulceration \r\n8. Prophylaxis of acid aspiration during anesthesia \r\nInteractions for Omeprazole\r\nDiazepam: Half life of diazepam is increased. \r\nPhenytoin: Increased", "Composition": "Each hard gelatin capsule contains:\r\nOmeprazole (20 or 40) mg.\r\nSodium bicarbonate 1100 mg.\r\n\r\nEach Packet of 3 gm powder for oral suspension contains:\r\nOmeprazole 20 mg + Sodium bicarbonate 1680 mg.", "Route": "ORAL.SOLID" }, { "ID": "570", "Trade_Name": "PHENYTOIN 50MG 40 CAPS.", "Generic_Name": "PHENYTOIN", "Price": "13.5", "Price_Old": "13.5", "Company": "EL NASR", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "phenytoin 100mg", "Route": "ORAL.SOLID" }, { "ID": "571", "Trade_Name": "CEREBRO 400MG 30 CAPS.", "Generic_Name": "PIRACETAM", "Price": "9.25", "Price_Old": "9.25", "Company": "UNIPHARMA CO.", "Pharmacology": "CEREBRAL CIRCULATORY INHANCER", "Category": "محسن #.ل#~و#^ة #.ل#~موية #.ل#~م#.غية", "Use": "–#?نشي#- #.ل#~و#^ة #.ل#~موية و#?وصيل #.ل#.#=سجين للمخ. \r\n\r\n–#.لح#~ من #.#_#-#^#.#%#.#? #.ل#~و#.#^ و #.ل#~وخة و#-نين #.ل#.ذن. \r\n\r\n–#>ل#.ج #.ل#?قلص#.#? #.ل#.#^#?ج#.#<ية #.ل#>#_لية #<ي #.لقش#^ة #.لمخية. \r\n\r\n–#>ل#.ج م#^#_ #.لزه#.يم#^ و #.لنسي#.ن و#.لخ#^#< #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?نشي#- #.لذ#.#=#^ة و#.ل#?#^#=يز و#.لح#~ من #_#>#< #.ل#?#^#=يز #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?حسين و#?نشي#- #.لق#~#^#.#? #.ل#>قلية #>ن#~ #.ل#.#-#<#.ل و#=#%#.#^ #.لسن و#%#>#~ #.لس#=#?#.#? #.ل#~م#.غية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.ل#=لي و #.ل#=#%#~. \r\n\r\n–يج#% #.خ#%#.#^ #.ل#-#%ي#% ق#%ل #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لح#.ل#.#? #.ل#.#?ية: \r\n\r\n–#.ذ#. #=ن#? ح#.مل أو #?خ#-#-ين للحمل ، #.ثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من نزي#< #%#.لمخ ، نزي#< غي#^ #-#%ي#>ي. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من م#?ل#.زمة هن#?نغ#?ون. \r\n\r\n–من ي#>#.ني #.#_#-#^#.#%#.#? #<ي #?خث#^ #.ل#~م.", "GI": "The way piracetam works is not fully understood. It may work by altering the availability of the brain s supply of neurochemicals (neurotransmitters, enzymes and hormones) or by improving the brain s oxygen supply.\r\n\r\nWhat is it used for?\r\nUncontrollable twitching or jerking of the muscles, particularly in the arms and legs, caused by a problem in the brain or nervous system (myoclonus of cortical origin). This medicine is used in combination with other treatments for this condition.", "Composition": "Piracetam 400 mg", "Route": "ORAL.SOLID" }, { "ID": "572", "Trade_Name": "PHENYTOIN 100MG 40 CAPS.", "Generic_Name": "PHENYTOIN", "Price": "16", "Price_Old": "16", "Company": "EL NASR", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "phenytoin 100mg", "Route": "ORAL.SOLID" }, { "ID": "573", "Trade_Name": "EPANUTIN 100MG 50CAPS.", "Generic_Name": "PHENYTOIN", "Price": "14.4", "Price_Old": "14.4", "Company": "EL NILE. > PFIZER", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "phenytoin 100mg or 30mg", "Route": "ORAL.SOLID" }, { "ID": "574", "Trade_Name": "NOOTROPIL 400 MG 30 CAPS.", "Generic_Name": "PIRACETAM", "Price": "9.2", "Price_Old": "9.2", "Company": "CID > UCB-BELGIUM", "Pharmacology": "CEREBRAL CIRCULATORY INHANCER", "Category": "محسن #.ل#~و#^ة #.ل#~موية #.ل#~م#.غية", "Use": "–#?نشي#- #.ل#~و#^ة #.ل#~موية و#?وصيل #.ل#.#=سجين للمخ. \r\n\r\n–#.لح#~ من #.#_#-#^#.#%#.#? #.ل#~و#.#^ و #.ل#~وخة و#-نين #.ل#.ذن. \r\n\r\n–#>ل#.ج #.ل#?قلص#.#? #.ل#.#^#?ج#.#<ية #.ل#>#_لية #<ي #.لقش#^ة #.لمخية. \r\n\r\n–#>ل#.ج م#^#_ #.لزه#.يم#^ و #.لنسي#.ن و#.لخ#^#< #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?نشي#- #.لذ#.#=#^ة و#.ل#?#^#=يز و#.لح#~ من #_#>#< #.ل#?#^#=يز #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?حسين و#?نشي#- #.لق#~#^#.#? #.ل#>قلية #>ن#~ #.ل#.#-#<#.ل و#=#%#.#^ #.لسن و#%#>#~ #.لس#=#?#.#? #.ل#~م#.غية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.ل#=لي و #.ل#=#%#~. \r\n\r\n–يج#% #.خ#%#.#^ #.ل#-#%ي#% ق#%ل #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لح#.ل#.#? #.ل#.#?ية: \r\n\r\n–#.ذ#. #=ن#? ح#.مل أو #?خ#-#-ين للحمل ، #.ثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من نزي#< #%#.لمخ ، نزي#< غي#^ #-#%ي#>ي. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من م#?ل#.زمة هن#?نغ#?ون. \r\n\r\n–من ي#>#.ني #.#_#-#^#.#%#.#? #<ي #?خث#^ #.ل#~م.", "GI": "The way piracetam works is not fully understood. It may work by altering the availability of the brain s supply of neurochemicals (neurotransmitters, enzymes and hormones) or by improving the brain s oxygen supply.\r\n\r\nWhat is it used for?\r\nUncontrollable twitching or jerking of the muscles, particularly in the arms and legs, caused by a problem in the brain or nervous system (myoclonus of cortical origin). This medicine is used in combination with other treatments for this condition.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "575", "Trade_Name": "CEREBROCETAM 400MG 30 CAPS.", "Generic_Name": "PIRACETAM", "Price": "19.25", "Price_Old": "12.75", "Company": "PHARCO", "Pharmacology": "CEREBRAL CIRCULATORY INHANCER", "Category": "محسن #.ل#~و#^ة #.ل#~موية #.ل#~م#.غية", "Use": "–#?نشي#- #.ل#~و#^ة #.ل#~موية و#?وصيل #.ل#.#=سجين للمخ. \r\n\r\n–#.لح#~ من #.#_#-#^#.#%#.#? #.ل#~و#.#^ و #.ل#~وخة و#-نين #.ل#.ذن. \r\n\r\n–#>ل#.ج #.ل#?قلص#.#? #.ل#.#^#?ج#.#<ية #.ل#>#_لية #<ي #.لقش#^ة #.لمخية. \r\n\r\n–#>ل#.ج م#^#_ #.لزه#.يم#^ و #.لنسي#.ن و#.لخ#^#< #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?نشي#- #.لذ#.#=#^ة و#.ل#?#^#=يز و#.لح#~ من #_#>#< #.ل#?#^#=يز #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?حسين و#?نشي#- #.لق#~#^#.#? #.ل#>قلية #>ن#~ #.ل#.#-#<#.ل و#=#%#.#^ #.لسن و#%#>#~ #.لس#=#?#.#? #.ل#~م#.غية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.ل#=لي و #.ل#=#%#~. \r\n\r\n–يج#% #.خ#%#.#^ #.ل#-#%ي#% ق#%ل #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لح#.ل#.#? #.ل#.#?ية: \r\n\r\n–#.ذ#. #=ن#? ح#.مل أو #?خ#-#-ين للحمل ، #.ثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من نزي#< #%#.لمخ ، نزي#< غي#^ #-#%ي#>ي. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من م#?ل#.زمة هن#?نغ#?ون. \r\n\r\n–من ي#>#.ني #.#_#-#^#.#%#.#? #<ي #?خث#^ #.ل#~م.", "GI": "The way piracetam works is not fully understood. It may work by altering the availability of the brain s supply of neurochemicals (neurotransmitters, enzymes and hormones) or by improving the brain s oxygen supply.\r\n\r\nWhat is it used for?\r\nUncontrollable twitching or jerking of the muscles, particularly in the arms and legs, caused by a problem in the brain or nervous system (myoclonus of cortical origin). This medicine is used in combination with other treatments for this condition.", "Composition": "1 capsule contains 400 mg of piracetam \r\n1 film coated tablet contains 800 mg of piracetam\r\n5 ml ampoule contains 1 gm piracetam \r\n1 ml of drinking solution 20 % contains 200 mg piracetam", "Route": "ORAL.SOLID" }, { "ID": "576", "Trade_Name": "PHENYTIN 100MG 50 CAPS.", "Generic_Name": "PHENYTOIN", "Price": "21", "Price_Old": "14.4", "Company": "EL NILE.", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "Capsule: 50 mg Capsule 100 mg Capsule\r\nPhenytoin sodium 50 mg/ cap. & Phenytoin sodium 100 mg/ cap.\r\n\r\n-Suspension:\r\nPhenytoin (micronized) 30 mg/5ml\r\n\r\n-Ampoule:\r\nEach 1 ml contains :\r\nPhenytoin sodium 50 mg", "Route": "ORAL.SOLID" }, { "ID": "577", "Trade_Name": "NEUROCET 400MG 30 CAPS.", "Generic_Name": "PIRACETAM", "Price": "7.9", "Price_Old": "7.9", "Company": "MISR", "Pharmacology": "CEREBRAL CIRCULATORY INHANCER", "Category": "محسن #.ل#~و#^ة #.ل#~موية #.ل#~م#.غية", "Use": "–#?نشي#- #.ل#~و#^ة #.ل#~موية و#?وصيل #.ل#.#=سجين للمخ. \r\n\r\n–#.لح#~ من #.#_#-#^#.#%#.#? #.ل#~و#.#^ و #.ل#~وخة و#-نين #.ل#.ذن. \r\n\r\n–#>ل#.ج #.ل#?قلص#.#? #.ل#.#^#?ج#.#<ية #.ل#>#_لية #<ي #.لقش#^ة #.لمخية. \r\n\r\n–#>ل#.ج م#^#_ #.لزه#.يم#^ و #.لنسي#.ن و#.لخ#^#< #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?نشي#- #.لذ#.#=#^ة و#.ل#?#^#=يز و#.لح#~ من #_#>#< #.ل#?#^#=يز #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?حسين و#?نشي#- #.لق#~#^#.#? #.ل#>قلية #>ن#~ #.ل#.#-#<#.ل و#=#%#.#^ #.لسن و#%#>#~ #.لس#=#?#.#? #.ل#~م#.غية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.ل#=لي و #.ل#=#%#~. \r\n\r\n–يج#% #.خ#%#.#^ #.ل#-#%ي#% ق#%ل #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لح#.ل#.#? #.ل#.#?ية: \r\n\r\n–#.ذ#. #=ن#? ح#.مل أو #?خ#-#-ين للحمل ، #.ثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من نزي#< #%#.لمخ ، نزي#< غي#^ #-#%ي#>ي. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من م#?ل#.زمة هن#?نغ#?ون. \r\n\r\n–من ي#>#.ني #.#_#-#^#.#%#.#? #<ي #?خث#^ #.ل#~م.", "GI": "The way piracetam works is not fully understood. It may work by altering the availability of the brain s supply of neurochemicals (neurotransmitters, enzymes and hormones) or by improving the brain s oxygen supply.\r\n\r\nWhat is it used for?\r\nUncontrollable twitching or jerking of the muscles, particularly in the arms and legs, caused by a problem in the brain or nervous system (myoclonus of cortical origin). This medicine is used in combination with other treatments for this condition.", "Composition": "piracetam 1g or 400mg", "Route": "ORAL.SOLID" }, { "ID": "578", "Trade_Name": "IPANTEN 100MG 50 CAPS.", "Generic_Name": "PHENYTOIN", "Price": "29", "Price_Old": "19.2", "Company": "ARAB CAPS > ACDIMA INTERNATIONAL TRADING", "Pharmacology": "ANTI-EPILEPTIC.HYDANTOIN", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–#>ل#.ج ح#.ل#.#? #.لص#^#> #.ل#=#%ي#^ (#.لنو#%#.#? #.ل#?و#?#^ية #.ل#^م#>ية) و #<ي #>ل#.ج #.لنو#%#.#? #.لجزئية #.لم#^#=#%ة، #=م#. يس#?خ#~م للوق#.ية من نو#%#.#? #.لص#^#> #<ي #.لم#^#_ى #.لذين #?#>#^#_و#. لإص#.#%ة أو خ#_#>و#. لج#^#.حة #<ي #.ل#~م#.غ أو #.ل#^أس.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي ح#.ل#.#? #.لحس#.سية #?ج#.ه م#=ون#.#? #.ل#>ق#.#^ \r\n\r\n–يمن#> خل#.ل ح#.ل#.#? ح#~وث #.نس#~#.#~ #.ل#>#_لة #.لقل#%ية \r\n\r\n–يس#?خ#~م #%حذ#^ خل#.ل ح#.ل#.#? #>جز وظ#.ئ#< #.ل#=لى و#.ل#=#%#~", "GI": "About Phenytoin\r\nHydantoin derivative, Anticonvulsant, Class Ib Antiarrhythmic Agent.\r\nMechanism of Action of Phenytoin\r\nPhenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. It prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by increasing the efflux or decreasing the influx of sodium ion across the cell membrane and inhibits the high frequency discharge. \r\nAntiarrhythmic action of Phenytoin is due to its membrane stabilizing effect and blockage of sodium channels. It causes depression of automaticity in ventricular and Purkinje fibres. \r\nAt high concentrations Phenytoin \r\n1. Enhances calcium binding to phospholipids in neuronal membrane and results in a more stable neuronal membrane. \r\n2. It enhances the concentration of inhibitory neurotransmitter GABA \r\n3. It inhibits the excitatory glutamate receptors. \r\nAll these indicate that Phenytoin limits the development of maximal seizure", "Composition": "Each 1 Capsule contains:\r\n 100mg Phenytoin sodium or Each 1 Capsule contains 50mg Phenytoin sodium", "Route": "ORAL.SOLID" }, { "ID": "579", "Trade_Name": "STIMULAN 400MG 30 CAPS.", "Generic_Name": "PIRACETAM", "Price": "14", "Price_Old": "9.2", "Company": "AMOUN", "Pharmacology": "CEREBRAL CIRCULATORY INHANCER", "Category": "محسن #.ل#~و#^ة #.ل#~موية #.ل#~م#.غية", "Use": "–#?نشي#- #.ل#~و#^ة #.ل#~موية و#?وصيل #.ل#.#=سجين للمخ. \r\n\r\n–#.لح#~ من #.#_#-#^#.#%#.#? #.ل#~و#.#^ و #.ل#~وخة و#-نين #.ل#.ذن. \r\n\r\n–#>ل#.ج #.ل#?قلص#.#? #.ل#.#^#?ج#.#<ية #.ل#>#_لية #<ي #.لقش#^ة #.لمخية. \r\n\r\n–#>ل#.ج م#^#_ #.لزه#.يم#^ و #.لنسي#.ن و#.لخ#^#< #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?نشي#- #.لذ#.#=#^ة و#.ل#?#^#=يز و#.لح#~ من #_#>#< #.ل#?#^#=يز #>ن#~ #=#%#.#^ #.لسن. \r\n\r\n–#?حسين و#?نشي#- #.لق#~#^#.#? #.ل#>قلية #>ن#~ #.ل#.#-#<#.ل و#=#%#.#^ #.لسن و#%#>#~ #.لس#=#?#.#? #.ل#~م#.غية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي وظ#.ئ#< #.ل#=لي و #.ل#=#%#~. \r\n\r\n–يج#% #.خ#%#.#^ #.ل#-#%ي#% ق#%ل #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لح#.ل#.#? #.ل#.#?ية: \r\n\r\n–#.ذ#. #=ن#? ح#.مل أو #?خ#-#-ين للحمل ، #.ثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من نزي#< #%#.لمخ ، نزي#< غي#^ #-#%ي#>ي. \r\n\r\n–#.ذ#. #=ن#? #?#>#.ني من م#?ل#.زمة هن#?نغ#?ون. \r\n\r\n–من ي#>#.ني #.#_#-#^#.#%#.#? #<ي #?خث#^ #.ل#~م.", "GI": "The way piracetam works is not fully understood. It may work by altering the availability of the brain s supply of neurochemicals (neurotransmitters, enzymes and hormones) or by improving the brain s oxygen supply.\r\n\r\nWhat is it used for?\r\nUncontrollable twitching or jerking of the muscles, particularly in the arms and legs, caused by a problem in the brain or nervous system (myoclonus of cortical origin). This medicine is used in combination with other treatments for this condition.", "Composition": "piracetam 1g or 400mg or 800mg", "Route": "ORAL.SOLID" }, { "ID": "580", "Trade_Name": "TREXAM 500MG 20 TAB.", "Generic_Name": "TRANEXAMIC ACID", "Price": "24", "Price_Old": "24", "Company": "MEMPHIS", "Pharmacology": "BLEEDDING.FIBRINOLYTICS INHIBITORS", "Category": "م#_#.#~ للنزي#< و غز#.#^ة #.ل#-مث", "Use": "–يس#?خ#~م #%#>#~ #.ج#^#.ء #.ل#>ملي#.#? لوق#< #.لنزي#< . \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? غز#.#^ة #.ل#-مث . \r\n\r\n–يس#?خ#~م لوق#< #.لنزي#< #%#>#~ #>ملي#.#? خل#> #.ل#.سن#.ن . \r\n\r\n–يس#?خ#~م لوق#< نزي#< #.ل#.ن#< . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لنزي#< #>ن#~ #.ل#.جه#.#_ . \r\n\r\n–وق#< #.لنزي#< #%#>#~ #>ملي#.#? #.لمث#.نة و#.ل#%#^وس#?#.#?#. . \r\n\r\n–وق#< #.لنزي#< #%#>#~ #>ملي#.#? #.س#?ئص#.ل س#^#-#.ن #.ل#^حم . \r\n\r\n–#>ل#.ج #.لوذمة #.لو#>#.ئية . \r\n\r\n–#>ل#.ج #.لنزي#< #.ل#~لخلي #<ي #.ل#>ين .", "Contraindications": "–يمن#> #<ي ح#.لة من ي#>#.ني #?خث#^ #.ل#~م . \r\n\r\n–يمن#> #<ي ح#.لة #>#~م #.ن#?ظ#.م #.ل#-مث . \r\n\r\n–يمن#> #<ي ح#.لة #.خ#?ل#.#- #.ل#%ول #%#.ل#~م . \r\n\r\n–يمن#> #<ي ح#.لة #?جل#- #.ل#.و#>ية #.ل#~موية .", "GI": "About Tranexamic Acid\r\nLysine Analog, Hemostatic, competitive plasminogen activationinhibitor, Antifibrinolytic,Antihemophilic.\r\nMechanism of Action of Tranexamic Acid\r\nTranexamic acid exerts antifibrinolytic effect by forming a reversible complex with plasminogen through the lysine binding site of fibrin and thus displaces the plasminogen from the fibrin surface - preventing the binding of plasmin to fibrinogen or fibrin monomers. It inhibits the activation of plasminogen (i.e. formation of plasmin). It also acts as a weak non competitive inhibitor of plasmin and blocks it`s action on fibrin.\r\nIndications for Tranexamic Acid\r\n1.Surgical procedures \r\n2.Menorrhagia \r\n3. Metrorrhagia \r\n4.Post partum haemorrhage \r\n5.Haemorrhage after abortion \r\n6.Haemorrhage due to contraceptive device insertion \r\n7.Tooth extractions and haemorrhage in other dental procedures \r\n8.Epistaxis \r\n9.Haemoptysis \r\n10.Gastrointestinal bleeding \r\n11.Prostatectomy \r\n12.Tonsillectomy \r\n13.Fibrinolysis", "Composition": "tranexamic acid 500mg", "Route": "ORAL.SOLID" }, { "ID": "581", "Trade_Name": "RISEK 20MG 28CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "75", "Price_Old": "75", "Company": "JULPHAR", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each capsule contains:\r\nRisek 10mg: Omeprazole 10mg\r\nRisek 20mg: Omeprazole 20mg\r\nRisek 40mg: Omeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "582", "Trade_Name": "RISEK 20MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "40", "Price_Old": "40", "Company": "JULPHAR", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each capsule contains:\r\nRisek 10mg: Omeprazole 10mg\r\nRisek 20mg: Omeprazole 20mg\r\nRisek 40mg: Omeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "583", "Trade_Name": "OMEPRAL 20MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "25.2", "Price_Old": "25.2", "Company": "MEMPHIS", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg", "Route": "ORAL.SOLID" }, { "ID": "584", "Trade_Name": "GASTROLOC 40MG 20 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "48", "Price_Old": "48", "Company": "SIGMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "585", "Trade_Name": "ULSTOP 20MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "42.4", "Price_Old": "42.4", "Company": "PHARCO", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg", "Route": "ORAL.SOLID" }, { "ID": "586", "Trade_Name": "PEPZOL 20 MG MR 14 CAP.", "Generic_Name": "OMEPRAZOLE", "Price": "24.5", "Price_Old": "16.2", "Company": "HIKMA PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Omeprazole 20 mg or 40 mg", "Route": "ORAL.SOLID" }, { "ID": "587", "Trade_Name": "FASTCURE 40MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "36", "Price_Old": "36", "Company": "OCTOBER PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "588", "Trade_Name": "OMISEC 20MG 14CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "42", "Price_Old": "42", "Company": "THE UNITED PHARMACEUTICALS CO LTD-JORDAN > MODERN PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "omeprazole 20mg", "Route": "ORAL.SOLID" }, { "ID": "589", "Trade_Name": "HEALSEC 40MG 14 CAPS.", "Generic_Name": "OMEPRAZOLE", "Price": "45", "Price_Old": "30", "Company": "BORG", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "–يس#?خ#~م #<ى ح#.ل#.#? #.#^#?ج#.#> #.لم#^ئ #.لن#.#?جة من زي#.#~ة #.#<#^#.ز#.#? #.لم#>#~ة #.لى #.لم#^ئ و#?س#%#% #.ل#.م ش#~ي#~ة وح#^قه #<ى #.لم#>#~ة و#.ل#?ه#.#%#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#%#.#? #.لجزء #.ل#.#>لى من #.ل#.م#>#.ء #.ل#~قيقة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ق#^حة #.ل#.ثنى #>ش#^ #%س#%#% #.#<#^#.ز#.#? #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج #.لق#^حة #.ذ#. #=#.ن س#%#%ه#. هى #.ل#.ص#.#%ة #%#>#~وى هيلي#=و#%#.#=#?#^ #%#.#%يو#^ى . \r\n\r\n–يس#?خ#~م #<ى #.ل#?خلص من #.ل#.م #.لم#>#~ة #.لن#.#?جة #>ن #=ث#^ه #?ن#.ول #.لمس#=ن#.#? . \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج زي#.#~ة #.ل#.حم#.#_ #.لن#.#%#>ة من نمو #.ل#%ن#=#^ي#.س .", "Contraindications": "–ل#. يس#?#>مل #<ى #.لم#^#_ى ذوى #.لحس#.سية #.لم#<#^#-ة للأومي#%#^#.زول.", "GI": "About Omeprazole\r\nProton Pump Inhibitor, Substituted Benzimidazole, Anti-secretory,antiulcer.\r\nMechanism of Action of Omeprazole\r\nOmeprazole is a proton pump inhibitor and it is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Omeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump \r\n(H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Omeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion.", "Composition": "Each nard gelatin capsule contains:\r\n- Active ingredients:\r\nHealsec 10 mg Hard Gelatin Capsules\r\nOmeprazole 10 mg\r\n\r\nHealsec 20 mg Hard Gelatin Capsules\r\nOmeprazole 20 mg\r\n\r\nHealsec 40 mg Hard Gelatin Capsules Omeprazole 40 mg", "Route": "ORAL.SOLID" }, { "ID": "590", "Trade_Name": "KEMIRICA 25 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "69", "Price_Old": "69", "Company": "CHEMIPHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each hard gelatin capsule contain \r\nActive Ingredient: Pregabalin 25, 50,75,100,150,200,300 mg", "Route": "ORAL.SOLID" }, { "ID": "591", "Trade_Name": "LYRIBALIN 50 MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "16.8", "Price_Old": "16.8", "Company": "BORG", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 50mg or 75mg or 100mg or 150mg", "Route": "ORAL.SOLID" }, { "ID": "592", "Trade_Name": "KEMIRICA 50 MG 30 CAPS", "Generic_Name": "PREGABALIN", "Price": "87", "Price_Old": "87", "Company": "CHEMIPHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each hard gelatin capsule contain \r\nActive Ingredient: Pregabalin 25, 50,75,100,150,200,300 mg", "Route": "ORAL.SOLID" }, { "ID": "593", "Trade_Name": "AVEROPREG 50MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "64", "Price_Old": "64", "Company": "EL-OBOUR > AVERROES PHARMA-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "594", "Trade_Name": "PREGDIN-APEX 50MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "64", "Price_Old": "64", "Company": "MULTI-APEX", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "595", "Trade_Name": "LYRICA 50MG 20 CAPS", "Generic_Name": "PREGABALIN", "Price": "126", "Price_Old": "90", "Company": "PFIZER", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 75mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "596", "Trade_Name": "GABLOVAC 50MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "32", "Price_Old": "32", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > GAST PHARMA GROUP-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "597", "Trade_Name": "PREGABA 50 MG 30 CAP.", "Generic_Name": "PREGABALIN", "Price": "96", "Price_Old": "96", "Company": "EGPI", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each capsule contains:\r\nPregabalin 50mg\r\nPregabalin 100mg", "Route": "ORAL.SOLID" }, { "ID": "598", "Trade_Name": "DRAGONOR 50 MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "64", "Price_Old": "64", "Company": "EL NILE. > OCTOBER PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 50mg", "Route": "ORAL.SOLID" }, { "ID": "599", "Trade_Name": "ANDOGABLIN 75MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "74", "Price_Old": "74", "Company": "ANDALOUS PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "75 mg Pregabalin", "Route": "ORAL.SOLID" }, { "ID": "600", "Trade_Name": "CLINDACINE 150MG 6 CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "10.5", "Price_Old": "10.5", "Company": "RAMEDA", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "clindamycin 1%", "Route": "ORAL.SOLID" }, { "ID": "601", "Trade_Name": "CLINDACINE 300 MG 12 CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "12", "Price_Old": "12", "Company": "RAMEDA", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "Clindamycin 150, 300mg", "Route": "ORAL.SOLID" }, { "ID": "602", "Trade_Name": "MEPACLIND 150MG 16CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "18", "Price_Old": "18", "Company": "MEPACO", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "clindamycin 150mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "603", "Trade_Name": "CLINACYN 150MG 16 CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "24", "Price_Old": "16", "Company": "SIGMA > EGYPTIAN PHARMACISTS COMPANY", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "Clindamycin 150, 300mg", "Route": "ORAL.SOLID" }, { "ID": "604", "Trade_Name": "DALACIN C 300MG 10 CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "52.5", "Price_Old": "35", "Company": "PFIZER", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "clindamycin 150mg. 300mg, 600mg", "Route": "ORAL.SOLID" }, { "ID": "605", "Trade_Name": "CLINACYN 300MG 16 CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "31.5", "Price_Old": "21", "Company": "SIGMA > EGYPTIAN PHARMACISTS COMPANY", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "Clindamycin 150, 300mg", "Route": "ORAL.SOLID" }, { "ID": "606", "Trade_Name": "FERITIN 24 CHEW. TABS.", "Generic_Name": "IRON+VITAMIN(B1+B3+B6+B12)+FOLIC ACID+VITAMIN C+ZINC+VITAMIN E+SELENIUM", "Price": "48", "Price_Old": "48", "Company": "NUTRIXIA > NEUTRA COMPANY", "Pharmacology": "IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~", "Use": "–#>ل#.ج #.نيمي#. نقص #.لح#~ي#~ #.و نقص حم#_ #.ل#<ولي#= أو #<ي#?#.مين #% 12 . \r\n\r\n–م#=مل غذ#.ئي ومقوي #>#.م للجسم يس#.#>#~ #>لي #.ل#?خلص من #.لوهن و#.ل#.#^ه#.ق . \r\n\r\n–يس#.#>#~ #.ل#>ق#.#^ #>لي #^#<#> من#.#>ة #.لجسم و#?#>زيز #>مل #.لجه#.ز #.لمن#.#>ي . \r\n\r\n–ي#>مل #>لي #?#>وي#_ #.لنزي#< #%#>#~ #.ج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية و#%#>#~ #.لول#.#~ة و#<ي ح#.لة #.لج#^وح و#.ل#.ص#.#%#.#? #.لش#~ي#~ة . \r\n\r\n–م#<ي#~ خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة . \r\n\r\n–م#<ي#~ ل#>ل#.ج ح#.ل#.#? #?س#.ق#- #.لش#>#^ #.لن#.#?جة #>ن #.ل#.ص#.#%ة #%#<ق#^ #.ل#~م .", "Contraindications": "–ق#~ يس#%#% #?غي#^ #<ى لون #.ل#%#^#.ز إلى #.للون #.لأسو#~ #.ل#~#.#=ن . \r\n\r\n–يج#% #?جن#% #?ن#.ول #.لقهوة و #.لش#.ي و #.لحلي#% و #.ل#%ي#_ #<ى ن#<س #.لوق#? م#> أ#~وية #.لح#~ي#~ ل#.نه#. #?قلل من إم#?ص#.ص #.لح#~ي#~ و يج#% #.ل#<صل #%ينهم#. #%س#.#>#?ين #>لى #.لأقل . \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ى #.لجه#.ز #.له#_مى مثل م#^#_ى ق#^حة #.لم#>#~ة و #.لأم#>#.ء و إل#?ه#.#%#.#? #.لقولون : ق#~ #?س#%#% إ#_#-#^#.#%#.#? #%#.لجه#.ز #.له#_مى . \r\n\r\n–ق#~ يس#%#% ح#~وث إمس#.#= . \r\n\r\n–ل#. يس#?خ#~م لم#~ة #?زي#~ #>ن 6 أشه#^ إل#. #%#>#~ إس#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–#<ي#?#.مين C يس#.#>#~ #>لى إم#?ص#.ص #.لح#~ي#~ و زي#.#~ة #<#.#>لي#?ه . \r\n\r\n–#.ل#?#~#.خل#.#? #.ل#~و#.ئية : \r\n\r\n–يج#% #.ل#<صل #%ين أ#~وية #.ل#=#.لسيوم و #.لح#~ي#~ و ل#. ي#?م #?ن#.ولهم#. م#>#. : حيث ي#>مل #.ل#=#.لسيوم #>لى #?قلل إم#?ص#.ص #.لح#~ي#~ و #%#.ل#?#.لى #?قل #<#.#>لية #>نص#^ #.لح#~ي#~ . \r\n\r\n–#.لأ#~وية #.لم#_#.#~ة للحمو#_ه و ح#^قة #.لم#>#~ة #.ل#?ى #?ح#?وى #>لى هي#~#^و#=سي#~ #.لم#.غنيسيوم أو هي#~#^و#=سي#~ #.لأليومنيوم أو #=#^#%ون#.#? #.ل#=#.لسيوم : #?قلل من إم#?ص#.ص أ#~وية #.لح#~ي#~ لذل#= يج#% #.ل#<صل #%ينهم #%م#~ة ل#. #?قل #>ن س#.#>#?ين .", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "clindamycin 2%", "Route": "ORAL.SOLID" }, { "ID": "607", "Trade_Name": "CLINDAM 300 MG 16 CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "38", "Price_Old": "25.2", "Company": "SIGMA > OCTOBER PHARMA", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "Clindamycin 150, 300mg", "Route": "ORAL.SOLID" }, { "ID": "608", "Trade_Name": "CLINDAM 150 MG 16 CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "28.5", "Price_Old": "19", "Company": "SIGMA > OCTOBER PHARMA", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "Clindamycin 150, 300mg", "Route": "ORAL.SOLID" }, { "ID": "609", "Trade_Name": "MEPACLIND 300MG 8CAPS.", "Generic_Name": "CLINDAMYCIN", "Price": "14.4", "Price_Old": "14.4", "Company": "MEPACO", "Pharmacology": "ANTIBIOTIC.LINCOMYCINS", "Category": "م#_#.#~ حيوي لين#=وميسين", "Use": "– يس#?خ#~م ل#>ل#.ج #.لجه#.ز #.ل#?ن#<سي مثل #.ل#?ه#.#% #^ئوي. \r\n\r\n– ي#>#.لج #.لخ#^#.ج #.ل#^ئة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.لجل#~ي و#.لأنسجة #.ل#^خوة. \r\n\r\n– ي#>#.لج #.ل#?ه#.#%#.#? #.ل#?ي #?صي#% #.لجه#.ز #.ل#?ن#.سلي #.لأنثوي. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #%#-#.نة #.ل#^حم. \r\n\r\n– ي#>#.لج خ#^#.#^يج #.لأسن#.ن. \r\n\r\n– ي#>#?#%#^ م#_#.#~ حيوي #%#~يل لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.ل#%نسيلين. \r\n\r\n– ي#>#.لج #.ل#%#=#?#^ي#. #.ل#?ي #?صي#% #.لجسم و#.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? إيج#.#%ية #.لج#^#.م #.لهو#.ئية و#.لل#.هو#.ئية #.لحس#.سة. \r\n\r\n– ي#>#.لج أم#^#.#_ #.للثة. \r\n\r\n– يس#?خ#~م #=#>ل#.ج #%#~يل ل#~#.ء #.لمقوس#.#?. \r\n\r\n– ي#>#.لج #.لمه#%ل #.ل#%#=#?ي#^ي. \r\n\r\n– ي#>#.لج #.ل#>#~وى #.ل#?ي #?س#%#%ه#. #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.لمق#.ومة للميثيسيلين. \r\n\r\n– ي#>#.لج #.لجم#^ة #.لخ#%يثة. \r\n\r\n– ي#>#.لج #.ل#?ه#% #.لم#<#.صل و#.ل#>ظ#.م #.لن#.#?جة #>ن #.لم#=و#^#.#? #.ل#>ق#~ية #.لذه#%ية و#.ل#?ي #?صي#% #.ل#%#.لغين و#.لأ#-#<#.ل #<وق #>م#^ خمس سنين. \r\n\r\n– ي#>#.لج #.ل#?ه#.#% #.ل#>#_لي قيحي.", "Contraindications": "– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة و#.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حيث يس#%#% #?شوه #.لأجنة. \r\n\r\n– يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> ويؤث#^ #>لى صح#?ه. \r\n\r\n– يحذ#^ #?ن#.ول #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% #.لسح#.ي#.. \r\n\r\n– #<ي ح#.لة #.لإص#.#%ة #%خلل #<ي #.ل#=#%#~ أو #.ل#=لي يجي#% إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^. \r\n\r\n– يج#% #.لحذ#^ #>ن#~ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.ل#?ه#.#% ح#.#~ #<ي #.لقولون ونزي#< #~موي أو إسه#.ل. \r\n\r\n– لمن #?#>#^#_و#. لز#^#.#>ة #.ل#=#%#~ أو #.ل#=لي إخ#%#.#^ #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^.", "GI": "mechanism\r\nClindamycin works by preventing bacteria from producing proteins that are essential to them. Without these proteins the bacteria cannot grow, replicate and increase in numbers. The remaining bacteria eventually die or are destroyed by the immune system. This treats the infection.\r\n\r\nindication:\r\nBacterial infections of the skin and soft tissue, such as infected ulcers, erysipelas, cellulitis.\r\nBacterial infections of joints and bone (eg osteomyelitis).\r\nBacterial infections of the abdominal cavity (peritonitis).\r\nDental abscesses.\r\nTreating falciparum malaria (unlicensed use).", "Composition": "clindamycin 150mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "610", "Trade_Name": "SLOW-ZEM 180MG 10 CAPS.", "Generic_Name": "DILTIAZEM", "Price": "12", "Price_Old": "12", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHYPERTENSIVE.NONSELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#>ل#.ج #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–لم#^#_ى #%#-ء #_#^#%#.#? #.لقل#% #.ل#?ي #?قل #>ن 50 #_#^#%ة #<ي #.ل#~قيقة . \r\n\r\n–#<ي ح#.لة #.نس#~#.#~ #.لقل#% من #.ل#~#^جة #.لث#.نية و#.لث#.لثة . \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #.ل#>ق#~ة #.لجي#%ية #.لم#^ي#_ة . \r\n\r\n–#<ي ح#.لة #<شل #.لقل#% #.لم#>#.و#_ . \r\n\r\n–لمن ي#>#.نون من #.خ#?ل#.ل #<ي #.ل#%#-ين #.لأيس#^ #%#>#~ #.ل#?#>#^#_ لذ#%حة قل#%ية . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> حقن #~#.ن#?#^ولين حيث #?س#%#% #.لإص#.#%ة #%#^ج#<#.ن #%#-يني .", "GI": "About DiltiazemSA Benzothiazepine derivative, Calcium channel blocker, Anti hypertensive, anti-anginal, class IV antiarrhythmic.SSMechanism of Action of DiltiazemSDiltiazem is a Benzothiazepine- Ca channel blocker. It exerts it`s antianginal, antihypertensive, antiarrythmic actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, and decrease BP in hypertensive individuals. SSIndications for DiltiazemS1. Hypertension S2. Prinzmetal`s angina S3. Stable angina", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "611", "Trade_Name": "PROSTACURE PLUS 20 CAPS.", "Generic_Name": "DOXAZOSIN+PYGEUM AFRICANUM EXTRACT", "Price": "40", "Price_Old": "40", "Company": "OCTOBER PHARMA", "Pharmacology": "PROSTATE DISORDER", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "–يقوم #.ل#~و#.ء #%#?خ#<ي#< و#>ل#.ج #.ح#?ق#.ن #.ل#%#^وس#?#.#?#. و#.ل#?ه#.#%#.#? #.ل#%#^وس#?#.#?#. #.لش#~ي#~ة. \r\n\r\n–يقوم #.ل#~و#.ء #%#.ل#?خلص من و#^م و#?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~ #<ق#-. \r\n\r\n–ي#>مل #.ل#~و#.ء #>لى #.ل#?خلص من #.لأ#>#^#.#_ #.لغي#^ م#^يحة ل#?#_خم #.ل#%#^وس#?#.#?#. مثل #.ل#?#%ول #%ص#>و#%ة و#>#~م #.ل#^#.حة أثن#.ء #.ل#?#%ول أو #=ث#^ة #.ل#?#%ول. \r\n\r\n–ق#~ ي#=ون هن#.#= #%#>#_ #.لح#.ل#.#? #.ل#?ي ل#. يم#=ن #.ل#?#~خل #.لج#^#.حي ل#>ل#.ج #.ل#%#^وس#?#.#?#. و#?#_خمه#. لذ#. يم#=نن#. أن نس#?خ#~م هذ#. #.ل#~و#.ء #%#~يل للحل #.لج#^#.حي.", "Contraindications": "–يج#% #>لى #.لم#^ي#_ أن ي#?ن#.ول #.ل#~و#.ء و#<ق#. لإ#^ش#.#~#.#? #.ل#-#%ي#% #.لم#>#.لج لأنه ي#>#^#< م#~ى #?#-و#^ #.لح#.لة وم#. #?ح#?#.جه من ج#^#>ة وم#~ة لل#>ل#.ج. \r\n\r\n–يج#% #.#=م#.ل #.لج#^#>ة #=#.ملة لأن #>ن#~ #.ل#?وق#< #>ن #?ن#.ول #.ل#~و#.ء ق#~ يس#%#% مش#=لة أ#=#%#^ #%#.لنس#%ة لل#%#^وس#?#.#?#. ول#. يم#=ن #.س#?خ#~#.مه م#^ة أخ#^ى. \r\n\r\n–يمن#> من#>#. #%#.#?#. #.س#?خ#~#.م #.ل#~و#.ء م#> م#^#_ى #.لذ#%حة #.لص#~#^ية لأنه له #?أثي#^ #_#.#^ #>ليهم #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص ح#?ى يسمح لهم #%#?ن#.ول #.ل#>ق#.#^ #%ج#^#>#.#? ومو#.#>ي#~ مح#~#~ة #?خ#?ل#< #>ن #.لأشخ#.ص #.لآخ#^ين.", "GI": "About Doxazosin\r\nAlpha-1 adrenergic Antagonist, Quinazoline derivative, Antihypertensive.\r\nMechanism of Action of Doxazosin\r\nThe drug exerts its antihypertensive action by acting as a selective alpha-1 antagonist. It dilates both arteries and veins, thus it reduces total peripheral resistance, reduce blood pressure, & reduce venous return and cardiac output. The alpha-1 blockade in non vascular smooth muscles cause relaxation of smooth muscles of prostate, internal sphincter of the bladder etc. thus decrease the resistance to urinary outflow in patients with benign prostatic hypertrophy. It decrease the tone of prostatic and bladder neck muscles and relaxes bladder trigone, prostate, and prostatic urethra- reduces dynamic obstruction, increases urinary flow rate, causing more complete emptying of bladder. It also induces apoptosis in prostate smooth muscle cells The drug decreases LDL cholesterol & increases HDL cholesterol.", "Composition": "b sitosterol 6mg, doxazosin, pygeum africanum 50mg", "Route": "ORAL.SOLID" }, { "ID": "612", "Trade_Name": "FARCOTILIUM 10MG 24 CAPS.", "Generic_Name": "DOMPERIDONE", "Price": "7.75", "Price_Old": "7.75", "Company": "PHARCO", "Pharmacology": "MOTILITY STIMULANT", "Category": "مش#.#=ل #.لجه#.ز #.له#_مي", "Use": "–#?خ#<ي#< أ#>#^#.#_ #.ل#?ه#.#% #.لم#>#~ة #.لمزمن وش#%ه #.لح#.#~. \r\n\r\n–#?خ#<ي#< أ#>#^#.#_ خَزَلُ #.لم#>ِ#~َة #.لم#^#.#<ق لم#^#_ #.لس#=#^ي. \r\n\r\n–ح#.ل#.#? #.لغثي#.ن و#.لقيء #.لمص#.ح#%ة ل#>ل#.ج#.#? م#^#_ #.ل#%#.#^#=ينسون #.لم#_#.#~ة لل#~و#%#.مين.", "Contraindications": "–وجو#~ #<#^#- حس#.سية لأي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#>ن#~ #?ن#.ول أ#~وية م#_#.#~ة لإ#<#^#.ز ه#^مون #.ل#%#^ول#.#=#?ين، حيث ي#>مل مو#?ينو#^م #>لى زي#.#~ة إ#<#^#.زه وزي#.#~ة #?#~#<ق حلي#% #.ل#^#_#.#>ة #<ي #.لنس#.ء؛ مم#. ي#?#>#.#^#_ م#> هذه #.لأ#~وية. ويس#%#% #.ل#?ث#~ي #>ن#~ #.ل#^ج#.ل. \r\n\r\n–ي#?#>#.#^#_ أي#_#. م#> #~و#.ء #=ي#?و#=ون#.زول (م#_#.#~ #.ل#<#-#^ي#.#?). \r\n\r\n–يحذ#^ #.س#?خ#~#.مه أي#_#. #>ن#~ وجو#~ و#^م #%#.لغ#~ة #.لنخ#.مية. \r\n\r\n–#>ن#~ وجو#~ نزي#< #%#.لم#>#~ة أو ثق#% أو #.نس#~#.#~ #%#.لأم#>#.ء.", "GI": "About Domperidone\r\nAntidopaminergic, Motility stimulant,Piperidine derivative, Antiemetic, anti-vertigo.\r\nMechanism of Action of Domperidone\r\nDomperidone is a potent dopamine receptor antagonist. It acts centrally and blocks the Dopamine receptor in the Chemoreceptor trigger zone and produces Antiemetic effect. \r\nDomperidone acts peripherally in the gastrointestinal system and increases oesophageal peristalsis, oesophageal sphincter pressure and gastric motility. These all facilitates gastric emptying. Domperidone is used in migraine to relieve nausea and vomiting. \r\nAnaesthetic adjuncts: It is used preoperatively in order to reduce the post operative vomiting. \r\n\r\nIndications for Domperidone\r\n1.Nausea and vomiting associated with gastrointestinal disorder and migraine. \r\n2.Delayed gastric emptying of functional origin \r\n3.As an Antiemetic in patient receiving cytotoxic drugs \r\n4.Preanaesthetic medication", "Composition": "Capsule:\r\nDomperidone 10 mg\r\n\r\nOral Supp.:\r\nDomperidone 5 mg/5 ml\r\n\r\nSupp.:\r\nDomperidone 60 mg", "Route": "ORAL.SOLID" }, { "ID": "613", "Trade_Name": "VOMISTOP 10 SOFT GELATIN CAPS.", "Generic_Name": "DIMETHICONE+METOCLOPRAMIDE+VITAMIN B6", "Price": "7", "Price_Old": "7", "Company": "AMOUN", "Pharmacology": "ANTIEMETIC", "Category": "م#_#.#~ للقيء", "Use": "–#>ل#.ج #>س#^ #.له#_م. \r\n\r\n–#>ل#.ج #.#^#?ج#.#> #.لم#^يء. \r\n\r\n–#.ل#?خلص من #.لغثي#.ن و#.لقيء. \r\n\r\n–#.ل#?خلص من #.لغثي#.ن و#.لقيء #.لمص#.ح#% ل#<#?#^ة #.لحمل. \r\n\r\n–#?نظيم ح#^#=ة #.لجه#.ز #.له#_مي. \r\n\r\n–#>ل#.ج #.لص#~#.#> #.لنص#<ي #.لن#.#?ج #%#>#~ إج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية أو #.ل#>ل#.ج #.ل#=يم#.وي و#.لإش#>#.#>ي للأو#^#.م. \r\n\r\n– يس#.#>#~ #<ي #>ل#.ج خمول ح#^#=ة #.لجه#.ز #.له#_مي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #~و#.ء #<وميس#?و#% لمن ي#>#.نون من حس#.سية للمو#.#~ #.ل#<#>#.لة #<ي #.ل#~و#.ء. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه للأ#-#<#.ل أقل من 18 #>#.م.", "GI": "About Dimethicone\r\nOral anti -foaming agent, a flexible silicone polymer, Antiflatulent ,Antibloating agent.\r\nMechanism of Action of Dimethicone\r\nActivated Dimethicone relieves flatulence by dispensing and preventing formation of mucus surrounding gas pockets in the gastro-intestinal tract. It lowers the surface tension of the gas bubbles and bringing together all the small bubbles of gas (coalesce) to form a large bubble, which is then expelled. Thus the gas is freed by belching or passing flatus. \r\nAntiflatulents are added to an antacid gum coating to be effective antigas materials and eliminate trapped gas. The most common antigas material is Dimethicone and when mixed with silicone dioxide becomes Simethicone. Simethicone is also referred to as activated Dimethicone. Simethicone is the most common antigas material and may be the only drug approved antiflatulent. \r\nAs the antacid chewing tablet is chewed, the active antacid and antiflatulent in the gum coating is released into the s", "Composition": "Each soft gelatin capsule contains:\r\nMetoclopramide hydrochloride 7.5 mg.\r\nVitamin B6 (Pyridoxine hydrochloride) 40 mg.\r\nDimethicone 50 mg.", "Route": "ORAL.SOLID" }, { "ID": "614", "Trade_Name": "FARCODOXIN 100MG 10 CAPS.", "Generic_Name": "DOXYCYCLINE", "Price": "11", "Price_Old": "11", "Company": "PHARCO", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–#.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=ل#.مي#~ي#.. \r\n\r\n–#%#~يلة للمي#<لو#=ين للوق#.ية من #.لمل#.#^ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#.لنيس#^ية #.ل#%نية. \r\n\r\n–#.لليس#?ي#^ي#. غي#^ #.لم#>ق#~ة. \r\n\r\n–#>ل#.ج #.لإل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#-ثية #<ي #.لم#^#_ى #.لذين ل#~يهم حس#.سية لل#%نسلين. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوية. \r\n\r\n–#.لجم#^ة #.لخ#%يثة #.لن#.#?جة من #>صي#.#? #.لجم#^ة #.لخ#%يثة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=#.ئن#.#? #.لحس#.سة غي#^ #.لش#.ئ#>ة س#.ل#%ة #.لغ#^#.م وموج#%ة #.لغ#^#.م. \r\n\r\n–م#^#_ ل#.يم. \r\n\r\n–#.لأمي#%#.#? #.لم#>وي. \r\n\r\n–ح#% #.لش#%#.#%. \r\n\r\n–#.ل#=ولي#^#.. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأسن#.ن مثل #.ل#?ه#.#% #~و#.#>م #.لسن. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#=و#^#.#? #.لم#>وية #.لمق#.ومة لل#<#.ن#=وميسن.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.ل#>م#^ #~ون 8 سنو#.#?، #.لإ #<ي ح#.لة #.لإص#.#%ة #%#.لجم#^ة #.لخ#%يثة.", "GI": "About Doxycycline\r\nTetracycline Derivative, Antibiotic.\r\n\r\nMechanism of Action of Doxycycline\r\nDoxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein and by passive diffusion & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals).Doxycycline interfering the attachment of aminoacyl-tRNA to the mRNA-ribosome complex and peptide chain fails to grow. It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. \r\n\r\nIndications for Doxycycline\r\n1. Syphilis \r\n2. Lympho granuloma veneram \r\n3. Typhus fever \r\n4. Respiratory tract infections \r\n5. Prophylaxis of malaria \r\n6. Urinogenital tract infections \r\n7. Trachoma \r\n8. Pelvic inflammatory disease\r\n9. Acne \r\n10. Diarrhoea \r\n11. Gonorrhea in penicillin allergic individuals \r\n12. Pneumonia", "Composition": "DOXYCYCLINE (AS HYDROCHLORIDE) 100 MG", "Route": "ORAL.SOLID" }, { "ID": "615", "Trade_Name": "DOXY M.R.100 MG 10 CAPS.", "Generic_Name": "DOXYCYCLINE", "Price": "9", "Price_Old": "9", "Company": "ADWIA", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–#.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=ل#.مي#~ي#.. \r\n\r\n–#%#~يلة للمي#<لو#=ين للوق#.ية من #.لمل#.#^ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#.لنيس#^ية #.ل#%نية. \r\n\r\n–#.لليس#?ي#^ي#. غي#^ #.لم#>ق#~ة. \r\n\r\n–#>ل#.ج #.لإل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#-ثية #<ي #.لم#^#_ى #.لذين ل#~يهم حس#.سية لل#%نسلين. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوية. \r\n\r\n–#.لجم#^ة #.لخ#%يثة #.لن#.#?جة من #>صي#.#? #.لجم#^ة #.لخ#%يثة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=#.ئن#.#? #.لحس#.سة غي#^ #.لش#.ئ#>ة س#.ل#%ة #.لغ#^#.م وموج#%ة #.لغ#^#.م. \r\n\r\n–م#^#_ ل#.يم. \r\n\r\n–#.لأمي#%#.#? #.لم#>وي. \r\n\r\n–ح#% #.لش#%#.#%. \r\n\r\n–#.ل#=ولي#^#.. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأسن#.ن مثل #.ل#?ه#.#% #~و#.#>م #.لسن. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#=و#^#.#? #.لم#>وية #.لمق#.ومة لل#<#.ن#=وميسن.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.ل#>م#^ #~ون 8 سنو#.#?، #.لإ #<ي ح#.لة #.لإص#.#%ة #%#.لجم#^ة #.لخ#%يثة.", "GI": "About Doxycycline\r\nTetracycline Derivative, Antibiotic.\r\n\r\nMechanism of Action of Doxycycline\r\nDoxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein and by passive diffusion & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals).Doxycycline interfering the attachment of aminoacyl-tRNA to the mRNA-ribosome complex and peptide chain fails to grow. It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. \r\n\r\nIndications for Doxycycline\r\n1. Syphilis \r\n2. Lympho granuloma veneram \r\n3. Typhus fever \r\n4. Respiratory tract infections \r\n5. Prophylaxis of malaria \r\n6. Urinogenital tract infections \r\n7. Trachoma \r\n8. Pelvic inflammatory disease\r\n9. Acne \r\n10. Diarrhoea \r\n11. Gonorrhea in penicillin allergic individuals \r\n12. Pneumonia", "Composition": "doxycycline 100mg", "Route": "ORAL.SOLID" }, { "ID": "616", "Trade_Name": "BONEFOS 400MG 60CAPS.", "Generic_Name": "DISODIUM CLODRONATE", "Price": "350", "Price_Old": "350", "Company": "BAYER SCHERING > BAYER HEALTHCARE", "Pharmacology": "OSTEOPOROSIS.BISPHOSPHONATES", "Category": "هش#.شة #.ل#>ظ#.م م#> م#_#.#~ #?آ#=ل #.ل#>ظ#.م", "Use": "–يس#?خ#~م #<ي #>ل#.ج #<#^#- #.ل#=#.لسيوم #<ي #.ل#~م. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #?#^قق #.ل#>ظ#.م. \r\n\r\n–ي#>#.لج هش#.شة #.ل#>ظ#.م. \r\n\r\n–ي#>#.لج م#^#_ #%#.جي#?.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه ثن#.ئية #.لصو#~يوم أو أي من م#=ون#.#? #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ #%ش#=ل م#?ز#.من م#> #%يس#<وس#<ون#.#? أخ#^ي. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #<ي ح#.لة #.لخ#_و#> ل#>ملي#.#? ج#^#.حية. \r\n\r\n–لمن ي#>#.نون من #.#_#-#^#.#%#.#? #=لوية أو م#>وية يج#% #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^.", "GI": "Mechanism of action/Effect:\r\n\r\nClodronate belongs to the class of bisphosphonates which bind to hydroxyapatite and then inhibit the formation and dissolution of calcium crystals in vitro.\r\n\r\nBone resorption inhibitor?Clodronate causes a reduction of normal and abnormal bone resorption in the human bony skeleton. By altering osteoclastic and osteoblastic activity, clodronate changes the balance of bone resorption and bone formation and results in a reduction of bone turnover.\r\n\r\nAntihypercalcemic agent?With the reduction in bone turnover, hypercalcemia of malignancy (with or without skeletal masses) is diminished.", "Composition": "clodronate disodium 300mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "617", "Trade_Name": "DOXYMYCIN 100 MG 10 CAPS.", "Generic_Name": "DOXYCYCLINE", "Price": "12", "Price_Old": "6", "Company": "EL NILE.", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–#.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=ل#.مي#~ي#.. \r\n\r\n–#%#~يلة للمي#<لو#=ين للوق#.ية من #.لمل#.#^ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#.لنيس#^ية #.ل#%نية. \r\n\r\n–#.لليس#?ي#^ي#. غي#^ #.لم#>ق#~ة. \r\n\r\n–#>ل#.ج #.لإل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#-ثية #<ي #.لم#^#_ى #.لذين ل#~يهم حس#.سية لل#%نسلين. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوية. \r\n\r\n–#.لجم#^ة #.لخ#%يثة #.لن#.#?جة من #>صي#.#? #.لجم#^ة #.لخ#%يثة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=#.ئن#.#? #.لحس#.سة غي#^ #.لش#.ئ#>ة س#.ل#%ة #.لغ#^#.م وموج#%ة #.لغ#^#.م. \r\n\r\n–م#^#_ ل#.يم. \r\n\r\n–#.لأمي#%#.#? #.لم#>وي. \r\n\r\n–ح#% #.لش#%#.#%. \r\n\r\n–#.ل#=ولي#^#.. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأسن#.ن مثل #.ل#?ه#.#% #~و#.#>م #.لسن. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#=و#^#.#? #.لم#>وية #.لمق#.ومة لل#<#.ن#=وميسن.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.ل#>م#^ #~ون 8 سنو#.#?، #.لإ #<ي ح#.لة #.لإص#.#%ة #%#.لجم#^ة #.لخ#%يثة.", "GI": "About Doxycycline\r\nTetracycline Derivative, Antibiotic.\r\n\r\nMechanism of Action of Doxycycline\r\nDoxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein and by passive diffusion & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals).Doxycycline interfering the attachment of aminoacyl-tRNA to the mRNA-ribosome complex and peptide chain fails to grow. It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. \r\n\r\nIndications for Doxycycline\r\n1. Syphilis \r\n2. Lympho granuloma veneram \r\n3. Typhus fever \r\n4. Respiratory tract infections \r\n5. Prophylaxis of malaria \r\n6. Urinogenital tract infections \r\n7. Trachoma \r\n8. Pelvic inflammatory disease\r\n9. Acne \r\n10. Diarrhoea \r\n11. Gonorrhea in penicillin allergic individuals \r\n12. Pneumonia", "Composition": "doxycycline 100mg", "Route": "ORAL.SOLID" }, { "ID": "618", "Trade_Name": "SULTAN 50MG 20 CAPS.", "Generic_Name": "DIPHENHYDRAMINE", "Price": "5", "Price_Old": "5", "Company": "PHAROPHARMA", "Pharmacology": "H1 ANTAGONIST", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "–#.ل#?ه#.#% #.لأن#< #.لأس#?ه#~#.#<ي مثل #.ل#.ل#?ه#.#%#.#? #.ل#~#.ئمة و#.لموسمية وأم#^#.#_ #.لحس#.سية #.لأن#<ية. \r\n\r\n–حس#.سية #.لجل#~ و#?شمل #.لح#=ة، #.لأ#^#?#=#.#^ي#.، حس#.سية #.لأ#~وية، #.لأ#^#?ي#=#.#^ي#. #.لمزمنة، #=#?و#%ية #.لجل#~ وح#=ة #.ل#.#=زيم#.. \r\n\r\n–أ#>#^#.#_ #.لحس#.سية #.لن#.جمة #>ن #>#_ ول#~غ #.لحش#^#.#?. \r\n\r\n–#.#_#-#^#.#%#.#? #.لنوم و#.لأ#^ق.", "Contraindications": "–ل#. يس#?خ#~م #<ي ح#.لة #.لم#^#_ى #.لذين ي#>#.نون من مش#.#=ل #<ي #.ل#?ن#<س، جلو#=وم#. و#?#_خم #.ل#%#^وس#?#.#?#. إل#. #%#.س#?ش#.#^ة #.ل#-#%ي#%. #.لحمل، #.ل#^#_#.#>ة و#.لأ#-#<#.ل أقل من 12 سنة. \r\n\r\n–#.ل#?#<#.#>ل#.#? #.ل#~و#.ئية: #=#%سول#.#? Sultan #?زي#~ من #?أثي#^ #.ل#=حول و#.لمه#~ئ#.#? #>لى #.لجه#.ز #.ل#>ص#%ي #.لم#^#=زي. \r\n\r\n–#.ل#.ح#?ي#.#-#.#?: إذ#. #.س#?م#^ #.لأ#^ق أ#=ث#^ من أس#%و#>ين يج#% #.س#?ش#.#^ة #.ل#-#%ي#%. #?جن#% #?ن#.ول أي مس#?ح#_#^ آخ#^ يح#?وي #>لى #~#.ي#<ينهي#~#^#.مين #<ي ن#<س #.لوق#?.", "GI": "About Diphenhydramine\r\nFirst Generation H1 Antagonist ,Ethanolamine derivative, Antihistamine, antiemetic, antivertigo,sedative, and hypnotic.\r\nMechanism of Action of Diphenhydramine\r\nAntiallergic action: It produces its antihistamine action by competitively blocking H1 receptors. It binds to the H1 receptors present in the smooth muscles of the gastrointestinal tract, bronchi, large blood vessels and uterus and inhibit Histamine induced allergic symptoms. They do not inhibit the release of Histamine. \r\nAntivertigo and antiemetic actions: Central antimuscarinic actions of antihistamines are responsible for these effects of Diphenhydramine. \r\nParkinsonism: Acetyl choline receptor antagonists are used for the treatment of Parkinsonism. Diphenhydramine reduces the unbalanced cholinergic activity in striatum of parkinsonian patients. \r\nAntitussive action: Diphenhydramine suppresses the cough reflex by a direct effect on the cough centre. \r\nMigraine: Diphenhydramine is used in migraine due", "Composition": "diphenhydramin 50mg", "Route": "ORAL.SOLID" }, { "ID": "619", "Trade_Name": "TABOCINE 100MG 10 CAPS.", "Generic_Name": "DOXYCYCLINE", "Price": "18", "Price_Old": "12", "Company": "TABUK PHARMACEUTICAL MANUFACTURING COMPANY", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–#.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=ل#.مي#~ي#.. \r\n\r\n–#%#~يلة للمي#<لو#=ين للوق#.ية من #.لمل#.#^ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#.لنيس#^ية #.ل#%نية. \r\n\r\n–#.لليس#?ي#^ي#. غي#^ #.لم#>ق#~ة. \r\n\r\n–#>ل#.ج #.لإل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#-ثية #<ي #.لم#^#_ى #.لذين ل#~يهم حس#.سية لل#%نسلين. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوية. \r\n\r\n–#.لجم#^ة #.لخ#%يثة #.لن#.#?جة من #>صي#.#? #.لجم#^ة #.لخ#%يثة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=#.ئن#.#? #.لحس#.سة غي#^ #.لش#.ئ#>ة س#.ل#%ة #.لغ#^#.م وموج#%ة #.لغ#^#.م. \r\n\r\n–م#^#_ ل#.يم. \r\n\r\n–#.لأمي#%#.#? #.لم#>وي. \r\n\r\n–ح#% #.لش#%#.#%. \r\n\r\n–#.ل#=ولي#^#.. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأسن#.ن مثل #.ل#?ه#.#% #~و#.#>م #.لسن. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#=و#^#.#? #.لم#>وية #.لمق#.ومة لل#<#.ن#=وميسن.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.ل#>م#^ #~ون 8 سنو#.#?، #.لإ #<ي ح#.لة #.لإص#.#%ة #%#.لجم#^ة #.لخ#%يثة.", "GI": "About Doxycycline\r\nTetracycline Derivative, Antibiotic.\r\n\r\nMechanism of Action of Doxycycline\r\nDoxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein and by passive diffusion & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals).Doxycycline interfering the attachment of aminoacyl-tRNA to the mRNA-ribosome complex and peptide chain fails to grow. It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. \r\n\r\nIndications for Doxycycline\r\n1. Syphilis \r\n2. Lympho granuloma veneram \r\n3. Typhus fever \r\n4. Respiratory tract infections \r\n5. Prophylaxis of malaria \r\n6. Urinogenital tract infections \r\n7. Trachoma \r\n8. Pelvic inflammatory disease\r\n9. Acne \r\n10. Diarrhoea \r\n11. Gonorrhea in penicillin allergic individuals \r\n12. Pneumonia", "Composition": "DOXYCYCLINE (AS HYCLATE) 100 MG", "Route": "ORAL.SOLID" }, { "ID": "620", "Trade_Name": "OLFEN 100MG S.R. 10 DEPOCAPS.", "Generic_Name": "DICLOFENAC SODIUM", "Price": "23.5", "Price_Old": "15.6", "Company": "MUP > ACINO", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=م#_#.#~ لل#.ل#?ه#.#%#.#?، وخ#.#<#_ للح#^#.#^ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لم#<صلية #.ل#^وم#.#?وي#~ية، وأي#_#. #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–مس#=ن للآل#.م #.لمص#.ح#%ة للحي#_ #>ن#~ #.لنس#.ء. \r\n\r\n–#?س#=ين #.لآل#.م ووج#> #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#<ق#.#^ #.لمقس#-، ومس#=ن لألم أس#<ل #.لظه#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن و#.لأن#<، و#.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–مس#=ن لآل#.م #.لجسم و#.لمغص #.لم#^#.#^ي و#.ل#=لوي. \r\n\r\n–مس#=ن للص#~#.#> و#.لص#~#.#> #.لنص#<ي. \r\n\r\n–#>ل#.ج #.لألم #.لمص#.ح#% لهش#.شة #.ل#>ظ#.م. \r\n\r\n–مس#=ن للآل#.م #.لن#.#?جة #>ن #.لإص#.#%ة و#.ل#.ل#?و#.ء#.#?، وأي#_#. #.لن#.#?جة #>ن إص#.#%#.#? #.لمل#.#>#% #.ل#^ي#.#_ية. \r\n\r\n–مس#=ن للآل#.م #.لن#.#?جة #>ن #.ل#?ه#.#% #.لأنسجة #.ل#>#_لية و#.لأنسجة #.ل#^خوة.", "Contraindications": "–#<#^#- #.لحس#.سية لم#.#~ة #~ي#=لو#<ين#.#= صو#~يوم أو للأس#%#^ين أو للأ#~وية غي#^ #.لإس#?ي#^وي#~ية #.لأخ#^ى. \r\n\r\n–#<ي ح#.لة وجو#~ ق#^حة #.لم#>#~ة #.لنش#-ة أو نزي#< #%#.لأم#>#.ء. \r\n\r\n–#.س#?#>م#.ل #.ل#~و#.ء #%حذ#^ م#> م#^#_ى #.ل#^#%و،حيث #?#?س#%#% م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لإس#?#^و#~ية #<ي أزم#.#? #^#%وية. \r\n\r\n–أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية مثل م#^#_ #=#^ون و#.ل#?ه#.#% #.لقولون #.ل#?ق#^حي. \r\n\r\n–#<ي ح#.ل#.#? أم#^#.#_ #.لقل#% و#.#^#?#<#.#> #_غ#- #.ل#~م، وم#^#_ى سيولة #.ل#~م، وقصو#^ #.لقل#% #.ل#>ني#<، وأم#^#.#_ ش#^#.يين #.لقل#% #.ل#?#.جية أو #.لألم #.لن#.#?ج #>ن #.لج#^#.ح#.#? ل#>ل#.جه#. هذه لمش#.#=ل؛ لأنه يزي#~ من ح#~وث #?جل#- #.ل#~م #%#.لش#^#.يين #.لقل#%ية و#.لو#>#.ئية. \r\n\r\n–#.لقصو#^ #.ل#=#%#~ي، و#.ل#=لوي #.ل#>ني#<. \r\n\r\n–يس#?خ#~م #%حذ#^ #<ي م#^#_ى #.ل#%#^و#<ي#^ي#. #.ل#=#%#~ية hepatic porphyria حيث ي#?س#%#% #<ي سوء #.لح#.لة. \r\n\r\n–يس#?#>مل #%حذ#^ #<ي ح#.ل#.#? #.لنزي#< #.لنش#- أو #.ل#>ني#<. \r\n\r\n–يج#% #?جن#% أ#~وية م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لإس#?#^و#~ية #%ش#=ل #>#.م #<ي م#^#_ى حمى #.ل#_ن#= #.لنز#<ية. \r\n\r\n–#<ي #.لنس#.ء #.لحو#.مل و#.لم#^#_#>#.#?.", "GI": "Description\t\r\nA non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. \r\n\r\nIndication\t:\r\nFor the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.\r\n\r\nMechanism of action\tThe antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.", "Composition": "1g gel contains Diclofenac sodium 10mg\r\nThe base is an aqueous-alcoholic gel without any fatty substances.", "Route": "ORAL.SOLID" }, { "ID": "621", "Trade_Name": "DELAY-TIAZEM SR 90 MG 10 CAPS.", "Generic_Name": "DILTIAZEM", "Price": "9.5", "Price_Old": "9.5", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTIHYPERTENSIVE.NONSELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#>ل#.ج #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–لم#^#_ى #%#-ء #_#^#%#.#? #.لقل#% #.ل#?ي #?قل #>ن 50 #_#^#%ة #<ي #.ل#~قيقة . \r\n\r\n–#<ي ح#.لة #.نس#~#.#~ #.لقل#% من #.ل#~#^جة #.لث#.نية و#.لث#.لثة . \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #.ل#>ق#~ة #.لجي#%ية #.لم#^ي#_ة . \r\n\r\n–#<ي ح#.لة #<شل #.لقل#% #.لم#>#.و#_ . \r\n\r\n–لمن ي#>#.نون من #.خ#?ل#.ل #<ي #.ل#%#-ين #.لأيس#^ #%#>#~ #.ل#?#>#^#_ لذ#%حة قل#%ية . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> حقن #~#.ن#?#^ولين حيث #?س#%#% #.لإص#.#%ة #%#^ج#<#.ن #%#-يني .", "GI": "About DiltiazemSA Benzothiazepine derivative, Calcium channel blocker, Anti hypertensive, anti-anginal, class IV antiarrhythmic.SSMechanism of Action of DiltiazemSDiltiazem is a Benzothiazepine- Ca channel blocker. It exerts it`s antianginal, antihypertensive, antiarrythmic actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, and decrease BP in hypertensive individuals. SSIndications for DiltiazemS1. Hypertension S2. Prinzmetal`s angina S3. Stable angina", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "622", "Trade_Name": "PAIN RELIEFER 30 CAPS.", "Generic_Name": "DICLOFENAC SODIUM+VITAMIN B1+VITAMIN B6+VITAMIN B12", "Price": "36", "Price_Old": "24", "Company": "DEBEIKY", "Pharmacology": "NSAID COMBINED WITH VITAMIN B", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> #<ي#?#.مين #%", "Use": "–#.ل#?ه#.#% #.ل#.#>ص#.#% \r\n\r\n–#.ل#.م #.ل#.#>ص#.#% \r\n\r\n–#>#^ق #.لنس#. \r\n\r\n–#.لص#~#.#> \r\n\r\n–#.ل#.م #.ل#^وم#.#?يزم #.لمخ#?ل#<ه \r\n\r\n–#.ل#?ه#.#% م#<#.صل #.ل#<ق#^#.#? #.لح#.#~ #.لمزمن \r\n\r\n–#.ل#?ه#.#% #.ل#<ق#^#.#? \r\n\r\n–نو#%#.#? #.لنق#^س #.لح#.#~ه \r\n\r\n–#.ل#^وم#.#?يزم #.لغي#^ م#<صلي", "Contraindications": "–ق#^حه #.لم#>#~ه #.و #.ل#.ثنى #>ش#^ \r\n\r\n–حس#.سيه للمس#?ح#_#^ #.و ل#.ى من م#=ون#.#?ه #.و لحم#_ #.لسلسلي#= \r\n\r\n–#<#?#^ه #.لحمل", "GI": "Mechanism of Action of Diclofenac Sodium\r\nDiclofenac possess analgesic, anti-inflammatory and antipyretic action. It inhibits the enzyme cyclo-oxygenase and there by inhibits the synthesis of Prostaglandins (PGs). It is more potent against cyclo-oxygenase-2 enzyme as compared to other NSAIDs like Indomethacin, Naproxen etc. It reduces intracellular concentrations of free arachidonic acid in leukocyte by altering its release or uptake. .\r\nPharmacokinets of Diclofenac Sodium\r\nAbsorption: Diclofenac sodium is rapidly absorbed after oral administration. It undergoes first pass metabolism and its bioavailability is 50 % only. Distribution: It is distributed in highly protein bound form. Metabolism: Diclofenac sodium is metabolised in the liver. Excretion: Drug and metabolites are primarily excreted in urine and some amount in the bile.", "Composition": "One capsule of Painreliefer contains:\r\nDiclofenac sodium 50 mg\r\n(Vitamin B 1) 50 mg\r\n(Vitamin B6) 50 mg\r\n(Vitamin B 12) 0.25 mg", "Route": "ORAL.SOLID" }, { "ID": "623", "Trade_Name": "DICLONERVE 30 CAPS.", "Generic_Name": "DICLOFENAC SODIUM+VITAMIN B1+VITAMIN B2+VITAMIN B12", "Price": "21", "Price_Old": "21", "Company": "ADWIA", "Pharmacology": "NSAID COMBINED WITH VITAMIN B", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> #<ي#?#.مين #%", "Use": "–#.ل#?ه#.#% #.ل#.#>ص#.#% \r\n\r\n–#.ل#.م #.ل#.#>ص#.#% \r\n\r\n–#>#^ق #.لنس#. \r\n\r\n–#.لص#~#.#> \r\n\r\n–#.ل#.م #.ل#^وم#.#?يزم #.لمخ#?ل#<ه \r\n\r\n–#.ل#?ه#.#% م#<#.صل #.ل#<ق#^#.#? #.لح#.#~ #.لمزمن \r\n\r\n–#.ل#?ه#.#% #.ل#<ق#^#.#? \r\n\r\n–نو#%#.#? #.لنق#^س #.لح#.#~ه \r\n\r\n–#.ل#^وم#.#?يزم #.لغي#^ م#<صلي", "Contraindications": "–ق#^حه #.لم#>#~ه #.و #.ل#.ثنى #>ش#^ \r\n\r\n–حس#.سيه للمس#?ح#_#^ #.و ل#.ى من م#=ون#.#?ه #.و لحم#_ #.لسلسلي#= \r\n\r\n–#<#?#^ه #.لحمل", "GI": "Mechanism of Action of Diclofenac Sodium\r\nDiclofenac possess analgesic, anti-inflammatory and antipyretic action. It inhibits the enzyme cyclo-oxygenase and there by inhibits the synthesis of Prostaglandins (PGs). It is more potent against cyclo-oxygenase-2 enzyme as compared to other NSAIDs like Indomethacin, Naproxen etc. It reduces intracellular concentrations of free arachidonic acid in leukocyte by altering its release or uptake. .\r\nPharmacokinets of Diclofenac Sodium\r\nAbsorption: Diclofenac sodium is rapidly absorbed after oral administration. It undergoes first pass metabolism and its bioavailability is 50 % only. Distribution: It is distributed in highly protein bound form. Metabolism: Diclofenac sodium is metabolised in the liver. Excretion: Drug and metabolites are primarily excreted in urine and some amount in the bile.", "Composition": "Each capsule contains:\r\nDiclofenac Sodium 50 mg.\r\nThiamine HCL(B1) 50 mg.\r\nPyridoxineHCL(B6) 50 mg.\r\nCyanocobalamine(B12) 0.25 mg.", "Route": "ORAL.SOLID" }, { "ID": "624", "Trade_Name": "SLOW-ZEM 120MG 10 CAPS.", "Generic_Name": "DILTIAZEM", "Price": "8.25", "Price_Old": "8.25", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHYPERTENSIVE.NONSELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#>ل#.ج #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–لم#^#_ى #%#-ء #_#^#%#.#? #.لقل#% #.ل#?ي #?قل #>ن 50 #_#^#%ة #<ي #.ل#~قيقة . \r\n\r\n–#<ي ح#.لة #.نس#~#.#~ #.لقل#% من #.ل#~#^جة #.لث#.نية و#.لث#.لثة . \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #.ل#>ق#~ة #.لجي#%ية #.لم#^ي#_ة . \r\n\r\n–#<ي ح#.لة #<شل #.لقل#% #.لم#>#.و#_ . \r\n\r\n–لمن ي#>#.نون من #.خ#?ل#.ل #<ي #.ل#%#-ين #.لأيس#^ #%#>#~ #.ل#?#>#^#_ لذ#%حة قل#%ية . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> حقن #~#.ن#?#^ولين حيث #?س#%#% #.لإص#.#%ة #%#^ج#<#.ن #%#-يني .", "GI": "About DiltiazemSA Benzothiazepine derivative, Calcium channel blocker, Anti hypertensive, anti-anginal, class IV antiarrhythmic.SSMechanism of Action of DiltiazemSDiltiazem is a Benzothiazepine- Ca channel blocker. It exerts it`s antianginal, antihypertensive, antiarrythmic actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, and decrease BP in hypertensive individuals. SSIndications for DiltiazemS1. Hypertension S2. Prinzmetal`s angina S3. Stable angina", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "625", "Trade_Name": "SLOW-ZEM 90MG 10 CAPS.", "Generic_Name": "DILTIAZEM", "Price": "7.5", "Price_Old": "7.5", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHYPERTENSIVE.NONSELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#>ل#.ج #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–لم#^#_ى #%#-ء #_#^#%#.#? #.لقل#% #.ل#?ي #?قل #>ن 50 #_#^#%ة #<ي #.ل#~قيقة . \r\n\r\n–#<ي ح#.لة #.نس#~#.#~ #.لقل#% من #.ل#~#^جة #.لث#.نية و#.لث#.لثة . \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #.ل#>ق#~ة #.لجي#%ية #.لم#^ي#_ة . \r\n\r\n–#<ي ح#.لة #<شل #.لقل#% #.لم#>#.و#_ . \r\n\r\n–لمن ي#>#.نون من #.خ#?ل#.ل #<ي #.ل#%#-ين #.لأيس#^ #%#>#~ #.ل#?#>#^#_ لذ#%حة قل#%ية . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> حقن #~#.ن#?#^ولين حيث #?س#%#% #.لإص#.#%ة #%#^ج#<#.ن #%#-يني .", "GI": "About DiltiazemSA Benzothiazepine derivative, Calcium channel blocker, Anti hypertensive, anti-anginal, class IV antiarrhythmic.SSMechanism of Action of DiltiazemSDiltiazem is a Benzothiazepine- Ca channel blocker. It exerts it`s antianginal, antihypertensive, antiarrythmic actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, and decrease BP in hypertensive individuals. SSIndications for DiltiazemS1. Hypertension S2. Prinzmetal`s angina S3. Stable angina", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "626", "Trade_Name": "NEUROFENAC 30 CAPS.", "Generic_Name": "DICLOFENAC SODIUM+VITAMIN B1+VITAMIN B6+VITAMIN B12", "Price": "25.5", "Price_Old": "25.5", "Company": "AMOUN > MERCK KGAA F.R.GERMANY", "Pharmacology": "NSAID COMBINED WITH VITAMIN B", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> #<ي#?#.مين #%", "Use": "–#.ل#?ه#.#% #.ل#.#>ص#.#% \r\n\r\n–#.ل#.م #.ل#.#>ص#.#% \r\n\r\n–#>#^ق #.لنس#. \r\n\r\n–#.لص#~#.#> \r\n\r\n–#.ل#.م #.ل#^وم#.#?يزم #.لمخ#?ل#<ه \r\n\r\n–#.ل#?ه#.#% م#<#.صل #.ل#<ق#^#.#? #.لح#.#~ #.لمزمن \r\n\r\n–#.ل#?ه#.#% #.ل#<ق#^#.#? \r\n\r\n–نو#%#.#? #.لنق#^س #.لح#.#~ه \r\n\r\n–#.ل#^وم#.#?يزم #.لغي#^ م#<صلي", "Contraindications": "–ق#^حه #.لم#>#~ه #.و #.ل#.ثنى #>ش#^ \r\n\r\n–حس#.سيه للمس#?ح#_#^ #.و ل#.ى من م#=ون#.#?ه #.و لحم#_ #.لسلسلي#= \r\n\r\n–#<#?#^ه #.لحمل", "GI": "Mechanism of Action of Diclofenac Sodium\r\nDiclofenac possess analgesic, anti-inflammatory and antipyretic action. It inhibits the enzyme cyclo-oxygenase and there by inhibits the synthesis of Prostaglandins (PGs). It is more potent against cyclo-oxygenase-2 enzyme as compared to other NSAIDs like Indomethacin, Naproxen etc. It reduces intracellular concentrations of free arachidonic acid in leukocyte by altering its release or uptake. .\r\nPharmacokinets of Diclofenac Sodium\r\nAbsorption: Diclofenac sodium is rapidly absorbed after oral administration. It undergoes first pass metabolism and its bioavailability is 50 % only. Distribution: It is distributed in highly protein bound form. Metabolism: Diclofenac sodium is metabolised in the liver. Excretion: Drug and metabolites are primarily excreted in urine and some amount in the bile.", "Composition": "diclofenac sod. 50mg+Vit B1 50mg+B12 250mcg+B6 50mg", "Route": "ORAL.SOLID" }, { "ID": "627", "Trade_Name": "DELAY-TIAZEM SR 120 MG 10 CAPS.", "Generic_Name": "DILTIAZEM", "Price": "11.8", "Price_Old": "11.8", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTIHYPERTENSIVE.NONSELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#>ل#.ج #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–لم#^#_ى #%#-ء #_#^#%#.#? #.لقل#% #.ل#?ي #?قل #>ن 50 #_#^#%ة #<ي #.ل#~قيقة . \r\n\r\n–#<ي ح#.لة #.نس#~#.#~ #.لقل#% من #.ل#~#^جة #.لث#.نية و#.لث#.لثة . \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #.ل#>ق#~ة #.لجي#%ية #.لم#^ي#_ة . \r\n\r\n–#<ي ح#.لة #<شل #.لقل#% #.لم#>#.و#_ . \r\n\r\n–لمن ي#>#.نون من #.خ#?ل#.ل #<ي #.ل#%#-ين #.لأيس#^ #%#>#~ #.ل#?#>#^#_ لذ#%حة قل#%ية . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> حقن #~#.ن#?#^ولين حيث #?س#%#% #.لإص#.#%ة #%#^ج#<#.ن #%#-يني .", "GI": "About DiltiazemSA Benzothiazepine derivative, Calcium channel blocker, Anti hypertensive, anti-anginal, class IV antiarrhythmic.SSMechanism of Action of DiltiazemSDiltiazem is a Benzothiazepine- Ca channel blocker. It exerts it`s antianginal, antihypertensive, antiarrythmic actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, and decrease BP in hypertensive individuals. SSIndications for DiltiazemS1. Hypertension S2. Prinzmetal`s angina S3. Stable angina", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "628", "Trade_Name": "ARTHINEUR 10 CAPS.", "Generic_Name": "DICLOFENAC SODIUM+VITAMIN B1+VITAMIN B6+VITAMIN B12", "Price": "8", "Price_Old": "8", "Company": "EGYPHAR", "Pharmacology": "NSAID COMBINED WITH VITAMIN B", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> #<ي#?#.مين #%", "Use": "–#.ل#?ه#.#% #.ل#.#>ص#.#% \r\n\r\n–#.ل#.م #.ل#.#>ص#.#% \r\n\r\n–#>#^ق #.لنس#. \r\n\r\n–#.لص#~#.#> \r\n\r\n–#.ل#.م #.ل#^وم#.#?يزم #.لمخ#?ل#<ه \r\n\r\n–#.ل#?ه#.#% م#<#.صل #.ل#<ق#^#.#? #.لح#.#~ #.لمزمن \r\n\r\n–#.ل#?ه#.#% #.ل#<ق#^#.#? \r\n\r\n–نو#%#.#? #.لنق#^س #.لح#.#~ه \r\n\r\n–#.ل#^وم#.#?يزم #.لغي#^ م#<صلي", "Contraindications": "–ق#^حه #.لم#>#~ه #.و #.ل#.ثنى #>ش#^ \r\n\r\n–حس#.سيه للمس#?ح#_#^ #.و ل#.ى من م#=ون#.#?ه #.و لحم#_ #.لسلسلي#= \r\n\r\n–#<#?#^ه #.لحمل", "GI": "Mechanism of Action of Diclofenac Sodium\r\nDiclofenac possess analgesic, anti-inflammatory and antipyretic action. It inhibits the enzyme cyclo-oxygenase and there by inhibits the synthesis of Prostaglandins (PGs). It is more potent against cyclo-oxygenase-2 enzyme as compared to other NSAIDs like Indomethacin, Naproxen etc. It reduces intracellular concentrations of free arachidonic acid in leukocyte by altering its release or uptake. .\r\nPharmacokinets of Diclofenac Sodium\r\nAbsorption: Diclofenac sodium is rapidly absorbed after oral administration. It undergoes first pass metabolism and its bioavailability is 50 % only. Distribution: It is distributed in highly protein bound form. Metabolism: Diclofenac sodium is metabolised in the liver. Excretion: Drug and metabolites are primarily excreted in urine and some amount in the bile.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "629", "Trade_Name": "DELAY-TIAZEM SR 180 MG 10 CAPS.", "Generic_Name": "DILTIAZEM", "Price": "15.95", "Price_Old": "15.95", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTIHYPERTENSIVE.NONSELECTIVE CALCIUM CHANNEL BLOCKER", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–#>ل#.ج #.لذ#%حة #.لص#~#^ية .", "Contraindications": "–لم#^#_ى #%#-ء #_#^#%#.#? #.لقل#% #.ل#?ي #?قل #>ن 50 #_#^#%ة #<ي #.ل#~قيقة . \r\n\r\n–#<ي ح#.لة #.نس#~#.#~ #.لقل#% من #.ل#~#^جة #.لث#.نية و#.لث#.لثة . \r\n\r\n–لمن ي#>#.نون من م#?ل#.زمة #.ل#>ق#~ة #.لجي#%ية #.لم#^ي#_ة . \r\n\r\n–#<ي ح#.لة #<شل #.لقل#% #.لم#>#.و#_ . \r\n\r\n–لمن ي#>#.نون من #.خ#?ل#.ل #<ي #.ل#%#-ين #.لأيس#^ #%#>#~ #.ل#?#>#^#_ لذ#%حة قل#%ية . \r\n\r\n–ل#. يس#?خ#~م #%ش#=ل م#?ز#.من م#> حقن #~#.ن#?#^ولين حيث #?س#%#% #.لإص#.#%ة #%#^ج#<#.ن #%#-يني .", "GI": "About DiltiazemSA Benzothiazepine derivative, Calcium channel blocker, Anti hypertensive, anti-anginal, class IV antiarrhythmic.SSMechanism of Action of DiltiazemSDiltiazem is a Benzothiazepine- Ca channel blocker. It exerts it`s antianginal, antihypertensive, antiarrythmic actions through blocking the influx of Ca ions through voltage gated L-type Ca channels to the peripheral vascular smooth muscle cells, Coronary smooth muscle cells and to the myocardial cells. Thus causes dilatation of vascular endothelium, decrease peripheral resistance, and decrease BP in hypertensive individuals. SSIndications for DiltiazemS1. Hypertension S2. Prinzmetal`s angina S3. Stable angina", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "630", "Trade_Name": "SUPRANIL 25MG 20 CAPS.", "Generic_Name": "CLOMIPRAMINE", "Price": "21", "Price_Old": "14", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "– ١-يس#?خ#~م #.ل#~و#.ء ل#>ل#.ج ح#.ل#.#? #.ل#.#=#?ئ#.#% #.لش#~ي#~ #%مخ#?ل#< أنو#.#>ه #=له#.. \r\n\r\n–٢-يس#.#>#~ #<ى #?خلص #.لإنس#.ن من أى وسو#.س قه#^ى أو قلق ي#>#.نى منه لأى س#%#% من #.لأس#%#.#% . \r\n\r\n–3\r\n\r\n–يس#?خ#~م #=#>ل#.ج م#=مل م#> أ#~وية #>ل#.ج #.لقلق و#.ل#.#=#?ئ#.#% وذل#= من#>#. لح#~وث نو#%#.#? #.لهي#.ج #.ل#?ى #?ح#~ث #%صو#^ة م#<#.جئة. \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من #.ل#.#=#?ئ#.#% #.لذى يص#.ح#% #.لأشخ#.ص #.لمص#.#%ين #%م#^#_ #.لس#^#-#.ن. \r\n\r\n– ٥-يس#?خ#~م #=#>ل#.ج مس#.#>#~ #<ى ح#.لة #.لنوم #.لم#<#.جئ. \r\n\r\n–٦-ي#>#.لج #.#_#-#^#.#%#.#? #.لشهية #.ل#?ى #?صي#% #.ل#=ثي#^ من #.لأ#<#^#.#~. \r\n\r\n– ٧-يس#?خ#~م أي#_#.ً #=#>ل#.ج مش#=لة #.لقذ#< #.لم#%#=#^ #.لذى ي#>#.نى منه #.ل#^ج#.ل .", "Contraindications": "–يج#% #.لإم#?ن#.#> #?م#.مً#. #>ن #?ن#.ول هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لنق#.هة #>ق#% #.لإص#.#%ة #%#.لذ#%حة #.لص#~#^ية. \r\n\r\n–يمن#> إس#?خ#~#.مه #<ى ح#.ل#.#? #?#_خم #.ل#%#^وس#?#.#?#.. \r\n\r\n–#<ى ح#.ل#.#? نش#.#- #>مل #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ح#~وث #_#>#< #<ى ح#^#=ة #.لأم#>#.ء. \r\n\r\n–يمن#> #?ن#.وله #<ىى ح#.لة ح#~وث خلل #<ى وظ#.ئ#< #=ل من #.ل#=#%#~ و#.ل#=لى. \r\n\r\n–يمن#> #?ن#.وله #<ى وق#? #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه ينزل م#> ل#%ن #.لأم و#%#.ل#?#.لي #<من #.لمح#?مل أن يؤ#~ي #%#_#^#^ #=#%ي#^ للأ#-#<#.ل .", "GI": "About Clomipramine\r\nTricyclic Antidepressant (Tertiary Amine), Antiobsessional.\r\n\r\nMechanism of Action \r\nClomipramine acts by inhibiting the re-uptake of Noradrenaline, and Serotonin (5 HT) in the CNS nerve terminals.This will result in an increased concentration of neurotransmitters in the synaptic cleft and produces antidepressant effect. \r\n\r\nIndications\r\n1.Depression, \r\n2.Obsessive compulsive disorder, \r\n3.Adjunctive treatment of cataplexy associated with narcolepsy.\r\n\r\ndose\r\nAdult: \r\nDepression: Initial dose: 10 mg at night. Dose can be gradually increased to 150 mg / day at night or in 3 - 4 divided doses. \r\nMaintenance dose: 30 - 50 mg daily \r\nMaximum dose: 250 mg / day \r\nObsessive compulsive disorder: \r\nInitial dose: 25 mg at night. Dose can be gradually increased to 150 mg / day at night or in 3 - 4 divided doses.", "Composition": "Active Ingredients:\r\nEach Supranil 25\\\" capsule contains: Clomipramine hydrochloride 25 mg. \r\n\r\nEach Supranil 50\\\" capsule contains: Clomipramine hydrochloride 50 mg.", "Route": "ORAL.SOLID" }, { "ID": "631", "Trade_Name": "FERRO-6 24 SOFT GELATIN CAPS.", "Generic_Name": "COPPER SULPHATE+FOLIC ACID+IRON+MANGANESE SULPHATE+VITAMIN B12+VITAMIN C", "Price": "15.75", "Price_Old": "10.5", "Company": "PHARCO", "Pharmacology": "IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~", "Use": "–#>ل#.ج أنيمي#. نقص #.لح#~ي#~ . \r\n\r\n–#.لح#~ي#~ يل#>#% #~و#^#. ه#.م#. #<ى إن#?#.ج م#.#~ة #.لهيموجلو#%ين #.لموجو#~ه #<ى خل#.ي#. #.ل#~م #.لحم#^#.ء و #.ل#?ى #?نقل #.لأ#=سجين إلى #.لخل#.ي#. .", "Contraindications": "–#.لحمل و #.ل#^#_#.#>ة : \r\n\r\n–#.لحمل : أمن للإس#?خ#~#.م أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–#?حذي#^#.#? : \r\n\r\n–ق#~ يس#%#% #?غي#^ #<ى لون #.ل#%#^#.ز إلى #.للون #.لأسو#~ #.ل#~#.#=ن . \r\n\r\n–يج#% #?جن#% #?ن#.ول #.لقهوة و #.لش#.ي و #.لحلي#% و #.ل#%ي#_ #<ى ن#<س #.لوق#? م#> أ#~وية #.لح#~ي#~ ل#.نه#. #?قلل من إم#?ص#.ص #.لح#~ي#~ و يج#% #.ل#<صل #%ينهم#. #%س#.#>#?ين #>لى #.لأقل . \r\n\r\n–يس#?خ#~م #%حذ#^ م#> م#^#_ى #.لجه#.ز #.له#_مى مثل م#^#_ى ق#^حة #.لم#>#~ة و #.لأم#>#.ء و إل#?ه#.#%#.#? #.لقولون : ق#~ #?س#%#% إ#_#-#^#.#%#.#? #%#.لجه#.ز #.له#_مى . \r\n\r\n–ق#~ يس#%#% ح#~وث إمس#.#= . \r\n\r\n–ل#. يس#?خ#~م لم#~ة #?زي#~ #>ن 6 أشه#^ إل#. #%#>#~ إس#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–#<ي#?#.مين C يس#.#>#~ #>لى إم#?ص#.ص #.لح#~ي#~ و زي#.#~ة #<#.#>لي#?ه . \r\n\r\n–#.ل#?#~#.خل#.#? #.ل#~و#.ئية : \r\n\r\n–يج#% #.ل#<صل #%ين أ#~وية #.ل#=#.لسيوم و #.لح#~ي#~ و ل#. ي#?م #?ن#.ولهم#. م#>#. : حيث ي#>مل #.ل#=#.لسيوم #>لى #?قلل إم#?ص#.ص #.لح#~ي#~ و #%#.ل#?#.لى #?قل #<#.#>لية #>نص#^ #.لح#~ي#~ . \r\n\r\n–#.لأ#~وية #.لم#_#.#~ة للحمو#_ه و ح#^قة #.لم#>#~ة #.ل#?ى #?ح#?وى #>لى هي#~#^و#=سي#~ #.لم#.غنيسيوم أو هي#~#^و#=سي#~ #.لأليومنيوم أو #=#^#%ون#.#? #.ل#=#.لسيوم : #?قلل من إم#?ص#.ص أ#~وية #.لح#~ي#~ لذل#= يج#% #.ل#<صل #%ينهم #%م#~ة ل#. #?قل #>ن س#.#>#?ين .", "GI": "About Copper\r\nThird most abundant essential trace mineral, A cofactor for many proteins, iron utilization enhancer, Copper deficiency.\r\nMechanism of Action of Copper\r\nCopper is one of a relatively small group of metallic elements which are essential to human health. These elements, along with amino and fatty acids as well as vitamins, are required for normal metabolic processes.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "632", "Trade_Name": "HAEMOCOMPLEX 30 CAPS.", "Generic_Name": "COPPER GLUCONATE+FOLIC ACID +IRON+VIT. B1+VIT. B2+VIT. B3+VIT. B6+VIT. B12+VIT. C+ZINC PICLONATE", "Price": "21.6", "Price_Old": "18", "Company": "OCTOBER PHARMA", "Pharmacology": "IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~", "Use": "–م#=مل غذ#.ئي #%#>ن#.ص#^ #~#.#>مة لل#~م يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.ل#.نيمي#. و #<ق#^ #.ل#~م .", "Contraindications": "–#<#^#- #.لحس#.سية من أي من #.لم#=ون#.#?.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "633", "Trade_Name": "SUPRANIL 50MG 20 CAPS.", "Generic_Name": "CLOMIPRAMINE", "Price": "24", "Price_Old": "16", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "– ١-يس#?خ#~م #.ل#~و#.ء ل#>ل#.ج ح#.ل#.#? #.ل#.#=#?ئ#.#% #.لش#~ي#~ #%مخ#?ل#< أنو#.#>ه #=له#.. \r\n\r\n–٢-يس#.#>#~ #<ى #?خلص #.لإنس#.ن من أى وسو#.س قه#^ى أو قلق ي#>#.نى منه لأى س#%#% من #.لأس#%#.#% . \r\n\r\n–3\r\n\r\n–يس#?خ#~م #=#>ل#.ج م#=مل م#> أ#~وية #>ل#.ج #.لقلق و#.ل#.#=#?ئ#.#% وذل#= من#>#. لح#~وث نو#%#.#? #.لهي#.ج #.ل#?ى #?ح#~ث #%صو#^ة م#<#.جئة. \r\n\r\n–يس#.#>#~ #>لى #.ل#?خلص من #.ل#.#=#?ئ#.#% #.لذى يص#.ح#% #.لأشخ#.ص #.لمص#.#%ين #%م#^#_ #.لس#^#-#.ن. \r\n\r\n– ٥-يس#?خ#~م #=#>ل#.ج مس#.#>#~ #<ى ح#.لة #.لنوم #.لم#<#.جئ. \r\n\r\n–٦-ي#>#.لج #.#_#-#^#.#%#.#? #.لشهية #.ل#?ى #?صي#% #.ل#=ثي#^ من #.لأ#<#^#.#~. \r\n\r\n– ٧-يس#?خ#~م أي#_#.ً #=#>ل#.ج مش#=لة #.لقذ#< #.لم#%#=#^ #.لذى ي#>#.نى منه #.ل#^ج#.ل .", "Contraindications": "–يج#% #.لإم#?ن#.#> #?م#.مً#. #>ن #?ن#.ول هذ#. #.ل#~و#.ء خل#.ل #<#?#^ة #.لنق#.هة #>ق#% #.لإص#.#%ة #%#.لذ#%حة #.لص#~#^ية. \r\n\r\n–يمن#> إس#?خ#~#.مه #<ى ح#.ل#.#? #?#_خم #.ل#%#^وس#?#.#?#.. \r\n\r\n–#<ى ح#.ل#.#? نش#.#- #>مل #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ح#~وث #_#>#< #<ى ح#^#=ة #.لأم#>#.ء. \r\n\r\n–يمن#> #?ن#.وله #<ىى ح#.لة ح#~وث خلل #<ى وظ#.ئ#< #=ل من #.ل#=#%#~ و#.ل#=لى. \r\n\r\n–يمن#> #?ن#.وله #<ى وق#? #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه ينزل م#> ل#%ن #.لأم و#%#.ل#?#.لي #<من #.لمح#?مل أن يؤ#~ي #%#_#^#^ #=#%ي#^ للأ#-#<#.ل .", "GI": "About Clomipramine\r\nTricyclic Antidepressant (Tertiary Amine), Antiobsessional.\r\n\r\nMechanism of Action \r\nClomipramine acts by inhibiting the re-uptake of Noradrenaline, and Serotonin (5 HT) in the CNS nerve terminals.This will result in an increased concentration of neurotransmitters in the synaptic cleft and produces antidepressant effect. \r\n\r\nIndications\r\n1.Depression, \r\n2.Obsessive compulsive disorder, \r\n3.Adjunctive treatment of cataplexy associated with narcolepsy.\r\n\r\ndose\r\nAdult: \r\nDepression: Initial dose: 10 mg at night. Dose can be gradually increased to 150 mg / day at night or in 3 - 4 divided doses. \r\nMaintenance dose: 30 - 50 mg daily \r\nMaximum dose: 250 mg / day \r\nObsessive compulsive disorder: \r\nInitial dose: 25 mg at night. Dose can be gradually increased to 150 mg / day at night or in 3 - 4 divided doses.", "Composition": "Active Ingredients:\r\nEach Supranil 25\\\" capsule contains: Clomipramine hydrochloride 25 mg. \r\n\r\nEach Supranil 50\\\" capsule contains: Clomipramine hydrochloride 50 mg.", "Route": "ORAL.SOLID" }, { "ID": "634", "Trade_Name": "R.B. CAL 30 F.C. TABS.", "Generic_Name": "CALCIUM CARBONATE+MAGNESIUM CARBONATE+VITAMIN D3+ZINC", "Price": "30", "Price_Old": "30", "Company": "MODERN PHARMACUTICAL CENTER", "Pharmacology": "CALCIUM SUPPLEMENT", "Category": "م#=مل #.ل#=#.لسيوم م#> #<ي#?#.مين #~", "Use": "– #<ق#~#.ن #.ل#>ظ#.م (هش#.شة #.ل#>ظ#.م). \r\n\r\n– #_#>#< #.ل#>ظ#.م (لين #.ل#>ظ#.م / #.ل#=س#.ح). \r\n\r\n– أثن#.ء #<#?#^#.#? #.ل#?سنين و #.لنمو #<ى #.ل#.#-#<#.ل . \r\n\r\n– م#^#_ى قصو#^ نش#.#- #.لغ#~ة #.ل#~#^قية. \r\n\r\n– م#^#_ يصي#% #.ل#>#_ل#.#? يسمى (latant tetany #.و #.ل#=ز#.ز #.ل#=#.من). \r\n\r\n– #=م#. يم#=ن #.س#?خ#~#.مه #<ي #%#>#_ #.لم#^#_ى لل#?أ#=#~ من #.نهم يحصلون #>لى م#. ي#=#<ي من #.ل#=#.لسيوم (#>لى س#%يل #.لمث#.ل، #.لنس#.ء #.لحو#.مل، و #.لم#^#_#>#.#?، أو #%#>#~ سن #.ليأس، و #.لم#^#_ى #.لذين ي#?ن#.ولون #%#>#_ #.لأ#~وية مثل #.ل#<يني#?وين، #.ل#<ينو#%#.#^#%ي#?#.ل، أو #%#^ي#~نيزون).", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج \r\n\r\n–أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج، \r\n\r\n–أو #<ي ح#.لة وجو#~ حصى مح#?وية #>لى #=#.لسيوم #<ي #.ل#=لى ، \r\n\r\n–أو #<ي ح#.لة وجو#~ نقص #<ي مس#?وى #.ل#<وس#<#.#? #<ي #.ل#~م، \r\n\r\n–أو #<ي #.لم#^#_ى #.لذين يش#?#%ه #%#?سممهم #%#~و#.ء #.ل#~يجو#=سين.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "635", "Trade_Name": "CROMOLYN 100 MG CAP.", "Generic_Name": "CROMOLYN SODIUM", "Price": "6.75", "Price_Old": "6.75", "Company": "MISR", "Pharmacology": "MAST CELL STABILIZER", "Category": "مش#.#=ل #.ل#>ين", "Use": "–يس#?خ#~م #<ى #>ل#.ج #.ل#?ه#.#% #.لق#^نية و #.لمل#?حمة #.ل#^#%ي#>ي، #.ل#^م#~ #.ل#^#%ي#>ي ، حس#.سية #.ل#>يون . #.لمس#?نشق منه ق#~ يس#?خ#~م #=#>ل#.ج مس#.#>#~ لمن#> #%#>#_ #.لأم#^#.#_ #.ل#?حسسية مثل #.ل#^#%و و #?#_يق #.لقص#%#.#? #.لن#.#?ج #>ن #.ل#?م#.#^ين .", "Contraindications": "–إذ#. لم #?#?حسن #.لأ#>#^#.#_ أو إذ#. أص#%ح#? ح#.ل#?#= أسوأ ، #.س#?ش#^ #-#%ي#%#=. \r\n\r\n–إذ#. #=ن#? #?أخذ أي#_#. #=و#^#?ي#=وس#?ي#^وي#~ أو موس#> قص#%ي ل#>ل#.ج #.ل#^#%و م#> #=#^ومولين #.لمس#?نشق، ل#. #?#?وق#< #>ن #?ن#.ول #=و#^#?ي#=وس#?ي#^وي#~ أو موس#> #.لقص#%#.#? ح#?ى لو #.ص#%ح #.ل#^#%و أ#<#_ل، إل#. إذ#. #-ل#% من#= #.ل#-#%ي#% #.لقي#.م #%ذل#=. \r\n\r\n–ق#~ يح#~ث ج#<#.#< #.ل#<م أو #.لحلق أو #?هيج #.لحلق #%#>#~ #.س#?خ#~#.م #=#^ومولين #.لمس#?نشق. #.لغ#^غ#^ة وش#-#< #.ل#<م أو ش#^#% #.لم#.ء #%#>#~ #=ل ج#^#>ة #?س#.#>#~ #>لى من#> هذه #.لآث#.#^.", "GI": "COMING SOON ..", "Composition": "cromoglycate sod. 2%", "Route": "ORAL.SOLID" }, { "ID": "636", "Trade_Name": "COENZYME Q10 30 MG 20 CAPS.", "Generic_Name": "COENZYME Q-10", "Price": "21", "Price_Old": "21", "Company": "MEPACO", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–م#=مل غذ#.ئي ي#>#?ق#~ #.نه ي#<ي#~ #<ي #.لح#.ل#.#? #.ل#?#.لية: \r\n\r\n–1) يقي من #.م#^#.#_ #.لقل#% حيث وج#~ #.ن #.لم#^#_ي #.لمص#.#%ين #%#<شل #.لقل#% و#.لذين ي#?ن#.ولون م#=مل #=و #.نزيم #=يو١٠ #%صو#^ة يومية، ق#~ #.نخ#<#_#? نس#%ة #.لو#<#.ة #%ينهم #% ٣١٪. \r\n\r\n–2) يخ#<#< #_غ#- #.ل#~م #.لم#^#?#<#> ل#~ى م#^#_ي #.لس#=#^ من #.لنو#> #.لث#.ني، و#=ذل#= خ#<#_ مس#?وي #.لس#=#^ #<ي #.ل#~م. \r\n\r\n–3) يخ#<#< #.#>#^#.#_ م#^#_ #.لشلل #.ل#^#>#.ش ” #%#.#^#=نسون” إذ#. م#. #?م #?ن#.ول #?#^#=يز#.#? #>#.لية منه #<ي #.لم#^#.حل #.ل#.ولي من #.لم#^#_. \r\n\r\n–4) يخ#<#< #.#>#^#.#_ #.ل#.م #.ل#>#_ل#.#? #.لمص#.ح#%ة ل#?ن#.ول #.ل#.#~وية #.ل#?ي #?ذي#% #.ل#~هون و#?ح#?وي #>لي م#.#~ة “س#?#.#?ين”. \r\n\r\n–5) يخ#<#< ح#~ة وم#^#.#? ح#~وث نو#%#.#? #.لص#~#.#> #.لنص#<ي. \r\n\r\n–6) يحسن #.ل#.#~#.ء #.لح#^#=ي للجسم، لذل#= ي#?ن#.وله #.ل#^ي#.#_يون وممن ي#^غ#%ون #<ي نقص#.ن #.لوزن حيث #.نه ي#>#-ي #.لجسم #.حس#.س #%#.لنش#.#- و#.لق#~#^ة #.لح#^#=ية. \r\n\r\n–7) وج#~ #.نه يس#.#>#~ #<ي #^#<#> م#>#~ل#.#? #.لخصو#%ة ل#~ى #.لذ#=و#^ و#.ل#.ن#.ث ويس#.هم #<ي صحة #.ل#%وي#_#.#? وس#^#>ة #.لحيو#.ن#.#? #.لمنوية. \r\n\r\n–8) #>ن#~ #.س#?خ#~#.مه مو#_#>ي#. #<ي صو#^ة #=#^يم لل#%ش#^ة #<#.نه يق#.وم #>ل#.م#.#? #?ق#~م #.لسن و#=ذل#= #.ل#.ث#.#^ #.لمؤ#=س#~ة #.ل#_#.#^ة لأش#>ة #.لشمس و#.ل#?ي #?س#%#% #.لشيخوخة لل#%ش#^ة. \r\n\r\n–ول#>ل #?ل#= #.لنق#-ة #?همني شخصي#. #=سي#~ة #<أح#% #.ن #.#_ي#< #.ليه#. قليل#.. \r\n\r\n–#.ن #.لجل#~ هو أ#=ث#^ #.ل#.#>#_#.ء مس#.حة #<ي جسم #.ل#.نس#.ن وهو خ#- #.ل#~#<#.#> #.ل#.ول للجسم و#.#=ث#^ه#. #>#^#_ة لل#?أثي#^#.#? #.لخ#.#^جية. \r\n\r\n–ومن #.جل ذل#= #<#.ن خل#.ي#. #.لجل#~ #~#.ئم#. #<ي ح#.لة م#?ج#~#~ة و#.ل#?ي #?س#?لزم #.لمزي#~ من #.ل#-#.قة. \r\n\r\n–يو#<#^ #.ل#=و #.نزيم #=يو١٠ #.لمس#.#>#~ة #.لل#.زمة لص#~ #.ل#.ث#.#^ #.لم#~م#^ة #.لمؤ#=س#~ة لأش#>ة #.لشمس و#.ل#?ي #?#>#?#%#^ #.لس#%#% #.لم#%#.ش#^ #<ي شيخوخة #.ل#%ش#^ة و#%#.ل#?#.لي #.ل#.ص#.#%ة #%#.ل#?ج#.#>ي#~ و#<ق#~#.ن #.لجل#~ م#^ون#?ه. \r\n\r\n–9) يخ#<#< #.#>#^#.#_ #.لزه#.يم#^ و خ#^#< #.لشيخوخة وهو ل#. ي#>#?#%#^ #>ل#.ج#. #<ي ح#~ ذ#.#?ه. \r\n\r\n–10) يحسن #.لق#~#^ة #.لمن#.#>ية ل#~ي م#^#_ي نقص #.لمن#.#>ة #.لم#=#?س#%ة “#.ل#.ي#~ز”. \r\n\r\n–11) يس#.#>#~ #<ي #>ل#.ج #.م#^#.#_ #.للثة #>ن #-#^يق #.س#?خ#~#.مه م#%#.ش#^ة #>لي #.لمن#.#-ق #.لمص#.#%ة #<ي صو#^ة جيل لل#<م.", "Contraindications": "–#<#^#- #.لحس#.سية من م#=ون#.#? #.ل#~و#.ء \r\n\r\n–يج#% #.لحذ#^ من #.س#?خ#~#.مه م#> م#.ن#>#.#? #.ل#?جل#- و#.#~وية #>ل#.ج #.لس#=#^ #=ذل#= لأنه يخ#<#_ مس#?وي#.#? #.لس#=#^ #<ي #.ل#~م. \r\n\r\n–#=ذل#= ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية حول #?أثي#^#.#?ه #<ي #<#?#^ة #.لحمل لذل#= يج#% #>#~م #?ن#.وله #<ي #.لحمل و#.ل#.#^#_#.#> \r\n\r\n–#=م#. ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية حول #.س#?خ#~#.مه #<ي #.ل#.#-#<#.ل.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "637", "Trade_Name": "HEPAPRO 20 SOFT GELATIN CAP.", "Generic_Name": "CURCUMIN+SILYMARIN", "Price": "24", "Price_Old": "24", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#~هون #.ل#=#%#~ #.ل#=حولية. \r\n\r\n–س#^#-#.ن #.لخل#.ي#. #.ل#=#%#~ية. \r\n\r\n–#.ل#=#%#~ #.ل#~هني #.لغي#^ #=حولى. \r\n\r\n–#.ل#.ل#?ه#.#% #.ل#=#%#~ي #.ل#<ي#^وسي. \r\n\r\n–#.ل#?سمم #.ل#=#%#~ي ، #?لي#< #.ل#=#%#~. \r\n\r\n–يس#.#>#~ #>لي #?حسين و#?نشي#- وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–يس#.#>#~ #>لي حم#.ية و#.#>#.#~ة #?#=وين خل#.ي#. #.ل#=#%#~.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#=#%سول#.#?. \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#=#%سول#.#? لل#.#-#<#.ل #.لأقل من 12 #>#.م.", "GI": "Indications:\r\n?General antioxidant\r\n?Supportive treatment in chronic inflammatory liver disease and hepatic cirrhosis\r\n?Liver & gall bladder complaints\r\n?Dyspeptic complaints\r\n?Toxic liver damage\r\n?Loss of appetite", "Composition": "curcumin 50mg, silymarin 100mg", "Route": "ORAL.SOLID" }, { "ID": "638", "Trade_Name": "BRONCHOLASE 10MG 20 CAPS. (CANCELLED)", "Generic_Name": "CODEINE+DIPHENHYDRAMINE", "Price": "4.09", "Price_Old": "4.09", "Company": "MEMPHIS", "Pharmacology": "COUGH DRUGS", "Category": "م#_#.#~ لل#=حة", "Use": "–#>ل#.ج #.ل#=حة #.لمصحو#%ة #%#.ل#%لغم و#.#>#^#.#_ #.لحس#.سية.", "Contraindications": "–ل#. #?وص#< أمل#.ح #.لأمونيوم #<ى #.لم#^#_ى #.لذين ي#>#.نون من قصو#^ #<ى وظي#<ة #.ل#=#%#~ أو وظي#<ة #.ل#=لى. \r\n\r\n–ل#. يوص#< #>#^ق #.لذه#% للم#^#_ى #.لذين يخشى #>ليهم من ح#~وث #?شنج#.#?.", "GI": "About Codeine\r\nAn opiate, methylmorphine , Narcotic analgesic, antitussive, and antidiarrheal.\r\nMechanism of Action of Codeine\r\nCodeine exerts it`s action through opioid receptors and posses antitussive properties. It selectively and directly acts on cough centre and suppresses cough. It also posses analgesic action due to it`s agonistic action on opioid receptors.", "Composition": "ammonium chloride 175mg, tincture ipeca 0.17ml, chlorpheniramine 0.8mg", "Route": "ORAL.SOLID" }, { "ID": "639", "Trade_Name": "ABILIFY 5MG 10 TAB.", "Generic_Name": "ARIPIPRAZOLE", "Price": "107.5", "Price_Old": "107.5", "Company": "OTSUKA", "Pharmacology": "PSYCHIATRIC.ANTIPSYCHOTICS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#>ل#.ج #.ن#<ص#.م #.لشخصية: ق#~ يح#?#.ج #.لم#^ي#_ إلى س#?ة أس#.#%ي#> ح#?ى يظه#^ #.ل#?أثي#^ #.ل#=#.مل لل#~و#.ء. \r\n\r\n–م#^#_ ثن#.ئية #.لق#-#% \r\n\r\n–#.#>#^#.#_ #.لهي#.ج #.لح#.#~ #.لمص#.ح#% لم#^#_ #^قم 1 و 2 \r\n\r\n–#>ل#.ج مس#.#>#~ #<ي م#^#_ #.ل#.#=#?ئ#.#% \r\n\r\n–#.ل#?هيج #.لمص#.ح#% لم#^#_ #.ل#?وح#~.", "Contraindications": "–ق#%ل إس#?خ#~#.م #.ل#~و#.ء يج#% إس#?ش#.#^ة #.ل#-#%ي#% أو #.لصي#~لي إذ#. #=ن#? #?#>#.ني من حس#.سية لل#~و#.ء أو لأي م#=ون من م#=ون#.#?ه . \r\n\r\n–ل#. ينصح #%#.س#?خ#~#.مه م#^#_ي #.لس#=#^ و#.لأشخ#.ص #.لذين ي#>#.نون من مش#.#=ل #<ي #.لقل#% #=إنخ#<#.#_ #<ي #_غ#- #.ل#~م وأم#^#.#_ #.لش#^#.يين #.ل#?#.جية و#=ذل#= قصو#^ #<ي #.لقل#% و#>#~م إن#?ظ#.م #_#^#%#.#? #.لقل#% . \r\n\r\n–يج#% إ#%#?ل#.#> أق#^#.ص #.ل#~و#.ء #=#.ملة #~ون #?قسيم أو سحق . \r\n\r\n–ق#%ل أس#?خ#~#.م #.ل#~و#.ء يج#% أن #?خ#%#^ #-#%ي#%#= إذ#. #=ن#? #?#>#.ني من #.لمش#.#=ل #.ل#?#.لية مثل #?#~#<ق #.ل#~م إلي #.لمخ أو #.لأو#>ية #.ل#~موية و#=ذل#= مش#.#=ل #<ي #.لجه#.ز #.ل#>ص#%ي مثل #.لخ#^#< و#.لص#^#> . \r\n\r\n–و#=ذل#= ل#.ينصح #.لأشخ#.ص #.لذين ي#>#.نون من #.لسمنة أس#?خ#~#.م #.ل#~و#.ء. \r\n\r\n–ل#. #?س#?خ#~م #.ل#~و#.ء #<#?#^ة أ#-ول من #.ل#-#%ي#% #.ل#?ي ح#~#~ه#. . \r\n\r\n–يس#?غ#^ق #.ل#~و#.ء أس#.#%ي#> ق#%ل أن #?ش#>#^ #%#.لأس#?#<#.#~ة منه ولذل#= ينصح #%#.س#?خ#~#.مه #%#.ن#?ظ#.م للحصول #>لي أ#<#_ل ن#?#.ئج . \r\n\r\n–يج#% أخذ #.لج#^#>ة #.لمح#~#~ة من #.ل#~و#.ء #<ي ن#<س #.لوق#? من #=ل يوم . \r\n\r\n–ل#.#?#?وق#< #>ن #?ن#.ول #.ل#~و#.ء #~ون إس#?ش#.#^ة #.ل#-#%ي#% #=م#. يج#% #.ل#?وق#< #>ن أس#?خ#~#.م #.ل#~و#.ء #%ش#=ل #?#~#^يجي . \r\n\r\n–م#^#.ج#>ة #.لأ#~وية #.لأخ#^ي م#> #.ل#-#%ي#% لأن هذ#. #.ل#~و#.ء ل#.يم#?زج م#> غي#^ه من #.لأ#~وية . \r\n\r\n–يج#% #?جن#% #?ن#.ول #.لمش#^و#%#.#? #.ل#=حولية و#.لمن#?ج#.#? #.لأخ#^ي #.ل#?ي #?ه#~يء من #^#~و#~ أ#<#>#.ل #.لم#^ي#_ #=#.لمس#=ن#.#? و#.لمن#%ه#.#? وم#_#.#~ #.لهس#?#.مين و#.لأ#~وية #.لأخ#^ي #.ل#?ي #?ؤث#^ #>لي #.لألم . \r\n\r\n–ل#. ينصح #%#.س#?خ#~مه خل#.ل #.لأشه#^ #.لأخي#^ة من #.لحمل لأنه ق#~ يس#%#% #?صل#% #.ل#>#_ل#.#? #.و #.ل#^#>شة أو #.لن#>#.س و#=ذل#= ص#>و#%ة #<ي #.ل#?ن#<س و#.ل#%#=#.ء #.لمس#?م#^ ل#~ي #.لمولو#~ . \r\n\r\n–ل#. ينصح #%#.ل#^#_#.#>ة #.ل#-#%ي#>ية خل#.ل #<#?#^ة #?ن#.ول #.ل#~و#.ء.", "GI": "About Aripiprazole\r\nSecond-Generation Atypical Antipsychotic, dopamine-serotonin stabilizer. \r\nMechanism of Action of Aripiprazole\r\nThe mechanism of action of Aripiprazole in the treatment of schizophrenia and bipolar disorder is unknown. The proposed mechanism is that Aripiprazole acts by combination of partial agonist activity at Dopamine (D2) and Serotonin (5HT1A) receptor and a potent antagonist at 5HT2A receptor. \r\nAripiprazole also has an antagonist activity at alpha1 adrenergic receptors. \r\nIndications for Aripiprazole\r\n1.Schizophrenia \r\n2.Bipolar disorder \r\nInteractions for Aripiprazole\r\nCarbamazepine: It cause an increase in Aripiprazole clearance and lower blood levels \r\nKetoconazole, Quinidine, Fluoxetine, Paroxetine: They inhibt Aripirazole elimination and cause increased blood levels.", "Composition": "aripiprazole 10mg or 15mg", "Route": "ORAL.SOLID" }, { "ID": "640", "Trade_Name": "ETHOXA 250MG 50 CAPS.", "Generic_Name": "ETHOSUXIMIDE", "Price": "56", "Price_Old": "56", "Company": "DELTA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.SUCCINIMIDE", "Category": "م#_#.#~ للص#^#> و #.ل#?و#?#^", "Use": "–ي#>مل #.ل#>ل#.ج #>لى من#> #?#=ون نو#%#.#? #.لص#^#> أو #.ل#.خ#?ل#.ج #<ي #.ل#~م#.غ #>ن #-#^يق #?ث#%#- #>ملي#.#? م#>ينة #?س#.#>#~ #<ي #?#=ون نو#%#.#? #.لص#^#>، ويس#.#>#~ #>لى #.ل#?ح#=م #<يه#.. \r\n\r\n–ل#. ي#>مل #.ل#>ل#.ج #>لى #.لش#<#.ء من م#^#_ #.لص#^#>، و ل#=ن يس#.#>#~ #>لى #.ل#?ح#=م #<ي #.لنو#%#.#? من حيث #?قليل #?#=#^#.#^ه#.، لذ#. ل#. يجوز #.ل#?وق#< #>ن #?ن#.ول #.ل#>ل#.ج #~ون #.س#?ش#.#^ة #.ل#-#%ي#% #%مج#^#~ #?حسن ح#.لة #.لم#^ي#_، إذ ق#~ #?#>#.و#~ #.لنو#%#.#? #%#.لظهو#^ #%#>#~ #.ل#?وق#< #>ن #.ل#>ل#.ج. \r\n\r\n–يس#?خ#~م #.ل#>ل#.ج #<ي #.لسي#-#^ة #>لى نو#%#.#? #.لص#^#> #.لصغي#^", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج أو لأي م#=ون آخ#^ من م#=ون#.#?ه أو لم#.#~ة #.لس#.#=سينيمي#~", "GI": "About Ethosuximide\r\nImide derivative, A succinimide anticonvulsant(mainly in absence seizures).\r\nMechanism of Action of Ethosuximide\r\nEthosuximide reduces low threshold T current in Ca2+ channel in thalamic neurons. Thalamus is responsible for the production of absence seizure. Ethosuximide produces its action by inhibiting T type calcium channel.\r\nIndications for Ethosuximide\r\nAbsence seizure (Petit mal epilepsy)\r\nBreast Feeding Related Information\r\nContraindicated\r\nChildren Related Information\r\nUse with caution \r\nBelow 3years: Contraindicated \r\nTypical Dosage for Ethosuximide\r\nAdult: \r\n500mg/day in 2 divided doses. Dose can be increased by 250mg every 4 - 7 days up to 1.5g/day. \r\nChildren above 6 years of age: same as adult dose \r\nChildren under 6 years of age: 250 mg /day", "Composition": "ethosuximide 250", "Route": "ORAL.SOLID" }, { "ID": "641", "Trade_Name": "FENOLIP 100 MG 10 CAPS.", "Generic_Name": "FENOFIBRATE", "Price": "5.5", "Price_Old": "5.5", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "fenofibrate 100mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "642", "Trade_Name": "LIPOLEX 67MG 10CAPSULE", "Generic_Name": "FENOFIBRATE", "Price": "3.25", "Price_Old": "3.25", "Company": "SIGMA", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "fenofibrate 200mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "643", "Trade_Name": "ETODINE 200MG 10 CAPS.", "Generic_Name": "ETODOLAC", "Price": "10", "Price_Old": "10", "Company": "TECHNOPHARM > PHARCO", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "– يس#?خ#~م #<ى #>ل#.ج #.ل#^وم#.#?وي#~ #.لم#<صلى #=م#. يقوم #%#>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى ، #%#.ل#.#_#.#<ة #.نه ي#>#.لج #.ل#.ل#.م #.س#<ل #.لظه#^ و#>#^ق #.لنس#. . \r\n\r\n– ي#>#.لج #.ل#~و#.ء #.ل#?ه#.#% م#<#.صل #.ل#<ق#^#.#? #=م#. يقوم #%#>ل#.ج #.ل#.م #.ل#=#?#< ، #%#.ل#.#_#.#<ة #.لى #.ل#?ه#.#%#.#? #.ل#.و#?#.#^ و#.ل#.#^#%#-ة . \r\n\r\n– يق#_ى #>لى #.ل#.م #.ل#.سن#.ن و#.للثة و#=ذل#= يقوم #%#>ل#.ج وج#^#.ح#.#? #.ل#<م وخل#> #.ل#.سن#.ن ، #%#.ل#.#_#.#<ة #.لى #.ل#.م #>ق#% #.ل#>ملي#.#? #.لج#^#.حية و#.ل#.ص#.#%#.#? . \r\n\r\n– يس#?#>مل #<ى #>ل#.ج #.ل#.م #.ل#>#_ل#.#? و#.ل#.#>ص#.#% #=م#. ي#>#.لج #?ي#%س #.ل#^ق#%ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.ل#.م #.ل#-مث و#.ل#.ل#.م #.لمص#.ح#%ة ل#.م#^#.#_ #.لنس#. .", "Contraindications": "– يمن#> لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى . \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #<ى ح#.لة وجو#~ ق#^حة #.ل#.ثنى #>ش#^ م#> وجو#~ نزي#< #<ى #.لجه#.ز #.له#_مى . \r\n\r\n– #<ى ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة ينصح #%#?جن#% #.ل#~و#.ء #?م#.م#.ً. \r\n\r\n– يحذ#^ #>لى #.لم#^#_ي #.لذين ل#~يهم قصو#^ #<ى وظ#.ئ#< #.ل#=#%#~ ووظ#.ئ#< #.ل#=لي.", "GI": "About Etodolac\r\nA member of pyranocarboxylic acid group of NSAID, Analgesic, Anti-inflammatory.\r\n\r\nMechanism of Action of Etodolac\r\nEtodolac is an acetic acid derivative. Etodolac produces its analgesics and anti-inflammatory actions by inhibiting Prostaglandin synthesis. It has also some COX2 selective action. So its anti-inflammatory action and the frequency of gastric irritation is less as compared to other NSAIDs.\r\n\r\nIndications for Etodolac\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3..Pain \r\n\r\nTypical Dosage for Etodolac\r\nAdult: 600mg - 1000mg / day in 2 - 3 divided doses. \r\nPain: 200 - 400 mg 3 - 4 times daily. Maximum 1g", "Composition": "Etodolac 200 or 300 mg", "Route": "ORAL.SOLID" }, { "ID": "644", "Trade_Name": "FINORATE RETARD 250MG 20 CAPS.", "Generic_Name": "FENOFIBRATE", "Price": "22", "Price_Old": "22", "Company": "EVA PHARMA", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "Finorate retard capsules:Fenofibrate / capsule 250 mg", "Route": "ORAL.SOLID" }, { "ID": "645", "Trade_Name": "FINORATE 100MG 20 CAPS.", "Generic_Name": "FENOFIBRATE", "Price": "11", "Price_Old": "11", "Company": "EVA PHARMA", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "FENOFIBRATE (MICRONIZED) 100 MG", "Route": "ORAL.SOLID" }, { "ID": "646", "Trade_Name": "LASTET 50MG 20 CAPS.(N/A)", "Generic_Name": "ETOPOSIDE", "Price": "350", "Price_Old": "350", "Company": "NIPPON KAYAKU-JAPAN > MULTIPHARMA", "Pharmacology": "ANTINEOPLASTIC", "Category": "م#_#.#~#.#? للأو#^#.م", "Use": "–س#?خ#~م #<ي #>ل#.ج: س#^#-#.ن #.ل#^ئة صَّغِيْ#^ #.لخَل#.َي#. س#^#-#.ن #.لخصية (#.لح#^ون)", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#~و#.ء أو لأي جزء من م#=ون#.#?ه.", "GI": "About Etoposide\r\nDerivative of podophyllotoxin, Antineoplastic Agent.\r\n\r\nMechanism of Action of Etoposide\r\nThis semi synthetic derivative of podophyllotoxin arrests cells in G2 phase. It stabilizes the DNA cleavage normally catalysed by topoisomerase 2 and inhibits the relegation of DNA.This drug also prevents the cells from entering mitosis and depressing RNA&DNA synthesis.\r\n\r\nInteractions for Etoposide\r\nWarfarin: Prolongation of prothrombin time may occur. \r\nOther cytotoxic drugs: Synergism.\r\n\r\nIndications for Etoposide\r\n1. Lung cancer \r\n2. Testicular cancer \r\n3. Lymphoma \r\n4. Non lymphocytic leukemia \r\n5. Glioblastoma multiforms \r\n6. Bladder cancer \r\n7. Brain tumor \r\n8. Germ cell tumor \r\n9. Gestational trophoblastic neoplasia \r\n10. Head and neck cancer \r\n11. Ovarian cancer \r\n12. Prostate cancer \r\n13. Ewings sarcoma \r\n14. Hepatoma \r\n15. Kaposi`s sarcoma \r\n16. Leukemia \r\n17. Neuroblastoma \r\n18. Rhabdomyosarcoma \r\n19. Wilm`s tumor", "Composition": "etoposide 100mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "647", "Trade_Name": "LIPOLEX 200MG 20 CAPS.", "Generic_Name": "FENOFIBRATE", "Price": "19", "Price_Old": "19", "Company": "SIGMA", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "fenofibrate 200mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "648", "Trade_Name": "NAPILAC 200MG 20 CAPS.", "Generic_Name": "ETODOLAC", "Price": "16", "Price_Old": "16", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "– يس#?خ#~م #<ى #>ل#.ج #.ل#^وم#.#?وي#~ #.لم#<صلى #=م#. يقوم #%#>ل#.ج #.ل#.ل#?ه#.#% #.ل#>ظمى #.لم#<صلى ، #%#.ل#.#_#.#<ة #.نه ي#>#.لج #.ل#.ل#.م #.س#<ل #.لظه#^ و#>#^ق #.لنس#. . \r\n\r\n– ي#>#.لج #.ل#~و#.ء #.ل#?ه#.#% م#<#.صل #.ل#<ق#^#.#? #=م#. يقوم #%#>ل#.ج #.ل#.م #.ل#=#?#< ، #%#.ل#.#_#.#<ة #.لى #.ل#?ه#.#%#.#? #.ل#.و#?#.#^ و#.ل#.#^#%#-ة . \r\n\r\n– يق#_ى #>لى #.ل#.م #.ل#.سن#.ن و#.للثة و#=ذل#= يقوم #%#>ل#.ج وج#^#.ح#.#? #.ل#<م وخل#> #.ل#.سن#.ن ، #%#.ل#.#_#.#<ة #.لى #.ل#.م #>ق#% #.ل#>ملي#.#? #.لج#^#.حية و#.ل#.ص#.#%#.#? . \r\n\r\n– يس#?#>مل #<ى #>ل#.ج #.ل#.م #.ل#>#_ل#.#? و#.ل#.#>ص#.#% #=م#. ي#>#.لج #?ي#%س #.ل#^ق#%ة ، #%#.ل#.#_#.#<ة #.لى #>ل#.ج #.ل#.م #.ل#-مث و#.ل#.ل#.م #.لمص#.ح#%ة ل#.م#^#.#_ #.لنس#. .", "Contraindications": "– يمن#> لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء #.ل#.خ#^ى . \r\n\r\n– يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #<ى ح#.لة وجو#~ ق#^حة #.ل#.ثنى #>ش#^ م#> وجو#~ نزي#< #<ى #.لجه#.ز #.له#_مى . \r\n\r\n– #<ى ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ة ينصح #%#?جن#% #.ل#~و#.ء #?م#.م#.ً. \r\n\r\n– يحذ#^ #>لى #.لم#^#_ي #.لذين ل#~يهم قصو#^ #<ى وظ#.ئ#< #.ل#=#%#~ ووظ#.ئ#< #.ل#=لي.", "GI": "About Etodolac\r\nA member of pyranocarboxylic acid group of NSAID, Analgesic, Anti-inflammatory.\r\n\r\nMechanism of Action of Etodolac\r\nEtodolac is an acetic acid derivative. Etodolac produces its analgesics and anti-inflammatory actions by inhibiting Prostaglandin synthesis. It has also some COX2 selective action. So its anti-inflammatory action and the frequency of gastric irritation is less as compared to other NSAIDs.\r\n\r\nIndications for Etodolac\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3..Pain \r\n\r\nTypical Dosage for Etodolac\r\nAdult: 600mg - 1000mg / day in 2 - 3 divided doses. \r\nPain: 200 - 400 mg 3 - 4 times daily. Maximum 1g", "Composition": "Each Napilac capsule contains 200 mg etodolac.", "Route": "ORAL.SOLID" }, { "ID": "649", "Trade_Name": "FENOLIP 300 MG 30 CAP.", "Generic_Name": "FENOFIBRATE", "Price": "36", "Price_Old": "36", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "fenofibrate 100mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "650", "Trade_Name": "VIBRAMYCIN 100MG 10 CAPS.", "Generic_Name": "DOXYCYCLINE", "Price": "32.5", "Price_Old": "21.6", "Company": "PFIZER", "Pharmacology": "ANTIBIOTIC.TETRACYCLINE", "Category": "م#_#.#~ حيوي #?#?#^#.سي#=لين", "Use": "–#.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=ل#.مي#~ي#.. \r\n\r\n–#%#~يلة للمي#<لو#=ين للوق#.ية من #.لمل#.#^ي#.. \r\n\r\n–#>ل#.ج #.لزه#^ي. \r\n\r\n–#.لنيس#^ية #.ل#%نية. \r\n\r\n–#.لليس#?ي#^ي#. غي#^ #.لم#>ق#~ة. \r\n\r\n–#>ل#.ج #.لإل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#-ثية #<ي #.لم#^#_ى #.لذين ل#~يهم حس#.سية لل#%نسلين. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#% #.ل#^ئوية. \r\n\r\n–#.لجم#^ة #.لخ#%يثة #.لن#.#?جة من #>صي#.#? #.لجم#^ة #.لخ#%يثة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#?ي #?س#%#%ه#. #.ل#=#.ئن#.#? #.لحس#.سة غي#^ #.لش#.ئ#>ة س#.ل#%ة #.لغ#^#.م وموج#%ة #.لغ#^#.م. \r\n\r\n–م#^#_ ل#.يم. \r\n\r\n–#.لأمي#%#.#? #.لم#>وي. \r\n\r\n–ح#% #.لش#%#.#%. \r\n\r\n–#.ل#=ولي#^#.. \r\n\r\n–#.ل#?ه#.#%#.#? #.لأسن#.ن مثل #.ل#?ه#.#% #~و#.#>م #.لسن. \r\n\r\n–#.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لم#=و#^#.#? #.لم#>وية #.لمق#.ومة لل#<#.ن#=وميسن.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.ل#>م#^ #~ون 8 سنو#.#?، #.لإ #<ي ح#.لة #.لإص#.#%ة #%#.لجم#^ة #.لخ#%يثة.", "GI": "About Doxycycline\r\nTetracycline Derivative, Antibiotic.\r\n\r\nMechanism of Action of Doxycycline\r\nDoxycycline is a broad spectrum antibiotic which acts against both gram positive and gram negative organisms. It exerts its bacteriostatic action by accumulating inside the bacteria through specific transporter protein and by passive diffusion & inhibits bacterial protein synthesis by attaching to 30 S subunit of bacterial ribosome (which are absent in mammals).Doxycycline interfering the attachment of aminoacyl-tRNA to the mRNA-ribosome complex and peptide chain fails to grow. It chelates cations like Ca &Mg and inhibits functioning of various enzymes & ribosome. \r\n\r\nIndications for Doxycycline\r\n1. Syphilis \r\n2. Lympho granuloma veneram \r\n3. Typhus fever \r\n4. Respiratory tract infections \r\n5. Prophylaxis of malaria \r\n6. Urinogenital tract infections \r\n7. Trachoma \r\n8. Pelvic inflammatory disease\r\n9. Acne \r\n10. Diarrhoea \r\n11. Gonorrhea in penicillin allergic individuals \r\n12. Pneumonia", "Composition": "doxycycline 100mg", "Route": "ORAL.SOLID" }, { "ID": "651", "Trade_Name": "CLUDINETECH 1MG 10 H.G.CAP", "Generic_Name": "ENTECAVIR", "Price": "182", "Price_Old": "140", "Company": "EUROPEAN EGYPTIAN PHARM. IND. > PHARMA-TECH", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#?", "Use": "–#.ل#?ه#.#% #.ل#=#%#~ #.ل#<ي#^وسي #.لمزمن من #.لنم#- #%", "Contraindications": "–مش#.#=ل #<ي جه#.ز #.لمن#.#>ة \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.خ#^ى #<ي #.ل#=#%#~ \r\n\r\n–#^#~ #<#>ل #?حسسي لل#~و#.ء أو لأ#~وية #.و #.غذية م#>ينة \r\n\r\n–حمل #.و #.ل#?خ#-ي#- للحمل \r\n\r\n–#^#_#.#>ة \r\n\r\n–#?ن#.ول #.#~وية أخ#^ى", "GI": "About Entecavir\r\nNucleoside analog, reverse transcriptase inhibitor, oral antiviral drug used in the treatment of hepatitis B infection.\r\n\r\nMechanism of Action of Entecavir\r\nBy competing with the natural substrate deoxyguanosine triphosphate, entecavir functionally inhibits all three activities of the HBV polymerase (reverse transcriptase, rt): (1) base priming, (2) reverse transcription of the negative strand from the pregenomic messenger RNA, and (3) synthesis of the positive strand of HBV DNA. Upon activation by kinases, the drug can be incorporated into the DNA which has the ultimate effect of inhibiting the HBV polymerase activity.\r\n\r\nIndications for Entecavir\r\nFor the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.", "Composition": "entecavir 0.5mg or 1mg", "Route": "ORAL.SOLID" }, { "ID": "652", "Trade_Name": "CLUDINETECH 0.5MG 10 H.G.CAP", "Generic_Name": "ENTECAVIR", "Price": "170", "Price_Old": "130", "Company": "EUROPEAN EGYPTIAN PHARM. IND. > PHARMA-TECH", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#?", "Use": "–#.ل#?ه#.#% #.ل#=#%#~ #.ل#<ي#^وسي #.لمزمن من #.لنم#- #%", "Contraindications": "–مش#.#=ل #<ي جه#.ز #.لمن#.#>ة \r\n\r\n–#.م#^#.#_ #.ل#=لى \r\n\r\n–#.م#^#.#_ #.خ#^ى #<ي #.ل#=#%#~ \r\n\r\n–#^#~ #<#>ل #?حسسي لل#~و#.ء أو لأ#~وية #.و #.غذية م#>ينة \r\n\r\n–حمل #.و #.ل#?خ#-ي#- للحمل \r\n\r\n–#^#_#.#>ة \r\n\r\n–#?ن#.ول #.#~وية أخ#^ى", "GI": "About Entecavir\r\nNucleoside analog, reverse transcriptase inhibitor, oral antiviral drug used in the treatment of hepatitis B infection.\r\n\r\nMechanism of Action of Entecavir\r\nBy competing with the natural substrate deoxyguanosine triphosphate, entecavir functionally inhibits all three activities of the HBV polymerase (reverse transcriptase, rt): (1) base priming, (2) reverse transcription of the negative strand from the pregenomic messenger RNA, and (3) synthesis of the positive strand of HBV DNA. Upon activation by kinases, the drug can be incorporated into the DNA which has the ultimate effect of inhibiting the HBV polymerase activity.\r\n\r\nIndications for Entecavir\r\nFor the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.", "Composition": "entecavir 0.5mg or 1mg", "Route": "ORAL.SOLID" }, { "ID": "653", "Trade_Name": "CYMBALTA 30 MG 28 CAPS.", "Generic_Name": "DULOXETINE", "Price": "223", "Price_Old": "162", "Company": "ELI LILLY", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–ي#>مل #>لى #?خ#<ي#< أ#>#^#.#_ #.ل#.#=#?ئ#.#%. \r\n\r\n–يُ#>#.لج آل#.م #.لأ#>ص#.#% #.ل#?ي #?ُصي#% #.لق#~مين. \r\n\r\n–يُ#>#.لج ح#.ل#.#? #.لقلق #.لمس#?#>صية و#.ل#?و#?#^. \r\n\r\n–يق#_ي #>لى ح#.ل#.#? #.لخو#< و#.لهل#> #.ل#?ي #?ُسي#-#^ #>لى #%#>#_ #.لأشخ#.ص. \r\n\r\n–#>#.مل #<#>#.ل #<ي #?حسين #.لح#.لة #.لمز#.جية #%ش#=ل س#^ي#>. \r\n\r\n–يُ#>#.لج م#. يُ#>#^#< #%سلس #.ل#%ول ل#~ى #.لنس#.ء. \r\n\r\n–يُ#>#.لج آل#.م #.#>#?ل#.ل #.ل#>ص#%ي #.لذي يُصي#% #.لأ#-#^#.#< ن#?يجة #.لإص#.#%ة #%م#^#_ #.لس#=#^. \r\n\r\n–يُ#>#.لج #.لأم#^#.#_ #.ل#>ص#%ية #.ل#?ي #?ُصي#% #.لق#~مين.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي: #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج، أو لأي م#=ون آخ#^ من م#=ون#.#?ه #=م#. يمن#> #.#>#-#.ء #.ل#>ل#.ج #%#.ل#?ز#.من م#> مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين و ح#?ى 14 يوم #%#>#~ #.ل#?وق#< #>ن #.س#?خ#~#.مه#.. و يمن#> #.#>#-#.ء #.ل#>ل#.ج للم#^#_ى #.لمص#.#%ين #%ـ: #.لز#^ق #_يق #.لز#.وية #.لغي#^ م#?ج#.و#% م#> #.ل#>ل#.ج/غي#^ م#>#.لج، #<شل #<ي #.ل#=#%#~ #<شل ح#.#~ #<ي #.ل#=لى \r\n\r\n–يُحذ#^ #?ن#.وله للأ#-#<#.ل و#.لح#.مل حيث ي#=ون له #?أثي#^ سل#%ي #>لى صح#?هم. \r\n\r\n–يُحذ#^ #?ن#.وله أثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–يحظ#^ #?ن#.وله لمن يُ#>#.نون من م#^#_ #_غ#- #.ل#~م.", "GI": "About Duloxetine\r\nA serotonin-norepinephrine reuptake inhibitor,Thiophene derivative, Antidepressant.\r\n\r\nMechanism of Action of Duloxetine\r\nDuloxetine preferentially inhibits the re-uptake of Noradrenaline and Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect\r\n\r\nIndications for Duloxetine\r\n1. Major depressive disorder \r\n2. Diabetic Peripheral Neuropathic Pain \r\n3. Generalised anxiety disorder \r\n\r\nTypical Dosage for Duloxetine\r\nMajor Depressive Disorder: 20 - 60mg / day in 2 divided doses \r\nDiabetic Peripheral Neuropathic Pain:60 mg/day \r\nGeneralized Anxiety Disorder: 60 mg/ day", "Composition": "duloxetine 20mg or 30mg or 60mg", "Route": "ORAL.SOLID" }, { "ID": "654", "Trade_Name": "MUCOTEC 300MG 20 CAPS.", "Generic_Name": "ERDOSTEINE", "Price": "48.75", "Price_Old": "32.4", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يس#?خ#~م للوق#.ية من نو#%#.#? #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية خ#.صة #<ي #<صل #.لش#?#.ء. \r\n\r\n–يس#?خ#~م للم#~خنين للوق#.ية من #.لمخ#.#- و#.لس#>#.ل #.لذي ق#~ يس#%#%ه #.ل#?#~خين. \r\n\r\n–أم#^#.#_ #.ل#.ل#?ه#.#% #.لح#.#~ و#.لأغشية #.لمخ#.#-ية. \r\n\r\n–م#>#.لح ل#.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج ه#.م م#> #?ن#.ول #.لم#_#.#~ #.لحيوي حيث يقلل من #.ل#>#~وي #.ل#%#=#?ي#^ية. \r\n\r\n–#.ل#?ه#.#% #.لقص#%ة #.لهو#.ئية. \r\n\r\n–#.ل#?ه#.#% #.لحنج#^ة.", "Contraindications": "–#<#^#- #.لحس#.سية من م#.#~ة أ#^#~وس#?#.ين و#.ل#?ي #?ؤ#~ي إلي #?ل#< #.ل#=#%#~. \r\n\r\n–أم#^#.#_ #.ل#=#%#~ و#.ل#=لي و#.لقصو#^ #.لح#.#~ #<يهم#.. \r\n\r\n–أثن#.ء #<#?#^ة #.لحمل ل#. ي#<#_ل #.س#?خ#~#.مه حيث لم #?ث#%#? #.لأ#%ح#.ث #%#>#~ م#~ي خ#-و#^#?ه #>لي صحة ونمو و#?#=وين #.لجنين أو ح#~وث أي #?شوه#.#? خلقية لذي #?جن#%ي #.س#?#>م#.له #<ي #<#?#^ة #.لحمل من ج#.ن#% #.ل#.ح#?ي#.#-. \r\n\r\n–أثن#.ء #.ل#^#_#.#>ة #.ل#-#%ي#>ية ل#. ي#<#_ل #.س#?#>م#.ل ميو#=و#?#= حيث ي#?خلل إلي ل#%ن #.ل#^#_ي#> ولم #?ث#%#? #.لأ#%ح#.ث #%#>#~ م#~ي #?أثي#^ه. \r\n\r\n–#.لمص#.#%ين #%ق#^حة #<ي #.لم#>#~ة #>ليهم #>#~م #?ن#.ول ميو#=و#?#= ح#?ي ل#. #?ز#~#.#~ #.لح#.لة سوء#.. \r\n\r\n–#<ي ح#.لة ق#^حة #.لأم#>#.ء ل#. يس#?خ#~م هذ#. #.ل#~و#.ء.", "GI": "Mechanism of action\t\r\nErdosteine, an orally mucolytic agent. Erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. Erdosteine contains 2 blocked sulfhydryl groups which are released following first-pass metabolism. The 3 active metabolites exhibit mucolytic and free radical scavenging activity. Erdosteine modulates mucus production and viscosity and increases mucociliary transport, thereby improving expectoration. It also exhibits inhibitory activity against the effects of free radicals produced by cigarette smoke. Clinical studies in patients with chronic obstructive lung disease have demonstrated the efficacy and tolerability of erdosteine. Erdosteine 300mg twice daily reduced cough (both frequency and severity) and sputum viscosity more quickly and more effectively than placebo and reduced the adhesivity of sputum more effectively than ambroxol 30mg twice daily.", "Composition": "Each Mucotec capsule contains 150 mg or 300 mg erdosteine.", "Route": "ORAL.SOLID" }, { "ID": "655", "Trade_Name": "MUCOTEC 150MG 20 CAPS.", "Generic_Name": "ERDOSTEINE", "Price": "33", "Price_Old": "22", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يس#?خ#~م للوق#.ية من نو#%#.#? #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية خ#.صة #<ي #<صل #.لش#?#.ء. \r\n\r\n–يس#?خ#~م للم#~خنين للوق#.ية من #.لمخ#.#- و#.لس#>#.ل #.لذي ق#~ يس#%#%ه #.ل#?#~خين. \r\n\r\n–أم#^#.#_ #.ل#.ل#?ه#.#% #.لح#.#~ و#.لأغشية #.لمخ#.#-ية. \r\n\r\n–م#>#.لح ل#.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج ه#.م م#> #?ن#.ول #.لم#_#.#~ #.لحيوي حيث يقلل من #.ل#>#~وي #.ل#%#=#?ي#^ية. \r\n\r\n–#.ل#?ه#.#% #.لقص#%ة #.لهو#.ئية. \r\n\r\n–#.ل#?ه#.#% #.لحنج#^ة.", "Contraindications": "–#<#^#- #.لحس#.سية من م#.#~ة أ#^#~وس#?#.ين و#.ل#?ي #?ؤ#~ي إلي #?ل#< #.ل#=#%#~. \r\n\r\n–أم#^#.#_ #.ل#=#%#~ و#.ل#=لي و#.لقصو#^ #.لح#.#~ #<يهم#.. \r\n\r\n–أثن#.ء #<#?#^ة #.لحمل ل#. ي#<#_ل #.س#?خ#~#.مه حيث لم #?ث#%#? #.لأ#%ح#.ث #%#>#~ م#~ي خ#-و#^#?ه #>لي صحة ونمو و#?#=وين #.لجنين أو ح#~وث أي #?شوه#.#? خلقية لذي #?جن#%ي #.س#?#>م#.له #<ي #<#?#^ة #.لحمل من ج#.ن#% #.ل#.ح#?ي#.#-. \r\n\r\n–أثن#.ء #.ل#^#_#.#>ة #.ل#-#%ي#>ية ل#. ي#<#_ل #.س#?#>م#.ل ميو#=و#?#= حيث ي#?خلل إلي ل#%ن #.ل#^#_ي#> ولم #?ث#%#? #.لأ#%ح#.ث #%#>#~ م#~ي #?أثي#^ه. \r\n\r\n–#.لمص#.#%ين #%ق#^حة #<ي #.لم#>#~ة #>ليهم #>#~م #?ن#.ول ميو#=و#?#= ح#?ي ل#. #?ز#~#.#~ #.لح#.لة سوء#.. \r\n\r\n–#<ي ح#.لة ق#^حة #.لأم#>#.ء ل#. يس#?خ#~م هذ#. #.ل#~و#.ء.", "GI": "Mechanism of action\t\r\nErdosteine, an orally mucolytic agent. Erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. Erdosteine contains 2 blocked sulfhydryl groups which are released following first-pass metabolism. The 3 active metabolites exhibit mucolytic and free radical scavenging activity. Erdosteine modulates mucus production and viscosity and increases mucociliary transport, thereby improving expectoration. It also exhibits inhibitory activity against the effects of free radicals produced by cigarette smoke. Clinical studies in patients with chronic obstructive lung disease have demonstrated the efficacy and tolerability of erdosteine. Erdosteine 300mg twice daily reduced cough (both frequency and severity) and sputum viscosity more quickly and more effectively than placebo and reduced the adhesivity of sputum more effectively than ambroxol 30mg twice daily.", "Composition": "Each Mucotec capsule contains 150 mg or 300 mg erdosteine.", "Route": "ORAL.SOLID" }, { "ID": "656", "Trade_Name": "NERVALTA 60 MG 10 DEL. REL. CAPS.", "Generic_Name": "DULOXETINE", "Price": "55", "Price_Old": "55", "Company": "PHARCO", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–ي#>مل #>لى #?خ#<ي#< أ#>#^#.#_ #.ل#.#=#?ئ#.#%. \r\n\r\n–يُ#>#.لج آل#.م #.لأ#>ص#.#% #.ل#?ي #?ُصي#% #.لق#~مين. \r\n\r\n–يُ#>#.لج ح#.ل#.#? #.لقلق #.لمس#?#>صية و#.ل#?و#?#^. \r\n\r\n–يق#_ي #>لى ح#.ل#.#? #.لخو#< و#.لهل#> #.ل#?ي #?ُسي#-#^ #>لى #%#>#_ #.لأشخ#.ص. \r\n\r\n–#>#.مل #<#>#.ل #<ي #?حسين #.لح#.لة #.لمز#.جية #%ش#=ل س#^ي#>. \r\n\r\n–يُ#>#.لج م#. يُ#>#^#< #%سلس #.ل#%ول ل#~ى #.لنس#.ء. \r\n\r\n–يُ#>#.لج آل#.م #.#>#?ل#.ل #.ل#>ص#%ي #.لذي يُصي#% #.لأ#-#^#.#< ن#?يجة #.لإص#.#%ة #%م#^#_ #.لس#=#^. \r\n\r\n–يُ#>#.لج #.لأم#^#.#_ #.ل#>ص#%ية #.ل#?ي #?ُصي#% #.لق#~مين.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي: #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج، أو لأي م#=ون آخ#^ من م#=ون#.#?ه #=م#. يمن#> #.#>#-#.ء #.ل#>ل#.ج #%#.ل#?ز#.من م#> مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين و ح#?ى 14 يوم #%#>#~ #.ل#?وق#< #>ن #.س#?خ#~#.مه#.. و يمن#> #.#>#-#.ء #.ل#>ل#.ج للم#^#_ى #.لمص#.#%ين #%ـ: #.لز#^ق #_يق #.لز#.وية #.لغي#^ م#?ج#.و#% م#> #.ل#>ل#.ج/غي#^ م#>#.لج، #<شل #<ي #.ل#=#%#~ #<شل ح#.#~ #<ي #.ل#=لى \r\n\r\n–يُحذ#^ #?ن#.وله للأ#-#<#.ل و#.لح#.مل حيث ي#=ون له #?أثي#^ سل#%ي #>لى صح#?هم. \r\n\r\n–يُحذ#^ #?ن#.وله أثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–يحظ#^ #?ن#.وله لمن يُ#>#.نون من م#^#_ #_غ#- #.ل#~م.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "657", "Trade_Name": "ERDOTINOL 300MG 10 CAPS.", "Generic_Name": "ERDOSTEINE", "Price": "13.5", "Price_Old": "13.5", "Company": "MULTI-APEX > SOBOL EL DAWA MISR-EGYPT", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يس#?خ#~م للوق#.ية من نو#%#.#? #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية خ#.صة #<ي #<صل #.لش#?#.ء. \r\n\r\n–يس#?خ#~م للم#~خنين للوق#.ية من #.لمخ#.#- و#.لس#>#.ل #.لذي ق#~ يس#%#%ه #.ل#?#~خين. \r\n\r\n–أم#^#.#_ #.ل#.ل#?ه#.#% #.لح#.#~ و#.لأغشية #.لمخ#.#-ية. \r\n\r\n–م#>#.لح ل#.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج ه#.م م#> #?ن#.ول #.لم#_#.#~ #.لحيوي حيث يقلل من #.ل#>#~وي #.ل#%#=#?ي#^ية. \r\n\r\n–#.ل#?ه#.#% #.لقص#%ة #.لهو#.ئية. \r\n\r\n–#.ل#?ه#.#% #.لحنج#^ة.", "Contraindications": "–#<#^#- #.لحس#.سية من م#.#~ة أ#^#~وس#?#.ين و#.ل#?ي #?ؤ#~ي إلي #?ل#< #.ل#=#%#~. \r\n\r\n–أم#^#.#_ #.ل#=#%#~ و#.ل#=لي و#.لقصو#^ #.لح#.#~ #<يهم#.. \r\n\r\n–أثن#.ء #<#?#^ة #.لحمل ل#. ي#<#_ل #.س#?خ#~#.مه حيث لم #?ث#%#? #.لأ#%ح#.ث #%#>#~ م#~ي خ#-و#^#?ه #>لي صحة ونمو و#?#=وين #.لجنين أو ح#~وث أي #?شوه#.#? خلقية لذي #?جن#%ي #.س#?#>م#.له #<ي #<#?#^ة #.لحمل من ج#.ن#% #.ل#.ح#?ي#.#-. \r\n\r\n–أثن#.ء #.ل#^#_#.#>ة #.ل#-#%ي#>ية ل#. ي#<#_ل #.س#?#>م#.ل ميو#=و#?#= حيث ي#?خلل إلي ل#%ن #.ل#^#_ي#> ولم #?ث#%#? #.لأ#%ح#.ث #%#>#~ م#~ي #?أثي#^ه. \r\n\r\n–#.لمص#.#%ين #%ق#^حة #<ي #.لم#>#~ة #>ليهم #>#~م #?ن#.ول ميو#=و#?#= ح#?ي ل#. #?ز#~#.#~ #.لح#.لة سوء#.. \r\n\r\n–#<ي ح#.لة ق#^حة #.لأم#>#.ء ل#. يس#?خ#~م هذ#. #.ل#~و#.ء.", "GI": "Mechanism of action\t\r\nErdosteine, an orally mucolytic agent. Erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. Erdosteine contains 2 blocked sulfhydryl groups which are released following first-pass metabolism. The 3 active metabolites exhibit mucolytic and free radical scavenging activity. Erdosteine modulates mucus production and viscosity and increases mucociliary transport, thereby improving expectoration. It also exhibits inhibitory activity against the effects of free radicals produced by cigarette smoke. Clinical studies in patients with chronic obstructive lung disease have demonstrated the efficacy and tolerability of erdosteine. Erdosteine 300mg twice daily reduced cough (both frequency and severity) and sputum viscosity more quickly and more effectively than placebo and reduced the adhesivity of sputum more effectively than ambroxol 30mg twice daily.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "658", "Trade_Name": "DULOXEPRIN 30 MG 28 CAPS.", "Generic_Name": "DULOXETINE", "Price": "120", "Price_Old": "120", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > UTOPIA PHARMACEUTICALS COMPANY", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–ي#>مل #>لى #?خ#<ي#< أ#>#^#.#_ #.ل#.#=#?ئ#.#%. \r\n\r\n–يُ#>#.لج آل#.م #.لأ#>ص#.#% #.ل#?ي #?ُصي#% #.لق#~مين. \r\n\r\n–يُ#>#.لج ح#.ل#.#? #.لقلق #.لمس#?#>صية و#.ل#?و#?#^. \r\n\r\n–يق#_ي #>لى ح#.ل#.#? #.لخو#< و#.لهل#> #.ل#?ي #?ُسي#-#^ #>لى #%#>#_ #.لأشخ#.ص. \r\n\r\n–#>#.مل #<#>#.ل #<ي #?حسين #.لح#.لة #.لمز#.جية #%ش#=ل س#^ي#>. \r\n\r\n–يُ#>#.لج م#. يُ#>#^#< #%سلس #.ل#%ول ل#~ى #.لنس#.ء. \r\n\r\n–يُ#>#.لج آل#.م #.#>#?ل#.ل #.ل#>ص#%ي #.لذي يُصي#% #.لأ#-#^#.#< ن#?يجة #.لإص#.#%ة #%م#^#_ #.لس#=#^. \r\n\r\n–يُ#>#.لج #.لأم#^#.#_ #.ل#>ص#%ية #.ل#?ي #?ُصي#% #.لق#~مين.", "Contraindications": "–يمن#> #.س#?خ#~#.مه #<ي: #.لم#^#_ى #.لذين أظه#^و#. #<#^#- #.لحس#.سية لل#>ل#.ج، أو لأي م#=ون آخ#^ من م#=ون#.#?ه #=م#. يمن#> #.#>#-#.ء #.ل#>ل#.ج #%#.ل#?ز#.من م#> مث#%#-#.#? أ#=سي#~#.ز أح#.#~ي #.لأمين و ح#?ى 14 يوم #%#>#~ #.ل#?وق#< #>ن #.س#?خ#~#.مه#.. و يمن#> #.#>#-#.ء #.ل#>ل#.ج للم#^#_ى #.لمص#.#%ين #%ـ: #.لز#^ق #_يق #.لز#.وية #.لغي#^ م#?ج#.و#% م#> #.ل#>ل#.ج/غي#^ م#>#.لج، #<شل #<ي #.ل#=#%#~ #<شل ح#.#~ #<ي #.ل#=لى \r\n\r\n–يُحذ#^ #?ن#.وله للأ#-#<#.ل و#.لح#.مل حيث ي#=ون له #?أثي#^ سل#%ي #>لى صح#?هم. \r\n\r\n–يُحذ#^ #?ن#.وله أثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–يحظ#^ #?ن#.وله لمن يُ#>#.نون من م#^#_ #_غ#- #.ل#~م.", "GI": "About Duloxetine\r\nA serotonin-norepinephrine reuptake inhibitor,Thiophene derivative, Antidepressant.\r\n\r\nMechanism of Action of Duloxetine\r\nDuloxetine preferentially inhibits the re-uptake of Noradrenaline and Serotonin (5 HT) in the CNS nerve terminals .This will result in an increased concentration of neurotransmitter Serotonin in the synaptic cleft and produces antidepressant effect\r\n\r\nIndications for Duloxetine\r\n1. Major depressive disorder \r\n2. Diabetic Peripheral Neuropathic Pain \r\n3. Generalised anxiety disorder \r\n\r\nTypical Dosage for Duloxetine\r\nMajor Depressive Disorder: 20 - 60mg / day in 2 divided doses \r\nDiabetic Peripheral Neuropathic Pain:60 mg/day \r\nGeneralized Anxiety Disorder: 60 mg/ day", "Composition": "duloxetine 60mg", "Route": "ORAL.SOLID" }, { "ID": "659", "Trade_Name": "PRIMOMYCIN 400/100 MG 12 CAPS.", "Generic_Name": "ERYTHROMYCIN+TRIMETHOPRIM", "Price": "10.5", "Price_Old": "10.5", "Company": "RAMEDA", "Pharmacology": "ANTIBIOTIC", "Category": "م#_#.#~ حيوي", "Use": "–#.م#^#.#_ #.لجه#.ز #.ل#?ن#<سى #.لمي#=#^و#%ية مثل #.لنزل#.#? #.لش#>#%ية و#.ل#.ل#?ه#.#% #.ل#^ئوى و#.ل#?ه#.#% #.لحويصل#.#? #.لهو#.ئية \r\n\r\n–#.م#^#.#_ #.ل#.ن#< و#.ل#.ذن و#.لحنج#^ة #.لمي#=#^و#%ية و#.ل#?ه#.#% #.لحلق و#.للوز#?ين و#.ل#.ذن #.لوس#-ى \r\n\r\n–#.م#^#.#_ #.لمس#.ل#= #.ل#%ولية #.لمي#=#^و#%ية \r\n\r\n–#.ل#.م#^#.#_ #.ل#?ن#.سلية و#.م#^#.#_ #.لنس#. #.لمي#=#^و#%ية \r\n\r\n–#.ل#?ه#.#%#.#? #.لمس#?قيم و#.لقولون #.لمي#=#^و#%ية \r\n\r\n–#=ذل#= يس#?#>مل لل#?خلص من #.لح#.ل#.#? #.لح#.ملة لل#%#=#?#^ي#. #.لو#?#~ية #.ل#~#<#?ي#^ية", "Contraindications": "–#.لم#^#_ى #.لس#.#%ق #?#>#^#_هم ل#.م#^#.#_ #.ل#=#%#~ #.و #.لص#<#^#.ء \r\n\r\n–#.لم#^#_ى #%نقص #.نزيم جلو#=وز 6 #<وس#<#.#? #~يهي#~#^وجين#.ز \r\n\r\n–ح#.ل#.#? #<#^#- #.لحس#.سية ل#.ى من #.#^يث#^وم#.يثين #.و #?#^#.ى ميثو#%#^يم \r\n\r\n–خل#.ل شهو#^ #.لحمل #.لثل#.ثة #.ل#.ولى و#.ثن#.ء #<#?#^ة #.ل#^#_#.#>ة", "GI": "About Erythromycin\r\nMacrolide Antibiotic.\r\nMechanism of Action of Erythromycin\r\nErythromycin is a member of macrolide antibiotics. It binds to the 50S sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly formed peptide chain from the A site to the P site and fails to expose the A site .So that A site is unable to bind with the next aminoacyl t RNA complex. This leads to premature termination of amino acid chain and there by inhibits protein synthesis.\r\nInteractions for Erythromycin\r\nAnticoagulants: Efficacy enhanced leading to haemorrhages. \r\nBromocriptine: Efficacy protentiated leading to toxicity. \r\nCarbamazepine: Dangerous toxic side effects requiring resuscitative measures and hospitalisation. \r\nDigoxin: Serum levels of digoxin enhanced, leading to toxicity. \r\nDisopyramide: Increased disopyramide plasma levels leading to arrhythmias. \r\nErgot Alkaloids: Acute ergotism manifested as peripheral ischaemia.", "Composition": "Erythromycin / Trimethoprim", "Route": "ORAL.SOLID" }, { "ID": "660", "Trade_Name": "DANTRELAX 25MG 30 CAPS.", "Generic_Name": "DANTROLENE", "Price": "58.5", "Price_Old": "39", "Company": "CHEMIPHARM", "Pharmacology": "SKELETAL MUSCLE RELAXANT.ANALGESIC.RYANODINE RECEPTOR (RYR1) CALCIUM CHANNEL BLOCKER PERIPHERAL", "Category": "#%#.س#- لل#>#_ل#.#? #.لهي#=لية", "Use": "–#>ل#.ج آلم #.لم#<#.صل. \r\n\r\n–#>ل#.ج #.ل#?شنج#.#? و#.لأم#^#.#_ #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج آلم #.لأذن و#.ل#.ل#?ه#.#% #.لذي يُصي#% من#-قة #.لأذن. \r\n\r\n–ي#?خلص من آل#.م #.لأسن#.ن. \r\n\r\n–#>ل#.ج أ#^#?#<#.#> #~#^جة ح#^#.#^ة #.لجسم. \r\n\r\n–ي#?خلص من آل#.م #.لص#~#.#>. \r\n\r\n–ي#?خلص من آل#.م #.ل#%#^#~ و#.لإن#<لونز#.. \r\n\r\n–مُس#=ن #<#>#.ل ل#?قلص #.ل#>#_ل#.#?.", "Contraindications": "–يمن#> #?ن#.وله #<ي وق#? #?ن#.ول أي مُه#~ئ#.#?. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل أقل من 5 سنو#.#?. \r\n\r\n–يمن#> #?ن#.وله لم#^#_ى قصو#^ #.ل#=لي و#.ل#=#%#~. \r\n\r\n–ي#=ون خ#-#^#.ً #>لى م#^#_ى #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>نه لمن ل#~يهم مش#.#=ل #<ي #.لقل#%. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.لة ح#~وث خلل #<ي وظ#.ئ#< #.ل#=لي.", "GI": "Mechanism of Action of Dantrolene sodium\r\nDantrolene is s skeletal muscle relaxant which differs from the classical neuromuscular blocking drugs. It inhibits the release of Calcium from sarcoplasmic reticulam and suppresses excitation contraction coupling. It reduces the calcium level associated with malignant hyperthermia crises.\r\n\r\nIndications for Dantrolene sodium\r\n1. Spasticity resulting from upper motor neuron lesions such as spinal cord injury, stroke, multiple sclerosis, cerebral palsy\r\nTypical Dosage for Dantrolene sodium\r\nOral \r\nAdult: 25mg/day if needed dose can be increased by 25mg every 4 - 7 days up to 400mg/day in 4 divided doses. \r\nChildren \r\nAbove 5 years: 0.5mg/kg 2 times daily, if needed dose can be gradually increased by 0.5mg/kg up to 3mg/kg 2 - 4 times daily. Maximum dose: 400 mg/day", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "661", "Trade_Name": "ARTICU-SAFE 50MG 30 CAPS.", "Generic_Name": "DIACERIN", "Price": "88.25", "Price_Old": "63", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTI-INFLAMMATORY", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "–#>ل#.ج خشونة #.ل#^#=#%ة. \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل . \r\n\r\n–حم#.ية #.ل#-#%قة #.لغ#_#^و#<ية و#.لس#.ئل من #.ل#?آ#=ل.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة وجو#~ #.ي حس#.سية #?ج#.ه أح#~ م#=ون#.#? #.ل#~و#.ء #.ل#^ئيسية. \r\n\r\n– يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.لحمل لمن#> #.ن#?ق#.له#. إلى #.لجنين وق#~ يس#%#% ذل#= مو#?ه أو #?شويهه. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه ق#~ ين#?قل لل#-#<ل ويس#%#% أ#_#^#.#^ #=ثي#^ة له. يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ أي خلل #<ي وظ#.ئ#< #.ل#=#%#~ و#.ل#=لى. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #_#>#< #<ي #>#_لة #.لقل#% . \r\n\r\n– يمن#> #.س#?خ#~#.مه للأ#-#<#.ل أقل من 15سنه. يمن#> #.س#?خ#~#.مه #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "(Indications) : \r\nThis medication is an anti-inflammatory agent, prescribed for osteoarthritis and chronic inflammatory arthritis. It works by inhibiting interleukin-1. \r\n\r\nDosage & When it is to be taken : \r\nOsteoarthritis- Adult-PO- The recommended dose is 50 mg to be taken twice daily. \r\n\r\nWarnings and Precautions : Caution should be exercised in patients with history of liver, kidney disease, during pregnancy and breastfeeding. \r\nMonitor complete blood count, liver function, and urinalysis regularly while taking this medication. \r\n\r\nSide Effects : Diarrhea, stomach pain, nausea, vomiting and intense yellow coloring of urine.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "662", "Trade_Name": "KELFER 500 MG 50 CAPS.", "Generic_Name": "DEFERIPRONE", "Price": "62", "Price_Old": "62", "Company": "CIPLA LTD. - INDIA > STAR INTERNATIONAL COMPANY", "Pharmacology": "IRON CHELATING AGENT", "Category": "#>ل#.ج ل#.#^#?#<#.#> #.لح#~ي#~ #%#.ل#~م", "Use": "–ي#>مل #>لى إز#.لة #.لح#~ي#~ #.لز#.ئ#~ من #.لجسم. \r\n\r\n–#>ل#.ج م#^#_ى #.لثل#.سيمي#. و#.ل#?ي ي#?#>#^#_ له#. #%#>#_ #.لأشخ#.ص #.لذين #?م نقل #~م لهم. \r\n\r\n–ي#>مل #>لى إز#.لة #.لح#~ي#~ #.لز#.ئ#~ من #.لجسم #>ن #-#^يق #.ل#=لى.", "Contraindications": "–خل#.ل #<#?#^ة #.لحمل، حيث يؤ#~ي #.لى ح#~وث #?شوه#.#? ل#~ى #.لجنين. \r\n\r\n–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لأ#-#<#.ل و#.لم#^#.هقين #~ون سن 18 #>#.م.", "GI": "Description\t\r\nDeferiprone is an oral iron chelator used as a second line agent in thalassemia syndromes when iron overload from blood transfusions occurs. Thalassemias are a type of hereditary anaemia due a defect in the production of hemoglobin. As a result, erythropoiesis, the production of new red blood cells, is impaired. FDA approved on October 14, 2011.\r\n\r\nIndication\t:\r\nDeferiprone is indicated in thalassemia syndromes when first line chelation agents are not adequate to treat transfusional iron overload.\r\n\r\nMechanism of action\tDeferiprone \\\"\r\nis an iron chelator that binds to ferric ions (iron III) and forms a 3:1 (deferiprone:iron) stable complex and is then eliminated in the urine. Deferiprone is more selective for iron in which other metals such as zinc, copper, and aluminum have a lower affinity for deferiprone.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "663", "Trade_Name": "DANTRONE 25 MG 10 CAPS.", "Generic_Name": "DANTROLENE", "Price": "11", "Price_Old": "11", "Company": "HIKMA PHARMA", "Pharmacology": "SKELETAL MUSCLE RELAXANT.ANALGESIC.RYANODINE RECEPTOR (RYR1) CALCIUM CHANNEL BLOCKER PERIPHERAL", "Category": "#%#.س#- لل#>#_ل#.#? #.لهي#=لية", "Use": "–#>ل#.ج آلم #.لم#<#.صل. \r\n\r\n–#>ل#.ج #.ل#?شنج#.#? و#.لأم#^#.#_ #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج آلم #.لأذن و#.ل#.ل#?ه#.#% #.لذي يُصي#% من#-قة #.لأذن. \r\n\r\n–ي#?خلص من آل#.م #.لأسن#.ن. \r\n\r\n–#>ل#.ج أ#^#?#<#.#> #~#^جة ح#^#.#^ة #.لجسم. \r\n\r\n–ي#?خلص من آل#.م #.لص#~#.#>. \r\n\r\n–ي#?خلص من آل#.م #.ل#%#^#~ و#.لإن#<لونز#.. \r\n\r\n–مُس#=ن #<#>#.ل ل#?قلص #.ل#>#_ل#.#?.", "Contraindications": "–يمن#> #?ن#.وله #<ي وق#? #?ن#.ول أي مُه#~ئ#.#?. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل أقل من 5 سنو#.#?. \r\n\r\n–يمن#> #?ن#.وله لم#^#_ى قصو#^ #.ل#=لي و#.ل#=#%#~. \r\n\r\n–ي#=ون خ#-#^#.ً #>لى م#^#_ى #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>نه لمن ل#~يهم مش#.#=ل #<ي #.لقل#%. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.لة ح#~وث خلل #<ي وظ#.ئ#< #.ل#=لي.", "GI": "Mechanism of Action of Dantrolene sodium\r\nDantrolene is s skeletal muscle relaxant which differs from the classical neuromuscular blocking drugs. It inhibits the release of Calcium from sarcoplasmic reticulam and suppresses excitation contraction coupling. It reduces the calcium level associated with malignant hyperthermia crises.\r\n\r\nIndications for Dantrolene sodium\r\n1. Spasticity resulting from upper motor neuron lesions such as spinal cord injury, stroke, multiple sclerosis, cerebral palsy\r\nTypical Dosage for Dantrolene sodium\r\nOral \r\nAdult: 25mg/day if needed dose can be increased by 25mg every 4 - 7 days up to 400mg/day in 4 divided doses. \r\nChildren \r\nAbove 5 years: 0.5mg/kg 2 times daily, if needed dose can be gradually increased by 0.5mg/kg up to 3mg/kg 2 - 4 times daily. Maximum dose: 400 mg/day", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "664", "Trade_Name": "OSTEORINE 50 MG 15 CAPS.", "Generic_Name": "DIACERIN", "Price": "31.8", "Price_Old": "31.8", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "ANTI-INFLAMMATORY", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "–#>ل#.ج خشونة #.ل#^#=#%ة. \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل . \r\n\r\n–حم#.ية #.ل#-#%قة #.لغ#_#^و#<ية و#.لس#.ئل من #.ل#?آ#=ل.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة وجو#~ #.ي حس#.سية #?ج#.ه أح#~ م#=ون#.#? #.ل#~و#.ء #.ل#^ئيسية. \r\n\r\n– يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.لحمل لمن#> #.ن#?ق#.له#. إلى #.لجنين وق#~ يس#%#% ذل#= مو#?ه أو #?شويهه. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه ق#~ ين#?قل لل#-#<ل ويس#%#% أ#_#^#.#^ #=ثي#^ة له. يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ أي خلل #<ي وظ#.ئ#< #.ل#=#%#~ و#.ل#=لى. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #_#>#< #<ي #>#_لة #.لقل#% . \r\n\r\n– يمن#> #.س#?خ#~#.مه للأ#-#<#.ل أقل من 15سنه. يمن#> #.س#?خ#~#.مه #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "(Indications) : \r\nThis medication is an anti-inflammatory agent, prescribed for osteoarthritis and chronic inflammatory arthritis. It works by inhibiting interleukin-1. \r\n\r\nDosage & When it is to be taken : \r\nOsteoarthritis- Adult-PO- The recommended dose is 50 mg to be taken twice daily. \r\n\r\nWarnings and Precautions : Caution should be exercised in patients with history of liver, kidney disease, during pregnancy and breastfeeding. \r\nMonitor complete blood count, liver function, and urinalysis regularly while taking this medication. \r\n\r\nSide Effects : Diarrhea, stomach pain, nausea, vomiting and intense yellow coloring of urine.", "Composition": "diacerin 50mg", "Route": "ORAL.SOLID" }, { "ID": "665", "Trade_Name": "DIACEREIN 50MG 30 CAP.", "Generic_Name": "DIACERIN", "Price": "92.5", "Price_Old": "66", "Company": "EVA PHARMA", "Pharmacology": "ANTI-INFLAMMATORY", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "–#>ل#.ج خشونة #.ل#^#=#%ة. \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل . \r\n\r\n–حم#.ية #.ل#-#%قة #.لغ#_#^و#<ية و#.لس#.ئل من #.ل#?آ#=ل.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة وجو#~ #.ي حس#.سية #?ج#.ه أح#~ م#=ون#.#? #.ل#~و#.ء #.ل#^ئيسية. \r\n\r\n– يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.لحمل لمن#> #.ن#?ق#.له#. إلى #.لجنين وق#~ يس#%#% ذل#= مو#?ه أو #?شويهه. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه ق#~ ين#?قل لل#-#<ل ويس#%#% أ#_#^#.#^ #=ثي#^ة له. يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ أي خلل #<ي وظ#.ئ#< #.ل#=#%#~ و#.ل#=لى. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #_#>#< #<ي #>#_لة #.لقل#% . \r\n\r\n– يمن#> #.س#?خ#~#.مه للأ#-#<#.ل أقل من 15سنه. يمن#> #.س#?خ#~#.مه #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "(Indications) : \r\nThis medication is an anti-inflammatory agent, prescribed for osteoarthritis and chronic inflammatory arthritis. It works by inhibiting interleukin-1. \r\n\r\nDosage & When it is to be taken : \r\nOsteoarthritis- Adult-PO- The recommended dose is 50 mg to be taken twice daily. \r\n\r\nWarnings and Precautions : Caution should be exercised in patients with history of liver, kidney disease, during pregnancy and breastfeeding. \r\nMonitor complete blood count, liver function, and urinalysis regularly while taking this medication. \r\n\r\nSide Effects : Diarrhea, stomach pain, nausea, vomiting and intense yellow coloring of urine.", "Composition": "Diacerein 50 mg", "Route": "ORAL.SOLID" }, { "ID": "666", "Trade_Name": "DANTRELAX COMPOUND 30 CAPS.", "Generic_Name": "DANTROLENE+PARACETAMOL(ACETAMINOPHEN)", "Price": "63", "Price_Old": "42", "Company": "CHEMIPHARM", "Pharmacology": "SKELETAL MUSCLE RELAXANT.ANALGESIC.RYANODINE RECEPTOR (RYR1) CALCIUM CHANNEL BLOCKER PERIPHERAL", "Category": "#%#.س#- لل#>#_ل#.#? #.لهي#=لية", "Use": "–#>ل#.ج آلم #.لم#<#.صل. \r\n\r\n–#>ل#.ج #.ل#?شنج#.#? و#.لأم#^#.#_ #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج آلم #.لأذن و#.ل#.ل#?ه#.#% #.لذي يصي#% من#-قة #.لأذن. \r\n\r\n–ي#?خلص من آل#.م #.لأسن#.ن. \r\n\r\n–#>ل#.ج أ#^#?#<#.#> #~#^جة ح#^#.#^ة #.لجسم. \r\n\r\n–ي#?خلص من آل#.م #.لص#~#.#>. \r\n\r\n–ي#?خلص من آل#.م #.ل#%#^#~ و#.لإن#<لونز#.. \r\n\r\n–مس#=ن #<#>#.ل ل#?قلص #.ل#>#_ل#.#?.", "Contraindications": "–يج#% #?جن#% #?ن#.ول هذه #.ل#=#%سول#.#? #<ي وق#? #.ل#^#_#.#>ة أو #.لحمل. \r\n\r\n–يمن#> #?ن#.وله #<ي وق#? #?ن#.ول أي مُه#~ئ#.#?. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل أقل من 5 سنو#.#?. \r\n\r\n–يمن#> #?ن#.وله لم#^#_ى قصو#^ #.ل#=لي و#.ل#=#%#~. \r\n\r\n–ي#=ون خ#-#^#.ً #>لى م#^#_ى #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>نه لمن ل#~يهم مش#.#=ل #<ي #.لقل#%. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.لة ح#~وث خلل #<ي وظ#.ئ#< #.ل#=لي.", "GI": "Mechanism of Action of Dantrolene sodium\r\nDantrolene is s skeletal muscle relaxant which differs from the classical neuromuscular blocking drugs. It inhibits the release of Calcium from sarcoplasmic reticulam and suppresses excitation contraction coupling. It reduces the calcium level associated with malignant hyperthermia crises\r\nIndications for Dantrolene sodium\r\n1. Spasticity resulting from upper motor neuron lesions such as spinal cord injury, stroke, multiple sclerosis, cerebral palsy\r\nTypical Dosage for Dantrolene sodium\r\nOral \r\nAdult: 25mg/day if needed dose can be increased by 25mg every 4 - 7 days up to 400mg/day in 4 divided doses. \r\nChildren \r\nAbove 5 years: 0.5mg/kg 2 times daily, if needed dose can be gradually increased by 0.5mg/kg up to 3mg/kg 2 - 4 times daily. Maximum dose: 400 mg/day", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "667", "Trade_Name": "OSTEOCEREIN 50MG 20 CAPS.", "Generic_Name": "DIACERIN", "Price": "44", "Price_Old": "44", "Company": "NOVARTIS", "Pharmacology": "ANTI-INFLAMMATORY", "Category": "م#_#.#~ للإل#?ه#.#%", "Use": "–#>ل#.ج خشونة #.ل#^#=#%ة. \r\n\r\n–#.ل#?ه#.#%#.#? #.لم#<#.صل . \r\n\r\n–حم#.ية #.ل#-#%قة #.لغ#_#^و#<ية و#.لس#.ئل من #.ل#?آ#=ل.", "Contraindications": "–يمن#> #.س#?خ#~#.م #.ل#~و#.ء #<ي ح#.لة وجو#~ #.ي حس#.سية #?ج#.ه أح#~ م#=ون#.#? #.ل#~و#.ء #.ل#^ئيسية. \r\n\r\n– يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.لحمل لمن#> #.ن#?ق#.له#. إلى #.لجنين وق#~ يس#%#% ذل#= مو#?ه أو #?شويهه. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية لأنه ق#~ ين#?قل لل#-#<ل ويس#%#% أ#_#^#.#^ #=ثي#^ة له. يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ أي خلل #<ي وظ#.ئ#< #.ل#=#%#~ و#.ل#=لى. \r\n\r\n–يمن#> #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #_#>#< #<ي #>#_لة #.لقل#% . \r\n\r\n– يمن#> #.س#?خ#~#.مه للأ#-#<#.ل أقل من 15سنه. يمن#> #.س#?خ#~#.مه #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "(Indications) : \r\nThis medication is an anti-inflammatory agent, prescribed for osteoarthritis and chronic inflammatory arthritis. It works by inhibiting interleukin-1. \r\n\r\nDosage & When it is to be taken : \r\nOsteoarthritis- Adult-PO- The recommended dose is 50 mg to be taken twice daily. \r\n\r\nWarnings and Precautions : Caution should be exercised in patients with history of liver, kidney disease, during pregnancy and breastfeeding. \r\nMonitor complete blood count, liver function, and urinalysis regularly while taking this medication. \r\n\r\nSide Effects : Diarrhea, stomach pain, nausea, vomiting and intense yellow coloring of urine.", "Composition": "Active: Each capsule contains 50mg Diacerein", "Route": "ORAL.SOLID" }, { "ID": "668", "Trade_Name": "DANTRONE 50 MG 10 CAPS.", "Generic_Name": "DANTROLENE", "Price": "16", "Price_Old": "16", "Company": "HIKMA PHARMA", "Pharmacology": "SKELETAL MUSCLE RELAXANT.ANALGESIC.RYANODINE RECEPTOR (RYR1) CALCIUM CHANNEL BLOCKER PERIPHERAL", "Category": "#%#.س#- لل#>#_ل#.#? #.لهي#=لية", "Use": "–#>ل#.ج آلم #.لم#<#.صل. \r\n\r\n–#>ل#.ج #.ل#?شنج#.#? و#.لأم#^#.#_ #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج آلم #.لأذن و#.ل#.ل#?ه#.#% #.لذي يُصي#% من#-قة #.لأذن. \r\n\r\n–ي#?خلص من آل#.م #.لأسن#.ن. \r\n\r\n–#>ل#.ج أ#^#?#<#.#> #~#^جة ح#^#.#^ة #.لجسم. \r\n\r\n–ي#?خلص من آل#.م #.لص#~#.#>. \r\n\r\n–ي#?خلص من آل#.م #.ل#%#^#~ و#.لإن#<لونز#.. \r\n\r\n–مُس#=ن #<#>#.ل ل#?قلص #.ل#>#_ل#.#?.", "Contraindications": "–يمن#> #?ن#.وله #<ي وق#? #?ن#.ول أي مُه#~ئ#.#?. \r\n\r\n–يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل أقل من 5 سنو#.#?. \r\n\r\n–يمن#> #?ن#.وله لم#^#_ى قصو#^ #.ل#=لي و#.ل#=#%#~. \r\n\r\n–ي#=ون خ#-#^#.ً #>لى م#^#_ى #.لجه#.ز #.ل#?ن#<سي. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>نه لمن ل#~يهم مش#.#=ل #<ي #.لقل#%. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.لة ح#~وث خلل #<ي وظ#.ئ#< #.ل#=لي.", "GI": "Mechanism of Action of Dantrolene sodium\r\nDantrolene is s skeletal muscle relaxant which differs from the classical neuromuscular blocking drugs. It inhibits the release of Calcium from sarcoplasmic reticulam and suppresses excitation contraction coupling. It reduces the calcium level associated with malignant hyperthermia crises.\r\n\r\nIndications for Dantrolene sodium\r\n1. Spasticity resulting from upper motor neuron lesions such as spinal cord injury, stroke, multiple sclerosis, cerebral palsy\r\nTypical Dosage for Dantrolene sodium\r\nOral \r\nAdult: 25mg/day if needed dose can be increased by 25mg every 4 - 7 days up to 400mg/day in 4 divided doses. \r\nChildren \r\nAbove 5 years: 0.5mg/kg 2 times daily, if needed dose can be gradually increased by 0.5mg/kg up to 3mg/kg 2 - 4 times daily. Maximum dose: 400 mg/day", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "669", "Trade_Name": "FLOTAC 75MG 20 CAPS.", "Generic_Name": "DICLOFENAC SODIUM", "Price": "45", "Price_Old": "30", "Company": "NOVARTIS", "Pharmacology": "NSAID.ACETIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> مس#=ن", "Use": "–يس#?خ#~م #=م#_#.#~ لل#.ل#?ه#.#%#.#?، وخ#.#<#_ للح#^#.#^ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لم#<صلية #.ل#^وم#.#?وي#~ية، وأي#_#. #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–مس#=ن للآل#.م #.لمص#.ح#%ة للحي#_ #>ن#~ #.لنس#.ء. \r\n\r\n–#?س#=ين #.لآل#.م ووج#> #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#<ق#.#^ #.لمقس#-، ومس#=ن لألم أس#<ل #.لظه#^. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لأذن و#.لأن#<، و#.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–مس#=ن لآل#.م #.لجسم و#.لمغص #.لم#^#.#^ي و#.ل#=لوي. \r\n\r\n–مس#=ن للص#~#.#> و#.لص#~#.#> #.لنص#<ي. \r\n\r\n–#>ل#.ج #.لألم #.لمص#.ح#% لهش#.شة #.ل#>ظ#.م. \r\n\r\n–مس#=ن للآل#.م #.لن#.#?جة #>ن #.لإص#.#%ة و#.ل#.ل#?و#.ء#.#?، وأي#_#. #.لن#.#?جة #>ن إص#.#%#.#? #.لمل#.#>#% #.ل#^ي#.#_ية. \r\n\r\n–مس#=ن للآل#.م #.لن#.#?جة #>ن #.ل#?ه#.#% #.لأنسجة #.ل#>#_لية و#.لأنسجة #.ل#^خوة.", "Contraindications": "–#<#^#- #.لحس#.سية لم#.#~ة #~ي#=لو#<ين#.#= صو#~يوم أو للأس#%#^ين أو للأ#~وية غي#^ #.لإس#?ي#^وي#~ية #.لأخ#^ى. \r\n\r\n–#<ي ح#.لة وجو#~ ق#^حة #.لم#>#~ة #.لنش#-ة أو نزي#< #%#.لأم#>#.ء. \r\n\r\n–#.س#?#>م#.ل #.ل#~و#.ء #%حذ#^ م#> م#^#_ى #.ل#^#%و،حيث #?#?س#%#% م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لإس#?#^و#~ية #<ي أزم#.#? #^#%وية. \r\n\r\n–أم#^#.#_ #.لأم#>#.ء #.ل#.ل#?ه#.#%ية مثل م#^#_ #=#^ون و#.ل#?ه#.#% #.لقولون #.ل#?ق#^حي. \r\n\r\n–#<ي ح#.ل#.#? أم#^#.#_ #.لقل#% و#.#^#?#<#.#> #_غ#- #.ل#~م، وم#^#_ى سيولة #.ل#~م، وقصو#^ #.لقل#% #.ل#>ني#<، وأم#^#.#_ ش#^#.يين #.لقل#% #.ل#?#.جية أو #.لألم #.لن#.#?ج #>ن #.لج#^#.ح#.#? ل#>ل#.جه#. هذه لمش#.#=ل؛ لأنه يزي#~ من ح#~وث #?جل#- #.ل#~م #%#.لش#^#.يين #.لقل#%ية و#.لو#>#.ئية. \r\n\r\n–#.لقصو#^ #.ل#=#%#~ي، و#.ل#=لوي #.ل#>ني#<. \r\n\r\n–يس#?خ#~م #%حذ#^ #<ي م#^#_ى #.ل#%#^و#<ي#^ي#. #.ل#=#%#~ية hepatic porphyria حيث ي#?س#%#% #<ي سوء #.لح#.لة. \r\n\r\n–يس#?#>مل #%حذ#^ #<ي ح#.ل#.#? #.لنزي#< #.لنش#- أو #.ل#>ني#<. \r\n\r\n–يج#% #?جن#% أ#~وية م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لإس#?#^و#~ية #%ش#=ل #>#.م #<ي م#^#_ى حمى #.ل#_ن#= #.لنز#<ية. \r\n\r\n–#<ي #.لنس#.ء #.لحو#.مل و#.لم#^#_#>#.#?.", "GI": "Description\t\r\nA non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. \r\n\r\nIndication\t:\r\nFor the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.\r\n\r\nMechanism of action\tThe antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.", "Composition": "diclofenac cholestyramine 75mg", "Route": "ORAL.SOLID" }, { "ID": "670", "Trade_Name": "BIORAZO 20MG 7 CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "13", "Price_Old": "9", "Company": "BIOPHARM EGYPT > SAJA PHARMACEUTICALS", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "671", "Trade_Name": "BIORAZO 40MG 7 CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "24", "Price_Old": "11.25", "Company": "BIOPHARM EGYPT > SAJA PHARMACEUTICALS", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "672", "Trade_Name": "PROTOPAN 20 MG 14 CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "27", "Price_Old": "27", "Company": "PHAROPHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "esomeprazole 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "673", "Trade_Name": "ESOPIROXAN 20 MG 21 DEL. REL. H.G. CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "52.5", "Price_Old": "46.5", "Company": "EGPI > ANDALOUS PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "674", "Trade_Name": "NIXPRAZOLE 40 MG 14 DELAYED REL. CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "63", "Price_Old": "36", "Company": "SIGMA > HOCHSTER PHARMACEUTICAL INDUSTRIES", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "675", "Trade_Name": "ESOPIROXAN 40 MG 21 DEL. REL. H.G. CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "54", "Price_Old": "48", "Company": "EGPI > ANDALOUS PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "676", "Trade_Name": "EZOGAST 20MG 14 DELA. REL. CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "60", "Price_Old": "60", "Company": "OCTOBER PHARMA > COPAD PHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "esomeprazole 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "677", "Trade_Name": "KLEMAZICE 40MG 14 CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "69", "Price_Old": "46", "Company": "SPIMACO MISR", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "esomeprazole 40mg", "Route": "ORAL.SOLID" }, { "ID": "678", "Trade_Name": "ESO-PROTOCOL 20 MG 10 CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "42", "Price_Old": "42", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > SANOFI", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "679", "Trade_Name": "PROTOPAN 40 MG 14 CAPS.", "Generic_Name": "ESOMEPRAZOLE", "Price": "38", "Price_Old": "38", "Company": "PHAROPHARMA", "Pharmacology": "PEPTIC ULCER.PROTON PUMP INHIBITOR", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> مث#%#-#.#? إ#<#^#.ز#.#? #.لم#>#~ة", "Use": "– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج ق#^حة #.ل#.ثني #>ش#^ #.لنش#-ة وأي#_#.ً #.لمل#?ئمة. \r\n\r\n– ي#?م #.س#?#>م#.ل #.ل#~و#.ء #<ي #>ل#.ج م#^#_ #.لجز#^ #.لم#>#~ي #.لم#^يئي وهو ي#>ني #.ل#.#^#?ج#.#> #.لم#^يئي. \r\n\r\n– ي#?م #.س#?خ#~#.م #.ل#~و#.ء #<ي #>ل#.ج #>س#^ وسوء #.له#_م. \r\n\r\n– #.ل#~و#.ء يس#?#>مل #<ي #>ل#.ج و#.لوق#.ية من #.لق#^حة #.لم#>#~ية #.لن#.#?جة #>ن #?ن#.ول م#_#.#~#.#? #.ل#.ل#?ه#.#% #.لغي#^ س#?ي#^وي#~ية. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج جمي#> ح#.ل#.#? #.ل#?ي #?#?ميز #%#<#^#- #<ي إ#<#^#.ز #.لم#>#~ة وهي مثل م#?ل#.زمة زولن#<#^ أليسون و#.ل#?ه#.#% #.لم#^يء #.لم#?آ#=ل. \r\n\r\n– ي#>#.لج #.ل#~و#.ء جمي#> ح#.ل#.#? #.لق#^حة #.ل#>ص#%ية وهذ#. ي#=ون ن#?يجة لل#?و#?#^.", "Contraindications": "– يمن#> #.س#?خ#~#.مة لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء أو لأي م#=ون آخ#^ من م#=ون#.#? #.ل#>ل#.ج. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.لحمل : لم #?ظه#^ #.ل#~#^#.س#.#? #.لح#.لية أ#_#^#.#^#.ً #>لى #.لجنين، يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل أخذ #.ل#>ل#.ج #<ي ح#.ل #=#.ن#? #.لم#^ي#_ة ح#.مل أو #?خ#-#- للحمل. \r\n\r\n– #<ى ح#.لة #.س#?خ#~#.مه م#> #.ل#^#_#.#>ة : من غي#^ #.لم#>#^و#< م#. إذ#. #=#.ن #.ل#~و#.ء ي#<#^ز #<ي حلي#% #.لأم #<ي ح#.لة #.لمُ#^#_#> و ل#=ن #%س#%#% آث#.#^ه #.ل#_#.#^ة #>لى جسم #.ل#.نس#.ن #=م#. ين#%غي #?جن#% #>ملية #.ل#^#_#.#>ة خل#.ل #<#?#^ة #.ل#>ل#.ج.", "GI": "About Esomeprazole\r\nA proton pump inhibitor, Substituted Benzimidazole, Antiulcer, antisecretory drug.\r\n\r\nMechanism of Action of Esomeprazole\r\nEsomeprazole is the S enantiomer of Omeprazole and is a proton pump inhibitor. It is a prodrug. After administration it diffuses in to the parietal cell of the stomach and accumulates in the secretory canaliculi. In the acidic medium Esomeprazole is converted to sulfenamide. This sulfenamide covalently interacts with sulfhydryl (SH) group in the proton pump (H+ K+ATPase) and inhibits the exchange of extracellular K+ for intracellular H+ ion. Esomeprazole irreversibly inhibits proton pumps activity and decreases gastric acid secretion. As compared to Omeprazole, Esomeprazole produces better control of intragastric acidity in Gastroesophageal reflux diseases. It is as effective as Omeprazole in other disease condition.\r\n\r\nIndications for Esomeprazole\r\n1.Gastric ulcer \r\n2.Gastroesophageal reflux disease \r\n3.Oesophagitis \r\n4.NSAID associated ulcerat", "Composition": "esomeprazole 20mg or 40mg", "Route": "ORAL.SOLID" }, { "ID": "680", "Trade_Name": "HEPAREX 320MG 20 CAPS.", "Generic_Name": "CYNARA DRY EXTRACT", "Price": "12.6", "Price_Old": "12.6", "Company": "KAHIRA > ATOS PHARMA", "Pharmacology": "CHOLECYSTITIS", "Category": "#.ل#?ه#.#% #.لم#^#.#^ة و مش#.#=ل #.ل#=#%#~", "Use": "– ي#>مل #>لي #?نشي#- خل#.ي#. #.ل#=#%#~. \r\n\r\n– يس#.#>#~ #>لي #?حسين وظ#.ئ#< #.ل#=#%#~. \r\n\r\n– #>ل#.ج #?#=ميلي مس#.#>#~ للح#.ل#.#? #.ل#.#?ية : \r\n\r\n–o #.ل#?ه#.#% #.ل#=#%#~. \r\n\r\n–o #?لي#< #.ل#=#%#~. \r\n\r\n– #.ل#=#%#~ #.ل#~هني. \r\n\r\n–o #?سمم #.ل#=#%#~.", "Contraindications": "–ل#. #?وج#~ مو#.ن#> #.س#?#>م#.ل لهذ#. #.ل#~و#.ء ول#=ن يج#% #.خ#%#.#^ #.ل#-#%ي#% #<ي ح#.لة #.ل#.ص#.#%ة #%#.ي #.م#^#.#_ مزمنة.", "GI": "Properties and actions:\r\nHeparex has choleretic and cholekinetic effects, which stimulate the digestive process and improve fatty dyspepsia. Higher bile secretion increases the yield of bicarbonate in the duodenum that neutralizes excessive acidity, and improves dyspepsia. It also has anti-cholestatic activity that enhances biliary excretion and reduces symptoms of irritable bowel syndrome.\r\nHeparex has an antioxidative effect. Its? active ingredients (luteolin, cynarin, chlorogenic acid and caffeic acid) protect the liver against toxins and reduce the free radicals induced hepatocyte killing effect. Its caffeoylquinoic acid acts as a cell membrane stabilizer.\r\n\r\n*Indications:\r\n-Dyspepsia, indigestion and irritable bowel syndrome (distension, flatulence, fat indigestion), etc.\r\n-Cholecystitis (especially calcular chole- cystitis, where it helps in stone dissolution)\r\n-Supportive therapy in chronic liver dis- eases (liver cirrhosis, fatty liver, etc.)\r\n\r\n*Dosage:\r\n1-2 capsules 3 times/", "Composition": "Each hard gelatin capsule contains:\r\nCynara scolymus dried extract 320 mg (equivalent to caffeoylquinoic acid 1.6 mg)", "Route": "ORAL.SOLID" }, { "ID": "681", "Trade_Name": "HEPATOCURE 21 SOFT GELATIN CAPS.", "Generic_Name": "CYSTEINE+PHOSPHOLIPIDS+SELENIUM+VITAMIN E", "Price": "22.5", "Price_Old": "22.5", "Company": "OCTOBER PHARMA", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#.#>#~ #>لي حم#.ية خل#.ي#. #.ل#=#%#~ من #.ل#?لي#<. \r\n\r\n–يس#.#>#~ #>لي #?حسين و #?نشي#- وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–#>ل#.ج #.م#^#.#_ #.ل#=#%#~ #.لمزمنة و#.لح#.#~ة. \r\n\r\n–#>ل#.ج س#^#-#.ن خل#.ي#. #.ل#=#%#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي. \r\n\r\n–#>ل#.ج #?سمم #.ل#=#%#~. \r\n\r\n–#>ل#.ج #.ل#=#%#~ #.ل#~هني.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Carbocysteine\r\nMucoactive drug, : local anti-infective agents, expectorants.\r\nMechanism of Action of Carbocysteine\r\nCarbocysteine is a mucolytic which liquefies the viscid sputum. It acts on the metabolism of mucus producing cells. It induces the production of mucus with increased sialomucin content. Sialomucin influences the rheological properties of mucus and also inhibits kinins and prevents bronchial inflammation and bronchospasm. It normalizes mucus viscosity and reduces goblet cell hyperplasia.", "Composition": "cysteine 100mg, essential phospholipids 300mg, selenium 15mcg, vit e 20i.u.", "Route": "ORAL.SOLID" }, { "ID": "682", "Trade_Name": "CYNCHOLINE 20CAPS.", "Generic_Name": "CYNARA+MAGNESIUM OXIDE+MENTHA", "Price": "6", "Price_Old": "6", "Company": "MEPACO", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#?خ#~م لحم#.ية #.ل#=#%#~ و#.لحويصلة #.لم#^#.#^ية من #.لأم#^#.#_. \r\n\r\n–يس#.#>#~ #<ي #?حسين #>ملية #.له#_م #.لن#.#?جة #>ن #.خ#?ل#.ل إ#<#^#.ز #.ل#>ص#.#^ة #.لص#<#^#.وية #%#.ل#=#%#~. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج أم#^#.#_ #.ل#=#%#~.", "Contraindications": "–#.ل#~و#.ء #.من ول#. #?وج#~ له أي مو#.ن#> سو#. #.ل#?#>#^#_ لحس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء يج#% #.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^ و#.س#?ش#.#^ة #.ل#-#%ي#%.", "GI": "COMING SOON ..", "Composition": "artichoke ext. 100mg, mg oxide 25mg, peppermint 25mg", "Route": "ORAL.SOLID" }, { "ID": "683", "Trade_Name": "HYDROXOCOBALAMIN 1000 MCG 3 AMP.", "Generic_Name": "HYDROXOCOBALAMIN", "Price": "8", "Price_Old": "8", "Company": "PHARCO B", "Pharmacology": "VITAMIN B", "Category": "#<ي#?#.مين #%", "Use": "– ل#>ل#.ج نقص #<ي#?#.مين #%12 #.لذي يس#%#% أنو#.#> مخ#?ل#<ة من #<ق#^ #.ل#~م و#.نخ#<#.#_ #>#~#~ خل#.ي#. #.ل#~م #.لحم#^#.ء. \r\n\r\n–#.#>#?ل#.ل / #?ل#< #.ل#>ص#% #.ل#%ص#^ي #.لن#.جم #>ن #.ل#.#<#^#.#- #<ي #.ل#?#~خين #.و #.ل#=حول \r\n\r\n– يم#=ن وص#<ه #<ي #%#>#_ #.ل#.م#^#.#_ #.و #.ل#>#~وي #.و #.ل#.#~وية #.ل#?ي #?قلل من ق#~#^ة #.لجسم #>لي #.ل#.س#?#<#.#~ة / #.م#?ص#.ص #<ي#?#.من #% 12 من #.لغذ#.ء", "Contraindications": "– #?#<#.#>ل#.#? #.لحس#.سية من #.لم#.#~ة #.ل#<#>#.لة هي#~#^و#=سو#=و#%#.ل#.مين أسي#?#.#? \r\n\r\n– ص#>و#%ة #<ي #.ل#?ن#<س", "GI": "Preservative free\r\nDescription\t\r\nInjectable form of vitamin B 12 that has been used therapeutically to treat vitamin B 12 deficiency.\r\n\r\nMechanism of action\t\r\nVitamin B12 exists in four major forms referred to collectively as cobalamins- deoxyadenosylcobalamin, methylcobalamin, hydroxocobalamin, and cyanocobalamin. Two of these, methylcobalamin and 5-deoxyadenosyl cobalamin, are primarily used by the body. Methionine synthase needs methylcobalamin as a cofactor. This enzyme is involved in the conversion of the amino acid homocysteine into methionine. Methionine in turn is required for DNA methylation. 5-Deoxyadenosyl cobalamin is a cofactor needed by the enzyme that converts L-methylmalonyl-CoA to succinyl-CoA. This conversion is an important step in the extraction of energy from proteins and fats. Furthermore, succinyl CoA is necessary for the production of hemoglobin, the substances that carries oxygen in red blood cells.", "Composition": "vit b12 1mg", "Route": "INJECTION" }, { "ID": "684", "Trade_Name": "DAZOL 200MG 10 CAPS.", "Generic_Name": "DANAZOL", "Price": "20", "Price_Old": "20", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "SYNTHETIC ANDROGEN", "Category": "مش#.#=ل #.ل#-مث", "Use": "–هو هو#^مون #.ص#-ن#.#>ي يُثَ#%ِّ#- إ#<#^#.ز #.لهو#^مون#.#? #.لجنسية من #.لغ#~ة #.لنُّخ#.مية (Pituitary Gland). #.س#?#>م#.له #.لأس#.سي هو #<ي #.ل#>ل#.ج #.لم#-وّل لل#.ن#?#%#.ذ #.ل#%ِ#-#.ني #.ل#^َّحِمي (Endometriosis)، وهو م#^#_ #?نمو #%ه أجز#.ء من نسيج #%ِ#-#.نة #.ل#^حم خ#.#^ج #.ل#^حم. يس#?#>مل #.ل#~#.ن#.زول أي#_ً#. ل#?خ#<ي#< #.لألم، #.لحس#.سية و#.ل#?#=#?ل #<ي #.لث#~ْيَيْن #.لن#.جمة #>ن م#^#_ #=يسي لي#<ي (Fibrocystic). يس#?#>مل #.ل#~#.ن#.زول أحي#.نً#. ل#>ل#.ج #.لحَيْ#_ م#> نزي#< ح#.#~ ول#?قليل #.ل#.ن#?#<#.خ #<ي ث#~يَيْ #.ل#^ج#.ل. \r\n\r\n–يم#=ن أي#_ً#. إ#>#-#.ء #.ل#~#.ن#.زول (Danazol) للأشخ#.ص #.لم#>#^ّ#_ين للإص#.#%ة #%#.لوَذَمَة #.لأُ#^ْجِيَّة #.لو#^#.ثية (م#^#_ ن#.#~#^ يؤ#~ي ل#.ن#?#<#.خ #.لمزم#.#^). \r\n\r\n–يُخِلُّ #.ل#>ل#.ج #%#.ل#~#.ن#.زول #<ي #.ل#>#~ي#~ من #.لأحي#.ن #%#.ن#?ظ#.م #.لحي#_. #?وق#< #.لحي#_ هو ظ#.ه#^ة #-#%ي#>ية وق#? #>ل#.ج #.ل#.ن#?#%#.ذ #.ل#%#-#.ني #.ل#^حمي. #?شمل #.ل#?أثي#^#.#? #.لج#.ن#%ية #.لأخ#^ى: غثي#.نً#.، #~وخة، #-#<حً#. جل#~يًّ#.، ألم ظه#^، زي#.#~ة #%#.لوزن وموج#.#? ح#^#.#^ة. ق#~ #?ص#.#% #.لنس#.ء #.لل#.#?ي ي#?#>#.#-َيْن ج#^#>#.#? #=#%ي#^ة من #.ل#~#.ن#.زول #%نمو ش#>#^ م#=ثّ#< و#%#?ثخين (خشونة) #.لصو#?.", "Contraindications": "–#.ثن#.ء #.لحمل: \r\n\r\n–يمن#> #.س#?#>م#.له #%أي ش#=ل من #.لأش#=#.ل (X). \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–#.ل#~و#.ء ين#?قل #.لى حلي#% #.ل#.م ومن #.لمم#=ن #.ن يؤث#^ #>لى #.ل#-#<ل. يج#% #.س#?ش#.#^ه #.ل#-#%ي#%. \r\n\r\n–#.لأ#-#<#.ل و#.ل#^#_#> \r\n\r\n–يج#% #?قليل ومل#.ئمة #.لج#^#>ه حس#% #.لجيل و#.لوزن. \r\n\r\n–#=#%#.#^ #.لسن: \r\n\r\n–ل#. #?وج#~ مش#.#=ل خ#.صه. \r\n\r\n–#.لسي#.قة: \r\n\r\n–ل#. #?وج#~ مش#.#=ل م#>#^و#<ه.", "GI": "About Danazol\r\nSynthetic steroid ethisterone derivative, an isoxazole of testosterone, Synthetic Androgen.\r\n\r\nMechanism of Action of Danazol\r\nIt is an orally effective ethisterone derivative- attenuated androgen which suppresses gonadotropin secretion from pituitary in both men and women and results in inhibition of testicular and ovarian function. It suppresses gonadal function directly and by inhibiting steroidogenic enzymes. It causes endometrial atrophy and amenorrhoea. It also decreases the rate of growth and nodularity of abnormal breast tissue in fibrocystic breast disease. It has mild androgenic, anabolic, and progestational activity. Androgenic effects increases the levels of C1 and C4 components of complements which reduce frequency and severity of attacks associated with hereditary angioedema.\r\n\r\nIndications for Danazol\r\n1.Endometriosis \r\n2.Fibrocystic breast disease \r\n3.Gynaecomastia \r\n4.Menorrhagia \r\n5.Hereditary angioedema.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "685", "Trade_Name": "NUCLEO CMP FORTE 10 CAPS.", "Generic_Name": "CYTIDINE+URIDINE", "Price": "6.5", "Price_Old": "6.5", "Company": "OCTOBER PHARMA > FERRER INTERNATIONAL SA -SPAIN", "Pharmacology": "NEUROPATHY", "Category": "ل#.#>#?ل#.ل #.لأ#>ص#.#%", "Use": "–#.ل#.#>#?ل#.ل#.#? #.ل#>ظمية #.لم#<صلية، مثل #>#^ق #.لنس#.، و#.ل#?ه#.#% #.لجذ#^. \r\n\r\n–#.ل#.#>#?ل#.ل#.#? #.لأي#_ية، مثل #.لس#=#^ي، و#.ل#?ه#.#% #.لأ#>ص#.#% #.لم#?#>#~#~ #.ل#=حولي. \r\n\r\n–#.ل#.#>#?ل#.ل#.#? #.ل#.ل#?ه#.#%ية #.لمنشأ، مثل #.لإص#.#%ة #%#>#~وى #<ي#^وس #.له#^#%س #.لن#-#.قي. \r\n\r\n–#.ل#.#>#?ل#.ل#.#? #.ل#>ص#%ية #.لأخ#^ى، مثل #.#>#?ل#.ل #>ص#% #.لوجه، أو #.ل#>ص#% ثل#.ثي #.ل#?و#.ئم، أو غي#^ه#..", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "Abstract\r\nThe pyrimidines cytidine (as CTP) and uridine (which is converted to UTP and then CTP) contribute to brain phosphatidylcholine and phosphatidylethanolamine synthesis via the Kennedy pathway. Their uptake into brain from the circulation is initiated by nucleoside transporters located at the blood-brain barrier (BBB), and the rate at which uptake occurs is a major factor determining phosphatide synthesis. Two such transporters have been described: a low-affinity equilibrative system and a high-affinity concentrative system. It is unlikely that the low-affinity transporter contributes to brain uridine or cytidine uptake except when plasma concentrations of these compounds are increased several-fold experimentally.", "Composition": "cytidine 5mguridine 1.33mg", "Route": "ORAL.SOLID" }, { "ID": "686", "Trade_Name": "CYNCHOLINE PLUS 20CAPS.", "Generic_Name": "CYNARA DRY EXTRACT+MENTHOL+MAGNESIUM OXIDE+SILYMARIN", "Price": "6.5", "Price_Old": "6.5", "Company": "MEPACO", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#?خ#~م لحم#.ية #.ل#=#%#~ و#.لحويصلة #.لم#^#.#^ية من #.لأم#^#.#_. \r\n\r\n–يس#.#>#~ #<ي #?حسين #>ملية #.له#_م #.لن#.#?جة #>ن #.خ#?ل#.ل إ#<#^#.ز #.ل#>ص#.#^ة #.لص#<#^#.وية #%#.ل#=#%#~. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج أم#^#.#_ #.ل#=#%#~.", "Contraindications": "–#.ل#~و#.ء #.من ول#. #?وج#~ له أي مو#.ن#> سو#. #.ل#?#>#^#_ لحس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء يج#% #.ل#?وق#< #>ن #?ن#.ول #.ل#>ق#.#^ و#.س#?ش#.#^ة #.ل#-#%ي#%.", "GI": "COMING SOON ..", "Composition": "Each capsule contains:\r\nCynara dry extract 100 mg\r\nSilymarin 50 mg\r\nMentha dry extract 25 mg\r\nHeavy magnesium oxide 40 mg", "Route": "ORAL.SOLID" }, { "ID": "687", "Trade_Name": "DANOL 200MG 60 CAPS.", "Generic_Name": "DANAZOL", "Price": "228", "Price_Old": "228", "Company": "SANOFI", "Pharmacology": "SYNTHETIC ANDROGEN", "Category": "مش#.#=ل #.ل#-مث", "Use": "–هو هو#^مون #.ص#-ن#.#>ي يُثَ#%ِّ#- إ#<#^#.ز #.لهو#^مون#.#? #.لجنسية من #.لغ#~ة #.لنُّخ#.مية (Pituitary Gland). #.س#?#>م#.له #.لأس#.سي هو #<ي #.ل#>ل#.ج #.لم#-وّل لل#.ن#?#%#.ذ #.ل#%ِ#-#.ني #.ل#^َّحِمي (Endometriosis)، وهو م#^#_ #?نمو #%ه أجز#.ء من نسيج #%ِ#-#.نة #.ل#^حم خ#.#^ج #.ل#^حم. يس#?#>مل #.ل#~#.ن#.زول أي#_ً#. ل#?خ#<ي#< #.لألم، #.لحس#.سية و#.ل#?#=#?ل #<ي #.لث#~ْيَيْن #.لن#.جمة #>ن م#^#_ #=يسي لي#<ي (Fibrocystic). يس#?#>مل #.ل#~#.ن#.زول أحي#.نً#. ل#>ل#.ج #.لحَيْ#_ م#> نزي#< ح#.#~ ول#?قليل #.ل#.ن#?#<#.خ #<ي ث#~يَيْ #.ل#^ج#.ل. \r\n\r\n–يم#=ن أي#_ً#. إ#>#-#.ء #.ل#~#.ن#.زول (Danazol) للأشخ#.ص #.لم#>#^ّ#_ين للإص#.#%ة #%#.لوَذَمَة #.لأُ#^ْجِيَّة #.لو#^#.ثية (م#^#_ ن#.#~#^ يؤ#~ي ل#.ن#?#<#.خ #.لمزم#.#^). \r\n\r\n–يُخِلُّ #.ل#>ل#.ج #%#.ل#~#.ن#.زول #<ي #.ل#>#~ي#~ من #.لأحي#.ن #%#.ن#?ظ#.م #.لحي#_. #?وق#< #.لحي#_ هو ظ#.ه#^ة #-#%ي#>ية وق#? #>ل#.ج #.ل#.ن#?#%#.ذ #.ل#%#-#.ني #.ل#^حمي. #?شمل #.ل#?أثي#^#.#? #.لج#.ن#%ية #.لأخ#^ى: غثي#.نً#.، #~وخة، #-#<حً#. جل#~يًّ#.، ألم ظه#^، زي#.#~ة #%#.لوزن وموج#.#? ح#^#.#^ة. ق#~ #?ص#.#% #.لنس#.ء #.لل#.#?ي ي#?#>#.#-َيْن ج#^#>#.#? #=#%ي#^ة من #.ل#~#.ن#.زول #%نمو ش#>#^ م#=ثّ#< و#%#?ثخين (خشونة) #.لصو#?.", "Contraindications": "–#.ثن#.ء #.لحمل: \r\n\r\n–يمن#> #.س#?#>م#.له #%أي ش#=ل من #.لأش#=#.ل (X). \r\n\r\n–#.ل#^#_#.#>ة: \r\n\r\n–#.ل#~و#.ء ين#?قل #.لى حلي#% #.ل#.م ومن #.لمم#=ن #.ن يؤث#^ #>لى #.ل#-#<ل. يج#% #.س#?ش#.#^ه #.ل#-#%ي#%. \r\n\r\n–#.لأ#-#<#.ل و#.ل#^#_#> \r\n\r\n–يج#% #?قليل ومل#.ئمة #.لج#^#>ه حس#% #.لجيل و#.لوزن. \r\n\r\n–#=#%#.#^ #.لسن: \r\n\r\n–ل#. #?وج#~ مش#.#=ل خ#.صه. \r\n\r\n–#.لسي#.قة: \r\n\r\n–ل#. #?وج#~ مش#.#=ل م#>#^و#<ه.", "GI": "About Danazol\r\nSynthetic steroid ethisterone derivative, an isoxazole of testosterone, Synthetic Androgen.\r\n\r\nMechanism of Action of Danazol\r\nIt is an orally effective ethisterone derivative- attenuated androgen which suppresses gonadotropin secretion from pituitary in both men and women and results in inhibition of testicular and ovarian function. It suppresses gonadal function directly and by inhibiting steroidogenic enzymes. It causes endometrial atrophy and amenorrhoea. It also decreases the rate of growth and nodularity of abnormal breast tissue in fibrocystic breast disease. It has mild androgenic, anabolic, and progestational activity. Androgenic effects increases the levels of C1 and C4 components of complements which reduce frequency and severity of attacks associated with hereditary angioedema.\r\n\r\nIndications for Danazol\r\n1.Endometriosis \r\n2.Fibrocystic breast disease \r\n3.Gynaecomastia \r\n4.Menorrhagia \r\n5.Hereditary angioedema.", "Composition": "danazol 200mg", "Route": "ORAL.SOLID" }, { "ID": "688", "Trade_Name": "FARCOVIT B12 30 CAPS.", "Generic_Name": "CYNARA DRY EXTRACT+INOSITOL+OROTIC ACID+PHOSPHOLIPIDS+SAFFLOWER OIL+VITAMINS", "Price": "13.5", "Price_Old": "9", "Company": "PHARCO", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#?س#?خ#~م هذه #.لأق#^#.ص #<ي #.ل#<شل #.لوظي#<ي لل#=#%#~ #.لذي ين#?ج من وجو#~ #.ل#?سمم ووجو#~ #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي أي#_#. ين#?ج هذ#. #.ل#<شل #.لوظي#<ي لل#=#%#~ من #.لإص#.#%ة #%#.ل#-#<يلي#.#? #.لم#>وية وأي#_#. يح#~ث ن#?يجة #.لإ#~م#.ن #.ل#=حولي. \r\n\r\n–#?س#.#>#~ هذه #.لأق#^#.ص #<ي #.ل#?خلص من #<شل #.ل#?مثيل #.لغذ#.ئي مثل م#. يح#~ث #<ي #.لح#.ل#.#? #.ل#?ي يوج#~ #>ن#~هم #.لس#=#^ أي#_#. من وجو#~ #.ل#?ه#.#% #.لأ#>ص#.#% #.ل#-#^#<ية #.لمل#.زمة له و#>#~م #=#<#.ءة #.لغ#~ة #.لن#=#.#<ية أي#_#. #<ي #%#>#_ #.لأم#^#.#_ #.لم#?و#-نة #<ي #.لم#>#~ة و#.ل#.ثني #>ش#^ أي#_#. #%#>#_ أم#^#.#_ #.لجل#~. \r\n\r\n–يس#?#>مل هذ#. #.ل#~و#.ء #=#~و#.ء مس#.#>#~ #<ي ح#.ل#.#? #.#^#?#<#.#> #_غ#- #.ل#~م. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#>ق#.#^ #<ي #?#>#% #?صل#% #.لش#^#.يين وأم#^#.#_ #.لسمنة. \r\n\r\n–#?س#?خ#~م هذه #.لأق#^#.ص #<ي #.ل#?خلص من #.لأنيمي#.. \r\n\r\n–ي#?م #.س#?#>م#.ل هذ#. #.ل#~و#.ء #<ي أشه#^ #.لحمل.", "Contraindications": "–يوج#~ #<ي هذ#. #.ل#~و#.ء م#.#~ة #.لسليم#.#^ين وهذه #.لم#.#~ة #?قوم #%#.لمس#.#>#~ة #>لي #?نشي#- #.ل#=#%#~ لهذ#. #.لس#%#% يلزم #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#>ق#.#^ ول#. ي#?م #?ن#.ول هذه #.لأق#^#.ص #%#~ون وص#<ة #-#%ية. \r\n\r\n–ل#. ينصح #%#.س#?#>م#.ل هذه #.ل#=#%سول#.#? للسي#~#.#? #.لحو#.مل إل#. #<ي ح#.لة #.س#?#~#>#.ء #.لأم#^ إذ#. #=#.ن#? ح#.لة #.لم#^ي#_ة #?س#?#~#>ي ذل#= وي#?م أخذه #?ح#? إش#^#.#< #.ل#-#%ي#%. \r\n\r\n–ينصح #%#>#~م #.خذ هذ#. #.ل#>ق#.#^ للأمه#.#? #.لم#^#_#>ة إل#. #<ي #.ل#_#^و#^ة و#<ي ح#.لة إذ#. #=#.ن#? ح#.لة #.لم#^ي#_ة #?#?#-ل#% لذل#= وي#?م ذل#= #?ح#? إش#^#.#< #.ل#-#%ي#% #.لمخ#?ص.", "GI": "COMING SOON ..", "Composition": "Each capsule contains;\r\nVitamin B1 (Thiamine Mononitrate) 2mg\r\nVitamin B2 ( Riboflavin) 1mg\r\nVitamin B6 ( Pyridoxine HCI) 2mg\r\nVitamin B12 ( Cyanocobalamin ) 10mcg\r\nCalcium-D-pantothenate 5mg\r\nNicotinamide 10mg\r\nInositol 50mg\r\nOrotic Acid 20mg\r\nFolic Acid 0.5mg\r\nD", "Route": "ORAL.SOLID" }, { "ID": "689", "Trade_Name": "ATROZEMB 20/10MG 30 F.C. TAB.", "Generic_Name": "ATORVASTATIN+EZETIMIBE", "Price": "126", "Price_Old": "126", "Company": "LIPTIS", "Pharmacology": "ANTIHYPERLIPIDEMIC.CHOLESTEROL ABSORPTION INHIBITORS.COMBINED WITH STATIN", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#^#<#> م#>#~ل #.ل#%#^و#?ين #.ل#~هني #.لن#.#<#> #.لم#>#^و#< #%#.سم #.ل#%#^و#?ين #.ل#~هني م#^#?#<#> #.ل#=ث#.#<ة. \r\n\r\n–خ#<#_ م#>#~ل #.ل#%#^و#?ين #.ل#~هني #.ل#_#.#^ أو م#. ي#>#^#< #%#.ل#%#^و#?ين #.ل#~هني منخ#<#_ #.ل#=ث#.#<ة. \r\n\r\n–#.ل#?ح#=م #<ي مس#?وي #.ل#=وليس#?#^ول لح#.ل#.#? #.#^#?#<#.#> #.ل#=وليس#?#^ول #.لو#^#.ثية. \r\n\r\n–#.لح#~ من #.#^#?#<#.#> #.ل#~هون #.لثل#.ثية #<ي #.ل#~م.", "Contraindications": "–إذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من حس#.سية من #.ح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–إذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من #.#_#-#^#.#% #<ي وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–إذ#. #=#.ن #.لم#^ي#_ ي#>#.ني من #.#_#-#^#.#% #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–#-#%ق#. للأ#%ح#.ث و#.ل#~#^#.س#.#? #.ل#>لمية هذ#. #.ل#~و#.ء ي#>#~ خ#-#^#. #>لى #.لأجنة، ل#. يج#% #.س#?خ#~#.مه #<ي #<#?#^#.#? #.لحمل، ل#. يس#?خ#~م #.ل#~و#.ء م#> #.لسي#~#.#? إل#. #<ي سن ل#. يسمح #%ح#~وث #.لحمل نه#.ئي#.. \r\n\r\n–أي#_#. #.لأ#%ح#.ث أث#%#?#? أن #.ل#>ق#.#^ ي#?م إ#<#^#.زه #<ي حلي#% #.لأم وهو يمثل خ#-و#^ة #>لى #.ل#^#_ي#> لذل#= يج#% #?جن#% #?ن#.وله أثن#.ء #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–يج#% #.لحذ#^ #>#~م #?ن#.ول #.ل#~و#.ء م#> #~و#.ء #.#^يث#^وم#.يسين. \r\n\r\n–يج#% #.لحذ#^ #.لش#~ي#~ م#> #.لم#^ي#_ #.لذي #=#.ن ي#?ن#.ول #.ل#=حول. \r\n\r\n–ل#. ي#?ن#.وله م#^ي#_ ي#?ن#.ول #.ل#=حول #>ليه إيق#.#< #.ل#=حول أو #.ل#~و#.ء. \r\n\r\n–ل#. يس#?خ#~مه م#^ي#_ ي#>#.ني من #_#>#< #.ل#>#_ل#.#?. \r\n\r\n–إذ#. #?#>#^#_ #.لم#^ي#_ ل#_#>#< #.ل#>#_ل#.#? أثن#.ء #.لج#^#>#.#? يج#% إيق#.#< #.ل#~و#.ء. \r\n\r\n–ل#. #?س#?خ#~م م#> م#^ي#_ ي#?ن#.ول أ#~وية #?قلل من مس#?وى #.لنش#.#- #.لذ#.#?ي أو ه#^مون#.#? #.لس#?ي#^وي#~. \r\n\r\n–ل#. يج#% إيق#.#< #?ن#.ول #.ل#~و#.ء #.#%#~#. #.ل#. #%#>#~ #.ل#^جو#> لل#-#%ي#% #.لمخ#?ص. \r\n\r\n–#.حذ#^ #.ن #?ص#< #.ل#~و#.ء لم#^ي#_ آخ#^ ح#?ى لو #=#.ن ي#>#.ني ن#<س #.لم#^#_.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "690", "Trade_Name": "LIPANTHYL 300MG 30 CAPS.", "Generic_Name": "FENOFIBRATE", "Price": "45", "Price_Old": "45", "Company": "MINA PHARM > FOURNIER-FRANCE", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "691", "Trade_Name": "NALFOSAB 300MG 10 CAPS.", "Generic_Name": "FENOPROFEN", "Price": "9", "Price_Old": "9", "Company": "SABAA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#?س#=ين #.لآلآم #.لخ#<ي#<ة و #.لم#?وس#-ة #.لش#~ة ، #>لى س#%يل #.لمث#.ل ل#. #.لحص#^ : ألم #.ل#.سن#.ن ، ألم #.ل#~و#^ة #.لشه#^ية ، ألم #.س#<ل #.لظه#^ ،#.لص#~#.#> ، ألم #.لم#<#.صل .", "Contraindications": "–#.ل#?حسس لم#.#~ة #.ل#<ينو#%#^و#<ين #.و #.ل#?حسس #?ج#.ة #.ى من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–ل#. يج#% #>لى م#^#_ى #.لق#^ح #.له#_مية #.لنش#-ة #.س#?#>م#.ل #.لمس#=ن#.#? #%وجة #>#.م إل#. #?ح#? #.ش#^#.#< #-#%ى مخ#?ص .", "GI": "Description\t\r\nAn anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.\r\n\r\nIndication\t\r\nFor relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain.\r\n\r\nMechanism of action\r\nFenoprofen s exact mode of action is unknown, but it is thought that prostaglandin synthetase inhibition is involved. Fenoprofen has been shown to inhibit prostaglandin synthetase isolated from bovine seminal vesicles.", "Composition": "fenoprofen 200mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "692", "Trade_Name": "FENOPROFEN 300MG 30 CAPS.", "Generic_Name": "FENOPROFEN", "Price": "27", "Price_Old": "27", "Company": "WESTERN PHARMACEUTICALS INDUSTRIES", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#?س#=ين #.لآلآم #.لخ#<ي#<ة و #.لم#?وس#-ة #.لش#~ة ، #>لى س#%يل #.لمث#.ل ل#. #.لحص#^ : ألم #.ل#.سن#.ن ، ألم #.ل#~و#^ة #.لشه#^ية ، ألم #.س#<ل #.لظه#^ ،#.لص#~#.#> ، ألم #.لم#<#.صل .", "Contraindications": "–#.ل#?حسس لم#.#~ة #.ل#<ينو#%#^و#<ين #.و #.ل#?حسس #?ج#.ة #.ى من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–ل#. يج#% #>لى م#^#_ى #.لق#^ح #.له#_مية #.لنش#-ة #.س#?#>م#.ل #.لمس#=ن#.#? #%وجة #>#.م إل#. #?ح#? #.ش#^#.#< #-#%ى مخ#?ص .", "GI": "Description\t\r\nAn anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.\r\n\r\nIndication\t\r\nFor relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain.\r\n\r\nMechanism of action\r\nFenoprofen s exact mode of action is unknown, but it is thought that prostaglandin synthetase inhibition is involved. Fenoprofen has been shown to inhibit prostaglandin synthetase isolated from bovine seminal vesicles.", "Composition": "fenoprofen 200mg or 300mg or 600mg", "Route": "ORAL.SOLID" }, { "ID": "693", "Trade_Name": "LIPOLEX 300MG 20 CAPS.", "Generic_Name": "FENOFIBRATE", "Price": "26.4", "Price_Old": "26.4", "Company": "SIGMA", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "fenofibrate 200mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "694", "Trade_Name": "FERRO SANOL DUODENAL 30 CAP.", "Generic_Name": "FERROUS GLYCINE SULPHATE COMPLEX", "Price": "54", "Price_Old": "36", "Company": "MINA PHARM", "Pharmacology": "ANEMIA.IRON SUPPLEMENT", "Category": "م#=مل #.لح#~ي#~ ل#<ق#^ #.ل#~م #.ل#.نيمي#.", "Use": "–ي#>#.لج #<ق#^ #.ل#~م. \r\n\r\n–#>ل#.ج #<#>#.ل لل#_#>#< #.ل#>#.م. \r\n\r\n–يس#?خ#~م #=م#=مل غذ#.ئي. \r\n\r\n–يم#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن. \r\n\r\n–يس#.#>#~ #<ي #.ل#?غذية #.لسليمة للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.لإ#^ه#.ق و#.ل#_#>#< #.ل#>#.م. \r\n\r\n–#>ل#.ج س#^ي#> لل#.نيمي#.. \r\n\r\n–يس#?#>مل #<ي #>ل#.ج نقص #.ل#<ي#?#.مين#.#? #>ن#~ #.لأ#-#<#.ل.", "Contraindications": "–يحذ#^ من #?ن#.ول هذ#. #.ل#~و#.ء #>ن#~ وجو#~ حس#.سية م#<#^#-ة #_#~ م#=ون#.#?ه. \r\n\r\n–ل#. يسمح #%#.س#?#>م#.ل #=#%سول#.#? هذ#. #.ل#~و#.ء لل#.#-#<#.ل #.لأقل من 6 سنو#.#?. \r\n\r\n–يمن#> #?ن#.وله #>ن#~ #.لم#>#.ن#.ة من #.#_#-#^#.#%#.#? #<ي #.لجه#.ز #.له#_مي. \r\n\r\n–من يلجأ لنقل #.ل#~م #>ليه #.ل#.م#?ن#.#> #>ن #.س#?#>م#.ل #.ل#~و#.ء. \r\n\r\n–يمن#> هذ#. #.ل#~و#.ء #<ي ح#.ل #.لقي#.#~ة و#.ل#>مل #%آل#.#? ح#.#~ة. \r\n\r\n–يمن#> #>ن#~ #.ن#?ه#.ء م#~ة صل#.حي#?ه.", "GI": "Indication\r\nIron-deficiency anemia, and various salts or complexes of iron are used as hematinics, including iron dextran, Iron , polysaccharide, i. sorbitex, and Iron sucrose. Hemochromatosis is an inherited disease in which too much iron builds up in your body. Breastfeeding Warnings,Pregnancy", "Composition": "Each capsule contains: \r\nferrous (ll)-glycine-sulphate complex 567.7 mg (equivalent to 497.9mg of ferrous 2 X equivalent to 100 mg Fe2+ )", "Route": "ORAL.SOLID" }, { "ID": "695", "Trade_Name": "FENOPROFEN 600MG 30 CAPS.", "Generic_Name": "FENOPROFEN", "Price": "36", "Price_Old": "36", "Company": "WESTERN PHARMACEUTICALS INDUSTRIES", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#?س#=ين #.لآلآم #.لخ#<ي#<ة و #.لم#?وس#-ة #.لش#~ة ، #>لى س#%يل #.لمث#.ل ل#. #.لحص#^ : ألم #.ل#.سن#.ن ، ألم #.ل#~و#^ة #.لشه#^ية ، ألم #.س#<ل #.لظه#^ ،#.لص#~#.#> ، ألم #.لم#<#.صل .", "Contraindications": "–#.ل#?حسس لم#.#~ة #.ل#<ينو#%#^و#<ين #.و #.ل#?حسس #?ج#.ة #.ى من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–ل#. يج#% #>لى م#^#_ى #.لق#^ح #.له#_مية #.لنش#-ة #.س#?#>م#.ل #.لمس#=ن#.#? #%وجة #>#.م إل#. #?ح#? #.ش#^#.#< #-#%ى مخ#?ص .", "GI": "Description\t\r\nAn anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.\r\n\r\nIndication\t\r\nFor relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain.\r\n\r\nMechanism of action\r\nFenoprofen s exact mode of action is unknown, but it is thought that prostaglandin synthetase inhibition is involved. Fenoprofen has been shown to inhibit prostaglandin synthetase isolated from bovine seminal vesicles.", "Composition": "fenoprofen 200mg or 300mg or 600mg", "Route": "ORAL.SOLID" }, { "ID": "696", "Trade_Name": "NALFOSAB 200MG 20 CAPS.", "Generic_Name": "FENOPROFEN", "Price": "16", "Price_Old": "16", "Company": "SABAA", "Pharmacology": "NSAID.PROPIONIC ACID DERIVATIVES", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–#?س#=ين #.لآلآم #.لخ#<ي#<ة و #.لم#?وس#-ة #.لش#~ة ، #>لى س#%يل #.لمث#.ل ل#. #.لحص#^ : ألم #.ل#.سن#.ن ، ألم #.ل#~و#^ة #.لشه#^ية ، ألم #.س#<ل #.لظه#^ ،#.لص#~#.#> ، ألم #.لم#<#.صل .", "Contraindications": "–#.ل#?حسس لم#.#~ة #.ل#<ينو#%#^و#<ين #.و #.ل#?حسس #?ج#.ة #.ى من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–ل#. يج#% #>لى م#^#_ى #.لق#^ح #.له#_مية #.لنش#-ة #.س#?#>م#.ل #.لمس#=ن#.#? #%وجة #>#.م إل#. #?ح#? #.ش#^#.#< #-#%ى مخ#?ص .", "GI": "Description\t\r\nAn anti-inflammatory analgesic and antipyretic highly bound to plasma proteins. It is pharmacologically similar to aspirin, but causes less gastrointestinal bleeding.\r\n\r\nIndication\t\r\nFor relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Also for the relief of mild to moderate pain.\r\n\r\nMechanism of action\r\nFenoprofen s exact mode of action is unknown, but it is thought that prostaglandin synthetase inhibition is involved. Fenoprofen has been shown to inhibit prostaglandin synthetase isolated from bovine seminal vesicles.", "Composition": "fenoprofen 200mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "697", "Trade_Name": "FUMIRON PLUS 30 CAPS.", "Generic_Name": "FERROUS FUMARATE+FOLIC ACID+VITAMIN C", "Price": "3.09", "Price_Old": "3.09", "Company": "ALEXANDRIA", "Pharmacology": "ANEMIA.IRON SUPPLEMENT COMBINED WITH FOLIC ACID", "Category": "م#=مل غذ#.ئي ل #.ل#.نيمي#. و #<ق#^ #.ل#~م م#> حم#_ #.ل#<ولي#=", "Use": "–يس#.#>#~ #>لي #%ن#.ء #.ل#~م #<ي ح#.ل#.#? #<ق#^ #.ل#~م. \r\n\r\n–يس#.#>#~ #>لي #.ن#?#.ج و#?#=وين خل#.ي#. #.ل#~م #.لحم#^#.ء. \r\n\r\n–#>ل#.ج #.ل#.نيمي#. و#<ق#^ #.ل#~م #.لن#.#?جة #>ن نقص #.لح#~ي#~ #%#.لجسم. \r\n\r\n–يس#?خ#~م للوق#.ية من نقص #.لح#~ي#~ #<ي ح#.ل#.#? #.ل#.نيمي#. ، #.لحمل ، سوء #.ل#?غذية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> لمن ي#>#.ني من #<ق#^ #.ل#~م #.لخ#%يث ، #.ل#.نحل#.لي. \r\n\r\n–يمن#> لمن ل#~يهم نس#% #>#.لية من #.لح#~ي#~ #<ي #.لجسم. \r\n\r\n–من ي#>#.ني مش#.#=ل #<ي #.س#?قل#.#% #.لح#~ي#~ و#.لنح#.س.", "GI": "Iron(II) fumarate, also known as ferrous fumarate, is the iron(II) salt of fumaric acid\r\nused to supplement iron intake. It has the chemical formula C4H2FeO4. Pure ferrous fumarate has an iron content of 32.87%, therefore one tablet of 300 mg iron fumarate will contain 98.6 mg of iron", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "698", "Trade_Name": "LIPOMEDIZEN 300MG 30 CAPS.", "Generic_Name": "FENOFIBRATE", "Price": "36", "Price_Old": "36", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES", "Pharmacology": "ANTIHYPERLIPIDEMIC.FIBRATES", "Category": "م#_#.#~ لل#~هون #.لثل#.ثية و #.ل#=وليس#?#^ول", "Use": "–#?قليل نس#%ة #.ل#=وليس#?#^ول #.ل#_#.#^ و #.ل#~هون #.لثل#.ثيه #%#.ل#~م مثل : \r\n\r\n–LDL Cholesterol , Triglycerides , Apolipoprotein B .", "Contraindications": "–ل#. يس#?خ#~م م#> أ#~وية #.لنق#^ص #.ل#?ى #?ح#?وى #>لى م#.#~ة COLCHICINE : #=ل منهم#. يزي#~ من #.لآث#.#^ #.لج#.ن#%ية للأخ#^ . \r\n\r\n–ل#. يس#?خ#~م م#> أ#~وية #.لسيولة #.ل#?ى #?ح#?وى #>لى م#.#~ة WARFARINE : #?ؤ#~ى إلى زي#.#~ة #.لآث#.#^ #.لج#.ن#%ية لم#.#~ة WARFARINE .", "GI": "About Fenofibrate\r\nFibric Acid Derivative, PPARa agonist, Antilipemic agent, Antigout.\r\n\r\nMechanism of Action of Fenofibrate\r\nIt is prodrug which has greater LDL (low density lipoprotein) cholesterol lowering potential. It lowers circulating triglyceride levels by activating lipoprotein lipase which is a key enzyme in the degradation of VLDL (very low density lipoprotein) cholesterol. This effect is exerted through paroxisome proliferator-activated receptor alpha (PPARalpha) which enhances lipoprotein lipase synthesis and fatty acid oxidation. It also reduces hepatic triglyceride synthesis. It also reduces VLDL levels and increases HDL (high density lipoprotein) cholesterol. The increase in HDL cholesterol is partly due to transfer of surface lipid components from catabolised VLDL to HDL and also due to increased production of HDL apoproteins by liver.", "Composition": "fenofibrate 300mg", "Route": "ORAL.SOLID" }, { "ID": "699", "Trade_Name": "FERROFOL 30 CAPS.", "Generic_Name": "FERROUS SULPHATE+FOLIC ACID", "Price": "6", "Price_Old": "6", "Company": "EIPICO", "Pharmacology": "ANEMIA.IRON SUPPLEMENT COMBINED WITH FOLIC ACID", "Category": "م#=مل غذ#.ئي ل #.ل#.نيمي#. و #<ق#^ #.ل#~م م#> حم#_ #.ل#<ولي#=", "Use": "–يس#?خ#~م ل#?#>وي#_ #.لجسم م#. يح#?#.جه من نقص #<ي نس#%ة #.لح#~ي#~ #<ي #.لجسم. \r\n\r\n– #>ل#.ج #.لأنيمي#. #<#^ق #.ل#~م. يس#?خ#~م أثن#.ء #<#?#^ة #.لحمل ل#?#>وي#_ #.لأم #%نس#%ة #.لح#~ي#~ #.لل#.زمة له#. ولجنينه#. ويحميه#. من #.لإص#.#%ة #%#<ق#^ #.ل#~م #=م#. يم#~ه#. #%حم#_ #.ل#<ولي#= #.له#.م لصحة #.لجنين و#.لذي يمن#> #?شوه #.لأجنة. \r\n\r\n– يس#?خ#~م للأ#-#<#.ل ل#>ل#.ج #.لأنيمي#. وسوء #.ل#?غذية و#?#>وي#_ م#. ي#<#?ق#~ه #.لجسم من #.لح#~ي#~. \r\n\r\n– #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.لش#~ي#~ و#.لهزل #.لذي يش#>#^ #%يه #.ل#-#<ل ويزي#~ من #?#^#=يزه ونش#.#-ه.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية م#<#^#-ة #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة أو #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n– يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول #.ل#>ق#.#^ حيث يوج#~ أس#%#.#% أخ#^ي ق#~ #?س#%#% #.لأنيمي#. مثل خ#^#.ج #.لم#>#~ة وأو#^#.م س#^#-#.نية. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ل#?ح#~ي#~ #.لج#^#>ة أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ح#?ى ل#. ي#?م أخذ ج#^#>#.#? #>#.لية #?ؤث#^ #>لى صحة #.لجنين و#.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– يحذ#^ #.ل#.س#?خ#~#.م #.لم#?ز#.من م#> أ#~وية #.لقل#% و#.لس#=#^ و#.ل#?ي #?ح#?وى #>لى م#.#~ة #.لسل#.مين.", "GI": "About Folic Acid\r\nDietary supplement, Folate derivative( B9 ), Water Soluble Vitamin.\r\nMechanism of Action of Folic Acid\r\nFolic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively. Tetrahydrofolic acid acts as a coenzyme which mediates a number of one carbon transfer reactions by carrying a methyl group as an adduct. It involves a number of reactions such as 1).conversion of homocysteine to methionine. 2).synthesis of thymidylate which is an essential constituent of DNA from methylene-tetrahydrofolic acid. 3). Conversion of serine to glycine by tetrahydrofolic acid and forms methylene-tetrahydrofolic acid. 4).to introduce carbon units at position 2 and 8 during de novo purine synthesis requires formyl-tetrahydrofolic acid and methenyl-tetrahydrofolic acid.5).generation and utilization of \\\"formate pool\\\". 6).For mediating formino group transfer in histidine metabolism. Folic acid is required to maintain normal", "Composition": "ferrous sulfate 150mg+folic acid 0.5mg", "Route": "ORAL.SOLID" }, { "ID": "700", "Trade_Name": "GLONERVYA 75 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "87", "Price_Old": "87", "Company": "EGPI > GLOBE INTERNATIONAL PHARMACEUTICALS", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "PREGABALIN 75 MG", "Route": "ORAL.SOLID" }, { "ID": "701", "Trade_Name": "LYRINEUR 75MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "48", "Price_Old": "48", "Company": "MARCYRL CO. > ELITE PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 75mg", "Route": "ORAL.SOLID" }, { "ID": "702", "Trade_Name": "LYRICA 75MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "134", "Price_Old": "134", "Company": "PFIZER", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 75mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "703", "Trade_Name": "HEXGABALIN 75 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "111", "Price_Old": "111", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each Hexgabalin 75 capsule contains pregabalin 75 mg.\r\nEach Hexgabalin 150 capsule contains pregabalin 150 mg.", "Route": "ORAL.SOLID" }, { "ID": "704", "Trade_Name": "PREGAVALEX 75 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "79.75", "Price_Old": "54.75", "Company": "EVA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each Capsule contains:\r\nPregabalin 75,150,300 mg", "Route": "ORAL.SOLID" }, { "ID": "705", "Trade_Name": "LYROLIN 75MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "85", "Price_Old": "60", "Company": "HIKMA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 75mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "706", "Trade_Name": "KEMIRICA 75 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "96", "Price_Old": "96", "Company": "CHEMIPHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each hard gelatin capsule contain \r\nActive Ingredient: Pregabalin 25, 50,75,100,150,200,300 mg", "Route": "ORAL.SOLID" }, { "ID": "707", "Trade_Name": "PAINICA 75MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "74", "Price_Old": "74", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > ALPHA GROUP COMPANY", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 300mg or 75mg", "Route": "ORAL.SOLID" }, { "ID": "708", "Trade_Name": "IRENYPATHIC 75MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "74", "Price_Old": "74", "Company": "AMOUN", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Pregabalin 75 mg & Or 150 mg", "Route": "ORAL.SOLID" }, { "ID": "709", "Trade_Name": "SERIGABTIN 75MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "58", "Price_Old": "58", "Company": "SEDICO > SERIO PHARM-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 75mg", "Route": "ORAL.SOLID" }, { "ID": "710", "Trade_Name": "RIBAVARIN 200MG 12 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "24", "Price_Old": "24", "Company": "MEMPHIS", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "711", "Trade_Name": "VIRIN 200MG 12 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "23.76", "Price_Old": "23.76", "Company": "SIGMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "Each capsule contains: \r\nRibavirin 200mg or 400 mg.", "Route": "ORAL.SOLID" }, { "ID": "712", "Trade_Name": "VIRACURE 200MG 12 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "58", "Price_Old": "58", "Company": "OCTOBER PHARMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "ribavirin 7.5%", "Route": "ORAL.SOLID" }, { "ID": "713", "Trade_Name": "RIBAVIRIN 200MG 10 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "50", "Price_Old": "50", "Company": "T3A PHARMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "* Ribavirin 200mg:\r\nEach capsule contains as active ingredient 200mg Ribavirin\r\n\r\n* Ribavirin 400mg:\r\nEach capsule contains as active ingredient 400mg Ribavirin", "Route": "ORAL.SOLID" }, { "ID": "714", "Trade_Name": "PANVIRIN 400MG 10 H.G.CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "48", "Price_Old": "48", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "ribavirin 200mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "715", "Trade_Name": "VIROKAN 200MG 6CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "17", "Price_Old": "17", "Company": "HIKMA PHARMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "ribavirin 400mg", "Route": "ORAL.SOLID" }, { "ID": "716", "Trade_Name": "RIBOVINAL 200 MG 8 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "12", "Price_Old": "12", "Company": "MASH PREMIERE", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "717", "Trade_Name": "HEPATOVIRIN 400 MG 30 CAP.", "Generic_Name": "RIBAVIRIN", "Price": "60", "Price_Old": "114", "Company": "MEPACO > EGYPHARMA-EGYPT", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "718", "Trade_Name": "RIBAVIRIN 200MG 12 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "22", "Price_Old": "22", "Company": "MINA PHARM", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "* Ribavirin 200mg:\r\nEach capsule contains as active ingredient 200mg Ribavirin\r\n\r\n* Ribavirin 400mg:\r\nEach capsule contains as active ingredient 400mg Ribavirin", "Route": "ORAL.SOLID" }, { "ID": "719", "Trade_Name": "RIBA 400MG 10 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "48", "Price_Old": "48", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "Each Riba 200 mg capsule contains 200 mg ribavirin.\r\nEach Riba 400 mg capsule contains 400 mg ribavirin.", "Route": "ORAL.SOLID" }, { "ID": "720", "Trade_Name": "PROSTACAP 50MG 24 CAPS.", "Generic_Name": "PYGEUM AFRICANUM EXTRACT", "Price": "18", "Price_Old": "18", "Company": "PHARCO", "Pharmacology": "PROSTATE SUPPORT", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "–#.ل#>ل#.ج و#.لوق#.ية من #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ل#>ل#.ج ص#>و#%ة #.ل#?#%ول #.لمص#.ح#%ة ل#?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~ #.لم#^حلة #.ل#.ولى و#.لث#.نية", "Contraindications": "–#.لأ#-#<#.ل ح#?ى ل#. يؤث#^ #>لى #.لجه#.ز #.ل#?ن#<سي لهم. \r\n\r\n–حس#.سية #_#~ أح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يج#% #.س#?خ#~#.م و#.قي ذ#=#^ي #>ن#~ #.لقي#.م #%#.ل#>ملية #.لجنسية أو #.س#?#>م#.ل #.لم#^أة لح#%و#% من#> #.لحمل.", "GI": "COMING SOON ..", "Composition": "b sitosterol 6mg, pygeum africanum 50mg", "Route": "ORAL.SOLID" }, { "ID": "721", "Trade_Name": "CORPRIL 5MG 7 CAPS.", "Generic_Name": "RAMIPRIL", "Price": "18", "Price_Old": "14.4", "Company": "GLOBAL NAPI PHARMACEUTICALS > REXCEL", "Pharmacology": "ANTIHYPERTENSIVE.ACE", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #_غ#- #.ل#~م #.لم#^#?#<#> . \r\n\r\n–للوق#.ية من ح#~وث #.لأزم#.#? #.لقل#%ية و#.لس#=#?ة #.ل#~م#.غية . \r\n\r\n–للوق#.ية من #?أخ#^ أم#^#.#_ #.ل#=لى . \r\n\r\n–#>ل#.ج ح#.ل#.#? قصو#^ #.لقل#% .", "Contraindications": "– #.لحس#.سية #.لش#~ي#~ة من م#.#~ة ” #^#.مي#%#^يل ” . \r\n\r\n– ح#.ل#.#? #.لإص#.#%ة #.لمس#%قة #%#.لوذمة #.لو#>#.ئية وظهو#^ أ#>#^#.#_ مثل #.لح#=ة و#.ل#.#^#?#=#.#^ي#. و#.ل#-#<ح #.لجل#~ي . \r\n\r\n– م#^#_ى #.لغسيل #.ل#=لوي . \r\n\r\n– م#^#_ى #.ل#=لى #.لمص#.#%ون #%#.نخ#<#.#_ #?#~#<ق #.ل#~م لل#=لي#?ين أو م#. ي#>#^#< #%#.سم #_يق #.لش#^ي#.ن #.ل#=لوي . \r\n\r\n– ح#.ل#.#? #.نخ#<#.#_ #_غ#- #.ل#~م . \r\n\r\n– وجو#~ أي أم#^#.#_ #<ي #.ل#=لى . \r\n\r\n– #.ل#?#>#^#_ لمش#=ل#.#? صحية #?س#%#%#? #<ي #<ق#~#.ن #.لجسم لنس#%ة #=#%ي#^ة من #.لأمل#.ح و#.لم#>#.#~ن و#.لسو#.ئل، #=م#. هو #.لح#.ل #<ي ح#.ل#.#? #.لإسه#.ل و#.لقيء #.لش#~ي#~ . \r\n\r\n– #<ي ح#.لة #.س#?خ#~#.م م#~#^#.#? #%ول . \r\n\r\n– ل#. يس#?خ#~م م#> أ#~وية #>ل#.ج #.لحس#.سية .", "GI": "About Ramipril\r\nAngiotensin - converting enzyme inhibitor, Antihypertensive.\r\nMechanism of Action of Ramipril\r\nIt is a prodrug and converted in to active Ramiprilat- which is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1 to angiotensin-2 and abolishes the pressor actions of angiotensin. It decreases aldosterone secretion, sodium and water retention, and total peripheral resistance, leads to fall in BP. The arterioles dilate and the compliance of larger arteries is increased. Both systolic and diastolic BP is lowered. The drug does not compromise renal, cerebral, and coronary blood flow. The drug also increases plasma kinin levels and potentiate the hypotensive action of exogenously administered bradykinin. It is used for treatment of systolic heart failure, because it improves symptoms, decrease mortality and reduce ventricular hypertrophy. It reduces both preload and after load and thus increasing cardiac out put in patients with heart failure.", "Composition": "ramipril 1.25mg or 2.5mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "722", "Trade_Name": "RAMIPRIL 2.5MG 7 CAPS.", "Generic_Name": "RAMIPRIL", "Price": "9.5", "Price_Old": "9.5", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHYPERTENSIVE.ACE", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #_غ#- #.ل#~م #.لم#^#?#<#> . \r\n\r\n–للوق#.ية من ح#~وث #.لأزم#.#? #.لقل#%ية و#.لس#=#?ة #.ل#~م#.غية . \r\n\r\n–للوق#.ية من #?أخ#^ أم#^#.#_ #.ل#=لى . \r\n\r\n–#>ل#.ج ح#.ل#.#? قصو#^ #.لقل#% .", "Contraindications": "– #.لحس#.سية #.لش#~ي#~ة من م#.#~ة ” #^#.مي#%#^يل ” . \r\n\r\n– ح#.ل#.#? #.لإص#.#%ة #.لمس#%قة #%#.لوذمة #.لو#>#.ئية وظهو#^ أ#>#^#.#_ مثل #.لح#=ة و#.ل#.#^#?#=#.#^ي#. و#.ل#-#<ح #.لجل#~ي . \r\n\r\n– م#^#_ى #.لغسيل #.ل#=لوي . \r\n\r\n– م#^#_ى #.ل#=لى #.لمص#.#%ون #%#.نخ#<#.#_ #?#~#<ق #.ل#~م لل#=لي#?ين أو م#. ي#>#^#< #%#.سم #_يق #.لش#^ي#.ن #.ل#=لوي . \r\n\r\n– ح#.ل#.#? #.نخ#<#.#_ #_غ#- #.ل#~م . \r\n\r\n– وجو#~ أي أم#^#.#_ #<ي #.ل#=لى . \r\n\r\n– #.ل#?#>#^#_ لمش#=ل#.#? صحية #?س#%#%#? #<ي #<ق#~#.ن #.لجسم لنس#%ة #=#%ي#^ة من #.لأمل#.ح و#.لم#>#.#~ن و#.لسو#.ئل، #=م#. هو #.لح#.ل #<ي ح#.ل#.#? #.لإسه#.ل و#.لقيء #.لش#~ي#~ . \r\n\r\n– #<ي ح#.لة #.س#?خ#~#.م م#~#^#.#? #%ول . \r\n\r\n– ل#. يس#?خ#~م م#> أ#~وية #>ل#.ج #.لحس#.سية .", "GI": "About Ramipril\r\nAngiotensin - converting enzyme inhibitor, Antihypertensive.\r\nMechanism of Action of Ramipril\r\nIt is a prodrug and converted in to active Ramiprilat- which is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1 to angiotensin-2 and abolishes the pressor actions of angiotensin. It decreases aldosterone secretion, sodium and water retention, and total peripheral resistance, leads to fall in BP. The arterioles dilate and the compliance of larger arteries is increased. Both systolic and diastolic BP is lowered. The drug does not compromise renal, cerebral, and coronary blood flow. The drug also increases plasma kinin levels and potentiate the hypotensive action of exogenously administered bradykinin. It is used for treatment of systolic heart failure, because it improves symptoms, decrease mortality and reduce ventricular hypertrophy. It reduces both preload and after load and thus increasing cardiac out put in patients with heart failure.", "Composition": "ramipril 1.25mg or 2.5mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "723", "Trade_Name": "PROSTACURE 50MG 20 CAPS.", "Generic_Name": "PYGEUM AFRICANUM EXTRACT", "Price": "44", "Price_Old": "22", "Company": "OCTOBER PHARMA", "Pharmacology": "PROSTATE SUPPORT", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "–#.ل#>ل#.ج و#.لوق#.ية من #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~. \r\n\r\n–ل#>ل#.ج ص#>و#%ة #.ل#?#%ول #.لمص#.ح#%ة ل#?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~ #.لم#^حلة #.ل#.ولى و#.لث#.نية", "Contraindications": "–#.لأ#-#<#.ل ح#?ى ل#. يؤث#^ #>لى #.لجه#.ز #.ل#?ن#<سي لهم. \r\n\r\n–حس#.سية #_#~ أح#~ م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يج#% #.س#?خ#~#.م و#.قي ذ#=#^ي #>ن#~ #.لقي#.م #%#.ل#>ملية #.لجنسية أو #.س#?#>م#.ل #.لم#^أة لح#%و#% من#> #.لحمل.", "GI": "COMING SOON ..", "Composition": "Each capsule contains:\r\nPygeum Africanum 50 mg Extract.", "Route": "ORAL.SOLID" }, { "ID": "724", "Trade_Name": "PANVIRIN 200MG 10 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "32", "Price_Old": "32", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "ribavirin 200mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "725", "Trade_Name": "RAMIPRIL 5MG 7 CAPS.", "Generic_Name": "RAMIPRIL", "Price": "13.2", "Price_Old": "13.2", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHYPERTENSIVE.ACE", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #_غ#- #.ل#~م #.لم#^#?#<#> . \r\n\r\n–للوق#.ية من ح#~وث #.لأزم#.#? #.لقل#%ية و#.لس#=#?ة #.ل#~م#.غية . \r\n\r\n–للوق#.ية من #?أخ#^ أم#^#.#_ #.ل#=لى . \r\n\r\n–#>ل#.ج ح#.ل#.#? قصو#^ #.لقل#% .", "Contraindications": "– #.لحس#.سية #.لش#~ي#~ة من م#.#~ة ” #^#.مي#%#^يل ” . \r\n\r\n– ح#.ل#.#? #.لإص#.#%ة #.لمس#%قة #%#.لوذمة #.لو#>#.ئية وظهو#^ أ#>#^#.#_ مثل #.لح#=ة و#.ل#.#^#?#=#.#^ي#. و#.ل#-#<ح #.لجل#~ي . \r\n\r\n– م#^#_ى #.لغسيل #.ل#=لوي . \r\n\r\n– م#^#_ى #.ل#=لى #.لمص#.#%ون #%#.نخ#<#.#_ #?#~#<ق #.ل#~م لل#=لي#?ين أو م#. ي#>#^#< #%#.سم #_يق #.لش#^ي#.ن #.ل#=لوي . \r\n\r\n– ح#.ل#.#? #.نخ#<#.#_ #_غ#- #.ل#~م . \r\n\r\n– وجو#~ أي أم#^#.#_ #<ي #.ل#=لى . \r\n\r\n– #.ل#?#>#^#_ لمش#=ل#.#? صحية #?س#%#%#? #<ي #<ق#~#.ن #.لجسم لنس#%ة #=#%ي#^ة من #.لأمل#.ح و#.لم#>#.#~ن و#.لسو#.ئل، #=م#. هو #.لح#.ل #<ي ح#.ل#.#? #.لإسه#.ل و#.لقيء #.لش#~ي#~ . \r\n\r\n– #<ي ح#.لة #.س#?خ#~#.م م#~#^#.#? #%ول . \r\n\r\n– ل#. يس#?خ#~م م#> أ#~وية #>ل#.ج #.لحس#.سية .", "GI": "About Ramipril\r\nAngiotensin - converting enzyme inhibitor, Antihypertensive.\r\nMechanism of Action of Ramipril\r\nIt is a prodrug and converted in to active Ramiprilat- which is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1 to angiotensin-2 and abolishes the pressor actions of angiotensin. It decreases aldosterone secretion, sodium and water retention, and total peripheral resistance, leads to fall in BP. The arterioles dilate and the compliance of larger arteries is increased. Both systolic and diastolic BP is lowered. The drug does not compromise renal, cerebral, and coronary blood flow. The drug also increases plasma kinin levels and potentiate the hypotensive action of exogenously administered bradykinin. It is used for treatment of systolic heart failure, because it improves symptoms, decrease mortality and reduce ventricular hypertrophy. It reduces both preload and after load and thus increasing cardiac out put in patients with heart failure.", "Composition": "ramipril 1.25mg or 2.5mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "726", "Trade_Name": "CORPRIL 2.5MG 7CAPS.", "Generic_Name": "RAMIPRIL", "Price": "9.75", "Price_Old": "8.4", "Company": "GLOBAL NAPI PHARMACEUTICALS > REXCEL", "Pharmacology": "ANTIHYPERTENSIVE.ACE", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #_غ#- #.ل#~م #.لم#^#?#<#> . \r\n\r\n–للوق#.ية من ح#~وث #.لأزم#.#? #.لقل#%ية و#.لس#=#?ة #.ل#~م#.غية . \r\n\r\n–للوق#.ية من #?أخ#^ أم#^#.#_ #.ل#=لى . \r\n\r\n–#>ل#.ج ح#.ل#.#? قصو#^ #.لقل#% .", "Contraindications": "– #.لحس#.سية #.لش#~ي#~ة من م#.#~ة ” #^#.مي#%#^يل ” . \r\n\r\n– ح#.ل#.#? #.لإص#.#%ة #.لمس#%قة #%#.لوذمة #.لو#>#.ئية وظهو#^ أ#>#^#.#_ مثل #.لح#=ة و#.ل#.#^#?#=#.#^ي#. و#.ل#-#<ح #.لجل#~ي . \r\n\r\n– م#^#_ى #.لغسيل #.ل#=لوي . \r\n\r\n– م#^#_ى #.ل#=لى #.لمص#.#%ون #%#.نخ#<#.#_ #?#~#<ق #.ل#~م لل#=لي#?ين أو م#. ي#>#^#< #%#.سم #_يق #.لش#^ي#.ن #.ل#=لوي . \r\n\r\n– ح#.ل#.#? #.نخ#<#.#_ #_غ#- #.ل#~م . \r\n\r\n– وجو#~ أي أم#^#.#_ #<ي #.ل#=لى . \r\n\r\n– #.ل#?#>#^#_ لمش#=ل#.#? صحية #?س#%#%#? #<ي #<ق#~#.ن #.لجسم لنس#%ة #=#%ي#^ة من #.لأمل#.ح و#.لم#>#.#~ن و#.لسو#.ئل، #=م#. هو #.لح#.ل #<ي ح#.ل#.#? #.لإسه#.ل و#.لقيء #.لش#~ي#~ . \r\n\r\n– #<ي ح#.لة #.س#?خ#~#.م م#~#^#.#? #%ول . \r\n\r\n– ل#. يس#?خ#~م م#> أ#~وية #>ل#.ج #.لحس#.سية .", "GI": "About Ramipril\r\nAngiotensin - converting enzyme inhibitor, Antihypertensive.\r\nMechanism of Action of Ramipril\r\nIt is a prodrug and converted in to active Ramiprilat- which is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1 to angiotensin-2 and abolishes the pressor actions of angiotensin. It decreases aldosterone secretion, sodium and water retention, and total peripheral resistance, leads to fall in BP. The arterioles dilate and the compliance of larger arteries is increased. Both systolic and diastolic BP is lowered. The drug does not compromise renal, cerebral, and coronary blood flow. The drug also increases plasma kinin levels and potentiate the hypotensive action of exogenously administered bradykinin. It is used for treatment of systolic heart failure, because it improves symptoms, decrease mortality and reduce ventricular hypertrophy. It reduces both preload and after load and thus increasing cardiac out put in patients with heart failure.", "Composition": "ramipril 1.25mg or 2.5mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "727", "Trade_Name": "HEPAVERIN 200MG 170 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "244", "Price_Old": "244", "Company": "AMRIYA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "Ribavirin 200mg", "Route": "ORAL.SOLID" }, { "ID": "728", "Trade_Name": "RAMIPRIL 1.25MG 7 CAPS.", "Generic_Name": "RAMIPRIL", "Price": "6.75", "Price_Old": "6.75", "Company": "PHAROPHARMA", "Pharmacology": "ANTIHYPERTENSIVE.ACE", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–ل#>ل#.ج #_غ#- #.ل#~م #.لم#^#?#<#> . \r\n\r\n–للوق#.ية من ح#~وث #.لأزم#.#? #.لقل#%ية و#.لس#=#?ة #.ل#~م#.غية . \r\n\r\n–للوق#.ية من #?أخ#^ أم#^#.#_ #.ل#=لى . \r\n\r\n–#>ل#.ج ح#.ل#.#? قصو#^ #.لقل#% .", "Contraindications": "– #.لحس#.سية #.لش#~ي#~ة من م#.#~ة ” #^#.مي#%#^يل ” . \r\n\r\n– ح#.ل#.#? #.لإص#.#%ة #.لمس#%قة #%#.لوذمة #.لو#>#.ئية وظهو#^ أ#>#^#.#_ مثل #.لح#=ة و#.ل#.#^#?#=#.#^ي#. و#.ل#-#<ح #.لجل#~ي . \r\n\r\n– م#^#_ى #.لغسيل #.ل#=لوي . \r\n\r\n– م#^#_ى #.ل#=لى #.لمص#.#%ون #%#.نخ#<#.#_ #?#~#<ق #.ل#~م لل#=لي#?ين أو م#. ي#>#^#< #%#.سم #_يق #.لش#^ي#.ن #.ل#=لوي . \r\n\r\n– ح#.ل#.#? #.نخ#<#.#_ #_غ#- #.ل#~م . \r\n\r\n– وجو#~ أي أم#^#.#_ #<ي #.ل#=لى . \r\n\r\n– #.ل#?#>#^#_ لمش#=ل#.#? صحية #?س#%#%#? #<ي #<ق#~#.ن #.لجسم لنس#%ة #=#%ي#^ة من #.لأمل#.ح و#.لم#>#.#~ن و#.لسو#.ئل، #=م#. هو #.لح#.ل #<ي ح#.ل#.#? #.لإسه#.ل و#.لقيء #.لش#~ي#~ . \r\n\r\n– #<ي ح#.لة #.س#?خ#~#.م م#~#^#.#? #%ول . \r\n\r\n– ل#. يس#?خ#~م م#> أ#~وية #>ل#.ج #.لحس#.سية .", "GI": "About Ramipril\r\nAngiotensin - converting enzyme inhibitor, Antihypertensive.\r\nMechanism of Action of Ramipril\r\nIt is a prodrug and converted in to active Ramiprilat- which is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1 to angiotensin-2 and abolishes the pressor actions of angiotensin. It decreases aldosterone secretion, sodium and water retention, and total peripheral resistance, leads to fall in BP. The arterioles dilate and the compliance of larger arteries is increased. Both systolic and diastolic BP is lowered. The drug does not compromise renal, cerebral, and coronary blood flow. The drug also increases plasma kinin levels and potentiate the hypotensive action of exogenously administered bradykinin. It is used for treatment of systolic heart failure, because it improves symptoms, decrease mortality and reduce ventricular hypertrophy. It reduces both preload and after load and thus increasing cardiac out put in patients with heart failure.", "Composition": "ramipril 1.25mg or 2.5mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "729", "Trade_Name": "RIBA 200MG 10 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "30", "Price_Old": "30", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "Each Riba 200 mg capsule contains 200 mg ribavirin.\r\nEach Riba 400 mg capsule contains 400 mg ribavirin.", "Route": "ORAL.SOLID" }, { "ID": "730", "Trade_Name": "VRONOGABIC 75MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "48", "Price_Old": "48", "Company": "MARCYRL CO.", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Pregabalin 75 or 150 mg", "Route": "ORAL.SOLID" }, { "ID": "731", "Trade_Name": "PREGATREND 100MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "38", "Price_Old": "38", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > TREND PHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 100mg", "Route": "ORAL.SOLID" }, { "ID": "732", "Trade_Name": "PREGABA 100 MG 30 CAP.", "Generic_Name": "PREGABALIN", "Price": "126", "Price_Old": "126", "Company": "EGPI", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each capsule contains:\r\nPregabalin 50mg\r\nPregabalin 100mg", "Route": "ORAL.SOLID" }, { "ID": "733", "Trade_Name": "AVEROPREG 100MG 15 CAPS.", "Generic_Name": "PREGABALIN", "Price": "69", "Price_Old": "69", "Company": "EL-OBOUR > AVERROES PHARMA-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "734", "Trade_Name": "DEPAPALIN 150MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "70", "Price_Old": "70", "Company": "DEBEIKY > RAMEDA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "735", "Trade_Name": "PREGDIN-APEX 100MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "84", "Price_Old": "84", "Company": "MULTI-APEX", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "736", "Trade_Name": "LYCROBALIN 100MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "42", "Price_Old": "42", "Company": "BORG > ELHAYATT PHARMA-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "737", "Trade_Name": "CONVUGABALIN 150MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "31.5", "Price_Old": "31.5", "Company": "AL ROWAD PHARMACEUTICAL INDUSTRIAL CO.", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg", "Route": "ORAL.SOLID" }, { "ID": "738", "Trade_Name": "KEMIRICA 100 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "105", "Price_Old": "105", "Company": "CHEMIPHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each hard gelatin capsule contain \r\nActive Ingredient: Pregabalin 25, 50,75,100,150,200,300 mg", "Route": "ORAL.SOLID" }, { "ID": "739", "Trade_Name": "GABLOVAC 150MG 10 CAPSULE", "Generic_Name": "PREGABALIN", "Price": "43", "Price_Old": "43", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > GAST PHARMA GROUP-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "740", "Trade_Name": "EXELON 4.5MG 28 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "210", "Price_Old": "210", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "741", "Trade_Name": "RIVAMEP 6 MG 20 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "60", "Price_Old": "60", "Company": "MEPACO", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 4.5mg or 6mg", "Route": "ORAL.SOLID" }, { "ID": "742", "Trade_Name": "EXELON 6 MG 14 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "105", "Price_Old": "105", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "743", "Trade_Name": "RIVAMEP 4.5 MG 20 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "58", "Price_Old": "58", "Company": "MEPACO", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 4.5mg or 6mg", "Route": "ORAL.SOLID" }, { "ID": "744", "Trade_Name": "ACTIVENT 8MG SR 20 CAP.", "Generic_Name": "SALBUTAMOL", "Price": "13.2", "Price_Old": "13.2", "Company": "MUP", "Pharmacology": "BRONCHODILATOR", "Category": "موس#> للش#>#% #.لهو#.ئية", "Use": "–لوق#< مش#.#=ل #.ل#?ن#<س أثن#.ء مم#.#^سة #.لنش#.#-#.#?. \r\n\r\n–ل#<#?ح #.لش#>#% #.لهو#.ئية #<ي أم#^#.#_ #.ل#^ئة حيث #?س#%#% #.ل#?شنج#.#? مش#.#=ل #<ي #.ل#?ن#<س.", "Contraindications": "–#<#^#- #.لحس#.سية للم#.#~ة #.ل#<#>#.لة", "GI": "About Salbutamol\r\nBeta2-Adrenergic Agonist, Phenethylamine derivative, Bronchodilator(Antiasthma), uterine relaxant.\r\nMechanism of Action of Salbutamol\r\nSalbutamol is a short acting ?2 receptor agonist. It selectively stimulates ?2 receptors present in airway, Uterus, and Vascular Smooth muscles. It directly relaxes the airway smooth muscles and produces bronchodilation. Stimulation of ?2 receptors activates Gs adenylyl-cyclase -cyclic AMP path way and produces reduction in smooth muscle tone. ?2 receptor agonists also increases the conductance of large Ca2+sensitive K+ channels in airway smooth muscles and leads to membrane hyperpolarisation and relaxation of smooth muscles. \r\n?2 receptor agonists also suppress the release of Leukotrienes and histamine from the mast cells in the lung tissue and enhance mucociliary function and decrease micro vascular permeability and also inhibits Phospholipase A2 which produces inhibition of prostaglandins production.", "Composition": "salbutamol 8mg", "Route": "ORAL.SOLID" }, { "ID": "745", "Trade_Name": "RIVAXEL 6MG 7 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "30", "Price_Old": "30", "Company": "HIKMA PHARMA", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 3mg or 4.5mg or 6mg", "Route": "ORAL.SOLID" }, { "ID": "746", "Trade_Name": "EXELON 6MG 28 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "210", "Price_Old": "210", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "747", "Trade_Name": "VENORUTON 300MG 20 CAPS.", "Generic_Name": "RUTOSIDE", "Price": "17.15", "Price_Old": "17.15", "Company": "NOVARTIS > GLAXO SMITHKLINE", "Pharmacology": "VASCULAR-PROTECTING AGENT", "Category": "لل#~و#.لي", "Use": "–أوج#.#> و ح#.ل#.#? #.ح#?ق#.ن #.ل#%و#.سي#^ \r\n\r\n–#.#_#-#^#.#%#.#? #.ل#~و#^ة #.ل#~موية", "Contraindications": "–#.ل#%و#.سي#^: يج#% #.خ#%#.#^ #.ل#-#%ي#% إذ#. لم #?خ#?#<ي نو#%#.#? #.ل#%و#.سي#^ #%#>#~ 15 يوم من #.ل#>ل#.ج \r\n\r\n–#.#_#-#^#.#%#.#? #.ل#~و#^ة #.ل#~موية: \r\n\r\n–#=ي ي#>#.لج هذ#. #.ل#~و#.ء #.#_#-#^#.#%#.#? #.ل#~و#^ة #.ل#~موية يج#% م#^#.#>#.ة ش#^و#- ح#<ظ #.لصحة مثل: \r\n\r\n–#>#~م #.ل#?#>#^#_ لأش#>ة #.لشمس أو #.لح#^#.#^ة ل#<#?#^ة #-ويلة . \r\n\r\n–#.لمشي #>لى #.لأق#~#.م م#> ل#%س جو#.#^#% مل#.ئمة #?نش#- #.ل#~و#^ة #.ل#~موية. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% #>ن أي أ#~وية ق#%ل أن #?#?ن#.وليه#. خل#.ل #<#?#^ة #.لحمل و #.لول#.#~ة", "GI": "Description\t\r\nA flavonol glycoside found in many plants, including buckwheat- tobacco- forsythia- hydrangea- viola, etc. It has been used therapeutically to decrease capillary fragility.", "Composition": "rutin 300mg", "Route": "ORAL.SOLID" }, { "ID": "748", "Trade_Name": "RIVAXEL 4.5MG 28 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "106", "Price_Old": "106", "Company": "HIKMA PHARMA", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 3mg or 4.5mg or 6mg", "Route": "ORAL.SOLID" }, { "ID": "749", "Trade_Name": "SHAM 300MG 24 CAPS.", "Generic_Name": "SALICYLHYDROXAMIC ACID", "Price": "18", "Price_Old": "18", "Company": "EL NASR", "Pharmacology": "UROLITHIAC", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–يمن#> #?#=ون حصو#.#? #.لجه#.ز #.ل#%ولي م#^ة أخ#^ى. \r\n\r\n–ي#>مل #>لى #?صغي#^ حجم #.لحصوة. \r\n\r\n–#.ل#?قليل من ح#^ق#.ن #.ل#%ول. \r\n\r\n–#?س#=ين أل#.م #.لحصو#.#? مثل #.لمغص #.ل#=لوي. \r\n\r\n–يم#=ن إس#?خ#~#.مه #=مس#=ن للص#~#.#> #.لنص#<ي.", "Contraindications": "–ينصح #%#>#~م إ#>#-#.ئه للنس#.ء #.لحو#.مل و#%خ#.صة #.لثل#.ثة شهو#^ #.لأولى من #.لحمل أو للأ#<#^#.#~ #.لمص#.#%ين #%نقص #=#.لسيوم #.ل#~م.", "GI": "It exerts a dual urolithiac activity. It inhibits both the urease enzyme activity and sulphation of mucopolysaccharides which are responsible for renal stone formation.\r\nSHAM is metabolized in the body to salicylamide which exerts analgesic, anti-pyretic as well as potent anti-inflammatory activities.\r\nDose: 1-2 caps. 3-4 times after meals", "Composition": "solidago virgaurea 300mg", "Route": "ORAL.SOLID" }, { "ID": "750", "Trade_Name": "RIBAVARIN 400MG 12CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "28.8", "Price_Old": "28.8", "Company": "MEMPHIS", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "751", "Trade_Name": "VIROKAN 400MG 12 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "52", "Price_Old": "52", "Company": "HIKMA PHARMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "ribavirin 400mg", "Route": "ORAL.SOLID" }, { "ID": "752", "Trade_Name": "VIRIN 400MG 12CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "36", "Price_Old": "36", "Company": "SIGMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "Each capsule contains: \r\nRibavirin 200mg or 400 mg.", "Route": "ORAL.SOLID" }, { "ID": "753", "Trade_Name": "RIBAVIRIN 400MG 12 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "38", "Price_Old": "38", "Company": "MINA PHARM", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "* Ribavirin 200mg:\r\nEach capsule contains as active ingredient 200mg Ribavirin\r\n\r\n* Ribavirin 400mg:\r\nEach capsule contains as active ingredient 400mg Ribavirin", "Route": "ORAL.SOLID" }, { "ID": "754", "Trade_Name": "RIFAMPICIN 300MG 8 CAPS.", "Generic_Name": "RIFAMPICIN", "Price": "9.5", "Price_Old": "9.5", "Company": "EL NASR", "Pharmacology": "ANTIBIOTIC.ANTITUBERCULOSIS", "Category": "م#_#.#~ حيوي للمس#.ل#= #.ل#%ولية", "Use": "–م#^#_ #.لسل، يس#?خ#~م #=#~و#.ء من #_من #.لأ#~وية #.لمس#?خ#~مة #<ي #>ل#.ج م#^#_ #.لسل م#> أيزوني#.زي#~ و#%ي#^#.زين#.مي#~. \r\n\r\n–#.لجذ#.م. \r\n\r\n–#~#.ء #.ل#<ي#.لقة. \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#.، #.لن#.جم #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.لمق#.ومة ل#%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون، يؤخذ م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين. \r\n\r\n–#.لحمى #.لم#.ل#-ية، #%#.لأ#_#.#<ة للأ#~وية #.ل#?#.لية #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول، و#?#^ي ميثو#%#^يم. \r\n\r\n–#.لوق#.ية من #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية و#.لمس#?#~مية #.لنزلية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون أخ#^ من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لي#^ق#.ن. \r\n\r\n–ل#. يجوز أخذه #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~.", "GI": "About Rifampicin\r\nRifamycin derivative, Antituberculosis antibiotic.\r\nMechanism of Action of Rifampicin\r\nRifampicin is primarily bactericidal and has some bacteriostatic properties also. It acts by inhibiting DNA dependent RNA polymerase and thus stopping the expression of bacterial genes.M.tuberculosis requires DNA dependent RNA polymerase enzyme for the synthesis of RNA and protein. Without this enzyme bacteria cannot reproduce and they die. \r\nIndications for Rifampicin\r\n1. Leprosy \r\n2. Tuberculosis \r\n3. Prophylaxis of meningococcal carriers \r\n4. Prophylaxis of H. influenzae \r\nInteractions for Rifampicin\r\nRifampicin by inducing the hepatic microsomal enzymes may reduce the efficacy of the following drugs: Acetaminophen, oral anticoagulants, barbiturates, benzodiazepines, chloramphenicol, clofibrate. Oral contraceptives, corticosteroids, cyclosporine, digitoxin, disopyramide, beta blockers oestrogens, hydantoins, mexiletine, quinidine, sulfones, sulphonylureas, theophylline, verapamil", "Composition": "Rifampicin 150,300mg", "Route": "ORAL.SOLID" }, { "ID": "755", "Trade_Name": "RIFAMPICIN 150MG 8 CAPS.", "Generic_Name": "RIFAMPICIN", "Price": "6.45", "Price_Old": "6.45", "Company": "EL NASR", "Pharmacology": "ANTIBIOTIC.ANTITUBERCULOSIS", "Category": "م#_#.#~ حيوي للمس#.ل#= #.ل#%ولية", "Use": "–م#^#_ #.لسل، يس#?خ#~م #=#~و#.ء من #_من #.لأ#~وية #.لمس#?خ#~مة #<ي #>ل#.ج م#^#_ #.لسل م#> أيزوني#.زي#~ و#%ي#^#.زين#.مي#~. \r\n\r\n–#.لجذ#.م. \r\n\r\n–#~#.ء #.ل#<ي#.لقة. \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#.، #.لن#.جم #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.لمق#.ومة ل#%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون، يؤخذ م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين. \r\n\r\n–#.لحمى #.لم#.ل#-ية، #%#.لأ#_#.#<ة للأ#~وية #.ل#?#.لية #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول، و#?#^ي ميثو#%#^يم. \r\n\r\n–#.لوق#.ية من #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية و#.لمس#?#~مية #.لنزلية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون أخ#^ من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لي#^ق#.ن. \r\n\r\n–ل#. يجوز أخذه #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~.", "GI": "About Rifampicin\r\nRifamycin derivative, Antituberculosis antibiotic.\r\nMechanism of Action of Rifampicin\r\nRifampicin is primarily bactericidal and has some bacteriostatic properties also. It acts by inhibiting DNA dependent RNA polymerase and thus stopping the expression of bacterial genes.M.tuberculosis requires DNA dependent RNA polymerase enzyme for the synthesis of RNA and protein. Without this enzyme bacteria cannot reproduce and they die. \r\nIndications for Rifampicin\r\n1. Leprosy \r\n2. Tuberculosis \r\n3. Prophylaxis of meningococcal carriers \r\n4. Prophylaxis of H. influenzae \r\nInteractions for Rifampicin\r\nRifampicin by inducing the hepatic microsomal enzymes may reduce the efficacy of the following drugs: Acetaminophen, oral anticoagulants, barbiturates, benzodiazepines, chloramphenicol, clofibrate. Oral contraceptives, corticosteroids, cyclosporine, digitoxin, disopyramide, beta blockers oestrogens, hydantoins, mexiletine, quinidine, sulfones, sulphonylureas, theophylline, verapamil", "Composition": "Rifampicin 150,300mg", "Route": "ORAL.SOLID" }, { "ID": "756", "Trade_Name": "VIRACURE 400MG 6 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "36", "Price_Old": "36", "Company": "OCTOBER PHARMA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "ribavirin 200mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "757", "Trade_Name": "RIFACTINE 300 MG 8 CAPS.", "Generic_Name": "RIFAMPICIN", "Price": "7.84", "Price_Old": "7.84", "Company": "MUP", "Pharmacology": "ANTIBIOTIC.ANTITUBERCULOSIS", "Category": "م#_#.#~ حيوي للمس#.ل#= #.ل#%ولية", "Use": "–م#^#_ #.لسل، يس#?خ#~م #=#~و#.ء من #_من #.لأ#~وية #.لمس#?خ#~مة #<ي #>ل#.ج م#^#_ #.لسل م#> أيزوني#.زي#~ و#%ي#^#.زين#.مي#~. \r\n\r\n–#.لجذ#.م. \r\n\r\n–#~#.ء #.ل#<ي#.لقة. \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#.، #.لن#.جم #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.لمق#.ومة ل#%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون، يؤخذ م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين. \r\n\r\n–#.لحمى #.لم#.ل#-ية، #%#.لأ#_#.#<ة للأ#~وية #.ل#?#.لية #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول، و#?#^ي ميثو#%#^يم. \r\n\r\n–#.لوق#.ية من #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية و#.لمس#?#~مية #.لنزلية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون أخ#^ من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لي#^ق#.ن. \r\n\r\n–ل#. يجوز أخذه #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~.", "GI": "About Rifampicin\r\nRifamycin derivative, Antituberculosis antibiotic.\r\nMechanism of Action of Rifampicin\r\nRifampicin is primarily bactericidal and has some bacteriostatic properties also. It acts by inhibiting DNA dependent RNA polymerase and thus stopping the expression of bacterial genes.M.tuberculosis requires DNA dependent RNA polymerase enzyme for the synthesis of RNA and protein. Without this enzyme bacteria cannot reproduce and they die. \r\nIndications for Rifampicin\r\n1. Leprosy \r\n2. Tuberculosis \r\n3. Prophylaxis of meningococcal carriers \r\n4. Prophylaxis of H. influenzae \r\nInteractions for Rifampicin\r\nRifampicin by inducing the hepatic microsomal enzymes may reduce the efficacy of the following drugs: Acetaminophen, oral anticoagulants, barbiturates, benzodiazepines, chloramphenicol, clofibrate. Oral contraceptives, corticosteroids, cyclosporine, digitoxin, disopyramide, beta blockers oestrogens, hydantoins, mexiletine, quinidine, sulfones, sulphonylureas, theophylline, verapamil", "Composition": "rifampicin 100mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "758", "Trade_Name": "RIBAZOLE 400MG 30 CAPS.", "Generic_Name": "RIBAVIRIN", "Price": "66", "Price_Old": "66", "Company": "ADWIA", "Pharmacology": "ANTIVIRAL.NUCLEOSIDE", "Category": "م#_#.#~ لل#<ي#^وس#.#? و#%#>#_ أنو#.#> #.لس#^#-#.ن", "Use": "–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #<ي#^وس #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي ج #%#.لإ#_#.#<ة إلى #?ولي#<ة من #.ل#~و#.ء م#> #.ن#?#^#<ي#^ون. \r\n\r\n– يس#?خ#~م #.ل#~و#.ء للأشخ#.ص #.لمص#.#%ين #%م#^#_ س#^#-#.ن #.لغ#~ة #.ل#~#^قية. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لمص#.#%ين #%#.لحمى #.لنز#<ية #.ل#?ي #?ح#~ث #.لإص#.#%ة م#> وجو#~ م#?ل#.زمة #=لوية. \r\n\r\n– ي#?م #.س#?خ#~#.م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.لإص#.#%#.#? #.لخ#-ي#^ة #.ل#?ي #?ح#~ث #%س#%#% #.ل#<ي#^وس #.لمخلوي #.ل#?ن#<سي RSV.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية م#<#^#-ة من #.لم#.#~ة #.ل#<#>#.لة #.ل#?ي #?وج#~ #<ي هذ#. #.ل#~و#.ء. \r\n\r\n–#?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. ي#?س#%#% #<ي ح#~وث #%#>#_ #.لم#_#.#>#<#.#? #.لج#.ن#%ية للجنين أو #.ل#-#<ل #.ل#^#_ي#> وق#?ه#. ق#%ل #.س#?خ#~#.م #.ل#-#%ي#% #.لمخ#?ص. \r\n\r\n– يمن#> #?ن#.ول هذ#. #.ل#~و#.ء للم#^#.هقين #?ح#? #>م#^ 18 سنه خ#.صة #>ن#~ وجو#~ #.#=#?ئ#.#% ح#.#~ #<يم#. س#%ق. #?جن#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من #.ل#<شل #.ل#=لوي #.لمزمن أو وجو#~ #%#>#_ #.لأم#^#.#_ #.لخ#-ي#^ة #<ي #.لقل#%. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #>ن#~ وجو#~ #.#_#-#^#.#% #<ي #.ل#~م مثل #.لإص#.#%ة #%#.لأنيمي#.. \r\n\r\n– يج#% #>#~م إيق#.#< #.ل#~و#.ء #%ش#=ل م#<#.جئ #~ون م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج ح#?ى ل#. #?س#%#% #<ي ظهو#^ #%#>#_ #.لآث#.#^ #.لج#.ن#%ية #.لخ#-ي#^ة. \r\n\r\n– #>ن#~ نسي#.ن #.لج#^#>ة يج#% أخذه#. ول#=ن يمن#> #?ن#.وله#. #>ن#~ مو#>#~ #.لج#^#>ة #.ل#?#.لية يج#% #?خ#-يه#. و#?ن#.ول #.لج#^#>ة #.ل#?#.لية. \r\n\r\n– #>ن#~ #.س#?خ#~#.م أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء يج#% إخ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. #?#?س#%#% #<ي ح#~وث #?#<#.#>ل#.#? #~و#.ئية م#> هذ#. #.ل#~و#.ء أو يقلل من م#<#>ول هذ#. #.ل#~و#.ء #>ن#~ #.س#?خ#~#.م هذه #.لأ#~وية م#> #%#>#_ه#..", "GI": "About Ribavirin\r\nA nucleoside antimetabolite, Triazole derivative, Antiviral.\r\nMechanism of Action of Ribavirin\r\nRibavirin is a nucleoside analogue and it is phosphorylated by adenosine kinase enzyme in the host cell to form Ribavirin monophosphate.This will inhibits Inosine monophosphate (IMP) formation and also cause degradation of guanosine triphosphate (GTP) .All these results in inhibition of protein synthesis and suppression of elongation of viral mRNA\r\nIndications for Ribavirin\r\n1. Respiratory syncytial virus (RSV) infection \r\n2. Influenza A & B virus infection \r\n3. Herpes simplex virus \r\n4. Hepatitis B virus \r\n5. Lassa fever \r\n6. Haemorrhagic fever \r\n7. Measles \r\n8. Para influenza virus infection in children", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "759", "Trade_Name": "RIFAMPIN 300MG 8 CAPS (MISR)", "Generic_Name": "RIFAMPICIN", "Price": "9.5", "Price_Old": "9.5", "Company": "MISR", "Pharmacology": "ANTIBIOTIC.ANTITUBERCULOSIS", "Category": "م#_#.#~ حيوي للمس#.ل#= #.ل#%ولية", "Use": "–م#^#_ #.لسل، يس#?خ#~م #=#~و#.ء من #_من #.لأ#~وية #.لمس#?خ#~مة #<ي #>ل#.ج م#^#_ #.لسل م#> أيزوني#.زي#~ و#%ي#^#.زين#.مي#~. \r\n\r\n–#.لجذ#.م. \r\n\r\n–#~#.ء #.ل#<ي#.لقة. \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#.، #.لن#.جم #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.لمق#.ومة ل#%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون، يؤخذ م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين. \r\n\r\n–#.لحمى #.لم#.ل#-ية، #%#.لأ#_#.#<ة للأ#~وية #.ل#?#.لية #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول، و#?#^ي ميثو#%#^يم. \r\n\r\n–#.لوق#.ية من #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية و#.لمس#?#~مية #.لنزلية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون أخ#^ من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لي#^ق#.ن. \r\n\r\n–ل#. يجوز أخذه #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~.", "GI": "About Rifampicin\r\nRifamycin derivative, Antituberculosis antibiotic.\r\nMechanism of Action of Rifampicin\r\nRifampicin is primarily bactericidal and has some bacteriostatic properties also. It acts by inhibiting DNA dependent RNA polymerase and thus stopping the expression of bacterial genes.M.tuberculosis requires DNA dependent RNA polymerase enzyme for the synthesis of RNA and protein. Without this enzyme bacteria cannot reproduce and they die. \r\nIndications for Rifampicin\r\n1. Leprosy \r\n2. Tuberculosis \r\n3. Prophylaxis of meningococcal carriers \r\n4. Prophylaxis of H. influenzae \r\nInteractions for Rifampicin\r\nRifampicin by inducing the hepatic microsomal enzymes may reduce the efficacy of the following drugs: Acetaminophen, oral anticoagulants, barbiturates, benzodiazepines, chloramphenicol, clofibrate. Oral contraceptives, corticosteroids, cyclosporine, digitoxin, disopyramide, beta blockers oestrogens, hydantoins, mexiletine, quinidine, sulfones, sulphonylureas, theophylline, verapamil", "Composition": "Rifampin 150mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "760", "Trade_Name": "VRONOGABIC 150MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "56", "Price_Old": "56", "Company": "MARCYRL CO.", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Pregabalin 75 or 150 mg", "Route": "ORAL.SOLID" }, { "ID": "761", "Trade_Name": "PAINICA 300MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "67", "Price_Old": "67", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > ALPHA GROUP COMPANY", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 300mg or 75mg", "Route": "ORAL.SOLID" }, { "ID": "762", "Trade_Name": "KEMIRICA 300 MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "60", "Price_Old": "60", "Company": "CHEMIPHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each hard gelatin capsule contain \r\nActive Ingredient: Pregabalin 25, 50,75,100,150,200,300 mg", "Route": "ORAL.SOLID" }, { "ID": "763", "Trade_Name": "KEMIRICA 200 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "135", "Price_Old": "135", "Company": "CHEMIPHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each hard gelatin capsule contain \r\nActive Ingredient: Pregabalin 25, 50,75,100,150,200,300 mg", "Route": "ORAL.SOLID" }, { "ID": "764", "Trade_Name": "PROGEST 100MG 24 ORAL/VAGINAL CAPS.", "Generic_Name": "PROGESTERONE", "Price": "43", "Price_Old": "32.5", "Company": "PHARCO", "Pharmacology": "PROGESTERONE REPLACEMENT", "Category": "مش#.#=ل #.ل#-مث", "Use": "–يس#?خ#~م #<ي #>ل#.ج #>#~م نزول #~م #.لحي#_. \r\n\r\n–يس#.#>#~ #<ي #?نظيم #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>#.لج زي#.#~ة #=مية #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–#>ل#.ج #.لأم#^#.#_ #.ل#?ي #?س#%ق نزول #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–ي#>#.لج #.لخلل #.لوظي#<ي لل#^حم و#.لمصحو#% #%نزول #~م. \r\n\r\n–ي#>#.لج آل#.م #.لث#~ي #%#>#~ #.لول#.#~ة. \r\n\r\n–ي#>#.لج ويقي من #?#_خم #%#-#.نة #.ل#^حم. \r\n\r\n–#=م#. يس#?خ#~م #<ي ح#.لة #.لإخص#.#% #.لمج#^ي ( #-#<ل #.لأن#.#%ي#%). \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#>قم من #.ل#~#^جة #.لأولي و#.لث#.نوية.", "Contraindications": "–لمن ي#>#.نون من أو#^#.م #<ي #.لث#~ي #.ل#.#%#?#>#.#~ #>ن #.س#?خ#~#.م #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من قصو#^ #<ي #.ل#=#%#~ #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من إجه#.#_ #=لي أو جزئي. \r\n\r\n–لمن ي#>#.نون من نزي#< مه#%لي غي#^ م#%#^#^.", "GI": "Indication\t\r\nFor progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency and for the treatment of secondary amenorrhea. Also used for the reduction of the incidence of endometrial hyperplasia and the attendant risk of endometrial carcinoma in postmenopausal women receiving estrogen replacement therapy, as well as treatment of abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology such as fibroids or uterine cancer.\r\nMechanism of action\tProgesterone shares the pharmacological actions of the progestins. Progesterone binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Progesterone will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (lu", "Composition": "progesterone 100mg", "Route": "ORAL.SOLID" }, { "ID": "765", "Trade_Name": "PREGAVALEX 300MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "134", "Price_Old": "134", "Company": "EVA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each Capsule contains:\r\nPregabalin 75,150,300 mg", "Route": "ORAL.SOLID" }, { "ID": "766", "Trade_Name": "GLOBAZURE 300 MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "50", "Price_Old": "50", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > GLOBAL HEALTH CARE-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "767", "Trade_Name": "PREGDIN-APEX 300MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "134", "Price_Old": "134", "Company": "MULTI-APEX", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "768", "Trade_Name": "DEPAPALIN 300MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "134", "Price_Old": "134", "Company": "DEBEIKY > RAMEDA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "769", "Trade_Name": "UTROCARE 100MG 30 SOFT GELATIN CAPS.", "Generic_Name": "PROGESTERONE", "Price": "44", "Price_Old": "29.25", "Company": "SAFE PHARMA > OCTOBER PHARMA", "Pharmacology": "PROGESTERONE REPLACEMENT", "Category": "مش#.#=ل #.ل#-مث", "Use": "–يس#?خ#~م #<ي #>ل#.ج #>#~م نزول #~م #.لحي#_. \r\n\r\n–يس#.#>#~ #<ي #?نظيم #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>#.لج زي#.#~ة #=مية #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–#>ل#.ج #.لأم#^#.#_ #.ل#?ي #?س#%ق نزول #.ل#~و#^ة #.لشه#^ية. \r\n\r\n–ي#>#.لج #.لخلل #.لوظي#<ي لل#^حم و#.لمصحو#% #%نزول #~م. \r\n\r\n–ي#>#.لج آل#.م #.لث#~ي #%#>#~ #.لول#.#~ة. \r\n\r\n–ي#>#.لج ويقي من #?#_خم #%#-#.نة #.ل#^حم. \r\n\r\n–#=م#. يس#?خ#~م #<ي ح#.لة #.لإخص#.#% #.لمج#^ي ( #-#<ل #.لأن#.#%ي#%). \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#>قم من #.ل#~#^جة #.لأولي و#.لث#.نوية.", "Contraindications": "–لمن ي#>#.نون من أو#^#.م #<ي #.لث#~ي #.ل#.#%#?#>#.#~ #>ن #.س#?خ#~#.م #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من قصو#^ #<ي #.ل#=#%#~ #?جن#% #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من إجه#.#_ #=لي أو جزئي. \r\n\r\n–لمن ي#>#.نون من نزي#< مه#%لي غي#^ م#%#^#^.", "GI": "Indication\t\r\nFor progesterone supplementation or replacement as part of an Assisted Reproductive Technology (ART) treatment for infertile women with progesterone deficiency and for the treatment of secondary amenorrhea. Also used for the reduction of the incidence of endometrial hyperplasia and the attendant risk of endometrial carcinoma in postmenopausal women receiving estrogen replacement therapy, as well as treatment of abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology such as fibroids or uterine cancer.\r\nMechanism of action\tProgesterone shares the pharmacological actions of the progestins. Progesterone binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Progesterone will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (lu", "Composition": "progesterone 100mg", "Route": "ORAL.SOLID" }, { "ID": "770", "Trade_Name": "RIFAMPIN 300MG 10 CAPS.", "Generic_Name": "RIFAMPICIN", "Price": "8", "Price_Old": "8", "Company": "ARAB CAPS", "Pharmacology": "ANTIBIOTIC.ANTITUBERCULOSIS", "Category": "م#_#.#~ حيوي للمس#.ل#= #.ل#%ولية", "Use": "–م#^#_ #.لسل، يس#?خ#~م #=#~و#.ء من #_من #.لأ#~وية #.لمس#?خ#~مة #<ي #>ل#.ج م#^#_ #.لسل م#> أيزوني#.زي#~ و#%ي#^#.زين#.مي#~. \r\n\r\n–#.لجذ#.م. \r\n\r\n–#~#.ء #.ل#<ي#.لقة. \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#.، #.لن#.جم #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.لمق#.ومة ل#%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون، يؤخذ م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين. \r\n\r\n–#.لحمى #.لم#.ل#-ية، #%#.لأ#_#.#<ة للأ#~وية #.ل#?#.لية #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول، و#?#^ي ميثو#%#^يم. \r\n\r\n–#.لوق#.ية من #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية و#.لمس#?#~مية #.لنزلية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون أخ#^ من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لي#^ق#.ن. \r\n\r\n–ل#. يجوز أخذه #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~.", "GI": "About Rifampicin\r\nRifamycin derivative, Antituberculosis antibiotic.\r\nMechanism of Action of Rifampicin\r\nRifampicin is primarily bactericidal and has some bacteriostatic properties also. It acts by inhibiting DNA dependent RNA polymerase and thus stopping the expression of bacterial genes.M.tuberculosis requires DNA dependent RNA polymerase enzyme for the synthesis of RNA and protein. Without this enzyme bacteria cannot reproduce and they die. \r\nIndications for Rifampicin\r\n1. Leprosy \r\n2. Tuberculosis \r\n3. Prophylaxis of meningococcal carriers \r\n4. Prophylaxis of H. influenzae \r\nInteractions for Rifampicin\r\nRifampicin by inducing the hepatic microsomal enzymes may reduce the efficacy of the following drugs: Acetaminophen, oral anticoagulants, barbiturates, benzodiazepines, chloramphenicol, clofibrate. Oral contraceptives, corticosteroids, cyclosporine, digitoxin, disopyramide, beta blockers oestrogens, hydantoins, mexiletine, quinidine, sulfones, sulphonylureas, theophylline, verapamil", "Composition": "Rifampin 150mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "771", "Trade_Name": "RIVAXEL 1.5MG 28 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "52", "Price_Old": "52", "Company": "HIKMA PHARMA", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 3mg or 4.5mg or 6mg", "Route": "ORAL.SOLID" }, { "ID": "772", "Trade_Name": "RIVAMEP 1.5 MG 20 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "33", "Price_Old": "33", "Company": "MEPACO", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 4.5mg or 6mg", "Route": "ORAL.SOLID" }, { "ID": "773", "Trade_Name": "RIMACTANE 300MG 8 CAPS.", "Generic_Name": "RIFAMPICIN", "Price": "10.1", "Price_Old": "10.1", "Company": "NOVARTIS", "Pharmacology": "ANTIBIOTIC.ANTITUBERCULOSIS", "Category": "م#_#.#~ حيوي للمس#.ل#= #.ل#%ولية", "Use": "–م#^#_ #.لسل، يس#?خ#~م #=#~و#.ء من #_من #.لأ#~وية #.لمس#?خ#~مة #<ي #>ل#.ج م#^#_ #.لسل م#> أيزوني#.زي#~ و#%ي#^#.زين#.مي#~. \r\n\r\n–#.لجذ#.م. \r\n\r\n–#~#.ء #.ل#<ي#.لقة. \r\n\r\n–#.ل#?ه#.#% #.لسح#.ي#.، #.لن#.جم #>ن #>ق#~ي#.#? ذ#.#? #.ل#^ئة #.لمق#.ومة ل#%نزيل #%نيسيللين أو سي#<#?#^ي#.#=سون، يؤخذ م#> سي#<و#?#.#=سيم و#<#.ن#=وم#.يسين. \r\n\r\n–#.لحمى #.لم#.ل#-ية، #%#.لأ#_#.#<ة للأ#~وية #.ل#?#.لية #~و#=سي سي#=لين أو سل#<#.ميثو#=س#.زول، و#?#^ي ميثو#%#^يم. \r\n\r\n–#.لوق#.ية من #.ل#?ه#.#% #.لسح#.ي#. #.لن#.#?ج #>ن #.لنيسي#^ية #.لسح#.ئية و#.لمس#?#~مية #.لنزلية.", "Contraindications": "–#<#^#- #.لحس#.سية لأي م#=ون أخ#^ من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–#.لي#^ق#.ن. \r\n\r\n–ل#. يجوز أخذه #>ن #-#^يق #.ل#>#_ل أو #?ح#? #.لجل#~.", "GI": "About Rifampicin\r\nRifamycin derivative, Antituberculosis antibiotic.\r\nMechanism of Action of Rifampicin\r\nRifampicin is primarily bactericidal and has some bacteriostatic properties also. It acts by inhibiting DNA dependent RNA polymerase and thus stopping the expression of bacterial genes.M.tuberculosis requires DNA dependent RNA polymerase enzyme for the synthesis of RNA and protein. Without this enzyme bacteria cannot reproduce and they die. \r\nIndications for Rifampicin\r\n1. Leprosy \r\n2. Tuberculosis \r\n3. Prophylaxis of meningococcal carriers \r\n4. Prophylaxis of H. influenzae \r\nInteractions for Rifampicin\r\nRifampicin by inducing the hepatic microsomal enzymes may reduce the efficacy of the following drugs: Acetaminophen, oral anticoagulants, barbiturates, benzodiazepines, chloramphenicol, clofibrate. Oral contraceptives, corticosteroids, cyclosporine, digitoxin, disopyramide, beta blockers oestrogens, hydantoins, mexiletine, quinidine, sulfones, sulphonylureas, theophylline, verapamil", "Composition": "rifampin 2% or 300mg", "Route": "ORAL.SOLID" }, { "ID": "774", "Trade_Name": "RIVAXEL 3MG 28 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "90", "Price_Old": "90", "Company": "HIKMA PHARMA", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 3mg or 4.5mg or 6mg", "Route": "ORAL.SOLID" }, { "ID": "775", "Trade_Name": "EXELON 3MG 28 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "210", "Price_Old": "210", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "776", "Trade_Name": "EXELON 1.5MG 14 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "105", "Price_Old": "105", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "777", "Trade_Name": "EXELON 3MG 14 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "105", "Price_Old": "105", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "778", "Trade_Name": "EXELON 1.5MG 28 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "210", "Price_Old": "210", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "779", "Trade_Name": "EXELON 4.5MG 14 CAPS.", "Generic_Name": "RIVASTIGMINE", "Price": "105", "Price_Old": "105", "Company": "NOVARTIS", "Pharmacology": "ANTICHOLINESTERASE", "Category": "#.لذه#.ن و #.لزه#.يم#^ و #.لخ#^#<", "Use": "–يس#.#>#~ هذ#. #.ل#~و#.ء #<ي م#>#.لجة #.#_#-#^#.#%#.#? #.لذ#.#=#^ة و#.لخ#^#<. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #%#.#^#=نسون. \r\n\r\n–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة م#^#_ #.لذه#.ن #.لذي يصي#% #.ل#>قل. \r\n\r\n– يس#?خ#~م هذ#. #.ل#~و#.ء #<ي #?قليل أ#>#^#.#_ م#^#_ #.لزه#.يم#^.", "Contraindications": "–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين ي#>#.نون من وجو#~ حس#.سية من إح#~ى م#=ون#.#? #.ل#~و#.ء. \r\n\r\n– يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء #.لحو#.مل أو #.لم#^#_#>#.#? ح#?ى ل#. يح#~ث #?أثي#^ #>لى #.لجنين أو #.ل#-#<ل #.ل#^#_ي#>. \r\n\r\n– #?جن#% #.س#?خ#~#.م ج#^#>#.#? ز#.ئ#~ة من هذ#. #.ل#~و#.ء من #?لق#.ء ن#<سه #%#~ون م#^#.ج#>ة #.ل#-#%ي#%. \r\n\r\n– يج#% #>#~م #?ن#.ول #.لج#^#>ة #.لمح#~#~ة #>ن#~ نسي#.نه#. و #.س#?ش#.#^ة #.ل#-#%ي#% أول#.. \r\n\r\n– يمن#> #?ن#.ول أ#~وية أخ#^ى م#> هذ#. #.ل#~و#.ء ح#?ى ل#. يح#~ث #?#<#.#>ل #%ين #.لأ#~وية و#%#.ل#?#.لي #?#?س#%#% #<ي ح#~وث #%#>#_ #.لأ#_#^#.#^ #.لصحية #>لى #.لم#^ي#_. \r\n\r\n–يمن#> #.س#?خ#~#.م هذ#. #.ل#~و#.ء للم#^#_ى #.لمص#.#%ين #%#.لأم#^#.#_ #.لمزمنة إل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لمخ#?ص.", "GI": "About Rivastigmine\r\nA central reversible non competitive Anticholinesterase, Antidementia.\r\nMechanism of Action of Rivastigmine\r\nAlzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another. Rivastigmine exerts its therapeutic effect by enhancing its cholinergic function. It increases the concentration of Acetylcholine through reversible inhibition of acetyl cholinesterase enzyme which is involved in the hydrolysis of Acetylcholine. It leads to increased concentration of Acetylcholine.This increased Acetylcholine concentrations are believed to be responsible for the improvement seen during treatment with Rivastigmine.\r\nIndications for Rivastigmine\r\n1. Mild to moderate dementia of the Alzheimer`s type.\r\nTypical Dosage for Rivastigmine\r\nAdult: 3mg / day in 2 divided doses with food dose can be increased by 3mg / day every 2 weeks. \r\nMaximum dose: 12 mg / day", "Composition": "rivastigmine 1.5mg or 18mg or 4.5mg or 6mg or 3mg", "Route": "ORAL.SOLID" }, { "ID": "780", "Trade_Name": "GLOBAZURE 150 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "117.75", "Price_Old": "84", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > GLOBAL HEALTH CARE-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "781", "Trade_Name": "LYRICA 150MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "174", "Price_Old": "174", "Company": "PFIZER", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 75mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "782", "Trade_Name": "LYRIBALIN 150MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "23.4", "Price_Old": "23.4", "Company": "BORG", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 50mg or 75mg or 100mg or 150mg", "Route": "ORAL.SOLID" }, { "ID": "783", "Trade_Name": "HEXGABALIN 150MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "120", "Price_Old": "120", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each Hexgabalin 75 capsule contains pregabalin 75 mg.\r\nEach Hexgabalin 150 capsule contains pregabalin 150 mg.", "Route": "ORAL.SOLID" }, { "ID": "784", "Trade_Name": "PREGAVALEX 150MG 10 CAPS.", "Generic_Name": "PREGABALIN", "Price": "52", "Price_Old": "52", "Company": "EVA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each Capsule contains:\r\nPregabalin 75,150,300 mg", "Route": "ORAL.SOLID" }, { "ID": "785", "Trade_Name": "LYROLIN 150MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "105", "Price_Old": "75", "Company": "HIKMA PHARMA", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 75mg or 50mg", "Route": "ORAL.SOLID" }, { "ID": "786", "Trade_Name": "KEMIRICA 150 MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "117", "Price_Old": "117", "Company": "CHEMIPHARM", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Each hard gelatin capsule contain \r\nActive Ingredient: Pregabalin 25, 50,75,100,150,200,300 mg", "Route": "ORAL.SOLID" }, { "ID": "787", "Trade_Name": "PAINICA 150MG 30 CAPS.", "Generic_Name": "PREGABALIN", "Price": "144", "Price_Old": "144", "Company": "MEDIZEN PHARMACEUTICAL INDUSTRIES > ALPHA GROUP COMPANY", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 300mg or 75mg", "Route": "ORAL.SOLID" }, { "ID": "788", "Trade_Name": "IRENYPATHIC 150MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "96", "Price_Old": "96", "Company": "AMOUN", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "Pregabalin 75 mg & Or 150 mg", "Route": "ORAL.SOLID" }, { "ID": "789", "Trade_Name": "SERIGABTIN 150MG 20 CAPS.", "Generic_Name": "PREGABALIN", "Price": "63", "Price_Old": "63", "Company": "SEDICO > SERIO PHARM-EGYPT", "Pharmacology": "ANTI-EPILEPTIC.GABA ANALOGS", "Category": "م#_#.#~ للص#^#> و مش#=ل#.#? #.لأ#>ص#.#%", "Use": "–يس#?خ#~م #=ح#%و#% مه#~ئة للأ#>ص#.#%. \r\n\r\n–#?س#?خ#~م ل#>ل#.ج #.لقلق. \r\n\r\n–#?س#?خ#~م #=مس#=ن للآل#.م #.لن#.#?جة #>ن م#^#_ #.لس#=#^. \r\n\r\n–ل#>ل#.ج #.لآل#.م #.لن#.#?جة #>ن إص#.#%ة #.لح#%ل #.لشو#=ي. \r\n\r\n–يق#_ي #>لى #.ل#?شنج#.#? #.ل#>ص#%ية. \r\n\r\n–#>ل#.ج مس#.#>#~ #<ى #.ل#?شنج#.#? ونو#%#.#? #.لص#^#> ..#?نميل #.ل#.#-#^#.#< م#> #.ل#^#>شه", "Contraindications": "–يُس#%#% #~و#.ء هذ#. #.ل#~و#.ء أذى #=#%ي#^ للجنين ولذل#= ينصح #.لأ#-#%#.ء #%#>#~م #?ن#.وله للم#^أة #.لح#.مل. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية حيث يم#=ن أن ين#?قل إلى #.ل#^#_ي#> #>ن #-#^يق حلي#% #.لأم وذل#= يُس#%#% خ#-#^ #=#%ي#^ #>لى صح#?ه. \r\n\r\n–يج#% #.س#?ش#.#^ة #.ل#-#%ي#% ق#%ل #?ن#.ول هذ#. #.ل#~و#.ء للأ#-#<#.ل #?جن#%#.ً لح#~وث أي مش#.#=ل صحية. \r\n\r\n–ي#=ون من #.لأ#<#_ل #.ل#.م#?ن#.#> #>ن #.لقي#.#~ة #<ي #<#?#^ة #.ل#>ل#.ج حيث #.نه يُس#%#% #.لن#>#.س. \r\n\r\n–يمن#> #?ن#.ول ج#^#>#.#? ز#.ئ#~ة #>ن #.لموصو#<ة من #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–ل#. ينصح #%وق#< هذ#. #.ل#~و#.ء #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% #.لمُ#>#.لج. \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #%جمي#> #.لأ#~وية #.لأخ#^ى #.ل#?ي ي#?م #?ن#.وله#..", "GI": "About Pregabalin\r\nA GABA agonist, Anticonvulsant.\r\nMechanism of Action of Pregabalin\r\nPregabalin is a GABA neurotransmitter analog. It produces its action by modulating calcium channels and also reduces the release of neurotransmitters such as Glutamate, Norepinephrine, Serotonin, Dopamine and Substance P.\r\nIndications for Pregabalin\r\n1.Epilepsy \r\n2.Generalised anxiety disorder \r\n3.Neuropathic pain \r\nTypical Dosage for Pregabalin\r\n150- 300mg / day in 2 divided doses", "Composition": "pregabalin 150mg or 75mg", "Route": "ORAL.SOLID" }, { "ID": "790", "Trade_Name": "PARKINEAST 5MG 30 CAPS.", "Generic_Name": "SELEGILINE CHLORIDE", "Price": "28.5", "Price_Old": "28.5", "Company": "WESTERN PHARMACEUTICALS INDUSTRIES", "Pharmacology": "PARKINSON S DISEASE.MAO-B INHIBITOR", "Category": "م#^#_ #.ل#%#.#^#=نسون و #.لشلل #.ل#^#>#.ش", "Use": "–#>ل#.ج م#^#_ #.لشلل #.ل#^#>#.ش .", "Contraindications": "–يس#?خ#~م #%حذ#^ م#> م#^#_ى #.ل#_غ#- #.لم#^#?#<#> ، لأنه ق#~ يس#%#% إ#^#?#<#.#> #_غ#- #.ل#~م لذل#= يج#% #?ظ#%ي#- ج#^#>ة أ#~وية #.ل#_غ#- #%م#>#^#<ة #.ل#-#%ي#% #.لم#?خصص. \r\n\r\n–ق#~ يس#%#% #.ل#~وخة و #.لن#>#.س أثن#.ء #.ليوم لذل#= يس#?خ#~م #%حذ#^ أثن#.ء #.لقي#.#~ة أو #.لقي#.م #%#.لأ#>م#.ل #.لخ#-ي#^ة. \r\n\r\n– ل#. يس#?خ#~م م#> #.لأ#~وية #.ل#?ى #?ح#?وى #>لى أى من #.لمو#.#~ #.ل#<#>#.لة #.ل#?#.لية: \r\n\r\n–DEXTROMETHORPHAN , KETAMINE , ONDANSETRONE , MIDODRINE , GRANISETRON , LINEZOLID ، و ذل#= ل#?جن#% ح#~وث آث#.#^ ج#.ن#%ية . \r\n\r\n–ل#. يس#?خ#~م م#> #.لأ#~وية #.لم#_#.#~ة للإ#=#?ئ#.#% و أ#~وية #.لأم#^#.#_ #.لن#<سية #.لأخ#^ى إل#. #?ح#? إش#^#.#< #.ل#-#%ي#% #.لم#?خصص #<ق#- .", "GI": "About Selegiline\r\nA selective irreversible MAO-B inhibitor, Phenethylamine derivative, Antiparkinsonian agent, Antidepressant.\r\nMechanism of Action of Selegiline\r\nSelegiline is a Monoamine oxidase enzyme inhibitor. It selectively blocks MAO-B than MAO-A at recommended dose. Selegiline inhibits the reuptake of Dopamine in to the presynaptic nerve terminal and also blocks presynaptic Dopamine receptor. This will produce Dopaminergic activity. Metabolites of Selegiline (Amphetamine and Methamphetamine) interferes the reuptake and enhances the release of neurotransmitters such as Noradrenaline, Dopamine and Serotonin and produces antidepressant effect. \r\nAntiparkinsonian action: MAO-B (Monoamine oxidase enzyme-B) in the CNS is responsible for the metabolism of Dopamine to DOPAC (3, 4 Dihydroxy-phenyl acetic acid). Selegiline binds to MAO-B and inhibits the Dopamine degradation. Selegiline produces an increase in the concentration of Dopamine in the CNS", "Composition": "selegiline 5mg", "Route": "ORAL.SOLID" }, { "ID": "791", "Trade_Name": "HEPATICUM 140MG 10 CAPS.", "Generic_Name": "SILYMARIN", "Price": "7.5", "Price_Old": "7.5", "Company": "MUP", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#>ل#.ج #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي. \r\n\r\n–#>ل#.ج م#^#_ #.ل#=#%#~ #.ل#~هني. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#=#%#~ي. \r\n\r\n–#>ل#.ج #.م#^#.#_ #.ل#=#%#~ #.لح#.#~ة و#.لمزمنة. \r\n\r\n–#>ل#.ج #.م#^#.#_ س#^#-#.ن #.لخل#.ي#. #.ل#=#%#~ية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.لن#%#.#?#.#? و#.ل#.#~وية #.ل#>ش#%ية. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #?#_خم #.ل#%#^وس#?#.#?#.. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #.لخلل #.له#^موني.", "GI": "About Silymarin\r\nA polyphenolic flavonoid, Hepatoprotective(antihepatotoxic),antioxidant.\r\nMechanism of Action of Silymarin\r\nSilymarin stimulates RNA polymerase A and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepatocytes and also increase the regenerative ability of the liver. \r\nIt stabilizes the hepatic cell membrane and prevents the penetration of toxin in to the cell and also slows the absorption of harmful substances in to the liver. \r\nSilymarin contains antioxidant flavanoid. It combines with free radicals formed from metabolic process and also from breakdown of toxic substances and neutralizes them. Because of its antioxidant action it has anti-inflammatory property and it is used in ulcerative colitis and in ulcers. \r\nIt increases the glutathione content in the liver and intestine and also increases the activity of super oxide dismutase enzymes and is helpful in detoxifying actions of liver.", "Composition": "Each capsule contains:\r\nSilymarin 140 mg., standardized to a content of more than 45 % Silybin {in the form\r\nof dry standardized extract of Milk Thistle (Silybum marianum)}.\r\n\r\n Each 100 ml suspension contains:\r\nSilymarin 1 g., standardized to a content of mor", "Route": "ORAL.SOLID" }, { "ID": "792", "Trade_Name": "HEPAMARIN 140MG 30 CAPS.", "Generic_Name": "SILYMARIN", "Price": "21", "Price_Old": "21", "Company": "UNIPHARMA CO.", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#>ل#.ج #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي. \r\n\r\n–#>ل#.ج م#^#_ #.ل#=#%#~ #.ل#~هني. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#=#%#~ي. \r\n\r\n–#>ل#.ج #.م#^#.#_ #.ل#=#%#~ #.لح#.#~ة و#.لمزمنة. \r\n\r\n–#>ل#.ج #.م#^#.#_ س#^#-#.ن #.لخل#.ي#. #.ل#=#%#~ية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.لن#%#.#?#.#? و#.ل#.#~وية #.ل#>ش#%ية. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #?#_خم #.ل#%#^وس#?#.#?#.. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #.لخلل #.له#^موني.", "GI": "About Silymarin\r\nA polyphenolic flavonoid, Hepatoprotective(antihepatotoxic),antioxidant.\r\nMechanism of Action of Silymarin\r\nSilymarin stimulates RNA polymerase A and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepatocytes and also increase the regenerative ability of the liver. \r\nIt stabilizes the hepatic cell membrane and prevents the penetration of toxin in to the cell and also slows the absorption of harmful substances in to the liver. \r\nSilymarin contains antioxidant flavanoid. It combines with free radicals formed from metabolic process and also from breakdown of toxic substances and neutralizes them. Because of its antioxidant action it has anti-inflammatory property and it is used in ulcerative colitis and in ulcers. \r\nIt increases the glutathione content in the liver and intestine and also increases the activity of super oxide dismutase enzymes and is helpful in detoxifying actions of liver.", "Composition": "silymarin 140mg", "Route": "ORAL.SOLID" }, { "ID": "793", "Trade_Name": "RELAXINE 4MG 6 AMP I.M.", "Generic_Name": "THIOCOLCHICOSIDE", "Price": "10", "Price_Old": "10", "Company": "MEMPHIS", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–ي#>#.لج ح#.ل#.#? #.لش#~ #.ل#>#_لى. \r\n\r\n–#.ل#?قلص #.ل#>#_لى. \r\n\r\n–ي#>مل #>لى أ#^#?خ#.ء #.ل#>#_ل#.#?. \r\n\r\n–أل#?ه#.#%#.#? #.ل#<ق#.#^#.#?، و#.لنق#^س. \r\n\r\n–هش#.شة #.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.لأل#?ه#.#%#.#? #.ل#%#=#?ي#^ي#. لل#>ظ#.م. \r\n\r\n–ي#>#.لج أل#?ه#.#%#.#? #.ل#.#>#_#.ء #.ل#?ن#.سليه. \r\n\r\n–يس#?خ#~م #<ى #>ل#.ج ألم #.س#<ل #.لظه#^. \r\n\r\n–ح#.ل#.#? #.لنق#^ص.", "Contraindications": "–يحذ#^ #?ن#.ول هذ#. #.ل#~و#.ء #.ثن#.ء #<#?#^ة #.لحمل. \r\n\r\n–ل#. يس#?خ#~م للأ#-#<#.ل #.ل#.قل من 12 سنه. \r\n\r\n–يمن#> لمن ي#>#.نون من أنخ#<#.#_ #<ى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>#~م أس#?خ#~#.مه للأشخ#.ص #.لذين ي#>#.نون من أم#^#.#_ #.ل#~م#.غ. \r\n\r\n–ومن ي#>#.نون من خلل #<ى وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–ومن ي#>#.نون من أ#^#?#<#.#> #<ى #_غ#- #.ل#~م. \r\n\r\n–يمن#> لمن ل#~يهم ق#^حة #<ى #.لم#>#~ة. \r\n\r\n–ومن ي#>#.نون من قصو#^ #.لقل#%. \r\n\r\n–#=م#. ل#. يم#=ن #?ن#.وله أي#_#. #<ى #<#?#^ة #.ل#^#_#.#>ة. \r\n\r\n–يحذ#^ #?ن#.وله لمن ي#>#.نون من حس#.سية لأح#~ى م#=ون#.#? هذ#. #.ل#~و#.ء.", "GI": "Thiocolchicoside is a muscle relaxant with anti-inflammatory and analgesic effects. It acts as a competitive GABAA receptor antagonist and also glycine receptor antagonist with similar potency and nicotinic acetylcholine receptors to a much lesser extent. It has powerful convulsant activity and should not be used in seizure-prone individuals.", "Composition": "Each tablet contains:\r\nThiocolchicoside 4 mg", "Route": "INJECTION" }, { "ID": "794", "Trade_Name": "URSOPLUS 20 CAP.", "Generic_Name": "SILYMARIN+URSODEOXYCHOLIC ACID", "Price": "63", "Price_Old": "42", "Company": "MINA PHARM", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–يس#?خ#~م ل#>ل#.ج ح#.ل#.#? #?لي#< #.لم#^#.#^ي #.لأولي. \r\n\r\n–ي#>#.لج #?#^#.#=م #.ل#~هون ول#=ن #%ش#^#- آل#. ي#=ون هن#.#= #?لي#< #=#%#~ي غي#^ ق#.#%ل لل#?#>وي#_. \r\n\r\n–يس#?خ#~م ل#?حسين وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–إذ#.#%ة حصو#.#? #.لم#^#.#^ة #.ل#=وليس#?#^ولية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #.نس#~#.#~ #<ي #.لقن#.ة #.لم#^#.#^ية. \r\n\r\n–لمن ي#>#.نون من #.نس#~#.#~ #.لأن#%و#% #.لم#^#.#^ي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ي#>#.نون من #.ل#?ه#.#%#.#? #<ي حويصلة #.لم#^#.#^ية أو #.لقن#.ه #.لم#^#.#^ية #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يج#% #?وق#< #?ن#.ول #.ل#>ق#.#^ #<ي ح#.لة زي#.#~ة مس#?وي إنزيم#.#? #.ل#=#%#~. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–ل#. يس#?خ#~م #.ل#>ق#.#^ ل#>ل#.ج حصي #.لم#^#.#^ة #.لم#?#=لس. \r\n\r\n–ل#. يس#?خ#~م #.ل#>ق#.#^ #<ي ح#.لة #.لحس#.سية من #.ح#~ي م#=ون#.#? #.ل#>ق#.#^.", "GI": "About Silymarin\r\nA polyphenolic flavonoid, Hepatoprotective(antihepatotoxic),antioxidant.\r\nMechanism of Action of Silymarin\r\nSilymarin stimulates RNA polymerase A and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepatocytes and also increase the regenerative ability of the liver. \r\nIt stabilizes the hepatic cell membrane and prevents the penetration of toxin in to the cell and also slows the absorption of harmful substances in to the liver. \r\nSilymarin contains antioxidant flavanoid. It combines with free radicals formed from metabolic process and also from breakdown of toxic substances and neutralizes them. Because of its antioxidant action it has anti-inflammatory property and it is used in ulcerative colitis and in ulcers. \r\nIt increases the glutathione content in the liver and intestine and also increases the activity of super oxide dismutase enzymes and is helpful in detoxifying actions of liver.", "Composition": "One Ursoplus capsule contains the following active ingredients:\r\n Ursodeoxycholic acid 250 mg.\r\n Silymarin (70%) 140 mg.", "Route": "ORAL.SOLID" }, { "ID": "795", "Trade_Name": "LEGALON 140MG 30 CAPS.", "Generic_Name": "SILYMARIN", "Price": "30", "Price_Old": "30", "Company": "CID > MADAUS AG", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#>ل#.ج #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي. \r\n\r\n–#>ل#.ج م#^#_ #.ل#=#%#~ #.ل#~هني. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#=#%#~ي. \r\n\r\n–#>ل#.ج #.م#^#.#_ #.ل#=#%#~ #.لح#.#~ة و#.لمزمنة. \r\n\r\n–#>ل#.ج #.م#^#.#_ س#^#-#.ن #.لخل#.ي#. #.ل#=#%#~ية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.لن#%#.#?#.#? و#.ل#.#~وية #.ل#>ش#%ية. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #?#_خم #.ل#%#^وس#?#.#?#.. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #.لخلل #.له#^موني.", "GI": "About Silymarin\r\nA polyphenolic flavonoid, Hepatoprotective(antihepatotoxic),antioxidant.\r\nMechanism of Action of Silymarin\r\nSilymarin stimulates RNA polymerase A and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepatocytes and also increase the regenerative ability of the liver. \r\nIt stabilizes the hepatic cell membrane and prevents the penetration of toxin in to the cell and also slows the absorption of harmful substances in to the liver. \r\nSilymarin contains antioxidant flavanoid. It combines with free radicals formed from metabolic process and also from breakdown of toxic substances and neutralizes them. Because of its antioxidant action it has anti-inflammatory property and it is used in ulcerative colitis and in ulcers. \r\nIt increases the glutathione content in the liver and intestine and also increases the activity of super oxide dismutase enzymes and is helpful in detoxifying actions of liver.", "Composition": "Each capsule contains 140 mg silymarin.", "Route": "ORAL.SOLID" }, { "ID": "796", "Trade_Name": "DEPR-STAT 50MG 10 CAPS.", "Generic_Name": "SERTRALINE", "Price": "21.6", "Price_Old": "21.6", "Company": "MEMPHIS", "Pharmacology": "PSYCHIATRIC.ANTIDEPRESSANTS", "Category": "للمش#.#=ل #.لن#<سية", "Use": "–#>ل#.ج #.ل#.#_#-#^#.#% #.ل#>قلي. \r\n\r\n–#.ل#.#_#-#^#.#%#.#? #<ي #<#?#^ة #.ل#-مث. \r\n\r\n–#>ل#.ج #.ل#.#=#?ئ#.#% #.لمزمن و#.لش#~ي#~. \r\n\r\n–يس#.هم #<ي #>ل#.ج #.ل#.#_#-#^#.#% #.ل#>قلي. \r\n\r\n–يس#.#>#~ #>لي #>ل#.ج س#^#>ة #.لقذ#< ل#~ي #.ل#^ج#.ل. \r\n\r\n–يس#.#>#~ #>لي #?خ#<ي#< ح#.لة #.ل#?و#?#^ و#.لقلق #.لن#<سي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> م#> #.ل#.شخ#.ص #.لذين ي#?ن#.ولون #.ل#=حولي#.#?. \r\n\r\n–يمن#> لمن ي#>#.ني #?صل#% #%#.ل#>#_ل#.#?. \r\n\r\n–يمن#> لمن #?#^#.و#~هم #<#=#^ة #.ل#.ن#?ح#.#^. \r\n\r\n–يُمن#> إ#>#-#.ء #.ل#~و#.ء لمن يُ#>#.نى من #.#_#-#^#.#%#.#? #<ي #.لنزي#<، وخ#.صةً #<ي #.لقن#.ة #.له#_مية. \r\n\r\n–يُمن#> #?ن#.وله لم#^#_ي #.لس#=#^. \r\n\r\n–يُمن#> #?ن#.وله لمن يُ#>#.ني من #.نخ#<#.#_ ش#~ي#~ #<ي وظ#.ئ#< #.ل#=لي.", "GI": "About Sertraline\r\nSelective Serotonin Reuptake Inhibitor (SSRI), Antidepressant, Antidepressant\r\nMechanism of Action of Sertraline\r\nSertraline blocks the re-uptake of neurotransmitter Serotonin from the synapse in to the presynaptic nerve terminal in the CNS. This will prolong the action of Serotonin (5HT) and it is useful in the treatment of depression.\r\nSide Effects of Sertraline\r\n1. Insomnia \r\n2. Nausea \r\n3. Diarrhoea \r\n4. Headache \r\n5. Fatigue \r\n6. Dizziness \r\n7. Tremor \r\n8. Somnolence \r\n9. Dry mouth \r\n10. Anorexia \r\n11. Impotence \r\n12. Increased sweating \r\n13. Constipation \r\n14. Dyspepsia \r\n15. Agitation \r\n16. Malaise \r\n17. Abdominal pain", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "797", "Trade_Name": "MARIAGON 140 MG 30 CAPS.", "Generic_Name": "SILYMARIN", "Price": "28.5", "Price_Old": "28.5", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "LIVER SUPPORT SUPPLEMENTS", "Category": "م#=مل#.#? #~#>م #.ل#=#%#~", "Use": "–#>ل#.ج #.ل#?ه#.#% #.ل#=#%#~ #.لو#%#.ئي. \r\n\r\n–#>ل#.ج م#^#_ #.ل#=#%#~ #.ل#~هني. \r\n\r\n–#>ل#.ج #.ل#?سمم #.ل#=#%#~ي. \r\n\r\n–#>ل#.ج #.م#^#.#_ #.ل#=#%#~ #.لح#.#~ة و#.لمزمنة. \r\n\r\n–#>ل#.ج #.م#^#.#_ س#^#-#.ن #.لخل#.ي#. #.ل#=#%#~ية.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.لن#%#.#?#.#? و#.ل#.#~وية #.ل#>ش#%ية. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #?#_خم #.ل#%#^وس#?#.#?#.. \r\n\r\n–يمن#> #<ي ح#.ل#.#? #.لخلل #.له#^موني.", "GI": "About Silymarin\r\nA polyphenolic flavonoid, Hepatoprotective(antihepatotoxic),antioxidant.\r\nMechanism of Action of Silymarin\r\nSilymarin stimulates RNA polymerase A and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepatocytes and also increase the regenerative ability of the liver. \r\nIt stabilizes the hepatic cell membrane and prevents the penetration of toxin in to the cell and also slows the absorption of harmful substances in to the liver. \r\nSilymarin contains antioxidant flavanoid. It combines with free radicals formed from metabolic process and also from breakdown of toxic substances and neutralizes them. Because of its antioxidant action it has anti-inflammatory property and it is used in ulcerative colitis and in ulcers. \r\nIt increases the glutathione content in the liver and intestine and also increases the activity of super oxide dismutase enzymes and is helpful in detoxifying actions of liver.", "Composition": "Each capsule contains:\r\nPowdered Milk Thistle Extract 80% 175 mg.\r\n(Equivalent to 140 mg Silymarin).", "Route": "ORAL.SOLID" }, { "ID": "798", "Trade_Name": "PROSTA-S 160MG 20 CAPS.", "Generic_Name": "SERENOA REPENS PURIFIED EXTRACT", "Price": "24.6", "Price_Old": "24.6", "Company": "MEMPHIS", "Pharmacology": "PROSTATE SUPPORT", "Category": "مش#.#=ل #.ل#%#^وس#?#.#?#.", "Use": "–يس#?خ#~م هذ#. #.ل#~و#.ء #<ي م#>#.لجة #_غ#- #.ل#~م #.لم#^#?#<#>. \r\n\r\n–يس#.#>#~ #<ي م#>#.لجة #?#_خم #.ل#%#^وس#?#.#?#. #.لحمي#~.", "Contraindications": "–ي#=ون خ#-#^#.ً #<ي ح#.لة #.لش#>و#^ #%#.لحس#.سية. \r\n\r\n–يمن#> #<ي ح#.لة #.ل#?#>#^#_ لم#^#_ #.نخ#<#.#_ #.ل#_غ#-. \r\n\r\n–ي#=ون خ#-#^#.ً #<ي ح#.لة ح#~وث ص#>و#%ة ش#~ي#~ة #<ي #.ل#?#%ول. \r\n\r\n–يمن#> #?ن#.ول #%#^وس#?#. #.س #<ي وق#? #<ق#~#.ن ح#.#~ #%#.لو#>ي. \r\n\r\n–يمن#> قي#.#~ة #.لسي#.#^ة أثن#.ء #.ل#>ل#.ج وذل#= لأنه يس#%#% #.لن#>#.س.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "799", "Trade_Name": "CYSTINOL 425MG 20 CAPS.", "Generic_Name": "SOLIDAGO VIRGAUREA", "Price": "10.5", "Price_Old": "10.5", "Company": "ATOS PHARMA", "Pharmacology": "COMING SOON ..", "Category": "مش#.#=ل #.لمس#.ل#= #.ل#%ولية", "Use": "–#>ن#~ #.ل#>ل#.ج من حصو#.#? #.ل#=لى و#.لوق#.ية منه#.، و#>ن#~ #?#=#^#.#^ #?ش#=يل #.لحصو#.#?. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج أم#^#.#_ #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#=م#. ي#>مل #=#>ل#.ج مس#.#>#~ لم#=#.#<حة #.لمي#=#^و#%#.#? #.ل#?ي #?س#%#% ح#~وث #.ل#?ه#.#%#.#? #=#%ي#^ة #<ي #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يؤخذ ق#%ل و#%#>#~ #.ل#>ملي#.#? و #>ن#~ أي إج#^#.ء #>ملية ج#^#.حية #<ي #.لمس#.ل#= #.ل#%ولية.", "Contraindications": "–#>ن#~ ح#~وث #.خ#?ل#.ل أو قصو#^ #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>ن#~ ح#~وث #.نس#~#.#~ #<ي #.لمس#.ل#= #.ل#%ولية #.لس#<لية #%س#%#% #?#_خم #.ل#%#^وس#?#.#?#.. \r\n\r\n–#.لحس#.سية #_#~ م#=ون#.#? #.ل#~و#.ء.", "GI": "Properties and actions:\r\nCystinol promotes the excretion of water more than electrolytes by increasing renal blood flow. This aquaretic effect facilitates the washout of bacteria from the urinary tract, prevents crystal formation and hence kidney stones. \r\nCystinol inhibits the synthesis of prostaglandinic acid metabolites and therefore has an anti-inflammatory effect. The flavonoid content of Cystinol also has anti-inflammatory, anti-microbial and immunomodulatory properties. This anti-inflammatory effect supports urinary tract healing after passage of stones. Cystinol has an analgesic effect because it binds pain receptors. The mild spasmolytic effect of Cystinol relaxes contracted smooth muscles and thus relieves the pain associated with inflammation and stones. \r\nThe saponin content of Cystinol provides anti-infective properties through non specific immunostimulation while the ester-saponin exerts an anti-fungal effect against candida albicans and other candida species.", "Composition": "425 mg of Solidago virgaurea extract", "Route": "ORAL.SOLID" }, { "ID": "800", "Trade_Name": "ROCALTROL 0.25MCG 30CAPS.", "Generic_Name": "CALCITRIOL", "Price": "35", "Price_Old": "35", "Company": "F.HOFFMAN LA ROCHE > EGYPTIAN PHARMACEUTICAL TRADING COMPANY", "Pharmacology": "DIETARY SUPPLEMENT", "Category": "#<ي#?#.مين #~", "Use": "–يش#.#^ إلى Rocaltrol ل#?صحيح #?شوه#.#? #.س#?قل#.#% #.ل#=#.لسيوم و#.ل#<وس#<#.#? #<ي #.لم#^#_ى #.لذين ي#>#.نون من حثل #.ل#>ظ#.م #.ل#=لوي. \r\n\r\n–يش#.#^ Rocaltrol أي#_#. ل#>ل#.ج هش#.شة #.ل#>ظ#.م #%#>#~ #.نق#-#.#> #.ل#-مث.", "Contraindications": "–#<ي جمي#> #.لأم#^#.#_ #.لم#^#?#%#-ة #%#<#^#- #=#.لسيوم #.ل#~م \r\n\r\n–#<ي #.لم#^#_ى #.لذين ل#~يهم #~ليل #>لى #?#=لس #.لنقيلي \r\n\r\n–#<ي #.لم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لل#=#.لسي#?#^يول (أو #.لأ#~وية من ن#<س #.ل#<ئة) وأي من #.لسو#.غ #.لم#=ونة \r\n\r\n–إذ#. #=#.ن هن#.#= #~ليل #>لى سمية #<ي#?#.مين #~.", "GI": "Mechanism of Action of Calcitriol\r\nCalcitriol is a 1, 25-dihydroxycholecalciferol or a Vitamin D analogue. It increases the absorption of Calcium from intestine by forming a calcium binding protein. It reverses the signs of rickets and osteomalacia.\r\nPharmacokinets of Calcitriol\r\nAbsorption: It is readily absorbed after oral administration. Distribution: It is widely distributed in protein bound form. Metabolism: It undergoes metabolism in the liver and kidney. Excretion: It is excreted mainly in the faeces.\r\nIndications for Calcitriol\r\n1.Management of Hypocalcaemia \r\n2.Management of hypoparathyroidism and pseudohypoparathyroidism", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "801", "Trade_Name": "BEKCIUM 500MG 30 CAPS.", "Generic_Name": "CALCIUM DOBESILATE", "Price": "27", "Price_Old": "27", "Company": "ALEXANDRIA", "Pharmacology": "VASOPROTECTIVE", "Category": "#.ل#.و#>ية #.ل#~موية", "Use": "–يس#?خ#~م #<ي #?وسي#> #.لأو#^#~ة. \r\n\r\n–ي#>#.لج #.#>#?ل#.ل #.لش#%#=ية لم#^#_ي #.لس#=#^. \r\n\r\n–ي#>#.لج #?جمي#> وزي#.#~ة #.لص#<يح#.#?. \r\n\r\n–ي#>#.لج م#^#_ #.ل#%#.سو#^ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#~و#.لي. \r\n\r\n–ي#>#.لج #.ل#%و#.سي#^. \r\n\r\n–ي#>#.لج قصو#^ #.لو#^ي#~ي #.لمزمن.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يس#?خ#~م #.ل#>ق#.#^ #%حذ#^ لمن #?قل أ#>م#.#^هم #>ن 18 #>#.م. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ #<ي #>#~#~ خل#.ي#. #.ل#~م #.ل#%ي#_#.ء. \r\n\r\n–يم#=ن #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل ول#=ن #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–ينصح #%#>#~م #.ل#^#_#.#>ة #.ل#-#%ي#>ية أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "(Indications) : \r\nThis medication is a vasoprotective, prescribed for circulatory disorders. \t\r\n\r\n\r\n(Contraindications): \r\nIt should not be administered during the first trimester of pregnancy. Contraindicated in patients with known hypersensitivity.\r\n\r\nDosage & When it is to be taken : \r\nAdult: PO- The recommended dose is 0.5-1 g/day in divided doses.", "Composition": "Calcium dobesilate 500mg or 250mg", "Route": "ORAL.SOLID" }, { "ID": "802", "Trade_Name": "DILASAL 250MG 30 CAPS.", "Generic_Name": "CALCIUM DOBESILATE", "Price": "16.5", "Price_Old": "16.5", "Company": "MULTI-APEX", "Pharmacology": "VASOPROTECTIVE", "Category": "#.ل#.و#>ية #.ل#~موية", "Use": "–يس#?خ#~م #<ي #?وسي#> #.لأو#^#~ة. \r\n\r\n–ي#>#.لج #.#>#?ل#.ل #.لش#%#=ية لم#^#_ي #.لس#=#^. \r\n\r\n–ي#>#.لج #?جمي#> وزي#.#~ة #.لص#<يح#.#?. \r\n\r\n–ي#>#.لج م#^#_ #.ل#%#.سو#^ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#~و#.لي. \r\n\r\n–ي#>#.لج #.ل#%و#.سي#^. \r\n\r\n–ي#>#.لج قصو#^ #.لو#^ي#~ي #.لمزمن.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يس#?خ#~م #.ل#>ق#.#^ #%حذ#^ لمن #?قل أ#>م#.#^هم #>ن 18 #>#.م. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ #<ي #>#~#~ خل#.ي#. #.ل#~م #.ل#%ي#_#.ء. \r\n\r\n–يم#=ن #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل ول#=ن #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–ينصح #%#>#~م #.ل#^#_#.#>ة #.ل#-#%ي#>ية أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "(Indications) : \r\nThis medication is a vasoprotective, prescribed for circulatory disorders. \t\r\n\r\n\r\n(Contraindications): \r\nIt should not be administered during the first trimester of pregnancy. Contraindicated in patients with known hypersensitivity.\r\n\r\nDosage & When it is to be taken : \r\nAdult: PO- The recommended dose is 0.5-1 g/day in divided doses.", "Composition": "calcium dobesilate 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "803", "Trade_Name": "ROCALTROL 0.5MCG 30CAPS.", "Generic_Name": "CALCITRIOL", "Price": "50", "Price_Old": "50", "Company": "F.HOFFMAN LA ROCHE > EGYPTIAN PHARMACEUTICAL TRADING COMPANY", "Pharmacology": "VITAMIN D", "Category": "#<ي#?#.مين #~", "Use": "–يش#.#^ إلى Rocaltrol ل#?صحيح #?شوه#.#? #.س#?قل#.#% #.ل#=#.لسيوم و#.ل#<وس#<#.#? #<ي #.لم#^#_ى #.لذين ي#>#.نون من حثل #.ل#>ظ#.م #.ل#=لوي. \r\n\r\n–يش#.#^ Rocaltrol أي#_#. ل#>ل#.ج هش#.شة #.ل#>ظ#.م #%#>#~ #.نق#-#.#> #.ل#-مث.", "Contraindications": "–#<ي جمي#> #.لأم#^#.#_ #.لم#^#?#%#-ة #%#<#^#- #=#.لسيوم #.ل#~م \r\n\r\n–#<ي #.لم#^#_ى #.لذين ل#~يهم #~ليل #>لى #?#=لس #.لنقيلي \r\n\r\n–#<ي #.لم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لل#=#.لسي#?#^يول (أو #.لأ#~وية من ن#<س #.ل#<ئة) وأي من #.لسو#.غ #.لم#=ونة \r\n\r\n–إذ#. #=#.ن هن#.#= #~ليل #>لى سمية #<ي#?#.مين #~.", "GI": "Mechanism of Action of Calcitriol\r\nCalcitriol is a 1, 25-dihydroxycholecalciferol or a Vitamin D analogue. It increases the absorption of Calcium from intestine by forming a calcium binding protein. It reverses the signs of rickets and osteomalacia.\r\nPharmacokinets of Calcitriol\r\nAbsorption: It is readily absorbed after oral administration. Distribution: It is widely distributed in protein bound form. Metabolism: It undergoes metabolism in the liver and kidney. Excretion: It is excreted mainly in the faeces.\r\nIndications for Calcitriol\r\n1.Management of Hypocalcaemia \r\n2.Management of hypoparathyroidism and pseudohypoparathyroidism", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "804", "Trade_Name": "ENRICH PLUS 14 CAPSULES", "Generic_Name": "CALCIUM GLUCONATE+COPPER+FERROUS FUMARATE+MANGANESE+FOLIC ACID+VIT.(B1+B2+B6+B12+C+E)", "Price": "13", "Price_Old": "13", "Company": "MARCYRL CO.", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–يس#?خ#~م #.ل#~و#.ء #<ي #>ل#.ج ح#.ل#.#? #.ل#.نيمي#. و#.لوق#.ية من #.ل#.ص#.#%ة #%ه . \r\n\r\n–يم#~ #.لجسم #%#.لح#~ي#~ وي#>و#_ه #>ن نقص #.لح#~ي#~ و#.ل#>ن#.ص#^ #.ل#.س#.سية #<ي #.لجسم . \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#.نيمي#. #.لن#.#?جة #>ن #.لنزي#< و#<ق#~#.ن #=مية #=#%ي#^ة من #.ل#~م#.ء . \r\n\r\n–يس#?خ#~م #~و#.ء ENRICH PLUS إن#^ي#?ش #%لس ل#?#>وي#_ #<ق#~#.ن #.ل#~م #.لذي ي#?م ل#~ي #.لسي#~#.#? خل#.ل #<#?#^ة #.ل#~و#^ة #.لشه#^ية . \r\n\r\n–يس#?خ#~م #.ي#_#.ً #<ي #>ل#.ج ح#.ل#.#? #.ل#.نيمي#. #.لن#.#?جة #>ن مش#=لة سوء #.ل#?غذية . \r\n\r\n–م#<ي#~ خل#.ل #<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية لم#>#.لجة #.ل#.نيمي#. . \r\n\r\n–م#<ي#~ #.ي#_#.ً للأ#-#<#.ل وصغ#.#^ #.لسن خل#.ل م#^حلة #.ل#%لوغ #=م#. يم#=ن #.س#?خ#~#.م من ق#%ل #.لمسنين . \r\n\r\n–ي#>مل #~و#.ء ENRICH PLUS إن#^ي#?ش #%لس #>لي #.#>#.#~ة #%ن#.ء خل#.ي#. #.لجسم و#?ج#~ي#~ه#. #%#>#~ #.ج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية . \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج ح#.ل#.#? #<ق#^ #.ل#~م #.ل#?ي #?صي#% #.لم#^ي#_ خل#.ل #<#?#^ة #.لنق#.هة .", "Contraindications": "–يج#% #.ل#.م#?ن#.#> #>ن #.س#?خ#~#.م #=#%سول#.#? ENRICH PLUS إن#^ي#?ش #%لس لل#.شخ#.ص #.لمص#.#%ون #%حس#.سية م#<#^#-ة #?ج#.ة #.ي من #.لمو#.#~ #.ل#?ي #?#~خل #<ي #?#^#=ي#% #.ل#~و#.ء . \r\n\r\n–ي#>#~ هذ#. #.ل#~و#.ء آمن #?م#.م#.ً خل#.ل #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية وهو من #.هم #.لم#=مل#.#? #.لغذ#.ئية #.ل#?ي #?ح#?#.جه#. #.لسي#~#.#? خل#.ل هذه #.ل#<#?#^#.#? ول#=ن يج#% #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج #.ول#.ً ق#%ل #.ل#%#~ء #<ي #.س#?#>م#.ل #.ي #~و#.ء .", "GI": "COMING SOON ..", "Composition": "calcium gluconate 35mg, copper 2.5mg, ferrous fumarate 375mg, folic acid 2mg, manganese 2.5mg, vit b1 15mg, vit b12 10mcg, vit b2 2mg, vit b6 10mg, vit c 150mg, vit e 10mg", "Route": "ORAL.SOLID" }, { "ID": "805", "Trade_Name": "DILASAL 500MG 30 CAPS.", "Generic_Name": "CALCIUM DOBESILATE", "Price": "22.5", "Price_Old": "22.5", "Company": "MULTI-APEX", "Pharmacology": "VASOPROTECTIVE", "Category": "#.ل#.و#>ية #.ل#~موية", "Use": "–يس#?خ#~م #<ي #?وسي#> #.لأو#^#~ة. \r\n\r\n–ي#>#.لج #.#>#?ل#.ل #.لش#%#=ية لم#^#_ي #.لس#=#^. \r\n\r\n–ي#>#.لج #?جمي#> وزي#.#~ة #.لص#<يح#.#?. \r\n\r\n–ي#>#.لج م#^#_ #.ل#%#.سو#^ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#~و#.لي. \r\n\r\n–ي#>#.لج #.ل#%و#.سي#^. \r\n\r\n–ي#>#.لج قصو#^ #.لو#^ي#~ي #.لمزمن.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يس#?خ#~م #.ل#>ق#.#^ #%حذ#^ لمن #?قل أ#>م#.#^هم #>ن 18 #>#.م. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ #<ي #>#~#~ خل#.ي#. #.ل#~م #.ل#%ي#_#.ء. \r\n\r\n–يم#=ن #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل ول#=ن #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–ينصح #%#>#~م #.ل#^#_#.#>ة #.ل#-#%ي#>ية أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "(Indications) : \r\nThis medication is a vasoprotective, prescribed for circulatory disorders. \t\r\n\r\n\r\n(Contraindications): \r\nIt should not be administered during the first trimester of pregnancy. Contraindicated in patients with known hypersensitivity.\r\n\r\nDosage & When it is to be taken : \r\nAdult: PO- The recommended dose is 0.5-1 g/day in divided doses.", "Composition": "calcium dobesilate 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "806", "Trade_Name": "BEKCIUM 250MG 30 CAPS.", "Generic_Name": "CALCIUM DOBESILATE", "Price": "16.2", "Price_Old": "16.2", "Company": "ALEXANDRIA", "Pharmacology": "VASOPROTECTIVE", "Category": "#.ل#.و#>ية #.ل#~موية", "Use": "–يس#?خ#~م #<ي #?وسي#> #.لأو#^#~ة. \r\n\r\n–ي#>#.لج #.#>#?ل#.ل #.لش#%#=ية لم#^#_ي #.لس#=#^. \r\n\r\n–ي#>#.لج #?جمي#> وزي#.#~ة #.لص#<يح#.#?. \r\n\r\n–ي#>#.لج م#^#_ #.ل#%#.سو#^ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#~و#.لي. \r\n\r\n–ي#>#.لج #.ل#%و#.سي#^. \r\n\r\n–ي#>#.لج قصو#^ #.لو#^ي#~ي #.لمزمن.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يس#?خ#~م #.ل#>ق#.#^ #%حذ#^ لمن #?قل أ#>م#.#^هم #>ن 18 #>#.م. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ #<ي #>#~#~ خل#.ي#. #.ل#~م #.ل#%ي#_#.ء. \r\n\r\n–يم#=ن #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل ول#=ن #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–ينصح #%#>#~م #.ل#^#_#.#>ة #.ل#-#%ي#>ية أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "(Indications) : \r\nThis medication is a vasoprotective, prescribed for circulatory disorders. \t\r\n\r\n\r\n(Contraindications): \r\nIt should not be administered during the first trimester of pregnancy. Contraindicated in patients with known hypersensitivity.\r\n\r\nDosage & When it is to be taken : \r\nAdult: PO- The recommended dose is 0.5-1 g/day in divided doses.", "Composition": "Calcium dobesilate 500mg or 250mg", "Route": "ORAL.SOLID" }, { "ID": "807", "Trade_Name": "DOXIUM 500MG 30 CAPS.", "Generic_Name": "CALCIUM DOBESILATE", "Price": "54", "Price_Old": "36", "Company": "MEMPHIS > OM-SWITZERLAND", "Pharmacology": "VASOPROTECTIVE", "Category": "#.ل#.و#>ية #.ل#~موية", "Use": "–يس#?خ#~م #<ي #?وسي#> #.لأو#^#~ة. \r\n\r\n–ي#>#.لج #.#>#?ل#.ل #.لش#%#=ية لم#^#_ي #.لس#=#^. \r\n\r\n–ي#>#.لج #?جمي#> وزي#.#~ة #.لص#<يح#.#?. \r\n\r\n–ي#>#.لج م#^#_ #.ل#%#.سو#^ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#~و#.لي. \r\n\r\n–ي#>#.لج #.ل#%و#.سي#^. \r\n\r\n–ي#>#.لج قصو#^ #.لو#^ي#~ي #.لمزمن.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يس#?خ#~م #.ل#>ق#.#^ #%حذ#^ لمن #?قل أ#>م#.#^هم #>ن 18 #>#.م. \r\n\r\n–لمن ي#>#.نون من #.نخ#<#.#_ #<ي #>#~#~ خل#.ي#. #.ل#~م #.ل#%ي#_#.ء. \r\n\r\n–يم#=ن #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل ول#=ن #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#%. \r\n\r\n–ينصح #%#>#~م #.ل#^#_#.#>ة #.ل#-#%ي#>ية أثن#.ء #<#?#^ة #.ل#>ل#.ج.", "GI": "(Indications) : \r\nThis medication is a vasoprotective, prescribed for circulatory disorders. \t\r\n\r\n\r\n(Contraindications): \r\nIt should not be administered during the first trimester of pregnancy. Contraindicated in patients with known hypersensitivity.\r\n\r\nDosage & When it is to be taken : \r\nAdult: PO- The recommended dose is 0.5-1 g/day in divided doses.", "Composition": "Calcium dobesilate 500 mg", "Route": "ORAL.SOLID" }, { "ID": "808", "Trade_Name": "CALCIMATE 500MG 12 CAPS.", "Generic_Name": "CALCIUM CARBONATE", "Price": "5", "Price_Old": "3", "Company": "EL NASR", "Pharmacology": "CALCIUM SUPPLEMENT", "Category": "م#=مل #.ل#=#.لسيوم", "Use": "–م#=مل غذ#.ئي للوق#.يه و#.ل#>ل#.ج من نقص #.ل#=#.لسيوم و#.ل#?ى #<ى #.ل#>#.#~ه م#.#?صي#% #<ئ#.#? م#>ينه من #.لن#.س \r\n\r\n–مثل #.لنس#.ء #%#>#~ #.نق#-#.#> #.ل#-مث و#.ولئ#= #.للذين ي#?#%#>ون نظ#.م غذ#.ئي ن#%#.#?ي. \r\n\r\n–_ #.لسي#-#^ه #>لى #.#^#?#<#.#> مس#?وي#.#? #.لمغنسيوم و#.ل#<س#<و#^ و#.ل#%و#?#.سيوم #<ي #.ل#~م. \r\n\r\n–_ يؤخذ جن#%#. #.لى جن#% م#> #<ي#?#.مين #~ ليس#.#>#~ #<ى #.لح#~ من #<ق#~#.ن #.لم#>#.#~ن \r\n\r\n–#<ي #.ل#>ظ#.م #<ى #.ل#.شخ#.ص #.للذين يس#?خ#~مون #>ق#.قي#^ #.ل#=و#^#?ي#=وس#?ي#^وي#~ #>لى #.لم#~ى #.ل#-ويل. \r\n\r\n–_ #<ي #.لنس#.ء #.لحو#.مل #.للو#.#?ي ي#?ن#.ولن #=ميه قليله من #.ل#=#.لسيوم #=جزء من نظ#.مهم #.لغذ#.ئي \r\n\r\n–#<#.ن #?ن#.وله يزي#~ من #=ث#.#<ة #.لم#>#.#~ن #<ي #>ظ#.م #.لجنين. \r\n\r\n–_ يقلل من مس#?وي#.#? ه#^مون #.لغ#~ه #.ل#~#^قيه #<ى #.ل#.شخ#.ص #.للذين ي#>#.نون من #.ل#<شل #.ل#=لوي \r\n\r\n–ومس#?وي#.#? ه#^مون #.لغ#~ه #.ل#~#^قيه #.لم#^#?#<#>ه. \r\n\r\n–_ لمن#> و#>ل#.ج هش#.شة #.ل#>ظ#.م . \r\n\r\n–_ #.لوق#.يه من #%#>#_ #.نو#.#> #.لس#^#-#.ن.", "Contraindications": "–ح#.ل#.#? زي#.#~ة نس#%ة #.ل#=#.لسيوم #<ى #.ل#~م و#.ل#%ول.", "GI": "Treating or preventing calcium deficiency. It may also be used for other conditions as determined by your doctor.\r\n\r\nCalcium carbonate is a dietary supplement. It works by providing extra calcium to the body.\r\n\r\nDo NOT use calcium carbonate if:\r\n\r\nyou are allergic to any ingredient in calcium carbonate\r\nyou have high blood calcium levels", "Composition": "calcium carbonate 1200mg", "Route": "ORAL.SOLID" }, { "ID": "809", "Trade_Name": "CROWN HAIR 50 CAP.", "Generic_Name": "CALCIUM PANTOTHENATE+KERATIN+L-CYSTINE+PARA-AMINOBENZOIC ACID+VITAMIN B1+YEAST", "Price": "21", "Price_Old": "21", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "HAIR CARE", "Category": "#.ل#>ن#.ية #%#.لش#>#^", "Use": "–#?س#.ق#- #.لش#>#^. \r\n\r\n–يقوي وينش#- #>ملية #.لأي#_ #.لم#?و#.ج#~ة #%#.لش#>#^. \r\n\r\n–#?غذية #.لش#>#^ وزي#.#~ة م#.#~ة #.ل#=ي#^#.#?ين. \r\n\r\n–يوج#~ #%ه #.ل#=ثي#^ من #.ل#<ي#?#.مين#.#? #.ل#?ي #?س#.#>#~ #>لى #?غذية #.لش#>#^ و#?#-ويله. \r\n\r\n–#?ج#~ي#~ و#?نشي#- خل#.ي#. #.لش#>#^. \r\n\r\n–حم#.ية #.لأظ#.#<#^ من #.ل#?قص#<. \r\n\r\n–نمو #.لأظ#.#<#^. \r\n\r\n–#?أخ#^ ظهو#^ #.لش#>#^ #.لش#.ي#%. \r\n\r\n–#?أخي#^ ظهو#^ #.لش#>#^ #.لأ#%ي#_.", "Contraindications": "–حس#.سية م#<#^#-ة. \r\n\r\n–#>#~م #?ن#.وله خل#.ل شهو#^ #.لحمل. \r\n\r\n–أثن#.ء #.ل#^#_#.#>ة.", "GI": "L-Cystine is a covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Cystine is a chemical substance which naturally occurs as a deposit in the urine, and can form a calculus (hard mineral formation) when deposited in the kidney. The compound produced when two cysteine molecules linked by a disulfide (S-S) bond. Cystine is required for proper vitamin B6 utilization and is also helpful in the healing of burns and wounds, breaking down mucus deposits in illnesses such as bronchitis as well as cystic fibrosis. Cysteine also assists in the supply of insulin to the pancreas, which is needed for the assimilation of sugars and starches. It increases the level of glutathione in the lungs, liver, kidneys and bone marrow, and this may have an anti-aging effect on the body by reducing age-spots etc.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "810", "Trade_Name": "SPECTRACEFOCURE 300 MG 10 CAPS.", "Generic_Name": "CEFDINIR", "Price": "45", "Price_Old": "45", "Company": "KAHIRA > EVERCURE COMPANY-EGYPT", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "811", "Trade_Name": "SUPRAX 400 MG 5 CAPS", "Generic_Name": "CEFIXIME", "Price": "85", "Price_Old": "60", "Company": "KAHIRA > HIKMA PHARMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م ل#>ل#.ج #>#~وي #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #>#~وي #.ل#=لي وحو#_ه#.. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~ية #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~ي #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي. \r\n\r\n–#>ل#.ج #>#~وي #.لمج#^ي #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لإص#.#%ة #%#.ل#%#=#?#^ي#.. \r\n\r\n–يس#?خ#~م #=#>ل#.ج وق#.ئي ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%#.ل#-ين ليقي من #.لإص#.#%ة #%#.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#?ن#.سلي #>ن#~ #.لنس#.ء. \r\n\r\n–#>ل#.ج ذ#.#? #.ل#^ئة. \r\n\r\n–#>ل#.ج #?قيح #.ل#~م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.لح#.#~. \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة أو #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حث ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية ل#?ث#%#? سل#.مة #.ل#>ق#.#^ #>لى #.لجنين #<هو ق#~ يس#%#% #?شوه #.لأجنة. \r\n\r\n–يج#% #.ل#?وق#< #>ن #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه #.ل#^#_ي#>.", "GI": "About Cefixime\r\nThird Generation Cephalosporin Oral antibiotic\r\n\r\nMechanism of Action of Cefixime\r\nCefixime is an orally active 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefixime inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefixime. It is highly active against enterobacteriaceae, Haemophilus influenzae, Streptococcus pyogens & Streptococcus pneumonia &many beta lactamase producing bacteria.\r\n\r\nIndications for Cefixime\r\n1.Tonsillitis \r\n2.Pharyngitis \r\n3.Otitismedia \r\n4.Bronchitis \r\n5.Urinary tract infections \r\n6.Gonorrhea \r\n7.Infections caused by susceptible organisms.", "Composition": "Suprax 200 mg\r\nEach hard gelatin capsule contains:\r\nCefixime trihydrate 223.8 mg (eq. To 200 mg cefixime)\r\n\r\nSuprax 400 mg\r\nEach hard gelatin capsule contains:\r\nCefixime Trihydrate 447.6 mg (eq. To 400 mg cefixime)\r\n\r\nSuprax 100 ml /5 ml Granules for oral suspens", "Route": "ORAL.SOLID" }, { "ID": "812", "Trade_Name": "HEBIXIME 400MG 5 CAPS.", "Generic_Name": "CEFIXIME", "Price": "46.25", "Price_Old": "30.75", "Company": "SHIFA MEDICAL PRODUCTS", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م ل#>ل#.ج #>#~وي #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #>#~وي #.ل#=لي وحو#_ه#.. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~ية #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~ي #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي. \r\n\r\n–#>ل#.ج #>#~وي #.لمج#^ي #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لإص#.#%ة #%#.ل#%#=#?#^ي#.. \r\n\r\n–يس#?خ#~م #=#>ل#.ج وق#.ئي ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%#.ل#-ين ليقي من #.لإص#.#%ة #%#.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#?ن#.سلي #>ن#~ #.لنس#.ء. \r\n\r\n–#>ل#.ج ذ#.#? #.ل#^ئة. \r\n\r\n–#>ل#.ج #?قيح #.ل#~م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.لح#.#~. \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة أو #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حث ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية ل#?ث#%#? سل#.مة #.ل#>ق#.#^ #>لى #.لجنين #<هو ق#~ يس#%#% #?شوه #.لأجنة. \r\n\r\n–يج#% #.ل#?وق#< #>ن #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه #.ل#^#_ي#>.", "GI": "About Cefixime\r\nThird Generation Cephalosporin Oral antibiotic\r\n\r\nMechanism of Action of Cefixime\r\nCefixime is an orally active 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefixime inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefixime. It is highly active against enterobacteriaceae, Haemophilus influenzae, Streptococcus pyogens & Streptococcus pneumonia &many beta lactamase producing bacteria.\r\n\r\nIndications for Cefixime\r\n1.Tonsillitis \r\n2.Pharyngitis \r\n3.Otitismedia \r\n4.Bronchitis \r\n5.Urinary tract infections \r\n6.Gonorrhea \r\n7.Infections caused by susceptible organisms.", "Composition": "cefixime 100mg or 200mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "813", "Trade_Name": "HEBIXIME 200MG 8 CAPS.", "Generic_Name": "CEFIXIME", "Price": "48", "Price_Old": "32", "Company": "SHIFA MEDICAL PRODUCTS", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م ل#>ل#.ج #>#~وي #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #>#~وي #.ل#=لي وحو#_ه#.. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~ية #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~ي #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي. \r\n\r\n–#>ل#.ج #>#~وي #.لمج#^ي #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لإص#.#%ة #%#.ل#%#=#?#^ي#.. \r\n\r\n–يس#?خ#~م #=#>ل#.ج وق#.ئي ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%#.ل#-ين ليقي من #.لإص#.#%ة #%#.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#?ن#.سلي #>ن#~ #.لنس#.ء. \r\n\r\n–#>ل#.ج ذ#.#? #.ل#^ئة. \r\n\r\n–#>ل#.ج #?قيح #.ل#~م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.لح#.#~. \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة أو #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حث ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية ل#?ث#%#? سل#.مة #.ل#>ق#.#^ #>لى #.لجنين #<هو ق#~ يس#%#% #?شوه #.لأجنة. \r\n\r\n–يج#% #.ل#?وق#< #>ن #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه #.ل#^#_ي#>.", "GI": "About Cefixime\r\nThird Generation Cephalosporin Oral antibiotic\r\n\r\nMechanism of Action of Cefixime\r\nCefixime is an orally active 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefixime inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefixime. It is highly active against enterobacteriaceae, Haemophilus influenzae, Streptococcus pyogens & Streptococcus pneumonia &many beta lactamase producing bacteria.\r\n\r\nIndications for Cefixime\r\n1.Tonsillitis \r\n2.Pharyngitis \r\n3.Otitismedia \r\n4.Bronchitis \r\n5.Urinary tract infections \r\n6.Gonorrhea \r\n7.Infections caused by susceptible organisms.", "Composition": "cefixime 100mg or 200mg or 400mg", "Route": "ORAL.SOLID" }, { "ID": "814", "Trade_Name": "CELEBREX 100MG 10 CAPS.", "Generic_Name": "CELECOXIB", "Price": "48.75", "Price_Old": "32.4", "Company": "PFIZER", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "celecoxib 100mg, 200mg", "Route": "ORAL.SOLID" }, { "ID": "815", "Trade_Name": "XIMACEF 400MG 5 CAPSULE", "Generic_Name": "CEFIXIME", "Price": "63", "Price_Old": "42", "Company": "SIGMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م ل#>ل#.ج #>#~وي #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #>#~وي #.ل#=لي وحو#_ه#.. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~ية #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~ي #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي. \r\n\r\n–#>ل#.ج #>#~وي #.لمج#^ي #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لإص#.#%ة #%#.ل#%#=#?#^ي#.. \r\n\r\n–يس#?خ#~م #=#>ل#.ج وق#.ئي ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%#.ل#-ين ليقي من #.لإص#.#%ة #%#.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#?ن#.سلي #>ن#~ #.لنس#.ء. \r\n\r\n–#>ل#.ج ذ#.#? #.ل#^ئة. \r\n\r\n–#>ل#.ج #?قيح #.ل#~م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.لح#.#~. \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة أو #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حث ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية ل#?ث#%#? سل#.مة #.ل#>ق#.#^ #>لى #.لجنين #<هو ق#~ يس#%#% #?شوه #.لأجنة. \r\n\r\n–يج#% #.ل#?وق#< #>ن #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه #.ل#^#_ي#>.", "GI": "About Cefixime\r\nThird Generation Cephalosporin Oral antibiotic\r\n\r\nMechanism of Action of Cefixime\r\nCefixime is an orally active 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefixime inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefixime. It is highly active against enterobacteriaceae, Haemophilus influenzae, Streptococcus pyogens & Streptococcus pneumonia &many beta lactamase producing bacteria.\r\n\r\nIndications for Cefixime\r\n1.Tonsillitis \r\n2.Pharyngitis \r\n3.Otitismedia \r\n4.Bronchitis \r\n5.Urinary tract infections \r\n6.Gonorrhea \r\n7.Infections caused by susceptible organisms.", "Composition": "Capsule:\r\nXIMACEF 200 mg capsules: cefixime 200 mg / cap.\r\nXIMACEF 400 mg capsules: cefixime 400 mg / cap.\r\n\r\nSuspension:\r\nXIMACEF 100 mg cefixime / 5 ml suspension in Bottle contains 30 ml - after reconstitution XIMACEF 100 mg cefixime / 5 ml suspension in Bo", "Route": "ORAL.SOLID" }, { "ID": "816", "Trade_Name": "XIMACEF 200 MG 8 CAPSULE", "Generic_Name": "CEFIXIME", "Price": "42", "Price_Old": "42", "Company": "SIGMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م ل#>ل#.ج #>#~وي #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #>#~وي #.ل#=لي وحو#_ه#.. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~ية #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~ي #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي. \r\n\r\n–#>ل#.ج #>#~وي #.لمج#^ي #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لإص#.#%ة #%#.ل#%#=#?#^ي#.. \r\n\r\n–يس#?خ#~م #=#>ل#.ج وق#.ئي ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%#.ل#-ين ليقي من #.لإص#.#%ة #%#.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#?ن#.سلي #>ن#~ #.لنس#.ء. \r\n\r\n–#>ل#.ج ذ#.#? #.ل#^ئة. \r\n\r\n–#>ل#.ج #?قيح #.ل#~م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.لح#.#~. \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة أو #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حث ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية ل#?ث#%#? سل#.مة #.ل#>ق#.#^ #>لى #.لجنين #<هو ق#~ يس#%#% #?شوه #.لأجنة. \r\n\r\n–يج#% #.ل#?وق#< #>ن #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه #.ل#^#_ي#>.", "GI": "About Cefixime\r\nThird Generation Cephalosporin Oral antibiotic\r\n\r\nMechanism of Action of Cefixime\r\nCefixime is an orally active 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefixime inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefixime. It is highly active against enterobacteriaceae, Haemophilus influenzae, Streptococcus pyogens & Streptococcus pneumonia &many beta lactamase producing bacteria.\r\n\r\nIndications for Cefixime\r\n1.Tonsillitis \r\n2.Pharyngitis \r\n3.Otitismedia \r\n4.Bronchitis \r\n5.Urinary tract infections \r\n6.Gonorrhea \r\n7.Infections caused by susceptible organisms.", "Composition": "Capsule:\r\nXIMACEF 200 mg capsules: cefixime 200 mg / cap.\r\nXIMACEF 400 mg capsules: cefixime 400 mg / cap.\r\n\r\nSuspension:\r\nXIMACEF 100 mg cefixime / 5 ml suspension in Bottle contains 30 ml - after reconstitution XIMACEF 100 mg cefixime / 5 ml suspension in Bo", "Route": "ORAL.SOLID" }, { "ID": "817", "Trade_Name": "ARYTHREX 100MG 10 CAPS.", "Generic_Name": "CELECOXIB", "Price": "21.6", "Price_Old": "21.6", "Company": "AMOUN", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "Each capsule contains:\r\nCelecoxib 200 mg.", "Route": "ORAL.SOLID" }, { "ID": "818", "Trade_Name": "SUPRAX 200 MG 8 CAPS", "Generic_Name": "CEFIXIME", "Price": "75", "Price_Old": "50", "Company": "KAHIRA > HIKMA PHARMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م ل#>ل#.ج #>#~وي #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #>#~وي #.ل#=لي وحو#_ه#.. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~ية #.لن#.#?جة #>ن #.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~ي #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي. \r\n\r\n–#>ل#.ج #>#~وي #.لمج#^ي #.ل#%ولي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.لن#.#?جة #>ن #.لإص#.#%ة #%#.ل#%#=#?#^ي#.. \r\n\r\n–يس#?خ#~م #=#>ل#.ج وق#.ئي ق#%ل #.ل#>ملي#.#? #.لج#^#.حية #%#.ل#-ين ليقي من #.لإص#.#%ة #%#.ل#>#~وى. \r\n\r\n–#>ل#.ج #>#~وي #.لجه#.ز #.ل#?ن#.سلي #>ن#~ #.لنس#.ء. \r\n\r\n–#>ل#.ج ذ#.#? #.ل#^ئة. \r\n\r\n–#>ل#.ج #?قيح #.ل#~م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي #.لح#.#~. \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة أو #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل حث ل#. #?وج#~ #~#^#.س#.#? #=#.#<ية ل#?ث#%#? سل#.مة #.ل#>ق#.#^ #>لى #.لجنين #<هو ق#~ يس#%#% #?شوه #.لأجنة. \r\n\r\n–يج#% #.ل#?وق#< #>ن #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> م#> حلي#% #.لأم ويؤث#^ #>لى صح#?ه #.ل#^#_ي#>.", "GI": "About Cefixime\r\nThird Generation Cephalosporin Oral antibiotic\r\n\r\nMechanism of Action of Cefixime\r\nCefixime is an orally active 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefixime inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefixime. It is highly active against enterobacteriaceae, Haemophilus influenzae, Streptococcus pyogens & Streptococcus pneumonia &many beta lactamase producing bacteria.\r\n\r\nIndications for Cefixime\r\n1.Tonsillitis \r\n2.Pharyngitis \r\n3.Otitismedia \r\n4.Bronchitis \r\n5.Urinary tract infections \r\n6.Gonorrhea \r\n7.Infections caused by susceptible organisms.", "Composition": "Suprax 200 mg\r\nEach hard gelatin capsule contains:\r\nCefixime trihydrate 223.8 mg (eq. To 200 mg cefixime)\r\n\r\nSuprax 400 mg\r\nEach hard gelatin capsule contains:\r\nCefixime Trihydrate 447.6 mg (eq. To 400 mg cefixime)\r\n\r\nSuprax 100 ml /5 ml Granules for oral suspens", "Route": "ORAL.SOLID" }, { "ID": "819", "Trade_Name": "CELOXIB 100MG 10CAPS.", "Generic_Name": "CELECOXIB", "Price": "19.2", "Price_Old": "19.2", "Company": "SEDICO", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "celecoxib 100mg", "Route": "ORAL.SOLID" }, { "ID": "820", "Trade_Name": "CEPHALEXIN 500MG 10 CAPS.", "Generic_Name": "CEFALEXIN", "Price": "10.1", "Price_Old": "10.1", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cephalexin 500mg", "Route": "ORAL.SOLID" }, { "ID": "821", "Trade_Name": "CEFATHIRD 300MG 10 CAPS.", "Generic_Name": "CEFDINIR", "Price": "45", "Price_Old": "45", "Company": "EGPI", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "cefdinir 125mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "822", "Trade_Name": "CEDENIR 300MG 10 CAPS.", "Generic_Name": "CEFDINIR", "Price": "45", "Price_Old": "45", "Company": "UNIPHARMA CO.", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "cefdinir 125mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "823", "Trade_Name": "KEFLEX 500 MG 12 CAPS.", "Generic_Name": "CEFALEXIN", "Price": "22", "Price_Old": "14.58", "Company": "KAHIRA > EPCI", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "KEFLEX 1gm tablets : Each tablet contains Cephalexin monohydrate eq. to Cephalexin ... 1gm. \r\n\r\nKEFLEX 500 tablets : Each tablet contains Cephalexin monohydrate eq. to Cephalexin ... 500mg. \r\n\r\nKEFLEX 250 capsules : Each capsule contains Cephalexin monohydrat", "Route": "ORAL.SOLID" }, { "ID": "824", "Trade_Name": "DINAR 300MG 10 CAPS.", "Generic_Name": "CEFDINIR", "Price": "69", "Price_Old": "46", "Company": "ADWIA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "Dinar Capsules contain 300 mg cefdinir.\r\n\r\nDinar for Oral Suspension, 60 ml after reconstitution, contains 125 mg cefdinir per 5 ml.", "Route": "ORAL.SOLID" }, { "ID": "825", "Trade_Name": "CEFDIN 300MG 10 CAPS.", "Generic_Name": "CEFDINIR", "Price": "63", "Price_Old": "63", "Company": "NOVARTIS", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "cefdinir 300mg or 125mg", "Route": "ORAL.SOLID" }, { "ID": "826", "Trade_Name": "STARCEF 500MG 20 CAP.", "Generic_Name": "CEFALEXIN", "Price": "18", "Price_Old": "18", "Company": "SIGMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cephalexin 1000mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "827", "Trade_Name": "DENROCEF 300MG 10 CAPS.", "Generic_Name": "CEFDINIR", "Price": "67.5", "Price_Old": "45", "Company": "SHIFA MEDICAL PRODUCTS > SPIMACO MISR", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "cefdinir 125mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "828", "Trade_Name": "NEOCEF 500MG 12 CAPS.", "Generic_Name": "CEFALEXIN", "Price": "12", "Price_Old": "12", "Company": "EL NILE.", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cephalexin 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "829", "Trade_Name": "OMNICEF 300 MG 10 CAP.", "Generic_Name": "CEFDINIR", "Price": "140", "Price_Old": "100", "Company": "AL JAZEERA PHARMACEUTICAL > HIKMA PHARMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.THIRD-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.لث", "Use": "–يس#?خ#~م للق#_#.ء #>لى #>#~#~ #=#%ي#^ من #.ل#%#=#?#^ي#. مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية و#.ل#>ق#~ية #.ل#^ئوية و#.ل#>ق#~ية #.لمقيحة و#.لمس#?#~يمة #.لنزلية و#.لقولونية و#.لم#?قل#%ة #.ل#^#.ئ#>ة و#.ل#=لي#%سيل#.. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لحلق. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لأذن #.لوس#-ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجل#~ و#.لأنسجة #.ل#^خوة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لحنج#^ة. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.ل#^ئة و#.لقص#%ة #.لهو#.ئية. \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من خلل #<ي #.ل#=#%#~. \r\n\r\n–#.ل#~و#.ء غي#^ مسموح #%يه أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–لمن ي#>#.نون من مش#.#=ل #<ي #.ل#=لي #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–لمن ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%حس#.سية #.#?ج#.ه م#.#~ة #.ل#%نسيلين.", "GI": "About Cefdinir\r\nSemisynthetic (Third Generation ) cephalosporin antibiotic, Oral broad-spectrum antibiotic.\r\n\r\nMechanism of Action \r\nCefdinir is a 3rd generation cephalosporin which exerts its bactericidal action against both gram positive & aerobic gram negative organisms by inhibiting bacterial cell wall synthesis. Cefdinir inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefdinir\r\n\r\nIndications for Cefdinir\r\n1.Pneumonia \r\n2.Bronchitis \r\n3.Pharyngitis \r\n4.Tonsillitis \r\n5.Skin & soft tissue infections \r\n6.Otitismedia \r\n7.Sinusitis", "Composition": "cefdinir 125mg or 300mg", "Route": "ORAL.SOLID" }, { "ID": "830", "Trade_Name": "LAFUREX 40MG/4ML 3 AMP.", "Generic_Name": "FUROSEMIDE", "Price": "13.5", "Price_Old": "13.5", "Company": "AMOUN", "Pharmacology": "DIURETIC.LOOP", "Category": "#_غ#- #.ل#~م #.لم#^#?#<#> و مش#.#=ل #.لقل#%", "Use": "–#.ل#?و#^م Edema \r\n\r\n–#.ل#.س#?سق#.ء Ascites \r\n\r\n–#.لوذمة #.ل#^ئوية (#.ل#.س#?سق#.ء #.ل#^ئوي) Pulmonary Edema \r\n\r\n–أزمة #<#^#- #_غ#- #.ل#~م Hypertensive Crisis \r\n\r\n–#.#^#?#<#.#> #.ل#_غ#- #~#.خل #.لجمجمة Increased Intracranial Pressure: \r\n\r\n–#<شل #.لقل#% #.ل#.ح#?ش#.ئي - يس#?خ#~م #<ي #>ل#.ج #.ل#?و#^م #.لمص#.ح#% ل#<شل #.لقل#% #.ل#.ح#?ق#.ني \r\n\r\n–#<ي #>ل#.ج #.ل#?و#^م و#.ح#?#%#.س #.لسو#.ئل #.لمص#.ح#% لل#?لي#< #.ل#=#%#~ي أو أم#^#.#_ #.ل#=لى \r\n\r\n–#>ن#~م#. ي#=ون #.لم#^ي#_ #%ح#.جةٍ لم#~#^ لل#%ول ذو #<#>#.لية #=#%ي#^ة \r\n\r\n–قلة #.ل#%ول #~ون #.نس#~#.#~ #<ي مج#^ى #.ل#%ول \r\n\r\n–#.ل#<شل #.ل#=لوي \r\n\r\n–ح#.لة ز#^#.#>ة #.ل#=لى \r\n\r\n–قلة #.ل#%ول \r\n\r\n–#_غ#- #.ل#~م #.لم#^#?#<#> #.لمق#.وم (#.لغي#^ مس#?جي#% لل#>ل#.ج) \r\n\r\n–#<ي #>ل#.ج #.#^#?#<#.#> #_غ#- #.ل#~م وح#~ه أو م#> #.لأ#~وية #.لخ#.#<#_ة ل#_غ#- #.ل#~م #.لم#^#?#<#> #.لأخ#^ى \r\n\r\n–#.لم#^ي#_ #.لذي ل#. يم#=ن #>ل#.ج #.#^#?#<#.#> #_غ#- #~مه #%#.لثي#.ز#.ي#~ غ#.ل#%ً#. ل#. يم#=ن #>ل#.جه #%#.ل#<و#^وسيمي#~ وح#~ه", "Contraindications": "–#<ي ح#.لة #.لحس#.سية لل#<يو#^وز#.مي#~ أو #.لس#.ل#<ون#.مي#~ \r\n\r\n–#<ي ح#.لة #.نق#-#.#> #.ل#%ول", "GI": "Description\t\r\nA benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for edema and chronic renal insufficiency.\r\n\r\nMechanism of action\tFurosemide\r\n a loop diuretic, inhibits water reabsorption in the nephron by blocking the sodium-potassium-chloride cotransporter (NKCC2) in the thick ascending limb of the loop of Henle. This is achieved through competitive inhibition at the chloride binding site on the cotransporter, thus preventing the transport of sodium from the lumen of the loop of Henle into the basolateral interstitium. Consequently, the lumen becomes more hypertonic while the interstitium becomes less hypertonic, which in turn diminishes the osmotic gradient for water reabsorption throughout the nephron. Because the thick ascending limb is responsible for 25% of sodium reabsorption in the nephron, furosemide is a very potent diuretic.", "Composition": "furosemide 20mg or 40mg", "Route": "INJECTION" }, { "ID": "831", "Trade_Name": "VITAPLEX FORTE 20CAPS.", "Generic_Name": "CALCIUM PANTOTHENATE+NICOTINAMIDE+VITAMIN B1+VITAMIN B2+VITAMIN B6+VITAMIN B12", "Price": "3.9", "Price_Old": "3.9", "Company": "KAHIRA", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–يم#~ #.لأ#-#<#.ل #%#.ل#<ي#?#.مين#.#? و #.لم#>#.#~ن و #.ل#>ن#.ص#^ #.له#.مة #.ل#?ى #?س#.#>#~ه #<ى #.لنمو #.لصحى و #?قوية #.ل#>ظ#.م و ظهو#^ #.لأسن#.ن و #?قوية جه#.زه #.لمن#.#>ى . \r\n\r\n–يس#.#>#~ #>لى #<#?ح شهية #.لأ#-#<#.ل #.لذين ي#^#<#_ون #.ل#^#_#.#>ة أو #?ن#.ول #.ل#-#>#.م حيث يس#.#>#~ #>لى #?حسين #>ملية #.له#_م ل#~ى #.لأ#-#<#.ل . \r\n\r\n–يس#.#>#~ #<ى إم#?ص#.ص #=#.#<ة #.ل#>ن#.ص#^ #.لغذ#.ئية من #.ل#-#>#.م و #.لإس#?#<#.#~ه منه#. . \r\n\r\n–يس#.#>#~ #>لى زي#.#~ة #.ل#?#^#=يز ل#~ى #.لأ#-#<#.ل أثن#.ء #.ل#~#^#.سة .", "Contraindications": "–وجو#~ #<#^#- حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء .", "GI": "All vitamins are excreted into milk.\r\nThe doses of all vitamins are above the rda in lactation, but can be used safely although high doses of vit B6 may inhibit lactation.", "Composition": "pantothenate ca. 25mg, vit b1 20mg, vit b12 10mcg, vit b2 10mg, vit b3 60mg, vit b6 10mg", "Route": "ORAL.SOLID" }, { "ID": "832", "Trade_Name": "COVIT 20 CAPS.", "Generic_Name": "CALCIUM PANTOTHENATE+NICOTINAMIDE+VITAMIN B1+VITAMIN B2+VITAMIN B6", "Price": "6.3", "Price_Old": "6.3", "Company": "EIPICO", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–#>ل#.ج و من#> #.نخ#<#.#_ نس#%ة #<ي#?#.مين#.#? “#%” #>ن#~ #.ل#.شخ#.ص #.لذين ي#>#.نو#. من سوء #.ل#?غذية . \r\n\r\n–#.ل#?ه#.#% #.لم#<#.صل . \r\n\r\n–#>ل#.ج #.ل#?نميل و#.لشلل #.لن#.#?ج #>ن #.ل#.#>#?ل#.ل #.ل#>ص#%ي . \r\n\r\n–#>ل#.ج #.ل#.نيمي#. . \r\n\r\n–#>ل#.ج #<ق#^ #.ل#~م . \r\n\r\n–#>ل#.ج م#_#.#>#<#.#? #.لحمل . \r\n\r\n–#>ل#.ج #?س#.ق#- #.لش#>#^ .", "Contraindications": "–وجو#~ #<#^#- حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء .", "GI": "COMING SOON ..", "Composition": "vit b1 20mg, vit b2 10mg, vit b3 60mg, vit b5 25mg, vit b6 10mg", "Route": "ORAL.SOLID" }, { "ID": "833", "Trade_Name": "FOR HAIR AND NAILS 30 CAPS.", "Generic_Name": "CALCIUM PANTOTHENATE+KERATIN+L-CYSTINE+PARA-AMINOBENZOIC ACID+VITAMIN B1+YEAST", "Price": "15", "Price_Old": "15", "Company": "AMOUN", "Pharmacology": "HAIR CARE", "Category": "#.ل#>ن#.ية #%#.لش#>#^", "Use": "–#?س#.ق#- #.لش#>#^. \r\n\r\n–يقوي وينش#- #>ملية #.لأي#_ #.لم#?و#.ج#~ة #%#.لش#>#^. \r\n\r\n–#?غذية #.لش#>#^ وزي#.#~ة م#.#~ة #.ل#=ي#^#.#?ين. \r\n\r\n–يوج#~ #%ه #.ل#=ثي#^ من #.ل#<ي#?#.مين#.#? #.ل#?ي #?س#.#>#~ #>لى #?غذية #.لش#>#^ و#?#-ويله. \r\n\r\n–#?ج#~ي#~ و#?نشي#- خل#.ي#. #.لش#>#^. \r\n\r\n–حم#.ية #.لأظ#.#<#^ من #.ل#?قص#<. \r\n\r\n–نمو #.لأظ#.#<#^. \r\n\r\n–#?أخ#^ ظهو#^ #.لش#>#^ #.لش#.ي#%. \r\n\r\n–#?أخي#^ ظهو#^ #.لش#>#^ #.لأ#%ي#_.", "Contraindications": "–حس#.سية م#<#^#-ة. \r\n\r\n–#>#~م #?ن#.وله خل#.ل شهو#^ #.لحمل. \r\n\r\n–أثن#.ء #.ل#^#_#.#>ة.", "GI": "L-Cystine is a covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Cystine is a chemical substance which naturally occurs as a deposit in the urine, and can form a calculus (hard mineral formation) when deposited in the kidney. The compound produced when two cysteine molecules linked by a disulfide (S-S) bond. Cystine is required for proper vitamin B6 utilization and is also helpful in the healing of burns and wounds, breaking down mucus deposits in illnesses such as bronchitis as well as cystic fibrosis. Cysteine also assists in the supply of insulin to the pancreas, which is needed for the assimilation of sugars and starches. It increases the level of glutathione in the lungs, liver, kidneys and bone marrow, and this may have an anti-aging effect on the body by reducing age-spots etc.", "Composition": "cysteine 20mg, keratin 20mg, pantothenate ca 60mg, para aminobenzoic acid 30mg, vit b1 60mg,yeast 130mg", "Route": "ORAL.SOLID" }, { "ID": "834", "Trade_Name": "FOLIBONIN 30 CAPS.", "Generic_Name": "CARBONYL IRON+FOLIC ACID+ZINC SULPHATE", "Price": "18", "Price_Old": "18", "Company": "EGPI > DKT", "Pharmacology": "ANEMIA.IRON SUPPLEMENT COMBINED WITH FOLIC ACID", "Category": "م#=مل غذ#.ئي ل #.ل#.نيمي#. و #<ق#^ #.ل#~م م#> حم#_ #.ل#<ولي#=", "Use": "–يش#.#^ إليه ل#>ل#.ج أو من#> نقص #.ل#>ن#.ص#^ #.لغذ#.ئية من #.لح#~ي#~ و#<ي#?#.مين#.#? #.ل#?ي ق#~ #?ح#~ث #<ي #%#>#_ #.لح#.ل#.#? #.لصحية (#>لى س#%يل #.لمث#.ل ، #<ق#^ #.ل#~م ، و#.لحمل ، وسوء #.ل#?غذية ، و#.س#?#>#.#~ة #.لج#^#.حة).", "Contraindications": "–#.لحس#.سية #.لم#<#^#-ة لأح#~ م#=ون#.#? #.ل#~و#.ء .", "GI": "COMING SOON ..", "Composition": "Carbonyl iron...50 mg, Folic acid...0.5 mg & Zinc sulphate.7H2O...99 mg (equivalent to zinc sulphate monohydrate 61.8 mg).", "Route": "ORAL.SOLID" }, { "ID": "835", "Trade_Name": "CARBOLASE 375MG 20 CAPS.", "Generic_Name": "CARBOCYSTEINE", "Price": "7.5", "Price_Old": "7.5", "Company": "AMRIYA", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–#>ل#.ج مش#.#=ل #.لجه#.ز #.ل#?ن#<سي #.لمزمنة . \r\n\r\n–مذي#% لل#%لغم ويسهل من #-#^#~ه . \r\n\r\n–ي#>#.لج #<ي ح#.ل#.#? #.لس#>#.ل #.لش#~ي#~ . \r\n\r\n–يس#.#>#~ #<ي ح#.ل#.#? #.لجيو#% #.لأن#<ية #.لح#.#~ منه#. و#.لمزمن . \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.لأذن #.لوس#-ى . \r\n\r\n–يس#?خ#~م #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية مذي#% للمخ#.#- و#.ل#%لغم . \r\n\r\n–#>ل#.ج أم#^#.#_ #.لش#>#% #.لهو#.ئية #.لمزمنة و#.لح#.#~ة . \r\n\r\n–يوص#< من #.لأ#-#%#.ء أحي#.ن#.ً أثن#.ء نزل#.#? #.ل#%#^#~ .", "Contraindications": "–يمن#> #?م#.م#.ً #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لم#^#_ى #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لأح#~ م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.لة #.لإص#.#%ة #%ق#^حة #.لم#>#~ة . \r\n\r\n–يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? #.ل#<شل #.ل#=لوي . \r\n\r\n–يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? قصو#^ وظ#.ئ#< #.ل#=#%#~ . \r\n\r\n–ل#. ي#<#_ل #.س#?#>م#.له من ق#%ل م#^#_ى #.لس#=#^ي .", "GI": "Carbocisteine works by breaking down the mucus that is produced in the lungs. This helps to make the mucus less thick and sticky, so it is easier to cough up.\r\nCarbocisteine can be used to help make mucus less sticky in respiratory tract problems such as bronchitis, chronic obstructive pulmonary disease or cystic fibrosis. Mucus produced in the lungs is also known as sputum or phlegm.\r\nWhat is it used for?\r\nMaking sputum (phlegm) easier to cough up in certain lung conditions, such as those listed below.\r\nChronic obstructive pulmonary disease (COPD).\r\nBronchitis.\r\nCystic fibrosis.", "Composition": "Each 100 ml contains:\r\nActive constituent\r\nCarbocisteine 2.00 g", "Route": "ORAL.SOLID" }, { "ID": "836", "Trade_Name": "COVIT 100 CAPS.", "Generic_Name": "CALCIUM PANTOTHENATE+NICOTINAMIDE+VITAMIN B1+VITAMIN B2+VITAMIN B6", "Price": "11.5", "Price_Old": "11.5", "Company": "EIPICO", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–#>ل#.ج و من#> #.نخ#<#.#_ نس#%ة #<ي#?#.مين#.#? “#%” #>ن#~ #.ل#.شخ#.ص #.لذين ي#>#.نو#. من سوء #.ل#?غذية . \r\n\r\n–#.ل#?ه#.#% #.لم#<#.صل . \r\n\r\n–#>ل#.ج #.ل#?نميل و#.لشلل #.لن#.#?ج #>ن #.ل#.#>#?ل#.ل #.ل#>ص#%ي . \r\n\r\n–#>ل#.ج #.ل#.نيمي#. . \r\n\r\n–#>ل#.ج #<ق#^ #.ل#~م . \r\n\r\n–#>ل#.ج م#_#.#>#<#.#? #.لحمل . \r\n\r\n–#>ل#.ج #?س#.ق#- #.لش#>#^ .", "Contraindications": "–وجو#~ #<#^#- حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء .", "GI": "COMING SOON ..", "Composition": "vit b1 20mg, vit b2 10mg, vit b3 60mg, vit b5 25mg, vit b6 10mg", "Route": "ORAL.SOLID" }, { "ID": "837", "Trade_Name": "MUCOSOL 375MG 20 CAPS.", "Generic_Name": "CARBOCYSTEINE", "Price": "11.75", "Price_Old": "7.5", "Company": "MUP", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–#>ل#.ج مش#.#=ل #.لجه#.ز #.ل#?ن#<سي #.لمزمنة . \r\n\r\n–مذي#% لل#%لغم ويسهل من #-#^#~ه . \r\n\r\n–ي#>#.لج #<ي ح#.ل#.#? #.لس#>#.ل #.لش#~ي#~ . \r\n\r\n–يس#.#>#~ #<ي ح#.ل#.#? #.لجيو#% #.لأن#<ية #.لح#.#~ منه#. و#.لمزمن . \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج ح#.ل#.#? #.لأذن #.لوس#-ى . \r\n\r\n–يس#?خ#~م #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية مذي#% للمخ#.#- و#.ل#%لغم . \r\n\r\n–#>ل#.ج أم#^#.#_ #.لش#>#% #.لهو#.ئية #.لمزمنة و#.لح#.#~ة . \r\n\r\n–يوص#< من #.لأ#-#%#.ء أحي#.ن#.ً أثن#.ء نزل#.#? #.ل#%#^#~ .", "Contraindications": "–يمن#> #?م#.م#.ً #.س#?#>م#.ل #.ل#~و#.ء #<ي #.لم#^#_ى #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة لأح#~ م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–يمن#> #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.لة #.لإص#.#%ة #%ق#^حة #.لم#>#~ة . \r\n\r\n–يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? #.ل#<شل #.ل#=لوي . \r\n\r\n–يحذ#^ #.س#?#>م#.ل #.ل#~و#.ء #<ي ح#.ل#.#? قصو#^ وظ#.ئ#< #.ل#=#%#~ . \r\n\r\n–ل#. ي#<#_ل #.س#?#>م#.له من ق#%ل م#^#_ى #.لس#=#^ي .", "GI": "Carbocisteine works by breaking down the mucus that is produced in the lungs. This helps to make the mucus less thick and sticky, so it is easier to cough up.\r\nCarbocisteine can be used to help make mucus less sticky in respiratory tract problems such as bronchitis, chronic obstructive pulmonary disease or cystic fibrosis. Mucus produced in the lungs is also known as sputum or phlegm.\r\nWhat is it used for?\r\nMaking sputum (phlegm) easier to cough up in certain lung conditions, such as those listed below.\r\nChronic obstructive pulmonary disease (COPD).\r\nBronchitis.\r\nCystic fibrosis.", "Composition": "Carbocisteine\r\nCapsules: each one Capsule contains 375 mg\r\n\r\nAdult Syrup: each 5 ml contains 250 mg\r\n\r\nPediatric Syrup: each 5 ml contains 125 mg", "Route": "ORAL.SOLID" }, { "ID": "838", "Trade_Name": "PANTOGAR 90 CAPS.", "Generic_Name": "CALCIUM PANTOTHENATE+KERATIN+L-CYSTINE+PARA-AMINOBENZOIC ACID+VITAMIN B1+YEAST", "Price": "85.25", "Price_Old": "60", "Company": "MARCYRL CO. > MERZ", "Pharmacology": "HAIR CARE", "Category": "#.ل#>ن#.ية #%#.لش#>#^", "Use": "–#?س#.ق#- #.لش#>#^. \r\n\r\n–يقوي وينش#- #>ملية #.لأي#_ #.لم#?و#.ج#~ة #%#.لش#>#^. \r\n\r\n–#?غذية #.لش#>#^ وزي#.#~ة م#.#~ة #.ل#=ي#^#.#?ين. \r\n\r\n–يوج#~ #%ه #.ل#=ثي#^ من #.ل#<ي#?#.مين#.#? #.ل#?ي #?س#.#>#~ #>لى #?غذية #.لش#>#^ و#?#-ويله. \r\n\r\n–#?ج#~ي#~ و#?نشي#- خل#.ي#. #.لش#>#^. \r\n\r\n–حم#.ية #.لأظ#.#<#^ من #.ل#?قص#<. \r\n\r\n–نمو #.لأظ#.#<#^. \r\n\r\n–#?أخ#^ ظهو#^ #.لش#>#^ #.لش#.ي#%. \r\n\r\n–#?أخي#^ ظهو#^ #.لش#>#^ #.لأ#%ي#_.", "Contraindications": "–حس#.سية م#<#^#-ة. \r\n\r\n–#>#~م #?ن#.وله خل#.ل شهو#^ #.لحمل. \r\n\r\n–أثن#.ء #.ل#^#_#.#>ة.", "GI": "L-Cystine is a covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Cystine is a chemical substance which naturally occurs as a deposit in the urine, and can form a calculus (hard mineral formation) when deposited in the kidney. The compound produced when two cysteine molecules linked by a disulfide (S-S) bond. Cystine is required for proper vitamin B6 utilization and is also helpful in the healing of burns and wounds, breaking down mucus deposits in illnesses such as bronchitis as well as cystic fibrosis. Cysteine also assists in the supply of insulin to the pancreas, which is needed for the assimilation of sugars and starches. It increases the level of glutathione in the lungs, liver, kidneys and bone marrow, and this may have an anti-aging effect on the body by reducing age-spots etc.", "Composition": "One capsule contains L-Cystine 20 mg, Keratin 20 mg, para-aminobenzoic add 20 mg, Sacchcaromyces mad (Vigar-yeast) 100 mg, Vitamin B1 60 mg, Calcium D-Pantothenate 60 mg, Excip.per caps, Colour: E 132 (Indigotine)", "Route": "ORAL.SOLID" }, { "ID": "839", "Trade_Name": "SOLVEX 375MG 20 CAPS.", "Generic_Name": "CARBOXYMETHYLCYSTEINE", "Price": "7", "Price_Old": "7", "Company": "SEDICO", "Pharmacology": "MUCOLYTIC", "Category": "مذي#% لل#%لغم", "Use": "–يس#?خ#~م ل#>ل#.ج #.لح#=ة #.لمصحو#%ة #%#%لغم \r\n\r\n–#>ل#.ج مس#.#>#~ ل#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي . \r\n\r\n–يحسن من وظ#.ئ#< #.لش#>#% #.لهو#.ئية . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية .", "Contraindications": "–ل#. ينصح أثن#.ء #<#?#^ة #.لحمل ح#?ى ل#. يؤث#^ #>لى #.لجنين . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة #.ل#-#%ي#>ية وي#=ون #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–لمن ي#>#.نون من ق#^حة م#>#~ية #.س#?خ#~#.مه #%حذ#^ . \r\n\r\n–يج#% إخ#%#.#^ #.ل#-#%ي#% #<ي ح#.لة وجو#~ مش#.#=ل #<ي #.ل#=#%#~ أو #.ل#=لي ق#%ل #?ن#.ول #.ل#>ق#.#^ . \r\n\r\n–ل#. ينصح #%وص#<ه لل#.#-#<#.ل أقل من #>#.مين #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه لمن ل#~يهم #<#^#- حس#.سية #?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ .", "GI": "Abstract\r\nPrescription of mucoactive drugs for chronic obstructive pulmonary disease (COPD) is increasing. This development in clinical practice arises, at least in part, from a growing understanding of the important role that exacerbation frequency, systemic inflammation and oxidative stress play in the pathogenesis of respiratory disease. S-carboxymethylcysteine (carbocisteine) is the most frequently prescribed mucoactive agent for long-term COPD use in the UK. In addition to its mucoregulatory activity, carbocisteine exhibits free-radical scavenging and anti-inflammatory properties. These characteristics have stimulated interest in the potential that this and other mucoactive drugs may offer for modification of the disease processes present in COPD.", "Composition": "carbocysteine 250mg or 375mg", "Route": "ORAL.SOLID" }, { "ID": "840", "Trade_Name": "BALKIS 8 CAPS.", "Generic_Name": "CHLORPHENIRAMINE+ETILEFRINE", "Price": "6", "Price_Old": "6", "Company": "EIPICO > DOLORGIT", "Pharmacology": "NASAL DECONGESTANT", "Category": "م#-ه#^ للأن#<", "Use": "–نزل#.#? #.ل#%#^#~ وحمى #.لقش. \r\n\r\n–#.ل#?ه#.#% #.لغش#.ء #.لمخ#.#-ى. \r\n\r\n–#%#>#_ #.لأم#^#.#_ #.ل#?ي #?صي#% #.لأن#<.", "Contraindications": "–#.ل#?#>#^#_ ل#.#^#?#<#.#> #<ي #_غ#- #.ل#~م. \r\n\r\n–زي#.#~ة ح#.#~ة #<ي إ#<#^#.ز#.#? #.لغ#~ة #.ل#~#^قية. \r\n\r\n–#<#?#^ة #.لحمل. \r\n\r\n–ي#=ون من #.لأ#<#_ل أس#?ش#.#^ة #.ل#-#%ي#% #>ن#~ ظهو#^ #.ح#~ #.لأ#>#^#.#_ #.لج#.ن#%ية", "GI": "Chlorpheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Chlorpheniramine is used to treat sneezing, itching, watery eyes, and runny nose caused by allergies or the common cold.", "Composition": "chlorpheniramine 2mg, etilefrine 6.7mg syrup\r\nor chlorpheniramine 6mg, etilefrine 20mg capsules", "Route": "ORAL.SOLID" }, { "ID": "841", "Trade_Name": "PROFENAZONE 20 CAPS.", "Generic_Name": "CHLORZOXAZONE+IBUPROFEN", "Price": "12", "Price_Old": "12", "Company": "ADWIA", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–#>ل#.ج #.لص#~#.#> ن#?يجة #.ل#?و#?#^. \r\n\r\n–#.ل#.م #.ل#^ق#%ة و#.لظه#^و#.ل#<ق#^#.#?. \r\n\r\n–ح#.ل#.#? #.ل#.ل#?و#.ء#.#? و#?صل#% #.ل#^ق#%ة. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.ل#?شنج#.#?. \r\n\r\n–#%#.س#- لل#>#_ل#.#? #<ي ح#.ل#.#? #.لش#~ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني من مش#.#=ل #%#?جل#- #.ل#~م. \r\n\r\n–من ي#>#.ني من م#^#_ #.ل#_غ#-. \r\n\r\n–من ي#?ن#.ول #.#~وية سيولة #.ل#~م. \r\n\r\n–من ي#>#.ني من نو#%#.#? #.ل#^#%و. \r\n\r\n–من ي#>#.ني من خلل #%#.لقل#%. \r\n\r\n–من ي#?ن#.ول #.ل#=حولي#.#?.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "Each capsule contains:\r\nActive ingredients:\r\nIbuprofen 200mg.\r\nChlorzoxazone 250mg.", "Route": "ORAL.SOLID" }, { "ID": "842", "Trade_Name": "SMECTA 20% SUSPENSION 90 ML", "Generic_Name": "DIOCTAHEDRAL SMECTITE", "Price": "9", "Price_Old": "9", "Company": "AMRIYA > IPSEN", "Pharmacology": "ANTIDIARRHEAL", "Category": "م#_#.#~ لل#.سه#.ل", "Use": "–#.لإسه#.ل و#.ل#?سمم #.لغذ#.ئي. \r\n\r\n–#.لقيء، و#.لغثي#.ن، و#>س#^ #.له#_م، و#.ل#.ن#?#<#.خ. \r\n\r\n–#.ل#>#~وى #.ل#%#=#?ي#^ية للجه#.ز #.له#_مي. \r\n\r\n–ح#.ل#.#? #.لمغص. \r\n\r\n–#.#_#-#^#.#%#.#? #.لجه#.ز #.له#_مي مثل #.لق#^حة، و#.ل#?ه#.#% #.لم#>#~ة، و#.ل#?ه#.#% #.لم#^يء، و#.ل#?ه#.#% #.لقولون، و#.ل#?ه#.#% #.لم#^#.#^ة.", "Contraindications": "–إذ#. #=ن#? #?#>#.ني من #.ل#?حسس لأي من م#=ون#.#?ه. \r\n\r\n–إذ#. #=ن#? #?#>#.ني من إمس#.#= مزمن. \r\n\r\n–يح#?وي سمي#=#?#. #>لى جلو#=وز وس#=#^وز، وي#<#_ل #>#~م #.س#?خ#~#.مه #<ي ح#.ل#.#? #>#~م #?حمل #.ل#<#^#=#?وز وسوء #.م#?ص#.ص #.لجلو#=وز. \r\n\r\n–إذ#. لم #?خ#?#<ي #.لأ#>#^#.#_ أو #=#.ن#? مُص#.ح#%ة #%حمى وقيء لأ#=ث#^ من 7 أي#.م أوق#< #.ل#~و#.ء و#.س#?ش#^ #.ل#-#%ي#%.", "GI": "Mode Of Action\r\nDioctahedral has adsorbent properties and is used in the management of diarrhoea. Dioctahedral has unique properties that allow for the adsorption of different toxins (such as Rotavirus, E. Coli and Staphylococcus). Dioctahedral interacts with the mucosa increasing its quantity, quality and life span, accelerating the recovery of the infected mucosa.\r\n\r\nIndications\r\nDioctahedral Semctite is primarily indicated in conditions like Diarrhoea, GI diseases, Oesophageal motility disorders.\r\n\r\nDrug Interactions\r\nMay interfere with absorption of other substances when administered simultaneously.", "Composition": "COMING SOON ..", "Route": "ORAL.LIQUID" }, { "ID": "843", "Trade_Name": "DECLOPHEN PLUS 50/250MG 20 CAPS.", "Generic_Name": "CHLORZOXAZONE+DICLOFENAC POTASSIUM", "Price": "12", "Price_Old": "12", "Company": "PHARCO", "Pharmacology": "SKELETAL MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#? #.لهي#=لية", "Use": "–يس#?خ#~م #.ل#~و#.ء #=مس#=ن للألم و#>#.مل خ#.#<#_ للح#^#.#^ة #=م#. أنه يس#?خ#~م ل#>ل#.ج هش#.شة #.ل#>ظ#.م #.لنق#^سي. \r\n\r\n–ي#?م #.س#?خ#~#.م هذ#. #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي، ويس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #%#.ل#.#_#.#<ة #.لي م#>#.لجة #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي. \r\n\r\n–يس#?خ#~م #.ل#~و#.ء #<ي م#>#.لجة #.ل#?ه#.#% #.لأو#?#.#^ و#.لج#^#.#% #=م#. ي#>مل #>لى #?خ#<ي#< #.لألم و#.ل#.ل#?ه#.#%#.#? #%#>#~ #.لج#^#.حة #<ي #.ل#>ين.", "Contraindications": "–يحظ#^ #>لى #.لأشخ#.ص #.لذين ل#~يهم #<#^#- حس#.سية لأح#~ م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^ لل#~و#.ء، ويحذ#^ من #?ن#.ول #.ل#~و#.ء للم#^#_ى #.لذين ي#>#.نون من ق#^حة #.لم#>#~ة أو #.لم#>#~ة. \r\n\r\n–يمن#> #?ن#.وله للم#^#_ى #.لذين ي#?وق#> أن يخ#_#>و#. ج#^#.حة #.لقل#% #.لم#<#?وح، و#=ذل#= #>ل#.ج #.لأشخ#.ص #.لذين ي#>#.نون من #.#_#-#^#.#%#.#? #.لنزي#<. \r\n\r\n–#<ي ح#.لة #.لحمل ي#?م #.س#?خ#~#.مه #<ي ح#.لة أن #.ل#<#.ئ#~ة #.ل#>ل#.جية #?#<وق #.لخ#-#^ #>لى #.لجنين #%#>#~ #.ل#?ش#.و#^ م#> #.ل#-#%ي#% #.لم#>#.لج. \r\n\r\n–#<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية ينصح #%#?جن#% #.ل#>ل#.ج لأن #.ل#~و#.ء يم#^ #<ي حلي#% #.لث#~ي، مم#. يؤ#~ي إلى خ#-#^ #>لى #.ل#-#<ل. \r\n\r\n–#>#~م #.س#?خ#~#.م هذ#. #.ل#~و#.ء من #?لق#.ء ن#<س#= #.ل#. #%#>#~ #.س#?ش#.#^ة #.ل#-#%ي#% #.لمخ#?ص لح#.لة #.لم#^ي#_. \r\n\r\n–#>ن#~ #?ن#.ول أ#~وية أخ#^ي م#> هذ#. #.ل#~و#.ء يج#% #.خ#%#.#^ #.ل#-#%ي#% ح#?ى ل#. يح#~ث #?#<#.#>ل #.لأ#~وية م#> #%#>#_ه#. ويس#%#% ح#~وث م#_#.#>#<#.#? ج#.ن#%ية #_#.#^ة. \r\n\r\n–يج#% #.س#?خ#~#.م هذ#. #.ل#~و#.ء #%حذ#^ للم#^#_ى #.لذين ي#>#.نون من وجو#~ خلل #<ي وظ#.ئ#< #.ل#=لى #.و #.ل#=#%#~ وخ#.صة #=#%#.#^ #.لسن وي#=ونو#. #?ح#? #.لم#^#.ق#%ة #%#.لإ#_#.#<ة إلى #.س#?خ#~#.م ج#^#>#.#? قليلة ح#?ى ل#. #?ؤث#^ #>لى وظ#.ئ#< #.ل#=لى. \r\n\r\n–#>ن#~ #.س#?خ#~#.مه لم#^#_ى #.ل#~م يج#% م#?#.#%#>#?ه #>لى #.ل#~و#.م. \r\n\r\n–#>ن#~ #?ن#.ول هذ#. #.ل#~و#.ء للأشخ#.ص #.لذين #=#.نو#. ي#>#.نون من وجو#~ قصو#^ #<ي #.لقل#% إلى زي#.#~ة #<ي #_غ#- #.ل#~م #>ن#~ #.س#?خ#~#.م #.لأ#~وية #.لم#_#.#~ة لل#.ل#?ه#.#%#.#?. \r\n\r\n–#>ن#~ مل#.حظة وجو#~ #-#<ح جل#~ي يج#% #>#~م #?ن#.ول #.ل#~و#.ء م#^ة أخ#^ى #.ل#. #%#>#~ م#^#.ج#>ة #.ل#-#%ي#% #.لم#>#.لج.", "GI": "About Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "Each capsule contains: \r\nActive Ingredients: \r\nDiclofenac potassium 50 mg\r\nChlorzoxazone 250 mg", "Route": "ORAL.SOLID" }, { "ID": "844", "Trade_Name": "MYOLGIN 250/300 MG 20 CAPS.", "Generic_Name": "CHLORZOXAZONE+PARACETAMOL(ACETAMINOPHEN)", "Price": "16", "Price_Old": "16", "Company": "GLAXO SMITHKLINE", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–ي#>#.لج #?لي#< #.ل#>#_ل#.#?. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #>#^ق #.لنس#.. \r\n\r\n–ي#>#.لج #.ل#.ل#?و#.ء#.#? #%#.لم#<#.صل. \r\n\r\n–مس#=ن ل#.ل#.م #.لظه#^ و#.ل#^ق#%ة. \r\n\r\n–ي#>مل #>لي #?م#~ي#~ #>نق #.ل#^حم. \r\n\r\n–ي#>#.لج #?آ#=ل #.لم#<#.صل و#.ل#<ق#^#.#?. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.لم#<#.صل. \r\n\r\n–#%#.س#- ل#?قلص#.#? و#?شنج#.#? #.ل#>#_ل#.#?. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لن#.#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لقل#% و#.ل#.و#>ية #.ل#~موية. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.ل#=#%#~ و#.ل#=لي. \r\n\r\n–يمن#> #<ي #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "Each capsule contains 250 mg of Chlorzoxazone & 300 mg of Paracetamol", "Route": "ORAL.SOLID" }, { "ID": "845", "Trade_Name": "FLEXOFAN 20 CAPS.", "Generic_Name": "CHLORZOXAZONE+KETOPROFEN", "Price": "13.1", "Price_Old": "11.1", "Company": "AMRIYA", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–مس#=ن لآل#.م #.ل#>#_ل#.#? . \r\n\r\n–#%#.س#- لل#>#_ل#.#? . \r\n\r\n–#>ل#.ج #?قلص#.#? و #?شنج#.#? #.ل#>#_ل#.#? . \r\n\r\n–مس#=ن لآل#.م #.لظه#^ .", "Contraindications": "–#.لحمل و #.ل#^#_#.#>ة : \r\n\r\n–#.لحمل : \r\n\r\n–#.لشهو#^ من 1 إلى 6 : يس#?خ#~م #%حذ#^ #<ى ح#.ل#.#? #.ل#_#^و#^ة #<ق#- و ل#<#?#^ة قصي#^ة و #?ح#? #.ش#^#.#< #.ل#-#%ي#% ( CATEGORY C ) . \r\n\r\n–#.لشهو#^ من 7 إلى 9 : غي#^ أمن للإس#?خ#~#.م ( CATEGORY D ) . \r\n\r\n–#.ل#^#_#.#>ة : غي#^ أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–#?حذي#^#.#? : \r\n\r\n–ل#. يس#?خ#~م للأ#-#<#.ل . \r\n\r\n–ل#. يس#?خ#~م م#> م#^#_ى #.لقل#% حيث #.نه#. #?زي#~ من م#_#.#>#<#.#? #.لأم#^#.#_ #.لقل#%ية . \r\n\r\n–ل#. يس#?خ#~م م#> م#^#_ى ق#^حة #.لم#>#~ة حيث #.نه#. #?زي#~ من أ#>#^#.#_ ق#^حة #.لم#>#~ة . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.لأزمة #.لص#~#^ية و حس#.سية #.لص#~#^ حيث أنه#. #?س#%#% #_يق #<ى #.لش#>#% #.لهو#.ئية . \r\n\r\n–ل#. ي#<#_ل إس#?خ#~#.مه م#> #.لنس#.ء #.للآ#?ى يخ#-#-ن للحمل : ق#~ يس#%#% #_#>#< #.لخصو#%ة . \r\n\r\n–ل#. يس#?خ#~م م#> م#^#_ى #.ل#_غ#- لأنه يزي#~ من #.#^#?#<#.#> #_غ#- #.ل#~م . \r\n\r\n–يس#?خ#~م #%حذ#^ ش#~ي#~ م#> م#^#_ى #.ل#=#%#~ و #.ل#=لى : يج#% #?ظ#%ي#- #.لج#^#>ة #%و#.س#-ة #.ل#-#%ي#% #.لم#>#.لج . \r\n\r\n–ق#~ يس#%#% #~وخة و #.لإحس#.س #%#.لن#>#.س لذل#= يج#% #.لحذ#^ أثن#.ء #.لقي#.#~ة أو #.لقي#.م #%#.لأ#>م#.ل #.لخ#-ي#^ة .", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "Ketoprofen 50 mg\r\nChlorzoxazone 250 mg", "Route": "ORAL.SOLID" }, { "ID": "846", "Trade_Name": "MYOFEN 30 CAPS.", "Generic_Name": "CHLORZOXAZONE+IBUPROFEN", "Price": "27", "Price_Old": "18", "Company": "EVA PHARMA", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–#>ل#.ج #.لص#~#.#> ن#?يجة #.ل#?و#?#^. \r\n\r\n–#.ل#.م #.ل#^ق#%ة و#.لظه#^و#.ل#<ق#^#.#?. \r\n\r\n–ح#.ل#.#? #.ل#.ل#?و#.ء#.#? و#?صل#% #.ل#^ق#%ة. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.ل#?شنج#.#?. \r\n\r\n–#%#.س#- لل#>#_ل#.#? #<ي ح#.ل#.#? #.لش#~ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني من مش#.#=ل #%#?جل#- #.ل#~م. \r\n\r\n–من ي#>#.ني من م#^#_ #.ل#_غ#-. \r\n\r\n–من ي#?ن#.ول #.#~وية سيولة #.ل#~م. \r\n\r\n–من ي#>#.ني من نو#%#.#? #.ل#^#%و. \r\n\r\n–من ي#>#.ني من خلل #%#.لقل#%. \r\n\r\n–من ي#?ن#.ول #.ل#=حولي#.#?.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "Each capsule contains:Active ingredients:\r\nChlorzoxazone 250.0 mg\r\nIbuprofen 200.0 mg", "Route": "ORAL.SOLID" }, { "ID": "847", "Trade_Name": "MYOLAX 20 CAPS.", "Generic_Name": "CHLORZOXAZONE+PARACETAMOL(ACETAMINOPHEN)", "Price": "21", "Price_Old": "14", "Company": "SIGMA > TOP PHARM", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–ي#>#.لج #?لي#< #.ل#>#_ل#.#?. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #>#^ق #.لنس#.. \r\n\r\n–ي#>#.لج #.ل#.ل#?و#.ء#.#? #%#.لم#<#.صل. \r\n\r\n–مس#=ن ل#.ل#.م #.لظه#^ و#.ل#^ق#%ة. \r\n\r\n–ي#>مل #>لي #?م#~ي#~ #>نق #.ل#^حم. \r\n\r\n–ي#>#.لج #?آ#=ل #.لم#<#.صل و#.ل#<ق#^#.#?. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.لم#<#.صل. \r\n\r\n–#%#.س#- ل#?قلص#.#? و#?شنج#.#? #.ل#>#_ل#.#?. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لن#.#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لقل#% و#.ل#.و#>ية #.ل#~موية. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.ل#=#%#~ و#.ل#=لي. \r\n\r\n–يمن#> #<ي #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "chlorzoxazone 250mg+paracetamol 300mg", "Route": "ORAL.SOLID" }, { "ID": "848", "Trade_Name": "MARK FAST 30 CAPS.", "Generic_Name": "CHLORZOXAZONE+IBUPROFEN", "Price": "18", "Price_Old": "18", "Company": "MARCYRL CO.", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–#>ل#.ج #.لص#~#.#> ن#?يجة #.ل#?و#?#^. \r\n\r\n–#.ل#.م #.ل#^ق#%ة و#.لظه#^و#.ل#<ق#^#.#?. \r\n\r\n–ح#.ل#.#? #.ل#.ل#?و#.ء#.#? و#?صل#% #.ل#^ق#%ة. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.ل#?شنج#.#?. \r\n\r\n–#%#.س#- لل#>#_ل#.#? #<ي ح#.ل#.#? #.لش#~ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني من مش#.#=ل #%#?جل#- #.ل#~م. \r\n\r\n–من ي#>#.ني من م#^#_ #.ل#_غ#-. \r\n\r\n–من ي#?ن#.ول #.#~وية سيولة #.ل#~م. \r\n\r\n–من ي#>#.ني من نو#%#.#? #.ل#^#%و. \r\n\r\n–من ي#>#.ني من خلل #%#.لقل#%. \r\n\r\n–من ي#?ن#.ول #.ل#=حولي#.#?.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "849", "Trade_Name": "PARAFON 250/300 18 CAPS.", "Generic_Name": "CHLORZOXAZONE+PARACETAMOL(ACETAMINOPHEN)", "Price": "18", "Price_Old": "18", "Company": "MINA PHARM > JANSSEN CILAG", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–ي#>#.لج #?لي#< #.ل#>#_ل#.#?. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #>#^ق #.لنس#.. \r\n\r\n–ي#>#.لج #.ل#.ل#?و#.ء#.#? #%#.لم#<#.صل. \r\n\r\n–مس#=ن ل#.ل#.م #.لظه#^ و#.ل#^ق#%ة. \r\n\r\n–ي#>مل #>لي #?م#~ي#~ #>نق #.ل#^حم. \r\n\r\n–ي#>#.لج #?آ#=ل #.لم#<#.صل و#.ل#<ق#^#.#?. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.لم#<#.صل. \r\n\r\n–#%#.س#- ل#?قلص#.#? و#?شنج#.#? #.ل#>#_ل#.#?. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لن#.#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لقل#% و#.ل#.و#>ية #.ل#~موية. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.ل#=#%#~ و#.ل#=لي. \r\n\r\n–يمن#> #<ي #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "1 capsule contains: Chlorzoxazone 250 mg and Paracetamol 300 mg", "Route": "ORAL.SOLID" }, { "ID": "850", "Trade_Name": "RHEUMAMAX 100MG 10 CAPS.", "Generic_Name": "CELECOXIB", "Price": "19.2", "Price_Old": "19.2", "Company": "HI-PHARM", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "851", "Trade_Name": "MEPADRIN 1 GM 10CAPS.", "Generic_Name": "CEPHRADINE", "Price": "14.4", "Price_Old": "14.4", "Company": "CHEMIPHARM", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.ل#.ول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي و#.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#>#~وي #.لجل#~ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمج#^ي #.ل#%ولي و#.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#=لى. \r\n\r\n–#.لوق#.ية من #.ل#>#~وى #%#>#~ إج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#>#.لة #%#.ل#~و#.ء م#.#~و سي#<#^#.#~ين. \r\n\r\n–لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لم#_#.#~#.#? #.لحيوية #.ل#?ي #?ن#?مي إلى #.ل#%نسيللين. \r\n\r\n–يج#% #?وخي #.لحذ#^ #>ن#~ إ#>#-#.ئه للأ#-#<#.ل ل#.ح#?و#.ئه #>لى م#.#~ة أ#^جينين. \r\n\r\n–#.لحمل: يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل إل#. أذ#. ق#^#^ #.ل#-#%ي#% #.لم#>#.لج #>#=س ذل#=. \r\n\r\n–#.ل#^#_#.#>ة: أث#%#?#? #.ل#~#^#.س#.#? أن #.لم#.#~ة #.ل#<#>#.لة لل#~و#.ء #?ن#?قل إلى #.ل#^#_ي#> #>#%#^ حلي#% #.لث#~ي ولذل#= يحذ#^ #.س#?خ#~#.مه أثن#.ء #.ل#^#_#.#>ة.", "GI": "Description\t\r\nA semi-synthetic cephalosporin antibiotic.\r\n\r\nMechanism of action\tCefradine\r\n is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Cefradine, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Cefradine interferes with an autolysin inhibitor.", "Composition": "cephradine 125mg or 250mg or 1gm", "Route": "ORAL.SOLID" }, { "ID": "852", "Trade_Name": "CELOXIB 200MG 10 CAPS.", "Generic_Name": "CELECOXIB", "Price": "28.8", "Price_Old": "28.8", "Company": "SEDICO", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "celecoxib 100mg", "Route": "ORAL.SOLID" }, { "ID": "853", "Trade_Name": "ARYTHREX 200MG 20 CAPS.", "Generic_Name": "CELECOXIB", "Price": "72", "Price_Old": "48", "Company": "AMOUN", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "Each capsule contains:\r\nCelecoxib 200 mg.", "Route": "ORAL.SOLID" }, { "ID": "854", "Trade_Name": "VELOSEF 500MG 16 CAPS.", "Generic_Name": "CEPHRADINE", "Price": "36", "Price_Old": "24", "Company": "SMITHKLINE BEECHAM > GLAXO SMITHKLINE", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.ل#.ول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي و#.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#>#~وي #.لجل#~ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمج#^ي #.ل#%ولي و#.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#=لى. \r\n\r\n–#.لوق#.ية من #.ل#>#~وى #%#>#~ إج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#>#.لة #%#.ل#~و#.ء م#.#~و سي#<#^#.#~ين. \r\n\r\n–لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لم#_#.#~#.#? #.لحيوية #.ل#?ي #?ن#?مي إلى #.ل#%نسيللين. \r\n\r\n–يج#% #?وخي #.لحذ#^ #>ن#~ إ#>#-#.ئه للأ#-#<#.ل ل#.ح#?و#.ئه #>لى م#.#~ة أ#^جينين. \r\n\r\n–#.لحمل: يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل إل#. أذ#. ق#^#^ #.ل#-#%ي#% #.لم#>#.لج #>#=س ذل#=. \r\n\r\n–#.ل#^#_#.#>ة: أث#%#?#? #.ل#~#^#.س#.#? أن #.لم#.#~ة #.ل#<#>#.لة لل#~و#.ء #?ن#?قل إلى #.ل#^#_ي#> #>#%#^ حلي#% #.لث#~ي ولذل#= يحذ#^ #.س#?خ#~#.مه أثن#.ء #.ل#^#_#.#>ة.", "GI": "Description\t\r\nA semi-synthetic cephalosporin antibiotic.\r\n\r\nMechanism of action\tCefradine\r\n is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Cefradine, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Cefradine interferes with an autolysin inhibitor.", "Composition": "Velosef 250 mg, 500mg capsules hard\r\nEach hard capsule contains 250 mg or 500 mg of Cephradine.\r\n\r\nVelosef 1 g tablets\r\nEach tablet contains 1 g of Cephradine .\r\n\r\nVelosef 250 mg/5 ml powder for oral suspension\r\n\r\nEach 5 ml of oral suspension after constitution c", "Route": "ORAL.SOLID" }, { "ID": "855", "Trade_Name": "VELOSEF 250MG 12 CAPS. (CANCELLED)", "Generic_Name": "CEPHRADINE", "Price": "9", "Price_Old": "9", "Company": "SMITHKLINE BEECHAM > GLAXO SMITHKLINE", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.ل#.ول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي و#.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#>#~وي #.لجل#~ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمج#^ي #.ل#%ولي و#.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#=لى. \r\n\r\n–#.لوق#.ية من #.ل#>#~وى #%#>#~ إج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#>#.لة #%#.ل#~و#.ء م#.#~و سي#<#^#.#~ين. \r\n\r\n–لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لم#_#.#~#.#? #.لحيوية #.ل#?ي #?ن#?مي إلى #.ل#%نسيللين. \r\n\r\n–يج#% #?وخي #.لحذ#^ #>ن#~ إ#>#-#.ئه للأ#-#<#.ل ل#.ح#?و#.ئه #>لى م#.#~ة أ#^جينين. \r\n\r\n–#.لحمل: يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل إل#. أذ#. ق#^#^ #.ل#-#%ي#% #.لم#>#.لج #>#=س ذل#=. \r\n\r\n–#.ل#^#_#.#>ة: أث#%#?#? #.ل#~#^#.س#.#? أن #.لم#.#~ة #.ل#<#>#.لة لل#~و#.ء #?ن#?قل إلى #.ل#^#_ي#> #>#%#^ حلي#% #.لث#~ي ولذل#= يحذ#^ #.س#?خ#~#.مه أثن#.ء #.ل#^#_#.#>ة.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "856", "Trade_Name": "CELECOX 200MG 10 CAPS.", "Generic_Name": "CELECOXIB", "Price": "25.8", "Price_Old": "25.8", "Company": "MEMPHIS", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "celecoxib 200mg", "Route": "ORAL.SOLID" }, { "ID": "857", "Trade_Name": "CEFADRIN 500MG 12CAPS.", "Generic_Name": "CEPHRADINE", "Price": "11", "Price_Old": "11", "Company": "T3A PHARMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.ل#.ول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#%#.#? #.لجيو#% #.لأن#<ية و#.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي و#.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#>#~وي #.لجل#~ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئوي. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمج#^ي #.ل#%ولي و#.لمث#.نة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.ل#=لى. \r\n\r\n–#.لوق#.ية من #.ل#>#~وى #%#>#~ إج#^#.ء #.ل#>ملي#.#? #.لج#^#.حية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من #<#^#- حس#.سية #.#?ج#.ه #.لم#.#~ة #.ل#<#>#.لة #%#.ل#~و#.ء م#.#~و سي#<#^#.#~ين. \r\n\r\n–لمن ي#>#.نون من حس#.سية #.#?ج#.ه #.لم#_#.#~#.#? #.لحيوية #.ل#?ي #?ن#?مي إلى #.ل#%نسيللين. \r\n\r\n–يج#% #?وخي #.لحذ#^ #>ن#~ إ#>#-#.ئه للأ#-#<#.ل ل#.ح#?و#.ئه #>لى م#.#~ة أ#^جينين. \r\n\r\n–#.لحمل: يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.لحمل إل#. أذ#. ق#^#^ #.ل#-#%ي#% #.لم#>#.لج #>#=س ذل#=. \r\n\r\n–#.ل#^#_#.#>ة: أث#%#?#? #.ل#~#^#.س#.#? أن #.لم#.#~ة #.ل#<#>#.لة لل#~و#.ء #?ن#?قل إلى #.ل#^#_ي#> #>#%#^ حلي#% #.لث#~ي ولذل#= يحذ#^ #.س#?خ#~#.مه أثن#.ء #.ل#^#_#.#>ة.", "GI": "Description\t\r\nA semi-synthetic cephalosporin antibiotic.\r\n\r\nMechanism of action\tCefradine\r\n is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Cefradine, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins- it is possible that Cefradine interferes with an autolysin inhibitor.", "Composition": "cephradine 1000mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "858", "Trade_Name": "CELEBREX 200MG 15 CAPS.", "Generic_Name": "CELECOXIB", "Price": "113.5", "Price_Old": "81", "Company": "PFIZER", "Pharmacology": "NSAID.SELECTIVE COX-2 INHIBITORS", "Category": "م#_#.#~#.#? #.ل#.ل#?ه#.#% غي#^ #.لس#?ي#^وئي#~ية م#> م#_#.#~ لل#^وم#.#?يزم م#> مس#=ن", "Use": "–يس#?خ#~م مس#=ن #>#.م لآل#.م #.لجسم . \r\n\r\n–ي#>#.لج #.ل#?ه#.#% #.لم#<#.صل #.ل#^وم#.#?وي#~ي . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لم#<#.صل #.ل#?ن#=سي . \r\n\r\n–يس#=ن من آل#.م #>س#^ #.ل#-مث . \r\n\r\n–مس#=ن لآل#.م #.لص#~#.#> . \r\n\r\n–يخ#<#< من #.ل#?و#^م#.#?. \r\n\r\n–يخ#<#< من #.ل#?ه#.#% #.لأسن#.ن و#.للثة . \r\n\r\n–يس#=ن آل#.م #.لأسن#.ن . \r\n\r\n–يس#?خ#~م #<ي #.ل#?خ#<ي#< من آل#.م #.لن#.#?ج #>ن هش#.شة #.ل#>ظ#.م . \r\n\r\n–ي#>#.لج #.ل#?ه#.#%#.#? #.ل#>مو#~ #.ل#<ق#^ي ويخ#<#< من آل#.مه . \r\n\r\n–يخ#<#< من آل#.م #.لظه#^ .", "Contraindications": "–ل#. يج#% #?ن#.وله لمن ي#>#.نون من #^#~ #<#>ل #?حسسي #.#?ج#.ه #?#^#=ي#%ة #.ل#>ق#.#^ . \r\n\r\n–لمن ي#>#.نون من نزي#< م#>#~ي. \r\n\r\n–ل#. يس#?خ#~م لمن ي#>#.نون من ق#^حة ه#_مية . \r\n\r\n–يس#?خ#~م #%حذ#^ ل#=#%#.#^ #.لسن حيث ي#=ونو#. أ#=ث#^ #>#^#_ة لظهو#^ #.لأ#>#^#.#_ #.لج#.ن#%ية . \r\n\r\n–يمن#> لمن ي#>#.نون من #<شل #=لوي . \r\n\r\n–هذ#. #.ل#~و#.ء من #.لأ#~وية #.لغي#^ أمنة #>لى #.لم#^أة #.لح#.مل . \r\n\r\n–ينصح #%#?جن#% #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? أثن#.ء #<#?#^ة #?ن#.ول #.ل#>ق#.#^ حيث إنه يس#%#% #.لن#>#.س . \r\n\r\n–ل#. يوص#< للأ#-#<#.ل أقل من 16 #>#.م .", "GI": "About Celecoxib\r\nNon-steroidal anti inflammatory drug (NSAID) ,COX-2 Selective inhibitor, Anti-inflammatory Agent.\r\n\r\nMechanism of Action of Celecoxib\r\nThis inhibits prostaglandin synthesis peripherally by selective noncompetitive inhibition of cyclooxygenase-2 (COX-2) enzyme. It binds with its polar sulfonamide side chain to a hydrophilic side pocket region close to the active COX-2 binding site (Both COX-1 and COX-2 catalyze the conversion of arachidonic acid to prostaglandin (PG) H2, the precursor of PGs and thromboxane). This results its anti-inflammatory action\r\n\r\nIndications for Celecoxib\r\n1. Osteoarthritis \r\n2. Rheumatoid arthritis \r\n3. Acute gout \r\n\r\nContra-indications of Celecoxib\r\n1. Hypersensitivity to celecoxib \r\n2. Allergic type reactions to sulphonamides /aspirin or other NSAIDs.", "Composition": "celecoxib 100mg, 200mg", "Route": "ORAL.SOLID" }, { "ID": "859", "Trade_Name": "ALLERCET COLD 10 CAPS.", "Generic_Name": "CETIRIZINE+PARACETAMOL(ACETAMINOPHEN)+PSEUDOEPHEDRINE", "Price": "15", "Price_Old": "10", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY.COMBINED WITH VASOCONSTRICTOR AGENT PLUS PARACETAMOL", "Category": "م#_#.#~ للحس#.سية", "Use": "–#.لص#~#.#> و#.ل#>#-س ونزل#.#? #.ل#%#^#~ #.لموسمية. \r\n\r\n–ح#.ل#.#? #.ل#%#^#~ و#.لز#=#.م و#.ح#?ق#.ن #.لأن#<. \r\n\r\n–حس#.سية #.لأن#< و#.لحس#.سية #.لموسمية. \r\n\r\n–#.لأم#^#.#_ #.لموسمية #.ل#?ي #?#=ون س#%#%#. #<ي #.ح#?ق#.ن #.ل#.ن#< و#?ز#.ي#~ إ#<#^#.ز #.ل#~مو#> #<ي #.ل#>ين. \r\n\r\n–#>ل#.ج #?و#^م #.لأن#<. \r\n\r\n–ص#>و#%ة #.ل#?ن#<س من #.لأن#< ن#?يجة #.ح#?ق#.ن #.لجيو#% #.لأن#<ية. \r\n\r\n–#.لص#~#.#> و#.لآل#.م #.ل#%سي#-ة لأنه يح#?وي #>لى #.ل#%#.#^#.سي#?#.مول #.لمس#=ن.", "Contraindications": "–ح#.لة #.#^#?#<#.#> #_غ#- #.ل#~م أو #.ل#.#_#-#^#.#%#.#? #.لقل#%ية. \r\n\r\n–#.لحمل . \r\n\r\n–#.ل#^#_#.#>ة . \r\n\r\n–ذل#= #.ل#>ل#.ج يس#%#% #.ل#^#=و#~ و#.لن#>#.س لهذ#. #<هو غي#^ آمن لل#>#.ملين #>لى #.لآل#.#? #.لخ#-#^ة و#.لس#.ئقين. \r\n\r\n–#<#^#- #.لحس#.سية ل#.ى من م#=ون#.#? هذ#. #.لمس#?ح#_#^", "GI": "About Cetirizine\r\nSecond Generation H1 Antagonist, Metabolite of hydroxyzine, Antihistamine.\r\nMechanism of Action of Cetirizine\r\nThis drug is a selective peripheral H1 receptor antagonist. Thus it inhibits the allergic symptoms produced by histamines like cold, rhinorrhea, sneezing, urticaria etc. The drug has some mast cell stabilizing properties. It also inhibit eotaxin-induced eosinophil TEM through both dermal and lung micro vascular endothelial cells. So inhibit eosinophil chemotaxis and also inflammation caused by it.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "860", "Trade_Name": "DURICEF 250MG 8CAPS.", "Generic_Name": "CEFADROXIL", "Price": "7.9", "Price_Old": "7.9", "Company": "SMITHKLINE BEECHAM", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cefadroxil 100mg or 124mg or 250mg or 500mg or 1gm", "Route": "ORAL.SOLID" }, { "ID": "861", "Trade_Name": "CEPHLEX 250 MG 12 CAPS.", "Generic_Name": "CEFALEXIN", "Price": "9", "Price_Old": "9", "Company": "KAHIRA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "862", "Trade_Name": "CEPHALEXIN 250MG 12CAPS. B.P.2000", "Generic_Name": "CEFALEXIN", "Price": "5.28", "Price_Old": "5.28", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cephalexin 500mg", "Route": "ORAL.SOLID" }, { "ID": "863", "Trade_Name": "IBIDROXIL 500 MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "20", "Price_Old": "13.2", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "Each hard capsule contains Cefadroxil monohydrate equivalent to 250 or 500 mg cefadroxil anhydrous.\r\n\r\nEach coated tablet contains Cefadroxil monohydrate equivalent to 1 gm cefadroxil anhydrous.\r\n\r\nEach 5 ml of dry powder after reconstitution contains Cefadro", "Route": "ORAL.SOLID" }, { "ID": "864", "Trade_Name": "CEFLODIX 500 MG 12 CAPS.", "Generic_Name": "CEFALEXIN", "Price": "9", "Price_Old": "9", "Company": "ARAB CAPS > PHAROPHARMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "865", "Trade_Name": "HERBA CAF SYRUP 80 ML", "Generic_Name": "GUAVA LEAVES+TILIA FLOWER+FENNEL OIL+LIQUORICE", "Price": "15.3", "Price_Old": "15.3", "Company": "AVERROES PHARMA-EGYPT", "Pharmacology": "COUGH DRUGS", "Category": "م#_#.#~ لل#=حة", "Use": "–#?حسين وظ#.ئ#< #.لجه#.ز #.ل#?ن#<سي \r\n\r\n–مه#~ئ لل#=حة \r\n\r\n–مذي#% لل#%لغم", "Contraindications": "–ل#. يس#?خ#~م للأ#-#<#.ل أقل من 4 سنو#.#? \r\n\r\n– إل#?ه#.#% #<ي #.لجه#.ز #.ل#%ولي و#.لجه#.ز #.له#_مي \r\n\r\n–#.#_#-#^#.#%#.#? #<ي #.لغ#~ة #.ل#~#^قية \r\n\r\n–له #?أثي#^ ملين #<ي #.لج#^#>#.#? #.ل#>#.لية نظ#^#.ً لآح#?و#.ئه #>لي سو#^#%ي#?ول \r\n\r\n– #.لحو#.مل و#.ل#.مه#.#? #.لم#^#_#>#.#? \r\n\r\n–م#~ة #.ل#>ل#.ج ل#. #?زي#~ #>ن #.س#%و#> ويج#% #.ن أل#. #?قل #.ل#<#?#^ة #.لزمنية #%ين #.لج#^#>#.#? #>ن 4 س#.#>#.#?", "GI": "COMING SOON ..", "Composition": "fennel 7.8mg, guava leaves 50mg, tilia flowers 15.6mg", "Route": "ORAL.LIQUID" }, { "ID": "866", "Trade_Name": "CEPHALEXCID 250MG 12CAPS.", "Generic_Name": "CEFALEXIN", "Price": "6.43", "Price_Old": "6.43", "Company": "CID", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "867", "Trade_Name": "KEFLEX 250 MG 12 CAP.", "Generic_Name": "CEFALEXIN", "Price": "10.55", "Price_Old": "10.55", "Company": "EPCI", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "KEFLEX 1gm tablets : Each tablet contains Cephalexin monohydrate eq. to Cephalexin ... 1gm. \r\n\r\nKEFLEX 500 tablets : Each tablet contains Cephalexin monohydrate eq. to Cephalexin ... 500mg. \r\n\r\nKEFLEX 250 capsules : Each capsule contains Cephalexin monohydrat", "Route": "ORAL.SOLID" }, { "ID": "868", "Trade_Name": "LONGICEF 500 MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "9", "Price_Old": "9", "Company": "KAHIRA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cefadroxil 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "869", "Trade_Name": "CEPHALEXIN 500MG 12 CAPS B.P.2007", "Generic_Name": "CEFALEXIN", "Price": "13.2", "Price_Old": "13.2", "Company": "SHIFA MEDICAL PRODUCTS > OCTOBER PHARMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#%#.#? #.لأذن #.لوس#-ي. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل و#.ل#>ظ#.م. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%#^وس#?#.#?#. #.لمزمن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.للثة. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>#_#.ء #.ل#?ن#.سلية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لش#>#% #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجه#.ز #.ل#?ن#<سي.", "Contraindications": "–يحذ#^ لمن ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #.ل#~#.خلة #<ي #.ل#>ق#.#^. \r\n\r\n–يحذ#^ أثن#.ء #<#?#^ة #.لحمل حيث يؤث#^ #>لى صحة #.لجنين. \r\n\r\n–يج#% #.ل#.م#?ن#.#> #>ن #.ل#^#_#.#>ة م#> #?ن#.ول #.ل#>ق#.#^ حيث ين#?قل #.لم#.#~ة #.ل#<#>#.لة م#> حلي#% #.لأم ويؤث#^ #>لى صحة #.ل#^#_ي#>. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه #<ي ح#.لة وجو#~ #?#.#^يخ م#^#_ي #?حسسي #?ج#.ه أ#~وية #.لسي#<#.ل#=سين و#.ل#%نسيلين. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%إسه#.ل ح#.#~ و#.#^#?#<#.#> #<ي #~#^جة #.لح#^#.#^ة. \r\n\r\n–#<ي ح#.لة #>مل أخ#?#%#.#^#.#? #<ي #.ل#%ول و#.ل#~م يج#% إخ#%#.#^ #.ل#-#%ي#%. \r\n\r\n–يحذ#^ لمن ي#>#.نون من خلل #<ي وظ#.ئ#< #.ل#=لي. \r\n\r\n–يمن#> #.س#?خ#~#.مه لم#^#_ي #.ل#=#%#~.", "GI": "About Cefalexin\r\nA first-generation cephalosporin antibiotic.\r\n\r\nMechanism of Action \r\nCephalexin is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cephalexin inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cephalexin \r\n\r\nIndications for Cefalexin\r\n1.Respiratory tract infections \r\n2.Urinary tract infections \r\n3.Surgical prophylaxis \r\n4.Skin infections` \r\n5.Joint & bone infections \r\n6.Otitis media` \r\n7.Reproductive tract infections` \r\n\r\nContra-indications\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cephalexin 500mg", "Route": "ORAL.SOLID" }, { "ID": "870", "Trade_Name": "ALLERCET 20 CAPS", "Generic_Name": "CETIRIZINE+PSEUDOEPHEDRINE", "Price": "18", "Price_Old": "18", "Company": "GLOBAL NAPI PHARMACEUTICALS", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY.COMBINED WITH VASOCONSTRICTOR AGENT", "Category": "م#_#.#~ للحس#.سية", "Use": "–#>ل#.ج #.ح#?ق#.ن #.ل#.ن#< و#.لجيو#% #.ل#.ن#<ية . \r\n\r\n–ي#>#.لج #.#>#^#.#_ #.ل#%#^#~ من #>#-س ، سيل#.ن ، #^شح ، ز#=#.م . \r\n\r\n–#>ل#.ج #.ح#?ق#.ن #.لحلق . \r\n\r\n–#>ل#.ج حس#.سية #.ل#>ين . \r\n\r\n–#>ل#.ج #.لح#=ة #.لجل#~ية . \r\n\r\n–#>ل#.ج #.ل#^م#~ #.ل#^#%ي#>ي . \r\n\r\n–#>ل#.ج #.ل#.#=زيم#. و#.لص#~#<ية .", "Contraindications": "–من ي#>#.ني #<#^#- حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–من ي#>#.ني #.#^#?#<#.#> #<ي #_غ#- #.ل#~م . \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لش#^ي#.ن #.ل#?#.جي .", "GI": "is a combination of cetirizine, an antihistamine that reduces the natural chemical histamine in the body, and pseudoephedrine, a decongestant that shrinks blood vessels in the nasal passages. It is used to treat cold or allergy symptoms such as nasal and sinus congestion, sneezing, itching, watery eyes, or runny nose. It is taken orally in tablet form. Possible side effects can include dry mouth, dizziness, drowsiness, tiredness, ringing in the ears, or problems with concentration.\r\n\r\nIt is not known whether cetirizine and pseudoephedrine is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. Cetirizine and pseudoephedrine can pass into breast milk and may harm a nursing baby.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "871", "Trade_Name": "CHLORAMPHENICOL 250 MG 12 CAPS. B.P93", "Generic_Name": "CHLORAMPHENICOL", "Price": "4.5", "Price_Old": "4.5", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIBIOTIC", "Category": "م#_#.#~ حيوي", "Use": "–يس#?خ#~م #<ي #>ل#.ج إص#.#%#.#? #.ل#>ين و#.لأجز#.ء #.لمحي#-ة مثل #.لمل#?حمة و#.لق#^نية #.ل#?ي #?س#%#%ه#. #.ل#%#=#?ي#^ي#. #.لحس#.سية لل#=لو#^#.م#<يني#=ول . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ين مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية . \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~ . \r\n\r\n–#>ل#. #.ل#>#~وى #.لح#.#~ة #%#.لس#.لمونيل#. . \r\n\r\n–#>ل#.ج #>#~وي #.لأغشية #.لسح#.ئية #.لن#.#?جة #>ن مي#=#^و#% هيمو#<يلس إن#<لونز#. . \r\n\r\n–#>#~وي #.ل#^#=#?سي#. . \r\n\r\n–#>ل#.ج #>#~وى #.لمي#=#^و#%#.#? س#.ل#%ة #.لج#^#.م و #.لمي#=#^و#%#.#? #.لل#.هو#.ئية . \r\n\r\n–#>ل#.ج #>#~وي أس#<ل #.لحج#.#% #.لح#.جز . \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لمي#=#^و#%#.#? #.لغي#^ حس#.سة للم#_#.#~#.#? #.لحيوية #.لأخ#^ى .", "Contraindications": "–ل#. يج#% #.س#?خ#~#.مه لمن ي#>#.نون من حس#.سية #?ج#.ه #=لو#^#.م#<يني#=ول . \r\n\r\n–ل#. ينصح #%#.س#?خ#~#.مه لمن ي#>#.نون من #>#~وى #.ل#_#>ي#<ة مثل ح#.ل#.#? #.ل#%#^#~ و#.ل#.ن#<لونز#.. \r\n\r\n–يحظ#^ #.س#?خ#~#.م #.ل#=لو#^#.م#<يني#=ول أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يج#% #?جن#% #.س#?خ#~#.مi لم#~ة #-ويلة أو ي#?م #?#=#^#.#^ #.ل#>ل#.ج #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–يج#% خ#<#_ #.لج#^#>ة لمن ي#>#.نون من قصو#^ #<ي #.ل#=لى أو #.ل#=#%#~ . \r\n\r\n–يج#% #>مل #<حوص#.#? لل#~م #~و#^ية أثن#.ء #<#?#^ة #.ل#>ل#.ج . \r\n\r\n–للأ#-#<#.ل ح#~يثي #.لول#.#~ة يج#% قي#.س #?#^#=يز #.ل#=لو#^#.م#<يني#=ول #<ي #.ل#~م #%ش#=ل #~و#^ي . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه #=#>ل#.ج #^و#?يني لمن ي#>#.نون من م#^#_ #.ل#?ي#<و#~ .", "GI": "Description\t\r\nAn antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic.\r\n\r\nIndication\r\nUsed in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.\r\n\r\nMechanism of action\r\nChloramphenicol is lipid-soluble, allowing it to diffuse through the bacterial cell membrane. It then reversibly binds to the L16 protein of the 50S subunit of bacterial ribosomes, where transfer of amino acids to growing peptide chains is prevented (perhaps by suppression of peptidyl transferase activity), thus inhibiting peptide bond formation and subsequent protein synthesis.", "Composition": "chloramphenicol 250mg", "Route": "ORAL.SOLID" }, { "ID": "872", "Trade_Name": "HEPARSAN 30 CAPS.", "Generic_Name": "CHELIDONIUM RHIZOME EXTRACT+CURCUMA EXTRACT+CURCUMA OIL", "Price": "28.8", "Price_Old": "28.8", "Company": "ATOS PHARMA", "Pharmacology": "ANTIOXIDANT", "Category": "م#_#.#~#.#? للأ#=س#~ة", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لم#<#.صل. \r\n\r\n–حم#.ية و#?نشي#- خل#.ي#. #.ل#=#%#~. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? و#?ق#^ح#.#? #.لم#>#~ة. \r\n\r\n–#>ل#.ج #.ل#.ل#?ه#.#%#.#? #.ل#%#=#?ي#^ية و#.ل#<ي#^وسية. \r\n\r\n–#>ل#.ج #.#^#?#<#.#> #.ل#=وليس#?#^ول و#.ل#~هون #.لثل#.ثية #<ي #.ل#~م.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي م#=ون من م#=ون#.#? #.ل#~و#.ء.", "GI": "Properties and actions:\r\nHeparsan has an antioxidant activity as it contains curcumin which protects the liver against exogenous toxins. Curcumin also proved, in studies, to suppress hepatic stellate cells and decrease fibrosis which may delay fibrosis in chronic liver diseases.\r\nIt has an anti-inflammatory activity due to isoquinoline alkaloids in chelidonium- its curcumin content inhibits prostaglandins while the volatile oils suppress acute edema by inhibition of hyaluronidase enzyme.\r\nHeparsan has a choleretic effect, which stimulates production of bile and pancreatic digestive enzymes that improves dyspepsia. It also has a cholecystokinetic effect.\r\nThe alkaloids in chelidonium and curcumin in curcuma relieve the spasm and stimulate the under-active gallbladder, that help in biliary dyskinesia, cholecystitis, and gallstones. \r\n\r\nIndications:\r\n-Liver support in chronic liver diseases\r\n-Biliary dysfunction (gallstones, cholecys titis, biliary dyskinesia)\r\n-Dyspepsia and indigestion.", "Composition": "Each soft gelatin capsule contains:\r\nDry extract chelidonium majus 100 mg\r\nDry extract of curcuma xanthorrhizae 60 mg\r\nCurcuma xanthorrhizae oil 10 mg", "Route": "ORAL.SOLID" }, { "ID": "873", "Trade_Name": "CLEAREST 14 CAPS.", "Generic_Name": "CETIRIZINE+PSEUDOEPHEDRINE", "Price": "21", "Price_Old": "14", "Company": "CHEMIPHARM", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY.COMBINED WITH VASOCONSTRICTOR AGENT", "Category": "م#_#.#~ للحس#.سية", "Use": "–#>ل#.ج #.ح#?ق#.ن #.ل#.ن#< و#.لجيو#% #.ل#.ن#<ية . \r\n\r\n–ي#>#.لج #.#>#^#.#_ #.ل#%#^#~ من #>#-س ، سيل#.ن ، #^شح ، ز#=#.م . \r\n\r\n–#>ل#.ج #.ح#?ق#.ن #.لحلق . \r\n\r\n–#>ل#.ج حس#.سية #.ل#>ين . \r\n\r\n–#>ل#.ج #.لح#=ة #.لجل#~ية . \r\n\r\n–#>ل#.ج #.ل#^م#~ #.ل#^#%ي#>ي . \r\n\r\n–#>ل#.ج #.ل#.#=زيم#. و#.لص#~#<ية .", "Contraindications": "–من ي#>#.ني #<#^#- حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–من ي#>#.ني #.#^#?#<#.#> #<ي #_غ#- #.ل#~م . \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لش#^ي#.ن #.ل#?#.جي .", "GI": "is a combination of cetirizine, an antihistamine that reduces the natural chemical histamine in the body, and pseudoephedrine, a decongestant that shrinks blood vessels in the nasal passages. It is used to treat cold or allergy symptoms such as nasal and sinus congestion, sneezing, itching, watery eyes, or runny nose. It is taken orally in tablet form. Possible side effects can include dry mouth, dizziness, drowsiness, tiredness, ringing in the ears, or problems with concentration.\r\n\r\nIt is not known whether cetirizine and pseudoephedrine is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. Cetirizine and pseudoephedrine can pass into breast milk and may harm a nursing baby.", "Composition": "cetirizine 5mg, pseudoephedrine 120mg", "Route": "ORAL.SOLID" }, { "ID": "874", "Trade_Name": "MIPHENICOL 250 MG 24 CAPS.", "Generic_Name": "CHLORAMPHENICOL", "Price": "6.8", "Price_Old": "6.8", "Company": "MISR", "Pharmacology": "ANTIBIOTIC", "Category": "م#_#.#~ حيوي", "Use": "–يس#?خ#~م #<ي #>ل#.ج إص#.#%#.#? #.ل#>ين و#.لأجز#.ء #.لمحي#-ة مثل #.لمل#?حمة و#.لق#^نية #.ل#?ي #?س#%#%ه#. #.ل#%#=#?ي#^ي#. #.لحس#.سية لل#=لو#^#.م#<يني#=ول . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ين مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية . \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~ . \r\n\r\n–#>ل#. #.ل#>#~وى #.لح#.#~ة #%#.لس#.لمونيل#. . \r\n\r\n–#>ل#.ج #>#~وي #.لأغشية #.لسح#.ئية #.لن#.#?جة #>ن مي#=#^و#% هيمو#<يلس إن#<لونز#. . \r\n\r\n–#>#~وي #.ل#^#=#?سي#. . \r\n\r\n–#>ل#.ج #>#~وى #.لمي#=#^و#%#.#? س#.ل#%ة #.لج#^#.م و #.لمي#=#^و#%#.#? #.لل#.هو#.ئية . \r\n\r\n–#>ل#.ج #>#~وي أس#<ل #.لحج#.#% #.لح#.جز . \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لمي#=#^و#%#.#? #.لغي#^ حس#.سة للم#_#.#~#.#? #.لحيوية #.لأخ#^ى .", "Contraindications": "–ل#. يج#% #.س#?خ#~#.مه لمن ي#>#.نون من حس#.سية #?ج#.ه #=لو#^#.م#<يني#=ول . \r\n\r\n–ل#. ينصح #%#.س#?خ#~#.مه لمن ي#>#.نون من #>#~وى #.ل#_#>ي#<ة مثل ح#.ل#.#? #.ل#%#^#~ و#.ل#.ن#<لونز#.. \r\n\r\n–يحظ#^ #.س#?خ#~#.م #.ل#=لو#^#.م#<يني#=ول أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يج#% #?جن#% #.س#?خ#~#.مi لم#~ة #-ويلة أو ي#?م #?#=#^#.#^ #.ل#>ل#.ج #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–يج#% خ#<#_ #.لج#^#>ة لمن ي#>#.نون من قصو#^ #<ي #.ل#=لى أو #.ل#=#%#~ . \r\n\r\n–يج#% #>مل #<حوص#.#? لل#~م #~و#^ية أثن#.ء #<#?#^ة #.ل#>ل#.ج . \r\n\r\n–للأ#-#<#.ل ح#~يثي #.لول#.#~ة يج#% قي#.س #?#^#=يز #.ل#=لو#^#.م#<يني#=ول #<ي #.ل#~م #%ش#=ل #~و#^ي . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه #=#>ل#.ج #^و#?يني لمن ي#>#.نون من م#^#_ #.ل#?ي#<و#~ .", "GI": "Description\t\r\nAn antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic.\r\n\r\nIndication\r\nUsed in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.\r\n\r\nMechanism of action\r\nChloramphenicol is lipid-soluble, allowing it to diffuse through the bacterial cell membrane. It then reversibly binds to the L16 protein of the 50S subunit of bacterial ribosomes, where transfer of amino acids to growing peptide chains is prevented (perhaps by suppression of peptidyl transferase activity), thus inhibiting peptide bond formation and subsequent protein synthesis.", "Composition": "chloramphenicol 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "875", "Trade_Name": "CIDOCETINE 250MG 12 CAPS.", "Generic_Name": "CHLORAMPHENICOL", "Price": "14", "Price_Old": "4.75", "Company": "CID", "Pharmacology": "ANTIBIOTIC", "Category": "م#_#.#~ حيوي", "Use": "–يس#?خ#~م #<ي #>ل#.ج إص#.#%#.#? #.ل#>ين و#.لأجز#.ء #.لمحي#-ة مثل #.لمل#?حمة و#.لق#^نية #.ل#?ي #?س#%#%ه#. #.ل#%#=#?ي#^ي#. #.لحس#.سية لل#=لو#^#.م#<يني#=ول . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ين مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية . \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~ . \r\n\r\n–#>ل#. #.ل#>#~وى #.لح#.#~ة #%#.لس#.لمونيل#. . \r\n\r\n–#>ل#.ج #>#~وي #.لأغشية #.لسح#.ئية #.لن#.#?جة #>ن مي#=#^و#% هيمو#<يلس إن#<لونز#. . \r\n\r\n–#>#~وي #.ل#^#=#?سي#. . \r\n\r\n–#>ل#.ج #>#~وى #.لمي#=#^و#%#.#? س#.ل#%ة #.لج#^#.م و #.لمي#=#^و#%#.#? #.لل#.هو#.ئية . \r\n\r\n–#>ل#.ج #>#~وي أس#<ل #.لحج#.#% #.لح#.جز . \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لمي#=#^و#%#.#? #.لغي#^ حس#.سة للم#_#.#~#.#? #.لحيوية #.لأخ#^ى .", "Contraindications": "–ل#. يج#% #.س#?خ#~#.مه لمن ي#>#.نون من حس#.سية #?ج#.ه #=لو#^#.م#<يني#=ول . \r\n\r\n–ل#. ينصح #%#.س#?خ#~#.مه لمن ي#>#.نون من #>#~وى #.ل#_#>ي#<ة مثل ح#.ل#.#? #.ل#%#^#~ و#.ل#.ن#<لونز#.. \r\n\r\n–يحظ#^ #.س#?خ#~#.م #.ل#=لو#^#.م#<يني#=ول أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يج#% #?جن#% #.س#?خ#~#.مi لم#~ة #-ويلة أو ي#?م #?#=#^#.#^ #.ل#>ل#.ج #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–يج#% خ#<#_ #.لج#^#>ة لمن ي#>#.نون من قصو#^ #<ي #.ل#=لى أو #.ل#=#%#~ . \r\n\r\n–يج#% #>مل #<حوص#.#? لل#~م #~و#^ية أثن#.ء #<#?#^ة #.ل#>ل#.ج . \r\n\r\n–للأ#-#<#.ل ح#~يثي #.لول#.#~ة يج#% قي#.س #?#^#=يز #.ل#=لو#^#.م#<يني#=ول #<ي #.ل#~م #%ش#=ل #~و#^ي . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه #=#>ل#.ج #^و#?يني لمن ي#>#.نون من م#^#_ #.ل#?ي#<و#~ .", "GI": "Description\t\r\nAn antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic.\r\n\r\nIndication\r\nUsed in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.\r\n\r\nMechanism of action\r\nChloramphenicol is lipid-soluble, allowing it to diffuse through the bacterial cell membrane. It then reversibly binds to the L16 protein of the 50S subunit of bacterial ribosomes, where transfer of amino acids to growing peptide chains is prevented (perhaps by suppression of peptidyl transferase activity), thus inhibiting peptide bond formation and subsequent protein synthesis.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "876", "Trade_Name": "CARBOSYLANE 48CAPS.", "Generic_Name": "CHARCOAL+DIMETHICONE", "Price": "16", "Price_Old": "16", "Company": "GLOBAL NAPI PHARMACEUTICALS > SEROLAM-FRANCE", "Pharmacology": "ANTIFLATULENT", "Category": "م#_#.#~ لل#.ن#?#<#.خ", "Use": "–يس#?خ#~م #<ي #>ل#.ج مش#.#=ل #.لم#>#~ه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.ن#?#<#.خ#.#?. \r\n\r\n–ي#>مل #>لي حم#.يه و#?خ#<ي#< #?شقق#.#? #.لجل#~. \r\n\r\n–ي#>مل #>لي #?خ#<ي#< #.ل#?و#?#^ للغ#.ز#.#? #.ل#?ي #?#?#=ون #~#.خل #.لم#>#~ه. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.#_#-#^#.#%#.#? #.لجه#.ز #.له#_مي.", "Contraindications": "–يمن#> #?ن#.وله لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.ل#.#? #.ل#>ل#.ج من #>#_#.#? #.لحيو#.ن#.#?. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.ل#.#? #.ل#>ل#.ج من #.لحس#.سيه. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.ل#.#? #.ل#>ل#.ج من #.لح#^وق #.لخ#-ي#^ه. \r\n\r\n–يمن#> #?ن#.وله #<ي ح#.ل#.#? #.ل#>ل#.ج من #.لج#^وج #.ل#>ميقه.", "GI": "COMING SOON ..", "Composition": "charcoal 140mg simethicone 45mg", "Route": "ORAL.SOLID" }, { "ID": "877", "Trade_Name": "LEVOCOL NASR 250MG 12CAPS.", "Generic_Name": "CHLORAMPHENICOL", "Price": "4.5", "Price_Old": "4.5", "Company": "EL NASR", "Pharmacology": "ANTIBIOTIC", "Category": "م#_#.#~ حيوي", "Use": "–يس#?خ#~م #<ي #>ل#.ج إص#.#%#.#? #.ل#>ين و#.لأجز#.ء #.لمحي#-ة مثل #.لمل#?حمة و#.لق#^نية #.ل#?ي #?س#%#%ه#. #.ل#%#=#?ي#^ي#. #.لحس#.سية لل#=لو#^#.م#<يني#=ول . \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#>ين مثل #.لم#=و#^#.#? #.ل#>نقو#~ية #.لذه#%ية . \r\n\r\n–#>ل#.ج حمي #.ل#?ي#<و#~ و#.ل#%#.#^#.#?ي#<و#~ . \r\n\r\n–#>ل#. #.ل#>#~وى #.لح#.#~ة #%#.لس#.لمونيل#. . \r\n\r\n–#>ل#.ج #>#~وي #.لأغشية #.لسح#.ئية #.لن#.#?جة #>ن مي#=#^و#% هيمو#<يلس إن#<لونز#. . \r\n\r\n–#>#~وي #.ل#^#=#?سي#. . \r\n\r\n–#>ل#.ج #>#~وى #.لمي#=#^و#%#.#? س#.ل#%ة #.لج#^#.م و #.لمي#=#^و#%#.#? #.لل#.هو#.ئية . \r\n\r\n–#>ل#.ج #>#~وي أس#<ل #.لحج#.#% #.لح#.جز . \r\n\r\n–#>ل#.ج #.ل#>#~وى #.لمي#=#^و#%#.#? #.لغي#^ حس#.سة للم#_#.#~#.#? #.لحيوية #.لأخ#^ى .", "Contraindications": "–ل#. يج#% #.س#?خ#~#.مه لمن ي#>#.نون من حس#.سية #?ج#.ه #=لو#^#.م#<يني#=ول . \r\n\r\n–ل#. ينصح #%#.س#?خ#~#.مه لمن ي#>#.نون من #>#~وى #.ل#_#>ي#<ة مثل ح#.ل#.#? #.ل#%#^#~ و#.ل#.ن#<لونز#.. \r\n\r\n–يحظ#^ #.س#?خ#~#.م #.ل#=لو#^#.م#<يني#=ول أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة. \r\n\r\n–يج#% #?جن#% #.س#?خ#~#.مi لم#~ة #-ويلة أو ي#?م #?#=#^#.#^ #.ل#>ل#.ج #%#~ون #.س#?ش#.#^ة #.ل#-#%ي#% . \r\n\r\n–يج#% خ#<#_ #.لج#^#>ة لمن ي#>#.نون من قصو#^ #<ي #.ل#=لى أو #.ل#=#%#~ . \r\n\r\n–يج#% #>مل #<حوص#.#? لل#~م #~و#^ية أثن#.ء #<#?#^ة #.ل#>ل#.ج . \r\n\r\n–للأ#-#<#.ل ح#~يثي #.لول#.#~ة يج#% قي#.س #?#^#=يز #.ل#=لو#^#.م#<يني#=ول #<ي #.ل#~م #%ش#=ل #~و#^ي . \r\n\r\n–ل#. يج#% #.س#?خ#~#.مه #=#>ل#.ج #^و#?يني لمن ي#>#.نون من م#^#_ #.ل#?ي#<و#~ .", "GI": "Description\t\r\nAn antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic.\r\n\r\nIndication\r\nUsed in treatment of cholera, as it destroys the vibrios and decreases the diarrhea. It is effective against tetracycline-resistant vibrios. It is also used in eye drops or ointment to treat bacterial conjunctivitis.\r\n\r\nMechanism of action\r\nChloramphenicol is lipid-soluble, allowing it to diffuse through the bacterial cell membrane. It then reversibly binds to the L16 protein of the 50S subunit of bacterial ribosomes, where transfer of amino acids to growing peptide chains is prevented (perhaps by suppression of peptidyl transferase activity), thus inhibiting peptide bond formation and subsequent protein synthesis.", "Composition": "chloramphenicol 250mg", "Route": "ORAL.SOLID" }, { "ID": "878", "Trade_Name": "XINASE 10 CAPS.", "Generic_Name": "CETIRIZINE+PSEUDOEPHEDRINE", "Price": "9", "Price_Old": "9", "Company": "AMRIYA", "Pharmacology": "ANTIHISTAMINE.ANTIALLERGY.COMBINED WITH VASOCONSTRICTOR AGENT", "Category": "م#_#.#~ للحس#.سية", "Use": "–#>ل#.ج #.ح#?ق#.ن #.ل#.ن#< و#.لجيو#% #.ل#.ن#<ية . \r\n\r\n–ي#>#.لج #.#>#^#.#_ #.ل#%#^#~ من #>#-س ، سيل#.ن ، #^شح ، ز#=#.م . \r\n\r\n–#>ل#.ج #.ح#?ق#.ن #.لحلق . \r\n\r\n–#>ل#.ج حس#.سية #.ل#>ين . \r\n\r\n–#>ل#.ج #.لح#=ة #.لجل#~ية . \r\n\r\n–#>ل#.ج #.ل#^م#~ #.ل#^#%ي#>ي . \r\n\r\n–#>ل#.ج #.ل#.#=زيم#. و#.لص#~#<ية .", "Contraindications": "–من ي#>#.ني #<#^#- حس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–من ي#>#.ني #.#^#?#<#.#> #<ي #_غ#- #.ل#~م . \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لش#^ي#.ن #.ل#?#.جي .", "GI": "is a combination of cetirizine, an antihistamine that reduces the natural chemical histamine in the body, and pseudoephedrine, a decongestant that shrinks blood vessels in the nasal passages. It is used to treat cold or allergy symptoms such as nasal and sinus congestion, sneezing, itching, watery eyes, or runny nose. It is taken orally in tablet form. Possible side effects can include dry mouth, dizziness, drowsiness, tiredness, ringing in the ears, or problems with concentration.\r\n\r\nIt is not known whether cetirizine and pseudoephedrine is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. Cetirizine and pseudoephedrine can pass into breast milk and may harm a nursing baby.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "879", "Trade_Name": "CLOXIDE 30 CAPS.", "Generic_Name": "CHLORDIAZEPOXIDE+CLIDINIUM BROMIDE", "Price": "6.5", "Price_Old": "6.5", "Company": "EVA PHARMA", "Pharmacology": "SPASTIC COLON", "Category": "#?شنج #.لقولون", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.لقولون #.ل#>ص#%ي و#.ل#?خ#<ي#< من أ#>#^#.#_ه. \r\n\r\n–يقلل من #.ل#?شنج#.#? #.لن#.#?جة #>ن #.لقولون #.ل#>ص#%ي. \r\n\r\n–#<ي ح#.لة زي#.#~ة #.لإ#<#^#.ز#.#? #.لح#^#=ة للقن#.ة #.له#_مية. \r\n\r\n–#<ي ح#.لة #>س#^ #.له#_م. \r\n\r\n–#<ي ح#.لة #?#>س#^ #.لح#^#=ة #%#.لحويصلة #.لم#^#.#^ية. \r\n\r\n–#<ي ح#.ل#.#? #.لق#^حة #.لم#>#~ة و#.لأثني #>ش#^ ويخ#<#< من #.ل#?ه#.#%#.#? #.لم#>#~ة. \r\n\r\n–يخ#<#< من #.ل#?ه#.#%#.#? #.لقولون. \r\n\r\n–#<ي ح#.لة #.لإسه#.ل. \r\n\r\n–ح#~وث #?شنج#.#? و#?قلص #%#.لح#.ل#% و#>#~م سهولة #.لح#^#=ة #<يه. \r\n\r\n–#<ي ح#.لة #.لإص#.#%ة #%#.لمث#.نة #.ل#>ص#%ية. \r\n\r\n–#<ي ح#.ل#.#? #>س#^ #.ل#-مث. \r\n\r\n–ي#>#.لج ح#.ل#.#? سلس #.ل#%ول #.لليلي.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #>ق#.#^ #.للي#%#^#.#=س لمن ي#>#.ني من #?#_خم #<ي #.ل#%#^وس#?#.#?#. أو #<ي ح#.لة #.لإص#.#%ة #%#.لجلو#=وم#. ( #.لمي#.ه #.لز#^ق#.ء). \r\n\r\n–يحذ#^ #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وى #>لى نس#%ة #=حول خل#.ل #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–يمن#> #?ن#.وله للح#.مل وللم#^أة #.لم#^#_#>ة. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه أثن#.ء #.لقي#.#~ة حيث إنه يغي#^ من سلو#= #.لم#^و#^ي لل#<#^#~ #>لى حس#% #.لج#^#>ة وم#~ى #.س#?ج#.#%ة #.لجسم له#.. \r\n\r\n–يحذ#^ #.س#?خ#~#.مه لم#^#_ي #.ل#.#=#?ئ#.#% ولمن ي#^#.و#~هم أ#<#=#.#^ #>ن #.ل#.ن#?ح#.#^. \r\n\r\n–لم#^#_ي #.ل#.#^#?ج#.#> #.لم#^يئي.", "GI": "(chlordiazepoxide and clidinium) combines in a single capsule formulation the antianxiety action of chlordiazepoxide hydrochloride and the anticholinergic/spasmolytic effects of clidinium bromide.\r\nChlordiazepoxide hydrochloride is a versatile, therapeutic agent of proven value for the relief of anxiety and tension. It is indicated when anxiety, tension or apprehension are significant components of the clinical profile. It is among the safer of the effective psychopharmacologic compounds.\r\nClidinium bromide is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract.", "Composition": "Each capsule contains: \r\nClidinium br. 2.5mg+Chlordiazpoxide hcl 5mg.", "Route": "ORAL.SOLID" }, { "ID": "880", "Trade_Name": "CEFACLOR 250MG 12 CAPS. (N/A)", "Generic_Name": "CEFACLOR", "Price": "25.2", "Price_Old": "25.2", "Company": "PHARCO B", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.SECOND-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.ني", "Use": "–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.للثه. \r\n\r\n–#>ل#.ج #>#~وي #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحلق و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لقص#%ة #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئ#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.ل#?ي #?صي#% أجز#.ء #.لجسم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية م#<#^#-ة #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #%#.ل#>ق#.#^ أو أي من #?#^#=ي#%ة #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–لمن ي#>#.نون من أم#^#.#_ #.ل#=لي وخلل #<ي وظ#.ئ#<ه#. #.ل#.م#?ن#.#> #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ #<ي أثن#.ء #<#?#^ة #.لحمل حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة للجنين و#?ؤث#^ #>لى صح#?ه. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> #>#%#^ حلي#% #.لأم. \r\n\r\n–يحذ#^ #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? #>ن#~ #?ن#.ول #.ل#>ق#.#^ حيث يس#%#% #.ل#~وخة و#.لن#>#.س.", "GI": "About Cefaclor\r\nA second-generation cephalosporin antibiotic, Oral Broad-spectrum antibiotics.\r\n\r\nMechanism of Action\r\nCefaclor is a 2nd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefaclor inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefaclor. \r\nCefaclor has more activity against ampicillin resistant haemophilus influenzae and branhamella catarrhalis \r\n\r\nIndications for Cefaclor\r\n1.Pneumonia & Pulmonary infections \r\n2.Otitismedia \r\n3.Urinary tract infections & genital tract infections \r\n4.Pharyngitis & Tonsillitis \r\n5.Skin & wound infections \r\n6.Bronchitis & Sinusitis", "Composition": "Each CEFACLOR capsule contains:\r\nCefaclor monohydrate (USP) equivalent to anhydrous cefaclor 250 mg or 500 mg \r\n\r\nEach 5 ml CEFACLOR suspension contains:\r\nCefaclor monohydrate (USP) equivalent to anhydrous cefaclor 125 mg or 250 mg", "Route": "ORAL.SOLID" }, { "ID": "881", "Trade_Name": "BIODROXIL 500MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "10.5", "Price_Old": "10.5", "Company": "KAHIRA > NOVARTIS", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cefadroxil 1gm or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "882", "Trade_Name": "IBIDROXIL 250 MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "7.9", "Price_Old": "7.9", "Company": "GLAXO SMITHKLINE", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "Each hard capsule contains Cefadroxil monohydrate equivalent to 250 or 500 mg cefadroxil anhydrous.\r\n\r\nEach coated tablet contains Cefadroxil monohydrate equivalent to 1 gm cefadroxil anhydrous.\r\n\r\nEach 5 ml of dry powder after reconstitution contains Cefadro", "Route": "ORAL.SOLID" }, { "ID": "883", "Trade_Name": "CEFBIOLOR 250 MG 10 CAPS.", "Generic_Name": "CEFACLOR", "Price": "16", "Price_Old": "16", "Company": "SIGMA > SABAA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.SECOND-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.ني", "Use": "–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.للثه. \r\n\r\n–#>ل#.ج #>#~وي #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحلق و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لقص#%ة #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئ#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.ل#?ي #?صي#% أجز#.ء #.لجسم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية م#<#^#-ة #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #%#.ل#>ق#.#^ أو أي من #?#^#=ي#%ة #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–لمن ي#>#.نون من أم#^#.#_ #.ل#=لي وخلل #<ي وظ#.ئ#<ه#. #.ل#.م#?ن#.#> #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ #<ي أثن#.ء #<#?#^ة #.لحمل حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة للجنين و#?ؤث#^ #>لى صح#?ه. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> #>#%#^ حلي#% #.لأم. \r\n\r\n–يحذ#^ #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? #>ن#~ #?ن#.ول #.ل#>ق#.#^ حيث يس#%#% #.ل#~وخة و#.لن#>#.س.", "GI": "About Cefaclor\r\nA second-generation cephalosporin antibiotic, Oral Broad-spectrum antibiotics.\r\n\r\nMechanism of Action\r\nCefaclor is a 2nd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefaclor inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefaclor. \r\nCefaclor has more activity against ampicillin resistant haemophilus influenzae and branhamella catarrhalis \r\n\r\nIndications for Cefaclor\r\n1.Pneumonia & Pulmonary infections \r\n2.Otitismedia \r\n3.Urinary tract infections & genital tract infections \r\n4.Pharyngitis & Tonsillitis \r\n5.Skin & wound infections \r\n6.Bronchitis & Sinusitis", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "884", "Trade_Name": "CURISAFE 500MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "15", "Price_Old": "10", "Company": "PHARCO B", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "Each CURISAFE Tablet contains 1 g of Cefadroxil activity.\r\n\r\nEach CURISAFE Capsule contains 500 mg of Cefadroxil activity.\r\n\r\nCURISAFE Powder for Oral Suspension:\r\n\r\n Each 5 ml of reconstituted CURISAFE Suspension contains 125 mg or 250 mg or 500 mg of Cefadrox", "Route": "ORAL.SOLID" }, { "ID": "885", "Trade_Name": "CEFADROXIL 500MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "7.5", "Price_Old": "7.5", "Company": "SIGMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cefadroxil 1gm or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "886", "Trade_Name": "CEFACLOR 500MG 12CAPS.USP 23 (N/A)", "Generic_Name": "CEFACLOR", "Price": "31.5", "Price_Old": "31.5", "Company": "PHARCO B", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.SECOND-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.ني", "Use": "–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.للثه. \r\n\r\n–#>ل#.ج #>#~وي #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحلق و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لقص#%ة #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئ#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.ل#?ي #?صي#% أجز#.ء #.لجسم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية م#<#^#-ة #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #%#.ل#>ق#.#^ أو أي من #?#^#=ي#%ة #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–لمن ي#>#.نون من أم#^#.#_ #.ل#=لي وخلل #<ي وظ#.ئ#<ه#. #.ل#.م#?ن#.#> #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ #<ي أثن#.ء #<#?#^ة #.لحمل حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة للجنين و#?ؤث#^ #>لى صح#?ه. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> #>#%#^ حلي#% #.لأم. \r\n\r\n–يحذ#^ #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? #>ن#~ #?ن#.ول #.ل#>ق#.#^ حيث يس#%#% #.ل#~وخة و#.لن#>#.س.", "GI": "About Cefaclor\r\nA second-generation cephalosporin antibiotic, Oral Broad-spectrum antibiotics.\r\n\r\nMechanism of Action\r\nCefaclor is a 2nd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefaclor inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefaclor. \r\nCefaclor has more activity against ampicillin resistant haemophilus influenzae and branhamella catarrhalis \r\n\r\nIndications for Cefaclor\r\n1.Pneumonia & Pulmonary infections \r\n2.Otitismedia \r\n3.Urinary tract infections & genital tract infections \r\n4.Pharyngitis & Tonsillitis \r\n5.Skin & wound infections \r\n6.Bronchitis & Sinusitis", "Composition": "Each CEFACLOR capsule contains:\r\nCefaclor monohydrate (USP) equivalent to anhydrous cefaclor 250 mg or 500 mg \r\n\r\nEach 5 ml CEFACLOR suspension contains:\r\nCefaclor monohydrate (USP) equivalent to anhydrous cefaclor 125 mg or 250 mg", "Route": "ORAL.SOLID" }, { "ID": "887", "Trade_Name": "CEFAXORAL 500MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "9.5", "Price_Old": "9.5", "Company": "T3A PHARMA", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "888", "Trade_Name": "BACTICLOR 500 MG 12CAPS.", "Generic_Name": "CEFACLOR", "Price": "33", "Price_Old": "33", "Company": "PHARCO B > RANBAXY", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.SECOND-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لث#.ني", "Use": "–#>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.للثه. \r\n\r\n–#>ل#.ج #>#~وي #.لأسن#.ن. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لحلق و#.للوز#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#%ل#>وم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لقص#%ة #.لهو#.ئية. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.ل#^ئ#?ين. \r\n\r\n–#>ل#.ج #.ل#?ه#.#%#.#? #.لجل#~. \r\n\r\n–#>ل#.ج #.ل#>#~وى #.ل#?ي #?صي#% أجز#.ء #.لجسم. \r\n\r\n–#>ل#.ج #.ل#?ه#.#% #.لمس#.ل#= #.ل#%ولية.", "Contraindications": "–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من حس#.سية م#<#^#-ة #.#?ج#.ه #.لمو#.#~ #.ل#<#>#.لة #%#.ل#>ق#.#^ أو أي من #?#^#=ي#%ة #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ لمن ي#>#.نون من قصو#^ #<ي وظ#.ئ#< #.ل#=#%#~. \r\n\r\n–لمن ي#>#.نون من أم#^#.#_ #.ل#=لي وخلل #<ي وظ#.ئ#<ه#. #.ل#.م#?ن#.#> #>ن #?ن#.ول #.ل#>ق#.#^. \r\n\r\n–يحذ#^ #.س#?خ#~#.م #.ل#>ق#.#^ #<ي أثن#.ء #<#?#^ة #.لحمل حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة للجنين و#?ؤث#^ #>لى صح#?ه. \r\n\r\n–يج#% #.ل#.#%#?#>#.#~ #>ن #?ن#.ول #.ل#>ق#.#^ أثن#.ء #<#?#^ة #.ل#^#_#.#>ة حيث #?ن#?قل #.لم#.#~ة #.ل#<#>#.لة لل#^#_ي#> #>#%#^ حلي#% #.لأم. \r\n\r\n–يحذ#^ #.لقي#.#~ة أو #.ل#>مل #>لى آل#.#? #>ن#~ #?ن#.ول #.ل#>ق#.#^ حيث يس#%#% #.ل#~وخة و#.لن#>#.س.", "GI": "About Cefaclor\r\nA second-generation cephalosporin antibiotic, Oral Broad-spectrum antibiotics.\r\n\r\nMechanism of Action\r\nCefaclor is a 2nd generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefaclor inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefaclor. \r\nCefaclor has more activity against ampicillin resistant haemophilus influenzae and branhamella catarrhalis \r\n\r\nIndications for Cefaclor\r\n1.Pneumonia & Pulmonary infections \r\n2.Otitismedia \r\n3.Urinary tract infections & genital tract infections \r\n4.Pharyngitis & Tonsillitis \r\n5.Skin & wound infections \r\n6.Bronchitis & Sinusitis", "Composition": "cefaclor 125mg or 250mg or 500mg", "Route": "ORAL.SOLID" }, { "ID": "889", "Trade_Name": "DURABIOTIC 500MG 8 CAPS.", "Generic_Name": "CEFADROXIL", "Price": "9", "Price_Old": "9", "Company": "LOGESTIC PHARMA FOR PHARMACEUTICALS", "Pharmacology": "ANTIBIOTIC.CEPHALOSPORIN.FIRST-GENERATION", "Category": "م#_#.#~ حيوي سي#<#.لوس#%و#^ين ، #.لجيل #.لأول", "Use": "–يس#?خ#~م #<ي #>ل#.ج #%#>#_ #.ل#.ل#?ه#.#%#.#? منه#. #.ل#?ه#.#% #.ل#%ل#>وم #=م#. ي#>#.لج #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.لمخ#?ل#<ة و#=ذل#= يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لجيو#% #.لأن#<ية #.لح#.#~ة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.للوز#?ين #=م#. يس#?خ#~م ل#>ل#.ج #.ل#?ه#.#% #.لأذن #.لوس#-ى #.لح#.#~ وأي#_#. ي#>#.لج #.ل#?ه#.#%#.#? #.لمس#.ل#= #.ل#%ولية. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#%#.#? صم#.م#.#? #.لقل#% #<ي #.لم#^#_ى #.لم#?وق#> خ#_و#>هم ل#>ملي#.#? ج#^#.حية م#>ينة #=م#. يس#?#>مل #<ي #>ل#.ج #>#~وى #.لجه#.ز #.ل#?ن#<سي #.ل#>لوي و#.لس#<لي. \r\n\r\n–يس#?خ#~م أي#_#. #<ي #>#~وى #.ل#>ظ#.م #=م#. يم#=ن #.س#?خ#~#.مه #<ي #>ل#.ج #>#~وى #.لجل#~ و#.لأنسجة #.ل#^خوة.", "Contraindications": "–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لإح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #.س#?خ#~#.مه للم#^#_ى #.لذين ي#>#.نون من #.ل#.#_#-#^#.#%#.#? #<ي وظ#.ئ#< #.ل#=لى. \r\n\r\n–#<ي أثن#.ء #<#?#^ة #.لحمل ي#<#_ل #.س#?ش#.#^ة #.ل#-#%ي#% #.لم#>#.لج ق#%ل أخذ #.ل#~و#.ء لم#>#^#<ة #.نه ل#. يوج#~ خ#-و#^ة #>لى #.لجنين أم#. #<ي ح#.لة #.ل#^#_#.#>ة #.ل#-#%ي#>ية #<#.ل#~و#.ء ي#<#^ز #<ي ل#%ن #.لأم لذ#. يج#% #.س#?#>م#.له #%حذ#^ ش#~ي#~.", "GI": "About Cefadroxil\r\nFirst Generation Cephalosporin, para-hydroxy derivative of cefalexin, Oral broad-spectrum antibiotic\r\n\r\nMechanism of Action \r\nCefadroxil is a 1st generation cephalosporin which exerts its bactericidal action against both gram positive & gram negative organisms by inhibiting bacterial cell wall synthesis. Cefadroxil inhibits transpeptidase & thus prevents cross linking of bacterial cell wall. Transpeptidase & associated proteins constitute various types of specific binding proteins which have affinity for cephalosporins like Cefadroxil \r\n\r\nIndications for Cefadroxil\r\n1. Urinay tract infections \r\n2. Tonsillitis & Pharyngitis \r\n3. Skin &soft tissue infections \r\n4. Otitis media. \r\n\r\nContra-indications of Cefadroxil\r\n1.Hypersensitivity to cephalosporins \r\n2.Porphyria \r\n3.Neuromuscular disorders.", "Composition": "cefadroxil 500mg", "Route": "ORAL.SOLID" }, { "ID": "890", "Trade_Name": "RELAXIGED 20 CAPS.", "Generic_Name": "CHLORZOXAZONE+PARACETAMOL(ACETAMINOPHEN)", "Price": "21", "Price_Old": "14", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–ي#>#.لج #?لي#< #.ل#>#_ل#.#?. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #>#^ق #.لنس#.. \r\n\r\n–ي#>#.لج #.ل#.ل#?و#.ء#.#? #%#.لم#<#.صل. \r\n\r\n–مس#=ن ل#.ل#.م #.لظه#^ و#.ل#^ق#%ة. \r\n\r\n–ي#>مل #>لي #?م#~ي#~ #>نق #.ل#^حم. \r\n\r\n–ي#>#.لج #?آ#=ل #.لم#<#.صل و#.ل#<ق#^#.#?. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.لم#<#.صل. \r\n\r\n–#%#.س#- ل#?قلص#.#? و#?شنج#.#? #.ل#>#_ل#.#?. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لن#.#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لقل#% و#.ل#.و#>ية #.ل#~موية. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.ل#=#%#~ و#.ل#=لي. \r\n\r\n–يمن#> #<ي #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "Each capsule contains:\r\nChlorzoxazone 225 mg\r\nParacetamol 325 mg", "Route": "ORAL.SOLID" }, { "ID": "891", "Trade_Name": "CARTILGIN 20 CAPS.", "Generic_Name": "CHONDROITIN+GLUCOSAMINE+VITAMIN C", "Price": "15.6", "Price_Old": "15.6", "Company": "AMOUN", "Pharmacology": "ANTIRHEUMATIC.OSTEOARTHRITIS.ANABOLIC AGENTS", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج و#?خ#<ي#< #.ل#.ل#.م. \r\n\r\n–يسنخ#~م #<ي #>ل#.ج و#?خ#<ي#< #.لص#~#.#> #.لنص#<ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#>#_#^و#<. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج و#.صل#.ح #.ل#.نسجه و#.لخل#.ي#..", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من نزي#< #.ل#~م. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من قصو#^ #<ي #.ل#=لي. \r\n\r\n–#.لحمل و#.ل#^#_#.#>ه: \r\n\r\n–يمن#> #?ن#.ول #=#.#^#?يلجين Cartilgin #<ي ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ه #.ل#-#%ي#>يه ل#.نه غي#^ #.من #<ي هذه #.ل#<#?#^ه ويج#% #.س#?ش#.#^ه #.ل#-#%ي#%.", "GI": "A combination formula providing critical nutrients to stimulate cells to help build joint cartilage.\r\nGlucosamine. Glucosamine is a naturally occurring chemical found throughout the human body, including in the fluids surrounding joints. This formula contains 1,500 mg of glucosamine sulfate, the form of glucosamine used most often in research.\r\n \r\nChondroitin. Chondroitin is another naturally occurring chemical, found in cartilage around joints in the body. Included are 1,200 mg of chondroitin sulfate, the most widely available and commonly used form of this nutrient.", "Composition": "chondroitin 250mg+glucosamine 250mg", "Route": "ORAL.SOLID" }, { "ID": "892", "Trade_Name": "VITAGINS 30 SOFT GELATIN CAPS.", "Generic_Name": "CHOLINE+CU+FE+GINSENG+MG+RUTIN+SULFATES+VIT A+VIT B COMPLEX+VIT D+VIT E", "Price": "14.51", "Price_Old": "14.51", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–م#=مل غذ#.ئي يس#?خ#~م ل#>ل#.ج أو #.لوق#.ية من نقص #<ي#?#.مين#.#? و #.لم#>#.#~ن #%س#%#% سوء #.ل#?غذية أو أم#^#.#_ م#>ينة.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه أي من م#=ون#.#? #.ل#~و#.ء.", "GI": "About Choline\r\nA water-soluble essential nutrient, natural quaternary saturated amine.\r\nMechanism of Action of Choline\r\nCholine is a water-soluble vitamin. Choline aids in nerve transmission and utilization of fat and hormone production. It also maintain normal kidney and bladder function. \r\nIt is most effective with Vitamin A, B-Complex, B-12, Folic Acid, and Inositol. Also, it helps lower cholesterol, transferring nerve impulse to the brain, helps against memory loss and senile dementia, and aids the liver in removing poisons and drugs from the bloodstream.", "Composition": "calcium, chloride, copper, ginseng 100mg, iron 10mg, magnesium 100mg, manganese, pantothenate ca., rutin, vit a, vit b1, vit b12, vit b2, vit b6, vit c, vit d, vit e", "Route": "ORAL.SOLID" }, { "ID": "893", "Trade_Name": "RELAXON 30 CAPS.", "Generic_Name": "CHLORZOXAZONE+PARACETAMOL(ACETAMINOPHEN)", "Price": "18", "Price_Old": "18", "Company": "JAMJOOM PHARMACEUTICALS", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–ي#>#.لج #?لي#< #.ل#>#_ل#.#?. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #>#^ق #.لنس#.. \r\n\r\n–ي#>#.لج #.ل#.ل#?و#.ء#.#? #%#.لم#<#.صل. \r\n\r\n–مس#=ن ل#.ل#.م #.لظه#^ و#.ل#^ق#%ة. \r\n\r\n–ي#>مل #>لي #?م#~ي#~ #>نق #.ل#^حم. \r\n\r\n–ي#>#.لج #?آ#=ل #.لم#<#.صل و#.ل#<ق#^#.#?. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.لم#<#.صل. \r\n\r\n–#%#.س#- ل#?قلص#.#? و#?شنج#.#? #.ل#>#_ل#.#?. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لن#.#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لقل#% و#.ل#.و#>ية #.ل#~موية. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.ل#=#%#~ و#.ل#=لي. \r\n\r\n–يمن#> #<ي #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة.", "GI": "COMING SOON ..", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "894", "Trade_Name": "CINARETAM 400/25MG 20 CAP.", "Generic_Name": "CINNARIZINE+PIRACETAM", "Price": "5.59", "Price_Old": "5.59", "Company": "MISR", "Pharmacology": "ANTIVERTIGO", "Category": "م#_#.#~ لل#~و#.#^", "Use": "–#?نشي#- وصول #.ل#~و#^ة #.ل#~موية و #.لأ#=سجين للمخ خصوص#. #%#>#~ #.ل#?#>#^#_ للس#=#?ة #.ل#~م#.غية . \r\n\r\n–يس#.#>#~ #>لى #?نشي#- #.لذ#.#=#^ة و #>ل#.ج #.لنسي#.ن و #.لزه#.يم#^ و #.لخ#^#< و #_#>#< #.ل#?#^#=يز ل#~ى #=#%#.#^ #.لسن . \r\n\r\n–يس#.#>#~ #>لى #?حسين #.لق#~#^#.#? #.ل#>قلية خصوص#. ل#~ى #=#%#.#^ #.لسن و #%#>#~ #.لإص#.#%ة #%#.لس#=#?ة #.ل#~م#.غية و ل#~ى #.لأ#-#<#.ل . \r\n\r\n–#>ل#.ج إ#_#-#^#.#% #.لإذنين و #.ل#~وخة و #.ل#~و#.#^ .", "Contraindications": "–#.لحمل و #.ل#^#_#.#>ة : \r\n\r\n–#.لحمل : غي#^ أمن للإس#?خ#~#.م أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : غي#^ أمن للإس#?خ#~#.م أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–#?حذي#^#.#? : \r\n\r\n–ل#. يس#?خ#~م #<ى ح#.لة وجو#~ نزي#< #%#.لمخ . \r\n\r\n–ل#. يس#?خ#~م م#> ح#.ل#.#? م#^#_ى #.ل#=لى #.لم#?أخ#^ة ، و ح#.ل#.#? م#^#_ى #.ل#=#%#~ . \r\n\r\n–ق#~ يس#%#% #~وخة و قلة #.ل#?و#.زن #<ى #%#~#.ية #.ل#>ل#.ج لذل#= يس#?خ#~م #%حذ#^ أثن#.ء #.لقي#.#~ة و #.لقي#.م #%#.لأ#>م#.ل #.لش#.قة . \r\n\r\n–#>ن#~ #.ل#?وق#< #>ن #?ن#.ول #.ل#~و#.ء يج#% #.ل#?وق#< #?#~#^يجي#. . \r\n\r\n–ل#. ي#<#_ل إس#?خ#~#.مه للأ#-#<#.ل أقل من 16 سنة .", "GI": "About Cinnarizine\r\nPiperazines derivative, Antihistamine, Antivertigo.\r\nMechanism of Action of Cinnarizine\r\nCinnarizine is a specific competitive H1 receptor antagonist. It suppresses the vestibular end organ receptors and thus inhibits the activation of central cholinergic receptors. Cinnarizine inhibits contractions of vascular smooth muscles by inhibiting the calcium channels preferably in the arterial smooth muscle.", "Composition": "cinnarizine 25mg piracetam 400mg", "Route": "ORAL.SOLID" }, { "ID": "895", "Trade_Name": "ELASTICIN 30 CAPS.", "Generic_Name": "CHONDROITIN+GLUCOSAMINE+VITAMIN C", "Price": "25.2", "Price_Old": "25.2", "Company": "PHAROPHARMA", "Pharmacology": "ANTIRHEUMATIC.OSTEOARTHRITIS.ANABOLIC AGENTS", "Category": "م#_#.#~ لل#^وم#.#?يزم و #.لم#<#.صل", "Use": "–يس#?خ#~م #<ي #>ل#.ج #.ل#?ه#.#% #.لم#<#.صل. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج و#?خ#<ي#< #.ل#.ل#.م. \r\n\r\n–يسنخ#~م #<ي #>ل#.ج و#?خ#<ي#< #.لص#~#.#> #.لنص#<ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#>#_#^و#<. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج و#.صل#.ح #.ل#.نسجه و#.لخل#.ي#..", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من #.لحس#.سيه من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من نزي#< #.ل#~م. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للح#.ل#.#? #.ل#?ي #?#>#.ني من قصو#^ #<ي #.ل#=لي. \r\n\r\n–#.لحمل و#.ل#^#_#.#>ه: \r\n\r\n–يمن#> #?ن#.ول #=#.#^#?يلجين Cartilgin #<ي ح#.ل#.#? #.لحمل و#.ل#^#_#.#>ه #.ل#-#%ي#>يه ل#.نه غي#^ #.من #<ي هذه #.ل#<#?#^ه ويج#% #.س#?ش#.#^ه #.ل#-#%ي#%.", "GI": "A combination formula providing critical nutrients to stimulate cells to help build joint cartilage.\r\nGlucosamine. Glucosamine is a naturally occurring chemical found throughout the human body, including in the fluids surrounding joints. This formula contains 1,500 mg of glucosamine sulfate, the form of glucosamine used most often in research.\r\n \r\nChondroitin. Chondroitin is another naturally occurring chemical, found in cartilage around joints in the body. Included are 1,200 mg of chondroitin sulfate, the most widely available and commonly used form of this nutrient.", "Composition": "chondroitin 200mg+glucosamine250mg+Vit C 30mg", "Route": "ORAL.SOLID" }, { "ID": "896", "Trade_Name": "RELAX 20 CAPS.", "Generic_Name": "CHLORZOXAZONE+PARACETAMOL(ACETAMINOPHEN)", "Price": "21", "Price_Old": "14", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "MUSCLE RELAXANT", "Category": "#%#.س#- لل#>#_ل#.#?", "Use": "–ي#>#.لج #?لي#< #.ل#>#_ل#.#?. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #>#^ق #.لنس#.. \r\n\r\n–ي#>#.لج #.ل#.ل#?و#.ء#.#? #%#.لم#<#.صل. \r\n\r\n–مس#=ن ل#.ل#.م #.لظه#^ و#.ل#^ق#%ة. \r\n\r\n–ي#>مل #>لي #?م#~ي#~ #>نق #.ل#^حم. \r\n\r\n–ي#>#.لج #?آ#=ل #.لم#<#.صل و#.ل#<ق#^#.#?. \r\n\r\n–مس#=ن ل#.ل#.م #.ل#>#_ل#.#? و#.لم#<#.صل. \r\n\r\n–#%#.س#- ل#?قلص#.#? و#?شنج#.#? #.ل#>#_ل#.#?. \r\n\r\n–ي#>#.لج #.لص#~#.#> #.لن#.#?ج #>ن #.ل#?و#?#^ #.ل#>#_لي.", "Contraindications": "–#<#^#- #.لحس#.سية #?ج#.ه #.ي م#=ون من م#=ون#.#? #.ل#~و#.ء. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.لقل#% و#.ل#.و#>ية #.ل#~موية. \r\n\r\n–من ي#>#.ني قصو#^ #<ي #.ل#=#%#~ و#.ل#=لي. \r\n\r\n–يمن#> #<ي #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة.", "GI": "(Indications) : \r\nThis medication is a muscle relaxant, prescribed for muscle spasm and the resulting pain or discomfort. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest. \r\nAbout Chlorzoxazone\r\nA benzoxazolone derivative, Centrally acting Muscle relaxant and mild sedative.\r\nMechanism of Action of Chlorzoxazone\r\nThis muscle relaxant works by blocking nerve impulses (or pain sensations) that are sent to your brain. It inhibits degranulation of mast cells, subsequently preventing the release of histamine and slow-reacting substance of anaphylaxis (SRS-A), mediators of type I allergic reactions. It may also reduce the release of inflammatory leukotrienes. Chlorzoxazone may act by inhibiting calcium influx.", "Composition": "Each capsule contains:\r\nActive Ingredients:\r\nChlorzoxazone 250 mg.\r\nParacetamol 300 mg.", "Route": "ORAL.SOLID" }, { "ID": "897", "Trade_Name": "CINNARIZINE 75MG 20 CAPS.", "Generic_Name": "CINNARIZINE", "Price": "9.75", "Price_Old": "5.5", "Company": "ARAB DRUG COMPANY.", "Pharmacology": "ANTIEMETIC.PROMOTE CEREBRAL BLOOD FLOW.ANTIHISTAMINE CALCIUM CHANNEL BLOCKER", "Category": "م#_#.#~ للقئ و ي#>زز #?#~#<ق #.ل#~م لل#~م#.غ و م#_#.#~ للحس#.سية و م#.ن#> قن#.ة #.ل#=#.لسيوم", "Use": "–يس#?خ#~م ل#>ل#.ج #?قلص #.لأو#>ية #.ل#~موية و#?صل#% #.لش#^#.يين و أي#_ً#. #>ل#.ج #.ل#-نين و#.ل#~و#.#^. \r\n\r\n–يس#?خ#~م ل#>ل#.ج #.ل#.#_#-#^#.#%#.#? #.ل#?ي #?ح#~ث #<ي #.ل#~و#^ة #.ل#~موية #%#.لمخ و#.ي#_ً#. #<ي #>ل#.ج #.لش#^#.يين #.لموجو#~ة #<ي #.لأ#-#^#.#< وي#>#.لج #~#.ء #.لح#^#=ة و#.ل#~وخة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لغثي#.ن و#.لقيء ويس#?خ#~م أي#_#. #<ي #>ل#.ج م#^#_ سلس #.ل#%ول و#>#~م #.لق#~#^ة #>لى #.ل#?#^#=يز وس#^#>ة #.لنسي#.ن وأي#_#. #<ي #>ل#.ج #%#^و#~ة #.لأ#-#^#.#< و#.ل#~وخة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#.#_#-#^#.#%#.#? #.ل#?ي #?ح#~ث أثن#.ء #.لنوم وأي#_#. #>ل#.ج #.ل#?قلص#.#? #.ل#?ي #?ح#~ث #%#.لس#.قين وأي#_#. #>ل#.ج #.لق#^وح #.ل#?ي #?ح#~ث ن#?يجة #.ل#~و#.لي.", "Contraindications": "–يمن#> #?ن#.ول #.ل#~و#.ء للم#^#_ى #.لذين ي#>#.نون من #<#^#- #.لحس#.سية لأح#~ى م#=ون#.#? #.ل#~و#.ء أو أي م#=ون آخ#^. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء للم#^#_ى #.لذين ي#>#.نون من نقص ش#~ي#~ #<ي وظ#.ئ#< #.ل#=#%#~ أو #.ل#=لى. \r\n\r\n–يمن#> #?ن#.ول #.ل#~و#.ء #<ي أثن#.ء #<#?#^ة #.لحمل #=م#. ل#. يم#=ن أخذة #<ي #<#?#^ة #.ل#^#_#.#>ة لأن #.ل#~و#.ء يم#^ #<ي ل#%ن #.لأم مم#. يؤ#~ي إلى خ#-و#^ة #>لى صحة #.ل#-#<ل #.ل#^#_ي#>.", "GI": "About Cinnarizine\r\nPiperazines derivative, Antihistamine, Antivertigo.\r\n\r\nMechanism of Action of Cinnarizine\r\nCinnarizine is a specific competitive H1 receptor antagonist. It suppresses the vestibular end organ receptors and thus inhibits the activation of central cholinergic receptors. Cinnarizine inhibits contractions of vascular smooth muscles by inhibiting the calcium channels preferably in the arterial smooth muscle.\r\n\r\nIndications for Cinnarizine\r\n1.Motion sickness \r\n2.Vertigo and other vestibular disturbances \r\n3.Vomiting in Meniere`s disease \r\n4.Treatment of vascular disorders (peripheral & Cerebrovascular) \r\n\r\nTypical Dosage for Cinnarizine\r\nAdult: \r\nMotion sickness: 30 mg to be taken 2 hour before beginning the journey and if necessary dose can be repeated every 8 hours \r\nVertigo and other vestibular disturbances, vomiting in Meniere`s disease: 90 mg / day in 3 divided doses \r\nTreatment of vascular disorders (peripheral & cerebrovascular): 75 mg 1-3 times daily.", "Composition": "cinnarizine 25mg or 75mg", "Route": "ORAL.SOLID" }, { "ID": "898", "Trade_Name": "SPASMOCURE 60MG 20 TABS", "Generic_Name": "DROTAVERINE", "Price": "18", "Price_Old": "12", "Company": "ALFACURE PHARMACEUTICALS", "Pharmacology": "ANTISPASMODIC", "Category": "م#_#.#~ لل#?قلص#.#?", "Use": "–#>ل#.ج #?قلص#.#? #.لم#^#.#^ة. \r\n\r\n–يُ#>#.لج #?قلص#.#? #.لجه#.ز #.له#_مي. \r\n\r\n–يُ#>#.لج ح#.ل#.#? #.لق#^حة #.لم#>#~ية. \r\n\r\n–#?قلص#.#? #<ُم #.لم#>#~ة.", "Contraindications": "–يمن#> #>ن #.لم#^#_ى #.لذين يُ#>#.نون من #~#.ء #.ل#<#^#<ي#^ين. \r\n\r\n–يج#% #?ن#.ول هذه #.لأق#^#.ص #%#~ون م#_غ. \r\n\r\n–يم#=ن #?ن#.ول #.لج#^#>ة #.لمنسية #%مج#^#~ #?ذ#=#^ه#.. \r\n\r\n–يمن#> #>ن م#^#_ى #.لقولون #.ل#>ص#%ي. \r\n\r\n–يمن#> #?ن#.وله #<ي #<#?#^ة #.لحمل حيث ي#=ون س#%#%#.ً #<ي #>#~م نمو #.لجنين. \r\n\r\n–ي#=ون خ#-#^#.ً #>لى #.لم#^أة #.ل#?ي #?ُ#^#_#> #-#%ي#>ي حيث يم#=ن #.ن يؤث#^ #>لى #.ل#^#_ي#> #%ش#=ل سل#%ي. \r\n\r\n–يمن#> #>ن #.لأشخ#.ص #.لذين يُ#>#.نون من حس#.سية #?ج#.ه م#=ون#.#? #.ل#~و#.ء.", "GI": "About Drotaverine\r\nDrotaverine is an effective spasmolytic drug. \r\n\r\nMechanism of Action of Drotaverine\r\nDrotaverine has spasmolytic and vasodilating action. It exerts its action by inhibiting phosphodiesterase enzyme IV. This will leads to a decrease in cyclic AMP level and reduction in calcium ions (Ca2+). The reduction of calcium ions will dilates the unstipped muscles and blood vessels strongly and relieves spasm of smooth muscles.\r\n\r\nIndications for Drotaverine\r\n1.Smooth muscle spasm \r\n2.Gastrointestinal colic pain \r\n3.Renal colic pain \r\n4.Dysmenorrhoea \r\n5.Uterine neck spasm \r\n6.Post MTP(Medical termination of pregnancy) \r\n7.Post D&C(Dilatation and curettage) \r\n8.Post surgical spasm \r\n9.Irritable bowel syndrome", "Composition": "Each tablet contains:\r\nDrotaverine HC1 60 mg.\r\n\r\nEach 2 ml ampoule contains:\r\nDrotaverine HC1 40 mg.", "Route": "ORAL.SOLID" }, { "ID": "899", "Trade_Name": "TRIO-CLAR 42 CAPS.", "Generic_Name": "CLARITHROMYCIN+OMEPRAZOLE+TINIDAZOLE", "Price": "118", "Price_Old": "118", "Company": "HIKMA PHARMA", "Pharmacology": "GIT.TRIPLE THERAPY", "Category": "مش#.#=ل #.لجه#.ز #.له#_مي", "Use": "–#>#~وي #.لمي#=#^و#% #.لحلزوني (ج#^ثومة #.لم#>#~ة) \r\n\r\n–ق#^حة #.لم#>#~ة و#.ل#.ثني #>ش#^ \r\n\r\n–ح#.ل#.#? #.ل#?ه#.#%#.#? #.ل#.ذن #.لوس#-ي و#.ل#.ل#?ه#.#%#.#? #.لجل#~ية \r\n\r\n–#.ل#?ه#.#%#.#? #%#-#.نة #.ل#^حم \r\n\r\n–#>#~وي #.للثة وي#>مل #>لي #.ل#?خلص من #.ل#.ل#?ه#.#%#.#? #.لش#~ي#~ة #.ل#?ي #?صي#% #.لص#~#^", "Contraindications": "–#<#^#- حس#.سية من #.لمو#.#~ #.ل#<#>#.لة لل#~و#.ء . \r\n\r\n–#<#?#^ة #.لحمل و#.ل#^#_#.#>ة #.ل#-#%ي#>ية وخ#.صة #.لشهو#^ #.ل#.ولي من #.لحمل . \r\n\r\n–يج#% #.لإم#?ن#.#> #>ن #?ن#.ول ج#^#>ة م#_#.#>#<ة من هذ#. #.ل#~و#.ء. \r\n\r\n–#.ل#.شخ#.ص #.لذين ي#>#.نون من #.م#^#.#_ #.ل#~م #.لمخ#?ل#<ة . \r\n\r\n–#.ل#.شخ#.ص #.لذين ل#~يهم #.#_#-#^#.#%#.#? #>ص#%ية ح#.#~ة .", "GI": "Triple therapy for Helicobacter Pylori", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "900", "Trade_Name": "MICONOL 2% POWDER 20 GM", "Generic_Name": "MICONAZOLE", "Price": "5", "Price_Old": "5", "Company": "MEMPHIS", "Pharmacology": "ANTIFUNGALS.IMIDAZOLES", "Category": "م#_#.#~ لل#<#-#^ي#.#? م#> إيمي#~#.زول#.#?", "Use": "–#>ل#.ج مو#_#>ي ل#~#.ء #.لم#%ي#_#.#? #.ل#<#^جي #.لمه#%لي و#.ل#>#~ي#~ من #.ل#.ل#?ه#.#%#.#? #.لجل#~ية #.ل#<#-#^ية #=#.لس#>#<#.#? مثل: س#>#<ة #.لجس#~، وس#>#<ة #.لأ#^#<#.غ (#.ل#<خ#~)، س#>#<ة #.لق#~م.", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.", "GI": "About Miconazole\r\nAn imidazole derivative, Broad spectrum Antifungal.\r\n\r\nMechanism of Action of Miconazole\r\nMiconazole is fungicidal or fungistatic depending on the drug concentrations. I t inhibits the conversion of Lanosterol to 14 demethyl Lanosterol by inhibiting the cytochromeP450 enzyme 14 alpha demethylase and impair ergosterol synthesis\r\nIndications for Miconazole\r\n1.Tinea versicolor \r\n2.Vulvovaginal candidiasis \r\n3.Tinea pedis \r\n4.Tinea corporis \r\n5.Tinea cruris \r\n6.Otomycosis \r\n7.Onychomycosis \r\n8.Oral candidiasis \r\n9.Intestinal candidiasis \r\n10.Diaper dermatitis", "Composition": "COMING SOON ..", "Route": "VAGINAL" }, { "ID": "901", "Trade_Name": "POLYSACC PLUS 30 CAP.", "Generic_Name": "VITAMINS", "Price": "51.75", "Price_Old": "9.5", "Company": "MARCYRL CO. > EGYPTIAN PHARMACEUTICAL CENTER", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "902", "Trade_Name": "MULTI-CAP 12 CAPS.", "Generic_Name": "VITAMINS", "Price": "7", "Price_Old": "7", "Company": "EL NILE.", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "903", "Trade_Name": "MAX VIT 20 CAPS.", "Generic_Name": "VITAMINS", "Price": "13.5", "Price_Old": "13.5", "Company": "MEMPHIS", "Pharmacology": "MULTIVITAMINS", "Category": "#<ي#?#.مين#.#? م#?#>#~#~ة", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "lisindapril 20mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "904", "Trade_Name": "V2 PLUS 24 CAPS.", "Generic_Name": "VITAMINS", "Price": "9", "Price_Old": "9", "Company": "PHARCO", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "905", "Trade_Name": "PREGVIT-ZINC 24 CAPS.", "Generic_Name": "VITAMINS", "Price": "14.4", "Price_Old": "14.4", "Company": "PHARCO", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "906", "Trade_Name": "MEGAVIT ZINC 20 CAPS.", "Generic_Name": "VITAMINS", "Price": "12.4", "Price_Old": "12.4", "Company": "EUROPEAN EGYPTIAN PHARM. IND.", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "Each capsule contains:\r\nGinseng extract 50 mg\r\nEssential phospholipids (EPL) 30 mg\r\nVit. A 5000 I.U\r\nVit. D 400 I.U\r\nVit. E 20 mg\r\nVit. B1 25 mg\r\nVit. B2 5 mg\r\nNicotinamide 25 mg\r\nCalcium Pantothenate 10 mg\r\nVit. B6 5 mg\r\nVit. B12 12 mcg\r\nVit. C 50 mg\r\nFolic acid 0.4", "Route": "ORAL.SOLID" }, { "ID": "907", "Trade_Name": "SUPERVINE 30 CAPS.", "Generic_Name": "VITAMINS", "Price": "3.7", "Price_Old": "3.7", "Company": "ALEXANDRIA", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "908", "Trade_Name": "THIOTACID 300MG 5 I.V. AMP 10 ML", "Generic_Name": "THIOCTIC ACID(ALPHA LIPOIC ACID)", "Price": "46.5", "Price_Old": "31", "Company": "EVA PHARMA", "Pharmacology": "ANTIOXIDANT", "Category": "ل#.#>#?ل#.ل #.لأ#>ص#.#%", "Use": "–#>ل#.ج #.ل#?ه#.#%#.#? #.لأ#>ص#.#%ِ #.ل#?ي #?ظه#^ #%س#%#% #.لس#=#^ي. \r\n\r\n–يس#.#>#~ #<ي #>ل#.ج #.ل#?ه#.#% #.ل#>ص#% #.ل#%ص#^يِ. \r\n\r\n–ي#>#.لج ح#.ل#.#? #_#>#< #.لخصو#%ة و#.ل#.ن#?ص#.#%ِ #>ن#~ #.ل#^ج#.ل.", "Contraindications": "–يمن#> #.لأشخ#.ص #.لذين ي#>#.نون من #.لحس#.سية #.لم#<#^#-ة #.#?ج#.ه م#=ون#.#? #.ل#>ق#.#^ من إس#?خ#~#.مه . \r\n\r\n–يمن#> إس#?خ#~#.مه أثن#.ء #<#?#^#?ي #.لحمل و#.ل#^#_#.#>ة لأنه يس#%#% خ#-و#^ة #>لى #.لجنين أو #.ل#^#_ي#> .يج#% #>لى م#^ي#_ #.لس#=#^ #>مل #<حص نس#%ة #.لس#=#^ #%صو#^ة مس#?م#^ة لأن #>ق#.#^ ثيو#?#.سي#~ ي#?س#%#% #<ي إنخ#<#.#_ نس#%ة #.لس#=#^ #<ي #.ل#~م . \r\n\r\n–يج#% #>لى مس#?خ#~مي #>ق#.#^ ثيو#?#.سي#~ #.لإ#%#?#>#.#~ #>ن #.لقي#.#~ة أو أي #>مل ي#?#-ل#% #.ل#?#^#=يز #.ل#=#.مل من #.لم#^ي#_ لأن هذ#. #.ل#>ق#.#^ ي#?س#%#% #<ي #_#>#< #.ل#^ؤية و#.لإص#.#%ة #%#>#~م #.ل#?#^#=يز .", "GI": "Indication\t\r\nFor nutritional supplementation, also for treating dietary shortage or imbalance.\r\nMechanism of action\tLipoic Acid is generally involved in oxidative decarboxylations of keto acids and is presented as a growth factor for some organisms. Lipoic acid exists as two enantiomers, the R-enantiomer and the S-enantiomer. Normally only the R-enantiomer of an amino acid is biologically active, but for lipoic acid the S-enantiomer assists in the reduction of the R-enantiomer when a racemic mixture is given. Some recent studies have suggested that the S-enantiomer in fact has an inhibiting effect on the R-enantiomer, reducing its biological activity substantially and actually adding to oxidative stress rather than reducing it. Furthermore, the S-enantiomer has been found to reduce the expression of GLUT-4s in cells, responsible for glucose uptake, and hence reduce insulin sensitivity.", "Composition": "Thiotacid tablets:\r\nEach tablet contains: Thioctic acid (alpha lipoic acid) 300 mg\r\n\r\nThiotacid 600 mg tablets:\r\nEach tablet contains: Thioctic acid (alpha lipoic acid) 600 mg\r\n\r\nThiotacid ampoules:\r\nEach ampoule 10 ml contains : Thioctic acid (alpha lipoic acid", "Route": "INJECTION" }, { "ID": "909", "Trade_Name": "V2 - 24 CAPS.", "Generic_Name": "VITAMINS", "Price": "7", "Price_Old": "7", "Company": "PHARCO", "Pharmacology": "VITAMINS", "Category": "#<ي#?#.مين#.#?", "Use": "–ي#>#.لج #.ل#?#>#% و#.لإ#^ه#.ق #.ل#%#~ني. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.لإجه#.#~ #.ل#%#~ني و#.لذهني. \r\n\r\n–ي#>#.لج #_#>#< #.ل#?#^#=يز و#.لذ#.#=#^ه. \r\n\r\n–ي#>#.لج #.ل#_#>#< #.لجنسي #>ن#~ #.ل#^ج#.ل وي#~خل #<ي #>ل#.ج ح#.ل#.#? #.ل#>قم. \r\n\r\n–ي#>مل #>لي #.لح#<#.ظ #>لى صحة #.لش#>#^ ومنحه #.لمظه#^ #.لصحي و#.لقوه. \r\n\r\n–ي#>مل #>لي #?حسين مظه#^ #.لأظ#.#<#^ ويقويه#.. \r\n\r\n–ي#>مل #>لي #>ل#.ج و#?حسين #.ل#%ش#^ة و#>ل#.ج مش#.#=له#.. \r\n\r\n–يس#?خ#~م #<ي ح#.ل#.#? #.نق#-#.#> #.ل#~و#^ة #.لشه#^ية #>ن#~ #.لنس#.ء. \r\n\r\n–ي#>مل #>لي #>ل#.ج أم#^#.#_ #.ل#=#%#~ #.لمزمنة. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.#^#?#<#.#> نس#%ة #.ل#=ولس#?#^ول #<ي #.ل#~م. \r\n\r\n–يس#.#>#~ #.ل#.شخ#.ص #.لذين ي#?#%#>ون نظ#.م #?خسيس ل#?#>وي#_ #.لجسم م#. ي#<#?ق#~ه #<ي نظ#.م #.لغذ#.ئي. \r\n\r\n–ي#>مل #>لي #>ل#.ج ح#.ل#.#? #.#>#?ل#.ل #.ل#>ص#%ي. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج آل#.م #.ل#>#_ل#.#?. \r\n\r\n–ي#>مل #>لي #>ل#.ج #.لأم#^#.#_ #.لمزمنة مثل #.ل#^وم#.#?يزم و#.لمي#.ه #.ل#%ي#_#.ء #<ي #.ل#>ين. \r\n\r\n–ي#>مل #>لي #?#>زيز #.لجه#.ز #.لمن#.#>ي للجسم. \r\n\r\n–ي#>#.لج ح#.ل#.#? #.ل#?ش#?#? #.لذهني و#<ق#~#.ن #.لذ#.#=#^ة. \r\n\r\n–ي#>مل #>لي م#~ #.لجسم #%#.ل#-#.قة للقي#.م #%#.لمه#.م #.ليومية. \r\n\r\n–ي#>مل #>لي منح #.لجسم #.ل#^#.حة. \r\n\r\n–يس#?خ#~م #<ي #>ل#.ج #.ل#_#>#< #.ل#>#.م و#.ل#.جه#.#~. \r\n\r\n–#<ي ح#.له #=#%#.#^ #.لسن يس#?خ#~م لمنحهم #.لحيويه و#.ل#-#.قه وحم#.يه #.لخل#.ي#. من #.ل#?ل#<. \r\n\r\n–ي#>مل #>لي #?قليل #.لإجه#.#~ #.ل#>ص#%ي ويقي من #.لإص#.#%ة #%#.لقلق.", "Contraindications": "–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من #<#^#- حس#.سية #?ج#.ه #.لمو#.#~ #.ل#~#.خلة #<ي #?#^#=ي#% #.ل#~و#.ء. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ي#>#.نون من م#^#_ #.لس#=#^. \r\n\r\n–يمن#> #.س#?#>م#.له لل#.شخ#.ص #.لذي ل#~يهم #?#.#^يخ م#^#_ي #%#.لإص#.#%ة #%مش#.#=ل ن#<سية و#>قلية. \r\n\r\n–يمن#> #?ن#.ول #.لمش#^و#%#.#? #.ل#?ي #?ح#?وي #>لى #.ل#=#.#<يين أثن#.ء #<#?#^ة #.ل#>ل#.ج. \r\n\r\n–#.حذ#^ #?ن#.ول أ#~وية #.ل#.#=#?ئ#.#% حيث #?#?#<#.#>ل #.لأ#~وية م#> #%#>#_ ويؤث#^ #>لى #.لجسم. \r\n\r\n–#<ي ح#.له #.لحمل و#.ل#^#_#.#>ه : ي#>#~ #.ل#~و#.ء من #.لم#=مل#.#? #.لغذ#.ئية و#.ل#?ي يم#=ن #?ن#.وله#. أثن#.ء #<#?#^ة #.لحمل و#.ل#^#_#.#>ة ل#.نه#. #?م#~ #.لجسم #%#.ل#<ي#?#.مين#.#? و#.لم#>#.#~ن #.ل#?ي ي#<#?ق#~ه#. جسم #.لم#^أة ول#=ن يج#% أن ي#=ون #.ل#.س#?خ#~#.م #>ن#~ #.لح#.جه و#%#>#~ #.س#?ش#.#^ه #-#%ي#%.", "GI": "About Vitamins\r\nVitamins are substances that are found in foods we eat. The term vitamin is derived from the words vital and amine, because vitamins are required for life and were originally thought to be amines. All vitamins are not amines. Vitamins are different in their chemistry, but they all are organic nutrients that are necessary in small amounts for normal metabolism and good health. Most vitamins must be provided by the diet or by supplements- only three vitamins (D, K, and the B vitamin biotin) can be manufactured in the body from non dietary sources. Vitamins are not sources of energy as are carbohydrates, fats, and proteins. Instead, vitamins serve as chemical partners for the enzymes involved in the body`s metabolism, cell production, tissue repair, and other vital processes. Vitamins serve crucial functions in almost all bodily processes example immune, hormonal and nervous systems. \r\nIn humans there are thirteen vitamins, divided into two groups.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "910", "Trade_Name": "ACICONE 720MG 24 CHEWABLE TAB.", "Generic_Name": "MAGALDRATE", "Price": "6.5", "Price_Old": "6.5", "Company": "MUP", "Pharmacology": "ANTACID", "Category": "حمو#_ة #.لم#>#~ة", "Use": "–#.لق#^حة #.لم#>#~ية و#~#.ء #.لجز#^ #.لم#>#~ي #.لم#^يئي. \r\n\r\n–#.لأ#>#^#.#_ #.لن#.#?جة #>ن وجو#~ غ#.ز#.#?، و#.ن#?#<#.خ #.ل#%#-ن، #%#.لجه#.ز #.له#_مي. \r\n\r\n–#?خ#<ي#< #=ل#.ً من ق#^حة #.ل#<ؤ#.#~، حمو#_ة #.لم#>#~ة، و#>س#^ #.له#_م #.لحم#_ي.", "Contraindications": "–#<#^#- #.لحس#.سية من #.لم#=ون#.#?. \r\n\r\n–#.#_#-#^#.#%#.#? ه#_مية مثل #.لغثي#.ن، و#.لميل #.لمس#?م#^ للقيء.", "GI": "About Magaldrate\r\nChemical complex of aluminum and magnesium hydroxides, Antacid.\r\n\r\nMechanism of Action of Magaldrate\r\nThis neutralizes the gastric acid and increases the gastric pH. This reduces the direct acid irritant effect. It also enhances mucosal barrier integrity and improves gastroesophageal sphincter tone.\r\n\r\nIndications for Magaldrate\r\n1. Peptic ulcer \r\n2. Gastritis \r\n3. Reflux oesophagitis \r\n4. Gastric hyperacidity", "Composition": "magaldrate 540mg or 720mg", "Route": "ORAL.SOLID" }, { "ID": "911", "Trade_Name": "MONTELAIR 4MG 20 CHEWABLE TAB.", "Generic_Name": "MONTELUKAST", "Price": "56", "Price_Old": "56", "Company": "JEDCO INT. CO. FOR PHARMACEUTICALS", "Pharmacology": "ASTHMA.ANTI-INFLAMMATORY.LEUKOTRIENE ANTAGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–من#> نو#%#.#? #.ل#^#%و ل#~ى #.ل#%#.لغين و#.لأ#-#<#.ل #.لذين أ#>م#.#^هم 12 شه#^#.ً. \r\n\r\n–من#> #?شنج #.لقص#%#.#? أو #.ل#^#%و إث#^ مم#.#^سة #.لنش#.#- #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 سنو#.#? أو أ#=#%#^. \r\n\r\n–#>ل#.ج أ#>#^#.#_ #.لحس#.سية #>لى م#~#.#^ #.لسنة (#.لم#>م#^ة) #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 أشه#^ وأ#=#%#^.", "Contraindications": "–يمن#> نه#.ئي #<ي #<#?#^ة #.لحمل حيث يؤ#~ي إلى #?شوه #.لجنين. \r\n\r\n–ي#=ون من #.لأ#<#_ل #>#~م #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة \r\n\r\n–#<#^#- #.لحس#.سية للم#=ون#.#?.", "GI": "About Montelukast\r\nLeukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma.\r\n\r\nMechanism of Action of Montelukast\r\nMontelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. \r\n\r\nIndications for Montelukast\r\nAsthma.\r\nInteractions for Montelukast\r\nBarbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.", "Composition": "montelukast 4mg", "Route": "ORAL.SOLID" }, { "ID": "912", "Trade_Name": "KOKAST 4MG 7 CHEWABLE TAB.", "Generic_Name": "MONTELUKAST", "Price": "21.6", "Price_Old": "21.6", "Company": "EGYPHAR", "Pharmacology": "ASTHMA.ANTI-INFLAMMATORY.LEUKOTRIENE ANTAGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–من#> نو#%#.#? #.ل#^#%و ل#~ى #.ل#%#.لغين و#.لأ#-#<#.ل #.لذين أ#>م#.#^هم 12 شه#^#.ً. \r\n\r\n–من#> #?شنج #.لقص#%#.#? أو #.ل#^#%و إث#^ مم#.#^سة #.لنش#.#- #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 سنو#.#? أو أ#=#%#^. \r\n\r\n–#>ل#.ج أ#>#^#.#_ #.لحس#.سية #>لى م#~#.#^ #.لسنة (#.لم#>م#^ة) #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 أشه#^ وأ#=#%#^.", "Contraindications": "–يمن#> نه#.ئي #<ي #<#?#^ة #.لحمل حيث يؤ#~ي إلى #?شوه #.لجنين. \r\n\r\n–ي#=ون من #.لأ#<#_ل #>#~م #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة \r\n\r\n–#<#^#- #.لحس#.سية للم#=ون#.#?.", "GI": "About Montelukast\r\nLeukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma.\r\n\r\nMechanism of Action of Montelukast\r\nMontelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. \r\n\r\nIndications for Montelukast\r\nAsthma.\r\nInteractions for Montelukast\r\nBarbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.", "Composition": "Composition: Each tablet contains\r\nMontelukast 4 mg", "Route": "ORAL.SOLID" }, { "ID": "913", "Trade_Name": "RIOPAN 800MG 20 CHEWABLE TAB.", "Generic_Name": "MAGALDRATE", "Price": "33.6", "Price_Old": "33.6", "Company": "NYCOMED > AUG PHARMA", "Pharmacology": "ANTACID", "Category": "حمو#_ة #.لم#>#~ة", "Use": "–#.لق#^حة #.لم#>#~ية و#~#.ء #.لجز#^ #.لم#>#~ي #.لم#^يئي. \r\n\r\n–#.لأ#>#^#.#_ #.لن#.#?جة #>ن وجو#~ غ#.ز#.#?، و#.ن#?#<#.خ #.ل#%#-ن، #%#.لجه#.ز #.له#_مي. \r\n\r\n–#?خ#<ي#< #=ل#.ً من ق#^حة #.ل#<ؤ#.#~، حمو#_ة #.لم#>#~ة، و#>س#^ #.له#_م #.لحم#_ي.", "Contraindications": "–#<#^#- #.لحس#.سية من #.لم#=ون#.#?. \r\n\r\n–#.#_#-#^#.#%#.#? ه#_مية مثل #.لغثي#.ن، و#.لميل #.لمس#?م#^ للقيء.", "GI": "About Magaldrate\r\nChemical complex of aluminum and magnesium hydroxides, Antacid.\r\n\r\nMechanism of Action of Magaldrate\r\nThis neutralizes the gastric acid and increases the gastric pH. This reduces the direct acid irritant effect. It also enhances mucosal barrier integrity and improves gastroesophageal sphincter tone.\r\n\r\nIndications for Magaldrate\r\n1. Peptic ulcer \r\n2. Gastritis \r\n3. Reflux oesophagitis \r\n4. Gastric hyperacidity", "Composition": "magaldrate 1600mg or 800mg", "Route": "ORAL.SOLID" }, { "ID": "914", "Trade_Name": "SINGULAIR 4MG PED. 14 CHEWABLE TABS.", "Generic_Name": "MONTELUKAST", "Price": "75", "Price_Old": "75", "Company": "MERCK SHARP & DOHME", "Pharmacology": "ASTHMA.ANTI-INFLAMMATORY.LEUKOTRIENE ANTAGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–من#> نو#%#.#? #.ل#^#%و ل#~ى #.ل#%#.لغين و#.لأ#-#<#.ل #.لذين أ#>م#.#^هم 12 شه#^#.ً. \r\n\r\n–من#> #?شنج #.لقص#%#.#? أو #.ل#^#%و إث#^ مم#.#^سة #.لنش#.#- #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 سنو#.#? أو أ#=#%#^. \r\n\r\n–#>ل#.ج أ#>#^#.#_ #.لحس#.سية #>لى م#~#.#^ #.لسنة (#.لم#>م#^ة) #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 أشه#^ وأ#=#%#^.", "Contraindications": "–يمن#> نه#.ئي #<ي #<#?#^ة #.لحمل حيث يؤ#~ي إلى #?شوه #.لجنين. \r\n\r\n–ي#=ون من #.لأ#<#_ل #>#~م #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة \r\n\r\n–#<#^#- #.لحس#.سية للم#=ون#.#?.", "GI": "About Montelukast\r\nLeukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma.\r\n\r\nMechanism of Action of Montelukast\r\nMontelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. \r\n\r\nIndications for Montelukast\r\nAsthma.\r\nInteractions for Montelukast\r\nBarbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.", "Composition": "montelukast 10mg or 4.2mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "915", "Trade_Name": "MONTELOSAB 4 MG 7 CHEWABLE TAB.", "Generic_Name": "MONTELUKAST", "Price": "8.5", "Price_Old": "8.5", "Company": "SABAA", "Pharmacology": "ASTHMA.ANTI-INFLAMMATORY.LEUKOTRIENE ANTAGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–من#> نو#%#.#? #.ل#^#%و ل#~ى #.ل#%#.لغين و#.لأ#-#<#.ل #.لذين أ#>م#.#^هم 12 شه#^#.ً. \r\n\r\n–من#> #?شنج #.لقص#%#.#? أو #.ل#^#%و إث#^ مم#.#^سة #.لنش#.#- #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 سنو#.#? أو أ#=#%#^. \r\n\r\n–#>ل#.ج أ#>#^#.#_ #.لحس#.سية #>لى م#~#.#^ #.لسنة (#.لم#>م#^ة) #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 أشه#^ وأ#=#%#^.", "Contraindications": "–يمن#> نه#.ئي #<ي #<#?#^ة #.لحمل حيث يؤ#~ي إلى #?شوه #.لجنين. \r\n\r\n–ي#=ون من #.لأ#<#_ل #>#~م #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة \r\n\r\n–#<#^#- #.لحس#.سية للم#=ون#.#?.", "GI": "About Montelukast\r\nLeukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma.\r\n\r\nMechanism of Action of Montelukast\r\nMontelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. \r\n\r\nIndications for Montelukast\r\nAsthma.\r\nInteractions for Montelukast\r\nBarbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "916", "Trade_Name": "CLEAR AIR 4MG 14 CHEWABLE TAB.", "Generic_Name": "MONTELUKAST", "Price": "42", "Price_Old": "42", "Company": "AMOUN", "Pharmacology": "ASTHMA.ANTI-INFLAMMATORY.LEUKOTRIENE ANTAGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–من#> نو#%#.#? #.ل#^#%و ل#~ى #.ل#%#.لغين و#.لأ#-#<#.ل #.لذين أ#>م#.#^هم 12 شه#^#.ً. \r\n\r\n–من#> #?شنج #.لقص#%#.#? أو #.ل#^#%و إث#^ مم#.#^سة #.لنش#.#- #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 سنو#.#? أو أ#=#%#^. \r\n\r\n–#>ل#.ج أ#>#^#.#_ #.لحس#.سية #>لى م#~#.#^ #.لسنة (#.لم#>م#^ة) #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 أشه#^ وأ#=#%#^.", "Contraindications": "–يمن#> نه#.ئي #<ي #<#?#^ة #.لحمل حيث يؤ#~ي إلى #?شوه #.لجنين. \r\n\r\n–ي#=ون من #.لأ#<#_ل #>#~م #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة \r\n\r\n–#<#^#- #.لحس#.سية للم#=ون#.#?.", "GI": "About Montelukast\r\nLeukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma.\r\n\r\nMechanism of Action of Montelukast\r\nMontelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. \r\n\r\nIndications for Montelukast\r\nAsthma.\r\nInteractions for Montelukast\r\nBarbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.", "Composition": "Clear air* 10 mg tablets: Montelukast sodium 10 mg\r\nClear air 5 mg chewable tablets: Montelukast sodium 5 mg\r\nClear air 4 mg chewable tablets: Montelukast sodium 4 mg\r\nClear air sachets: Montelukast sodium 4 mg oral granules", "Route": "ORAL.SOLID" }, { "ID": "917", "Trade_Name": "SEDOKAST 4MG 7 CHEWABLE TABS.", "Generic_Name": "MONTELUKAST", "Price": "11", "Price_Old": "11", "Company": "SEDICO", "Pharmacology": "ASTHMA.ANTI-INFLAMMATORY.LEUKOTRIENE ANTAGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–من#> نو#%#.#? #.ل#^#%و ل#~ى #.ل#%#.لغين و#.لأ#-#<#.ل #.لذين أ#>م#.#^هم 12 شه#^#.ً. \r\n\r\n–من#> #?شنج #.لقص#%#.#? أو #.ل#^#%و إث#^ مم#.#^سة #.لنش#.#- #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 سنو#.#? أو أ#=#%#^. \r\n\r\n–#>ل#.ج أ#>#^#.#_ #.لحس#.سية #>لى م#~#.#^ #.لسنة (#.لم#>م#^ة) #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 أشه#^ وأ#=#%#^.", "Contraindications": "–يمن#> نه#.ئي #<ي #<#?#^ة #.لحمل حيث يؤ#~ي إلى #?شوه #.لجنين. \r\n\r\n–ي#=ون من #.لأ#<#_ل #>#~م #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة \r\n\r\n–#<#^#- #.لحس#.سية للم#=ون#.#?.", "GI": "About Montelukast\r\nLeukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma.\r\n\r\nMechanism of Action of Montelukast\r\nMontelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. \r\n\r\nIndications for Montelukast\r\nAsthma.\r\nInteractions for Montelukast\r\nBarbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.", "Composition": "- Each chewable tablet contains:\r\nMontelukast sodium 4.2 mg\r\n(Equivalent to Montelukast 4 mg)\r\n\r\n- Each film- coated tablet contains:\r\nMontelukast sodium 10.4 mg\r\n(equivalent to montelukast 10 mg)", "Route": "ORAL.SOLID" }, { "ID": "918", "Trade_Name": "ACICONE-S 24 CHEWABLE TAB.", "Generic_Name": "MAGALDRATE+SIMETHICONE", "Price": "6.5", "Price_Old": "6.5", "Company": "MUP", "Pharmacology": "ANTACID", "Category": "حمو#_ة #.لم#>#~ة", "Use": "–#?خ#<ي#< س#^ي#> و#>ل#.ج لل#.#>#^#.#_ #.لمص#.ح#%ة لح#.ل#.#? ح#^ق#.ن #<م #.لم#>#~ة. \r\n\r\n–إ#_#-#^#.#%#.#? #.له#_م #.لمص#.ح#%ة #%#.لإن#?#<#.خ وآل#.م #.لم#>#~ة. \r\n\r\n–يس#?خ#~م أسي#=ون إس #<ى #>ل#.ج آل#.م #.لحمو#_ة #.ل#>#.لية #.لمص#.ح#%ة لق#^حة #.لم#>#~ة (peptic ulcer) و#.لإثنى #>ش#^ و#=ذل#= #.ل#?ه#.#%#.#? #.لم#>#~ة و#.لم#^يء و#<#?#.ق #.لحج#.#% #.لح#.جز. \r\n\r\n–إن#?#<#.خ م#. #%#>#~ #.ل#>ملي#.#? #.لج#^#.حية. \r\n\r\n–للوق#.ية من م#_#.#>#<#.#? ق#^حة #.لم#>#~ة (peptic ulcer) و#.لإثنى #>ش#^.", "Contraindications": "–يمن#> للم#^#_ى #.لذين ي#>#.نون من #.لقصو#^ #.لش#~ي#~ #<ى و ظ#.ئ#< #.ل#=لى . \r\n\r\n–يمن#> لل#.شخ#.ص #.لذين ي#>#.نون من #<#^#- #.لحس#.سية ل#.ح#~ى م#=ون#.#? #.ل#~و#.ء #.و #.ى م#=ون #.خ#^ من م#=ون#.#? #.ل#~و#.ء . \r\n\r\n–#.لحمل : ل#. ي#<#_ل إس#?خ#~#.مه أثن#.ء #.لحمل . \r\n\r\n–#.ل#^#_#.#>ة : ل#. ي#<#_ل إس#?خ#~#.مه أثن#.ء #.ل#^#_#.#>ة . \r\n\r\n–ق#~ ي#?#<#.#>ل م#> #.لأ#~وية و #.لمن#?ج#.#? #.ل#?#.لية: \r\n\r\n–Chlorpromazine \r\n\r\n–Dicumarol \r\n\r\n–Digoxin \r\n\r\n–H2-antagonists \r\n\r\n–Indomethacin \r\n\r\n–Iron salts", "GI": "About Magaldrate\r\nChemical complex of aluminum and magnesium hydroxides, Antacid.\r\nMechanism of Action of Magaldrate\r\nThis neutralizes the gastric acid and increases the gastric pH. This reduces the direct acid irritant effect. It also enhances mucosal barrier integrity and improves gastroesophageal sphincter tone.\r\n\r\nSimethicone\r\nAbout Simethicone\r\nOral anti-foaming agent, Silicones, Antiflatulent.\r\nMechanism of Action of Simethicone\r\nThis anti-gas (anti-flatulence) medication acts in the stomach and intestines to change the surface tension of gas bubbles, enabling smaller bubbles to join together into bigger bubbles. It results elimination of gas more easily by belching or passing flatus.", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "919", "Trade_Name": "DELMONKAST 5MG 14 CHEWABLE TABS.", "Generic_Name": "MONTELUKAST", "Price": "38.4", "Price_Old": "38.4", "Company": "DELTA PHARMA", "Pharmacology": "ASTHMA.ANTI-INFLAMMATORY.LEUKOTRIENE ANTAGONIST", "Category": "#.ل#^#%و و مش#.#=ل #.ل#?ن#<س", "Use": "–من#> نو#%#.#? #.ل#^#%و ل#~ى #.ل#%#.لغين و#.لأ#-#<#.ل #.لذين أ#>م#.#^هم 12 شه#^#.ً. \r\n\r\n–من#> #?شنج #.لقص#%#.#? أو #.ل#^#%و إث#^ مم#.#^سة #.لنش#.#- #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 سنو#.#? أو أ#=#%#^. \r\n\r\n–#>ل#.ج أ#>#^#.#_ #.لحس#.سية #>لى م#~#.#^ #.لسنة (#.لم#>م#^ة) #<ي #.ل#%#.لغين و#.لأ#-#<#.ل #%#>م#^ 6 أشه#^ وأ#=#%#^.", "Contraindications": "–يمن#> نه#.ئي #<ي #<#?#^ة #.لحمل حيث يؤ#~ي إلى #?شوه #.لجنين. \r\n\r\n–ي#=ون من #.لأ#<#_ل #>#~م #?ن#.وله #<ي #<#?#^ة #.ل#^#_#.#>ة \r\n\r\n–#<#^#- #.لحس#.سية للم#=ون#.#?.", "GI": "About Montelukast\r\nLeukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma.\r\n\r\nMechanism of Action of Montelukast\r\nMontelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. \r\n\r\nIndications for Montelukast\r\nAsthma.\r\nInteractions for Montelukast\r\nBarbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.", "Composition": "montelukast 10mg or 5mg", "Route": "ORAL.SOLID" }, { "ID": "920", "Trade_Name": "ALUCAL PLUS 20 CHEW. TAB.", "Generic_Name": "DIHYDROXYALUMINUM SODIUM CARBONATE+SIMETHICONE", "Price": "4.5", "Price_Old": "4.5", "Company": "AMRIYA", "Pharmacology": "ANTACID", "Category": "حمو#_ة #.لم#>#~ة", "Use": "–م#_#.#~ للحمو#_ة و #.لح#^ق#.ن #.لذى يصي#% #.لم#>#~ة و #.لجه#.ز #.له#_مى . \r\n\r\n–#>ل#.ج ح#.ل#.#? إ#^#?ج#.#> #.لم#^ئ . \r\n\r\n–م#_#.#~ للإن#?#<#.خ#.#? و #.ل#?قلص#.#? .", "Contraindications": "–#<#^#- #.لحس#.سية لأي من #.لم#=ون#.#?.. \r\n\r\n–ق#~ يزي#~ أو يقل م#>#~ل و/أو م#~ى #.م#?ص#.ص #%#>#_ #.ل#.#~وية #>ن#~ #?ن#.وله#. مص#.ح#%ة #.لم#_#.#~#.#? #.لحمو#_ة لذل#= يج#% #?جن#% #.س#?#>م#.ل أي أ#~وية خل#.ل س#.#>ة أو س#.#>#?ين من #?ن#.ول م#_#.#~#.#? #.لحمو#_ة. \r\n\r\n–يج#% #.س#?#>م#.ل م#_#.#~#.#? #.لحمو#_ة #.لمح#?وية #>لى #.لألومنيوم #%حذ#^ و#?ح#? #.ش#^#.#< #-#%ي م#> #.لم#^#_ى ذوي #.لخلل #<ي وظ#.ئ#< #.ل#=لى.", "GI": "Treating acid indigestion, heartburn, and sour stomach. It may also be used for other conditions as determined by your doctor.\r\n\r\nDihydroxyaluminum sodium chewable tablets is an antacid. It works by neutralizing acid in the stomach.", "Composition": "dihydroxyaluminium carbonate 320mg", "Route": "ORAL.SOLID" }, { "ID": "921", "Trade_Name": "FEROSE-F 30 CHEWABLE TAB.", "Generic_Name": "FOLIC ACID+IRON", "Price": "42", "Price_Old": "28", "Company": "SPIMACO > EIMC", "Pharmacology": "ANEMIA.IRON SUPPLEMENT COMBINED WITH FOLIC ACID", "Category": "م#=مل غذ#.ئي ل #.ل#.نيمي#. و #<ق#^ #.ل#~م م#> حم#_ #.ل#<ولي#=", "Use": "–ي#>#.لج نقص #.لح#~ي#~ وحم#_ #.ل#<ولي#=.\r\n\r\n–للوق#.ية #.و #>ل#.ج نقص #.لح#~ي#~ وحم#_ #.ل#<ولي#= خل#.ل #.لحمل #.و أثن#.ء #.ل#^#_#.#>ة.\r\n\r\n–#.لح#~ي#~ يس#?#>مل #<ي #>ل#.ج #.نمي#. نقص #.لح#~ي#~.", "Contraindications": "–يمن#> #<ي ح#.ل#.#? #.لحس#.سية لأي من م#=ون#.#? #.ل#>ق#.#^\r\n\r\n–يمن#> #<ي ح#.ل#.#? زي#.#~ة نس#%ة #.لح#~ي#~ #~#.خل #.لجسم ق#%ل #.ل#.س#?خ#~#.م\r\n\r\n–يمن#> #<ي ح#.ل#.#? #<ق#^ #.ل#~م", "GI": "About Folic Acid\r\nDietary supplement, Folate derivative( B9 ), Water Soluble Vitamin.\r\nMechanism of Action of Folic Acid\r\nFolic acid reduced by enzymes folate reductase and dihydrofolate reductase and forms dihydrofolic acid tetrahydrofolic acid respectively. Tetrahydrofolic acid acts as a coenzyme which mediates a number of one carbon transfer reactions by carrying a methyl group as an adduct. It involves a number of reactions such as 1).conversion of homocysteine to methionine. 2).synthesis of thymidylate which is an essential constituent of DNA from methylene-tetrahydrofolic acid. 3). Conversion of serine to glycine by tetrahydrofolic acid and forms methylene-tetrahydrofolic acid. 4).to introduce carbon units at position 2 and 8 during de novo purine synthesis requires formyl-tetrahydrofolic acid and methenyl-tetrahydrofolic acid.5).generation and utilization of \\\"formate pool\\\". 6).For mediating formino group transfer in histidine metabolism. Folic acid is required to maintain normal", "Composition": "COMING SOON ..", "Route": "ORAL.SOLID" }, { "ID": "922", "Trade_Name": "PEPTOFAM 10MG 20 CHEWABLE TAB.", "Generic_Name": "FAMOTIDINE", "Price": "15", "Price_Old": "15", "Company": "ARAB CAPS", "Pharmacology": "PEPTIC ULCER.ANTI-HISTAMINE.H2 ANTAGONIST", "Category": "م#_#.#~ للق#^حة #.له#_مية م#> م#_#.#~ للهيس#?#.مين م#> م#_#.#~ ل#>س#^ #.له#_م", "Use": "–#>ل#.ج #>س#^ #.له#_م. \r\n\r\n–يُس#?#>مل #<ي #?خ#<ي#< #.لآل#.م #.لن#.#?جة #>ن #.ل#?ه#.#%#.#? #.لم#^#.#^ة. \r\n\r\n–يُس#?#>مل #<ي #>ل#.ج ح#^قة #.لم#>#~ة و#.لأم#>#.ء. \r\n\r\n–ق#^حة #.لم#>#~ة. \r\n\r\n–يُ#>#.لج #.ل#.#^#?ج#.#> #.لم#^ئي #.لن#.#?ج #>ن #.ل#?ه#.#% #.لم#^يء. \r\n\r\n–ح#^ق#.ن #.لإثنى #>ش#^. \r\n\r\n–يوص#< #<ي #>ل#.ج مل#.#?زمة زولنغ#^ “زولينج#^” \r\n\r\n– أليسون", "Contraindications": "–يُمن#> #.س#?#>م#.ل #.ل#~و#.ء م#> #.لم#^#_ى #.لذين ل#~يهم #<#^#- #.لحس#.سية لأح#~ م#=ون#.#? #.ل#~و#.ء أو #.لم#.#~ة #.ل#<#>#.لة لل#~و#.ء أو م#^#_ى #?لي#< #.ل#=#%#~.", "GI": "About Famotidine\r\nGuanidine:Thiazole derivative,a histamine H2-receptor antagonist, Anti-secretory,Antiulcer.\r\n\r\nMechanism of Action of Famotidine\r\nFamotidine is a H2 (Histamine) receptor antagonist. Histamine is the most potent stimulus of acid secretion and acts as the common mediator. H2 receptor is a G-protein coupled receptor. It induces adenylate cyclase which converts ATP to cyclic AMP. This cyclic AMP acts on proton pump and exchange extracellular potassium ion for intracellular hydrogen ion across the parietal cell membrane. Famotidine reversibly competes with Histamine for binding to H2 receptors on the parietal cells and predominantly inhibits basal acid secretion. \r\nAnaesthetic adjuncts: It is used in patients undergoing prolonged operations, caesarian section- obese patients are at increased risk of gastric regurgitation and aspiration pneumonia. It raises pH of gastric juice and also reduces its volume and thus